
<html lang="en"     class="pb-page"  data-request-id="2b488ae9-d2e8-41ec-849d-f341bd739220"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;article:article:10.1021/acs.jmedchem.8b00961;ctype:string:Journal Content;wgroup:string:ACHS website Group;issue:issue:10.1021/jmcmar.2019.62.issue-3;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Overview of the Development of Glutaminase Inhibitors: Achievements and Future Directions" /></meta><meta name="dc.Creator" content="Xi  Xu" /></meta><meta name="dc.Creator" content="Ying  Meng" /></meta><meta name="dc.Creator" content="Lei  Li" /></meta><meta name="dc.Creator" content="Pengfei  Xu" /></meta><meta name="dc.Creator" content="Jubo  Wang" /></meta><meta name="dc.Creator" content="Zhiyu  Li" /></meta><meta name="dc.Creator" content="Jinlei  Bian" /></meta><meta name="dc.Description" content="It has been demonstrated that glutamine metabolism has become the main energy and building blocks supply for the growth and viability of a potentially large subset of malignant tumors. The glutamin..." /></meta><meta name="Description" content="It has been demonstrated that glutamine metabolism has become the main energy and building blocks supply for the growth and viability of a potentially large subset of malignant tumors. The glutamin..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="August 27, 2018" /></meta><meta name="dc.Type" content="review-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.8b00961" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright © 2018 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.8b00961" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.8b00961" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.8b00961" /></link>
        
    
    

<title>Overview of the Development of Glutaminase Inhibitors: Achievements and Future Directions | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.8b00961" /></meta><meta property="og:title" content="Overview of the Development of Glutaminase Inhibitors: Achievements and Future Directions" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b00961/20190211/images/large/jm-2018-009616_0020.jpeg" /></meta><meta property="og:description" content="It has been demonstrated that glutamine metabolism has become the main energy and building blocks supply for the growth and viability of a potentially large subset of malignant tumors. The glutamine metabolism often depends upon mitochondrial glutaminase (GLS) activity, which converts glutamine to glutamate and serves as a significant role for bioenergetic processes. Thus, recently, the GLS has become a key target for small molecule therapeutic intervention. Numerous medicinal chemistry studies are currently aimed at the design of novel and potent inhibitors for GLS, however, to date, only one compound (named CB-839) have entered clinical trials for the treatment of advanced solid tumors and hematological malignancies. The perspective summarizes the progress in the discovery and development of GLS inhibitors, including the potential binding site, biochemical techniques for inhibitor identification, and approaches for identifying small-molecule inhibitors, as well as future therapeutic perspectives in glutamine metabolism are also put forward in order to provide reference and rational for the drug discovery of novel and potent glutamine metabolism modulators." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.8b00961"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.8b00961">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-14/achre4.2021.54.issue-14/20210720/achre4.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-29/aamick.2021.13.issue-29/20210728/aamick.2021.13.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-14/acncdm.2021.12.issue-14/20210721/acncdm.2021.12.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-7/amlcef.2021.3.issue-7/20210705/amlcef.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-29/acsodf.2021.6.issue-29/20210727/acsodf.2021.6.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-29/ascecg.2021.9.issue-29/20210726/ascecg.2021.9.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-29/ancham.2021.93.issue-29/20210727/ancham.2021.93.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-29/bichaw.2021.60.issue-29/20210727/bichaw.2021.60.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-27/cgeabj.2021.99.issue-27/20210726-01/cgeabj.2021.99.issue-27.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-7/cgdefu.2021.21.issue-7/20210707/cgdefu.2021.21.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-14/esthag.2021.55.issue-14/20210720/esthag.2021.55.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-29/iecred.2021.60.issue-29/20210728/iecred.2021.60.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-14/inocaj.2021.60.issue-14/20210719/inocaj.2021.60.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-29/jafcau.2021.69.issue-29/20210728/jafcau.2021.69.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-29/jacsat.2021.143.issue-29/20210728/jacsat.2021.143.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-7/jamsef.2021.32.issue-7/20210707/jamsef.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-29/langd5.2021.37.issue-29/20210727/langd5.2021.37.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-7/mpohbp.2021.18.issue-7/20210705/mpohbp.2021.18.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.8b00961&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.8b00961&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.8b00961&amp;href=/doi/10.1021/acs.jmedchem.8b00961" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2019</span><span class="cit-fg-volume">, 62</span><span class="cit-fg-issue">, 3</span><span class="cit-fg-pageRange">, 1096-1115</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/62/3" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.8b00888" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Perspective</span><a href="/doi/10.1021/acs.jmedchem.8b01048" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Overview of the Development of Glutaminase Inhibitors: Achievements and Future Directions</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Xi Xu</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Xi Xu</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Medicinal Chemistry, China Pharmaceutical University, 24 Tongjiaxiang, Nanjing 210009, P. R. China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Xi++Xu">Xi Xu</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath1">View Biography</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Ying Meng</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Ying Meng</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Medicinal Chemistry, China Pharmaceutical University, 24 Tongjiaxiang, Nanjing 210009, P. R. China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Ying++Meng">Ying Meng</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath2">View Biography</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Lei Li</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Lei Li</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Medicinal Chemistry, China Pharmaceutical University, 24 Tongjiaxiang, Nanjing 210009, P. R. China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Lei++Li">Lei Li</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath3">View Biography</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Pengfei Xu</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Pengfei Xu</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Medicinal Chemistry, China Pharmaceutical University, 24 Tongjiaxiang, Nanjing 210009, P. R. China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Pengfei++Xu">Pengfei Xu</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath4">View Biography</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Jubo Wang</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jubo Wang</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Medicinal Chemistry, China Pharmaceutical University, 24 Tongjiaxiang, Nanjing 210009, P. R. China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jubo++Wang">Jubo Wang</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath5">View Biography</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Zhiyu Li</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Zhiyu Li</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Medicinal Chemistry, China Pharmaceutical University, 24 Tongjiaxiang, Nanjing 210009, P. R. China</div><div class="loa-info-affiliations-info">Jiangsu Key Laboratory of Drug Design and Optimization, China Pharmaceutical University, Nanjing 21009, P. R. China</div></div><span class="conrtib-corresp"><strong>*</strong>For Z.L.: phone, +86 13951678592; E-mail, <a href="/cdn-cgi/l/email-protection#7a001213030f16133a190a0f541f1e0f541914"><span class="__cf_email__" data-cfemail="b3c9dbdacac6dfdaf3d0c3c69dd6d7c69dd0dd">[email protected]</span></a></span><span class="conrtib-corresp"></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Zhiyu++Li">Zhiyu Li</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath6">View Biography</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-6492-9511" title="Orcid link">http://orcid.org/0000-0001-6492-9511</a></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Jinlei Bian</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jinlei Bian</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Medicinal Chemistry, China Pharmaceutical University, 24 Tongjiaxiang, Nanjing 210009, P. R. China</div><div class="loa-info-affiliations-info">Jiangsu Key Laboratory of Drug Design and Optimization, China Pharmaceutical University, Nanjing 21009, P. R. China</div></div><span class="conrtib-corresp"><strong>*</strong>For J.B.: phone, +8615151865295; E-mail, <a href="/cdn-cgi/l/email-protection#e7858e86898d8ba7849792c9828392c98489"><span class="__cf_email__" data-cfemail="ccaea5ada2a6a08cafbcb9e2a9a8b9e2afa2">[email protected]</span></a></span><span class="conrtib-corresp"></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jinlei++Bian">Jinlei Bian</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath7">View Biography</a></span></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.8b00961&amp;href=/doi/10.1021%2Facs.jmedchem.8b00961" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2019</span></span><span class="cit-volume">, 62</span><span class="cit-issue">, 3</span><span class="cit-pageRange">, 1096–1115</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">August 27, 2018</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>15 June 2018</li><li><span class="item_label"><b>Published</b> online</span>27 August 2018</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 14 February 2019</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.8b00961" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b00961</a></div><div class="article_header-article-copyright"><strong>Copyright © 2018 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D1096%26pageCount%3D20%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DXi%2BXu%252C%2BYing%2BMeng%252C%2BLei%2BLi%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D62%26issueNum%3D3%26contentID%3Dacs.jmedchem.8b00961%26title%3DOverview%2Bof%2Bthe%2BDevelopment%2Bof%2BGlutaminase%2BInhibitors%253A%2BAchievements%2Band%2BFuture%2BDirections%26numPages%3D20%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D1115%26publicationDate%3DFebruary%2B2019">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.8b00961"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">3360</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">32</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.8b00961" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Overview of the Development of Glutaminase Inhibitors: Achievements and Future Directions&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Xi&quot;,&quot;last_name&quot;:&quot;Xu&quot;},{&quot;first_name&quot;:&quot;Ying&quot;,&quot;last_name&quot;:&quot;Meng&quot;},{&quot;first_name&quot;:&quot;Lei&quot;,&quot;last_name&quot;:&quot;Li&quot;},{&quot;first_name&quot;:&quot;Pengfei&quot;,&quot;last_name&quot;:&quot;Xu&quot;},{&quot;first_name&quot;:&quot;Jubo&quot;,&quot;last_name&quot;:&quot;Wang&quot;},{&quot;first_name&quot;:&quot;Zhiyu&quot;,&quot;last_name&quot;:&quot;Li&quot;},{&quot;first_name&quot;:&quot;Jinlei&quot;,&quot;last_name&quot;:&quot;Bian&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2018&quot;,&quot;month&quot;:&quot;08&quot;,&quot;day&quot;:&quot;27&quot;,&quot;issue&quot;:&quot;3&quot;,&quot;volume&quot;:&quot;62&quot;,&quot;pages&quot;:&quot;1096-1115&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.8b00961&quot;},&quot;abstract&quot;:&quot;It has been demonstrated that glutamine metabolism has become the main energy and building blocks supply for the growth and viability of a potentially large subset of malignant tumors. The glutamine metabolism often depends upon mitochondrial glutaminase (GLS) activity, which converts glutamine to glutamate and serves as a significant role for bioenergetic processes. Thus, recently, the GLS has become a key target for small molecule therapeutic intervention. Numerous medicinal chemistry studies are currently aimed at the design of novel and potent inhibitors for GLS, however, to date, only one compound (named CB-839) have entered clinical trials for the treatment of advanced solid tumors and hematological malignancies. The perspective summarizes the progress in the discovery and development of GLS inhibitors, including the potential binding site, biochemical techniques for inhibitor identification, and approaches for identifying small-molecule inhibitors, as well as future therapeutic perspectives in glutamin&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b00961&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b00961" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b00961&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b00961" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b00961&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b00961" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.8b00961&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b00961&amp;href=/doi/10.1021/acs.jmedchem.8b00961" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.8b00961" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.8b00961" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (9 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b00961&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.8b00961%26sid%3Dliteratum%253Aachs%26pmid%3D30148361%26genre%3Darticle%26aulast%3DXu%26date%3D2019%26atitle%3DOverview%2Bof%2Bthe%2BDevelopment%2Bof%2BGlutaminase%2BInhibitors%253A%2BAchievements%2Band%2BFuture%2BDirections%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D62%26issue%3D3%26spage%3D1096%26epage%3D1115%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=290831" title="Monomers">Monomers</a>,</li><li><a href="/action/doSearch?ConceptID=291350" title="Assays">Assays</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=290896" title="Cells">Cells</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/62/3" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/jmcmar.2019.62.issue-3/20190214/jmcmar.2019.62.issue-3.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b00961/20190211/images/medium/jm-2018-009616_0020.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b00961/20190211/images/large/jm-2018-009616_0020.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00961&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">It has been demonstrated that glutamine metabolism has become the main energy and building blocks supply for the growth and viability of a potentially large subset of malignant tumors. The glutamine metabolism often depends upon mitochondrial glutaminase (GLS) activity, which converts glutamine to glutamate and serves as a significant role for bioenergetic processes. Thus, recently, the GLS has become a key target for small molecule therapeutic intervention. Numerous medicinal chemistry studies are currently aimed at the design of novel and potent inhibitors for GLS, however, to date, only one compound (named <b>CB-839</b>) have entered clinical trials for the treatment of advanced solid tumors and hematological malignancies. The perspective summarizes the progress in the discovery and development of GLS inhibitors, including the potential binding site, biochemical techniques for inhibitor identification, and approaches for identifying small-molecule inhibitors, as well as future therapeutic perspectives in glutamine metabolism are also put forward in order to provide reference and rational for the drug discovery of novel and potent glutamine metabolism modulators.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">1.  Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_76113" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_76113" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec1_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i3" class="anchor-spacer"></div><h3 class="article-section__title" id="_i3">1.1.  An Overview of the Glutamine Metabolic Pathway and Related Catalytic Enzymes</h3><div class="NLM_p">Cancer cells develop extensive reprogramming of cellular energy metabolism.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Tumor cells are different from normal cells in their utilization of glucose which are more likely to convert glucose to lactic acid by glycolysis and transport it out of the cell, even under conditions of sufficient oxygen. This phenomenon was called the Warburg effect which was first proposed nearly a century ago.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> In addition to glucose metabolism, the involvement of glutamine metabolism has attracted attention as a potential hallmark for the development of novel therapeutic drugs for cancer treatment.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> Glutamine (Gln) is the most abundant amino acid in plasma<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> and serves as a significant role in many energy-generating and biosynthesis process for the growth and proliferation of cancer cells by entering the tricarboxylic acid (TCA) cycle.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> Under catabolic stressed conditions, e.g., postoperation, injury, or sepsis, glutamine is dramatically consumed by kidney, gastrointestinal tract, and immune compartment.<a onclick="showRef(event, 'ref116'); return false;" href="javascript:void(0);" class="ref ref116">(116)</a> Studies have demonstrated that the intestinal mucosa cells particularly dependent on glutamine undergo necrosis if glutamine is deprived.<a onclick="showRef(event, 'ref116'); return false;" href="javascript:void(0);" class="ref ref116">(116)</a> Moreover, some growing cancer cells also exhibited highly dependence on glutamine, with rapid dying after glutamine depletion.<a onclick="showRef(event, 'ref117 ref118'); return false;" href="javascript:void(0);" class="ref ref117 ref118">(117,118)</a> This so-called “glutamine addiction” has been well characterized in cancers including glioblastoma (GBM), leukemia, lymphomas, lung, triple-negative breast cancer, and pancreatic cancer.<a onclick="showRef(event, 'ref5 ref6 ref7 ref8 ref9 ref10'); return false;" href="javascript:void(0);" class="ref ref5 ref6 ref7 ref8 ref9 ref10">(5−10)</a> Glutamine enters into cells via transporter or macrocytosis, e.g., the solute carrier family 1 neutral amino acid transporter member 5 (SLC1A5, also known as ASCT2), which is one of transporter proteins.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> After glutamine enters the cell, a significant fraction of it is converted to glutamate (Glu) and ammonia by glutaminase (GLS) in the mitochondria.<a onclick="showRef(event, 'ref12 ref13'); return false;" href="javascript:void(0);" class="ref ref12 ref13">(12,13)</a> Glu is further oxidatively deaminated into α-ketoglutarate (α-KG) through two mechanisms.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> The two mechanism involved two key enzymes, one of which is aminotransferases involved in maintaining the stability of intracellular amino acid pools to provide nonessential amino acids for cell growth.<a onclick="showRef(event, 'ref15 ref16 ref17 ref18'); return false;" href="javascript:void(0);" class="ref ref15 ref16 ref17 ref18">(15−18)</a> The other is glutamate dehydrogenase (GDH), which is widely expressed in the liver and catalyzes the reversible deamination of glutamate to produce α-KG and ammonium at near thermodynamic equilibrium.<a onclick="showRef(event, 'ref14 ref19'); return false;" href="javascript:void(0);" class="ref ref14 ref19">(14,19)</a> This α-KG then enters the tricarboxylic acid (TCA) cycle and involves in the production of nucleotides, ATP, certain amino acids, lipids, and glutathione in mitochondria (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>).<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> Thus, glutamine can fulfill both the energetic and biomass requirements of proliferating cells in this way. Throughout the metabolic pathways, the requirement is met by the overexpression of GLS, which catalyzes the first step in glutamine metabolism and therefore represents a potential therapeutic target.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b00961/20190211/images/medium/jm-2018-009616_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b00961/20190211/images/large/jm-2018-009616_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. An overview of the glutamine metabolic pathway for therapy in cancer. Glutamine is imported via SLC1A5 (also known as ASCT2).<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> Glutamine can also be exchanged for essential amino acids, such as leucine, through the <span class="smallcaps smallerCapital">l</span>-type amino acid transporter 1 (LAT1).<a onclick="showRef(event, 'ref112'); return false;" href="javascript:void(0);" class="ref ref112">(112)</a> Glutamine can also contribute to nucleotide biosynthesis and uridine diphosphate <i>N</i>-acetylglucosamine (UDP-GlcNAc) synthesis for support of protein folding and trafficking.<a onclick="showRef(event, 'ref113'); return false;" href="javascript:void(0);" class="ref ref113">(113)</a> Glutamine is hydrolyzed to glutamate through glutaminase (GLS1/2). Glutamate can be converted to α-ketoglutarate (α-KG) through glutamate dehydrogenase (GDH) or aminotransferases.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> Through the actions of various aminotransferases, e.g., phosphoserine aminotransferase 1 (PSAT1), glutamic pyruvate transaminase (GPT), and glutamic oxaloacetic transaminase (GOT), glutamate derived from glutamine can supply nitrogen atoms for the biosynthesis of amino acids. In addition, glutamine can also directly provide nitrogen for asparagine by asparagine synthetase (ASNS). α-KG enters the tricarboxylic acid (TCA) cycle and can provide energy and building blocks for the growth and proliferation of cell. Modulators that target various aspects of glutamine metabolism are shown in red.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b00961/20190211/images/large/jm-2018-009616_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00961&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec1_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4">1.2.  The First Step in the Glutaminolysis: Phosphate-Activated Glutaminase (GLS)</h3><div class="NLM_p">Glutaminase has been proved to control the first step in the glutaminolysis pathway which has become an intriguing and promising target for the developing antitumor drugs. By now, four informs of human glutaminase have been identified, including kidney-type glutaminase (KGA/GLS1), the splice KGA variant (Glutaminase C or GAC), liver-type glutaminase (LGA/GLS2), and glutaminase B (GAB).<a onclick="showRef(event, 'ref21 ref22'); return false;" href="javascript:void(0);" class="ref ref21 ref22">(21,22)</a> The transcripts of KGA and GAC belong to <i>GLS</i> (<i>GLS1</i>) gene, while LGA and GAB for <i>GLS2</i>. The <i>GLS</i> gene is overexpressed in many tumor cell lines and primary tumors, while <i>GLS2</i> gene is not widely expressed in tumors.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> Treating with efficient GLS1 inhibitor in different tumor models, or by genetic silencing of <i>GLS1</i> have validated GLS1 as a therapeutic target.<a onclick="showRef(event, 'ref26 ref35 ref38 ref114 ref115'); return false;" href="javascript:void(0);" class="ref ref26 ref35 ref38 ref114 ref115">(26,35,38,114,115)</a> Expression of GAC, which is more active than KGA, is increased in a number of cancers, indicating that <i>GLS</i> alternative splicing may have an important role in the presumed higher glutaminolytic flux in cancers.<a onclick="showRef(event, 'ref27 ref28 ref29 ref30 ref31 ref32'); return false;" href="javascript:void(0);" class="ref ref27 ref28 ref29 ref30 ref31 ref32">(27−32)</a> As for GLS2, it showed more complex roles in cancers. Upregulated GLS2 enzymatic activity has also been demonstrated to be related with tumor cell growth in vitro and in vivo recently,<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> although there is controversy over the role of GLS2 as a tumor suppressor.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> The context-dependent role of GLS2 in cancer needs further study and validation. It is worth noting that GLS2 is mainly found in adult liver, while GLS1 is widely expressed throughout extrahepatic tissues, which is considered to be a definite target for tumor suppression.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> In addition, GLS1 has recently been intensively studied, as it has been linked to the progression of various cancers.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> The evaluated activity of GLS1 has been correlated with a number of pathways, such as HIF1α, cMyc, Raf, miRNA23, EGFR, and Ras/MAPK, as well as to the hyperactivation of Rho GTpases.<a onclick="showRef(event, 'ref37 ref38 ref39 ref40 ref41 ref42 ref43'); return false;" href="javascript:void(0);" class="ref ref37 ref38 ref39 ref40 ref41 ref42 ref43">(37−43)</a> Thus, GLS1 would be a potentially more attractive target for inhibiting cancer cell growth compared with GLS2.</div><div class="NLM_p last">To date, there is no compound has been progressed as a potential GLS1 inhibitor from discovery to market. Indeed, most of these modulators are still in need of substantial medicinal chemistry optimization. In this Perspective, we focused on the discovery and development of small molecule modulators targeting glutaminase. In addition, the molecular basis and clinical progress of the representative compounds are also reviewed. Future directions and potential challenges faced in the race to develop new therapeutics in this field are discussed to provide a reference for developing novel glutaminase modulator for the treatment of cancers.</div></div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i5">2.  GLS1 Structural Aspects</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_31261" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_31261" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The two splicing variants KGA and GAC, which derived from <i>GLS1</i> genes, share a common N-terminal sequence (1–550) but contain unique C-terminal regions (551–669 for KGA, 551–598 for GAC).<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> Generally, GLS1 exists as either a dimer or a tetramer. The dimer is inactive while the tetramer showed catalytic activity.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> It has been shown that the dimer to tetramer transition is necessary for the enzymatic activation of GLS1. The activated tetramer could be facilitated in vitro based on the addition of inorganic phosphate or other polyvalent anions and substrate entry to the pocket by competing with the product glutamate.<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> The activity of KGA or GAC is also modulated by several compounds, e.g., glutamate, citrate, calcium, protons, fatty acyl-CoA derivatives, TCA cycle intermediates, and certain long chain fatty acids under physiological conditions.<a onclick="showRef(event, 'ref33 ref119'); return false;" href="javascript:void(0);" class="ref ref33 ref119">(33,119)</a> The acyl-CoA derivatives have dual effects on phosphate-activated GLS with low concentrations activate the enzyme but inhibit at higher concentrations. Generally, acyl-CoA derivatives are more effective inhibitors when the fatty acyl chain is elongated and more effective activators on unsaturation of the fatty acyl group.<a onclick="showRef(event, 'ref119'); return false;" href="javascript:void(0);" class="ref ref119">(119)</a> Recently, the structure of GLS1 has been determined by X-ray crystallography (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>), revealing the presence of four molecules in the asymmetric unit (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>). This quaternary involves two sets of interfaces, and one interface consists of the contacts between monomers <b>a</b> and <b>b</b> and <b>c</b> and <b>d</b>. The other interface is made up of the contacts between monomers <b>a</b> and <b>c</b> and <b>b</b> and <b>d</b>. The first interface buries considerably more surface area than the second interface. The constructs employed for crystallography include the isolated glutaminase catalytic domain of KGA and the entire biologically processed form of the enzyme (refer to GAC, residues 71–598). The Ile221-Leu533 has been considered as the catalytic domain of KGA (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>A). Neither the N- nor C-termini of GLS1 have been resolved up to now. However, the C-terminus has been proved to influence the enzyme function due to GAC has greater catalytic activity than KGA. Recently, structures with substrate glutamine, glutamate, or assorted inhibitors have also been determined (e.g., PDBs <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3UO9">3UO9</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4O7D">4O7D</a>, and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5JYO">5JYO</a>).<a onclick="showRef(event, 'ref47 ref49 ref52'); return false;" href="javascript:void(0);" class="ref ref47 ref49 ref52">(47,49,52)</a> According to the information on these crystal structures, we found that there were different binding sites for ligand occupying to inhibit the enzyme activity of GLS1. Two main pockets which have been confirmed by X-ray crystallography are the substrate binding pocket and the allosteric binding pocket (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>B).</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Summary of the Available Crystal Structures of GLS1 and GLS1–Ligand Complex<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">GLS1 isoform</th><th class="colsep0 rowsep0" align="center">residues used</th><th class="colsep0 rowsep0" align="center">ligand</th><th class="colsep0 rowsep0" align="center">PDB code</th><th class="colsep0 rowsep0" align="center">publication year</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="5" align="left">Apo GLS1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">GAC</td><td class="colsep0 rowsep0" align="center">72–598</td><td class="colsep0 rowsep0" align="center">none</td><td class="colsep0 rowsep0" align="center"><a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5D3O">5D3O</a></td><td class="colsep0 rowsep0" align="center">2015.08.06</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">GLS</td><td class="colsep0 rowsep0" align="center">221–533</td><td class="colsep0 rowsep0" align="center">none</td><td class="colsep0 rowsep0" align="center"><a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3VOY">3VOY</a><a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a></td><td class="colsep0 rowsep0" align="center">2012.02.23</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">GAC (m)<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="center">134–609</td><td class="colsep0 rowsep0" align="center">none</td><td class="colsep0 rowsep0" align="center"><a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3SS3">3SS3</a><a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a></td><td class="colsep0 rowsep0" align="center">2011.07.07</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="5" align="left">GLS1 with Substrates or Phosphate</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">GLS1</td><td class="colsep0 rowsep0" align="center">221–533</td><td class="colsep0 rowsep0" align="center"><span class="smallcaps smallerCapital">l</span>-glutamine</td><td class="colsep0 rowsep0" align="center"><a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3VP0">3VP0</a><a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a></td><td class="colsep0 rowsep0" align="center">2012.02.23</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">GAC (m)<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="center">134–609</td><td class="colsep0 rowsep0" align="center">phosphate</td><td class="colsep0 rowsep0" align="center"><a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3SS4">3SS4</a><a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a></td><td class="colsep0 rowsep0" align="center">2011.07.07</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">GAC (m)<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="center">134–609</td><td class="colsep0 rowsep0" align="center"><span class="smallcaps smallerCapital">l</span>-glutamate</td><td class="colsep0 rowsep0" align="center"><a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3SS5">3SS5</a><a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a></td><td class="colsep0 rowsep0" align="center">2011.07.07</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">GAC</td><td class="colsep0 rowsep0" align="center">71–598</td><td class="colsep0 rowsep0" align="center"><span class="smallcaps smallerCapital">l</span>-glutamate</td><td class="colsep0 rowsep0" align="center"><a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3UNW">3UNW</a><a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a></td><td class="colsep0 rowsep0" align="center">2011.11.16</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">GLS1</td><td class="colsep0 rowsep0" align="center">221–533</td><td class="colsep0 rowsep0" align="center"><span class="smallcaps smallerCapital">l</span>-glutamate</td><td class="colsep0 rowsep0" align="center"><a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3CZD">3CZD</a><a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a></td><td class="colsep0 rowsep0" align="center">2008.04.29</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="5" align="left">GLS1 with Inhibitors</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">GAC</td><td class="colsep0 rowsep0" align="center">60–598</td><td class="colsep0 rowsep0" align="center">UPGL00004</td><td class="colsep0 rowsep0" align="center"><a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5WJ6">5WJ6</a><a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a></td><td class="colsep0 rowsep0" align="center">2017.07.21</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">GLS1</td><td class="colsep0 rowsep0" align="center">139–656</td><td class="colsep0 rowsep0" align="center">BPTES</td><td class="colsep0 rowsep0" align="center"><a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5UQE">5UQE</a></td><td class="colsep0 rowsep0" align="center">2017.02.08</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">GLS1</td><td class="colsep0 rowsep0" align="center">221–533</td><td class="colsep0 rowsep0" align="center">CB-839</td><td class="colsep0 rowsep0" align="center"><a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5JYO">5JYO</a><a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a></td><td class="colsep0 rowsep0" align="center">2016.05.15</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">GLS1</td><td class="colsep0 rowsep0" align="center">221–533</td><td class="colsep0 rowsep0" align="center">trans-CBTBP</td><td class="colsep0 rowsep0" align="center"><a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5JYP">5JYP</a><a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a></td><td class="colsep0 rowsep0" align="center">2016.05.15</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">GAC</td><td class="colsep0 rowsep0" align="center">72–598</td><td class="colsep0 rowsep0" align="center">UPGL_00019</td><td class="colsep0 rowsep0" align="center"><a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5I94">5I94</a><a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a></td><td class="colsep0 rowsep0" align="center">2016.02.19</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">GAC</td><td class="colsep0 rowsep0" align="center">72–598</td><td class="colsep0 rowsep0" align="center">CB-839</td><td class="colsep0 rowsep0" align="center"><a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5HL1">5HL1</a></td><td class="colsep0 rowsep0" align="center">2016.01.14</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">GAC</td><td class="colsep0 rowsep0" align="center">72–598</td><td class="colsep0 rowsep0" align="center">UPGL_00009</td><td class="colsep0 rowsep0" align="center"><a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5FI2">5FI2</a><a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a></td><td class="colsep0 rowsep0" align="center">2015.12.22</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">GAC</td><td class="colsep0 rowsep0" align="center">72–598</td><td class="colsep0 rowsep0" align="center">UPGL_00011</td><td class="colsep0 rowsep0" align="center"><a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5FI6">5FI6</a><a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a></td><td class="colsep0 rowsep0" align="center">2015.12.22</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">GAC</td><td class="colsep0 rowsep0" align="center">72–598</td><td class="colsep0 rowsep0" align="center">UPGL_00015</td><td class="colsep0 rowsep0" align="center"><a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5FI7">5FI7</a><a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a></td><td class="colsep0 rowsep0" align="center">2015.12.22</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">GLS1</td><td class="colsep0 rowsep0" align="center">221–531</td><td class="colsep0 rowsep0" align="center">DON</td><td class="colsep0 rowsep0" align="center"><a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4O7D">4O7D</a><a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a></td><td class="colsep0 rowsep0" align="center">2013.12.24</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">GAC (m)<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="center">128–555</td><td class="colsep0 rowsep0" align="center">BPTES</td><td class="colsep0 rowsep0" align="center"><a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4JKT">4JKT</a><a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a></td><td class="colsep0 rowsep0" align="center">2013.03.11</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">GLS1</td><td class="colsep0 rowsep0" align="center">221–533</td><td class="colsep0 rowsep0" align="center">BPTES</td><td class="colsep0 rowsep0" align="center"><a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3VOZ">3VOZ</a><a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a></td><td class="colsep0 rowsep0" align="center">2012.02.23</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">GLS1</td><td class="colsep0 rowsep0" align="center">221–533</td><td class="colsep0 rowsep0" align="center">BPTES</td><td class="colsep0 rowsep0" align="center"><a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3VP1">3VP1</a><a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a></td><td class="colsep0 rowsep0" align="center">2012.02.23</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">GLS1</td><td class="colsep0 rowsep0" align="center">221–533</td><td class="colsep0 rowsep0" align="center">BPTES derivate 2</td><td class="colsep0 rowsep0" align="center"><a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3VP2">3VP2</a><a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a></td><td class="colsep0 rowsep0" align="center">2012.02.23</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">GLS1</td><td class="colsep0 rowsep0" align="center">221–533</td><td class="colsep0 rowsep0" align="center">BPTES derivate 3</td><td class="colsep0 rowsep0" align="center"><a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3VP3">3VP3</a><a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a></td><td class="colsep0 rowsep0" align="center">2012.02.23</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">GLS1</td><td class="colsep0 rowsep0" align="center">221–533</td><td class="colsep0 rowsep0" align="center">BPTES derivate 4</td><td class="colsep0 rowsep0" align="center"><a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3VP4">3VP4</a><a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a></td><td class="colsep0 rowsep0" align="center">2012.02.23</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">GAC</td><td class="colsep0 rowsep0" align="center">71–598</td><td class="colsep0 rowsep0" align="center">BPTES</td><td class="colsep0 rowsep0" align="center"><a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3UO9">3UO9</a><a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a></td><td class="colsep0 rowsep0" align="center">2011.11.16</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup><sup>a</sup></sup><p class="last">The table is an update and specific classification of the <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a> from Katt et al.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a></p></div><div class="footnote" id="t1fn2"><sup><sup>b</sup></sup><p class="last">m represents mouse.</p></div></div></div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b00961/20190211/images/medium/jm-2018-009616_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b00961/20190211/images/large/jm-2018-009616_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Schematic view and structure of GLS. (A) KGA/GAC domains. (B) Structure and binding sites of GLS1. Allosteric binding pocket is shown in red, and substrate catalytic site is shown in green.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b00961/20190211/images/large/jm-2018-009616_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00961&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i7" class="anchor-spacer"></div><h3 class="article-section__title" id="_i7">2.1.  Substrate Catalytic Site</h3><div class="NLM_p">Until 2008, the structural features of the enzyme were disclosed for the first time by <span class="smallcaps smallerCapital">l</span>-glutamate-bound structure (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3CZD">3CZD</a>).<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> After that, several other crystal structures containing <span class="smallcaps smallerCapital">l</span>-glutamate have also been reported (PDBs <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3UO9">3UO9</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3UNW">3UNW</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3SS5">3SS5</a>, and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3VP1">3VP1</a>). The structure of GLS1 has two domains with the catalytic site located at the interfaces. The domain I consists of Ile221-Pro281 and Cys424-Leu533 of a five-stranded antiparallel β-sheet surrounded by six α-helices and several loops (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>A, marked as orange). The domain II comprises Phe282-Thr423 of seven α-helices (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>A, marked as blue). The active site is highly basic, and the substrate makes several key hydrogen-bonding interactions and hydrophobic interactions with Tyr249, Gln285, Ser286, Asn335, Glu381, Asn388, Tyr414, Tyr466, and Val484 (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>B). The distance between the side chain of glutamate and Ser286 is within hydrogen-bonding range, while other key residues Lys289, Tyr414, and Tyr466 are in the vicinity of the active site. The carbonyl oxygen of the substrate glutamine could form a hydrogen bond with the main chain amino groups of Ser286 and Val484, composing the oxyanion hole.<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> In addition, Lys289 and Tyr466 could form a hydrogen bond with Ser286, while Lys289 acts as a general base for the nucleophilic attack by accepting the proton from Ser286, and Tyr466 is involved in proton transfer during catalysis.</div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b00961/20190211/images/medium/jm-2018-009616_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b00961/20190211/images/large/jm-2018-009616_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Structure and important amino acids of substrate catalytic site and allosteric binding pocket of GLS1. (A) Structure of GLS1 and bound substrate (GLN) is shown as a purple stick. N-Terminal is labeled as N and C-terminal is labeled as C. (B) The key residues of substrate catalytic site and hydrogen bonds with substrate GLN are shown. The hydrogen bonds were shown as dotted lines. (C) The allosteric binding pocket of GLS1. (D) The key residues in the allosteric binding pocket.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b00961/20190211/images/large/jm-2018-009616_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00961&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8">2.2.  Allosteric Binding Pocket</h3><div class="NLM_p">Except for the catalytic site, there is an allosteric pocket in the solvent-exposed region at the dimer interface of GLS1 for the ligand to occupy to inhibit the protein activity. Recently, several crystal structures (PDBs <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3UO9">3UO9</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3VP1">3VP1</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3VOZ">3VOZ</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5JYO">5JYO</a>, and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4JKT">4JKT</a>)<a onclick="showRef(event, 'ref46 ref47 ref49 ref51'); return false;" href="javascript:void(0);" class="ref ref46 ref47 ref49 ref51">(46,47,49,51)</a> have disclosed the allosteric binding pocket, opening the way for structure-based design of GLS1 inhibitors. The allosteric binding pocket located about 18 Å away from the active site Ser286 (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>C). The hydrophobic pocket consists of Phe318, Leu321, Phe322, Leu323, Asn324, Glu325, and Tyr394 from each monomer, and the side chain of Phe322 is found at the bottom of the allosteric pocket (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>D). When the ligand occupies the allosteric pocket, it would interact with loop region comprised of residues 312–329 and interface helix α-13, residues 386–399, triggering a dramatic conformational change of the key loop (Leu316 to Leu320) referred to as the “gating loop or activation loop” near the catalytic site and rendering it inactive.<a onclick="showRef(event, 'ref28 ref51'); return false;" href="javascript:void(0);" class="ref ref28 ref51">(28,51)</a> Therefore, by binding in an allosteric pocket, ligands would inhibit the enzymatic activity through triggering a major conformational change on the key residues which involves in stabilizing the active sites and regulating its enzymatic activity. In sum, a stable inactive tetrameric GLS1 would be formed through occupying the allosteric pocket by small molecule modulators.</div><div class="NLM_p last">Some other binding pockets have also been speculated which could be occupied by small molecules to inhibit the enzyme activity according to molecular modeling and site-directed mutagenesis studies. We present them combined with specific inhibitors in the following sections.</div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i9">3.  Assays to Monitor GLS1Modulation</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_38776" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_38776" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">It is significant to study the assay technology platforms for discovering GLS1 inhibitors due to the potential mechanism of compound action and compound-mediated assay interference. Such knowledge would be helpful for the discovery of efficacious GLS1 inhibitors. Therefore, we will describe currently available assays for the identification and evaluation of GLS1 inhibitors. Basic principles of the different assay types will be included.</div><div id="sec3_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10">3.1.  Enzymatic Assays</h3><div class="NLM_p">Understanding the underlying biochemical principles of GLS1 assays is necessary to interpret apparent compound response. On the basis of the assay readout, certain types of compound-mediated interferences may be enriched while others are negligible. Many parameters can profoundly affect observed compound activity, including buffer composition and reaction time (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>). The mainly principle of enzymatic assays for discovering and evaluating GLS1 inhibitors is the hydrolysis of glutamine to glutamate.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Composition of Enzymatic Assay</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b00961/20190211/images/medium/jm-2018-009616_0016.gif" alt="" id="GRAPHIC-d7e1175-autogenerated" /></img><div></div></div><div id="sec3_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i12" class="anchor-spacer"></div><h4 class="article-section__title" id="_i12">3.1.1.  Glutamine Hydrolysis Assay</h4><div id="sec3_1_1_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i13" class="anchor-spacer"></div><h5 class="article-section__title" id="_i13"> Two-Step Glutaminase Assay.<a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">(53)</a></h5><div class="NLM_p">GLS1 can catalyze the hydrolysis of glutamine to glutamate which can be further converted to α-KG and NADH/NADPH through the oxidative deamination of glutamate dehydrogenase. In the process, hydrazine is used to react with α-KG to form hydrazide in order to completely oxidize the glutamate. The activity of glutaminase can be quantitatively reflected by measuring the absorbance of NADH/NADPH at 340 nm. The disadvantage of the method is the relatively short and unspecific wavelengths at which many other organic compounds absorb (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>). Therefore, as an alternative, a three-step enzyme assay system is used to evaluate the inhibitory activity.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Summary of Glutamine Hydrolysis Assays for Evaluating GLS1 Inhibitors</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b00961/20190211/images/medium/jm-2018-009616_0017.gif" alt="" id="GRAPHIC-d7e1197-autogenerated" /></img><div></div></div></div><div id="sec3_1_1_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i15" class="anchor-spacer"></div><h5 class="article-section__title" id="_i15"> Three-Step Glutaminase Assay.<a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a></h5><div class="NLM_p last">Similar to the two-step glutaminase assay, the method also employed the principle that glutamine can be hydrolyzed to glutamate. First, glutamine is hydrolyzed to glutamate and ammonia. Then, through the oxidation of glutamate oxidase, glutamate is converted to α-KG, ammonia, and hydrogen peroxide (H<sub>2</sub>O<sub>2</sub>). Finally, the H<sub>2</sub>O<sub>2</sub> is reacted with Amplex Red reagent (10-acetyl-3,7-dihydroxyphenoxazine) in a 1:1 stoichiometry in the presence of horseradish peroxidase (HRP) to generate the highly fluorescent product resorufin. On the basis of resorufin fluorescence (excitation at 530–560 nm, emission detection at 590 nm), the inhibition activity of various compounds against glutaminase can be quantitatively measured. The advantage of this method is that the autofluorescence of most biological samples has little interference with the emission fluorescence of resorufin (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>). In addition, to repeat the second-step reaction and amplify the detection signal, <span class="smallcaps smallerCapital">l</span>-alanine and <span class="smallcaps smallerCapital">l</span>-glutamate-pyruvate transaminase can be included to regenerate glutamate by transamination of α-KG. With the exception of glutaminase, all other enzymes and reagents mentioned above can be found in Amplex Red Glutamic Acid/Glutamate Oxidase Assay Kit (Invitrogen, catalogue no. A12221). Several researchers also made use of the kit to detect the level of intracellular glutamate so as to reflect the inhibitory activity of compounds against glutaminase.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a></div></div><div id="sec3_1_1_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i16" class="anchor-spacer"></div><h5 class="article-section__title" id="_i16"> Radiolabeled Glutamine Assay.<a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a></h5><div class="NLM_p">Except for the methods that determine the hydrolyzed product, the radiolabeled glutamine assay can also determine the enzymatic activity in a direct way. The method employed radiolabeled glutamine, [<sup>3</sup>H]-glutamine, as the substrate to determine the activity of glutaminase inhibitors. After incubation of [<sup>3</sup>H]-glutamine, inhibitors, and glutaminase together, the substrate and reaction product are then isolated through 96-well spin columns packed with strong anion ion-exchange resin. Imidazole buffer is used to wash the unreacted [<sup>3</sup>H]-glutamine. Then the reaction product, [<sup>3</sup>H]-glutamate, is eluted with HCl and analyzed for radioactivity so as to reflect the inhibitory potency of inhibitors in glutaminase.</div><div class="NLM_p last">Comparing these three methods, the two-step or three-step glutaminase assay using the principle of quantifying glutamate by coupling to glutamate dehydrogenase-mediated NADH production are the most commonly used method to measure the inhibitory activity of GLS1. While the radioactive assay has the advantage of producing fewer false positives due to assay interference compared with the other two methods (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>)</div></div></div><div id="sec3_1_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i17" class="anchor-spacer"></div><h4 class="article-section__title" id="_i17">3.1.2.  GLS1 Binding Assay</h4><div class="NLM_p">The most straightforward parameter reflecting binding strength of compounds is the equilibrium dissociation constant <i>K</i><sub>d</sub>. Hence, assays that can determine <i>K</i><sub>d</sub> and precisely measure direct binding affinity are valuable in evaluating GLS1 inhibitors. However, these methods have not been widely used to screen for novel GLS1 inhibitors compared with the glutamine hydrolysis assays. The combination of glutamine hydrolysis assays and binding assays are supported to ensure the precise assessment of GLS1 inhibitors and provide useful information for further optimization.</div><div id="sec3_1_2_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i18" class="anchor-spacer"></div><h5 class="article-section__title" id="_i18"> Fluorescence Resonance Energy Transfer (FRET)-Based Assay</h5><div class="NLM_p last">As for allosteric inhibitors, some proximity-based fluorescent methods have also been developed. Among them, a fluorescence resonance energy transfer (FRET)-based assay has been established recently.<a onclick="showRef(event, 'ref105'); return false;" href="javascript:void(0);" class="ref ref105">(105)</a> FRET is the radiation-free transmission of energy from a donor molecule that initially absorbs the energy to an acceptor molecule to which the energy is subsequently transferred. The efficiency of this energy transfer is inversely proportional to the sixth power of the distance between donor and acceptor.<a onclick="showRef(event, 'ref106'); return false;" href="javascript:void(0);" class="ref ref106">(106)</a> The character makes the FRET method sensitive to small changes in distance which can be adapted to detect the distance of dimer-to-tetramer transition. Cerione group has successfully developed a FRET assay to monitor the effects that allosteric inhibitors have on GAC tetramer formation in real time.<a onclick="showRef(event, 'ref105'); return false;" href="javascript:void(0);" class="ref ref105">(105)</a> Addition of the allosteric inhibitors to GAC labeled with FRET pairs increased the FRET readout, indicating the rapid formation of tetramers upon the binding of the inhibitors. The method has also been employed to evaluate the mechanism of GAC activation and illustrate how a distinct class of allosteric inhibitors impacts the metabolic program of transformed cells.</div></div><div id="sec3_1_2_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i19" class="anchor-spacer"></div><h5 class="article-section__title" id="_i19"> Biolayer Interferometry (BLI)-Based Assay.<a onclick="showRef(event, 'ref107'); return false;" href="javascript:void(0);" class="ref ref107">(107)</a></h5><div class="NLM_p last">The equilibrium dissociation constant <i>K</i><sub>d</sub> is the most straightforward parameter which reflects binding strength. Thus, assays which can determine <i>K</i><sub>d</sub> and precisely measure direct binding are useful in evaluating GLS1 inhibitors. BLI is a commonly used technique for the binding kinetic method and can monitor the association and dissociation process in real time and obtain the association rate constant <i>k</i><sub>on</sub> and the dissociation rate constant <i>k</i><sub>off</sub>. Ruan et al. developed a direct kinetic binding assay for KGA using BLI as a detection method for rigorous characterization. The biomolecular interaction analysis of compounds binding to the biotinylated KGA protein was performed using a ForteBio K2 instrument with Super Streptavidin (SSA) biosensors. Human KGA showed does dependent direct binding to its substrate Gln (<i>K</i><sub>d</sub> 4 μM) and the allosteric inhibitor <b>BPTES</b> (<i>K</i><sub>d</sub> 0.2 μM). In the BLI-based assays, the small molecule would be identified as a potent and strong binder if <i>K</i><sub>d</sub> < 100 nM. The developed BLI-based direct binding assay could provide high throughput screening and reliable characterization of GLS1 inhibitors.</div></div><div id="sec3_1_2_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i20" class="anchor-spacer"></div><h5 class="article-section__title" id="_i20"> Microscale Thermophoresis (MST)-Based Assay.<a onclick="showRef(event, 'ref56'); return false;" href="javascript:void(0);" class="ref ref56">(56)</a></h5><div class="NLM_p last">MST method is another technology to assess the binding affinity of GLS1 and inhibitors. The method is usually employed to determine the binding affinity between protein–protein interactions or protein–small molecule interactions through detecting the change of fluorescence during thermophoresis.<a onclick="showRef(event, 'ref108'); return false;" href="javascript:void(0);" class="ref ref108">(108)</a> Chen et al. using the protein labeled with the Monolith NT Protein Labeling Kit RED (catalogue no. L001) under the manufacturer’s instructions to test the binding ability of inhibitor and purified KGA.<a onclick="showRef(event, 'ref56'); return false;" href="javascript:void(0);" class="ref ref56">(56)</a> The method could ensure the precise assessment of GLS1–ligand binding and provide useful tips for further optimization.</div></div></div></div><div id="sec3_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21">3.2.  Cellular Assay</h3><div id="sec3_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i22" class="anchor-spacer"></div><h4 class="article-section__title" id="_i22">3.2.1.  Cell-Based Intracellular GAC Activity Assay</h4><div class="NLM_p last">Compared with the determination of the GLS1 inhibition activity in vitro, direct evaluation of GLS1 inhibition activity in cells is harder to achieve due to the complexity of cells. Recently, the ability of each inhibitor to affect intracellular GAC activity was performed by monitoring the level of ammonia in different cancer cells. Ammonia is the second product of GAC catalyzed hydrolysis of glutamine to glutamate.<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a> Drug-sensitive triple-negative breast cancer cell lines and the highly drug-resistant MDA-MB-453 cell lines were employed as model cell lines. When these cells were treated with inhibitors for a certain time, the amount of ammonia was determined with the Ammonia Assay Kit from Megazyme (Bray, Ireland). Effective GLS1 inhibitors would reduce the production of ammonia in both two cell lines, while the triple-negative breast cancer cells would be more sensitive to GLS1 inhibitors than drug-resistant (HER2-positive) MDA-MB-453 cells.</div></div><div id="sec3_2_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i23" class="anchor-spacer"></div><h4 class="article-section__title" id="_i23">3.2.2.  Inhibition of Cell Proliferation</h4><div class="NLM_p">The anticancer cell growth and proliferation assays in vitro are so critical for the early effort of medicinal chemistry regardless of the drug targets. With respect to glutaminase inhibitors, the selection of appropriate carcinoma cell lines is significant for stable and reliable cellular effects. Obviously, cancer cells that exhibit high expression of glutaminase or glutamine addition are preferred for the anticancer cell growth and proliferation assays. It has been demonstrated that glutamine metabolism can be increased by Myc-induced the expression of glutaminase directly or by suppression of miR23a and miR23b. Thus, P493 human B lymphoma cells, in which Myc is overexpressed in the absence of tetracycline, are used to assess antitumor effects of glutaminase inhibitors in vitro.<a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a></div><div class="NLM_p last">TNBC primary tumors are reported to have high levels of glutaminase and low levels of glutamine synthetase. These protein expression levels suggest that the growth and proliferation of TNBC cells is highly dependent on glutamine. More importantly, the antiproliferative effects of <b>CB-839</b> across a panel of 28 breast cancer cell lines (20 TNBC, 4 ER<sup>+</sup>/HER<sup>–</sup>, and 4 ER<sup>–</sup>/HER2<sup>+</sup>) has been evaluated, and the result was that <b>CB-839</b> shows antitumor activity toward most of the TNBC cell lines with IC<sub>50</sub> at 2–300 nmol/L.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> Thus, these results provide strong evidence that TNBC cell lines are a large class of reliable cells that can be used for rapidly screening anticancer activity of GLS inhibitors in vitro, of which the most commonly used are MDA-MB-231 and HCC1806. In addition, cells used to evaluate carcinoma cell growth inhibition activity of glutaminase inhibitors in literatures also include pancreatic cancer AsPC-1.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> Human hepatoma HepG2 and lung carcinoma A549 cells are found to show high expression levels of GAB and KGA protein.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> KGA was also found to be highly expressed in SW1990<a onclick="showRef(event, 'ref55'); return false;" href="javascript:void(0);" class="ref ref55">(55)</a> and erlotinib-resistant NSCLC cells HCC827-ER.<a onclick="showRef(event, 'ref56'); return false;" href="javascript:void(0);" class="ref ref56">(56)</a> Finally, the methods for counting live cells mainly include CellTiter Glo Luminescent Cell Viability Assay kit (Promega) and trypan blue dye exclusion in a hemocytometer.</div></div></div><div id="sec3_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24">3.3.  In Vivo Assays</h3><div class="NLM_p">The key point for in vivo antitumor growth and proliferation experiments of GLS inhibitors are still focused on the selection of tumor xenograft models. Just as in the vitro carcinoma cell growth inhibition assay, a tumor xenograft model in vivo with high expression of glutaminase or high-dependence on glutamine is valuable for GLS inhibitors, mainly including TNBC,<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> P493 human lymphoma B cells,<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> and AsPC-1 xenograft.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> In addition, it has been demonstrated that renal clear cell carcinoma cells, KRAS and EGFR mutant NSCLC lines, exhibited more sensitivity to glutaminase inhibitors <b>CB-839</b>.<a onclick="showRef(event, 'ref58'); return false;" href="javascript:void(0);" class="ref ref58">(58)</a> The method of administration and dosage of drugs should also be determined based on the physicochemical and pharmacokinetic properties of compounds. Taking <b>CB-839</b> as an example, due to its high clearance rate in mice, researchers take use of twice daily administration in order to maintain continuous target coverage.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a></div><div class="NLM_p">More importantly, the concern that synergistically antitumor proliferation study targeting glutaminase combined with other signaling pathways in vivo is increasing more and more. For example, <b>CB-839</b> was coadministered with paclitaxel and achieved a 100% tumor inhibition rate in the JIMT-1 xenograft model.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a><b>CB-839</b> shows a significant single agent and combines with pomalidomide to produce strong antitumor activity in the IMiD-resistant RPMI-8226 xenograft model.<a onclick="showRef(event, 'ref57'); return false;" href="javascript:void(0);" class="ref ref57">(57)</a> In the paper, representative antitumor proliferation assays in vivo of glutaminase inhibitors are listed below (<a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>).</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Representative Antitumor Proliferation Assays in Vivo of GLS Inhibitors<a onclick="showRef(event, 'ref25 ref26 ref39 ref57 ref58 ref59 ref60 ref61'); return false;" href="javascript:void(0);" class="ref ref25 ref26 ref39 ref57 ref58 ref59 ref60 ref61">(25,26,39,57−61)</a><a class="ref internalNav" href="#t4fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b00961/20190211/images/medium/jm-2018-009616_0018.gif" alt="" id="GRAPHIC-d7e1453-autogenerated" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup><sup>a</sup></sup><p class="last">TNBC, triple negative breast cancer; EGFR, epidermal growth factor receptor; NSCLC, nonsmall cell lung cancer; PDX, patient derived xenograft; RCC, renal cell carcinoma; TGI, tumor growth inhibition; BID, twice a day; QD, once a day; ip, intraperitoneal.</p></div></div><div></div></div></div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i26">4.  Modulators of GLS</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_55754" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_55754" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">In this review, we will highlight key tool compounds, clinical candidates, and new preclinical inhibitors for which potentially useful GLS1-inhibitors structural data have been reported.</div><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27">4.1.  Glutamine Mimetics</h3><div class="NLM_p">6-Diazo-5-oxo-<span class="smallcaps smallerCapital">l</span>-norleucine (<b>DON</b>), <b>azaserine</b>, and <b>acivicin</b> (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>A) isolated from <i>Streptomyces</i> bacteria as glutamine mimetics were reported to irreversibly interact with catalytic serine of both glutaminase isozymes and exhibit potent function in blocking glutamine metabolism.<a onclick="showRef(event, 'ref62 ref63'); return false;" href="javascript:void(0);" class="ref ref62 ref63">(62,63)</a> The previous reported crystal structure (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4O7D">4O7D</a>) of the catalytic domain of KGA (cKGA) in complex with <b>DON</b> disclosed that <b>DON</b> could covalently bind with the active site Ser286 and have interactions with residues including Tyr249, Asn335, Glu381, Asn388, Tyr414, Tyr466, and Val484 (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>B).<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a> The nucleophilic attack of Ser286 side chain on <b>DON</b> releases the diazo group (N<sub>2</sub>) from the inhibitor and leads to the formation of an enzyme–<b>DON</b> complex (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>C).<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a></div><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b00961/20190211/images/medium/jm-2018-009616_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b00961/20190211/images/large/jm-2018-009616_0004.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. (A) The structures of glutamine mimetics. (B) The interactions of <b>DON</b> with the catalytic site of KGA (cKGA, PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4O7D">4O7D</a>). <b>DON</b> is shown as a red stick, and cKGA residues are shown in cyan. (C) Proposed active site inhibition mechanism of KGA.<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b00961/20190211/images/large/jm-2018-009616_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00961&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In preclinical studies, all of the three agents showed robust inhibitory effect in tumor models of glutamine dependence both in in vitro culture and in vivo mouse xenograft models.<a onclick="showRef(event, 'ref64 ref65'); return false;" href="javascript:void(0);" class="ref ref64 ref65">(64,65)</a> There were also some studies demonstrating that <b>DON</b> exhibited promising results in several clinical trials.<a onclick="showRef(event, 'ref66 ref67 ref68 ref69 ref70 ref71 ref72'); return false;" href="javascript:void(0);" class="ref ref66 ref67 ref68 ref69 ref70 ref71 ref72">(66−72)</a> However, the glutamine mimetic had severe off-target effects, e.g., <b>DON</b> could alkylate other enzymes except for GLS, such as NAD synthase,<a onclick="showRef(event, 'ref73'); return false;" href="javascript:void(0);" class="ref ref73">(73)</a> CTP synthetase,<a onclick="showRef(event, 'ref74'); return false;" href="javascript:void(0);" class="ref ref74">(74)</a> and FGAR aminotransferase<a onclick="showRef(event, 'ref75'); return false;" href="javascript:void(0);" class="ref ref75">(75)</a> due to the overactive diazo group. Therefore, the clinical developments of <b>DON</b> and its diazo analogues were greatly limited due to dose-limiting toxicity and narrower therapeutic window.<a onclick="showRef(event, 'ref52 ref76 ref77'); return false;" href="javascript:void(0);" class="ref ref52 ref76 ref77">(52,76,77)</a></div><div class="NLM_p">Although <b>DON</b> exhibited some off-target and side effects as discussed above, the study on it has never been terminated. In 2016, Barbara S. Slusher and co-workers demonstrated that <b>DON</b> indeed had robust antagonist activity in glutamine metabolism.<a onclick="showRef(event, 'ref78'); return false;" href="javascript:void(0);" class="ref ref78">(78)</a> More importantly, it showed potent antitumor efficacy in a murine model of glioblastoma. To minimize the toxicity of <b>DON</b> in periphery, researchers adopted the most common prodrug strategy in medicinal chemistry, leading to the obviously improvement in the blood–brain barrier permeability of designed <b>DON</b> derivatives and decrease in systemic exposure (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>). Initially, compounds <b>Rais-2a</b> and <b>Rais-2b</b> (compounds in the paper are named by first author for academic publications, or patent assignee for patents, and then by the compound code within the relevant publication), just masking <b>DON</b>’s carboxylic acid with a simple alkyl ester, were instable in chemical structure. Next, prodrug molecule <b>Rais-5C</b> (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>) was synthesized by masking both amine and carboxyl groups of <b>DON</b> with prodrug moieties (methyl-pivaloyl-oxy-methyl (POM)-DON-isopropyl-ester). Although <b>Rais-5C</b> showed instability and was rapidly metabolized in mouse plasma, it was found that <b>Rais-5C</b> could be excellent stable in the plasma of human and monkey. Studies indicated that <b>Rais-5C</b> administration increased its brain delivery (1.43 nmol/g DON) compared to <b>DON</b> (0.33 nmol/g DON) in the cerebrospinal fluid (CSF) at 30 min postdose and decreased plasma exposure (AUC<sub>0–<i>t</i></sub> = 5.71 nmol/h/mL) compared to <b>DON</b> (AUC<sub>0–<i>t</i></sub> = 42.7 nmol/h/mL). In other words, prodrug molecule <b>Rais-5C</b> achieved a nearly 10-fold enhancement CSF to plasma ratio compared to <b>DON</b> in pigtail macaques.<a onclick="showRef(event, 'ref78'); return false;" href="javascript:void(0);" class="ref ref78">(78)</a></div><figure id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b00961/20190211/images/medium/jm-2018-009616_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b00961/20190211/images/large/jm-2018-009616_0005.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Chemical structures of glutamine analogues and the strategy of <b>DON</b> prodrugs.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b00961/20190211/images/large/jm-2018-009616_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00961&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">HIV-associated neurocognitive disorder (HAND) is associated with aberrant excitatory neurotransmission which is mainly related to the overexpression of glutamate. On the basis of the physiological mechanism, researchers proposed to attenuate glutamate production by <b>DON</b> so as to treat HAND. First, researchers confirmed that <b>DON</b> indeed had a significant effect in reducing cognitive decline in chimeric EcoHIV-infected mice, a model of HAND.<a onclick="showRef(event, 'ref79'); return false;" href="javascript:void(0);" class="ref ref79">(79)</a> However, the problem is still in <b>DON</b> itself with the peripheral toxicity. Similar to the content described above, researchers also adopted the strategy of prodrugs in order to achieve high blood–brain barrier penetration and low plasma exposure. Given some other successful prodrugs,<a onclick="showRef(event, 'ref80 ref81 ref82 ref83'); return false;" href="javascript:void(0);" class="ref ref80 ref81 ref82 ref83">(80−83)</a> modifications of the <i>N</i>-(pivaloyloxy)methoxy-carbonyl pro-moiety of <b>Rais-5C</b> with additional steric bulk on the methylene bridge were conducted. Compound <b>Nedelcovych-13d</b> (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>) introducing a phenyl group exhibited the most desired activity. In addition to increasing steric hindrance and metabolic stability, lipophilicity of <b>Nedelcovych-13d</b> was also substantially increased compared with <b>DON</b>, where the values of calculated partition coefficients (cLogP) of <b>Nedelcovych-13d</b> and <b>DON</b> were 2.75 and −2.5, respectively. Finally, to researchers’ most excitement, when dosed systemically in swine, <b>Nedelcovych-13d</b> provided a 15-fold enhanced CSF to plasma ratio and a 9-fold enhanced brain to plasma ratio relative to <b>DON</b>.</div><div class="NLM_p last">In sum, the two efforts described above open innovation directions for the development and application of <b>DON</b> on one hand. On the other hand, the prodrug approaches provide new options for the treatment of central nervous system diseases associated with aberrant glutamine metabolism.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28">4.2.  <b>BPTES</b> and Its Derivatives</h3><div class="NLM_p">On the basis of screening of a library of chemical compounds, Robinson et al. discovered a potent and specific KGA inhibitor <b>BPTES</b> [bis-2-(5-phenylacetamido-1,2,4-thiadiazol-2-yl)ethyl sulfide] with completely novel scaffold in 2007.<a onclick="showRef(event, 'ref24 ref84'); return false;" href="javascript:void(0);" class="ref ref24 ref84">(24,84)</a> The <i>K</i><sub>i</sub> value of <b>BPTES</b> in inhibiting KGA is highly potent with IC<sub>50</sub> at 3 μM, which is more potent than previously reported KGA inhibitors.<a onclick="showRef(event, 'ref76 ref85'); return false;" href="javascript:void(0);" class="ref ref76 ref85">(76,85)</a> In addition, the specific inhibition experiments indicated that <b>BPTES</b> treatment in 10 μM lead to 80% inhibition of KGA activity. Comparing the chemical structure with <b>DON</b>, <b>BPTES</b> does not possess any reactive chemical groups which might cause toxicity by irreversibly forming covalent adducts with the enzyme. Through further analysis, the structure of <b>BPTES</b>, we find that it is a highly long, symmetrical, and flexible and bears no similar group to substrate glutamine. This suggested that the interactions of <b>BPTES</b> with other glutamine-related enzymes, transporters, or receptors could be minimized so as to avoid off-target effects. Indeed, preliminary toxicity studies of <b>BPTES</b> in mice showed no histopathology in liver, heart, lung, skeletal muscle, kidney, and brain.<a onclick="showRef(event, 'ref86'); return false;" href="javascript:void(0);" class="ref ref86">(86)</a> Further, <b>BPTES</b> did not show any significant effects on body weight, blood chemistries, and hematology measurements. The X-ray crystallographic complex structures of mouse or human GLS1 with <b>BPTES</b> have been determined (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3UO9">3UO9</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3VP1">3VP1</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3VOZ">3VOZ</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5UQE">5UQE</a>, and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4JKT">4JKT</a>). The X-ray crystal structures of the GLS1-<b>BPTES</b> complex show that <b>BPTES</b> occupies the allosteric binding site and effectively traps GLS1 as an inactive tetramer. The first reported cocrystal structure (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3UO9">3UO9</a>)<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> of GAC with <b>BPTES</b> is shown in <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>. <b>BPTES</b> has two exactly equivalent parts, including a thiadiazole, amide, and a phenyl group which could equally interact with each monomer. The thiadiazole group and the aliphatic linker occupies well in the allosteric pocket and forms hydrogen bonds with Lys320, Leu321, and Leu323. When superimposing the <b>BPTES</b>-KGA complex structure with apo KGA, a major conformational change at the Glu312 to Pro329 loop was observed. The <b>BPTES</b>-induced conformational change was supposed to stabilize an open and inactive conformation of the catalytic site (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>C). The discovery of these cocrystal complex structures opens the way for the subsequent design and modification of <b>BPTES</b> analogues. However, studies on <b>BPTES</b> have been terminated in the preclinical phase due to poor metabolic stability and low solubility of <b>BPTES</b>.</div><figure id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b00961/20190211/images/medium/jm-2018-009616_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b00961/20190211/images/large/jm-2018-009616_0006.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. (A) A close-up view of the interactions of <b>BPTES</b> in the GLS allosteric inhibitor binding pocket. (B) The chemical structure of <b>BPTES</b>. (C) Conformational changes on GLS induced by binding of the <b>BPTES</b>. (<b>BPTES</b>-KGA PDB, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3UO9">3UO9</a>; Apo GLS PDB, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3VOY">3VOY</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b00961/20190211/images/large/jm-2018-009616_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00961&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">To discover more potent GLS inhibitors with improved drug-like properties, the Takashi Tsukamoto group designed a series of <b>BPTES</b> derivatives (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>) and obtained the comprehensive SAR.<a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a> The authors first attempted to identify the pharmacophore required for GLS1 binding, and different truncated analogues of <b>BPTES</b> were synthesized and evaluated for their activity to inhibit GLS1. Compound <b>Shukla-5</b>, which was synthesized by removing the two phenylacetyl groups of <b>BPTES</b> scaffold, showed no potency in inhibiting GLS1. However, <b>Shukla-6</b> (GLS IC<sub>50</sub> = 2.7 μM) recovered the potency against GLS1 when introducing one of the phenylacetyls. The result demonstrated that one phenyl ring from <b>BPTES</b> was able to be removed without sacrificing potency. Such molecules maintain much of the <b>BPTES</b> scaffold with one hydrophobic end and one charged end. The two asymmetric molecules (<b>Shukla-5</b> and <b>Shukla-6</b>) have not been determined by crystallographic studies but have been supposed to bind the same location as <b>BPTES</b>. Next, they tried to explore the SAR of middle linker. According the inhibitory activity of compound <b>Shukla-7</b> (GLS-IC<sub>50</sub> = 61 μM) and <b>Shukla-11b</b> (GLS-IC<sub>50</sub> = 1.9 μM), the length and type of the middle linkers were proved to play an important role in inhibiting GLS1. Moreover, different substitution groups were introduced into the phenylacetyl group of <b>Shukla-11b</b>. The results showed that the terminal aromatic ring was not necessary to maintain GLS inhibitory activity, which was consistent with <b>Shukla-6</b>. Researchers speculated that there was no specific interaction between the terminal substituent and the allosteric binding site. The fact that <b>Shukla-20</b> and <b>Shukla-27</b> were synthesized by replacing the one of thiadiazole ring of <b>Shukla-11b</b> with 1,3-thiazole ring completely lost activity highlighted the crucial role played by N<sub>4</sub> of the thiadiazole. To further investigate the effect of the thiadiazole ring on the activity, <b>Shukla-29a</b> was obtained by replacing one of the thiadiazole rings with a variety of amide groups. The results showed that the terminal thiadiazole can be replaced by other groups while maintaining the inhibitory activity of GLS. Finally, the aqueous solubility of <b>Shukla-6</b>, <b>Shukla-11b</b>, and <b>Shukla-29a</b> (the values being 13, 3.4, and 683 μg/mL, respectively) were indeed increased compared to <b>BPTES</b> (the value being 0.144 μg/mL). In summary, through the Takashi Tsukamoto group early work, the aqueous solubility of the truncated analogues of <b>BPTES</b> was successfully improved, but no significant improvement in glutaminase inhibitory potency was achieved.<a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a></div><figure id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b00961/20190211/images/medium/jm-2018-009616_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b00961/20190211/images/large/jm-2018-009616_0007.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Representative chemical structures of truncated <b>BPTES</b> analogues.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b00961/20190211/images/large/jm-2018-009616_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00961&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In 2016, starting from the reported crystal structure of GLS1 in complex with <b>BPTES</b>, the Takashi Tsukamoto group used 1,4-di(5-amino-1,3,4-thiadiazol-2-yl)-butane as a core skeleton to explore the SAR of terminal phenylacetyl groups in an attempt to obtain additional interactions with the GLS allosteric binding site (<a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>).<a onclick="showRef(event, 'ref87'); return false;" href="javascript:void(0);" class="ref ref87">(87)</a> The introduction of large steric hindered groups or positively charged groups into one of the phenylacetyl groups resulted in a loss or slight decrease of inhibitory activity against GLS1. Compounds <b>Zimmermann-2h</b>, <b>-2i</b>, and <b>-2m</b> containing hydrogen bond acceptors exhibited higher potencies in GLS inhibitory with IC<sub>50</sub> values below 100 nM. The IC<sub>50</sub> of <b>Zimmermann-2j</b> (GLS-IC<sub>50</sub> = 0.54 μM), synthesized by replacing phenolic group with acetoxy, was nearly 8-fold weaker than that of <b>Zimmermann-2m</b> (GLS-IC<sub>50</sub> = 0.07 μM). On the basis of the results, researchers speculated that the phenolic group of <b>Zimmermann-2m</b> might play an important role in interacting with GLS acting as both a hydrogen bond acceptor and a donor. Through the analysis of the cocrystal complex structure of GLS1 with <b>BPTES</b> (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3VOZ">3VOZ</a>),<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> it is supposed that the phenolic group of <b>Zimmermann-2m</b> might bind with the guanidinium group of Arg317 and the carboxylate group of Glu325 that both located in the nearby phenolic group. In addition, the phenolic group also contributed to the improvement of the aqueous solubility of <b>Zimmermann-2m</b> (17 μg/mL) as compared to <b>BPTES</b> (0.14 μg/mL). Finally, researchers modified the phenylacetyl groups on both sides. The results showed that the both phenylacetyl groups can be modified without sacrificing the GLS inhibitor. More importantly, the fact that compound <b>Zimmermann-2q</b> (IC<sub>50</sub> being 0.12 μM) with two phenols was less potent than <b>Zimmermann-2m</b> (IC<sub>50</sub> being 0.07 μM) containing one phenol demonstrated that the substituents on both sides may have little synergistic effects on bounding to GLS.<a onclick="showRef(event, 'ref87'); return false;" href="javascript:void(0);" class="ref ref87">(87)</a></div><figure id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b00961/20190211/images/medium/jm-2018-009616_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b00961/20190211/images/large/jm-2018-009616_0008.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Representative structures of compounds (<b>Zimmermann-2h</b>–<b>2q</b>) with 1,4-di(5-amino-1,3,4-thiadiazol-2-yl)-butane scaffold. These compounds focused on exploring the SAR of terminal phenylacetyl groups.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b00961/20190211/images/large/jm-2018-009616_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00961&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Further studies have demonstrated that the lipophilic connecting chains (diethylthio in <b>BPTES</b>) were the main cause of poor hydrophilicity and drug-like properties for these compounds.<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a> To improve the physicochemical properties, the flexible connecting chains were replaced by appropriate size ring systems. Bioactivity evaluations against GAC and MDA-MB-231 cell indicated that small to medium size heteroatom substituted rings are beneficial to activity, but too large rings are detrimental (<a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a></a>). <b>trans-CBTBP</b> was synthesized by the replacement of aliphatic flexible linker on <b>BPTES</b> with 1,3-disubstituted cyclohexyl.<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> Compared to <b>BPTES</b>, <b>trans-CBTBP</b> displays a smaller number of rotatable bonds (NRB, 8 in <b>trans-CBTBP</b> vs 12 in <b>BPTES</b>). The reduction of NRBs in <b>trans-CBTBP</b> would improve the probability of good absorption. In addition, due to greater cell permeability, the IC<sub>50</sub> for glutaminase inhibition for <b>trans-CBTBP</b> (IC<sub>50</sub> = 0.1 μM) is only a moderate improvement over that for <b>BPTES</b> (IC<sub>50</sub> = 0.16 μM). Among two <b>trans-CBTBP</b> enantiomers, <b>1</b><i><b>S</b></i>,<b>3</b><i><b>S</b></i> and <b>1</b><i><b>R</b></i>,<b>3</b><i><b>R</b></i>, only <b>1</b><i><b>S</b></i>,<b>3</b><i><b>S</b></i><b>-CBTBP</b> was found to crystallize with cKGA (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5JYP">5JYP</a>).<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> This indicated that the <b>1</b><i><b>S</b></i>,<b>3</b><i><b>S</b></i><b>-CBTBP</b> stereoisomer was preferred for cKGA over the <b>1</b><i><b>R</b></i>,<b>3</b><i><b>R</b></i> form. Compared to <b>BPTES</b>, <b>1</b><i><b>S</b></i>,<b>3</b><i><b>S</b></i><b>-CBTBP</b> shared identical hydrogen bonding interactions with cKGA. However, the cyclohexane linker from <b>1</b><i><b>S</b></i>,<b>3</b><i><b>S</b></i><b>-CBTBP</b> formed different hydrophobic interactions with the side chains of Tyr394, Phe322, and Leu321 from both the neighboring cKGA monomers compared to the aliphatic linker of <b>BPTES</b>.<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> The activity against GAC of <b>McDermott-7c</b> (IC<sub>50</sub> = 29 nM) containing 4-piperidinyl is more than 10-fold than <b>BPTES</b> (IC<sub>50</sub> = 371 nM).<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a> The physicochemical properties, e.g., number of rotatable bonds (NRB),<a onclick="showRef(event, 'ref109'); return false;" href="javascript:void(0);" class="ref ref109">(109)</a> ligand efficiency (LE),<a onclick="showRef(event, 'ref110'); return false;" href="javascript:void(0);" class="ref ref110">(110)</a> lipophilic efficiency (LiPE),<a onclick="showRef(event, 'ref111'); return false;" href="javascript:void(0);" class="ref ref111">(111)</a> and calculated octanol–water partition coefficient (ClogP), of the series analogues have indeed been improved compared to BPTES.</div><figure id="fig9" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b00961/20190211/images/medium/jm-2018-009616_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b00961/20190211/images/large/jm-2018-009616_0009.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Representative compounds with appropriate size rings replacing flexible connecting linker.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b00961/20190211/images/large/jm-2018-009616_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00961&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The human liver microsome (HLM) stability assay demonstrated that <b>McDermott-7c</b> exhibited more microsomal stability compared to <b>BPTES</b>. Finally, X-ray complex structures of GAC with constrained derivatives (<b>McDermott-7d</b>, <b>McDermott-7e</b>, and <b>McDermott-14d</b>) confirmed that these compounds bind in the similar allosteric pocket just as <b>BPTES</b> (PDBs <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5FI2">5FI2</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5FI6">5FI6</a>, and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5I94">5I94</a>).<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a> The ring linkers of these compounds lie in the same location of the <b>BPTES</b> flexible connector chain. The thiadiazole groups can also occupy the same pocket of <b>BPTES</b> thiadiazoles in the <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3UO9">3UO9</a> X-ray structure (<a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a></a>). Overlaying the crystal structures and the variable orientation of the phenylacetic acid moieties suggested that the allosteric pocket of GLS1 is rigid, and the flexibility only comes from the various inhibitors to better dock with the allosteric site to enhance the interactions. In view of the effectiveness of this strategy, many pharmaceutical companies also followed similar efforts. The specific contents are not reviewed here and can be seen in refs <a onclick="showRef(event, 'ref88 ref89 ref90 ref91'); return false;" href="javascript:void(0);" class="ref ref88 ref89 ref90 ref91">(88−91)</a>.</div><figure id="fig10" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b00961/20190211/images/medium/jm-2018-009616_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b00961/20190211/images/large/jm-2018-009616_0010.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. Overlay of binding modes of <b>BPTES</b> (pink, PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3UO9">3UO9</a>), <b>McDermott-7d</b> (yellow, PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5FI2">5FI2</a>), <b>McDermott-7e</b> (orange, PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5FI6">5FI6</a>), and <b>McDermott-14d</b> (green, PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5I94">5I94</a>) with GAC.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b00961/20190211/images/large/jm-2018-009616_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00961&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec4_2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29">4.3.  <b>BPTES</b> Derivative in Clinical (<b>CB-839</b>)</h3><div class="NLM_p">More recently, Gross et al. reported the development of <b>CB-839</b>, which was discovered from several hundred <b>BPTES</b> derivatives.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> Currently, <b>CB-839</b> is the only one GLS inhibitor undergoing several different clinical studies.<a onclick="showRef(event, 'ref92 ref93'); return false;" href="javascript:void(0);" class="ref ref92 ref93">(92,93)</a><b>CB-839</b> is similar to <b>BPTES</b> in structure, just replacing one thiadiazole ring by pyridazine and replacing the two terminal phenyl rings by pyridine and trifluoromethoxy substituted phenyl ring. To explore the structural basis for the inhibitory efficacy, the complex structures of <b>CB-839</b> with KGA and GAC have been solved (PDBs <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5JYO">5JYO</a> and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5HL1">5HL1</a>).<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> The conformations of <b>CB-839</b> in KGA and GAC complex crystal structures are not exactly the same. According to both of the crystal structures, <b>CB-839</b> was found to interact with the same allosteric pocket of GLS1 as reported to <b>BPTES</b> (<a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">11</a></a>). The KGA-<b>CB-839</b> (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5JYO">5JYO</a>)<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> complex crystal structure shows that <b>CB-839</b> could form hydrogen bonding contacts with the protein backbone amide groups of the Phe322 and Leu323. The pyridazinyl and acetyl groups of the inhibitor make hydrogen bonds with Tyr394, Lys320, and Asn324. In addition, the thiadiazol group of <b>CB-839</b> is also involved in a water-mediated interaction with Asp327.</div><figure id="fig11" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b00961/20190211/images/medium/jm-2018-009616_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b00961/20190211/images/large/jm-2018-009616_0011.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 11. Cocrystal structures of GLS1 in complex with <b>CB-839</b> bound to the allosteric pocket. (A) Detailed binding mode of <b>CB-839</b>-KGA (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5JYO">5JYO</a>). (B) Detailed binding mode of <b>CB-839</b>-GAC (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5HL1">5HL1</a>). Carbon atoms of <b>CB-839</b> are shown in yellow sticks. The residues involved in allosteric site are highlighted in rose red. Hydrogen bonds are represented by black dashed lines, and H···π binding is represented by red dashed lines. (C) The structures of <b>BPTES</b> and <b>CB-839</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b00961/20190211/images/large/jm-2018-009616_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00961&amp;id=fig11"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">As for the terminal moieties of the trifluoromethoxy group, two different crystal structures, <b>CB-839</b>-KGA and <b>CB-839</b>-GAC, show inconsistent results (<a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">11</a></a>). In the KGA-<b>CB-839</b> complex crystal structure (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5JYO">5JYO</a>, <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">11</a></a>A),<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> the trifluoromethoxy group is not engaged in any hydrogen bonding with KGA, while in the GAC-<b>CB-839</b> complex (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5HL1">5HL1</a>, <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">11</a></a>B),<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> the inhibitor-fluorine atoms can form hydrogen binding with Lys320. In addition, the trifluoromethoxy phenyl group is supposed to improve the solubility of <b>CB-839</b>.</div><div class="NLM_p">The biological experiment data disclosed that <b>CB-839</b> is a potent, selective, and orally bioavailable inhibitor of both KGA and GAC (the IC<sub>50</sub> = 20 nM). In addition, <b>CB-839</b> exhibited time-dependent inhibitory activity against GAC.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> This unique property did not appear in <b>BPTES</b>, and some researchers speculated that this may have a certain relationship with the pyridazine ring of <b>CB-839</b>. The in vitro antitumor activity toward triple-negative breast cancer (TNBC) cell lines HCC-1806 and MDA-MB-231 showed that TNBC were sensitive to <b>CB-839</b>.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> It should be noted that the sensitivity of TNBC cells toward <b>CB-839</b> was correlated with two potential biomarkers: one marker is the overexpression of GAC but not KGA, and the other is the high baseline ratio of glutamate to glutamine. Thus, these two markers that could be used to enrich for corresponding patients in clinical trials. Further in vivo antitumor experiment showed that <b>CB-839</b> has potent antitumor activity in two xenograft models: as a single agent in a patient-derived TNBC model and in a basal like HER2<sup>+</sup> cell line model, JIMT-1, and both showed antitumor activity as a single agent and in combination with paclitaxel.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> Moreover, the oral bioavailability and drug-like properties of <b>CB-839</b> is excellent compared to <b>BPTES</b>. <b>CB-839</b> is now in clinical trials for several different indications, both alone and as part of drug cocktails in multiple solid and liquid tumors.<a onclick="showRef(event, 'ref94'); return false;" href="javascript:void(0);" class="ref ref94">(94)</a> The reported clinical trials have been summarized in <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a></a>.</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. All reported Clinical Trials for GLS Inhibitor <b>CB-839</b><a class="ref internalNav" href="#t5fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b00961/20190211/images/medium/jm-2018-009616_0019.gif" alt="" id="GRAPHIC-d7e2553-autogenerated" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup><sup>a</sup></sup><p class="last">The data is from <a href="http://www.clinicaltrials.gov" class="extLink">www.clinicaltrials.gov</a></p></div></div><div></div></div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31">4.4.  Benzophenanthridinone Scaffold Derivatives</h3><div class="NLM_p">A novel small molecule <b>968</b>, a dibenzophenanthridine, was identified as GLS inhibitor by screening for small molecule inhibitors of the transforming capabilities of activated Rho GTPases in 2010.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> Through the docking study together with mutational analysis of GAC, <b>968</b> is an allosteric regulator of recombinant GAC and its binding site lies in a cavity where two GAC monomers form a dimer that is different from above-reported <b>BPTES</b> derivatives (<a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">12</a></a>). SAR study indicated that the 3-bromo-4-(dimethylamino)phenyl ring of <b>968</b>, also named “hot-spot” ring, was significant for potency and required a large, antiplanar group at the para position for robust inhibitory potency (e.g., <b>968</b> vs <b>Katt-14</b> vs <b>Katt-22</b> in <a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">12</a></a>).<a onclick="showRef(event, 'ref95'); return false;" href="javascript:void(0);" class="ref ref95">(95)</a> The biological result that introducing isopropyl (<b>Katt-22</b>) or <i>tert</i>-butyl (<b>Katt-23</b>) group at position 4 of the hot-spot ring restored the enzyme activity demonstrated bulkiness could compensate for the loss of the bromine atom. Because <b>Katt-26</b> bearing a nitrile group exhibited no activity, it could be concluded that in addition to steric bulk, substituted groups must be oriented toward the para-position of the hot-spot ring. Moreover, researchers indicated that it is most effective to hold this steric bulk antiplanar to the hot-spot ring just as shown in <a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">12</a></a>. Replacement of the naphthyl group of <b>968</b> could not significantly affect inhibitory activity (<b>Stalnecker-SU14</b> or <b>Stalnecker-SU8</b>).<a onclick="showRef(event, 'ref96'); return false;" href="javascript:void(0);" class="ref ref96">(96)</a> It had been demonstrated that <b>968</b> had no inhibitory effect against the glutaminase protein which had already been activated. This shortcoming and hydrophobicity limit the further application and continued research of <b>968</b> in the antitumor field.<a onclick="showRef(event, 'ref95 ref96 ref97'); return false;" href="javascript:void(0);" class="ref ref95 ref96 ref97">(95−97)</a></div><figure id="fig12" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 12</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b00961/20190211/images/medium/jm-2018-009616_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b00961/20190211/images/large/jm-2018-009616_0012.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 12. Structures of <b>968</b> and its representative derivatives. (A) SAR of benzophenanthridinone scaffold derivatives. (B) Crystal structure of the GAC tetramer in complex with <b>BPTES</b> (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3UO9">3UO9</a>), with the proposed <b>968</b>-binding site indicated by the arrow pointing toward the C-terminal monomer–monomer interface. <b>BPTES</b> and <b>968</b> were indicated by red and gray sphere, respectively.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b00961/20190211/images/large/jm-2018-009616_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00961&amp;id=fig12"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32">4.5.  Thiazolidine-2,4-dione Derivatives</h3><div class="NLM_p">In 2017, Shiow-Ju Lee and co-workers discovered a series of thiazolidine-2,4-dione derivatives which were completely distinct from reported GLS inhibitors <b>DON</b>, <b>BPTES</b>, or <b>CB839</b> in chemical structure exhibited preferentially inhibitory activity against GLS1 over GLS2.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> Initial hit compound <b>Yeh-2</b> was identified by a high-throughput screening (HTS) against KGA. Bioactivity evaluation indicated that the IC<sub>50</sub> of <b>Yeh-2</b> against KGA and GAB were 3097 and >100000 nM, respectively. <b>Yeh-3</b>, replacing the methyl group of <b>Yeh-2</b> with the thiophene group, achieved an increase in the enzymatic inhibitory activity against KGA (IC<sub>50</sub> = 754 nM). Further, compounds <b>Yeh-5</b> and <b>Yeh-6</b> were obtained by medicinal chemistry optimization of hit compound <b>Yeh-2</b> (<a data-tab="pane-pcw-Figures" href="#fig13" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig13" id="" class=" internalNav">13</a></a>A). They exhibited improved activity against KGA with the IC<sub>50</sub> being 102 and 50 nM, respectively. Biochemical profiling indicated that <b>Yeh-5</b> and <b>Yeh-6</b> can inhibit tumor cell growth, including triple-negative breast cancer MDA-MB-231 (the IC<sub>50</sub>s being 42 and 28.7 μM, respectively) and pancreatic cancer AsPC-1 (the IC<sub>50</sub>s being 34.5 and 14.8 μM, respectively) in vitro. Moreover, using the GLS1 knocked out cells AsPC-1<sup>GLS–/–</sup> cells, the selectivity of <b>Yeh-6</b> was examined. The result shows that <b>Yeh-6</b> can decrease the glutamate level both in AsPC-1<sup>WT</sup> cells and AsPC-1<sup>GLS–/–</sup> cells. However, <b>BPTES</b> can only decrease the glutamate level in AsPC-1<sup>WT</sup> cells but not AsPC-1<sup>GLS–/–</sup> cells. It is concluded that, unlike <b>BPTES</b>, the selectivity of <b>Yeh-6</b> for GLS1 and GLS2 is relatively weak, with the selectivity index just being ∼2. In human pancreatic AsPC-1 xenograft antitumor assay, compound <b>Yeh-5</b> and <b>Yeh-6</b> exhibited about 50–60% tumor growth inhibition at a dose of 25 or 50 mg/kg. Through molecular modeling and site-directed mutagenesis studies, researchers predicted that compound <b>Yeh-5</b> may bind to the substrate binding site of KGA and interacts with R387 through hydrophobic bonding interactions (<a data-tab="pane-pcw-Figures" href="#fig13" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig13" id="" class=" internalNav">13</a></a>B). This finding may open another potential binding site for novel allosteric inhibitors which bind GLS1 at the substrate binding pocket. The author also demonstrated when compound <b>Yeh-6</b> was administered in combination with <b>BPTES</b>, a synergistic effect was also observed. In summary, this series of thiazolidine-2,4-dione compounds breaks through the structural framework of <b>BPTES</b> analogues described above and provides a novel backbone for the development of GLS inhibitors. However, its cell activity and enzyme activity remain moderate. Further efforts focus on structural modification and optimization of this scaffold are still needed.</div><figure id="fig13" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 13</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b00961/20190211/images/medium/jm-2018-009616_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b00961/20190211/images/large/jm-2018-009616_0013.jpeg" id="gr13" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 13. (A) Representative glutaminase inhibitors of thiazolidine-2,4-dione scaffold. (B) Overview of the proposed association of compound <b>Yeh-5</b> in a GLS1 tetramer.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b00961/20190211/images/large/jm-2018-009616_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00961&amp;id=fig13"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33">4.6.  Other GLS1 Inhibitors from Natural Products</h3><div class="NLM_p"><b>Physapubescin</b> and <b>Brachyantheraoside A</b><sub><b>8</b></sub> (<a data-tab="pane-pcw-Figures" href="#fig14" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig14" id="" class=" internalNav">14</a></a>), two novel kidney-type glutaminase (KGA) inhibitors, were identified from natural products by structure-based virtual screening.<a onclick="showRef(event, 'ref55 ref56'); return false;" href="javascript:void(0);" class="ref ref55 ref56">(55,56)</a> The enzyme inhibition experiments indicated that the IC<sub>50</sub> values of <b>physapubescin</b><a onclick="showRef(event, 'ref56'); return false;" href="javascript:void(0);" class="ref ref56">(56)</a> and <b>brachyantheraoside A</b><sub><b>8</b></sub><a onclick="showRef(event, 'ref55'); return false;" href="javascript:void(0);" class="ref ref55">(55)</a> were 9.89 and 6.10 μM, respectively, with a closely similar effect compared with <b>BPTES</b> (IC<sub>50</sub> = 8.60 μM). The cell-based assays revealed that the IC<sub>50</sub> value of <b>physapubescin</b> against HCC827-ER and HT1080 cells were 2.73 and 6.99 μM, respectively, and the IC<sub>50</sub> value against the HCC1806 cell was 24.94 μM. In addition, a wound healing assay indicated that <b>brachyantheraoside A</b><sub><b>8</b></sub> treatment (30 μM) exerted robust effects in inhibiting HCC1806 cell migration ability. Finally, researchers confirmed that the antitumor activity of <b>brachyantheraoside A</b><sub><b>8</b></sub> is achieved by inducing cancer cell apoptosis through the modulating Bax/Bcl-2 ratio in a dose-dependent manner. Further evaluations of the two natural products in vivo need to be carried out. The discovery of these two KGA inhibitors from natural products may bring some new ideas for extending the structural diversity of GLS inhibitors.</div><figure id="fig14" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 14</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b00961/20190211/images/medium/jm-2018-009616_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b00961/20190211/images/large/jm-2018-009616_0014.jpeg" id="gr14" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 14. Structures of two KGA inhibitors isolated from natural products.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b00961/20190211/images/large/jm-2018-009616_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00961&amp;id=fig14"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34">4.7.  Natural Alkyl Benzoquinones as GLS2 Inhibitors</h3><div class="NLM_p">The efforts in GLS2 inhibitors are limited in that the role of GLS2 as a tumor suppressor is still controversial. In this review, we would also make a brief introduction of GLS2 inhibitors. A series of natural products alkyl benzoquinones isolated from <i>Ardisia virens</i> exhibited potent and selective potency against recombinant human GLS2 enzyme.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> SAR study (<a data-tab="pane-pcw-Figures" href="#fig15" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig15" id="" class=" internalNav">15</a></a>) indicated that introducing the keto (hydroxyl) groups at positions 1 and 4 on the benzoquinone scaffold and the acetate group at position 2′ contribute to the inhibitory activity for KGA and GLS2. Compound <b>Lee-AV1</b> (also namely as <b>ardisianone</b>) exhibited almost 10-fold selectivity against GLS2 (IC<sub>50</sub> being 0.28 μM) and KGA (IC<sub>50</sub> being 2.1 μM). Moreover, through homologous modeling and docking studies, researchers proposed that the binding pocket of <b>Lee-AV1</b> with GLS2 distinct from the reported sites for <b>BPTES</b>, <b>968</b>, or <b>DON</b> on GLS was located at the C-terminal end of GLS2 monomer (<a data-tab="pane-pcw-Figures" href="#fig15" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig15" id="" class=" internalNav">15</a></a>), and the selectivity of <b>Lee-AV1</b> for GLS2 over KGA was mainly related to GLS2 residues Q452 and K453. Finally, to further explore the mechanism how <b>Lee-AV1</b> inhibit cancer cell growth, researchers examined some signaling factors associated with autophagy and apoptosis.<a onclick="showRef(event, 'ref98 ref99'); return false;" href="javascript:void(0);" class="ref ref98 ref99">(98,99)</a><b>Lee-AV1</b> treatment can induce autophagy by activating AMPK ULK1 axis signaling and inhibiting mTORC1 but no apoptosis. Thus, the autophagy was responsible for the inhibition of malignant cells growth.</div><figure id="fig15" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Figure 15</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b00961/20190211/images/medium/jm-2018-009616_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b00961/20190211/images/large/jm-2018-009616_0015.jpeg" id="gr15" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 15. Structure of alkyl benzoquinones and the mechanism that <b>AV-1</b> inhibits glutaminase-2.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b00961/20190211/images/large/jm-2018-009616_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00961&amp;id=fig15"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i35">5.  Future Directions and Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_63601" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_63601" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Because of the unique characteristics of rapid proliferation and differentiation, cancer cells inevitably reprogram metabolic mechanisms to meet the energy needs for cell growth and maintain the balance of redox homeostasis. Glutamine, the most abundant amino acid in plasma, is a versatile nutrient required for the survival and growth of a potentially large subset of tumors. Moreover, the importance of glutamine as a nutrient in cancer derives from its abilities to donate its nitrogen and carbon into an array of growth-promoting pathways. It has been shown that for cancer cells exhibiting resistance to chemotherapy, it is the upregulation of compensatory pathways when metabolic stress is induced by chemotherapy. Given this situation, some studies have demonstrated the combination of glutamine metabolism modulators and chemotherapy drugs may be a promising strategy to suppress the development of resistance to conventional chemotherapy for cancer.<a onclick="showRef(event, 'ref8 ref100 ref101'); return false;" href="javascript:void(0);" class="ref ref8 ref100 ref101">(8,100,101)</a> In addition, to circumvent the resistance of chemotherapy, another important role of glutamine metabolism in cancer treatment is that it can contribute to sensitivity in radiotherapy.<a onclick="showRef(event, 'ref102'); return false;" href="javascript:void(0);" class="ref ref102">(102)</a></div><div class="NLM_p">In various small molecule modulators targeting glutamine metabolism pathways, GLS1 inhibitors are the most widely studied, fastest developed, and largest amount.<a onclick="showRef(event, 'ref3 ref20'); return false;" href="javascript:void(0);" class="ref ref3 ref20">(3,20)</a> Whether in preclinical or current clinical studies, they have demonstrated a promising role in the treatment of tumors, especially tumors that are highly dependent on glutamine.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> GLS1 possess a conserved substrate binding site<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> and such a structure poses a key challenge in designing selective GLS1 inhibitors. Thus, the discovery of inhibitors targeting allosteric binding site could be a new strategy. The recent great progress in GLS1 crystallography has solved 16 GLS1 (including GAC and KGA) in complex with their small molecule allosteric inhibitors.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> These solved receptor–inhibitor structural complexes pave the way for structure-based drug design or virtual screening to identify novel allosteric leads and to improve the binding affinity to existing allosteric modulators.</div><div class="NLM_p">Among the reported GLS1 allosteric inhibitors, <b>CB-839</b><a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> is the first-in-class GLS1 inhibitor in glutamine metabolism that displays on-target cellular activity as indicated by its ability to suppress key glutamate-derived metabolic intermediates that support macromolecule synthesis, ATP production, and cellular redox balance. However, by now, nearly all preclinical studies or clinical studies have focused on the scaffold of <b>BPTES</b> and its derivatives.<a onclick="showRef(event, 'ref24 ref49 ref50 ref54 ref87'); return false;" href="javascript:void(0);" class="ref ref24 ref49 ref50 ref54 ref87">(24,49,50,54,87)</a> Several scaffolds have never been used after their initial report, probably because of specificity and/or poor drug-like properties in follow-up studies. Hence, the discovery of novel chemotypes serving as GLS1 inhibitors is urgent needed. To support the quest for novel GLS1 inhibitors, possible strategies in the scope of medicinal chemistry would be employed, such as scaffold hopping, bioisosteric replacement, combination of high throughput, and in silico screening, and so on for the design of GLS1 inhibitors. To accelerate future progress, the assays to monitor GLS1 modulation have also been reviewed. In the next period, further studies around novel scaffolds are anticipated to be discovered to obtain the deep insight into the mechanism of GLS1 activation.</div><div class="NLM_p">In the future, except for waiting the progress of <b>CB-839</b> in clinical studies which may bring a new research direction for the treatment of cancer, the combination strategy should also get some attention. Because tumor cells could bypass the need for glutamine through different oncogenic drivers, recent findings have proved that inhibition of GLS alone is insufficient to halt progression of some tumors. Thus, inhibiting multiple targets in glutamine metabolism pathway synergistically may be a more effective strategy to employ the glutamine metabolism to cancer therapy. While researching GLS1 inhibitors, several other inhibitors focus on the different targets in glutamine metabolism have been well studied, e.g., the discovery of <b>V-9302</b>,<a onclick="showRef(event, 'ref103 ref104'); return false;" href="javascript:void(0);" class="ref ref103 ref104">(103,104)</a> the first pharmacological inhibitor of the glutamine transporter ASCT2, substantially supported that antagonizing glutamine metabolism at the transporter level represents a potentially viable approach in precision cancer medicine. Combination of this inhibitor with efficient GLS1 inhibitors could be a potential strategy for pairing patients harboring glutamine-dependent tumors.</div><div class="NLM_p last">The huge therapeutic potential of glutamine metabolism has led the drug discovery for it. The glutaminase enzymes are the key players in facilitating the use of glutamine as an energy source, especially for GLS1, which is now the research hot-spot in this field. By now, although several potent inhibitors have been developed, the drug-like properties need to be optimized. Furthermore, the GLS1 inhibition or the exhaustion of glutamine metabolism pathway have been identified, but the applicable patient still need to be clarified. It is of paramount important for glutamine-based imaging into clinical practice to differentiate tumors that take up glutamine from those that do not.</div></div><div class="NLM_back"><div class="article_supporting-info" id="NOTES-d7e3009-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i36"><a href="/doi/suppl/10.1021/acs.jmedchem.8b00961" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_52474" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_52474" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.8b00961" class="ext-link">10.1021/acs.jmedchem.8b00961</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Summary of chemical structures, IC<sub>50</sub>, and reference of representative GLS1 inhibitors (<a href="/doi/suppl/10.1021/acs.jmedchem.8b00961/suppl_file/jm8b00961_si_001.docx" class="ext-link">DOCX</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b00961/suppl_file/jm8b00961_si_001.docx">jm8b00961_si_001.docx (454.37 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.8b00961" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_21422" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_21422" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Zhiyu Li</span> - <span class="hlFld-Affiliation affiliation">Department
of Medicinal Chemistry, China Pharmaceutical
University, 24 Tongjiaxiang, Nanjing 210009, P. R. China</span>; 
    <span class="hlFld-Affiliation affiliation">Jiangsu
Key Laboratory of Drug Design and Optimization, China Pharmaceutical University, Nanjing 21009, P. R. China</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-6492-9511" title="Orcid link">http://orcid.org/0000-0001-6492-9511</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#94eefcfdede1f8fdd4f7e4e1baf1f0e1baf7fa"><span class="__cf_email__" data-cfemail="92e8fafbebe7fefbd2f1e2e7bcf7f6e7bcf1fc">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jinlei Bian</span> - <span class="hlFld-Affiliation affiliation">Department
of Medicinal Chemistry, China Pharmaceutical
University, 24 Tongjiaxiang, Nanjing 210009, P. R. China</span>; 
    <span class="hlFld-Affiliation affiliation">Jiangsu
Key Laboratory of Drug Design and Optimization, China Pharmaceutical University, Nanjing 21009, P. R. China</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#1f7d767e7175735f7c6f6a317a7b6a317c71"><span class="__cf_email__" data-cfemail="04666d656a6e68446774712a6160712a676a">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Xi Xu</span> - <span class="hlFld-Affiliation affiliation">Department
of Medicinal Chemistry, China Pharmaceutical
University, 24 Tongjiaxiang, Nanjing 210009, P. R. China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ying Meng</span> - <span class="hlFld-Affiliation affiliation">Department
of Medicinal Chemistry, China Pharmaceutical
University, 24 Tongjiaxiang, Nanjing 210009, P. R. China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Lei Li</span> - <span class="hlFld-Affiliation affiliation">Department
of Medicinal Chemistry, China Pharmaceutical
University, 24 Tongjiaxiang, Nanjing 210009, P. R. China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Pengfei Xu</span> - <span class="hlFld-Affiliation affiliation">Department
of Medicinal Chemistry, China Pharmaceutical
University, 24 Tongjiaxiang, Nanjing 210009, P. R. China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jubo Wang</span> - <span class="hlFld-Affiliation affiliation">Department
of Medicinal Chemistry, China Pharmaceutical
University, 24 Tongjiaxiang, Nanjing 210009, P. R. China</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>Jinlei Bian and Xi Xu are responsible for writing the whole manuscript. Zhiyu Li, Jinlei Bian, and Ying Meng are in charge of checking and revision. Ying Meng contributed much work to create figures of the glutamine metabolism pathway.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="bio" rid="ath1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="biographies">Biographies</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_81505" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_81505" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><figure id="ath1" data-index="16" class="article__inlineFigure"><h2 class="fig-label">Xi Xu</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00961&amp;id=BIO-d7e3035-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Xi Xu</b> received his Master’s degree at China Pharmaceutical University in 2017. Currently, he is pursuing his Ph.D. in the major of Medicinal Chemistry under the supervision of Professor Zhiyu Li. His research topic is mainly focused on the design, synthesis, and biological evaluation of potent and selective small molecule GLS1 inhibitors.</p></figure></div><div class="bio" rid="ath2"><figure id="ath2" data-index="17" class="article__inlineFigure"><h2 class="fig-label">Ying Meng</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00961&amp;id=BIO-d7e3040-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Ying Meng</b> got her Bachelor’s degree from Shandong University of Traditional Chinese Medicine in 2017. She is currently a postgraduate student at the Department of Medicinal Chemistry, China Pharmaceutical University, under the supervision of Professor Zhiyu Li. Her research mainly focuses on the structural optimization and biological evaluation of GLS1 inhibitors.</p></figure></div><div class="bio" rid="ath3"><figure id="ath3" data-index="18" class="article__inlineFigure"><h2 class="fig-label">Lei Li</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00961&amp;id=BIO-d7e3045-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Lei Li</b> got his Bachelor’s degree from Huaqiao University in 2016. He went on to advanced study in medicinal chemistry, China Pharmaceutical University, in the research group of Professor Zhiyu Li. His research focuses on design and synthesis of androgen receptor antagonists for the treatment of prostate cancer.</p></figure></div><div class="bio" rid="ath4"><figure id="ath4" data-index="19" class="article__inlineFigure"><h2 class="fig-label">Pengfei Xu</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00961&amp;id=BIO-d7e3050-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Pengfei Xu</b>, a graduate student, will soon receive his Master’s degree at China Pharmaceutical University under the supervision of Professor Zhiyu Li. Meanwhile, he will also continue pursuing his Ph.D. degree in our group. During his postgraduate stage, his research work mainly focused on the optimization of synthetic processes.</p></figure></div><div class="bio" rid="ath5"><figure id="ath5" data-index="20" class="article__inlineFigure"><h2 class="fig-label">Jubo Wang</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00961&amp;id=BIO-d7e3055-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Jubo Wang</b> achieved his Master’s degree at China Pharmaceutical University in 2012. After working several years in pharmaceutical companies, he selected to study his Ph.D. in the major of Medicinal Chemistry under the supervision of Professor Zhiyu Li in 2016. His research topic is mainly focused on the design, synthesis, and biological evaluation of potent and selective CDK9 inhibitors.</p></figure></div><div class="bio" rid="ath6"><figure id="ath6" data-index="21" class="article__inlineFigure"><h2 class="fig-label">Zhiyu Li</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00961&amp;id=BIO-d7e3060-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Zhiyu Li</b> graduated from China Pharmaceutical University with his Bachelor’s and Master’s degrees in 1988. He received his Ph.D. in medicinal chemistry at the same institute in 2000. Currently, he is the director and a full professor of the Department of Medical Chemistry, School of Pharmacy, at CPU. He has published more than 50 papers in peer-reviewed journals and owns approximately 30 granted patents. His major research interests focus on the discovery and development of targeted anticancer drugs.</p></figure></div><div class="bio" rid="ath7"><figure id="ath7" data-index="22" class="article__inlineFigure"><h2 class="fig-label">Jinlei Bian</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00961&amp;id=BIO-d7e3065-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Jinlei Bian</b> received his Bachelor’s degree from China Pharmaceutical University, where he also obtained his Ph.D. in Medicinal Chemistry under the supervision of Professor Qi-Dong You. He is currently a member of the Department of Medicinal Chemistry, School of Pharmacy, China Pharmaceutical University. He works as a medicinal chemist, and his main research topics focus on the following: (i) rational design of modulators targeting tumor metabolism and (ii) the chemical biology study of GLS1.</p></figure></div><div class="ack" id="ACK-d7e3070-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i45">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_47378" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_47378" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We are thankful for the financial support of the National Natural Science Foundation of China (no. 81703347, 21672260, and 21372260), the financial support of the National Natural Science Foundation of Jiangsu Province of China (no. BK20170743 and BK20171393), the Fundamental Research Funds for the Central Universities (2632017PY13), the National Found for Fostering Talents of Basic Science (NFFTBS) of China (no. 201710316077).</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations Used</td></tr><tr><td class="NLM_term">ALL</td><td class="NLM_def"><p class="first last">acute lymphocytic leukemia</p></td></tr><tr><td class="NLM_term">AML</td><td class="NLM_def"><p class="first last">acute myeloid leukemia</p></td></tr><tr><td class="NLM_term">ASCT2</td><td class="NLM_def"><p class="first last">alanine-serine-cysteine transporter 2</p></td></tr><tr><td class="NLM_term">ASNS</td><td class="NLM_def"><p class="first last">asparagine synthetase</p></td></tr><tr><td class="NLM_term">BID</td><td class="NLM_def"><p class="first last">twice a day</p></td></tr><tr><td class="NLM_term">BLI</td><td class="NLM_def"><p class="first last">biolayer interferometry</p></td></tr><tr><td class="NLM_term">BPTES</td><td class="NLM_def"><p class="first last">bis-2-(5-phenylacetamido-1,2,4-thiadiazol-2-yl)ethyl sulfide</p></td></tr><tr><td class="NLM_term">ClogP</td><td class="NLM_def"><p class="first last">calculated octanol–water partition coefficient</p></td></tr><tr><td class="NLM_term">CSF</td><td class="NLM_def"><p class="first last">cerebrospinal fluid</p></td></tr><tr><td class="NLM_term">DLBCL</td><td class="NLM_def"><p class="first last">diffuse large B-cell lymphoma</p></td></tr><tr><td class="NLM_term">DON</td><td class="NLM_def"><p class="first last">6-diazo-5-oxo-<span class="smallcaps smallerCapital">l</span>-norleucine</p></td></tr><tr><td class="NLM_term">EDTA</td><td class="NLM_def"><p class="first last">ethylene diamine tetra acetic acid</p></td></tr><tr><td class="NLM_term">EGFR</td><td class="NLM_def"><p class="first last">epidermal growth factor receptor</p></td></tr><tr><td class="NLM_term">FRET</td><td class="NLM_def"><p class="first last">fluorescence resonance energy transfer</p></td></tr><tr><td class="NLM_term">GAC</td><td class="NLM_def"><p class="first last">glutaminase C</p></td></tr><tr><td class="NLM_term">GAB</td><td class="NLM_def"><p class="first last">glutaminase B</p></td></tr><tr><td class="NLM_term">GBM</td><td class="NLM_def"><p class="first last">glioblastoma</p></td></tr><tr><td class="NLM_term">GDH</td><td class="NLM_def"><p class="first last">glutamate dehydrogenase</p></td></tr><tr><td class="NLM_term">Gln</td><td class="NLM_def"><p class="first last">glutamine</p></td></tr><tr><td class="NLM_term">Glu</td><td class="NLM_def"><p class="first last">glutamate</p></td></tr><tr><td class="NLM_term">GLS</td><td class="NLM_def"><p class="first last">glutaminase</p></td></tr><tr><td class="NLM_term">GOT</td><td class="NLM_def"><p class="first last">glutamic oxaloacetic transaminase</p></td></tr><tr><td class="NLM_term">GPT</td><td class="NLM_def"><p class="first last">glutamic pyruvate transaminase</p></td></tr><tr><td class="NLM_term">HAND</td><td class="NLM_def"><p class="first last">HIV-associated neurocognitive disorders</p></td></tr><tr><td class="NLM_term">HLM</td><td class="NLM_def"><p class="first last">human liver microsome</p></td></tr><tr><td class="NLM_term">H<sub>2</sub>O<sub>2</sub></td><td class="NLM_def"><p class="first last">hydrogen peroxide</p></td></tr><tr><td class="NLM_term">HRP</td><td class="NLM_def"><p class="first last">horseradish peroxidase</p></td></tr><tr><td class="NLM_term">HTS</td><td class="NLM_def"><p class="first last">high-throughput screening</p></td></tr><tr><td class="NLM_term">ip</td><td class="NLM_def"><p class="first last">intraperitoneal</p></td></tr><tr><td class="NLM_term">KGA/GLS1</td><td class="NLM_def"><p class="first last">kidney-type glutaminase</p></td></tr><tr><td class="NLM_term">α-KG</td><td class="NLM_def"><p class="first last">α-ketoglutarate</p></td></tr><tr><td class="NLM_term">LAT1</td><td class="NLM_def"><p class="first last"><span class="smallcaps smallerCapital">l</span>-type amino acid transporter 1</p></td></tr><tr><td class="NLM_term">LE</td><td class="NLM_def"><p class="first last">ligand efficiency</p></td></tr><tr><td class="NLM_term">LiPE</td><td class="NLM_def"><p class="first last">lipophilic efficiency</p></td></tr><tr><td class="NLM_term">LGA/GLS2</td><td class="NLM_def"><p class="first last">liver-type glutaminase</p></td></tr><tr><td class="NLM_term">MDS</td><td class="NLM_def"><p class="first last">myelodysplastic syndrome</p></td></tr><tr><td class="NLM_term">MST</td><td class="NLM_def"><p class="first last">microscale thermophoresis</p></td></tr><tr><td class="NLM_term">NAD</td><td class="NLM_def"><p class="first last">nicotinamide adenine dinucleotide</p></td></tr><tr><td class="NLM_term">NADP</td><td class="NLM_def"><p class="first last">nicotinamide adenine dinucleotide phosphate</p></td></tr><tr><td class="NLM_term">NHL</td><td class="NLM_def"><p class="first last">non-Hodgkin’s lymphoma</p></td></tr><tr><td class="NLM_term">NRB</td><td class="NLM_def"><p class="first last">number of rotatable bonds</p></td></tr><tr><td class="NLM_term">NSCLC</td><td class="NLM_def"><p class="first last">nonsmall cell lung cancer</p></td></tr><tr><td class="NLM_term">PDX</td><td class="NLM_def"><p class="first last">patient derived xenograft</p></td></tr><tr><td class="NLM_term">PIK3CA</td><td class="NLM_def"><p class="first last">phosphatidylinositol-4,5-bisphosphonate 3-kinase, catalytic subunit alpha polypeptide gene</p></td></tr><tr><td class="NLM_term">PSAT1</td><td class="NLM_def"><p class="first last">phosphoserine aminotransferase 1</p></td></tr><tr><td class="NLM_term">QD</td><td class="NLM_def"><p class="first last">once a day</p></td></tr><tr><td class="NLM_term">RCC</td><td class="NLM_def"><p class="first last">renal cell carcinoma</p></td></tr><tr><td class="NLM_term">SLC1A5</td><td class="NLM_def"><p class="first last">solute carrier family 1 neutral amino acid transporter member 5</p></td></tr><tr><td class="NLM_term">TCA</td><td class="NLM_def"><p class="first last">tricarboxylic acid</p></td></tr><tr><td class="NLM_term">TGI</td><td class="NLM_def"><p class="first last">tumor growth inhibition</p></td></tr><tr><td class="NLM_term">TNBC</td><td class="NLM_def"><p class="first last">triple negative breast cancer</p></td></tr><tr><td class="NLM_term">UDP-GlcNAc</td><td class="NLM_def"><p class="first last">uridine diphosphate <i>N</i>-acetylglucosamine</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i47">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_81715" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_81715" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 119 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schulze, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harris, A. L.</span></span> <span> </span><span class="NLM_article-title">How cancer metabolism is tuned for proliferation and vulnerable to disruption</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>491</i></span> (<span class="NLM_issue">7424</span>),  <span class="NLM_fpage">364</span>– <span class="NLM_lpage">373</span>, <span class="refDoi"> DOI: 10.1038/nature11706</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=10.1038%2Fnature11706" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=23151579" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhs1Ogt77F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=491&publication_year=2012&pages=364-373&issue=7424&author=A.+Schulzeauthor=A.+L.+Harris&title=How+cancer+metabolism+is+tuned+for+proliferation+and+vulnerable+to+disruption&doi=10.1038%2Fnature11706"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">How cancer metabolism is tuned for proliferation and vulnerable to disruption</span></div><div class="casAuthors">Schulze, Almut; Harris, Adrian L.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">491</span>
        (<span class="NLM_cas:issue">7424</span>),
    <span class="NLM_cas:pages">364-373</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Cancer metab. has received a substantial amt. of interest over the past decade.  The advances in anal. tools have, along with the rapid progress of cancer genomics, generated an increasingly complex understanding of metabolic reprogramming in cancer.  As numerous connections between oncogenic signalling pathways and metabolic activities emerge, the importance of metabolic reprogramming in cancer is being increasingly recognized.  The identification of metabolic weaknesses of cancer cells has been used to create strategies for treating cancer, but there are still challenges to be faced in bringing the drugs that target cancer metab. to the clinic.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoBw8y9SFJ0lLVg90H21EOLACvtfcHk0lh-xlF6DqlxKg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhs1Ogt77F&md5=73cdad5f0a8652993ff162b9b1ba6fe7</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1038%2Fnature11706&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature11706%26sid%3Dliteratum%253Aachs%26aulast%3DSchulze%26aufirst%3DA.%26aulast%3DHarris%26aufirst%3DA.%2BL.%26atitle%3DHow%2520cancer%2520metabolism%2520is%2520tuned%2520for%2520proliferation%2520and%2520vulnerable%2520to%2520disruption%26jtitle%3DNature%26date%3D2012%26volume%3D491%26issue%3D7424%26spage%3D364%26epage%3D373%26doi%3D10.1038%2Fnature11706" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Warburg, O.</span></span> <span> </span><span class="NLM_article-title">On the origin of cancer cells</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">1956</span>,  <span class="NLM_volume"><i>123</i></span>,  <span class="NLM_fpage">309</span>– <span class="NLM_lpage">314</span>, <span class="refDoi"> DOI: 10.1126/science.123.3191.309</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=10.1126%2Fscience.123.3191.309" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=13298683" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=1%3ACAS%3A280%3ADyaG28%252FltV2ktQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=123&publication_year=1956&pages=309-314&author=O.+Warburg&title=On+the+origin+of+cancer+cells&doi=10.1126%2Fscience.123.3191.309"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">On the origin of cancer cells</span></div><div class="casAuthors">WARBURG O</div><div class="citationInfo"><span class="NLM_cas:title">Science (New York, N.Y.)</span>
        (<span class="NLM_cas:date">1956</span>),
    <span class="NLM_cas:volume">123</span>
        (<span class="NLM_cas:issue">3191</span>),
    <span class="NLM_cas:pages">309-14</span>
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRDsp1coYpQW669lAbTj9rGfW6udTcc2ebhnb55pcFVgrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaG28%252FltV2ktQ%253D%253D&md5=860d5ce9456831968fcc897b37d6d9c2</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1126%2Fscience.123.3191.309&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.123.3191.309%26sid%3Dliteratum%253Aachs%26aulast%3DWarburg%26aufirst%3DO.%26atitle%3DOn%2520the%2520origin%2520of%2520cancer%2520cells%26jtitle%3DScience%26date%3D1956%26volume%3D123%26spage%3D309%26epage%3D314%26doi%3D10.1126%2Fscience.123.3191.309" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hensley, C. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wasti, A. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeBerardinis, R. J.</span></span> <span> </span><span class="NLM_article-title">Glutamine and cancer: cell biology, physiology, and clinical opportunities</span>. <i>J. Clin. Invest.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>123</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">3678</span>– <span class="NLM_lpage">3684</span>, <span class="refDoi"> DOI: 10.1172/JCI69600</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=10.1172%2FJCI69600" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=123&publication_year=2013&pages=3678-3684&issue=9&author=C.+T.+Hensleyauthor=A.+T.+Wastiauthor=R.+J.+DeBerardinis&title=Glutamine+and+cancer%3A+cell+biology%2C+physiology%2C+and+clinical+opportunities&doi=10.1172%2FJCI69600"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1172%2FJCI69600&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1172%252FJCI69600%26sid%3Dliteratum%253Aachs%26aulast%3DHensley%26aufirst%3DC.%2BT.%26aulast%3DWasti%26aufirst%3DA.%2BT.%26aulast%3DDeBerardinis%26aufirst%3DR.%2BJ.%26atitle%3DGlutamine%2520and%2520cancer%253A%2520cell%2520biology%252C%2520physiology%252C%2520and%2520clinical%2520opportunities%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2013%26volume%3D123%26issue%3D9%26spage%3D3678%26epage%3D3684%26doi%3D10.1172%2FJCI69600" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bergström, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fürst, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Norée, L. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vinnars, E.</span></span> <span> </span><span class="NLM_article-title">Intracellular free amino acid concentration in human muscle tissue</span>. <i>J. Appl. Physiol.</i> <span class="NLM_year" style="font-weight: bold;">1974</span>,  <span class="NLM_volume"><i>36</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">693</span>– <span class="NLM_lpage">697</span>, <span class="refDoi"> DOI: 10.1152/jappl.1974.36.6.693</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=10.1152%2Fjappl.1974.36.6.693" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=1974&pages=693-697&issue=6&author=J.+Bergstr%C3%B6mauthor=P.+F%C3%BCrstauthor=L.+O.+Nor%C3%A9eauthor=E.+Vinnars&title=Intracellular+free+amino+acid+concentration+in+human+muscle+tissue&doi=10.1152%2Fjappl.1974.36.6.693"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1152%2Fjappl.1974.36.6.693&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1152%252Fjappl.1974.36.6.693%26sid%3Dliteratum%253Aachs%26aulast%3DBergstr%25C3%25B6m%26aufirst%3DJ.%26aulast%3DF%25C3%25BCrst%26aufirst%3DP.%26aulast%3DNor%25C3%25A9e%26aufirst%3DL.%2BO.%26aulast%3DVinnars%26aufirst%3DE.%26atitle%3DIntracellular%2520free%2520amino%2520acid%2520concentration%2520in%2520human%2520muscle%2520tissue%26jtitle%3DJ.%2520Appl.%2520Physiol.%26date%3D1974%26volume%3D36%26issue%3D6%26spage%3D693%26epage%3D697%26doi%3D10.1152%2Fjappl.1974.36.6.693" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dranoff, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elion, G. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Friedman, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campbell, G. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bigner, D. D.</span></span> <span> </span><span class="NLM_article-title">Influence of glutamine on the growth of human glioma and medulloblastoma in culture</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">1985</span>,  <span class="NLM_volume"><i>45</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">4077</span>– <span class="NLM_lpage">4081</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=1985&pages=4077-4081&issue=9&author=G.+Dranoffauthor=G.+B.+Elionauthor=H.+S.+Friedmanauthor=G.+L.+Campbellauthor=D.+D.+Bigner&title=Influence+of+glutamine+on+the+growth+of+human+glioma+and+medulloblastoma+in+culture"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDranoff%26aufirst%3DG.%26aulast%3DElion%26aufirst%3DG.%2BB.%26aulast%3DFriedman%26aufirst%3DH.%2BS.%26aulast%3DCampbell%26aufirst%3DG.%2BL.%26aulast%3DBigner%26aufirst%3DD.%2BD.%26atitle%3DInfluence%2520of%2520glutamine%2520on%2520the%2520growth%2520of%2520human%2520glioma%2520and%2520medulloblastoma%2520in%2520culture%26jtitle%3DCancer%2520Res.%26date%3D1985%26volume%3D45%26issue%3D9%26spage%3D4077%26epage%3D4081" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fogal, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Babic, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pastorino, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mukthavaram, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cho, Y. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pingle, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crawford, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piccioni, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kesari, S.</span></span> <span> </span><span class="NLM_article-title">Mitochondrial p32 is upregulated in Myc expressing brain cancers and mediates glutamine addiction</span>. <i>Oncotarget</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>6</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">1157</span>– <span class="NLM_lpage">1170</span>, <span class="refDoi"> DOI: 10.18632/oncotarget.2708</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=10.18632%2Foncotarget.2708" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=1157-1170&issue=2&author=V.+Fogalauthor=I.+Babicauthor=Y.+Chaoauthor=S.+Pastorinoauthor=R.+Mukthavaramauthor=P.+Jiangauthor=Y.+J.+Choauthor=S.+C.+Pingleauthor=J.+R.+Crawfordauthor=D.+E.+Piccioniauthor=S.+Kesari&title=Mitochondrial+p32+is+upregulated+in+Myc+expressing+brain+cancers+and+mediates+glutamine+addiction&doi=10.18632%2Foncotarget.2708"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.2708&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.2708%26sid%3Dliteratum%253Aachs%26aulast%3DFogal%26aufirst%3DV.%26aulast%3DBabic%26aufirst%3DI.%26aulast%3DChao%26aufirst%3DY.%26aulast%3DPastorino%26aufirst%3DS.%26aulast%3DMukthavaram%26aufirst%3DR.%26aulast%3DJiang%26aufirst%3DP.%26aulast%3DCho%26aufirst%3DY.%2BJ.%26aulast%3DPingle%26aufirst%3DS.%2BC.%26aulast%3DCrawford%26aufirst%3DJ.%2BR.%26aulast%3DPiccioni%26aufirst%3DD.%2BE.%26aulast%3DKesari%26aufirst%3DS.%26atitle%3DMitochondrial%2520p32%2520is%2520upregulated%2520in%2520Myc%2520expressing%2520brain%2520cancers%2520and%2520mediates%2520glutamine%2520addiction%26jtitle%3DOncotarget%26date%3D2015%26volume%3D6%26issue%3D2%26spage%3D1157%26epage%3D1170%26doi%3D10.18632%2Foncotarget.2708" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ru, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chakravarti, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, D.</span></span> <span> </span><span class="NLM_article-title">Tumor metabolism of malignant gliomas</span>. <i>Cancers</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>5</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">1469</span>– <span class="NLM_lpage">1484</span>, <span class="refDoi"> DOI: 10.3390/cancers5041469</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=10.3390%2Fcancers5041469" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2013&pages=1469-1484&issue=4&author=P.+Ruauthor=T.+M.+Williamsauthor=A.+Chakravartiauthor=D.+Guo&title=Tumor+metabolism+of+malignant+gliomas&doi=10.3390%2Fcancers5041469"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.3390%2Fcancers5041469&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fcancers5041469%26sid%3Dliteratum%253Aachs%26aulast%3DRu%26aufirst%3DP.%26aulast%3DWilliams%26aufirst%3DT.%2BM.%26aulast%3DChakravarti%26aufirst%3DA.%26aulast%3DGuo%26aufirst%3DD.%26atitle%3DTumor%2520metabolism%2520of%2520malignant%2520gliomas%26jtitle%3DCancers%26date%3D2013%26volume%3D5%26issue%3D4%26spage%3D1469%26epage%3D1484%26doi%3D10.3390%2Fcancers5041469" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tanaka, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sasayama, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Irino, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takata, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagashima, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Satoh, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kyotani, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mizowaki, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Imahori, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ejima, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Masui, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gini, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hosoda, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sasaki, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mischel, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kohmura, E.</span></span> <span> </span><span class="NLM_article-title">Compensatory glutamine metabolism promotes glioblastoma resistance to mTOR inhibitor treatment</span>. <i>J. Clin. Invest.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>125</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">1591</span>– <span class="NLM_lpage">1602</span>, <span class="refDoi"> DOI: 10.1172/JCI78239</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=10.1172%2FJCI78239" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=125&publication_year=2015&pages=1591-1602&issue=4&author=K.+Tanakaauthor=T.+Sasayamaauthor=Y.+Irinoauthor=K.+Takataauthor=H.+Nagashimaauthor=N.+Satohauthor=K.+Kyotaniauthor=T.+Mizowakiauthor=T.+Imahoriauthor=Y.+Ejimaauthor=K.+Masuiauthor=B.+Giniauthor=H.+Yangauthor=K.+Hosodaauthor=R.+Sasakiauthor=P.+S.+Mischelauthor=E.+Kohmura&title=Compensatory+glutamine+metabolism+promotes+glioblastoma+resistance+to+mTOR+inhibitor+treatment&doi=10.1172%2FJCI78239"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1172%2FJCI78239&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1172%252FJCI78239%26sid%3Dliteratum%253Aachs%26aulast%3DTanaka%26aufirst%3DK.%26aulast%3DSasayama%26aufirst%3DT.%26aulast%3DIrino%26aufirst%3DY.%26aulast%3DTakata%26aufirst%3DK.%26aulast%3DNagashima%26aufirst%3DH.%26aulast%3DSatoh%26aufirst%3DN.%26aulast%3DKyotani%26aufirst%3DK.%26aulast%3DMizowaki%26aufirst%3DT.%26aulast%3DImahori%26aufirst%3DT.%26aulast%3DEjima%26aufirst%3DY.%26aulast%3DMasui%26aufirst%3DK.%26aulast%3DGini%26aufirst%3DB.%26aulast%3DYang%26aufirst%3DH.%26aulast%3DHosoda%26aufirst%3DK.%26aulast%3DSasaki%26aufirst%3DR.%26aulast%3DMischel%26aufirst%3DP.%2BS.%26aulast%3DKohmura%26aufirst%3DE.%26atitle%3DCompensatory%2520glutamine%2520metabolism%2520promotes%2520glioblastoma%2520resistance%2520to%2520mTOR%2520inhibitor%2520treatment%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2015%26volume%3D125%26issue%3D4%26spage%3D1591%26epage%3D1602%26doi%3D10.1172%2FJCI78239" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wise, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, C. B.</span></span> <span> </span><span class="NLM_article-title">Glutamine addiction: a new therapeutic target in cancer</span>. <i>Trends Biochem. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>35</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">427</span>– <span class="NLM_lpage">433</span>, <span class="refDoi"> DOI: 10.1016/j.tibs.2010.05.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=10.1016%2Fj.tibs.2010.05.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=20570523" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=1%3ACAS%3A528%3ADC%252BC3cXpvFKqs7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2010&pages=427-433&issue=8&author=D.+R.+Wiseauthor=C.+B.+Thompson&title=Glutamine+addiction%3A+a+new+therapeutic+target+in+cancer&doi=10.1016%2Fj.tibs.2010.05.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Glutamine addiction: A new therapeutic target in cancer</span></div><div class="casAuthors">Wise, David R.; Thompson, Craig B.</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Biochemical Sciences</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">427-433</span>CODEN:
                <span class="NLM_cas:coden">TBSCDB</span>;
        ISSN:<span class="NLM_cas:issn">0968-0004</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Most cancers depend on a high rate of aerobic glycolysis for their continued growth and survival.  Paradoxically, some cancer cell lines also display addiction to glutamine despite the fact that glutamine is a nonessential amino acid that can be synthesized from glucose.  The high rate of glutamine uptake exhibited by glutamine-dependent cells does not appear to result solely from its role as a nitrogen donor in nucleotide and amino acid biosynthesis.  Instead, glutamine plays a required role in the uptake of essential amino acids and in maintaining activation of TOR (target of rapamycin) kinase.  Moreover, in many cancer cells, glutamine is the primary mitochondrial substrate and is required for maintenance of mitochondrial membrane potential and integrity and for support of the NADPH prodn. needed for redox control and macromol. synthesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo4Gv_LsNdulLVg90H21EOLACvtfcHk0ljaeBC4xmr2kA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXpvFKqs7s%253D&md5=915fa51996bc1c9b3ec3970b2dae7163</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2Fj.tibs.2010.05.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tibs.2010.05.003%26sid%3Dliteratum%253Aachs%26aulast%3DWise%26aufirst%3DD.%2BR.%26aulast%3DThompson%26aufirst%3DC.%2BB.%26atitle%3DGlutamine%2520addiction%253A%2520a%2520new%2520therapeutic%2520target%2520in%2520cancer%26jtitle%3DTrends%2520Biochem.%2520Sci.%26date%3D2010%26volume%3D35%26issue%3D8%26spage%3D427%26epage%3D433%26doi%3D10.1016%2Fj.tibs.2010.05.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stern, H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ge, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Brien, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haydu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Honchell, C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haverty, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peters, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, T. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amler, L. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chant, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stokoe, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lackner, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cavet, G.</span></span> <span> </span><span class="NLM_article-title">Genetic alterations and oncogenic pathways associated with breast cancer subtypes</span>. <i>Mol. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">511</span>– <span class="NLM_lpage">522</span>, <span class="refDoi"> DOI: 10.1158/1541-7786.MCR-08-0107</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=10.1158%2F1541-7786.MCR-08-0107" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=19372580" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=1%3ACAS%3A528%3ADC%252BD1MXks1antb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2009&pages=511-522&author=X.+Huauthor=H.+M.+Sternauthor=L.+Geauthor=C.+O%E2%80%99Brienauthor=L.+Hayduauthor=C.+D.+Honchellauthor=P.+M.+Havertyauthor=B.+A.+Petersauthor=T.+D.+Wuauthor=L.+C.+Amlerauthor=J.+Chantauthor=D.+Stokoeauthor=M.+R.+Lacknerauthor=G.+Cavet&title=Genetic+alterations+and+oncogenic+pathways+associated+with+breast+cancer+subtypes&doi=10.1158%2F1541-7786.MCR-08-0107"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Genetic alterations and oncogenic pathways associated with breast cancer subtypes</span></div><div class="casAuthors">Hu, Xiaolan; Stern, Howard M.; Ge, Lin; O'Brien, Carol; Haydu, Lauren; Honchell, Cynthia D.; Haverty, Peter M.; Peters, Brock A.; Wu, Thomas D.; Amler, Lukas C.; Chant, John; Stokoe, David; Lackner, Mark R.; Cavet, Guy</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Research</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">511-522</span>CODEN:
                <span class="NLM_cas:coden">MCROC5</span>;
        ISSN:<span class="NLM_cas:issn">1541-7786</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Breast cancers can be divided into subtypes with important implications for prognosis and treatment.  We set out to characterize the genetic alterations obsd. in different breast cancer subtypes and to identify specific candidate genes and pathways assocd. with subtype biol. mRNA expression levels of estrogen receptor, progesterone receptor, and HER2 were shown to predict marker status detd. by immunohistochem. and to be effective at assigning samples to subtypes.  HER2+ cancers were shown to have the greatest frequency of high-level amplification (independent of the ERBB2 amplicon itself), but triple-neg. cancers had the highest overall frequencies of copy gain.  Triple-neg. cancers also were shown to have more frequent loss of phosphatase and tensin homolog and mutation of RB1, which may contribute to genomic instability.  We identified and validated seven regions of copy no. alteration assocd. with different subtypes, and used integrative bioinformatics anal. to identify candidate oncogenes and tumor suppressors, including ERBB2, GRB7, MYST2, PPM1D, CCND1, HDAC2, FOXA1, and RASA1.  We tested the candidate oncogene MYST2 and showed that it enhances the anchorage-independent growth of breast cancer cells.  The genome-wide and region-specific differences between subtypes suggest the differential activation of oncogenic pathways.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoJudYxsDHmfrVg90H21EOLACvtfcHk0ljaeBC4xmr2kA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXks1antb0%253D&md5=018b11118ce93239c92e229f81b286e4</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1158%2F1541-7786.MCR-08-0107&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1541-7786.MCR-08-0107%26sid%3Dliteratum%253Aachs%26aulast%3DHu%26aufirst%3DX.%26aulast%3DStern%26aufirst%3DH.%2BM.%26aulast%3DGe%26aufirst%3DL.%26aulast%3DO%25E2%2580%2599Brien%26aufirst%3DC.%26aulast%3DHaydu%26aufirst%3DL.%26aulast%3DHonchell%26aufirst%3DC.%2BD.%26aulast%3DHaverty%26aufirst%3DP.%2BM.%26aulast%3DPeters%26aufirst%3DB.%2BA.%26aulast%3DWu%26aufirst%3DT.%2BD.%26aulast%3DAmler%26aufirst%3DL.%2BC.%26aulast%3DChant%26aufirst%3DJ.%26aulast%3DStokoe%26aufirst%3DD.%26aulast%3DLackner%26aufirst%3DM.%2BR.%26aulast%3DCavet%26aufirst%3DG.%26atitle%3DGenetic%2520alterations%2520and%2520oncogenic%2520pathways%2520associated%2520with%2520breast%2520cancer%2520subtypes%26jtitle%3DMol.%2520Cancer%2520Res.%26date%3D2009%26volume%3D7%26spage%3D511%26epage%3D522%26doi%3D10.1158%2F1541-7786.MCR-08-0107" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bhutia, Y. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Babu, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramachandran, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ganapathy, V.</span></span> <span> </span><span class="NLM_article-title">Amino acid transporters in cancer and their relevance to “glutamine addiction”: novel targets for the design of a new class of anticancer drugs</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>75</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">1782</span>– <span class="NLM_lpage">1788</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-14-3745</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=10.1158%2F0008-5472.CAN-14-3745" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=75&publication_year=2015&pages=1782-1788&issue=9&author=Y.+D.+Bhutiaauthor=E.+Babuauthor=S.+Ramachandranauthor=V.+Ganapathy&title=Amino+acid+transporters+in+cancer+and+their+relevance+to+%E2%80%9Cglutamine+addiction%E2%80%9D%3A+novel+targets+for+the+design+of+a+new+class+of+anticancer+drugs&doi=10.1158%2F0008-5472.CAN-14-3745"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-14-3745&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-14-3745%26sid%3Dliteratum%253Aachs%26aulast%3DBhutia%26aufirst%3DY.%2BD.%26aulast%3DBabu%26aufirst%3DE.%26aulast%3DRamachandran%26aufirst%3DS.%26aulast%3DGanapathy%26aufirst%3DV.%26atitle%3DAmino%2520acid%2520transporters%2520in%2520cancer%2520and%2520their%2520relevance%2520to%2520%25E2%2580%259Cglutamine%2520addiction%25E2%2580%259D%253A%2520novel%2520targets%2520for%2520the%2520design%2520of%2520a%2520new%2520class%2520of%2520anticancer%2520drugs%26jtitle%3DCancer%2520Res.%26date%3D2015%26volume%3D75%26issue%3D9%26spage%3D1782%26epage%3D1788%26doi%3D10.1158%2F0008-5472.CAN-14-3745" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Krebs, H. A.</span></span> <span> </span><span class="NLM_article-title">Metabolism of amino-acids: The synthesis of glutamine from glutamic acid and ammonia, and the enzymic hydrolysis of glutamine in animal tissues</span>. <i>Biochem. J.</i> <span class="NLM_year" style="font-weight: bold;">1935</span>,  <span class="NLM_volume"><i>29</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">1951</span>– <span class="NLM_lpage">1969</span>, <span class="refDoi"> DOI: 10.1042/bj0291951</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=10.1042%2Fbj0291951" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=1935&pages=1951-1969&issue=8&author=H.+A.+Krebs&title=Metabolism+of+amino-acids%3A+The+synthesis+of+glutamine+from+glutamic+acid+and+ammonia%2C+and+the+enzymic+hydrolysis+of+glutamine+in+animal+tissues&doi=10.1042%2Fbj0291951"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1042%2Fbj0291951&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252Fbj0291951%26sid%3Dliteratum%253Aachs%26aulast%3DKrebs%26aufirst%3DH.%2BA.%26atitle%3DMetabolism%2520of%2520amino-acids%253A%2520The%2520synthesis%2520of%2520glutamine%2520from%2520glutamic%2520acid%2520and%2520ammonia%252C%2520and%2520the%2520enzymic%2520hydrolysis%2520of%2520glutamine%2520in%2520animal%2520tissues%26jtitle%3DBiochem.%2520J.%26date%3D1935%26volume%3D29%26issue%3D8%26spage%3D1951%26epage%3D1969%26doi%3D10.1042%2Fbj0291951" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Curthoys, N. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watford, M.</span></span> <span> </span><span class="NLM_article-title">Regulation of glutaminase activity and glutamine metabolism</span>. <i>Annu. Rev. Nutr.</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">133</span>– <span class="NLM_lpage">159</span>, <span class="refDoi"> DOI: 10.1146/annurev.nu.15.070195.001025</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=10.1146%2Fannurev.nu.15.070195.001025" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=8527215" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=1%3ACAS%3A528%3ADyaK2MXntVCjsro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=1995&pages=133-159&author=N.+P.+Curthoysauthor=M.+Watford&title=Regulation+of+glutaminase+activity+and+glutamine+metabolism&doi=10.1146%2Fannurev.nu.15.070195.001025"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Regulation glutaminase activity and glutamine metabolism</span></div><div class="casAuthors">Curthoys, Norman P.; Watford, Malcolm</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Nutrition</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">133-59</span>CODEN:
                <span class="NLM_cas:coden">ARNTD8</span>;
        ISSN:<span class="NLM_cas:issn">0199-9885</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews</span>)
        </div><div class="casAbstract">A review with 140 refs.  Glutamine is synthesized primarily in skeletal muscle, lungs, and adipose tissue.  Plasma glutamine plays an important role as a carrier of nitrogen, carbon, and energy between organs and is used for hepatic urea synthesis, for renal ammoniagenesis, for gluconeogenesis in both liver and kidney, and as a major respiratory fuel for many cells.  The catabolism of glutamine is initiated by either of two isoforms of the mitochondrial glutaminase.  Liver-type glutaminase is expressed only in periportal hepatocytes of the postnatal liver, where it effectively couples ammonia prodn. with urea synthesis.  Kidney-type glutaminase is abundant in kidney, brain, intestine, fetal liver, lymphocytes, and transformed cells, where the resulting ammonia is released without further metab.  The two isoenzymes have different structural and kinetic properties that contribute to their function and short-term regulation.  Although there is a high degree of identity in amino acid sequences, the two glutaminases are the products of different but related genes.  The two isoenzymes are also subject to long-term regulation.  Hepatic glutaminase is increased during starvation, diabetes, and feeding a high-protein diet, whereas kidney-type glutaminase is increased only in kidney in response to metabolic acidosis.  The adaptations in hepatic glutaminase are mediated by changes in the rate of transcription, whereas kidney-type glutaminase is regulated at a posttranscriptional level.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpuwFIcwEfNprVg90H21EOLACvtfcHk0lh2ZyPMs52vmQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXntVCjsro%253D&md5=dade1bde55e6f616f609d5072bf591db</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1146%2Fannurev.nu.15.070195.001025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.nu.15.070195.001025%26sid%3Dliteratum%253Aachs%26aulast%3DCurthoys%26aufirst%3DN.%2BP.%26aulast%3DWatford%26aufirst%3DM.%26atitle%3DRegulation%2520of%2520glutaminase%2520activity%2520and%2520glutamine%2520metabolism%26jtitle%3DAnnu.%2520Rev.%2520Nutr.%26date%3D1995%26volume%3D15%26spage%3D133%26epage%3D159%26doi%3D10.1146%2Fannurev.nu.15.070195.001025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Moreadith, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lehninger, A. L.</span></span> <span> </span><span class="NLM_article-title">The pathways of glutamate and glutamine oxidation by tumor cell mitochondria. Role of mitochondrial NAD(P)<sup>+</sup>-dependent malic enzyme</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1984</span>,  <span class="NLM_volume"><i>259</i></span>,  <span class="NLM_fpage">6215</span>– <span class="NLM_lpage">6221</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=259&publication_year=1984&pages=6215-6221&author=R.+W.+Moreadithauthor=A.+L.+Lehninger&title=The+pathways+of+glutamate+and+glutamine+oxidation+by+tumor+cell+mitochondria.+Role+of+mitochondrial+NAD%28P%29%2B-dependent+malic+enzyme"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMoreadith%26aufirst%3DR.%2BW.%26aulast%3DLehninger%26aufirst%3DA.%2BL.%26atitle%3DThe%2520pathways%2520of%2520glutamate%2520and%2520glutamine%2520oxidation%2520by%2520tumor%2520cell%2520mitochondria.%2520Role%2520of%2520mitochondrial%2520NAD%2528P%2529%252B-dependent%2520malic%2520enzyme%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1984%26volume%3D259%26spage%3D6215%26epage%3D6221" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sullivan, L. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gui, D. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hosios, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bush, L. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Freinkman, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vander Heiden, M. G.</span></span> <span> </span><span class="NLM_article-title">Supporting aspartate biosynthesis is an essential function of respiration in proliferating cells</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>162</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">552</span>– <span class="NLM_lpage">563</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2015.07.017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=10.1016%2Fj.cell.2015.07.017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=26232225" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=1%3ACAS%3A528%3ADC%252BC2MXht12jsrrO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=162&publication_year=2015&pages=552-563&issue=3&author=L.+B.+Sullivanauthor=D.+Y.+Guiauthor=A.+M.+Hosiosauthor=L.+N.+Bushauthor=E.+Freinkmanauthor=M.+G.+Vander+Heiden&title=Supporting+aspartate+biosynthesis+is+an+essential+function+of+respiration+in+proliferating+cells&doi=10.1016%2Fj.cell.2015.07.017"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Supporting aspartate biosynthesis is an essential function of respiration in proliferating cells</span></div><div class="casAuthors">Sullivan, Lucas B.; Gui, Dan Y.; Hosios, Aaron M.; Bush, Lauren N.; Freinkman, Elizaveta; Vander Heiden, Matthew G.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">162</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">552-563</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Mitochondrial respiration is important for cell proliferation; however, the specific metabolic requirements fulfilled by respiration to support proliferation have not been defined.  Here, the authors show that a major role of respiration in proliferating cells is to provide electron acceptors for aspartate biosynthesis.  This finding was consistent with the observation that cells lacking a functional respiratory chain are auxotrophic for pyruvate, which serves as an exogenous electron acceptor.  Further, the pyruvate requirement could be fulfilled with an alternative electron acceptor, α-ketobutyrate, which provides cells neither carbon nor ATP.  α-Ketobutyrate restores proliferation when respiration is inhibited, suggesting that an alternative electron acceptor can substitute for respiration to support proliferation.  The authors found that electron acceptors were limiting for producing aspartate, and that supplying aspartate enabled proliferation of respiration-deficient cells in the absence of exogenous electron acceptors.  Together, these data argue a major function of respiration in proliferating cells is to support aspartate biosynthesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGodRkr248gPCLVg90H21EOLACvtfcHk0ligaqF1ZlTqbg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXht12jsrrO&md5=73ee8247da401b5dbdac31ca1954383e</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2015.07.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2015.07.017%26sid%3Dliteratum%253Aachs%26aulast%3DSullivan%26aufirst%3DL.%2BB.%26aulast%3DGui%26aufirst%3DD.%2BY.%26aulast%3DHosios%26aufirst%3DA.%2BM.%26aulast%3DBush%26aufirst%3DL.%2BN.%26aulast%3DFreinkman%26aufirst%3DE.%26aulast%3DVander%2BHeiden%26aufirst%3DM.%2BG.%26atitle%3DSupporting%2520aspartate%2520biosynthesis%2520is%2520an%2520essential%2520function%2520of%2520respiration%2520in%2520proliferating%2520cells%26jtitle%3DCell%26date%3D2015%26volume%3D162%26issue%3D3%26spage%3D552%26epage%3D563%26doi%3D10.1016%2Fj.cell.2015.07.017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Birsoy, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, W. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Freinkman, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abu-Remaileh, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sabatini, D. M.</span></span> <span> </span><span class="NLM_article-title">An essential role of the mitochondrial electron transport chain in cell proliferation is to enable aspartate synthesis</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>162</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">540</span>– <span class="NLM_lpage">551</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2015.07.016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=10.1016%2Fj.cell.2015.07.016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=26232224" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=1%3ACAS%3A528%3ADC%252BC2MXht12jsrrL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=162&publication_year=2015&pages=540-551&issue=3&author=K.+Birsoyauthor=T.+Wangauthor=W.+W.+Chenauthor=E.+Freinkmanauthor=M.+Abu-Remailehauthor=D.+M.+Sabatini&title=An+essential+role+of+the+mitochondrial+electron+transport+chain+in+cell+proliferation+is+to+enable+aspartate+synthesis&doi=10.1016%2Fj.cell.2015.07.016"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">An essential role of the mitochondrial electron transport chain in cell proliferation is to enable aspartate synthesis</span></div><div class="casAuthors">Birsoy, Kivanc; Wang, Tim; Chen, Walter W.; Freinkman, Elizaveta; Abu-Remaileh, Monther; Sabatini, David M.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">162</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">540-551</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">The mitochondrial electron transport chain (ETC) enables many metabolic processes, but why its inhibition suppresses cell proliferation is unclear.  It is also not well understood why pyruvate supplementation allows cells lacking ETC function to proliferate.  Here, the authors used a CRISPR-based genetic screen to identify genes whose loss sensitizes human cells to phenformin, a complex I inhibitor.  The screen yielded GOT1, the cytosolic aspartate aminotransferase, loss of which kills cells upon ETC inhibition.  GOT1 normally consumes aspartate to transfer electrons into mitochondria, but, upon ETC inhibition, it reverses to generate aspartate in the cytosol, which partially compensates for the loss of mitochondrial aspartate biosynthesis.  Pyruvate stimulates aspartate biosynthesis in a GOT1-dependent fashion, which is required for pyruvate to rescue proliferation of cells with ETC dysfunction.  Aspartate supplementation or overexpression of an aspartate transporter allows cells without ETC activity to proliferate.  Thus, enabling aspartate biosynthesis is an essential role of the ETC in cell proliferation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrSh9Ap9MlPcbVg90H21EOLACvtfcHk0ligaqF1ZlTqbg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXht12jsrrL&md5=d2e142821b9e2e5ff8932c6ba60f0892</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2015.07.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2015.07.016%26sid%3Dliteratum%253Aachs%26aulast%3DBirsoy%26aufirst%3DK.%26aulast%3DWang%26aufirst%3DT.%26aulast%3DChen%26aufirst%3DW.%2BW.%26aulast%3DFreinkman%26aufirst%3DE.%26aulast%3DAbu-Remaileh%26aufirst%3DM.%26aulast%3DSabatini%26aufirst%3DD.%2BM.%26atitle%3DAn%2520essential%2520role%2520of%2520the%2520mitochondrial%2520electron%2520transport%2520chain%2520in%2520cell%2520proliferation%2520is%2520to%2520enable%2520aspartate%2520synthesis%26jtitle%3DCell%26date%3D2015%26volume%3D162%26issue%3D3%26spage%3D540%26epage%3D551%26doi%3D10.1016%2Fj.cell.2015.07.016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Venneti, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cross, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takagi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhinder, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Djaballah, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kanai, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, E. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Judkins, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pawel, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baggs, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cherry, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rabinowitz, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, C. B.</span></span> <span> </span><span class="NLM_article-title">Asparagine plays a critical role in regulating cellular adaptation to glutamine depletion</span>. <i>Mol. Cell</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">205</span>– <span class="NLM_lpage">218</span>, <span class="refDoi"> DOI: 10.1016/j.molcel.2014.08.018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=10.1016%2Fj.molcel.2014.08.018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=25242145" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsFyltbbL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2014&pages=205-218&author=J.+Zhangauthor=J.+Fanauthor=S.+Vennetiauthor=J.+R.+Crossauthor=T.+Takagiauthor=B.+Bhinderauthor=H.+Djaballahauthor=M.+Kanaiauthor=E.+H.+Chengauthor=A.+R.+Judkinsauthor=B.+Pawelauthor=J.+Baggsauthor=S.+Cherryauthor=J.+D.+Rabinowitzauthor=C.+B.+Thompson&title=Asparagine+plays+a+critical+role+in+regulating+cellular+adaptation+to+glutamine+depletion&doi=10.1016%2Fj.molcel.2014.08.018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Asparagine Plays a Critical Role in Regulating Cellular Adaptation to Glutamine Depletion</span></div><div class="casAuthors">Zhang, Ji; Fan, Jing; Venneti, Sriram; Cross, Justin R.; Takagi, Toshimitsu; Bhinder, Bhavneet; Djaballah, Hakim; Kanai, Masayuki; Cheng, Emily H.; Judkins, Alexander R.; Pawel, Bruce; Baggs, Julie; Cherry, Sara; Rabinowitz, Joshua D.; Thompson, Craig B.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cell</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">205-218</span>CODEN:
                <span class="NLM_cas:coden">MOCEFL</span>;
        ISSN:<span class="NLM_cas:issn">1097-2765</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Many cancer cells consume large quantities of glutamine to maintain TCA cycle anaplerosis and support cell survival.  It was therefore surprising when RNAi screening revealed that suppression of citrate synthase (CS), the first TCA cycle enzyme, prevented glutamine-withdrawal-induced apoptosis.  CS suppression reduced TCA cycle activity and diverted oxaloacetate, the substrate of CS, into prodn. of the nonessential amino acids aspartate and asparagine.  We found that asparagine was necessary and sufficient to suppress glutamine-withdrawal-induced apoptosis without restoring the levels of other nonessential amino acids or TCA cycle intermediates.  In complete medium, tumor cells exhibiting high rates of glutamine consumption underwent rapid apoptosis when glutamine-dependent asparagine synthesis was suppressed, and expression of asparagine synthetase was statistically correlated with poor prognosis in human tumors.  Coupled with the success of L-asparaginase as a therapy for childhood leukemia, the data suggest that intracellular asparagine is a crit. suppressor of apoptosis in many human tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoQvODG2u6p1LVg90H21EOLACvtfcHk0liYxNUOhqk7lQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsFyltbbL&md5=b43ac7e343ce59ca1eeee592904f1122</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1016%2Fj.molcel.2014.08.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molcel.2014.08.018%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DFan%26aufirst%3DJ.%26aulast%3DVenneti%26aufirst%3DS.%26aulast%3DCross%26aufirst%3DJ.%2BR.%26aulast%3DTakagi%26aufirst%3DT.%26aulast%3DBhinder%26aufirst%3DB.%26aulast%3DDjaballah%26aufirst%3DH.%26aulast%3DKanai%26aufirst%3DM.%26aulast%3DCheng%26aufirst%3DE.%2BH.%26aulast%3DJudkins%26aufirst%3DA.%2BR.%26aulast%3DPawel%26aufirst%3DB.%26aulast%3DBaggs%26aufirst%3DJ.%26aulast%3DCherry%26aufirst%3DS.%26aulast%3DRabinowitz%26aufirst%3DJ.%2BD.%26aulast%3DThompson%26aufirst%3DC.%2BB.%26atitle%3DAsparagine%2520plays%2520a%2520critical%2520role%2520in%2520regulating%2520cellular%2520adaptation%2520to%2520glutamine%2520depletion%26jtitle%3DMol.%2520Cell%26date%3D2014%26volume%3D56%26spage%3D205%26epage%3D218%26doi%3D10.1016%2Fj.molcel.2014.08.018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Locasale, J. W.</span></span> <span> </span><span class="NLM_article-title">Serine, glycine and one-carbon units: cancer metabolism in full circle</span>. <i>Nat. Rev. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>13</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">572</span>– <span class="NLM_lpage">583</span>, <span class="refDoi"> DOI: 10.1038/nrc3557</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=10.1038%2Fnrc3557" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=23822983" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtVGrsLzE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2013&pages=572-583&issue=8&author=J.+W.+Locasale&title=Serine%2C+glycine+and+one-carbon+units%3A+cancer+metabolism+in+full+circle&doi=10.1038%2Fnrc3557"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Serine, glycine and one-carbon units: cancer metabolism in full circle</span></div><div class="casAuthors">Locasale, Jason W.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">572-583</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  One-carbon metab. involving the folate and methionine cycles integrates nutritional status from amino acids, glucose and vitamins, and generates diverse outputs, such as the biosynthesis of lipids, nucleotides and proteins, the maintenance of redox status and the substrates for methylation reactions.  Long considered a 'housekeeping' process, this pathway has recently been shown to have addnl. complexity.  Genetic and functional evidence suggests that hyperactivation of this pathway is a driver of oncogenesis and establishes a link to cellular epigenetic status.  Given the wealth of clin. available agents that target one-carbon metab., these new findings could present opportunities for translation into precision cancer medicine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGro6rIkiwOb8LVg90H21EOLACvtfcHk0liYxNUOhqk7lQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtVGrsLzE&md5=96e34f61a4dd32c09cc196493804b5fc</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1038%2Fnrc3557&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc3557%26sid%3Dliteratum%253Aachs%26aulast%3DLocasale%26aufirst%3DJ.%2BW.%26atitle%3DSerine%252C%2520glycine%2520and%2520one-carbon%2520units%253A%2520cancer%2520metabolism%2520in%2520full%2520circle%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2013%26volume%3D13%26issue%3D8%26spage%3D572%26epage%3D583%26doi%3D10.1038%2Fnrc3557" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Botman, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tigchelaar, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Noorden, C. J.</span></span> <span> </span><span class="NLM_article-title">Determination of glutamate dehydrogenase activity and its kinetics in mouse tissues using metabolic mapping (quantitative enzyme histochemistry)</span>. <i>J. Histochem. Cytochem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>62</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">802</span>– <span class="NLM_lpage">812</span>, <span class="refDoi"> DOI: 10.1369/0022155414549071</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=10.1369%2F0022155414549071" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=25124006" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvFyhsb3M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2014&pages=802-812&issue=11&author=D.+Botmanauthor=W.+Tigchelaarauthor=C.+J.+Van+Noorden&title=Determination+of+glutamate+dehydrogenase+activity+and+its+kinetics+in+mouse+tissues+using+metabolic+mapping+%28quantitative+enzyme+histochemistry%29&doi=10.1369%2F0022155414549071"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Determination of glutamate dehydrogenase activity and its kinetics in mouse tissues using metabolic mapping (quantitative enzyme histochemistry)</span></div><div class="casAuthors">Botman, Dennis; Tigchelaar, Wikky; Van Noorden, Cornelis J. F.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Histochemistry and Cytochemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">802-812, 11 pp.</span>CODEN:
                <span class="NLM_cas:coden">JHCYAS</span>;
        ISSN:<span class="NLM_cas:issn">0022-1554</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications</span>)
        </div><div class="casAbstract">Glutamate dehydrogenase (GDH) catalyzes the reversible conversion of glutamate into α-ketoglutarate with the concomitant redn. of NAD(P)+ to NAD(P)H or vice versa.  GDH activity is subject to complex allosteric regulation including substrate inhibition.  To det. GDH kinetics in situ, we assessed the effects of various glutamate concns. in combination with either the coenzyme NAD+ or NADP+ on GDH activity in mouse liver cryostat sections using metabolic mapping.  NAD+-dependent GDH Vmax was 2.5-fold higher than NADP+-dependent Vmax, whereas the Km was similar, 1.92 mM vs. 1.66 mM, when NAD+ or NADP+ was used, resp.  With either coenzyme, Vmax was detd. at 10 mM glutamate and substrate inhibition was obsd. at higher glutamate concns. with a Ki of 12.2 and 3.95 for NAD+ and NADP+ used as coenzyme, resp.  NAD+- and NADP+-dependent GDH activities were examd. in various mouse tissues.  GDH activity was highest in liver and much lower in other tissues.  In all tissues, the highest activity was found when NAD+ was used as a coenzyme.  In conclusion, GDH activity in mice is highest in the liver with NAD+ as a coenzyme and highest GDH activity was detd. at a glutamate concn. of 10 mM.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqxxK2vgUMwwrVg90H21EOLACvtfcHk0liYxNUOhqk7lQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvFyhsb3M&md5=f43e572599bc5ab53c6a54b3f4e60824</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1369%2F0022155414549071&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1369%252F0022155414549071%26sid%3Dliteratum%253Aachs%26aulast%3DBotman%26aufirst%3DD.%26aulast%3DTigchelaar%26aufirst%3DW.%26aulast%3DVan%2BNoorden%26aufirst%3DC.%2BJ.%26atitle%3DDetermination%2520of%2520glutamate%2520dehydrogenase%2520activity%2520and%2520its%2520kinetics%2520in%2520mouse%2520tissues%2520using%2520metabolic%2520mapping%2520%2528quantitative%2520enzyme%2520histochemistry%2529%26jtitle%3DJ.%2520Histochem.%2520Cytochem.%26date%3D2014%26volume%3D62%26issue%3D11%26spage%3D802%26epage%3D812%26doi%3D10.1369%2F0022155414549071" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Altman, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stine, Z. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dang, C. V.</span></span> <span> </span><span class="NLM_article-title">From kerbs to clinic: glutamine metabolism to cancer therapy</span>. <i>Nat. Rev. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">619</span>– <span class="NLM_lpage">634</span>, <span class="refDoi"> DOI: 10.1038/nrc.2016.71</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=10.1038%2Fnrc.2016.71" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=27492215" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=1%3ACAS%3A528%3ADC%252BC28Xht12jurbI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2016&pages=619-634&author=B.+J.+Altmanauthor=Z.+E.+Stineauthor=C.+V.+Dang&title=From+kerbs+to+clinic%3A+glutamine+metabolism+to+cancer+therapy&doi=10.1038%2Fnrc.2016.71"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">From Krebs to clinic: glutamine metabolism to cancer therapy</span></div><div class="casAuthors">Altman, Brian J.; Stine, Zachary E.; Dang, Chi V.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">619-634</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The resurgence of research into cancer metab. has recently broadened interests beyond glucose and the Warburg effect to other nutrients, including glutamine.  Because oncogenic alterations of metab. render cancer cells addicted to nutrients, pathways involved in glycolysis or glutaminolysis could be exploited for therapeutic purposes.  In this Review, we provide an updated overview of glutamine metab. and its involvement in tumorigenesis in vitro and in vivo, and explore the recent potential applications of basic science discoveries in the clin. setting.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq2GDHcwHXcnLVg90H21EOLACvtfcHk0lj82647Pb5hXA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xht12jurbI&md5=00b34261d90a91151a3e833605c4aaec</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1038%2Fnrc.2016.71&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc.2016.71%26sid%3Dliteratum%253Aachs%26aulast%3DAltman%26aufirst%3DB.%2BJ.%26aulast%3DStine%26aufirst%3DZ.%2BE.%26aulast%3DDang%26aufirst%3DC.%2BV.%26atitle%3DFrom%2520kerbs%2520to%2520clinic%253A%2520glutamine%2520metabolism%2520to%2520cancer%2520therapy%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2016%26volume%3D16%26spage%3D619%26epage%3D634%26doi%3D10.1038%2Fnrc.2016.71" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nagase, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishikawa, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suyama, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kikuno, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirosawa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miyajima, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanaka, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kotani, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nomura, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohara, O.</span></span> <span> </span><span class="NLM_article-title">Prediction of the coding sequences of unidentifed human genes. XII. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro</span>. <i>DNA Res.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">355</span>– <span class="NLM_lpage">364</span>, <span class="refDoi"> DOI: 10.1093/dnares/5.6.355</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=10.1093%2Fdnares%2F5.6.355" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=10048485" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=1%3ACAS%3A528%3ADyaK1MXpvVSrtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=1998&pages=355-364&author=T.+Nagaseauthor=K.+Ishikawaauthor=M.+Suyamaauthor=R.+Kikunoauthor=M.+Hirosawaauthor=N.+Miyajimaauthor=A.+Tanakaauthor=H.+Kotaniauthor=N.+Nomuraauthor=O.+Ohara&title=Prediction+of+the+coding+sequences+of+unidentifed+human+genes.+XII.+The+complete+sequences+of+100+new+cDNA+clones+from+brain+which+code+for+large+proteins+in+vitro&doi=10.1093%2Fdnares%2F5.6.355"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Prediction of the coding sequences of unidentified human genes. XII. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro</span></div><div class="casAuthors">Nagase, Takahiro; Ishikawa, Ken-Ichi; Suyama, Mikita; Kikuno, Reiko; Hirosawa, Makoto; Miyajima, Nobuyuki; Tanaka, Ayako; Kotani, Hirokazu; Nomura, Nobuo; Ohara, Osamu</div><div class="citationInfo"><span class="NLM_cas:title">DNA Research</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">355-364</span>CODEN:
                <span class="NLM_cas:coden">DARSE8</span>;
        ISSN:<span class="NLM_cas:issn">1340-2838</span>.
    
            (<span class="NLM_cas:orgname">Universal Academy Press</span>)
        </div><div class="casAbstract">In this paper, we report the sequences of 100 cDNA clones newly detd. from a set of size-fractionated human brain cDNA libraries and predict the coding sequences of the corresponding genes, named KIAA0819 to KIAA0918.  These cDNA clones were selected on the basis of their coding potentials of large proteins (50 kDa and more) by using in vitro transcription/translation assays.  The sequence data showed that the av. sizes of the inserts and corresponding open reading frames are 4.4 kb and 2.5 kb (831 amino acid residues), resp.  Homol. and motif/domain searches against the public databases indicated that the predicted coding sequences of 83 genes were similar to those of known genes, 59% of which (49 genes) were categorized as coding for proteins functionally related to cell signaling/communication, cell structure/motility, and nucleic acid management.  The chromosomal locations and the expression profiles of all the genes were also examd.  For 54 clones including brain-specific ones, the mRNA levels were further examd. among 8 brain regions (amygdala, corpus callosum, cerebellum, caudate nucleus, hippocampus, substantia nigra, subthalamic nucleus, and thalamus), spinal cord, and fetal brain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGosaPvKEMOip7Vg90H21EOLACvtfcHk0lj82647Pb5hXA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXpvVSrtg%253D%253D&md5=7c1dcc5c233dea0ed711a7aca5e765bc</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1093%2Fdnares%2F5.6.355&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fdnares%252F5.6.355%26sid%3Dliteratum%253Aachs%26aulast%3DNagase%26aufirst%3DT.%26aulast%3DIshikawa%26aufirst%3DK.%26aulast%3DSuyama%26aufirst%3DM.%26aulast%3DKikuno%26aufirst%3DR.%26aulast%3DHirosawa%26aufirst%3DM.%26aulast%3DMiyajima%26aufirst%3DN.%26aulast%3DTanaka%26aufirst%3DA.%26aulast%3DKotani%26aufirst%3DH.%26aulast%3DNomura%26aufirst%3DN.%26aulast%3DOhara%26aufirst%3DO.%26atitle%3DPrediction%2520of%2520the%2520coding%2520sequences%2520of%2520unidentifed%2520human%2520genes.%2520XII.%2520The%2520complete%2520sequences%2520of%2520100%2520new%2520cDNA%2520clones%2520from%2520brain%2520which%2520code%2520for%2520large%2520proteins%2520in%2520vitro%26jtitle%3DDNA%2520Res.%26date%3D1998%26volume%3D5%26spage%3D355%26epage%3D364%26doi%3D10.1093%2Fdnares%2F5.6.355" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Elgadi, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meguid, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qian, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Souba, W. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abcouwer, S. F.</span></span> <span> </span><span class="NLM_article-title">Cloning and analysis of unique human glutaminase isoforms generated by tissue-specifc alternative splicing</span>. <i>Physiol. Genomics</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>1</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">51</span>– <span class="NLM_lpage">62</span>, <span class="refDoi"> DOI: 10.1152/physiolgenomics.1999.1.2.51</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=10.1152%2Fphysiolgenomics.1999.1.2.51" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=11015561" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=1%3ACAS%3A528%3ADC%252BD3cXlt1Orsb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=1999&pages=51-62&issue=2&author=K.+M.+Elgadiauthor=R.+A.+Meguidauthor=M.+Qianauthor=W.+W.+Soubaauthor=S.+F.+Abcouwer&title=Cloning+and+analysis+of+unique+human+glutaminase+isoforms+generated+by+tissue-specifc+alternative+splicing&doi=10.1152%2Fphysiolgenomics.1999.1.2.51"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Cloning and analysis of unique human glutaminase isoforms generated by tissue-specific alternative splicing</span></div><div class="casAuthors">Elgadi, Khaled M.; Meguid, Robert A.; Qian, Ming; Souba, Wiley W.; Abcouwer, Steve F.</div><div class="citationInfo"><span class="NLM_cas:title">Physiological Genomics [online computer file]</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">51-62</span>CODEN:
                <span class="NLM_cas:coden">PHGEFP</span>;
        ISSN:<span class="NLM_cas:issn">1094-8341</span>.
    
            (<span class="NLM_cas:orgname">American Physiological Society</span>)
        </div><div class="casAbstract">Three human glutaminase (hGA) isoforms were identified, two of which represent isoforms previously unidentified in any species.  One isoform contains an open reading frame with high homol. with the rat kidney-type glutaminase, suggesting that this isoform represents the human kidney-type glutaminase, hKGA.  A second isoform, termed hGAC, contains an open reading frame that matches hKGA except for a unique COOH-terminal amino acid sequence.  In addn., a third human glutaminase isoform was identified from a computer search and on further anal. was found to represent an addnl. unique isoform, hGAM.  HKGA is expressed predominantly in brain and kidney but not in liver, hGAC is expressed principally in cardiac muscle and pancreas but not in liver or brain, and hGAM is expressed solely in cardiac and skeletal muscle.  HGAC is the predominant isoform expressed by a human breast cancer cell line that exhibits a high rate of glutamine utilization and glutaminase activity.  Genomic Southern anal. as well as isolation and anal. of five glutaminase genomic clones suggested that all three hGA isoforms originate from the same locus and therefore represent mRNA species that are produced by tissue-specific alternative splicing of a single pre-mRNA.  Furthermore, an RT-PCR assay was developed that can be used to easily differentiate between hKGA and hGAC mRNA species.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqVX2eTYfnRjLVg90H21EOLACvtfcHk0lhaMZ1SlJcMjg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXlt1Orsb8%253D&md5=668ada41617e771b951b4b23819372de</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1152%2Fphysiolgenomics.1999.1.2.51&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1152%252Fphysiolgenomics.1999.1.2.51%26sid%3Dliteratum%253Aachs%26aulast%3DElgadi%26aufirst%3DK.%2BM.%26aulast%3DMeguid%26aufirst%3DR.%2BA.%26aulast%3DQian%26aufirst%3DM.%26aulast%3DSouba%26aufirst%3DW.%2BW.%26aulast%3DAbcouwer%26aufirst%3DS.%2BF.%26atitle%3DCloning%2520and%2520analysis%2520of%2520unique%2520human%2520glutaminase%2520isoforms%2520generated%2520by%2520tissue-specifc%2520alternative%2520splicing%26jtitle%3DPhysiol.%2520Genomics%26date%3D1999%26volume%3D1%26issue%3D2%26spage%3D51%26epage%3D62%26doi%3D10.1152%2Fphysiolgenomics.1999.1.2.51" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Katt, W. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lukey, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cerione, R. A.</span></span> <span> </span><span class="NLM_article-title">A tale of two glutaminases: homologous enzymes with distinct roles in tumorigenesis</span>. <i>Future Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>9</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">223</span>– <span class="NLM_lpage">243</span>, <span class="refDoi"> DOI: 10.4155/fmc-2016-0190</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=10.4155%2Ffmc-2016-0190" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=28111979" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhslWnur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2017&pages=223-243&issue=2&author=W.+P.+Kattauthor=M.+J.+Lukeyauthor=R.+A.+Cerione&title=A+tale+of+two+glutaminases%3A+homologous+enzymes+with+distinct+roles+in+tumorigenesis&doi=10.4155%2Ffmc-2016-0190"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">A tale of two glutaminases: homologous enzymes with distinct roles in tumorigenesis</span></div><div class="casAuthors">Katt, William P.; Lukey, Michael J.; Cerione, Richard A.</div><div class="citationInfo"><span class="NLM_cas:title">Future Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">223-243</span>CODEN:
                <span class="NLM_cas:coden">FMCUA7</span>;
        ISSN:<span class="NLM_cas:issn">1756-8919</span>.
    
            (<span class="NLM_cas:orgname">Future Science Ltd.</span>)
        </div><div class="casAbstract">A review.  Many cancer cells exhibit an altered metabolic phenotype, in which glutamine consumption is upregulated relative to healthy cells.  This metabolic reprogramming often depends upon mitochondrial glutaminase activity, which converts glutamine to glutamate, a key precursor for biosynthetic and bioenergetic processes.  Two isoenzymes of glutaminase exist, a kidney-type (GLS) and a liver-type enzyme (GLS2 or LGA).  While a majority of studies have focused on GLS, here we summarize key findings on both glutaminases, describing their structure and function, their roles in cancer and pharmacol. approaches to inhibiting their activities.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoTYjzSACf4q7Vg90H21EOLACvtfcHk0lhaMZ1SlJcMjg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhslWnur4%253D&md5=6b4bd6dfe8d18402f41bd420c25974b2</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.4155%2Ffmc-2016-0190&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Ffmc-2016-0190%26sid%3Dliteratum%253Aachs%26aulast%3DKatt%26aufirst%3DW.%2BP.%26aulast%3DLukey%26aufirst%3DM.%2BJ.%26aulast%3DCerione%26aufirst%3DR.%2BA.%26atitle%3DA%2520tale%2520of%2520two%2520glutaminases%253A%2520homologous%2520enzymes%2520with%2520distinct%2520roles%2520in%2520tumorigenesis%26jtitle%3DFuture%2520Med.%2520Chem.%26date%3D2017%26volume%3D9%26issue%3D2%26spage%3D223%26epage%3D243%26doi%3D10.4155%2Ffmc-2016-0190" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Robinson, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McBryant, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsukamoto, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rojas, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferraris, D. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamilton, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hansen, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Curthoys, N. P.</span></span> <span> </span><span class="NLM_article-title">Novel mechanism of inhibition of rat kidney-type glutaminase by bis-2-(5-phenylacetamido-1,2,4-thiadiazol-2-yl)ethyl sulfide (BPTES)</span>. <i>Biochem. J.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>406</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">407</span>– <span class="NLM_lpage">414</span>, <span class="refDoi"> DOI: 10.1042/BJ20070039</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=10.1042%2FBJ20070039" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=406&publication_year=2007&pages=407-414&issue=3&author=M.+M.+Robinsonauthor=S.+J.+McBryantauthor=T.+Tsukamotoauthor=C.+Rojasauthor=D.+V.+Ferrarisauthor=S.+K.+Hamiltonauthor=J.+C.+Hansenauthor=N.+P.+Curthoys&title=Novel+mechanism+of+inhibition+of+rat+kidney-type+glutaminase+by+bis-2-%285-phenylacetamido-1%2C2%2C4-thiadiazol-2-yl%29ethyl+sulfide+%28BPTES%29&doi=10.1042%2FBJ20070039"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1042%2FBJ20070039&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBJ20070039%26sid%3Dliteratum%253Aachs%26aulast%3DRobinson%26aufirst%3DM.%2BM.%26aulast%3DMcBryant%26aufirst%3DS.%2BJ.%26aulast%3DTsukamoto%26aufirst%3DT.%26aulast%3DRojas%26aufirst%3DC.%26aulast%3DFerraris%26aufirst%3DD.%2BV.%26aulast%3DHamilton%26aufirst%3DS.%2BK.%26aulast%3DHansen%26aufirst%3DJ.%2BC.%26aulast%3DCurthoys%26aufirst%3DN.%2BP.%26atitle%3DNovel%2520mechanism%2520of%2520inhibition%2520of%2520rat%2520kidney-type%2520glutaminase%2520by%2520bis-2-%25285-phenylacetamido-1%252C2%252C4-thiadiazol-2-yl%2529ethyl%2520sulfide%2520%2528BPTES%2529%26jtitle%3DBiochem.%2520J.%26date%3D2007%26volume%3D406%26issue%3D3%26spage%3D407%26epage%3D414%26doi%3D10.1042%2FBJ20070039" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gross, M. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Demo, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dennison, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chernov-Rogan, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goyal, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janes, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laidig, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lewis, E. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mackinnon, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parlati, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodriguez, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shwonek, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sjogren, E. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stanton, T. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bennett, M. K.</span></span> <span> </span><span class="NLM_article-title">Antitumor activity of the glutaminase inhibitor CB-839 in triple-negative breast cancer</span>. <i>Mol. Cancer Ther.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>13</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">890</span>– <span class="NLM_lpage">901</span>, <span class="refDoi"> DOI: 10.1158/1535-7163.MCT-13-0870</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=10.1158%2F1535-7163.MCT-13-0870" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=24523301" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=1%3ACAS%3A528%3ADC%252BC2cXls1Gjurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2014&pages=890-901&issue=4&author=M.+I.+Grossauthor=S.+D.+Demoauthor=J.+B.+Dennisonauthor=L.+Chenauthor=T.+Chernov-Roganauthor=B.+Goyalauthor=J.+R.+Janesauthor=G.+J.+Laidigauthor=E.+R.+Lewisauthor=J.+Liauthor=A.+L.+Mackinnonauthor=F.+Parlatiauthor=M.+L.+Rodriguezauthor=P.+J.+Shwonekauthor=E.+B.+Sjogrenauthor=T.+F.+Stantonauthor=T.+Wangauthor=J.+Yangauthor=F.+Zhaoauthor=M.+K.+Bennett&title=Antitumor+activity+of+the+glutaminase+inhibitor+CB-839+in+triple-negative+breast+cancer&doi=10.1158%2F1535-7163.MCT-13-0870"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Antitumor Activity of the Glutaminase Inhibitor CB-839 in Triple-Negative Breast Cancer</span></div><div class="casAuthors">Gross, Matt I.; Demo, Susan D.; Dennison, Jennifer B.; Chen, Lijing; Chernov-Rogan, Tania; Goyal, Bindu; Janes, Julie R.; Laidig, Guy J.; Lewis, Evan R.; Li, Jim; MacKinnon, Andrew L.; Parlati, Francesco; Rodriguez, Mirna L. M.; Shwonek, Peter J.; Sjogren, Eric B.; Stanton, Timothy F.; Wang, Taotao; Yang, Jinfu; Zhao, Frances; Bennett, Mark K.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">890-901</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Glutamine serves as an important source of energy and building blocks for many tumor cells.  The first step in glutamine utilization is its conversion to glutamate by the mitochondrial enzyme glutaminase.  CB-839 is a potent, selective, and orally bioavailable inhibitor of both splice variants of glutaminase (KGA and GAC).  CB-839 had antiproliferative activity in a triple-neg. breast cancer (TNBC) cell line, HCC-1806, that was assocd. with a marked decrease in glutamine consumption, glutamate prodn., oxygen consumption, and the steady-state levels of glutathione and several tricarboxylic acid cycle intermediates.  In contrast, no antiproliferative activity was obsd. in an estrogen receptor-pos. cell line, T47D, and only modest effects on glutamine consumption and downstream metabolites were obsd.  Across a panel of breast cancer cell lines, GAC protein expression and glutaminase activity were elevated in the majority of TNBC cell lines relative to receptor pos. cells.  Furthermore, the TNBC subtype displayed the greatest sensitivity to CB-839 treatment and this sensitivity was correlated with (i) dependence on extracellular glutamine for growth, (ii) intracellular glutamate and glutamine levels, and (iii) GAC (but not KGA) expression, a potential biomarker for sensitivity.  CB-839 displayed significant antitumor activity in two xenograft models: as a single agent in a patient-derived TNBC model and in a basal like HER2+ cell line model, JIMT-1, both as a single agent and in combination with paclitaxel.  Together, these data provide a strong rationale for the clin. investigation of CB-839 as a targeted therapeutic in patients with TNBC and other glutamine-dependent tumors.  Mol Cancer Ther; 13(4); 890-901.2014 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpDfUGWU-VZObVg90H21EOLACvtfcHk0liJ2eVeAUOxxQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXls1Gjurg%253D&md5=5b9ddb35c56409b58ce2b889bbbbc33f</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-13-0870&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-13-0870%26sid%3Dliteratum%253Aachs%26aulast%3DGross%26aufirst%3DM.%2BI.%26aulast%3DDemo%26aufirst%3DS.%2BD.%26aulast%3DDennison%26aufirst%3DJ.%2BB.%26aulast%3DChen%26aufirst%3DL.%26aulast%3DChernov-Rogan%26aufirst%3DT.%26aulast%3DGoyal%26aufirst%3DB.%26aulast%3DJanes%26aufirst%3DJ.%2BR.%26aulast%3DLaidig%26aufirst%3DG.%2BJ.%26aulast%3DLewis%26aufirst%3DE.%2BR.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DMackinnon%26aufirst%3DA.%2BL.%26aulast%3DParlati%26aufirst%3DF.%26aulast%3DRodriguez%26aufirst%3DM.%2BL.%26aulast%3DShwonek%26aufirst%3DP.%2BJ.%26aulast%3DSjogren%26aufirst%3DE.%2BB.%26aulast%3DStanton%26aufirst%3DT.%2BF.%26aulast%3DWang%26aufirst%3DT.%26aulast%3DYang%26aufirst%3DJ.%26aulast%3DZhao%26aufirst%3DF.%26aulast%3DBennett%26aufirst%3DM.%2BK.%26atitle%3DAntitumor%2520activity%2520of%2520the%2520glutaminase%2520inhibitor%2520CB-839%2520in%2520triple-negative%2520breast%2520cancer%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2014%26volume%3D13%26issue%3D4%26spage%3D890%26epage%3D901%26doi%3D10.1158%2F1535-7163.MCT-13-0870" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yeh, T. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuo, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, Y. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ke, Y. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chu, K. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hsu, H. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, H. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuo, P. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shih, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, C. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsou, L. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S. J.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis, and evaluation of thiazolidine-2–4-dione derivatives as a novel class of glutaminase inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span> (<span class="NLM_issue">13</span>),  <span class="NLM_fpage">5599</span>– <span class="NLM_lpage">5612</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00282</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00282" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=5599-5612&issue=13&author=T.+K.+Yehauthor=C.+C.+Kuoauthor=Y.+Z.+Leeauthor=Y.+Y.+Keauthor=K.+F.+Chuauthor=H.+Y.+Hsuauthor=H.+Y.+Changauthor=Y.+W.+Liuauthor=J.+S.+Songauthor=C.+W.+Yangauthor=L.+M.+Linauthor=M.+Sunauthor=S.+H.+Wuauthor=P.+C.+Kuoauthor=C.+Shihauthor=C.+T.+Chenauthor=L.+K.+Tsouauthor=S.+J.+Lee&title=Design%2C+synthesis%2C+and+evaluation+of+thiazolidine-2%E2%80%934-dione+derivatives+as+a+novel+class+of+glutaminase+inhibitors&doi=10.1021%2Facs.jmedchem.7b00282"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00282&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00282%26sid%3Dliteratum%253Aachs%26aulast%3DYeh%26aufirst%3DT.%2BK.%26aulast%3DKuo%26aufirst%3DC.%2BC.%26aulast%3DLee%26aufirst%3DY.%2BZ.%26aulast%3DKe%26aufirst%3DY.%2BY.%26aulast%3DChu%26aufirst%3DK.%2BF.%26aulast%3DHsu%26aufirst%3DH.%2BY.%26aulast%3DChang%26aufirst%3DH.%2BY.%26aulast%3DLiu%26aufirst%3DY.%2BW.%26aulast%3DSong%26aufirst%3DJ.%2BS.%26aulast%3DYang%26aufirst%3DC.%2BW.%26aulast%3DLin%26aufirst%3DL.%2BM.%26aulast%3DSun%26aufirst%3DM.%26aulast%3DWu%26aufirst%3DS.%2BH.%26aulast%3DKuo%26aufirst%3DP.%2BC.%26aulast%3DShih%26aufirst%3DC.%26aulast%3DChen%26aufirst%3DC.%2BT.%26aulast%3DTsou%26aufirst%3DL.%2BK.%26aulast%3DLee%26aufirst%3DS.%2BJ.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520evaluation%2520of%2520thiazolidine-2%25E2%2580%25934-dione%2520derivatives%2520as%2520a%2520novel%2520class%2520of%2520glutaminase%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26issue%3D13%26spage%3D5599%26epage%3D5612%26doi%3D10.1021%2Facs.jmedchem.7b00282" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Timmerman, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holton, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuneva, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Louie, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Padro, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daemen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ethier, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van’tVeer, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Polyak, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCormick, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gray, J. W.</span></span> <span> </span><span class="NLM_article-title">Glutamine sensitivity analysis identifies the xCT antiporter as a common triple-negative breast tumor therapeutic target</span>. <i>Cancer Cell</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>24</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">450</span>– <span class="NLM_lpage">465</span>, <span class="refDoi"> DOI: 10.1016/j.ccr.2013.08.020</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=10.1016%2Fj.ccr.2013.08.020" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=24094812" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsFOltbvM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2013&pages=450-465&issue=4&author=L.+A.+Timmermanauthor=T.+Holtonauthor=M.+Yunevaauthor=R.+J.+Louieauthor=M.+Padroauthor=A.+Daemenauthor=M.+Huauthor=D.+A.+Chanauthor=S.+P.+Ethierauthor=L.+J.+Van%E2%80%99tVeerauthor=K.+Polyakauthor=F.+McCormickauthor=J.+W.+Gray&title=Glutamine+sensitivity+analysis+identifies+the+xCT+antiporter+as+a+common+triple-negative+breast+tumor+therapeutic+target&doi=10.1016%2Fj.ccr.2013.08.020"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Glutamine Sensitivity Analysis Identifies the xCT Antiporter as a Common Triple-Negative Breast Tumor Therapeutic Target</span></div><div class="casAuthors">Timmerman, Luika A.; Holton, Thomas; Yuneva, Mariia; Louie, Raymond J.; Padro, Merce; Daemen, Anneleen; Hu, Min; Chan, Denise A.; Ethier, Stephen P.; Van't Veer, Laura J.; Polyak, Kornelia; McCormick, Frank; Gray, Joe W.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Cell</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">450-465</span>CODEN:
                <span class="NLM_cas:coden">CCAECI</span>;
        ISSN:<span class="NLM_cas:issn">1535-6108</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">A handful of tumor-derived cell lines form the mainstay of cancer therapeutic development, yielding drugs with an impact typically measured as months to disease progression.  To develop more effective breast cancer therapeutics and more readily understand their clin. impact, we constructed a functional metabolic portrait of 46 independently derived breast cell lines.  Our anal. of glutamine uptake and dependence identified a subset of triple-neg. samples that are glutamine auxotrophs.  Ambient glutamine indirectly supports environmental cystine acquisition via the xCT antiporter, which is expressed on one-third of triple-neg. tumors in vivo. xCT inhibition with the clin. approved anti-inflammatory sulfasalazine decreases tumor growth, revealing a therapeutic target in breast tumors of poorest prognosis and a lead compd. for rapid, effective drug development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGooQUS6ziR5HrVg90H21EOLACvtfcHk0lidWB2DZjVeCg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsFOltbvM&md5=f3cd8acfc6915115600fcc8cfc6659dd</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1016%2Fj.ccr.2013.08.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ccr.2013.08.020%26sid%3Dliteratum%253Aachs%26aulast%3DTimmerman%26aufirst%3DL.%2BA.%26aulast%3DHolton%26aufirst%3DT.%26aulast%3DYuneva%26aufirst%3DM.%26aulast%3DLouie%26aufirst%3DR.%2BJ.%26aulast%3DPadro%26aufirst%3DM.%26aulast%3DDaemen%26aufirst%3DA.%26aulast%3DHu%26aufirst%3DM.%26aulast%3DChan%26aufirst%3DD.%2BA.%26aulast%3DEthier%26aufirst%3DS.%2BP.%26aulast%3DVan%25E2%2580%2599tVeer%26aufirst%3DL.%2BJ.%26aulast%3DPolyak%26aufirst%3DK.%26aulast%3DMcCormick%26aufirst%3DF.%26aulast%3DGray%26aufirst%3DJ.%2BW.%26atitle%3DGlutamine%2520sensitivity%2520analysis%2520identifies%2520the%2520xCT%2520antiporter%2520as%2520a%2520common%2520triple-negative%2520breast%2520tumor%2520therapeutic%2520target%26jtitle%3DCancer%2520Cell%26date%3D2013%26volume%3D24%26issue%3D4%26spage%3D450%26epage%3D465%26doi%3D10.1016%2Fj.ccr.2013.08.020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cassago, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferreira, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferreira, I. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fornezari, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gomes, E. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greene, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pereira, H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garratt, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dias, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ambrosio, A. L.</span></span> <span> </span><span class="NLM_article-title">Mitochondrial localization and structure-based phosphate activation mechanism of Glutaminase C with implications for cancer metabolism</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>109</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">1092</span>– <span class="NLM_lpage">1097</span>, <span class="refDoi"> DOI: 10.1073/pnas.1112495109</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=10.1073%2Fpnas.1112495109" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2012&pages=1092-1097&issue=4&author=A.+Cassagoauthor=A.+P.+Ferreiraauthor=I.+M.+Ferreiraauthor=C.+Fornezariauthor=E.+R.+Gomesauthor=K.+S.+Greeneauthor=H.+M.+Pereiraauthor=R.+C.+Garrattauthor=S.+M.+Diasauthor=A.+L.+Ambrosio&title=Mitochondrial+localization+and+structure-based+phosphate+activation+mechanism+of+Glutaminase+C+with+implications+for+cancer+metabolism&doi=10.1073%2Fpnas.1112495109"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1112495109&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1112495109%26sid%3Dliteratum%253Aachs%26aulast%3DCassago%26aufirst%3DA.%26aulast%3DFerreira%26aufirst%3DA.%2BP.%26aulast%3DFerreira%26aufirst%3DI.%2BM.%26aulast%3DFornezari%26aufirst%3DC.%26aulast%3DGomes%26aufirst%3DE.%2BR.%26aulast%3DGreene%26aufirst%3DK.%2BS.%26aulast%3DPereira%26aufirst%3DH.%2BM.%26aulast%3DGarratt%26aufirst%3DR.%2BC.%26aulast%3DDias%26aufirst%3DS.%2BM.%26aulast%3DAmbrosio%26aufirst%3DA.%2BL.%26atitle%3DMitochondrial%2520localization%2520and%2520structure-based%2520phosphate%2520activation%2520mechanism%2520of%2520Glutaminase%2520C%2520with%2520implications%2520for%2520cancer%2520metabolism%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2012%26volume%3D109%26issue%3D4%26spage%3D1092%26epage%3D1097%26doi%3D10.1073%2Fpnas.1112495109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Redis, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vela, L. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferreira de Oliveira, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ivan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodriguez-Aguayo, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adamoski, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pasculli, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taguchi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fernandez, A. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valledor, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Roosbroeck, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shah, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kinnebrew, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Atlasi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheung, L. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, G. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monroig, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramirez, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Catela
Ivkovic, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ling, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gafà, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kapitanovic, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lanza, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bankson, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lai, S. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bast, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenblum, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Radovich, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ivan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bartholomeusz, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fraga, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Widger, W. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanash, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berindan-Neagoe, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lopez-Berestein, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ambrosio, A. L. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gomes
Dias, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calin, G. A.</span></span> <span> </span><span class="NLM_article-title">Allele-specific reprogramming of cancer metabolism by the Long Non-coding RNA CCAT2</span>. <i>Mol. Cell</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">520</span>– <span class="NLM_lpage">534</span>, <span class="refDoi"> DOI: 10.1016/j.molcel.2016.01.015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=10.1016%2Fj.molcel.2016.01.015" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2016&pages=520-534&author=R.+S.+Redisauthor=L.+E.+Velaauthor=W.+Luauthor=J.+Ferreira+de+Oliveiraauthor=C.+Ivanauthor=C.+Rodriguez-Aguayoauthor=D.+Adamoskiauthor=B.+Pasculliauthor=A.+Taguchiauthor=Y.+Chenauthor=A.+F.+Fernandezauthor=L.+Valledorauthor=K.+Van+Roosbroeckauthor=S.+Changauthor=M.+Shahauthor=G.+Kinnebrewauthor=L.+Hanauthor=Y.+Atlasiauthor=L.+H.+Cheungauthor=G.+Y.+Huangauthor=P.+Monroigauthor=M.+S.+Ramirezauthor=T.+Catela%0AIvkovicauthor=L.+Vanauthor=H.+Lingauthor=R.+Gaf%C3%A0author=S.+Kapitanovicauthor=G.+Lanzaauthor=J.+A.+Banksonauthor=P.+Huangauthor=S.+Y.+Laiauthor=R.+C.+Bastauthor=M.+G.+Rosenblumauthor=M.+Radovichauthor=M.+Ivanauthor=G.+Bartholomeuszauthor=H.+Liangauthor=M.+F.+Fragaauthor=W.+R.+Widgerauthor=S.+Hanashauthor=I.+Berindan-Neagoeauthor=G.+Lopez-Beresteinauthor=A.+L.+B.+Ambrosioauthor=S.+M.+Gomes%0ADiasauthor=G.+A.+Calin&title=Allele-specific+reprogramming+of+cancer+metabolism+by+the+Long+Non-coding+RNA+CCAT2&doi=10.1016%2Fj.molcel.2016.01.015"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1016%2Fj.molcel.2016.01.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molcel.2016.01.015%26sid%3Dliteratum%253Aachs%26aulast%3DRedis%26aufirst%3DR.%2BS.%26aulast%3DVela%26aufirst%3DL.%2BE.%26aulast%3DLu%26aufirst%3DW.%26aulast%3DFerreira%2Bde%2BOliveira%26aufirst%3DJ.%26aulast%3DIvan%26aufirst%3DC.%26aulast%3DRodriguez-Aguayo%26aufirst%3DC.%26aulast%3DAdamoski%26aufirst%3DD.%26aulast%3DPasculli%26aufirst%3DB.%26aulast%3DTaguchi%26aufirst%3DA.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DFernandez%26aufirst%3DA.%2BF.%26aulast%3DValledor%26aufirst%3DL.%26aulast%3DVan%2BRoosbroeck%26aufirst%3DK.%26aulast%3DChang%26aufirst%3DS.%26aulast%3DShah%26aufirst%3DM.%26aulast%3DKinnebrew%26aufirst%3DG.%26aulast%3DHan%26aufirst%3DL.%26aulast%3DAtlasi%26aufirst%3DY.%26aulast%3DCheung%26aufirst%3DL.%2BH.%26aulast%3DHuang%26aufirst%3DG.%2BY.%26aulast%3DMonroig%26aufirst%3DP.%26aulast%3DRamirez%26aufirst%3DM.%2BS.%26aulast%3DCatela%2BIvkovic%26aufirst%3DT.%26aulast%3DVan%26aufirst%3DL.%26aulast%3DLing%26aufirst%3DH.%26aulast%3DGaf%25C3%25A0%26aufirst%3DR.%26aulast%3DKapitanovic%26aufirst%3DS.%26aulast%3DLanza%26aufirst%3DG.%26aulast%3DBankson%26aufirst%3DJ.%2BA.%26aulast%3DHuang%26aufirst%3DP.%26aulast%3DLai%26aufirst%3DS.%2BY.%26aulast%3DBast%26aufirst%3DR.%2BC.%26aulast%3DRosenblum%26aufirst%3DM.%2BG.%26aulast%3DRadovich%26aufirst%3DM.%26aulast%3DIvan%26aufirst%3DM.%26aulast%3DBartholomeusz%26aufirst%3DG.%26aulast%3DLiang%26aufirst%3DH.%26aulast%3DFraga%26aufirst%3DM.%2BF.%26aulast%3DWidger%26aufirst%3DW.%2BR.%26aulast%3DHanash%26aufirst%3DS.%26aulast%3DBerindan-Neagoe%26aufirst%3DI.%26aulast%3DLopez-Berestein%26aufirst%3DG.%26aulast%3DAmbrosio%26aufirst%3DA.%2BL.%2BB.%26aulast%3DGomes%2BDias%26aufirst%3DS.%2BM.%26aulast%3DCalin%26aufirst%3DG.%2BA.%26atitle%3DAllele-specific%2520reprogramming%2520of%2520cancer%2520metabolism%2520by%2520the%2520Long%2520Non-coding%2520RNA%2520CCAT2%26jtitle%3DMol.%2520Cell%26date%3D2016%26volume%3D61%26spage%3D520%26epage%3D534%26doi%3D10.1016%2Fj.molcel.2016.01.015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xia, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Donehower, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cooper, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neilson, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wheeler, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wagner, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, W.</span></span> <span> </span><span class="NLM_article-title">Dynamic analyses of alternative polyadenylation from RNA-seq reveal a 3′-UTR landscape across seven tumour types</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">5274</span>, <span class="refDoi"> DOI: 10.1038/ncomms6274</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=10.1038%2Fncomms6274" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=25409906" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=1%3ACAS%3A528%3ADC%252BC2MXksVelt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=5274&author=Z.+Xiaauthor=L.+A.+Donehowerauthor=T.+A.+Cooperauthor=J.+R.+Neilsonauthor=D.+A.+Wheelerauthor=E.+J.+Wagnerauthor=W.+Li&title=Dynamic+analyses+of+alternative+polyadenylation+from+RNA-seq+reveal+a+3%E2%80%B2-UTR+landscape+across+seven+tumour+types&doi=10.1038%2Fncomms6274"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Dynamic analyses of alternative polyadenylation from RNA-seq reveal a 3'-UTR landscape across seven tumour types</span></div><div class="casAuthors">Xia, Zheng; Donehower, Lawrence A.; Cooper, Thomas A.; Neilson, Joel R.; Wheeler, David A.; Wagner, Eric J.; Li, Wei</div><div class="citationInfo"><span class="NLM_cas:title">Nature Communications</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">5274</span>CODEN:
                <span class="NLM_cas:coden">NCAOBW</span>;
        ISSN:<span class="NLM_cas:issn">2041-1723</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Alternative polyadenylation (APA) is a pervasive mechanism in the regulation of most human genes, and its implication in diseases including cancer is only beginning to be appreciated.  Since conventional APA profiling has not been widely adopted, global cancer APA studies are very limited.  Here we develop a novel bioinformatics algorithm (DaPars) for the de novo identification of dynamic APAs from std. RNA-seq.  When applied to 358 TCGA Pan-Cancer tumor/normal pairs across seven tumor types, DaPars reveals 1,346 genes with recurrent and tumor-specific APAs.  Most APA genes (91%) have shorter 3'-untranslated regions (3' UTRs) in tumors that can avoid microRNA-mediated repression, including glutaminase (GLS), a key metabolic enzyme for tumor proliferation.  Interestingly, selected APA events add strong prognostic power beyond common clin. and mol. variables, suggesting their potential as novel prognostic biomarkers.  Finally, our results implicate CstF64, an essential polyadenylation factor, as a master regulator of 3'-UTR shortening across multiple tumor types.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqsJbPJg31kHrVg90H21EOLACvtfcHk0lgc_WXRdCJmYw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXksVelt70%253D&md5=545a074f8a01de0d73f4bad0824e8153</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1038%2Fncomms6274&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms6274%26sid%3Dliteratum%253Aachs%26aulast%3DXia%26aufirst%3DZ.%26aulast%3DDonehower%26aufirst%3DL.%2BA.%26aulast%3DCooper%26aufirst%3DT.%2BA.%26aulast%3DNeilson%26aufirst%3DJ.%2BR.%26aulast%3DWheeler%26aufirst%3DD.%2BA.%26aulast%3DWagner%26aufirst%3DE.%2BJ.%26aulast%3DLi%26aufirst%3DW.%26atitle%3DDynamic%2520analyses%2520of%2520alternative%2520polyadenylation%2520from%2520RNA-seq%2520reveal%2520a%25203%25E2%2580%25B2-UTR%2520landscape%2520across%2520seven%2520tumour%2520types%26jtitle%3DNat.%2520Commun.%26date%3D2014%26volume%3D5%26spage%3D5274%26doi%3D10.1038%2Fncomms6274" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">van
den Heuvel, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jing, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wooster, R. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bachman, K. E.</span></span> <span> </span><span class="NLM_article-title">Analysis of glutamine dependency in non-small cell lung cancer: GLS1 splice variant GAC is essential for cancer cell growth</span>. <i>Cancer Biol. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>13</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">1185</span>– <span class="NLM_lpage">1194</span>, <span class="refDoi"> DOI: 10.4161/cbt.21348</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=10.4161%2Fcbt.21348" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=22892846" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=1%3ACAS%3A528%3ADC%252BC3sXisF2nu78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2012&pages=1185-1194&issue=12&author=A.+P.+van%0Aden+Heuvelauthor=J.+Jingauthor=R.+F.+Woosterauthor=K.+E.+Bachman&title=Analysis+of+glutamine+dependency+in+non-small+cell+lung+cancer%3A+GLS1+splice+variant+GAC+is+essential+for+cancer+cell+growth&doi=10.4161%2Fcbt.21348"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Analysis of glutamine dependency in non-small cell lung cancer: GLS1 splice variant GAC is essential for cancer cell growth</span></div><div class="casAuthors">van den Heuvel, A. Pieter J.; Jing, Junping; Wooster, Richard F.; Bachman, Kurtis E.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Biology & Therapy</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1185-1194</span>CODEN:
                <span class="NLM_cas:coden">CBTAAO</span>;
        ISSN:<span class="NLM_cas:issn">1538-4047</span>.
    
            (<span class="NLM_cas:orgname">Landes Bioscience</span>)
        </div><div class="casAbstract">One of the hallmarks of cancer is metabolic deregulation.  Many tumors display increased glucose uptake and breakdown through the process of aerobic glycolysis, also known as the Warburg effect.  Less studied in cancer development and progression is the importance of the glutamine (Gln) pathway, which provides cells with a variety of essential products to sustain cell proliferation, such as ATP and macromols. for biosynthesis.  To this end Gln dependency was assessed in a panel of non-small cell lung cancer lines (NSCLC).  Gln was found to be essential for the growth of cells with high rates of glutaminolysis, and after exploring multiple genes in the Gln pathway, GLS1 was found to be the key enzyme assocd. with this dependence.  This dependence was confirmed by observing the rescue of decreased growth by exogenous addn. of downstream metabolites of glutaminolysis.  Expression of the GLS1 splice variant KGA was found to be decreased in tumors compared with normal lung tissue.  Transient knock down of GLS1 splice variants indicated that loss of GAC had the most detrimental effect on cancer cell growth.  In conclusion, NSCLC cell lines depend on Gln for glutaminolysis to a varying degree, in which the GLS1 splice variant GAC plays an essential role and is a potential target for cancer metab.-directed therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrnWgR5NZWykLVg90H21EOLACvtfcHk0ljAhPXLnR7ygQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXisF2nu78%253D&md5=521cd23a9f2a3a7f31c7024603b3a0ca</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.4161%2Fcbt.21348&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4161%252Fcbt.21348%26sid%3Dliteratum%253Aachs%26aulast%3Dvan%2Bden%2BHeuvel%26aufirst%3DA.%2BP.%26aulast%3DJing%26aufirst%3DJ.%26aulast%3DWooster%26aufirst%3DR.%2BF.%26aulast%3DBachman%26aufirst%3DK.%2BE.%26atitle%3DAnalysis%2520of%2520glutamine%2520dependency%2520in%2520non-small%2520cell%2520lung%2520cancer%253A%2520GLS1%2520splice%2520variant%2520GAC%2520is%2520essential%2520for%2520cancer%2520cell%2520growth%26jtitle%3DCancer%2520Biol.%2520Ther.%26date%3D2012%26volume%3D13%26issue%3D12%26spage%3D1185%26epage%3D1194%26doi%3D10.4161%2Fcbt.21348" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jacque, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ronchetti, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Larrue, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meunier, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Birsen, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Willems, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saland, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Decroocq, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maciel, T. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lambert, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poulain, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hospital, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sujobert, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joseph, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chapuis, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lacombe, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moura, I. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Demo, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sarry, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Recher, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mayeux, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tamburini, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bouscary, D.</span></span> <span> </span><span class="NLM_article-title">Targeting glutaminolysis has antileukemic activity in acute myeloid leukemia and synergizes with BCL-2 inhibition</span>. <i>Blood</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>126</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">1346</span>– <span class="NLM_lpage">1356</span>, <span class="refDoi"> DOI: 10.1182/blood-2015-01-621870</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=10.1182%2Fblood-2015-01-621870" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=26186940" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=1%3ACAS%3A528%3ADC%252BC28Xht1WisLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=126&publication_year=2015&pages=1346-1356&issue=11&author=N.+Jacqueauthor=A.+M.+Ronchettiauthor=C.+Larrueauthor=G.+Meunierauthor=R.+Birsenauthor=L.+Willemsauthor=E.+Salandauthor=J.+Decroocqauthor=T.+T.+Macielauthor=M.+Lambertauthor=L.+Poulainauthor=M.+A.+Hospitalauthor=P.+Sujobertauthor=L.+Josephauthor=N.+Chapuisauthor=C.+Lacombeauthor=I.+C.+Mouraauthor=S.+Demoauthor=J.+E.+Sarryauthor=C.+Recherauthor=P.+Mayeuxauthor=J.+Tamburiniauthor=D.+Bouscary&title=Targeting+glutaminolysis+has+antileukemic+activity+in+acute+myeloid+leukemia+and+synergizes+with+BCL-2+inhibition&doi=10.1182%2Fblood-2015-01-621870"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting glutaminolysis has antileukemic activity in acute myeloid leukemia and synergizes with BCL-2 inhibition</span></div><div class="casAuthors">Jacque, Nathalie; Ronchetti, Anne Marie; Larrue, Clement; Meunier, Godelieve; Birsen, Rudy; Willems, Lise; Saland, Estelle; Decroocq, Justine; Macie, Thiago Trovati; Lambert, Mireille; Poulain, Laury; Hospital, Marie Anne; Sujobert, Pierre; Joseph, Laure; Chapuis, Nicolas; Lacombe, Catherine; Moura, Ivan Cruz; Demo, Susan; Sarry, Jean Emmanuel; Recher, Christian; Mayeux, Patrick; Tamburini, Jerome; Bouscary, Didier</div><div class="citationInfo"><span class="NLM_cas:title">Blood</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">126</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1346-1356</span>CODEN:
                <span class="NLM_cas:coden">BLOOAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-4971</span>.
    
            (<span class="NLM_cas:orgname">American Society of Hematology</span>)
        </div><div class="casAbstract">Cancer cells require glutamine to adapt to increased biosynthetic activity.  The limiting step in intracellular glutamine catabolism involves its conversion to glutamate by glutaminase (GA).  Different GA isoforms are encoded by the genes GLS1 and GLS2 in humans.  Herein, we show that glutamine levels control mitochondrial oxidative phosphorylation (OXPHOS) in acute myeloid leukemia (AML) cells.  Glutaminase C (GAC) is the GA isoform that is most abundantly expressed in AML.  Both knockdown of GLS1 expression and pharmacol. GLS1 inhibition by the drug CB-839 can reduce OXPHOS, leading to leukemic cell proliferation arrest and apoptosis without causing cytotoxic activity against normal human CD34+ progenitors.  Strikingly, GLS1 knockdown dramatically inhibited AML development in NSG mice.  The antileukemic activity of CB-839 was abrogated by both the expression of a hyperactive GACK320A allele and the addn. of the tricarboxyclic acid cycle product α-ketoglutarate, indicating the crit. function of GLS1 in AML cell survival.  Finally, glutaminolysis inhibition activated mitochondrial apoptosis and synergistically sensitized leukemic cells to priming with the BCL-2 inhibitor ABT-199.  These findings show that targeting glutamine addiction via GLS1 inhibition offers a potential novel therapeutic strategy for AML.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr_p-hOsAD2CbVg90H21EOLACvtfcHk0ljAhPXLnR7ygQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xht1WisLs%253D&md5=b4530d3ae6fd6d6c3e74fdcbf8967f76</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1182%2Fblood-2015-01-621870&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2015-01-621870%26sid%3Dliteratum%253Aachs%26aulast%3DJacque%26aufirst%3DN.%26aulast%3DRonchetti%26aufirst%3DA.%2BM.%26aulast%3DLarrue%26aufirst%3DC.%26aulast%3DMeunier%26aufirst%3DG.%26aulast%3DBirsen%26aufirst%3DR.%26aulast%3DWillems%26aufirst%3DL.%26aulast%3DSaland%26aufirst%3DE.%26aulast%3DDecroocq%26aufirst%3DJ.%26aulast%3DMaciel%26aufirst%3DT.%2BT.%26aulast%3DLambert%26aufirst%3DM.%26aulast%3DPoulain%26aufirst%3DL.%26aulast%3DHospital%26aufirst%3DM.%2BA.%26aulast%3DSujobert%26aufirst%3DP.%26aulast%3DJoseph%26aufirst%3DL.%26aulast%3DChapuis%26aufirst%3DN.%26aulast%3DLacombe%26aufirst%3DC.%26aulast%3DMoura%26aufirst%3DI.%2BC.%26aulast%3DDemo%26aufirst%3DS.%26aulast%3DSarry%26aufirst%3DJ.%2BE.%26aulast%3DRecher%26aufirst%3DC.%26aulast%3DMayeux%26aufirst%3DP.%26aulast%3DTamburini%26aufirst%3DJ.%26aulast%3DBouscary%26aufirst%3DD.%26atitle%3DTargeting%2520glutaminolysis%2520has%2520antileukemic%2520activity%2520in%2520acute%2520myeloid%2520leukemia%2520and%2520synergizes%2520with%2520BCL-2%2520inhibition%26jtitle%3DBlood%26date%3D2015%26volume%3D126%26issue%3D11%26spage%3D1346%26epage%3D1356%26doi%3D10.1182%2Fblood-2015-01-621870" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, Y. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, H. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hsu, H. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, I. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiu, Y. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chao, Y. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S. J.</span></span> <span> </span><span class="NLM_article-title">Discovery of selective inhibitors of Glutaminase-2, which inhibit mTORC1, activate autophagy and inhibit proliferation in cancer cells</span>. <i>Oncotarget</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>5</i></span> (<span class="NLM_issue">15</span>),  <span class="NLM_fpage">6087</span>– <span class="NLM_lpage">6101</span>, <span class="refDoi"> DOI: 10.18632/oncotarget.2173</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=10.18632%2Foncotarget.2173" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=25026281" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=1%3ACAS%3A280%3ADC%252BC2cbitF2htA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=6087-6101&issue=15&author=Y.+Z.+Leeauthor=C.+W.+Yangauthor=H.+Y.+Changauthor=H.+Y.+Hsuauthor=I.+S.+Chenauthor=H.+S.+Changauthor=C.+H.+Leeauthor=J.+C.+Leeauthor=C.+R.+Kumarauthor=Y.+Q.+Qiuauthor=Y.+S.+Chaoauthor=S.+J.+Lee&title=Discovery+of+selective+inhibitors+of+Glutaminase-2%2C+which+inhibit+mTORC1%2C+activate+autophagy+and+inhibit+proliferation+in+cancer+cells&doi=10.18632%2Foncotarget.2173"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of selective inhibitors of Glutaminase-2, which inhibit mTORC1, activate autophagy and inhibit proliferation in cancer cells</span></div><div class="casAuthors">Lee Yue-Zhi; Yang Cheng-Wei; Chang Hsin-Yu; Hsu Hsing-Yu; Chen Ih-Shen; Chang Hsun-Shuo; Lee Chih-Hao; Lee Jinq-chyi; Kumar Chidambaram Ramesh; Chao Yu-Sheng; Lee Shiow-Ju; Qiu Ya-Qi</div><div class="citationInfo"><span class="NLM_cas:title">Oncotarget</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">6087-101</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Glutaminase, which converts glutamine to glutamate, is involved in Warburg effect in cancer cells.  Two human glutaminase genes have been identified, GLS (GLS1) and GLS2.  Two alternative transcripts arise from each glutaminase gene: first, the kidney isoform (KGA) and glutaminase C (GAC) for GLS; and, second, the liver isoform (LGA) and glutaminase B (GAB) for GLS2.  While GLS1 is considered as a cancer therapeutic target, the potential role of GLS2 in cancer remains unclear.  Here, we discovered a series of alkyl benzoquinones that preferentially inhibit glutaminase B isoform (GAB, GLS2) rather than the kidney isoform of glutaminase (KGA, GLS1).  We identified amino acid residues in an allosteric binding pocket responsible for the selectivity.  Treatment with the alkyl benzoquinones decreased intracellular glutaminase activity and glutamate levels.  GLS2 inhibition by either alkyl benzoquinones or GLS2 siRNA reduced carcinoma cell proliferation and anchorage-independent colony formation, and induced autophagy via AMPK mediated mTORC1 inhibition.  Our findings demonstrate amino acid sequences for selective inhibition of glutaminase isozymes and validate GLS2 as a potential anti-cancer target.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS7ipugdsmO_SjiVMCqkKxVfW6udTcc2eb6nCs9DPcCsLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2cbitF2htA%253D%253D&md5=0f0e4f0d6a1960aa8a87d645f55b5f68</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.2173&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.2173%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DY.%2BZ.%26aulast%3DYang%26aufirst%3DC.%2BW.%26aulast%3DChang%26aufirst%3DH.%2BY.%26aulast%3DHsu%26aufirst%3DH.%2BY.%26aulast%3DChen%26aufirst%3DI.%2BS.%26aulast%3DChang%26aufirst%3DH.%2BS.%26aulast%3DLee%26aufirst%3DC.%2BH.%26aulast%3DLee%26aufirst%3DJ.%2BC.%26aulast%3DKumar%26aufirst%3DC.%2BR.%26aulast%3DQiu%26aufirst%3DY.%2BQ.%26aulast%3DChao%26aufirst%3DY.%2BS.%26aulast%3DLee%26aufirst%3DS.%2BJ.%26atitle%3DDiscovery%2520of%2520selective%2520inhibitors%2520of%2520Glutaminase-2%252C%2520which%2520inhibit%2520mTORC1%252C%2520activate%2520autophagy%2520and%2520inhibit%2520proliferation%2520in%2520cancer%2520cells%26jtitle%3DOncotarget%26date%3D2014%26volume%3D5%26issue%3D15%26spage%3D6087%26epage%3D6101%26doi%3D10.18632%2Foncotarget.2173" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xiao, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ren, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yue, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiu, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qing, G.</span></span> <span> </span><span class="NLM_article-title">Myc promotes glutaminolysis in human neuroblastoma through direct activation of glutaminase 2</span>. <i>Oncotarget</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">40655</span>– <span class="NLM_lpage">40666</span>, <span class="refDoi"> DOI: 10.18632/oncotarget.5821</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=10.18632%2Foncotarget.5821" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=40655-40666&author=D.+Xiaoauthor=P.+Renauthor=H.+Suauthor=M.+Yueauthor=R.+Xiuauthor=Y.+Huauthor=H.+Liuauthor=G.+Qing&title=Myc+promotes+glutaminolysis+in+human+neuroblastoma+through+direct+activation+of+glutaminase+2&doi=10.18632%2Foncotarget.5821"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.5821&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.5821%26sid%3Dliteratum%253Aachs%26aulast%3DXiao%26aufirst%3DD.%26aulast%3DRen%26aufirst%3DP.%26aulast%3DSu%26aufirst%3DH.%26aulast%3DYue%26aufirst%3DM.%26aulast%3DXiu%26aufirst%3DR.%26aulast%3DHu%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DH.%26aulast%3DQing%26aufirst%3DG.%26atitle%3DMyc%2520promotes%2520glutaminolysis%2520in%2520human%2520neuroblastoma%2520through%2520direct%2520activation%2520of%2520glutaminase%25202%26jtitle%3DOncotarget%26date%3D2015%26volume%3D6%26spage%3D40655%26epage%3D40666%26doi%3D10.18632%2Foncotarget.5821" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erickson, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fuji, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramachandran, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dinavahi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, K. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ambrosio, A. L. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dias, S. M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dang, C. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cerione, R. A.</span></span> <span> </span><span class="NLM_article-title">Targeting mitochondrial glutaminase activity inhibits oncogenic transformation</span>. <i>Cancer Cell</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>18</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">207</span>– <span class="NLM_lpage">219</span>, <span class="refDoi"> DOI: 10.1016/j.ccr.2010.08.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=10.1016%2Fj.ccr.2010.08.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=20832749" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtFGht7bO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2010&pages=207-219&issue=3&author=J.+B.+Wangauthor=J.+W.+Ericksonauthor=R.+Fujiauthor=S.+Ramachandranauthor=P.+Gaoauthor=R.+Dinavahiauthor=K.+F.+Wilsonauthor=A.+L.+B.+Ambrosioauthor=S.+M.+G.+Diasauthor=C.+V.+Dangauthor=R.+A.+Cerione&title=Targeting+mitochondrial+glutaminase+activity+inhibits+oncogenic+transformation&doi=10.1016%2Fj.ccr.2010.08.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting Mitochondrial Glutaminase Activity Inhibits Oncogenic Transformation</span></div><div class="casAuthors">Wang, Jian-Bin; Erickson, Jon W.; Fuji, Reina; Ramachandran, Sekar; Gao, Ping; Dinavahi, Ramani; Wilson, Kristin F.; Ambrosio, Andre L. B.; Dias, Sandra M. G.; Dang, Chi-V.; Cerione, Richard A.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Cell</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">207-219</span>CODEN:
                <span class="NLM_cas:coden">CCAECI</span>;
        ISSN:<span class="NLM_cas:issn">1535-6108</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Rho GTPases impact a no. of activities important for oncogenesis.  We describe a small mol. inhibitor that blocks oncogenic transformation induced by various Rho GTPases in fibroblasts, and the growth of human breast cancer and B lymphoma cells, without affecting normal cells.  We identify the target of this inhibitor to be the metabolic enzyme glutaminase, which catalyzes the hydrolysis of glutamine to glutamate.  We show that transformed fibroblasts and breast cancer cells exhibit elevated glutaminase activity that is dependent on Rho GTPases and NF-κB activity, and is blocked by the small mol. inhibitor.  These findings highlight a previously unappreciated connection between Rho GTPase activation and cellular metab. and demonstrate that targeting glutaminase activity can inhibit oncogenic transformation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpTP6YsyzRd1LVg90H21EOLACvtfcHk0ljeV1F8QKQViA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtFGht7bO&md5=67b64e99c992bbe6636ecfc04b83aac0</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1016%2Fj.ccr.2010.08.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ccr.2010.08.009%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DJ.%2BB.%26aulast%3DErickson%26aufirst%3DJ.%2BW.%26aulast%3DFuji%26aufirst%3DR.%26aulast%3DRamachandran%26aufirst%3DS.%26aulast%3DGao%26aufirst%3DP.%26aulast%3DDinavahi%26aufirst%3DR.%26aulast%3DWilson%26aufirst%3DK.%2BF.%26aulast%3DAmbrosio%26aufirst%3DA.%2BL.%2BB.%26aulast%3DDias%26aufirst%3DS.%2BM.%2BG.%26aulast%3DDang%26aufirst%3DC.%2BV.%26aulast%3DCerione%26aufirst%3DR.%2BA.%26atitle%3DTargeting%2520mitochondrial%2520glutaminase%2520activity%2520inhibits%2520oncogenic%2520transformation%26jtitle%3DCancer%2520Cell%26date%3D2010%26volume%3D18%26issue%3D3%26spage%3D207%26epage%3D219%26doi%3D10.1016%2Fj.ccr.2010.08.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Seltzer, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bennett, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joshi, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferraris, D. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsukamoto, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rojas, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Slusher, B. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rabinowitz, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dang, C. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riggins, G. J.</span></span> <span> </span><span class="NLM_article-title">Inhibition of glutaminase preferentially slows growth of glioma cells with mutant IDH1</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>70</i></span> (<span class="NLM_issue">22</span>),  <span class="NLM_fpage">8981</span>– <span class="NLM_lpage">8987</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-10-1666</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=10.1158%2F0008-5472.CAN-10-1666" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2010&pages=8981-8987&issue=22&author=M.+J.+Seltzerauthor=B.+D.+Bennettauthor=A.+D.+Joshiauthor=P.+Gaoauthor=A.+G.+Thomasauthor=D.+V.+Ferrarisauthor=T.+Tsukamotoauthor=C.+J.+Rojasauthor=B.+S.+Slusherauthor=J.+D.+Rabinowitzauthor=C.+V.+Dangauthor=G.+J.+Riggins&title=Inhibition+of+glutaminase+preferentially+slows+growth+of+glioma+cells+with+mutant+IDH1&doi=10.1158%2F0008-5472.CAN-10-1666"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-10-1666&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-10-1666%26sid%3Dliteratum%253Aachs%26aulast%3DSeltzer%26aufirst%3DM.%2BJ.%26aulast%3DBennett%26aufirst%3DB.%2BD.%26aulast%3DJoshi%26aufirst%3DA.%2BD.%26aulast%3DGao%26aufirst%3DP.%26aulast%3DThomas%26aufirst%3DA.%2BG.%26aulast%3DFerraris%26aufirst%3DD.%2BV.%26aulast%3DTsukamoto%26aufirst%3DT.%26aulast%3DRojas%26aufirst%3DC.%2BJ.%26aulast%3DSlusher%26aufirst%3DB.%2BS.%26aulast%3DRabinowitz%26aufirst%3DJ.%2BD.%26aulast%3DDang%26aufirst%3DC.%2BV.%26aulast%3DRiggins%26aufirst%3DG.%2BJ.%26atitle%3DInhibition%2520of%2520glutaminase%2520preferentially%2520slows%2520growth%2520of%2520glioma%2520cells%2520with%2520mutant%2520IDH1%26jtitle%3DCancer%2520Res.%26date%3D2010%26volume%3D70%26issue%3D22%26spage%3D8981%26epage%3D8987%26doi%3D10.1158%2F0008-5472.CAN-10-1666" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wise, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deberardinis, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mancuso, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sayed, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pfeiffer, H. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nissim, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daikhin, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yudkoff, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McMahon, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, C. B.</span></span> <span> </span><span class="NLM_article-title">Myc regulates a transcriptional program that stimulates mitochondrial glutaminolysis and leads to glutamine addiction</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>105</i></span> (<span class="NLM_issue">48</span>),  <span class="NLM_fpage">18782</span>– <span class="NLM_lpage">18787</span>, <span class="refDoi"> DOI: 10.1073/pnas.0810199105</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=10.1073%2Fpnas.0810199105" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2008&pages=18782-18787&issue=48&author=D.+R.+Wiseauthor=R.+J.+Deberardinisauthor=A.+Mancusoauthor=N.+Sayedauthor=X.+Y.+Zhangauthor=H.+K.+Pfeifferauthor=I.+Nissimauthor=E.+Daikhinauthor=M.+Yudkoffauthor=S.+B.+McMahonauthor=C.+B.+Thompson&title=Myc+regulates+a+transcriptional+program+that+stimulates+mitochondrial+glutaminolysis+and+leads+to+glutamine+addiction&doi=10.1073%2Fpnas.0810199105"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0810199105&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0810199105%26sid%3Dliteratum%253Aachs%26aulast%3DWise%26aufirst%3DD.%2BR.%26aulast%3DDeberardinis%26aufirst%3DR.%2BJ.%26aulast%3DMancuso%26aufirst%3DA.%26aulast%3DSayed%26aufirst%3DN.%26aulast%3DZhang%26aufirst%3DX.%2BY.%26aulast%3DPfeiffer%26aufirst%3DH.%2BK.%26aulast%3DNissim%26aufirst%3DI.%26aulast%3DDaikhin%26aufirst%3DE.%26aulast%3DYudkoff%26aufirst%3DM.%26aulast%3DMcMahon%26aufirst%3DS.%2BB.%26aulast%3DThompson%26aufirst%3DC.%2BB.%26atitle%3DMyc%2520regulates%2520a%2520transcriptional%2520program%2520that%2520stimulates%2520mitochondrial%2520glutaminolysis%2520and%2520leads%2520to%2520glutamine%2520addiction%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2008%26volume%3D105%26issue%3D48%26spage%3D18782%26epage%3D18787%26doi%3D10.1073%2Fpnas.0810199105" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gao, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tchernyshyov, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, T. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, Y. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kita, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ochi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeller, K. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Marzo, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Eyk, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mendell, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dang, C. V.</span></span> <span> </span><span class="NLM_article-title">c-Myc suppression of miR-23a/b enhances mitochondrial glutaminase expression and glutamine metabolism</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>458</i></span> (<span class="NLM_issue">7239</span>),  <span class="NLM_fpage">762</span>– <span class="NLM_lpage">765</span>, <span class="refDoi"> DOI: 10.1038/nature07823</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=10.1038%2Fnature07823" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=19219026" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhvFKjtrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=458&publication_year=2009&pages=762-765&issue=7239&author=P.+Gaoauthor=I.+Tchernyshyovauthor=T.+C.+Changauthor=Y.+S.+Leeauthor=K.+Kitaauthor=T.+Ochiauthor=K.+I.+Zellerauthor=A.+M.+De+Marzoauthor=J.+E.+Van+Eykauthor=J.+T.+Mendellauthor=C.+V.+Dang&title=c-Myc+suppression+of+miR-23a%2Fb+enhances+mitochondrial+glutaminase+expression+and+glutamine+metabolism&doi=10.1038%2Fnature07823"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">c-Myc suppression of miR-23a/b enhances mitochondrial glutaminase expression and glutamine metabolism</span></div><div class="casAuthors">Gao, Ping; Tchernyshyov, Irina; Chang, Tsung-Cheng; Lee, Yun-Sil; Kita, Kayoko; Ochi, Takafumi; Zeller, Karen I.; De Marzo, Angelo M.; Van Eyk, Jennifer E.; Mendell, Joshua T.; Dang, Chi V.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">458</span>
        (<span class="NLM_cas:issue">7239</span>),
    <span class="NLM_cas:pages">762-765</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Altered glucose metab. in cancer cells is termed the Warburg effect, which describes the propensity of most cancer cells to take up glucose avidly and convert it primarily to lactate, despite available oxygen.  Notwithstanding the renewed interest in the Warburg effect, cancer cells also depend on continued mitochondrial function for metab., specifically glutaminolysis that catabolizes glutamine to generate ATP and lactate.  Glutamine, which is highly transported into proliferating cells, is a major source of energy and nitrogen for biosynthesis, and a carbon substrate for anabolic processes in cancer cells, but the regulation of glutamine metab. is not well understood.  Here the authors report that the c-Myc (hereafter referred to as Myc) oncogenic transcription factor, which is known to regulate microRNAs and stimulate cell proliferation, transcriptionally represses miR-23a and miR-23b, resulting in greater expression of their target protein, mitochondrial glutaminase, in human P-493 B lymphoma cells and PC3 prostate cancer cells.  This leads to upregulation of glutamine catabolism.  Glutaminase converts glutamine to glutamate, which is further catabolized through the tricarboxylic acid cycle for the prodn. of ATP or serves as substrate for glutathione synthesis.  The unique means by which Myc regulates glutaminase uncovers a previously unsuspected link between Myc regulation of miRNAs, glutamine metab., and energy and reactive oxygen species homeostasis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqueU1pXBd0orVg90H21EOLACvtfcHk0ljYiZNdAHAE8A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhvFKjtrY%253D&md5=9da429f047042a95d28f8335391db97d</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1038%2Fnature07823&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature07823%26sid%3Dliteratum%253Aachs%26aulast%3DGao%26aufirst%3DP.%26aulast%3DTchernyshyov%26aufirst%3DI.%26aulast%3DChang%26aufirst%3DT.%2BC.%26aulast%3DLee%26aufirst%3DY.%2BS.%26aulast%3DKita%26aufirst%3DK.%26aulast%3DOchi%26aufirst%3DT.%26aulast%3DZeller%26aufirst%3DK.%2BI.%26aulast%3DDe%2BMarzo%26aufirst%3DA.%2BM.%26aulast%3DVan%2BEyk%26aufirst%3DJ.%2BE.%26aulast%3DMendell%26aufirst%3DJ.%2BT.%26aulast%3DDang%26aufirst%3DC.%2BV.%26atitle%3Dc-Myc%2520suppression%2520of%2520miR-23a%252Fb%2520enhances%2520mitochondrial%2520glutaminase%2520expression%2520and%2520glutamine%2520metabolism%26jtitle%3DNature%26date%3D2009%26volume%3D458%26issue%3D7239%26spage%3D762%26epage%3D765%26doi%3D10.1038%2Fnature07823" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Le, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lane, A. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamaker, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bose, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gouw, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barbi, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsukamoto, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rojas, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Slusher, B. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zimmerman, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liebler, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Slebos, R. J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lorkiewicz, P. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Higashi, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, T. W. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dang, C. V.</span></span> <span> </span><span class="NLM_article-title">Glucose-independent glutamine metabolism via TCA cycling for proliferation and survival in B cells</span>. <i>Cell Metab.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>15</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">110</span>– <span class="NLM_lpage">121</span>, <span class="refDoi"> DOI: 10.1016/j.cmet.2011.12.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=10.1016%2Fj.cmet.2011.12.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=22225880" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=1%3ACAS%3A528%3ADC%252BC38XkvF2nsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2012&pages=110-121&issue=1&author=A.+Leauthor=A.+N.+Laneauthor=M.+Hamakerauthor=S.+Boseauthor=A.+Gouwauthor=J.+Barbiauthor=T.+Tsukamotoauthor=C.+J.+Rojasauthor=B.+S.+Slusherauthor=H.+X.+Zhangauthor=L.+J.+Zimmermanauthor=D.+C.+Lieblerauthor=R.+J.+C.+Slebosauthor=P.+K.+Lorkiewiczauthor=R.+M.+Higashiauthor=T.+W.+M.+Fanauthor=C.+V.+Dang&title=Glucose-independent+glutamine+metabolism+via+TCA+cycling+for+proliferation+and+survival+in+B+cells&doi=10.1016%2Fj.cmet.2011.12.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Glucose-Independent Glutamine Metabolism via TCA Cycling for Proliferation and Survival in B Cells</span></div><div class="casAuthors">Le, Anne; Lane, Andrew N.; Hamaker, Max; Bose, Sminu; Gouw, Arvin; Barbi, Joseph; Tsukamoto, Takashi; Rojas, Camilio J.; Slusher, Barbara S.; Zhang, Haixia; Zimmerman, Lisa J.; Liebler, Daniel C.; Slebos, Robbert J. C.; Lorkiewicz, Pawel K.; Higashi, Richard M.; Fan, Teresa W. M.; Dang, Chi V.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Metabolism</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">110-121</span>CODEN:
                <span class="NLM_cas:coden">CMEEB5</span>;
        ISSN:<span class="NLM_cas:issn">1550-4131</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Because MYC plays a causal role in many human cancers, including those with hypoxic and nutrient-poor tumor microenvironments, we have detd. the metabolic responses of a MYC-inducible human Burkitt lymphoma model P493 cell line to aerobic and hypoxic conditions, and to glucose deprivation, using stable isotope-resolved metabolomics.  Using [U-13C]-glucose as the tracer, both glucose consumption and lactate prodn. were increased by MYC expression and hypoxia.  Using [U-13C,15N]-glutamine as the tracer, glutamine import and metab. through the TCA cycle persisted under hypoxia, and glutamine contributed significantly to citrate Cs.  Under glucose deprivation, glutamine-derived fumarate, malate, and citrate were significantly increased.  Their 13C-labeling patterns demonstrate an alternative energy-generating glutaminolysis pathway involving a glucose-independent TCA cycle.  The essential role of glutamine metab. in cell survival and proliferation under hypoxia and glucose deficiency makes them susceptible to the glutaminase inhibitor BPTES and hence could be targeted for cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpxz5K5YyvT6rVg90H21EOLACvtfcHk0ljYiZNdAHAE8A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XkvF2nsg%253D%253D&md5=0e71d2f1fff5795ba1d22afc8a2fefae</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1016%2Fj.cmet.2011.12.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cmet.2011.12.009%26sid%3Dliteratum%253Aachs%26aulast%3DLe%26aufirst%3DA.%26aulast%3DLane%26aufirst%3DA.%2BN.%26aulast%3DHamaker%26aufirst%3DM.%26aulast%3DBose%26aufirst%3DS.%26aulast%3DGouw%26aufirst%3DA.%26aulast%3DBarbi%26aufirst%3DJ.%26aulast%3DTsukamoto%26aufirst%3DT.%26aulast%3DRojas%26aufirst%3DC.%2BJ.%26aulast%3DSlusher%26aufirst%3DB.%2BS.%26aulast%3DZhang%26aufirst%3DH.%2BX.%26aulast%3DZimmerman%26aufirst%3DL.%2BJ.%26aulast%3DLiebler%26aufirst%3DD.%2BC.%26aulast%3DSlebos%26aufirst%3DR.%2BJ.%2BC.%26aulast%3DLorkiewicz%26aufirst%3DP.%2BK.%26aulast%3DHigashi%26aufirst%3DR.%2BM.%26aulast%3DFan%26aufirst%3DT.%2BW.%2BM.%26aulast%3DDang%26aufirst%3DC.%2BV.%26atitle%3DGlucose-independent%2520glutamine%2520metabolism%2520via%2520TCA%2520cycling%2520for%2520proliferation%2520and%2520survival%2520in%2520B%2520cells%26jtitle%3DCell%2520Metab.%26date%3D2012%26volume%3D15%26issue%3D1%26spage%3D110%26epage%3D121%26doi%3D10.1016%2Fj.cmet.2011.12.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Son, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lyssiotis, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ying, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hua, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ligorio, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perera, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferrone, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mullarky, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shyh-Chang, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fleming, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bardeesy, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Asara, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haigis, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DePinho, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cantley, L. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kimmelman, A. C.</span></span> <span> </span><span class="NLM_article-title">Glutamine supports pancreatic cancer growth through a Kras-regulated metabolic pathway</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>496</i></span>,  <span class="NLM_fpage">101</span>– <span class="NLM_lpage">105</span>, <span class="refDoi"> DOI: 10.1038/nature12040</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=10.1038%2Fnature12040" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=23535601" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=1%3ACAS%3A528%3ADC%252BC3sXkvFyjsrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=496&publication_year=2013&pages=101-105&author=J.+Sonauthor=C.+A.+Lyssiotisauthor=H.+Yingauthor=X.+Wangauthor=S.+Huaauthor=M.+Ligorioauthor=R.+M.+Pereraauthor=C.+R.+Ferroneauthor=E.+Mullarkyauthor=N.+Shyh-Changauthor=Y.+Kangauthor=J.+B.+Flemingauthor=N.+Bardeesyauthor=J.+M.+Asaraauthor=M.+C.+Haigisauthor=R.+A.+DePinhoauthor=L.+C.+Cantleyauthor=A.+C.+Kimmelman&title=Glutamine+supports+pancreatic+cancer+growth+through+a+Kras-regulated+metabolic+pathway&doi=10.1038%2Fnature12040"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Glutamine supports pancreatic cancer growth through a KRAS-regulated metabolic pathway</span></div><div class="casAuthors">Son, Jaekyoung; Lyssiotis, Costas A.; Ying, Haoqiang; Wang, Xiaoxu; Hua, Sujun; Ligorio, Matteo; Perera, Rushika M.; Ferrone, Cristina R.; Mullarky, Edouard; Ng, Shyh-Chang; Kang, Ya'an; Fleming, Jason B.; Bardeesy, Nabeel; Asara, John M.; Haigis, Marcia C.; DePinho, Ronald A.; Cantley, Lewis C.; Kimmelman, Alec C.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">496</span>
        (<span class="NLM_cas:issue">7443</span>),
    <span class="NLM_cas:pages">101-105</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Cancer cells have metabolic dependencies that distinguish them from their normal counterparts.  Among these dependencies is an increased use of the amino acid glutamine to fuel anabolic processes.  Indeed, the spectrum of glutamine-dependent tumors and the mechanisms whereby glutamine supports cancer metab. remain areas of active investigation.  Here we report the identification of a non-canonical pathway of glutamine use in human pancreatic ductal adenocarcinoma (PDAC) cells that is required for tumor growth.  Whereas most cells use glutamate dehydrogenase (GLUD1) to convert glutamine-derived glutamate into α-ketoglutarate in the mitochondria to fuel the tricarboxylic acid cycle, PDAC relies on a distinct pathway in which glutamine-derived aspartate is transported into the cytoplasm where it can be converted into oxaloacetate by aspartate transaminase (GOT1).  Subsequently, this oxaloacetate is converted into malate and then pyruvate, ostensibly increasing the NADPH/NADP+ ratio which can potentially maintain the cellular redox state.  Importantly, PDAC cells are strongly dependent on this series of reactions, as glutamine deprivation or genetic inhibition of any enzyme in this pathway leads to an increase in reactive oxygen species and a redn. in reduced glutathione.  Moreover, knockdown of any component enzyme in this series of reactions also results in a pronounced suppression of PDAC growth in vitro and in vivo.  Furthermore, we establish that the reprogramming of glutamine metab. is mediated by oncogenic KRAS, the signature genetic alteration in PDAC, through the transcriptional upregulation and repression of key metabolic enzymes in this pathway.  The essentiality of this pathway in PDAC and the fact that it is dispensable in normal cells may provide novel therapeutic approaches to treat these refractory tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpzWAEWZvCWcbVg90H21EOLACvtfcHk0lgMzosVytD-YQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXkvFyjsrc%253D&md5=162af18c1102745226aa2096179f1cc6</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1038%2Fnature12040&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature12040%26sid%3Dliteratum%253Aachs%26aulast%3DSon%26aufirst%3DJ.%26aulast%3DLyssiotis%26aufirst%3DC.%2BA.%26aulast%3DYing%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DHua%26aufirst%3DS.%26aulast%3DLigorio%26aufirst%3DM.%26aulast%3DPerera%26aufirst%3DR.%2BM.%26aulast%3DFerrone%26aufirst%3DC.%2BR.%26aulast%3DMullarky%26aufirst%3DE.%26aulast%3DShyh-Chang%26aufirst%3DN.%26aulast%3DKang%26aufirst%3DY.%26aulast%3DFleming%26aufirst%3DJ.%2BB.%26aulast%3DBardeesy%26aufirst%3DN.%26aulast%3DAsara%26aufirst%3DJ.%2BM.%26aulast%3DHaigis%26aufirst%3DM.%2BC.%26aulast%3DDePinho%26aufirst%3DR.%2BA.%26aulast%3DCantley%26aufirst%3DL.%2BC.%26aulast%3DKimmelman%26aufirst%3DA.%2BC.%26atitle%3DGlutamine%2520supports%2520pancreatic%2520cancer%2520growth%2520through%2520a%2520Kras-regulated%2520metabolic%2520pathway%26jtitle%3DNature%26date%3D2013%26volume%3D496%26spage%3D101%26epage%3D105%26doi%3D10.1038%2Fnature12040" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Weinberg, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamanaka, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wheaton, W. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weinberg, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joseph, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lopez, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalyanaraman, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mutlu, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Budinger, G. R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chandel, N. S.</span></span> <span> </span><span class="NLM_article-title">Mitochondrial metabolism and ROS generation are essential for Kras-mediated tumorigenicity</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>107</i></span>,  <span class="NLM_fpage">8788</span>– <span class="NLM_lpage">8793</span>, <span class="refDoi"> DOI: 10.1073/pnas.1003428107</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=10.1073%2Fpnas.1003428107" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=20421486" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=1%3ACAS%3A528%3ADC%252BC3cXmsFWmurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=107&publication_year=2010&pages=8788-8793&author=F.+Weinbergauthor=R.+Hamanakaauthor=W.+W.+Wheatonauthor=S.+Weinbergauthor=J.+Josephauthor=M.+Lopezauthor=B.+Kalyanaramanauthor=G.+M.+Mutluauthor=G.+R.+S.+Budingerauthor=N.+S.+Chandel&title=Mitochondrial+metabolism+and+ROS+generation+are+essential+for+Kras-mediated+tumorigenicity&doi=10.1073%2Fpnas.1003428107"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Mitochondrial metabolism and ROS generation are essential for Kras-mediated tumorigenicity</span></div><div class="casAuthors">Weinberg, Frank; Hamanaka, Robert; Wheaton, William W.; Weinberg, Samuel; Joseph, Joy; Lopez, Marcos; Kalyanaraman, Balaraman; Mutlu, Gokhan M.; Budinger, G. R. Scott; Chandel, Navdeep S.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">107</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">8788-8793, S8788/1-S8788/9</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Otto Warburg's theory on the origins of cancer postulates that tumor cells have defects in mitochondrial oxidative phosphorylation and therefore rely on high levels of aerobic glycolysis as the major source of ATP to fuel cellular proliferation (the Warburg effect).  This is in contrast to normal cells, which primarily utilize oxidative phosphorylation for growth and survival.  Here we report that the major function of glucose metab. for Kras-induced anchorage-independent growth, a hallmark of transformed cells, is to support the pentose phosphate pathway.  The major function of glycolytic ATP is to support growth under hypoxic conditions.  Glutamine conversion into the tricarboxylic acid cycle intermediate alpha-ketoglutarate through glutaminase and alanine aminotransferase is essential for Kras-induced anchorage-independent growth.  Mitochondrial metab. allows for the generation of reactive oxygen species (ROS) which are required for Kras-induced anchorage-independent growth through regulation of the ERK MAPK signaling pathway.  We show that the major source of ROS generation required for anchorage-independent growth is the Q0 site of mitochondrial complex III.  Furthermore, disruption of mitochondrial function by loss of the mitochondrial transcription factor A (TFAM) gene reduced tumorigenesis in an oncogenic Kras-driven mouse model of lung cancer.  These results demonstrate that mitochondrial metab. and mitochondrial ROS generation are essential for Kras-induced cell proliferation and tumorigenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGphMhaUC-tau7Vg90H21EOLACvtfcHk0lgMzosVytD-YQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXmsFWmurs%253D&md5=cc8197db5581ed62f5ce5f5e78823eb0</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1003428107&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1003428107%26sid%3Dliteratum%253Aachs%26aulast%3DWeinberg%26aufirst%3DF.%26aulast%3DHamanaka%26aufirst%3DR.%26aulast%3DWheaton%26aufirst%3DW.%2BW.%26aulast%3DWeinberg%26aufirst%3DS.%26aulast%3DJoseph%26aufirst%3DJ.%26aulast%3DLopez%26aufirst%3DM.%26aulast%3DKalyanaraman%26aufirst%3DB.%26aulast%3DMutlu%26aufirst%3DG.%2BM.%26aulast%3DBudinger%26aufirst%3DG.%2BR.%2BS.%26aulast%3DChandel%26aufirst%3DN.%2BS.%26atitle%3DMitochondrial%2520metabolism%2520and%2520ROS%2520generation%2520are%2520essential%2520for%2520Kras-mediated%2520tumorigenicity%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2010%26volume%3D107%26spage%3D8788%26epage%3D8793%26doi%3D10.1073%2Fpnas.1003428107" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gaglio, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soldati, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vanoni, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alberghina, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiaradonna, F.</span></span> <span> </span><span class="NLM_article-title">Glutamine deprivation induces abortive s-phase rescued by deoxyribonucleotides in k-ras transformed fibroblasts</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>4</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">e4715</span>, <span class="refDoi"> DOI: 10.1371/journal.pone.0004715</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=10.1371%2Fjournal.pone.0004715" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=19262748" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2009&pages=e4715&issue=3&author=D.+Gaglioauthor=C.+Soldatiauthor=M.+Vanoniauthor=L.+Alberghinaauthor=F.+Chiaradonna&title=Glutamine+deprivation+induces+abortive+s-phase+rescued+by+deoxyribonucleotides+in+k-ras+transformed+fibroblasts&doi=10.1371%2Fjournal.pone.0004715"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0004715&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0004715%26sid%3Dliteratum%253Aachs%26aulast%3DGaglio%26aufirst%3DD.%26aulast%3DSoldati%26aufirst%3DC.%26aulast%3DVanoni%26aufirst%3DM.%26aulast%3DAlberghina%26aufirst%3DL.%26aulast%3DChiaradonna%26aufirst%3DF.%26atitle%3DGlutamine%2520deprivation%2520induces%2520abortive%2520s-phase%2520rescued%2520by%2520deoxyribonucleotides%2520in%2520k-ras%2520transformed%2520fibroblasts%26jtitle%3DPLoS%2520One%26date%3D2009%26volume%3D4%26issue%3D3%26spage%3De4715%26doi%3D10.1371%2Fjournal.pone.0004715" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gaglio, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Metallo, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gameiro, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hiller, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Danna, L. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balestrieri, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alberghina, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stephanopoulos, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiaradonna, F.</span></span> <span> </span><span class="NLM_article-title">Oncogenic K-ras decouples glucose and glutamine metabolism to support cancer cell growth</span>. <i>Mol. Syst. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">523</span>, <span class="refDoi"> DOI: 10.1038/msb.2011.56</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=10.1038%2Fmsb.2011.56" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2011&pages=523&author=D.+Gaglioauthor=C.+M.+Metalloauthor=P.+A.+Gameiroauthor=K.+Hillerauthor=L.+S.+Dannaauthor=C.+Balestrieriauthor=L.+Alberghinaauthor=G.+Stephanopoulosauthor=F.+Chiaradonna&title=Oncogenic+K-ras+decouples+glucose+and+glutamine+metabolism+to+support+cancer+cell+growth&doi=10.1038%2Fmsb.2011.56"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1038%2Fmsb.2011.56&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fmsb.2011.56%26sid%3Dliteratum%253Aachs%26aulast%3DGaglio%26aufirst%3DD.%26aulast%3DMetallo%26aufirst%3DC.%2BM.%26aulast%3DGameiro%26aufirst%3DP.%2BA.%26aulast%3DHiller%26aufirst%3DK.%26aulast%3DDanna%26aufirst%3DL.%2BS.%26aulast%3DBalestrieri%26aufirst%3DC.%26aulast%3DAlberghina%26aufirst%3DL.%26aulast%3DStephanopoulos%26aufirst%3DG.%26aulast%3DChiaradonna%26aufirst%3DF.%26atitle%3DOncogenic%2520K-ras%2520decouples%2520glucose%2520and%2520glutamine%2520metabolism%2520to%2520support%2520cancer%2520cell%2520growth%26jtitle%3DMol.%2520Syst.%2520Biol.%26date%3D2011%26volume%3D7%26spage%3D523%26doi%3D10.1038%2Fmsb.2011.56" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Porter, L. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ibrahim, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Curthoys, N. P.</span></span> <span> </span><span class="NLM_article-title">Complexity and species variation of the kidney-type glutaminase gene</span>. <i>Physiol. Genomics</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>9</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">157</span>– <span class="NLM_lpage">166</span>, <span class="refDoi"> DOI: 10.1152/physiolgenomics.00017.2002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=10.1152%2Fphysiolgenomics.00017.2002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=12045296" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=1%3ACAS%3A528%3ADC%252BD38Xms1eju74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2002&pages=157-166&issue=3&author=L.+D.+Porterauthor=H.+Ibrahimauthor=L.+Taylorauthor=N.+P.+Curthoys&title=Complexity+and+species+variation+of+the+kidney-type+glutaminase+gene&doi=10.1152%2Fphysiolgenomics.00017.2002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Complexity and species variation of the kidney-type glutaminase gene</span></div><div class="casAuthors">Porter, L. David; Ibrahim, Hend; Taylor, Lynn; Curthoys, Norman P.</div><div class="citationInfo"><span class="NLM_cas:title">Physiological Genomics [online computer file]</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">157-166</span>CODEN:
                <span class="NLM_cas:coden">PHGEFP</span>;
        ISSN:<span class="NLM_cas:issn">1094-8341</span>.
    
            (<span class="NLM_cas:orgname">American Physiological Society</span>)
        </div><div class="casAbstract">Increased expression of rat kidney-type glutaminase (KGA) during metabolic acidosis results from selective mRNA stabilization.  This process is mediated by an 8-base Au-sequence that functions as a pH-response element (pHRE).  LLC-PK1-FBPase+ cells, a pH-responsive porcine kidney cell line, express four distinct GA mRNAs.  RNase H mapping indicated that three of the GA mRNAs are generated by use of alternative polyadenylation sites and are homologs of the rat KGA mRNA, while the fourth contains a different COOH-terminal coding and 3'-untranslated sequence.  PCR cloning and sequencing established that the latter GA mRNA is the homolog of the human GAC mRNA.  A rat GAC cDNA was also cloned from a rat kidney library.  The 3'-untranslated regions of the GAC mRNAs, but not the porcine or human KGA mRNAs, contain identifiable pHREs.  The human KGA gene spans 82 kb and is composed of 19 exons.  The unique sequence from the hGAC cDNA is contained in a single exon.  Thus in humans, alternative splicing of the initial transcript could produce two GA mRNAs, only one of which may be increased during acidosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGojn1ujZ95BvbVg90H21EOLACvtfcHk0lgj3QZY_2rzdQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xms1eju74%253D&md5=71665cfd66cf3b0ac097f52fe326402d</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1152%2Fphysiolgenomics.00017.2002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1152%252Fphysiolgenomics.00017.2002%26sid%3Dliteratum%253Aachs%26aulast%3DPorter%26aufirst%3DL.%2BD.%26aulast%3DIbrahim%26aufirst%3DH.%26aulast%3DTaylor%26aufirst%3DL.%26aulast%3DCurthoys%26aufirst%3DN.%2BP.%26atitle%3DComplexity%2520and%2520species%2520variation%2520of%2520the%2520kidney-type%2520glutaminase%2520gene%26jtitle%3DPhysiol.%2520Genomics%26date%3D2002%26volume%3D9%26issue%3D3%26spage%3D157%26epage%3D166%26doi%3D10.1152%2Fphysiolgenomics.00017.2002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erickson, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stalnecker, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katt, W. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cerione, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramachandran, S.</span></span> <span> </span><span class="NLM_article-title">Mechanistic basis of glutaminase activation: a key enzyme that promotes glutamine metabolism in cancer cells</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>291</i></span> (<span class="NLM_issue">40</span>),  <span class="NLM_fpage">20900</span>– <span class="NLM_lpage">20910</span>, <span class="refDoi"> DOI: 10.1074/jbc.M116.720268</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=10.1074%2Fjbc.M116.720268" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=291&publication_year=2016&pages=20900-20910&issue=40&author=Y.+Liauthor=J.+W.+Ericksonauthor=C.+A.+Stalneckerauthor=W.+P.+Kattauthor=Q.+Huangauthor=R.+A.+Cerioneauthor=S.+Ramachandran&title=Mechanistic+basis+of+glutaminase+activation%3A+a+key+enzyme+that+promotes+glutamine+metabolism+in+cancer+cells&doi=10.1074%2Fjbc.M116.720268"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M116.720268&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M116.720268%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DY.%26aulast%3DErickson%26aufirst%3DJ.%2BW.%26aulast%3DStalnecker%26aufirst%3DC.%2BA.%26aulast%3DKatt%26aufirst%3DW.%2BP.%26aulast%3DHuang%26aufirst%3DQ.%26aulast%3DCerione%26aufirst%3DR.%2BA.%26aulast%3DRamachandran%26aufirst%3DS.%26atitle%3DMechanistic%2520basis%2520of%2520glutaminase%2520activation%253A%2520a%2520key%2520enzyme%2520that%2520promotes%2520glutamine%2520metabolism%2520in%2520cancer%2520cells%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2016%26volume%3D291%26issue%3D40%26spage%3D20900%26epage%3D20910%26doi%3D10.1074%2Fjbc.M116.720268" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Thangavelu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pan, C. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karlberg, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balaji, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uttamchandani, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suresh, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schuler, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Low, B. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sivaraman, J.</span></span> <span> </span><span class="NLM_article-title">Structural basis for the allosteric inhibitory mechanism of human kidney type glutaminase (KGA) and its regulation by Raf-Mek-Erk signaling in cancer cell metabolism</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>109</i></span> (<span class="NLM_issue">20</span>),  <span class="NLM_fpage">7705</span>– <span class="NLM_lpage">7710</span>, <span class="refDoi"> DOI: 10.1073/pnas.1116573109</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=10.1073%2Fpnas.1116573109" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2012&pages=7705-7710&issue=20&author=K.+Thangaveluauthor=C.+Q.+Panauthor=T.+Karlbergauthor=G.+Balajiauthor=M.+Uttamchandaniauthor=V.+Sureshauthor=H.+Schulerauthor=B.+C.+Lowauthor=J.+Sivaraman&title=Structural+basis+for+the+allosteric+inhibitory+mechanism+of+human+kidney+type+glutaminase+%28KGA%29+and+its+regulation+by+Raf-Mek-Erk+signaling+in+cancer+cell+metabolism&doi=10.1073%2Fpnas.1116573109"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1116573109&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1116573109%26sid%3Dliteratum%253Aachs%26aulast%3DThangavelu%26aufirst%3DK.%26aulast%3DPan%26aufirst%3DC.%2BQ.%26aulast%3DKarlberg%26aufirst%3DT.%26aulast%3DBalaji%26aufirst%3DG.%26aulast%3DUttamchandani%26aufirst%3DM.%26aulast%3DSuresh%26aufirst%3DV.%26aulast%3DSchuler%26aufirst%3DH.%26aulast%3DLow%26aufirst%3DB.%2BC.%26aulast%3DSivaraman%26aufirst%3DJ.%26atitle%3DStructural%2520basis%2520for%2520the%2520allosteric%2520inhibitory%2520mechanism%2520of%2520human%2520kidney%2520type%2520glutaminase%2520%2528KGA%2529%2520and%2520its%2520regulation%2520by%2520Raf-Mek-Erk%2520signaling%2520in%2520cancer%2520cell%2520metabolism%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2012%26volume%3D109%26issue%3D20%26spage%3D7705%26epage%3D7710%26doi%3D10.1073%2Fpnas.1116573109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">DeLaBarre, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gross, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jha, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, W. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hurov, J. B.</span></span> <span> </span><span class="NLM_article-title">Full-length human glutaminase in complex with an allosteric inhibitor</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">10764</span>– <span class="NLM_lpage">10770</span>, <span class="refDoi"> DOI: 10.1021/bi201613d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi201613d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsVSks73K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2011&pages=10764-10770&author=B.+DeLaBarreauthor=S.+Grossauthor=C.+Fangauthor=Y.+Gaoauthor=A.+Jhaauthor=F.+Jiangauthor=J.+Songauthor=W.+T.+Weiauthor=J.+B.+Hurov&title=Full-length+human+glutaminase+in+complex+with+an+allosteric+inhibitor&doi=10.1021%2Fbi201613d"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Full-Length Human Glutaminase in Complex with an Allosteric Inhibitor</span></div><div class="casAuthors">DeLaBarre, Byron; Gross, Stefan; Fang, Cheng; Gao, Yi; Jha, Abhishek; Jiang, Fan; Song J., Juanhua; Wei, Wentao; Hurov, Jonathan B.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">50</span>),
    <span class="NLM_cas:pages">10764-10770</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Glutaminase (GLS1/2) catalyzes the conversion of L-glutamine to L-glutamate and ammonia.  The level of a splice variant of GLS1 (GAC) is elevated in certain cancers, and GAC is specifically inhibited by bis-2-(5-phenylacetimido-1,2,4,thiadiazol-2-yl)ethyl sulfide (BPTES).  We report here the first full-length crystal structure of GAC in the presence and absence of BPTES mols.  Two BPTES mols. bind at an interface region of the GAC tetramer in a manner that appears to lock the GAC tetramer into a nonproductive conformation.  The importance of these loops with regard to overall enzymic activity of the tetramer was revealed by a series of GAC point mutants designed to create a BPTES resistant GAC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrrj21-Ko0HGLVg90H21EOLACvtfcHk0ljATV9QTAtC3g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsVSks73K&md5=bd94996062f54c4f51a138c8e9f5f99a</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1021%2Fbi201613d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi201613d%26sid%3Dliteratum%253Aachs%26aulast%3DDeLaBarre%26aufirst%3DB.%26aulast%3DGross%26aufirst%3DS.%26aulast%3DFang%26aufirst%3DC.%26aulast%3DGao%26aufirst%3DY.%26aulast%3DJha%26aufirst%3DA.%26aulast%3DJiang%26aufirst%3DF.%26aulast%3DSong%26aufirst%3DJ.%26aulast%3DWei%26aufirst%3DW.%2BT.%26aulast%3DHurov%26aufirst%3DJ.%2BB.%26atitle%3DFull-length%2520human%2520glutaminase%2520in%2520complex%2520with%2520an%2520allosteric%2520inhibitor%26jtitle%3DBiochemistry%26date%3D2011%26volume%3D50%26spage%3D10764%26epage%3D10770%26doi%3D10.1021%2Fbi201613d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stalnecker, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McDermott, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iyer, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Neill, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reimer, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cerione, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katt, W. P.</span></span> <span> </span><span class="NLM_article-title">Characterization of the interactions of potent allosteric inhibitors with glutaminase C, a key enzyme in cancer cell glutamine metabolism</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>293</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">3535</span>– <span class="NLM_lpage">3545</span>, <span class="refDoi"> DOI: 10.1074/jbc.M117.810101</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=10.1074%2Fjbc.M117.810101" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=293&publication_year=2018&pages=3535-3545&issue=10&author=Q.+Huangauthor=C.+Stalneckerauthor=C.+Zhangauthor=L.+A.+McDermottauthor=P.+Iyerauthor=J.+O%E2%80%99Neillauthor=S.+Reimerauthor=R.+A.+Cerioneauthor=W.+P.+Katt&title=Characterization+of+the+interactions+of+potent+allosteric+inhibitors+with+glutaminase+C%2C+a+key+enzyme+in+cancer+cell+glutamine+metabolism&doi=10.1074%2Fjbc.M117.810101"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M117.810101&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M117.810101%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DQ.%26aulast%3DStalnecker%26aufirst%3DC.%26aulast%3DZhang%26aufirst%3DC.%26aulast%3DMcDermott%26aufirst%3DL.%2BA.%26aulast%3DIyer%26aufirst%3DP.%26aulast%3DO%25E2%2580%2599Neill%26aufirst%3DJ.%26aulast%3DReimer%26aufirst%3DS.%26aulast%3DCerione%26aufirst%3DR.%2BA.%26aulast%3DKatt%26aufirst%3DW.%2BP.%26atitle%3DCharacterization%2520of%2520the%2520interactions%2520of%2520potent%2520allosteric%2520inhibitors%2520with%2520glutaminase%2520C%252C%2520a%2520key%2520enzyme%2520in%2520cancer%2520cell%2520glutamine%2520metabolism%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2018%26volume%3D293%26issue%3D10%26spage%3D3535%26epage%3D3545%26doi%3D10.1074%2Fjbc.M117.810101" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ramachandran, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pan, C. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zimmermann, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duvall, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsukamoto, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Low, B. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sivaraman, J.</span></span> <span> </span><span class="NLM_article-title">Structural basis for exploring the allosteric inhibition of human kidney type glutaminase</span>. <i>Oncotarget</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">57943</span>– <span class="NLM_lpage">57954</span>, <span class="refDoi"> DOI: 10.18632/oncotarget.10791</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=10.18632%2Foncotarget.10791" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=27462863" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=1%3ACAS%3A280%3ADC%252BC2s3kvVSitw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=57943-57954&author=S.+Ramachandranauthor=C.+Q.+Panauthor=S.+C.+Zimmermannauthor=B.+Duvallauthor=T.+Tsukamotoauthor=B.+C.+Lowauthor=J.+Sivaraman&title=Structural+basis+for+exploring+the+allosteric+inhibition+of+human+kidney+type+glutaminase&doi=10.18632%2Foncotarget.10791"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Structural basis for exploring the allosteric inhibition of human kidney type glutaminase</span></div><div class="casAuthors">Ramachandran Sarath; Low Boon Chuan; Sivaraman J; Pan Catherine Qiurong; Low Boon Chuan; Zimmermann Sarah C; Duvall Bridget; Tsukamoto Takashi</div><div class="citationInfo"><span class="NLM_cas:title">Oncotarget</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">36</span>),
    <span class="NLM_cas:pages">57943-57954</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Cancer cells employ glutaminolysis to provide a source of intermediates for their upregulated biosynthetic needs.  Glutaminase, which catalyzes the conversion of glutamine to glutamate, is gaining increasing attention as a potential drug target.  Small-molecule inhibitors such as BPTES and CB-839, which target the allosteric site of glutaminase with high specificity, demonstrate immense promise as anti-tumor drugs.  Here, we report the study of a new BPTES analog, N,N'-(5,5'-(trans-cyclohexane-1,3-diyl)bis(1,3,4-tiadiazole-5,2-diyl))bis(2-phenylacetamide) (trans-CBTBP), and compared its inhibitory effect against that of CB-839 and BPTES.  We show that CB-839 has a 30- and 50-fold lower IC50 than trans-CBTBP and BPTES, respectively.  To explore the structural basis for the differences in their inhibitory efficacy, we solved the complex structures of cKGA with 1S, 3S-CBTBP and CB-839.  We found that CB-839 produces a greater degree of interaction with cKGA than 1S, 3S-CBTBP or BPTES.  The results of this study will facilitate the rational design of new KGA inhibitors to better treat glutamine-addicted cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTM3CV8sADQTzW1zwg2yUK5fW6udTcc2eaM7nJGtwmFirntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2s3kvVSitw%253D%253D&md5=1d2f516dde7da1a59f53d770a0f7c257</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.10791&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.10791%26sid%3Dliteratum%253Aachs%26aulast%3DRamachandran%26aufirst%3DS.%26aulast%3DPan%26aufirst%3DC.%2BQ.%26aulast%3DZimmermann%26aufirst%3DS.%2BC.%26aulast%3DDuvall%26aufirst%3DB.%26aulast%3DTsukamoto%26aufirst%3DT.%26aulast%3DLow%26aufirst%3DB.%2BC.%26aulast%3DSivaraman%26aufirst%3DJ.%26atitle%3DStructural%2520basis%2520for%2520exploring%2520the%2520allosteric%2520inhibition%2520of%2520human%2520kidney%2520type%2520glutaminase%26jtitle%3DOncotarget%26date%3D2016%26volume%3D7%26spage%3D57943%26epage%3D57954%26doi%3D10.18632%2Foncotarget.10791" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McDermott, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iyer, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vernetti, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rimer, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boby, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, T. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fioravanti, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Neill, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drakes, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katt, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, Q. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cerione, R.</span></span> <span> </span><span class="NLM_article-title">Design and evaluation of novel glutaminase inhibitors</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>24</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">1819</span>– <span class="NLM_lpage">1839</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2016.03.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=10.1016%2Fj.bmc.2016.03.009" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2016&pages=1819-1839&issue=8&author=L.+A.+McDermottauthor=P.+Iyerauthor=L.+Vernettiauthor=S.+Rimerauthor=J.+R.+Sunauthor=M.+Bobyauthor=T.+Y.+Yangauthor=M.+Fioravantiauthor=J.+O%E2%80%99Neillauthor=L.+W.+Wangauthor=D.+Drakesauthor=W.+Kattauthor=Q.+Q.+Huangauthor=R.+Cerione&title=Design+and+evaluation+of+novel+glutaminase+inhibitors&doi=10.1016%2Fj.bmc.2016.03.009"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2016.03.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2016.03.009%26sid%3Dliteratum%253Aachs%26aulast%3DMcDermott%26aufirst%3DL.%2BA.%26aulast%3DIyer%26aufirst%3DP.%26aulast%3DVernetti%26aufirst%3DL.%26aulast%3DRimer%26aufirst%3DS.%26aulast%3DSun%26aufirst%3DJ.%2BR.%26aulast%3DBoby%26aufirst%3DM.%26aulast%3DYang%26aufirst%3DT.%2BY.%26aulast%3DFioravanti%26aufirst%3DM.%26aulast%3DO%25E2%2580%2599Neill%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DL.%2BW.%26aulast%3DDrakes%26aufirst%3DD.%26aulast%3DKatt%26aufirst%3DW.%26aulast%3DHuang%26aufirst%3DQ.%2BQ.%26aulast%3DCerione%26aufirst%3DR.%26atitle%3DDesign%2520and%2520evaluation%2520of%2520novel%2520glutaminase%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2016%26volume%3D24%26issue%3D8%26spage%3D1819%26epage%3D1839%26doi%3D10.1016%2Fj.bmc.2016.03.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Scota
Ferreira, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cassago, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Almeida Goncalves, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meira Dias, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adamoski, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodrigues Ascencao, C. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vargas Honorato, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferreira de Oliveira, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monteze
Ferreira, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fornezari, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bettini, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lopes Oliveira, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paes Leme, A. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Villares Portugal, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berteli Ambrosio, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gomes Dias, S. M.</span></span> <span> </span><span class="NLM_article-title">Active glutaminase C self-assembles into a supra-tetrameric oligomer which can be disrupted by an allosteric inhibitor</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>288</i></span>,  <span class="NLM_fpage">28009</span>– <span class="NLM_lpage">28020</span>, <span class="refDoi"> DOI: 10.1074/jbc.M113.501346</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=10.1074%2Fjbc.M113.501346" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=288&publication_year=2013&pages=28009-28020&author=A.+P.+Scota%0AFerreiraauthor=A.+Cassagoauthor=K.+de+Almeida+Goncalvesauthor=M.+Meira+Diasauthor=D.+Adamoskiauthor=C.+F.+Rodrigues+Ascencaoauthor=R.+Vargas+Honoratoauthor=J.+Ferreira+de+Oliveiraauthor=I.+Monteze%0AFerreiraauthor=C.+Fornezariauthor=J.+Bettiniauthor=P.+S.+Lopes+Oliveiraauthor=A.+F.+Paes+Lemeauthor=R.+Villares+Portugalauthor=A.+L.+Berteli+Ambrosioauthor=S.+M.+Gomes+Dias&title=Active+glutaminase+C+self-assembles+into+a+supra-tetrameric+oligomer+which+can+be+disrupted+by+an+allosteric+inhibitor&doi=10.1074%2Fjbc.M113.501346"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M113.501346&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M113.501346%26sid%3Dliteratum%253Aachs%26aulast%3DScota%2BFerreira%26aufirst%3DA.%2BP.%26aulast%3DCassago%26aufirst%3DA.%26aulast%3Dde%2BAlmeida%2BGoncalves%26aufirst%3DK.%26aulast%3DMeira%2BDias%26aufirst%3DM.%26aulast%3DAdamoski%26aufirst%3DD.%26aulast%3DRodrigues%2BAscencao%26aufirst%3DC.%2BF.%26aulast%3DVargas%2BHonorato%26aufirst%3DR.%26aulast%3DFerreira%2Bde%2BOliveira%26aufirst%3DJ.%26aulast%3DMonteze%2BFerreira%26aufirst%3DI.%26aulast%3DFornezari%26aufirst%3DC.%26aulast%3DBettini%26aufirst%3DJ.%26aulast%3DLopes%2BOliveira%26aufirst%3DP.%2BS.%26aulast%3DPaes%2BLeme%26aufirst%3DA.%2BF.%26aulast%3DVillares%2BPortugal%26aufirst%3DR.%26aulast%3DBerteli%2BAmbrosio%26aufirst%3DA.%2BL.%26aulast%3DGomes%2BDias%26aufirst%3DS.%2BM.%26atitle%3DActive%2520glutaminase%2520C%2520self-assembles%2520into%2520a%2520supra-tetrameric%2520oligomer%2520which%2520can%2520be%2520disrupted%2520by%2520an%2520allosteric%2520inhibitor%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2013%26volume%3D288%26spage%3D28009%26epage%3D28020%26doi%3D10.1074%2Fjbc.M113.501346" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Thangavelu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chong, Q. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Low, B. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sivaraman, J.</span></span> <span> </span><span class="NLM_article-title">Structural basis for the active site inhibition mechanism of human kidney-type glutaminase (KGA)</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">3827</span>, <span class="refDoi"> DOI: 10.1038/srep03827</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=10.1038%2Fsrep03827" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2015&pages=3827&author=K.+Thangaveluauthor=Q.+Y.+Chongauthor=B.+C.+Lowauthor=J.+Sivaraman&title=Structural+basis+for+the+active+site+inhibition+mechanism+of+human+kidney-type+glutaminase+%28KGA%29&doi=10.1038%2Fsrep03827"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1038%2Fsrep03827&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsrep03827%26sid%3Dliteratum%253Aachs%26aulast%3DThangavelu%26aufirst%3DK.%26aulast%3DChong%26aufirst%3DQ.%2BY.%26aulast%3DLow%26aufirst%3DB.%2BC.%26aulast%3DSivaraman%26aufirst%3DJ.%26atitle%3DStructural%2520basis%2520for%2520the%2520active%2520site%2520inhibition%2520mechanism%2520of%2520human%2520kidney-type%2520glutaminase%2520%2528KGA%2529%26jtitle%3DSci.%2520Rep.%26date%3D2015%26volume%3D4%26spage%3D3827%26doi%3D10.1038%2Fsrep03827" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kenny, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamm, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toth, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wagers, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Curthoys, N. P.</span></span> <span> </span><span class="NLM_article-title">Bacterial expression, purification, and characterization of rat kidney-type mitochondrial glutaminase</span>. <i>Protein Expression Purif.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>31</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">140</span>– <span class="NLM_lpage">148</span>, <span class="refDoi"> DOI: 10.1016/S1046-5928(03)00161-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=10.1016%2FS1046-5928%2803%2900161-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=12963351" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=1%3ACAS%3A528%3ADC%252BD3sXntVGkt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2003&pages=140-148&issue=1&author=J.+Kennyauthor=Y.+Baoauthor=B.+Hammauthor=L.+Taylorauthor=A.+Tothauthor=B.+Wagersauthor=N.+P.+Curthoys&title=Bacterial+expression%2C+purification%2C+and+characterization+of+rat+kidney-type+mitochondrial+glutaminase&doi=10.1016%2FS1046-5928%2803%2900161-X"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Bacterial expression, purification, and characterization of rat kidney-type mitochondrial glutaminase</span></div><div class="casAuthors">Kenny, John; Bao, Yuhne; Hamm, Brian; Taylor, Lynn; Toth, Ann; Wagers, Brian; Curthoys, Norman P.</div><div class="citationInfo"><span class="NLM_cas:title">Protein Expression and Purification</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">140-148</span>CODEN:
                <span class="NLM_cas:coden">PEXPEJ</span>;
        ISSN:<span class="NLM_cas:issn">1046-5928</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science</span>)
        </div><div class="casAbstract">The human gene that encodes kidney-type glutaminase (KGA) spans 84-kb, contains 19 exons, and encodes 2 alternatively spliced mRNAs.  Here, various segments of rat KGA cDNA were PCR amplified and cloned into a bacterial expression vector and expressed in Escherichia coli to det. whether the N- and C- terminal ends of the glutaminase protein were essential for activity.  A recombinant glutaminase, lacking the coding sequence contained in exon 1, was found to be fully active.  In contrast, proteins that lacked sequences from exons 1 and 2 and exons 1-3 were inactive.  An addnl. construct that corresponded to the sequence encoded by exons 2-14 also retained full activity.  Both of the fully active, truncated proteins were purified to apparent homogeneity using an incorporated N-terminal His6-tag and Ni2+-affinity chromatog.  The Km values for glutamine of the native and recombinant forms of glutaminase were nearly identical.  However, the 2 truncated forms of glutaminase exhibited the characteristic phosphate activation profile only when dialyzed into a buffer lacking phosphate.  Dialysis vs. 10 mM Tris-phosphate was sufficient to form an active tetramer.  Thus, the deleted N-terminal sequence may contribute to the phosphate-dependent oligomerization and activation of the native glutaminase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoDLrJrBVieI7Vg90H21EOLACvtfcHk0lgxDJmnj43Zhw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXntVGkt7s%253D&md5=f7e79be9442292154cbd86c162af53d3</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1016%2FS1046-5928%2803%2900161-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1046-5928%252803%252900161-X%26sid%3Dliteratum%253Aachs%26aulast%3DKenny%26aufirst%3DJ.%26aulast%3DBao%26aufirst%3DY.%26aulast%3DHamm%26aufirst%3DB.%26aulast%3DTaylor%26aufirst%3DL.%26aulast%3DToth%26aufirst%3DA.%26aulast%3DWagers%26aufirst%3DB.%26aulast%3DCurthoys%26aufirst%3DN.%2BP.%26atitle%3DBacterial%2520expression%252C%2520purification%252C%2520and%2520characterization%2520of%2520rat%2520kidney-type%2520mitochondrial%2520glutaminase%26jtitle%3DProtein%2520Expression%2520Purif.%26date%3D2003%26volume%3D31%26issue%3D1%26spage%3D140%26epage%3D148%26doi%3D10.1016%2FS1046-5928%2803%2900161-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shukla, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferraris, D. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stathis, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duvall, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delahanty, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alt, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rais, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rojas, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dang, C. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Slusher, B. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsukamoto, T.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis, and pharmacological evaluation of bis-2-(5-phenylacetamido-1,2,4-thiadiazol-2-yl)ethyl sulfide 3 (BPTES) analogs as glutaminase inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span> (<span class="NLM_issue">23</span>),  <span class="NLM_fpage">10551</span>– <span class="NLM_lpage">10563</span>, <span class="refDoi"> DOI: 10.1021/jm301191p</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm301191p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=10551-10563&issue=23&author=K.+Shuklaauthor=D.+V.+Ferrarisauthor=A.+G.+Thomasauthor=M.+Stathisauthor=B.+Duvallauthor=G.+Delahantyauthor=J.+Altauthor=R.+Raisauthor=C.+Rojasauthor=P.+Gaoauthor=Y.+Xiangauthor=C.+V.+Dangauthor=B.+S.+Slusherauthor=T.+Tsukamoto&title=Design%2C+synthesis%2C+and+pharmacological+evaluation+of+bis-2-%285-phenylacetamido-1%2C2%2C4-thiadiazol-2-yl%29ethyl+sulfide+3+%28BPTES%29+analogs+as+glutaminase+inhibitors&doi=10.1021%2Fjm301191p"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1021%2Fjm301191p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301191p%26sid%3Dliteratum%253Aachs%26aulast%3DShukla%26aufirst%3DK.%26aulast%3DFerraris%26aufirst%3DD.%2BV.%26aulast%3DThomas%26aufirst%3DA.%2BG.%26aulast%3DStathis%26aufirst%3DM.%26aulast%3DDuvall%26aufirst%3DB.%26aulast%3DDelahanty%26aufirst%3DG.%26aulast%3DAlt%26aufirst%3DJ.%26aulast%3DRais%26aufirst%3DR.%26aulast%3DRojas%26aufirst%3DC.%26aulast%3DGao%26aufirst%3DP.%26aulast%3DXiang%26aufirst%3DY.%26aulast%3DDang%26aufirst%3DC.%2BV.%26aulast%3DSlusher%26aufirst%3DB.%2BS.%26aulast%3DTsukamoto%26aufirst%3DT.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520pharmacological%2520evaluation%2520of%2520bis-2-%25285-phenylacetamido-1%252C2%252C4-thiadiazol-2-yl%2529ethyl%2520sulfide%25203%2520%2528BPTES%2529%2520analogs%2520as%2520glutaminase%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26issue%3D23%26spage%3D10551%26epage%3D10563%26doi%3D10.1021%2Fjm301191p" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, P. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meng, D. L.</span></span> <span> </span><span class="NLM_article-title">Brachyantheraoside A<sub>8</sub>, a new natural nor-oleanane triterpenoid as a kidney-type glutaminase inhibitor from Stauntonia brachyanthera</span>. <i>RSC Adv.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">52533</span>– <span class="NLM_lpage">52542</span>, <span class="refDoi"> DOI: 10.1039/C7RA11270J</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=10.1039%2FC7RA11270J" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvVSmsbvJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2017&pages=52533-52542&author=R.+Liauthor=P.+F.+Weiauthor=Y.+Wangauthor=Y.+Liuauthor=X.+L.+Liuauthor=D.+L.+Meng&title=Brachyantheraoside+A8%2C+a+new+natural+nor-oleanane+triterpenoid+as+a+kidney-type+glutaminase+inhibitor+from+Stauntonia+brachyanthera&doi=10.1039%2FC7RA11270J"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Brachyantheraoside A8, a new natural nor-oleanane triterpenoid as a kidney-type glutaminase inhibitor from Stauntonia brachyanthera</span></div><div class="casAuthors">Li, Rong; Wei, Peifeng; Wang, Yue; Liu, Ying; Liu, Xuanli; Meng, Dali</div><div class="citationInfo"><span class="NLM_cas:title">RSC Advances</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">83</span>),
    <span class="NLM_cas:pages">52533-52542</span>CODEN:
                <span class="NLM_cas:coden">RSCACL</span>;
        ISSN:<span class="NLM_cas:issn">2046-2069</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">With the aim of finding a better kidney-type glutaminase (KGA) inhibitor with potential anti-cancer properties, 18 nor-oleanane triterpenoids from Stauntonia brachyanthera, including 2 new ones, were screened against KGA.  The structure-based virtual ligand screening identified 8 compds., which might have more chance to become inhibitors of KGA with low binding energy.  Glutaminase inhibition expts. and a series of cellular level assays, including cytotoxicity, wound healing, transwell invasion, western blot, and cell apoptosis, further confirmed the inhibitory effect of 5 (brachyantheraoside A8).  These provided the possibility for 5 to become an inhibitor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqId9qfcQYP4rVg90H21EOLACvtfcHk0lh96FiXtmlEPQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvVSmsbvJ&md5=1f1162977499b403d63947bc97717c44</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1039%2FC7RA11270J&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC7RA11270J%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DR.%26aulast%3DWei%26aufirst%3DP.%2BF.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DX.%2BL.%26aulast%3DMeng%26aufirst%3DD.%2BL.%26atitle%3DBrachyantheraoside%2520A8%252C%2520a%2520new%2520natural%2520nor-oleanane%2520triterpenoid%2520as%2520a%2520kidney-type%2520glutaminase%2520inhibitor%2520from%2520Stauntonia%2520brachyanthera%26jtitle%3DRSC%2520Adv.%26date%3D2017%26volume%3D7%26spage%3D52533%26epage%3D52542%26doi%3D10.1039%2FC7RA11270J" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, L. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, L. X.</span></span> <span> </span><span class="NLM_article-title">Physapubescin, a natural withanolide as a kidney-type glutaminase (KGA) inhibitor</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>27</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">1243</span>– <span class="NLM_lpage">1246</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2017.01.057</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=10.1016%2Fj.bmcl.2017.01.057" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2017&pages=1243-1246&issue=5&author=L.+Chengauthor=C.+R.+Wuauthor=L.+H.+Zhuauthor=H.+Liauthor=L.+X.+Chen&title=Physapubescin%2C+a+natural+withanolide+as+a+kidney-type+glutaminase+%28KGA%29+inhibitor&doi=10.1016%2Fj.bmcl.2017.01.057"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2017.01.057&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2017.01.057%26sid%3Dliteratum%253Aachs%26aulast%3DCheng%26aufirst%3DL.%26aulast%3DWu%26aufirst%3DC.%2BR.%26aulast%3DZhu%26aufirst%3DL.%2BH.%26aulast%3DLi%26aufirst%3DH.%26aulast%3DChen%26aufirst%3DL.%2BX.%26atitle%3DPhysapubescin%252C%2520a%2520natural%2520withanolide%2520as%2520a%2520kidney-type%2520glutaminase%2520%2528KGA%2529%2520inhibitor%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2017%26volume%3D27%26issue%3D5%26spage%3D1243%26epage%3D1246%26doi%3D10.1016%2Fj.bmcl.2017.01.057" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Parlati, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gross, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janes, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lewis, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MacKinnon, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodriguez, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shwonek, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bennett, M.</span></span> <span> </span><span class="NLM_article-title">Glutaminase Inhibitor CB-839 Synergizes with Pomalidomide in Preclinical Multiple Myeloma Models</span>. <i>Blood</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>124</i></span>,  <span class="NLM_fpage">4720</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=124&publication_year=2014&pages=4720&author=F.+Parlatiauthor=M.+Grossauthor=J.+Janesauthor=E.+Lewisauthor=A.+MacKinnonauthor=M.+Rodriguezauthor=P.+Shwonekauthor=M.+Bennett&title=Glutaminase+Inhibitor+CB-839+Synergizes+with+Pomalidomide+in+Preclinical+Multiple+Myeloma+Models"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DParlati%26aufirst%3DF.%26aulast%3DGross%26aufirst%3DM.%26aulast%3DJanes%26aufirst%3DJ.%26aulast%3DLewis%26aufirst%3DE.%26aulast%3DMacKinnon%26aufirst%3DA.%26aulast%3DRodriguez%26aufirst%3DM.%26aulast%3DShwonek%26aufirst%3DP.%26aulast%3DBennett%26aufirst%3DM.%26atitle%3DGlutaminase%2520Inhibitor%2520CB-839%2520Synergizes%2520with%2520Pomalidomide%2520in%2520Preclinical%2520Multiple%2520Myeloma%2520Models%26jtitle%3DBlood%26date%3D2014%26volume%3D124%26spage%3D4720" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Parlati, F.</span></span> <span> </span><span class="NLM_article-title">CB-839, A Selective Glutaminase Inhibitor, Synergizes with Signaling Pathway Inhibitors to Produce an Anti-Tumor Effect in cell Lines and Tumor Xenografts</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>75</i></span>,  <span class="NLM_fpage">4711</span>, <span class="refDoi"> DOI: 10.1158/1538-7445.AM2015-4711</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=10.1158%2F1538-7445.AM2015-4711" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=75&publication_year=2015&pages=4711&author=F.+Parlati&title=CB-839%2C+A+Selective+Glutaminase+Inhibitor%2C+Synergizes+with+Signaling+Pathway+Inhibitors+to+Produce+an+Anti-Tumor+Effect+in+cell+Lines+and+Tumor+Xenografts&doi=10.1158%2F1538-7445.AM2015-4711"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1158%2F1538-7445.AM2015-4711&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1538-7445.AM2015-4711%26sid%3Dliteratum%253Aachs%26aulast%3DParlati%26aufirst%3DF.%26atitle%3DCB-839%252C%2520A%2520Selective%2520Glutaminase%2520Inhibitor%252C%2520Synergizes%2520with%2520Signaling%2520Pathway%2520Inhibitors%2520to%2520Produce%2520an%2520Anti-Tumor%2520Effect%2520in%2520cell%2520Lines%2520and%2520Tumor%2520Xenografts%26jtitle%3DCancer%2520Res.%26date%3D2015%26volume%3D75%26spage%3D4711%26doi%3D10.1158%2F1538-7445.AM2015-4711" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Momcilovic, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bailey, S. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fishbein, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Magyar, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Braas, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graeber, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jackson, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Czernin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Emberley, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gross, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janes, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mackinnon, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodriguez, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Works, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parlati, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Demo, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garon, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krysan, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walser, T. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dubinett, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sadeghi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christofk, H. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shackelford, D. B.</span></span> <span> </span><span class="NLM_article-title">Targeted inhibition of EGFR and glutaminase induces metabolic crisis in EGFR mutant lung cancer</span>. <i>Cell Rep.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>18</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">601</span>– <span class="NLM_lpage">610</span>, <span class="refDoi"> DOI: 10.1016/j.celrep.2016.12.061</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=10.1016%2Fj.celrep.2016.12.061" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=28099841" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=1%3ACAS%3A528%3ADC%252BC2sXht1ChsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2017&pages=601-610&issue=3&author=M.+Momcilovicauthor=S.+T.+Baileyauthor=J.+T.+Leeauthor=M.+C.+Fishbeinauthor=C.+Magyarauthor=D.+Braasauthor=T.+Graeberauthor=N.+J.+Jacksonauthor=J.+Czerninauthor=E.+Emberleyauthor=M.+Grossauthor=J.+Janesauthor=A.+Mackinnonauthor=A.+Panauthor=M.+Rodriguezauthor=M.+Worksauthor=W.+Zhangauthor=F.+Parlatiauthor=S.+Demoauthor=E.+Garonauthor=K.+Krysanauthor=T.+C.+Walserauthor=S.+M.+Dubinettauthor=S.+Sadeghiauthor=H.+R.+Christofkauthor=D.+B.+Shackelford&title=Targeted+inhibition+of+EGFR+and+glutaminase+induces+metabolic+crisis+in+EGFR+mutant+lung+cancer&doi=10.1016%2Fj.celrep.2016.12.061"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">Targeted Inhibition of EGFR and Glutaminase Induces Metabolic Crisis in EGFR Mutant Lung Cancer</span></div><div class="casAuthors">Momcilovic, Milica; Bailey, Sean T.; Lee, Jason T.; Fishbein, Michael C.; Magyar, Clara; Braas, Daniel; Graeber, Thomas; Jackson, Nicholas J.; Czernin, Johannes; Emberley, Ethan; Gross, Matthew; Janes, Julie; MacKinnon, Andy; Pan, Alison; Rodriguez, Mirna; Works, Melissa; Zhang, Winter; Parlati, Francesco; Demo, Susan; Garon, Edward; Krysan, Kostyantyn; Walser, Tonya C.; Dubinett, Steven M.; Sadeghi, Saman; Christofk, Heather R.; Shackelford, David B.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Reports</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">601-610</span>CODEN:
                <span class="NLM_cas:coden">CREED8</span>;
        ISSN:<span class="NLM_cas:issn">2211-1247</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Cancer cells exhibit increased use of nutrients, including glucose and glutamine, to support the bioenergetic and biosynthetic demands of proliferation.  We tested the small-mol. inhibitor of glutaminase CB-839 in combination with erlotinib on epidermal growth factor receptor (EGFR) mutant non-small cell lung cancer (NSCLC) as a therapeutic strategy to simultaneously impair cancer glucose and glutamine utilization and thereby suppress tumor growth.  Here, we show that CB-839 cooperates with erlotinib to drive energetic stress and activate the AMP-activated protein kinase (AMPK) pathway in EGFR (del19) lung tumors.  Tumor cells undergo metabolic crisis and cell death, resulting in rapid tumor regression in vivo in mouse NSCLC xenografts.  Consistently, positron emission tomog. (PET) imaging with 18F-fluoro-2-deoxyglucose (18F-FDG) and 11C-glutamine (11C-Gln) of xenografts indicated reduced glucose and glutamine uptake in tumors following treatment with CB-839 + erlotinib.  Therefore, PET imaging with 18F-FDG and 11C-Gln tracers can be used to non-invasively measure metabolic response to CB-839 and erlotinib combination therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqDi9ghbRHBG7Vg90H21EOLACvtfcHk0lj0_MBxfM8pxg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXht1ChsL4%253D&md5=b335b9e4ba83b1d462f8baceae85074f</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1016%2Fj.celrep.2016.12.061&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.celrep.2016.12.061%26sid%3Dliteratum%253Aachs%26aulast%3DMomcilovic%26aufirst%3DM.%26aulast%3DBailey%26aufirst%3DS.%2BT.%26aulast%3DLee%26aufirst%3DJ.%2BT.%26aulast%3DFishbein%26aufirst%3DM.%2BC.%26aulast%3DMagyar%26aufirst%3DC.%26aulast%3DBraas%26aufirst%3DD.%26aulast%3DGraeber%26aufirst%3DT.%26aulast%3DJackson%26aufirst%3DN.%2BJ.%26aulast%3DCzernin%26aufirst%3DJ.%26aulast%3DEmberley%26aufirst%3DE.%26aulast%3DGross%26aufirst%3DM.%26aulast%3DJanes%26aufirst%3DJ.%26aulast%3DMackinnon%26aufirst%3DA.%26aulast%3DPan%26aufirst%3DA.%26aulast%3DRodriguez%26aufirst%3DM.%26aulast%3DWorks%26aufirst%3DM.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DParlati%26aufirst%3DF.%26aulast%3DDemo%26aufirst%3DS.%26aulast%3DGaron%26aufirst%3DE.%26aulast%3DKrysan%26aufirst%3DK.%26aulast%3DWalser%26aufirst%3DT.%2BC.%26aulast%3DDubinett%26aufirst%3DS.%2BM.%26aulast%3DSadeghi%26aufirst%3DS.%26aulast%3DChristofk%26aufirst%3DH.%2BR.%26aulast%3DShackelford%26aufirst%3DD.%2BB.%26atitle%3DTargeted%2520inhibition%2520of%2520EGFR%2520and%2520glutaminase%2520induces%2520metabolic%2520crisis%2520in%2520EGFR%2520mutant%2520lung%2520cancer%26jtitle%3DCell%2520Rep.%26date%3D2017%26volume%3D18%26issue%3D3%26spage%3D601%26epage%3D610%26doi%3D10.1016%2Fj.celrep.2016.12.061" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Emberley, E.</span>; <span class="NLM_string-name">Bennett, M.</span>; <span class="NLM_string-name">Chen, J.</span>; <span class="NLM_string-name">Gross, M.</span>; <span class="NLM_string-name">Huang, T.</span>; <span class="NLM_string-name">Li, W.</span>; <span class="NLM_string-name">MacKinnon, A.</span>; <span class="NLM_string-name">Pan, A.</span>; <span class="NLM_string-name">Rodriguez, M.</span>; <span class="NLM_string-name">Steggerda, S.</span>; <span class="NLM_string-name">Wang, T.</span>; <span class="NLM_string-name">Zhang, W.</span>; <span class="NLM_string-name">Zhang, J.</span>; <span class="NLM_string-name">Parlati, F.</span></span> <span> </span><span class="NLM_article-title">CB-839, a Selective Glutaminase Inhibitor, has Anti-Tumor Activity in Renal Cell Carcinoma and Synergizes with Cabozantinib and Everolimus</span>.  <i>Keystone Symposia, Tumor Metabolism: Mechanisms and Targets, Whistler Canada, March 5–9</i>, <span class="NLM_year">2017</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&author=E.+Emberley&author=M.+Bennett&author=J.+Chen&author=M.+Gross&author=T.+Huang&author=W.+Li&author=A.+MacKinnon&author=A.+Pan&author=M.+Rodriguez&author=S.+Steggerda&author=T.+Wang&author=W.+Zhang&author=J.+Zhang&author=F.+Parlati&title=CB-839%2C+a+Selective+Glutaminase+Inhibitor%2C+has+Anti-Tumor+Activity+in+Renal+Cell+Carcinoma+and+Synergizes+with+Cabozantinib+and+Everolimus"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dconf-proc%26sid%3Dliteratum%253Aachs%26aulast%3DEmberley%26aufirst%3DE.%26atitle%3DCB-839%252C%2520a%2520Selective%2520Glutaminase%2520Inhibitor%252C%2520has%2520Anti-Tumor%2520Activity%2520in%2520Renal%2520Cell%2520Carcinoma%2520and%2520Synergizes%2520with%2520Cabozantinib%2520and%2520Everolimus%26jtitle%3DKeystone%2520Symposia%252C%2520Tumor%2520Metabolism%253A%2520Mechanisms%2520and%2520Targets%252C%2520Whistler%2520Canada%252C%2520March%25205%25E2%2580%25939%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit61"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Emberley, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bennett, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gross, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Makkouk, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marguier, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spurlock, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steggerda, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parlati, F.</span></span> <span> </span><span class="NLM_article-title">The Glutaminase Inhibitor CB-839 Synergizes with CDK4/6 and PARP Inhibitors in Pre-Clinical Tumor Models</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>78</i></span>,  <span class="NLM_fpage">3509</span>, <span class="refDoi"> DOI: 10.1158/1538-7445.AM2018-3509</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=10.1158%2F1538-7445.AM2018-3509" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=78&publication_year=2018&pages=3509&author=E.+Emberleyauthor=M.+Bennettauthor=J.+Chenauthor=M.+Grossauthor=T.+Huangauthor=A.+Makkoukauthor=G.+Marguierauthor=A.+Panauthor=S.+Spurlockauthor=S.+Steggerdaauthor=F.+Parlati&title=The+Glutaminase+Inhibitor+CB-839+Synergizes+with+CDK4%2F6+and+PARP+Inhibitors+in+Pre-Clinical+Tumor+Models&doi=10.1158%2F1538-7445.AM2018-3509"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1158%2F1538-7445.AM2018-3509&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1538-7445.AM2018-3509%26sid%3Dliteratum%253Aachs%26aulast%3DEmberley%26aufirst%3DE.%26aulast%3DBennett%26aufirst%3DM.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DGross%26aufirst%3DM.%26aulast%3DHuang%26aufirst%3DT.%26aulast%3DMakkouk%26aufirst%3DA.%26aulast%3DMarguier%26aufirst%3DG.%26aulast%3DPan%26aufirst%3DA.%26aulast%3DSpurlock%26aufirst%3DS.%26aulast%3DSteggerda%26aufirst%3DS.%26aulast%3DParlati%26aufirst%3DF.%26atitle%3DThe%2520Glutaminase%2520Inhibitor%2520CB-839%2520Synergizes%2520with%2520CDK4%252F6%2520and%2520PARP%2520Inhibitors%2520in%2520Pre-Clinical%2520Tumor%2520Models%26jtitle%3DCancer%2520Res.%26date%3D2018%26volume%3D78%26spage%3D3509%26doi%3D10.1158%2F1538-7445.AM2018-3509" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref62"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref62'); return false;" data-citation="" class="refNumLink">62</a></strong><div class="NLM_citation" id="cit62"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Driscoll, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bressler, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaufmann, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rojas, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Slusher, B. S.</span></span> <span> </span><span class="NLM_article-title">Small molecule glutaminase inhibitors block glutamate release from stimulated microglia</span>. <i>Biochem. Biophys. Res. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>443</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">32</span>– <span class="NLM_lpage">36</span>, <span class="refDoi"> DOI: 10.1016/j.bbrc.2013.11.043</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=10.1016%2Fj.bbrc.2013.11.043" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=443&publication_year=2014&pages=32-36&issue=1&author=A.+G.+Thomasauthor=C.+M.+O%E2%80%99Driscollauthor=J.+Bresslerauthor=W.+Kaufmannauthor=C.+J.+Rojasauthor=B.+S.+Slusher&title=Small+molecule+glutaminase+inhibitors+block+glutamate+release+from+stimulated+microglia&doi=10.1016%2Fj.bbrc.2013.11.043"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1016%2Fj.bbrc.2013.11.043&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbrc.2013.11.043%26sid%3Dliteratum%253Aachs%26aulast%3DThomas%26aufirst%3DA.%2BG.%26aulast%3DO%25E2%2580%2599Driscoll%26aufirst%3DC.%2BM.%26aulast%3DBressler%26aufirst%3DJ.%26aulast%3DKaufmann%26aufirst%3DW.%26aulast%3DRojas%26aufirst%3DC.%2BJ.%26aulast%3DSlusher%26aufirst%3DB.%2BS.%26atitle%3DSmall%2520molecule%2520glutaminase%2520inhibitors%2520block%2520glutamate%2520release%2520from%2520stimulated%2520microglia%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2014%26volume%3D443%26issue%3D1%26spage%3D32%26epage%3D36%26doi%3D10.1016%2Fj.bbrc.2013.11.043" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref63"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref63'); return false;" data-citation="" class="refNumLink">63</a></strong><div class="NLM_citation" id="cit63"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pinkus, L. M.</span></span> <span> </span><span class="NLM_article-title">Glutamine binding sites</span>. <i>Methods Enzymol.</i> <span class="NLM_year" style="font-weight: bold;">1977</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">414</span>– <span class="NLM_lpage">427</span>, <span class="refDoi"> DOI: 10.1016/S0076-6879(77)46049-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=10.1016%2FS0076-6879%2877%2946049-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=909432" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=1%3ACAS%3A528%3ADyaE2sXlvFGqu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=1977&pages=414-427&author=L.+M.+Pinkus&title=Glutamine+binding+sites&doi=10.1016%2FS0076-6879%2877%2946049-X"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">Glutamine binding sites</span></div><div class="casAuthors">Pinkus, Lawrence M.</div><div class="citationInfo"><span class="NLM_cas:title">Methods in Enzymology</span>
        (<span class="NLM_cas:date">1977</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">Affinity Labeling</span>),
    <span class="NLM_cas:pages">414-27</span>CODEN:
                <span class="NLM_cas:coden">MENZAU</span>;
        ISSN:<span class="NLM_cas:issn">0076-6879</span>.
    </div><div class="casAbstract">A review with 78 refs. on the use of glutamine analogs as affinity labels for glutamine binding sites on enzymes of N metab., including amidotransferases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGodgvAxF90vv7Vg90H21EOLACvtfcHk0lij8DBcfq9cXg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE2sXlvFGqu7w%253D&md5=681826f0608c7c9b9f7e4aa51c0c078b</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1016%2FS0076-6879%2877%2946049-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0076-6879%252877%252946049-X%26sid%3Dliteratum%253Aachs%26aulast%3DPinkus%26aufirst%3DL.%2BM.%26atitle%3DGlutamine%2520binding%2520sites%26jtitle%3DMethods%2520Enzymol.%26date%3D1977%26volume%3D46%26spage%3D414%26epage%3D427%26doi%3D10.1016%2FS0076-6879%2877%2946049-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref64"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref64'); return false;" data-citation="" class="refNumLink">64</a></strong><div class="NLM_citation" id="cit64"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ahluwalia, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grem, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hao, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cooney, D. A.</span></span> <span> </span><span class="NLM_article-title">Metabolism and action of amino acid analog anti-cancer agents</span>. <i>Pharmacol. Ther.</i> <span class="NLM_year" style="font-weight: bold;">1990</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">243</span>– <span class="NLM_lpage">271</span>, <span class="refDoi"> DOI: 10.1016/0163-7258(90)90094-I</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=10.1016%2F0163-7258%2890%2990094-I" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=2108451" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=1%3ACAS%3A528%3ADyaK3cXhslWmtbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=1990&pages=243-271&author=G.+S.+Ahluwaliaauthor=J.+L.+Gremauthor=Z.+Haoauthor=D.+A.+Cooney&title=Metabolism+and+action+of+amino+acid+analog+anti-cancer+agents&doi=10.1016%2F0163-7258%2890%2990094-I"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">Metabolism and action of amino acid analog anticancer agents</span></div><div class="casAuthors">Ahluwalia, Gurpreet S.; Grem, Jean L.; Hao, Zhang; Cooney, David A.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">243-71</span>CODEN:
                <span class="NLM_cas:coden">PHTHDT</span>;
        ISSN:<span class="NLM_cas:issn">0163-7258</span>.
    </div><div class="casAbstract">A review with ≈320 refs.  The preclin. pharmacol., antitumor activity, and toxicity of seven of the more important amino acid analogs with antineoplastic activity are discussed.  Three of these compds. are antagonists of L-glutamine: acivicin, 6-diazo-5-oxo-L-nonleucine (DON), and azaserine; and two are analogs of L-aspartic acid: N-(phsophonacetyl)-L-aspartate (PALA) and L-alanosine.  All five of these antimetabolites interrupt cellular nucleotide synthesis and thereby halt the formation of DNA and/or RNA in the tumor cell.  Buthionine sulfoximine and difluoromethylornithine are inhibitors of glutathione and polyamine synthesis, resp., with limited intrinsic antitumor activity, however, because of their powerful biochem. actions and their low systemic toxicities, they are being evaluated as chemotherapeutic adjuncts to or modulators of other more toxic antineoplastic agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGprwFG7JaY_7LVg90H21EOLACvtfcHk0lij8DBcfq9cXg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3cXhslWmtbc%253D&md5=57d816e5e990ce0994e51dbda0137ffb</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1016%2F0163-7258%2890%2990094-I&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0163-7258%252890%252990094-I%26sid%3Dliteratum%253Aachs%26aulast%3DAhluwalia%26aufirst%3DG.%2BS.%26aulast%3DGrem%26aufirst%3DJ.%2BL.%26aulast%3DHao%26aufirst%3DZ.%26aulast%3DCooney%26aufirst%3DD.%2BA.%26atitle%3DMetabolism%2520and%2520action%2520of%2520amino%2520acid%2520analog%2520anti-cancer%2520agents%26jtitle%3DPharmacol.%2520Ther.%26date%3D1990%26volume%3D46%26spage%3D243%26epage%3D271%26doi%3D10.1016%2F0163-7258%2890%2990094-I" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref65"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref65'); return false;" data-citation="" class="refNumLink">65</a></strong><div class="NLM_citation" id="cit65"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cervantes-Madrid, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romero, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duenas-Gonzalez, A.</span></span> <span> </span><span class="NLM_article-title">Reviving lonidamine and 6-diazo-5-oxo-L-norleucine to be used in combination for metabolic cancer therapy</span>. <i>BioMed Res. Int.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>2015</i></span>,  <span class="NLM_fpage">690492</span>, <span class="refDoi"> DOI: 10.1155/2015/690492</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=10.1155%2F2015%2F690492" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=26425550" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=1%3ACAS%3A280%3ADC%252BC283nvFaqsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2015&publication_year=2015&pages=690492&author=D.+Cervantes-Madridauthor=Y.+Romeroauthor=A.+Duenas-Gonzalez&title=Reviving+lonidamine+and+6-diazo-5-oxo-L-norleucine+to+be+used+in+combination+for+metabolic+cancer+therapy&doi=10.1155%2F2015%2F690492"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">Reviving Lonidamine and 6-Diazo-5-oxo-L-norleucine to Be Used in Combination for Metabolic Cancer Therapy</span></div><div class="casAuthors">Cervantes-Madrid Diana; Romero Yair; Duenas-Gonzalez Alfonso</div><div class="citationInfo"><span class="NLM_cas:title">BioMed research international</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">2015</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">690492</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Abnormal metabolism is another cancer hallmark.  The two most characterized altered metabolic pathways are high rates of glycolysis and glutaminolysis, which are natural targets for cancer therapy.  Currently, a number of newer compounds to block glycolysis and glutaminolysis are being developed; nevertheless, lonidamine and 6-diazo-5-oxo-L-norleucine (DON) are two old drugs well characterized as inhibitors of glycolysis and glutaminolysis, respectively, whose clinical development was abandoned years ago when the importance of cancer metabolism was not fully appreciated and clinical trial methodology was less developed.  In this review, a PubMed search using the words lonidamine and 6-diazo-5-oxo-L-norleucine (DON) was undertaken to analyse existing information on the preclinical and clinical studies of these drugs for cancer treatment.  Data show that they exhibit antitumor effects; besides there is also the suggestion that they are synergistic.  We conclude that lonidamine and DON are safe and potentially effective drugs that need to be reevaluated in combination as metabolic therapy of cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQXmwDecegJaPSAs_PE1QvifW6udTcc2eaWeyNloFtlcbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC283nvFaqsw%253D%253D&md5=e193b6d310cd748fb76d3b441df2b4b8</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1155%2F2015%2F690492&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1155%252F2015%252F690492%26sid%3Dliteratum%253Aachs%26aulast%3DCervantes-Madrid%26aufirst%3DD.%26aulast%3DRomero%26aufirst%3DY.%26aulast%3DDuenas-Gonzalez%26aufirst%3DA.%26atitle%3DReviving%2520lonidamine%2520and%25206-diazo-5-oxo-L-norleucine%2520to%2520be%2520used%2520in%2520combination%2520for%2520metabolic%2520cancer%2520therapy%26jtitle%3DBioMed%2520Res.%2520Int.%26date%3D2015%26volume%3D2015%26spage%3D690492%26doi%3D10.1155%2F2015%2F690492" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref66"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref66'); return false;" data-citation="" class="refNumLink">66</a></strong><div class="NLM_citation" id="cit66"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Eagan, R. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frytak, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nichols, W. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Creagan, E. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ingle, J. N.</span></span> <span> </span><span class="NLM_article-title">Phase II study on DON in patients with previously treated advanced lung cancer</span>. <i>Cancer Treat. Rep.</i> <span class="NLM_year" style="font-weight: bold;">1982</span>,  <span class="NLM_volume"><i>66</i></span>,  <span class="NLM_fpage">1665</span>– <span class="NLM_lpage">1666</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=6286122" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=1%3ACAS%3A280%3ADyaL383lvFWguw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=1982&pages=1665-1666&author=R.+T.+Eaganauthor=S.+Frytakauthor=W.+C.+Nicholsauthor=E.+T.+Creaganauthor=J.+N.+Ingle&title=Phase+II+study+on+DON+in+patients+with+previously+treated+advanced+lung+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">Phase II study on DON in patients with previously treated advanced lung cancer</span></div><div class="casAuthors">Eagan R T; Frytak S; Nichols W C; Creagan E T; Ingle J N</div><div class="citationInfo"><span class="NLM_cas:title">Cancer treatment reports</span>
        (<span class="NLM_cas:date">1982</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1665-6</span>
        ISSN:<span class="NLM_cas:issn">0361-5960</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRUEh-c_J6KzT69zv1FsJFMfW6udTcc2eaWeyNloFtlcbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaL383lvFWguw%253D%253D&md5=01325c423a6c0fbdae0734130cbeba70</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEagan%26aufirst%3DR.%2BT.%26aulast%3DFrytak%26aufirst%3DS.%26aulast%3DNichols%26aufirst%3DW.%2BC.%26aulast%3DCreagan%26aufirst%3DE.%2BT.%26aulast%3DIngle%26aufirst%3DJ.%2BN.%26atitle%3DPhase%2520II%2520study%2520on%2520DON%2520in%2520patients%2520with%2520previously%2520treated%2520advanced%2520lung%2520cancer%26jtitle%3DCancer%2520Treat.%2520Rep.%26date%3D1982%26volume%3D66%26spage%3D1665%26epage%3D1666" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref67"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref67'); return false;" data-citation="" class="refNumLink">67</a></strong><div class="NLM_citation" id="cit67"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Earhart, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koeller, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, H. L.</span></span> <span> </span><span class="NLM_article-title">Phase I trial of 6-diazo-5-oxo-L-norleucine (DON) administered by 5-day courses</span>. <i>Cancer Treat. Rep.</i> <span class="NLM_year" style="font-weight: bold;">1982</span>,  <span class="NLM_volume"><i>66</i></span>,  <span class="NLM_fpage">1215</span>– <span class="NLM_lpage">1217</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=7083223" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=1%3ACAS%3A280%3ADyaL383gvVenuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=1982&pages=1215-1217&author=R.+H.+Earhartauthor=J.+M.+Koellerauthor=H.+L.+Davis&title=Phase+I+trial+of+6-diazo-5-oxo-L-norleucine+%28DON%29+administered+by+5-day+courses"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">Phase I trial of 6-diazo-5-oxo-L-norleucine (DON) administered by 5-day courses</span></div><div class="casAuthors">Earhart R H; Koeller J M; Davis H L</div><div class="citationInfo"><span class="NLM_cas:title">Cancer treatment reports</span>
        (<span class="NLM_cas:date">1982</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1215-7</span>
        ISSN:<span class="NLM_cas:issn">0361-5960</span>.
    </div><div class="casAbstract">6-Diazo-5-oxo-L-norleucine (DON), an L-glutamine antagonist, was administered to 25 evaluable patients with refractory advanced solid tumors in a phase I trial.  A total of 58 evaluable courses of five daily iv injections every 3-4 weeks were given, at doses ranging from 7.5 to 90 mg/m2/day.  The major dose-limiting toxicity was a syndrome of nausea, vomiting, malaise, and anorexia, which became severe at doses greater than 52.5 mg/m2/day.  Diarrhea and stomatitis were less frequent.  Hematologic toxicity included mild leukopenia with nadir on Day 6-8 and mild thrombocytopenia with nadir on Day 7-12.  Transient decreases in serum calcium to 8.5--8.9 mg/dl were seen in seven of 12 patients receiving greater than or equal to 67.5 mg/m2/day.  Dose reduction was required for all patients who received a course of DON at greater than 67.5 mg/m2/day, and a maximum tolerated total dose of 250 mg/m2 (50 mg/m2/day x 5) is suggested for this schedule.  Mixed responses were seen in one patient with bladder carcinoma and in one with pulmonary adenocarcinoma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT6fL2BdWfWCMNIRw0GKUoEfW6udTcc2eaWeyNloFtlcbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaL383gvVenuw%253D%253D&md5=cc563efa251aea27609451075dd5bbf2</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEarhart%26aufirst%3DR.%2BH.%26aulast%3DKoeller%26aufirst%3DJ.%2BM.%26aulast%3DDavis%26aufirst%3DH.%2BL.%26atitle%3DPhase%2520I%2520trial%2520of%25206-diazo-5-oxo-L-norleucine%2520%2528DON%2529%2520administered%2520by%25205-day%2520courses%26jtitle%3DCancer%2520Treat.%2520Rep.%26date%3D1982%26volume%3D66%26spage%3D1215%26epage%3D1217" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref68"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref68'); return false;" data-citation="" class="refNumLink">68</a></strong><div class="NLM_citation" id="cit68"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lynch, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kemeny, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Casper, E.</span></span> <span> </span><span class="NLM_article-title">Phase II evaluation of DON (6-diazo-5-oxo-L-norleucine) in patients with advanced colorectal carcinoma</span>. <i>Am. J. Clin. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">1982</span>,  <span class="NLM_volume"><i>5</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">541</span>– <span class="NLM_lpage">543</span>, <span class="refDoi"> DOI: 10.1097/00000421-198210000-00014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=10.1097%2F00000421-198210000-00014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=7180833" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=1%3ACAS%3A280%3ADyaL3s%252FpslChsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=1982&pages=541-543&issue=5&author=G.+Lynchauthor=N.+Kemenyauthor=E.+Casper&title=Phase+II+evaluation+of+DON+%286-diazo-5-oxo-L-norleucine%29+in+patients+with+advanced+colorectal+carcinoma&doi=10.1097%2F00000421-198210000-00014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">Phase II evaluation of DON (6-diazo-5-oxo-L-norleucine) in patients with advanced colorectal carcinoma</span></div><div class="casAuthors">Lynch G; Kemeny N; Casper E</div><div class="citationInfo"><span class="NLM_cas:title">American journal of clinical oncology</span>
        (<span class="NLM_cas:date">1982</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">541-3</span>
        ISSN:<span class="NLM_cas:issn">0277-3732</span>.
    </div><div class="casAbstract">Twenty-three patients with advanced colorectal carcinoma, previously treated with chemotherapy, were entered in a phase II trial of DON (6-Diazo-5-Oxo-L-Norleucine), an antagonist of L-glutamine.  One of 14 adequately treated patients had a partial response of 6 weeks duration.  The dose-limiting toxicity was nausea and vomiting; 48% of patients originally entered on the study withdrew because of vomiting.  Myelosuppression was minimal, with only mild thrombocytopenia noted.  The dose and schedule used in this study were beyond the maximally tolerated dose for many patients; future phase II studies of DON will be difficult to complete unless schedules and doses are found which result in less nausea and vomiting.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR3qxkSLMwzPcvLc4ARHEmzfW6udTcc2eY-5DI_BHi6rLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaL3s%252FpslChsA%253D%253D&md5=c5603efffc9908e628d0d780025d60a3</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1097%2F00000421-198210000-00014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F00000421-198210000-00014%26sid%3Dliteratum%253Aachs%26aulast%3DLynch%26aufirst%3DG.%26aulast%3DKemeny%26aufirst%3DN.%26aulast%3DCasper%26aufirst%3DE.%26atitle%3DPhase%2520II%2520evaluation%2520of%2520DON%2520%25286-diazo-5-oxo-L-norleucine%2529%2520in%2520patients%2520with%2520advanced%2520colorectal%2520carcinoma%26jtitle%3DAm.%2520J.%2520Clin.%2520Oncol.%26date%3D1982%26volume%3D5%26issue%3D5%26spage%3D541%26epage%3D543%26doi%3D10.1097%2F00000421-198210000-00014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref69"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref69'); return false;" data-citation="" class="refNumLink">69</a></strong><div class="NLM_citation" id="cit69"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Magill, G. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Myers, W. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reilly, H. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Putnam, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Magill, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sykes, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Escher, G. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karnofsky, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burchenal, J. H.</span></span> <span> </span><span class="NLM_article-title">Pharmacological and initial therapeutic observations on 6-diazo-5-oxo-1-norleucine (DON) in human neoplastic disease</span>. <i>Cancer</i> <span class="NLM_year" style="font-weight: bold;">1957</span>,  <span class="NLM_volume"><i>10</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">1138</span>– <span class="NLM_lpage">1150</span>, <span class="refDoi"> DOI: 10.1002/1097-0142(195711/12)10:6<1138::AID-CNCR2820100608>3.0.CO;2-K</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=10.1002%2F1097-0142%28195711%2F12%2910%3A6%3C1138%3A%3AAID-CNCR2820100608%3E3.0.CO%3B2-K" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=13489662" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=1%3ACAS%3A528%3ADyaG1cXit1aqsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=1957&pages=1138-1150&issue=6&author=G.+B.+Magillauthor=W.+P.+Myersauthor=H.+C.+Reillyauthor=R.+C.+Putnamauthor=J.+W.+Magillauthor=M.+P.+Sykesauthor=G.+C.+Escherauthor=D.+A.+Karnofskyauthor=J.+H.+Burchenal&title=Pharmacological+and+initial+therapeutic+observations+on+6-diazo-5-oxo-1-norleucine+%28DON%29+in+human+neoplastic+disease&doi=10.1002%2F1097-0142%28195711%2F12%2910%3A6%3C1138%3A%3AAID-CNCR2820100608%3E3.0.CO%3B2-K"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit69R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological and initial therapeutic observations on 6-diazo-5-oxo-L-norleucine (DON) in human neoplastic disease</span></div><div class="casAuthors">Magill, G. B.; Myers, W. P. L.; Reilly, H. C.; Putnam, R. C.; Magill, J. W.; Sykes, M. P.; Escher, G. C.; Karnofsky, D. A.; Burchenal, J. H.</div><div class="citationInfo"><span class="NLM_cas:title"></span>
        (<span class="NLM_cas:date">1957</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1138-50</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Peak serum levels of DON were present 5-15 min. after i.v. administration of 0.2-0.3 mg./kg. of the drug to patients.  After i.m. or oral administration the blood-level peaks were at 0.5-1 h. and 15 min.-2 h., resp.  Less than 1% was recovered in active form in the urine.  Patients could tolerate 0.1-0.3 mg./kg./day of DON for prolonged courses.  The drug caused oral soreness, diarrhea, nausea, and vomiting, and other less well defined events such as leukopenia, gastrointestinal bleeding, and thrombocytopenia.  Adenine and 4-amino-5-imidazolecarboxamide appeared to block the oral toxic effects of DON.  Therapy with DON led to more normal serum alk. phosphatase, lactic acid dehydrogenase, and phosphohexose isomerase levels in one patient in whom these enzymes were detd.  DON appeared to cause temporary regressions or some improvement in approx. 25% of the patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoDjNFkXXSxqrVg90H21EOLACvtfcHk0ljqZ_PAlY6HYA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaG1cXit1aqsQ%253D%253D&md5=9ffada87efe0574489415bf431dce5ae</span></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1002%2F1097-0142%28195711%2F12%2910%3A6%3C1138%3A%3AAID-CNCR2820100608%3E3.0.CO%3B2-K&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F1097-0142%2528195711%252F12%252910%253A6%253C1138%253A%253AAID-CNCR2820100608%253E3.0.CO%253B2-K%26sid%3Dliteratum%253Aachs%26aulast%3DMagill%26aufirst%3DG.%2BB.%26aulast%3DMyers%26aufirst%3DW.%2BP.%26aulast%3DReilly%26aufirst%3DH.%2BC.%26aulast%3DPutnam%26aufirst%3DR.%2BC.%26aulast%3DMagill%26aufirst%3DJ.%2BW.%26aulast%3DSykes%26aufirst%3DM.%2BP.%26aulast%3DEscher%26aufirst%3DG.%2BC.%26aulast%3DKarnofsky%26aufirst%3DD.%2BA.%26aulast%3DBurchenal%26aufirst%3DJ.%2BH.%26atitle%3DPharmacological%2520and%2520initial%2520therapeutic%2520observations%2520on%25206-diazo-5-oxo-1-norleucine%2520%2528DON%2529%2520in%2520human%2520neoplastic%2520disease%26jtitle%3DCancer%26date%3D1957%26volume%3D10%26issue%3D6%26spage%3D1138%26epage%3D1150%26doi%3D10.1002%2F1097-0142%28195711%2F12%2910%3A6%3C1138%3A%3AAID-CNCR2820100608%3E3.0.CO%3B2-K" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref70"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref70'); return false;" data-citation="" class="refNumLink">70</a></strong><div class="NLM_citation" id="cit70"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rahman, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, F. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luc, P. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woolley, P. V.</span></span> <span> </span><span class="NLM_article-title">Phase I study and clinical pharmacology of 6-diazo-5-oxo-L-norleucine (DON)</span>. <i>Invest. New Drugs</i> <span class="NLM_year" style="font-weight: bold;">1985</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">369</span>– <span class="NLM_lpage">374</span>, <span class="refDoi"> DOI: 10.1007/BF00170760</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=10.1007%2FBF00170760" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=1985&pages=369-374&author=A.+Rahmanauthor=F.+P.+Smithauthor=P.+T.+Lucauthor=P.+V.+Woolley&title=Phase+I+study+and+clinical+pharmacology+of+6-diazo-5-oxo-L-norleucine+%28DON%29&doi=10.1007%2FBF00170760"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1007%2FBF00170760&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF00170760%26sid%3Dliteratum%253Aachs%26aulast%3DRahman%26aufirst%3DA.%26aulast%3DSmith%26aufirst%3DF.%2BP.%26aulast%3DLuc%26aufirst%3DP.%2BT.%26aulast%3DWoolley%26aufirst%3DP.%2BV.%26atitle%3DPhase%2520I%2520study%2520and%2520clinical%2520pharmacology%2520of%25206-diazo-5-oxo-L-norleucine%2520%2528DON%2529%26jtitle%3DInvest.%2520New%2520Drugs%26date%3D1985%26volume%3D3%26spage%3D369%26epage%3D374%26doi%3D10.1007%2FBF00170760" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref71"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref71'); return false;" data-citation="" class="refNumLink">71</a></strong><div class="NLM_citation" id="cit71"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sklaroff, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Casper, E. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Magill, G. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Young, C. W.</span></span> <span> </span><span class="NLM_article-title">Phase I study of 6-diazo-5-oxo-L-norleucine (DON)</span>. <i>Cancer Treat. Rep.</i> <span class="NLM_year" style="font-weight: bold;">1980</span>,  <span class="NLM_volume"><i>64</i></span>,  <span class="NLM_fpage">1247</span>– <span class="NLM_lpage">1251</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=7471114" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=1%3ACAS%3A280%3ADyaL3M7jsFKgug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=1980&pages=1247-1251&author=R.+B.+Sklaroffauthor=E.+S.+Casperauthor=G.+B.+Magillauthor=C.+W.+Young&title=Phase+I+study+of+6-diazo-5-oxo-L-norleucine+%28DON%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit71R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">Phase I study of 6-diazo-5-oxo-L-norleucine (DON)</span></div><div class="casAuthors">Sklaroff R B; Casper E S; Magill G B; Young C W</div><div class="citationInfo"><span class="NLM_cas:title">Cancer treatment reports</span>
        (<span class="NLM_cas:date">1980</span>),
    <span class="NLM_cas:volume">64</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1247-51</span>
        ISSN:<span class="NLM_cas:issn">0361-5960</span>.
    </div><div class="casAbstract">We conducted a phase I study of 6-diazo-5-oxo-L-norleucine given iv on a twice weekly schedule.  Twenty-six evaluable patients received 31 courses of the drug.  Doses ranged from 100 to 500 mg/m2.  Nausea with vomiting was the dose-limiting toxic effect, transient thrombocytopenia was seen frequently, and mucositis occurred in 39% of the patients.  No definite therapeutic responses were observed in 18 patients with measurable lesions.  The recommended dose for phase II studies is 200-300 mg/m2 iv twice weekly.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRr5J6AmhNS-Q20zIbnCCI3fW6udTcc2eY-5DI_BHi6rLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaL3M7jsFKgug%253D%253D&md5=1e5d3241b3e4834c46fc432306faae4c</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSklaroff%26aufirst%3DR.%2BB.%26aulast%3DCasper%26aufirst%3DE.%2BS.%26aulast%3DMagill%26aufirst%3DG.%2BB.%26aulast%3DYoung%26aufirst%3DC.%2BW.%26atitle%3DPhase%2520I%2520study%2520of%25206-diazo-5-oxo-L-norleucine%2520%2528DON%2529%26jtitle%3DCancer%2520Treat.%2520Rep.%26date%3D1980%26volume%3D64%26spage%3D1247%26epage%3D1251" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref72"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref72'); return false;" data-citation="" class="refNumLink">72</a></strong><div class="NLM_citation" id="cit72"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sullivan, M.
P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beatty, E. C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hyman, C. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murphy, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pierce, M. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Severo, N. C.</span></span> <span> </span><span class="NLM_article-title">A comparison of the effectiveness of standard dose 6-mercaptopurine, combination 6- mercaptopurine and DON, and high-loading 6-mercaptopurine therapies in treatment of the acute leukemias of childhood: results of a cooperative study</span>. <i>Cancer Chemother. Rep.</i> <span class="NLM_year" style="font-weight: bold;">1962</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">161</span>– <span class="NLM_lpage">164</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=13918322" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=1%3ACAS%3A280%3ADyaF387gvF2gsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=1962&pages=161-164&author=M.%0AP.+Sullivanauthor=E.+C.+J.+Beattyauthor=C.+B.+Hymanauthor=M.+L.+Murphyauthor=M.+I.+Pierceauthor=N.+C.+Severo&title=A+comparison+of+the+effectiveness+of+standard+dose+6-mercaptopurine%2C+combination+6-+mercaptopurine+and+DON%2C+and+high-loading+6-mercaptopurine+therapies+in+treatment+of+the+acute+leukemias+of+childhood%3A+results+of+a+cooperative+study"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit72R"><div class="casContent"><span class="casTitleNuber">72</span><div class="casTitle"><span class="NLM_cas:atitle">A comparison of the effectiveness of standard dose 6-mercaptopurine, combination 6-mercaptopurine and DON, and high-loading 6-mercaptopurine therapies in the treatment of acute leukemia in children: results of cooperative study</span></div><div class="casAuthors">SULLIVAN M P; BEATTY E C Jr; HYMAN C P; MURPHY M L; PHERCE M I; SEVERO N C</div><div class="citationInfo"><span class="NLM_cas:title">Cancer chemotherapy reports</span>
        (<span class="NLM_cas:date">1962</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">161-4</span>
        ISSN:<span class="NLM_cas:issn">0069-0112</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRD9eCdRUxoXOLt9HypzAgQfW6udTcc2eawvpo7bQRh37ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaF387gvF2gsQ%253D%253D&md5=539c8fa3eb8f2960e1b8b88375c9874b</span></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSullivan%26aufirst%3DM.%2BP.%26aulast%3DBeatty%26aufirst%3DE.%2BC.%2BJ.%26aulast%3DHyman%26aufirst%3DC.%2BB.%26aulast%3DMurphy%26aufirst%3DM.%2BL.%26aulast%3DPierce%26aufirst%3DM.%2BI.%26aulast%3DSevero%26aufirst%3DN.%2BC.%26atitle%3DA%2520comparison%2520of%2520the%2520effectiveness%2520of%2520standard%2520dose%25206-mercaptopurine%252C%2520combination%25206-%2520mercaptopurine%2520and%2520DON%252C%2520and%2520high-loading%25206-mercaptopurine%2520therapies%2520in%2520treatment%2520of%2520the%2520acute%2520leukemias%2520of%2520childhood%253A%2520results%2520of%2520a%2520cooperative%2520study%26jtitle%3DCancer%2520Chemother.%2520Rep.%26date%3D1962%26volume%3D16%26spage%3D161%26epage%3D164" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref73"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref73'); return false;" data-citation="" class="refNumLink">73</a></strong><div class="NLM_citation" id="cit73"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Barclay, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phillipps, M. A.</span></span> <span> </span><span class="NLM_article-title">Effects of 6-diazo-5-oxolnorleucine and other tumor inhibitors on the biosynthesis of nicotinamide adenine dinucleotide in mice</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">1966</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">282</span>– <span class="NLM_lpage">286</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=1966&pages=282-286&author=R.+K.+Barclayauthor=M.+A.+Phillipps&title=Effects+of+6-diazo-5-oxolnorleucine+and+other+tumor+inhibitors+on+the+biosynthesis+of+nicotinamide+adenine+dinucleotide+in+mice"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBarclay%26aufirst%3DR.%2BK.%26aulast%3DPhillipps%26aufirst%3DM.%2BA.%26atitle%3DEffects%2520of%25206-diazo-5-oxolnorleucine%2520and%2520other%2520tumor%2520inhibitors%2520on%2520the%2520biosynthesis%2520of%2520nicotinamide%2520adenine%2520dinucleotide%2520in%2520mice%26jtitle%3DCancer%2520Res.%26date%3D1966%26volume%3D26%26spage%3D282%26epage%3D286" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref74"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref74'); return false;" data-citation="" class="refNumLink">74</a></strong><div class="NLM_citation" id="cit74"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hofer, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steverding, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chabes, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brun, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thelander, L.</span></span> <span> </span><span class="NLM_article-title">Trypanosoma brucei CTP synthetase: a target for the treatment of african sleeping sickness</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>98</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">6412</span>– <span class="NLM_lpage">6416</span>, <span class="refDoi"> DOI: 10.1073/pnas.111139498</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=10.1073%2Fpnas.111139498" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=11353848" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=1%3ACAS%3A528%3ADC%252BD3MXktVWkt74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=98&publication_year=2001&pages=6412-6416&issue=11&author=A.+Hoferauthor=D.+Steverdingauthor=A.+Chabesauthor=R.+Brunauthor=L.+Thelander&title=Trypanosoma+brucei+CTP+synthetase%3A+a+target+for+the+treatment+of+african+sleeping+sickness&doi=10.1073%2Fpnas.111139498"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit74R"><div class="casContent"><span class="casTitleNuber">74</span><div class="casTitle"><span class="NLM_cas:atitle">Trypanosoma brucei CTP synthetase: a target for the treatment of African sleeping sickness</span></div><div class="casAuthors">Hofer, Anders; Steverding, Dietmar; Chabes, Andrei; Brun, Reto; Thelander, Lars</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">98</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">6412-6416</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The drugs in clin. use against African sleeping sickness are toxic, costly, or inefficient.  We show that Trypanosoma brucei, which causes this disease, has very low levels of CTP, which are due to a limited capacity for de novo synthesis and the lack of salvage pathways.  The CTP synthetase inhibitors 6-diazo-5-oxo-L-norleucine (DON) and α-amino-3-chloro-4,5-dihydro-5-isoxazoleacetic acid (acivicin) reduced the parasite CTP levels even further and inhibited trypanosome proliferation in vitro and in T. brucei-infected mice.  In mammalian cells, DON mainly inhibits de novo purine biosynthesis, a pathway lacking in trypanosomes.  We could rescue DON-treated human and mouse fibroblasts by the addn. of the purine base hypoxanthine to the growth medium.  For treatment of sleeping sickness, we propose the use of CTP synthetase inhibitors alone or in combination with appropriate nucleosides or bases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr8inLobtvSV7Vg90H21EOLACvtfcHk0ljaU57Shb8kgQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXktVWkt74%253D&md5=66c382dafbe2526962f14f0ac9bbdd96</span></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.1073%2Fpnas.111139498&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.111139498%26sid%3Dliteratum%253Aachs%26aulast%3DHofer%26aufirst%3DA.%26aulast%3DSteverding%26aufirst%3DD.%26aulast%3DChabes%26aufirst%3DA.%26aulast%3DBrun%26aufirst%3DR.%26aulast%3DThelander%26aufirst%3DL.%26atitle%3DTrypanosoma%2520brucei%2520CTP%2520synthetase%253A%2520a%2520target%2520for%2520the%2520treatment%2520of%2520african%2520sleeping%2520sickness%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2001%26volume%3D98%26issue%3D11%26spage%3D6412%26epage%3D6416%26doi%3D10.1073%2Fpnas.111139498" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref75"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref75'); return false;" data-citation="" class="refNumLink">75</a></strong><div class="NLM_citation" id="cit75"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Grayzel, A. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seegmiller, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Love, E.</span></span> <span> </span><span class="NLM_article-title">Suppression of uric acid synthesis in the gouty human by the use of 6-diazo-5-oxo-L-norleucine</span>. <i>J. Clin. Invest.</i> <span class="NLM_year" style="font-weight: bold;">1960</span>,  <span class="NLM_volume"><i>39</i></span>,  <span class="NLM_fpage">447</span>– <span class="NLM_lpage">454</span>, <span class="refDoi"> DOI: 10.1172/JCI104057</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=10.1172%2FJCI104057" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=13829149" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=1%3ACAS%3A528%3ADyaF3cXhtFantLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=1960&pages=447-454&author=A.+I.+Grayzelauthor=J.+E.+Seegmillerauthor=E.+Love&title=Suppression+of+uric+acid+synthesis+in+the+gouty+human+by+the+use+of+6-diazo-5-oxo-L-norleucine&doi=10.1172%2FJCI104057"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit75R"><div class="casContent"><span class="casTitleNuber">75</span><div class="casTitle"><span class="NLM_cas:atitle">Suppression of the uric acid synthesis in the gouty human by the use of 6-diazo-5-oxo-L-norleucine (DON)</span></div><div class="casAuthors">Grayzel, Arthur I.; Seegmiller, J. E.; Love, Ethel</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Investigation</span>
        (<span class="NLM_cas:date">1960</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">447-54</span>CODEN:
                <span class="NLM_cas:coden">JCINAO</span>;
        ISSN:<span class="NLM_cas:issn">0021-9738</span>.
    </div><div class="casAbstract">Studies on 3 patients demonstrated that DON suppressed the incorporation of glycine-1-C14 into urinary uric acid.  Balance studies demonstrated that in 2 patients there was a significant decrease in serum urate levels and 24 h. urinary uric acid excretion following administration of DON.  It is concluded that DON suppresses uric acid biosynthesis but such suppression is not always reflected in a short term balance study, esp. in the presence of an expanded urate pool.  The use of pharmacol. agents to suppress synthesis in subjects who overproduce uric acid represents a new and rational approach to their therapy.  DON produces a high incidence of side effects.  25 refs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrSFsZTw-FQarVg90H21EOLACvtfcHk0ljaU57Shb8kgQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaF3cXhtFantLo%253D&md5=e8e89e028a8c02bb27b889bc83d4626e</span></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1172%2FJCI104057&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1172%252FJCI104057%26sid%3Dliteratum%253Aachs%26aulast%3DGrayzel%26aufirst%3DA.%2BI.%26aulast%3DSeegmiller%26aufirst%3DJ.%2BE.%26aulast%3DLove%26aufirst%3DE.%26atitle%3DSuppression%2520of%2520uric%2520acid%2520synthesis%2520in%2520the%2520gouty%2520human%2520by%2520the%2520use%2520of%25206-diazo-5-oxo-L-norleucine%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D1960%26volume%3D39%26spage%3D447%26epage%3D454%26doi%3D10.1172%2FJCI104057" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref76"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref76'); return false;" data-citation="" class="refNumLink">76</a></strong><div class="NLM_citation" id="cit76"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shapiro, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clark, V. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Curthoys, N. P.</span></span> <span> </span><span class="NLM_article-title">Inactivation of rat renal phosphate-dependent glutaminase with 6-diazo-5-oxo-L-norleucine. Evidence for interaction at the glutamine binding site</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1979</span>,  <span class="NLM_volume"><i>254</i></span>,  <span class="NLM_fpage">2835</span>– <span class="NLM_lpage">2838</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=429321" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=1%3ACAS%3A528%3ADyaE1MXktFGrtb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=254&publication_year=1979&pages=2835-2838&author=R.+A.+Shapiroauthor=V.+M.+Clarkauthor=N.+P.+Curthoys&title=Inactivation+of+rat+renal+phosphate-dependent+glutaminase+with+6-diazo-5-oxo-L-norleucine.+Evidence+for+interaction+at+the+glutamine+binding+site"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit76R"><div class="casContent"><span class="casTitleNuber">76</span><div class="casTitle"><span class="NLM_cas:atitle">Inactivation of rat renal phosphate-dependent glutaminase with 6-diazo-5-oxo-L-norleucine.  Evidence for interaction at the glutamine binding site</span></div><div class="casAuthors">Shapiro, Richard A.; Clark, Virginia M.; Curthoys, Norman P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">1979</span>),
    <span class="NLM_cas:volume">254</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2835-8</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    </div><div class="casAbstract">Inactivation of rat renal phosphate-dependent glutaminase (I) by 6-diazo-5-oxo-L-norleucine (II) occurred only under conditions where the enzyme was catalytically active.  The I activity and the rate of inactivation by II exhibited very similar phosphate concn.-dependent activation profiles.  Because of this phosphate dependency, it was not possible to differentiate an apparent protection by glutamine from the strong inhibition of inactivation caused by glutamate.  The ability of glutamate to protect I against inactivation was reversed by increasing concns. of phosphate.  The obsd. characteristics of inactivation by II differed considerably from those reported for the inactivation by L-2-amino-4-oxo-5-chloropentanoic acid (III).  In addn. the presence of O-carbamoyl-L-serine stimulated inactivation by II, but protected I against inactivation by III.  Preinactivation of I by II only slightly reduced the stoichiometry of binding of III.  These observations suggest that II and III interact with different sites on I which are specific for binding glutamine and glutamate, resp.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGomJg8GQCT7nbVg90H21EOLACvtfcHk0lgi6R07ZrlGSQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE1MXktFGrtb8%253D&md5=f866075ef2fb25bd436c87487fb240c6</span></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DShapiro%26aufirst%3DR.%2BA.%26aulast%3DClark%26aufirst%3DV.%2BM.%26aulast%3DCurthoys%26aufirst%3DN.%2BP.%26atitle%3DInactivation%2520of%2520rat%2520renal%2520phosphate-dependent%2520glutaminase%2520with%25206-diazo-5-oxo-L-norleucine.%2520Evidence%2520for%2520interaction%2520at%2520the%2520glutamine%2520binding%2520site%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1979%26volume%3D254%26spage%3D2835%26epage%3D2838" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref77"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref77'); return false;" data-citation="" class="refNumLink">77</a></strong><div class="NLM_citation" id="cit77"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Catane, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Von Hoff, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glaubiger, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muggia, F. M.</span></span> <span> </span><span class="NLM_article-title">Azaserine, DON, and azotomycin: three diazo analogs of L-glutamine with clinical antitumor activity</span>. <i>Cancer Treat. Rep.</i> <span class="NLM_year" style="font-weight: bold;">1979</span>,  <span class="NLM_volume"><i>63</i></span>,  <span class="NLM_fpage">1033</span>– <span class="NLM_lpage">1038</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=380801" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=1%3ACAS%3A280%3ADyaE1M3jsVGnug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=1979&pages=1033-1038&author=R.+Cataneauthor=D.+D.+Von+Hoffauthor=D.+L.+Glaubigerauthor=F.+M.+Muggia&title=Azaserine%2C+DON%2C+and+azotomycin%3A+three+diazo+analogs+of+L-glutamine+with+clinical+antitumor+activity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit77R"><div class="casContent"><span class="casTitleNuber">77</span><div class="casTitle"><span class="NLM_cas:atitle">Azaserine, DON, and azotomycin: three diazo analogs of L-glutamine with clinical antitumor activity</span></div><div class="casAuthors">Catane R; Von Hoff D D; Glaubiger D L; Muggia F M</div><div class="citationInfo"><span class="NLM_cas:title">Cancer treatment reports</span>
        (<span class="NLM_cas:date">1979</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1033-8</span>
        ISSN:<span class="NLM_cas:issn">0361-5960</span>.
    </div><div class="casAbstract">A review of the clinical data on azaserine, DON, and azotomycin reveals that these agents have limited but definite antitumor activity.  All three drugs are analogs of L-glutamine and contain a diazo group.  They have been studied as single agents in a wide variety of human malignancies and have also been included in trials using combination chemotherapy.  Most of these studies were performed early in the history of clinical trials and, therefore, the method of reporting results and the evaluation criteria were quite different from those in use today.  A renewed interest in these agents has been triggered by the remarkable activity of DON and azotomycin against human tumor lines implanted into nude mice.  On the basis of this activity and the clinical data we have compiled, we feel that new clinical trials with these agents are warranted.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTbiKrl9gpbebHHuJhbyicZfW6udTcc2ead2ozX0rD4lbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaE1M3jsVGnug%253D%253D&md5=614e83ba5c50755ee3f89c0ac10305f1</span></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCatane%26aufirst%3DR.%26aulast%3DVon%2BHoff%26aufirst%3DD.%2BD.%26aulast%3DGlaubiger%26aufirst%3DD.%2BL.%26aulast%3DMuggia%26aufirst%3DF.%2BM.%26atitle%3DAzaserine%252C%2520DON%252C%2520and%2520azotomycin%253A%2520three%2520diazo%2520analogs%2520of%2520L-glutamine%2520with%2520clinical%2520antitumor%2520activity%26jtitle%3DCancer%2520Treat.%2520Rep.%26date%3D1979%26volume%3D63%26spage%3D1033%26epage%3D1038" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref78"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref78'); return false;" data-citation="" class="refNumLink">78</a></strong><div class="NLM_citation" id="cit78"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rais, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jancarik, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tenora, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nedelcovych, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alt, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Englert, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rojas, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elgogary, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monincova, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pate, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adams, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferraris, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Powell, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Majer, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Slusher, B. S.</span></span> <span> </span><span class="NLM_article-title">Discovery of 6-diazo-5-oxo-L-norleucine (DON) prodrugs with enhanced CSF delivery in monkeys: a potential treatment for glioblastoma</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span> (<span class="NLM_issue">18</span>),  <span class="NLM_fpage">8621</span>– <span class="NLM_lpage">8633</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01069</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01069" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=8621-8633&issue=18&author=R.+Raisauthor=A.+Jancarikauthor=L.+Tenoraauthor=M.+Nedelcovychauthor=J.+Altauthor=J.+Englertauthor=C.+Rojasauthor=A.+Leauthor=A.+Elgogaryauthor=J.+Tanauthor=L.+Monincovaauthor=K.+Pateauthor=R.+Adamsauthor=D.+Ferrarisauthor=J.+Powellauthor=P.+Majerauthor=B.+S.+Slusher&title=Discovery+of+6-diazo-5-oxo-L-norleucine+%28DON%29+prodrugs+with+enhanced+CSF+delivery+in+monkeys%3A+a+potential+treatment+for+glioblastoma&doi=10.1021%2Facs.jmedchem.6b01069"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01069&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01069%26sid%3Dliteratum%253Aachs%26aulast%3DRais%26aufirst%3DR.%26aulast%3DJancarik%26aufirst%3DA.%26aulast%3DTenora%26aufirst%3DL.%26aulast%3DNedelcovych%26aufirst%3DM.%26aulast%3DAlt%26aufirst%3DJ.%26aulast%3DEnglert%26aufirst%3DJ.%26aulast%3DRojas%26aufirst%3DC.%26aulast%3DLe%26aufirst%3DA.%26aulast%3DElgogary%26aufirst%3DA.%26aulast%3DTan%26aufirst%3DJ.%26aulast%3DMonincova%26aufirst%3DL.%26aulast%3DPate%26aufirst%3DK.%26aulast%3DAdams%26aufirst%3DR.%26aulast%3DFerraris%26aufirst%3DD.%26aulast%3DPowell%26aufirst%3DJ.%26aulast%3DMajer%26aufirst%3DP.%26aulast%3DSlusher%26aufirst%3DB.%2BS.%26atitle%3DDiscovery%2520of%25206-diazo-5-oxo-L-norleucine%2520%2528DON%2529%2520prodrugs%2520with%2520enhanced%2520CSF%2520delivery%2520in%2520monkeys%253A%2520a%2520potential%2520treatment%2520for%2520glioblastoma%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26issue%3D18%26spage%3D8621%26epage%3D8633%26doi%3D10.1021%2Facs.jmedchem.6b01069" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref79"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref79'); return false;" data-citation="" class="refNumLink">79</a></strong><div class="NLM_citation" id="cit79"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nedelcovych, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tenora, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, B. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelschenbach, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chao, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hadas, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jancarik, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prchalova, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zimmermann, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dash, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gadiano, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garrett, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Furtmuller, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oh, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brandacher, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alt, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Majer, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Volsky, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rais, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Slusher, B. S.</span></span> <span> </span><span class="NLM_article-title">N-(Pivaloyloxy)alkoxy-carbonyl prodrugs of the glutamine antagonist 6-diazo-5-oxo-L- norleucine (DON) as a potential treatment for HIV associated neurocognitive disorders</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span> (<span class="NLM_issue">16</span>),  <span class="NLM_fpage">7186</span>– <span class="NLM_lpage">7198</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00966</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00966" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=7186-7198&issue=16&author=M.+T.+Nedelcovychauthor=L.+Tenoraauthor=B.+H.+Kimauthor=J.+Kelschenbachauthor=W.+Chaoauthor=E.+Hadasauthor=A.+Jancarikauthor=E.+Prchalovaauthor=S.+C.+Zimmermannauthor=R.+P.+Dashauthor=A.+J.+Gadianoauthor=C.+Garrettauthor=G.+Furtmullerauthor=B.+Ohauthor=G.+Brandacherauthor=J.+Altauthor=P.+Majerauthor=D.+J.+Volskyauthor=R.+Raisauthor=B.+S.+Slusher&title=N-%28Pivaloyloxy%29alkoxy-carbonyl+prodrugs+of+the+glutamine+antagonist+6-diazo-5-oxo-L-+norleucine+%28DON%29+as+a+potential+treatment+for+HIV+associated+neurocognitive+disorders&doi=10.1021%2Facs.jmedchem.7b00966"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00966&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00966%26sid%3Dliteratum%253Aachs%26aulast%3DNedelcovych%26aufirst%3DM.%2BT.%26aulast%3DTenora%26aufirst%3DL.%26aulast%3DKim%26aufirst%3DB.%2BH.%26aulast%3DKelschenbach%26aufirst%3DJ.%26aulast%3DChao%26aufirst%3DW.%26aulast%3DHadas%26aufirst%3DE.%26aulast%3DJancarik%26aufirst%3DA.%26aulast%3DPrchalova%26aufirst%3DE.%26aulast%3DZimmermann%26aufirst%3DS.%2BC.%26aulast%3DDash%26aufirst%3DR.%2BP.%26aulast%3DGadiano%26aufirst%3DA.%2BJ.%26aulast%3DGarrett%26aufirst%3DC.%26aulast%3DFurtmuller%26aufirst%3DG.%26aulast%3DOh%26aufirst%3DB.%26aulast%3DBrandacher%26aufirst%3DG.%26aulast%3DAlt%26aufirst%3DJ.%26aulast%3DMajer%26aufirst%3DP.%26aulast%3DVolsky%26aufirst%3DD.%2BJ.%26aulast%3DRais%26aufirst%3DR.%26aulast%3DSlusher%26aufirst%3DB.%2BS.%26atitle%3DN-%2528Pivaloyloxy%2529alkoxy-carbonyl%2520prodrugs%2520of%2520the%2520glutamine%2520antagonist%25206-diazo-5-oxo-L-%2520norleucine%2520%2528DON%2529%2520as%2520a%2520potential%2520treatment%2520for%2520HIV%2520associated%2520neurocognitive%2520disorders%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26issue%3D16%26spage%3D7186%26epage%3D7198%26doi%3D10.1021%2Facs.jmedchem.7b00966" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref80"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref80'); return false;" data-citation="" class="refNumLink">80</a></strong><div class="NLM_citation" id="cit80"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rasheed, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, C. K. A.</span></span> <span> </span><span class="NLM_article-title">Novel approaches on prodrug based drug design</span>. <i>Pharm. Chem. J.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>42</i></span>,  <span class="NLM_fpage">677</span>– <span class="NLM_lpage">686</span>, <span class="refDoi"> DOI: 10.1007/s11094-009-0213-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=10.1007%2Fs11094-009-0213-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=1%3ACAS%3A528%3ADC%252BD1MXksVyisbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2008&pages=677-686&author=A.+Rasheedauthor=C.+K.+A.+Kumar&title=Novel+approaches+on+prodrug+based+drug+design&doi=10.1007%2Fs11094-009-0213-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit80R"><div class="casContent"><span class="casTitleNuber">80</span><div class="casTitle"><span class="NLM_cas:atitle">Novel approaches on prodrug based drug design</span></div><div class="casAuthors">Rasheed, A.; Kumar, C. K. A.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmaceutical Chemistry Journal</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">677-686</span>CODEN:
                <span class="NLM_cas:coden">PCJOAU</span>;
        ISSN:<span class="NLM_cas:issn">0091-150X</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  Prodrug design is really not different from the general drug discovery process, in which a unique substance is obsd. to have desirable pharmacol. effects, and studies of its properties lead to the design of better drugs.  It is a very fruitful way of research, and its introduction in human therapy has given successful results in improving the clin. and therapeutic effectiveness of drugs suffering from some undesirable properties that otherwise hinder their clin. usefulness.  The present article reviews various prodrugs and their applications and presents the developments in this field during the last few decades.  This review also highlights developing strategies in targeted prodrug design, including antibody-directed enzyme prodrug therapy, gene-directed enzyme prodrug therapy and peptide transporter-assocd. prodrug therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGovQl2xd15Bq7Vg90H21EOLACvtfcHk0lioVLHJsNDA2Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXksVyisbs%253D&md5=2f276e9dcfbebdd479906e3697663121</span></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=10.1007%2Fs11094-009-0213-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11094-009-0213-3%26sid%3Dliteratum%253Aachs%26aulast%3DRasheed%26aufirst%3DA.%26aulast%3DKumar%26aufirst%3DC.%2BK.%2BA.%26atitle%3DNovel%2520approaches%2520on%2520prodrug%2520based%2520drug%2520design%26jtitle%3DPharm.%2520Chem.%2520J.%26date%3D2008%26volume%3D42%26spage%3D677%26epage%3D686%26doi%3D10.1007%2Fs11094-009-0213-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref81"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref81'); return false;" data-citation="" class="refNumLink">81</a></strong><div class="NLM_citation" id="cit81"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maag, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alfredson, T.</span></span> <span> </span><span class="NLM_article-title">Prodrugs of nucleoside analogues for improved oral absorption and tissue targeting</span>. <i>J. Pharm. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>97</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">1109</span>– <span class="NLM_lpage">1134</span>, <span class="refDoi"> DOI: 10.1002/jps.21047</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=10.1002%2Fjps.21047" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=17696166" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=1%3ACAS%3A280%3ADC%252BD1c%252FovVCgtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=97&publication_year=2008&pages=1109-1134&issue=3&author=F.+Liauthor=H.+Maagauthor=T.+Alfredson&title=Prodrugs+of+nucleoside+analogues+for+improved+oral+absorption+and+tissue+targeting&doi=10.1002%2Fjps.21047"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit81R"><div class="casContent"><span class="casTitleNuber">81</span><div class="casTitle"><span class="NLM_cas:atitle">Prodrugs of nucleoside analogues for improved oral absorption and tissue targeting</span></div><div class="casAuthors">Li Fujun; Maag Hans; Alfredson Tom</div><div class="citationInfo"><span class="NLM_cas:title">Journal of pharmaceutical sciences</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">97</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1109-34</span>
        ISSN:<span class="NLM_cas:issn">0022-3549</span>.
    </div><div class="casAbstract">Nucleoside analogues are widely used for the treatment of antiviral infections and anticancer chemotherapy.  However, many nucleoside analogues suffer from poor oral bioavailability due to their high polarity and low intestinal permeability.  In order to improve oral absorption of these polar drugs, prodrugs have been employed to increase lipophilicity by chemical modification of the parent.  Alternatively, prodrugs targeting transporters present in the intestine have been exploited to facilitate the transport of the nucleoside analogues.  Valacyclovir and valganciclovir are two successful valine ester prodrugs transported by the PepT1 transporter.  Recently, research efforts have focused on design of prodrugs for tissue specific delivery to improve efficacy and safety.  This review presents advances of prodrug approaches for improved oral absorption of nucleoside analogues and recent developments in tissue targeting.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS-KOBK65zide2qxNLjzXe8fW6udTcc2ebFfV1dOJW5fbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1c%252FovVCgtQ%253D%253D&md5=ed6aeaf75134be8bc9ef23a89b673b80</span></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=10.1002%2Fjps.21047&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjps.21047%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DF.%26aulast%3DMaag%26aufirst%3DH.%26aulast%3DAlfredson%26aufirst%3DT.%26atitle%3DProdrugs%2520of%2520nucleoside%2520analogues%2520for%2520improved%2520oral%2520absorption%2520and%2520tissue%2520targeting%26jtitle%3DJ.%2520Pharm.%2520Sci.%26date%3D2008%26volume%3D97%26issue%3D3%26spage%3D1109%26epage%3D1134%26doi%3D10.1002%2Fjps.21047" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref82"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref82'); return false;" data-citation="" class="refNumLink">82</a></strong><div class="NLM_citation" id="cit82"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fattash, B.</span>; <span class="NLM_string-name">Karaman, R.</span></span> <i>Chemical Approaches Used in Prodrugs Design in Prodrugs Design—A New Era</i>. <span class="NLM_publisher-name">Nova Science Publishers, Inc.</span>, <span class="NLM_year">2014</span>; pp  <span class="NLM_fpage">103</span>– <span class="NLM_lpage">137</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&pages=103-137&author=B.+Fattash&author=R.+Karaman&title=Chemical+Approaches+Used+in+Prodrugs+Design+in+Prodrugs+Design%E2%80%94A+New+Era"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DFattash%26aufirst%3DB.%26btitle%3DChemical%2520Approaches%2520Used%2520in%2520Prodrugs%2520Design%2520in%2520Prodrugs%2520Design%25E2%2580%2594A%2520New%2520Era%26pub%3DNova%2520Science%2520Publishers%252C%2520Inc%26date%3D2014%26spage%3D103%26epage%3D137" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref83"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref83'); return false;" data-citation="" class="refNumLink">83</a></strong><div class="NLM_citation" id="cit83"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liederer, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borchardt, R. T.</span></span> <span> </span><span class="NLM_article-title">Enzymes involved in the bioconversion of ester-based prodrugs</span>. <i>J. Pharm. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>95</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">1177</span>– <span class="NLM_lpage">1195</span>, <span class="refDoi"> DOI: 10.1002/jps.20542</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=10.1002%2Fjps.20542" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=16639719" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=1%3ACAS%3A528%3ADC%252BD28XlsFWmu7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=2006&pages=1177-1195&issue=6&author=B.+M.+Liedererauthor=R.+T.+Borchardt&title=Enzymes+involved+in+the+bioconversion+of+ester-based+prodrugs&doi=10.1002%2Fjps.20542"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit83R"><div class="casContent"><span class="casTitleNuber">83</span><div class="casTitle"><span class="NLM_cas:atitle">Enzymes involved in the bioconversion of ester-based prodrugs</span></div><div class="casAuthors">Liederer, Bianca M.; Borchardt, Ronald T.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmaceutical Sciences</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">95</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1177-1195</span>CODEN:
                <span class="NLM_cas:coden">JPMSAE</span>;
        ISSN:<span class="NLM_cas:issn">0022-3549</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">A review.  Enzymes are essential for the activation of many prodrugs.  In this review, the most important enzymes (e.g., paraoxonase, carboxylesterase, acetylcholinesterase, cholinesterase) involved in the bioconversion of ester-based prodrugs will be discussed in terms of their biol. and biochem.  Most of these enzymes fall into the category of hydrolytic enzymes.  However, nonhydrolytic enzymes, including cytochrome P450s, can also catalyze the bioconversion of ester prodrugs and thus will be discussed here.  Other factors influencing the ability of these enzymes to catalyze the bioconversion of ester-based prodrugs, particularly species and interindividual differences and stereochem. and structural features of the prodrugs, will be discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp0llDjMqFZU7Vg90H21EOLACvtfcHk0ljx9bkJdhe9zQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XlsFWmu7Y%253D&md5=c4bb34d8918f2b4de099a0502c5bdb00</span></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=10.1002%2Fjps.20542&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjps.20542%26sid%3Dliteratum%253Aachs%26aulast%3DLiederer%26aufirst%3DB.%2BM.%26aulast%3DBorchardt%26aufirst%3DR.%2BT.%26atitle%3DEnzymes%2520involved%2520in%2520the%2520bioconversion%2520of%2520ester-based%2520prodrugs%26jtitle%3DJ.%2520Pharm.%2520Sci.%26date%3D2006%26volume%3D95%26issue%3D6%26spage%3D1177%26epage%3D1195%26doi%3D10.1002%2Fjps.20542" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref84"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref84'); return false;" data-citation="" class="refNumLink">84</a></strong><div class="NLM_citation" id="cit84"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Newcomb, R. W.</span>; <span class="NLM_string-name">Newocmb, M.</span></span> <span> </span><span class="NLM_article-title">Selective Inhibition of Glutaminase by Bis-Thiadiazoles</span>. <span class="NLM_patent">US6451828B1</span>, Sep 17, <span class="NLM_year">2002</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2002&author=R.+W.+Newcomb&author=M.+Newocmb&title=Selective+Inhibition+of+Glutaminase+by+Bis-Thiadiazoles"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DNewcomb%26aufirst%3DR.%2BW.%26atitle%3DSelective%2520Inhibition%2520of%2520Glutaminase%2520by%2520Bis-Thiadiazoles%26date%3D2002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref85"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref85'); return false;" data-citation="" class="refNumLink">85</a></strong><div class="NLM_citation" id="cit85"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shapiro, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clark, V. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Curthoys, N. P.</span></span> <span> </span><span class="NLM_article-title">Covalent interaction of L-2-amino-4-oxo-5- chloropentanoic acid with rat renal phosphate-dependent glutaminase. Evidence for a specific glutamate binding site and of subunit heterogeneity</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1978</span>,  <span class="NLM_volume"><i>253</i></span>,  <span class="NLM_fpage">7086</span>– <span class="NLM_lpage">7090</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=253&publication_year=1978&pages=7086-7090&author=R.+A.+Shapiroauthor=V.+M.+Clarkauthor=N.+P.+Curthoys&title=Covalent+interaction+of+L-2-amino-4-oxo-5-+chloropentanoic+acid+with+rat+renal+phosphate-dependent+glutaminase.+Evidence+for+a+specific+glutamate+binding+site+and+of+subunit+heterogeneity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DShapiro%26aufirst%3DR.%2BA.%26aulast%3DClark%26aufirst%3DV.%2BM.%26aulast%3DCurthoys%26aufirst%3DN.%2BP.%26atitle%3DCovalent%2520interaction%2520of%2520L-2-amino-4-oxo-5-%2520chloropentanoic%2520acid%2520with%2520rat%2520renal%2520phosphate-dependent%2520glutaminase.%2520Evidence%2520for%2520a%2520specific%2520glutamate%2520binding%2520site%2520and%2520of%2520subunit%2520heterogeneity%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1978%26volume%3D253%26spage%3D7086%26epage%3D7090" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref86"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref86'); return false;" data-citation="" class="refNumLink">86</a></strong><div class="NLM_citation" id="cit86"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xiang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stine, Z. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xia, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Connor, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Altman, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hsieh, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gouw, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Slusher, B. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhuo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ooi, L. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, C. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mancuso, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCallion, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Milone, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rayport, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Felsher, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dang, C. V.</span></span> <span> </span><span class="NLM_article-title">Targeted inhibition of tumor-specific glutaminase diminishes cell-autonomous tumorigenesis</span>. <i>J. Clin. Invest.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>125</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">2293</span>– <span class="NLM_lpage">2306</span>, <span class="refDoi"> DOI: 10.1172/JCI75836</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=10.1172%2FJCI75836" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=125&publication_year=2015&pages=2293-2306&issue=6&author=Y.+Xiangauthor=Z.+E.+Stineauthor=J.+Xiaauthor=Y.+Luauthor=R.+S.+O%E2%80%99Connorauthor=B.+J.+Altmanauthor=A.+L.+Hsiehauthor=A.+M.+Gouwauthor=A.+G.+Thomasauthor=P.+Gaoauthor=L.+Sunauthor=L.+Songauthor=B.+Yanauthor=B.+S.+Slusherauthor=J.+Zhuoauthor=L.+L.+Ooiauthor=C.+G.+Leeauthor=A.+Mancusoauthor=A.+S.+McCallionauthor=A.+Leauthor=M.+C.+Miloneauthor=S.+Rayportauthor=D.+W.+Felsherauthor=C.+V.+Dang&title=Targeted+inhibition+of+tumor-specific+glutaminase+diminishes+cell-autonomous+tumorigenesis&doi=10.1172%2FJCI75836"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=10.1172%2FJCI75836&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1172%252FJCI75836%26sid%3Dliteratum%253Aachs%26aulast%3DXiang%26aufirst%3DY.%26aulast%3DStine%26aufirst%3DZ.%2BE.%26aulast%3DXia%26aufirst%3DJ.%26aulast%3DLu%26aufirst%3DY.%26aulast%3DO%25E2%2580%2599Connor%26aufirst%3DR.%2BS.%26aulast%3DAltman%26aufirst%3DB.%2BJ.%26aulast%3DHsieh%26aufirst%3DA.%2BL.%26aulast%3DGouw%26aufirst%3DA.%2BM.%26aulast%3DThomas%26aufirst%3DA.%2BG.%26aulast%3DGao%26aufirst%3DP.%26aulast%3DSun%26aufirst%3DL.%26aulast%3DSong%26aufirst%3DL.%26aulast%3DYan%26aufirst%3DB.%26aulast%3DSlusher%26aufirst%3DB.%2BS.%26aulast%3DZhuo%26aufirst%3DJ.%26aulast%3DOoi%26aufirst%3DL.%2BL.%26aulast%3DLee%26aufirst%3DC.%2BG.%26aulast%3DMancuso%26aufirst%3DA.%26aulast%3DMcCallion%26aufirst%3DA.%2BS.%26aulast%3DLe%26aufirst%3DA.%26aulast%3DMilone%26aufirst%3DM.%2BC.%26aulast%3DRayport%26aufirst%3DS.%26aulast%3DFelsher%26aufirst%3DD.%2BW.%26aulast%3DDang%26aufirst%3DC.%2BV.%26atitle%3DTargeted%2520inhibition%2520of%2520tumor-specific%2520glutaminase%2520diminishes%2520cell-autonomous%2520tumorigenesis%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2015%26volume%3D125%26issue%3D6%26spage%3D2293%26epage%3D2306%26doi%3D10.1172%2FJCI75836" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref87"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref87'); return false;" data-citation="" class="refNumLink">87</a></strong><div class="NLM_citation" id="cit87"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zimmermann, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolf, E. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luu, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stathis, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poore, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rojas, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Slusher, B. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsukamoto, T.</span></span> <span> </span><span class="NLM_article-title">Allosteric glutaminase inhibitors based on a 1,4-di(5-amino-1,3,4-thiadiazol-2-yl)butane scaffold</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">520</span>– <span class="NLM_lpage">524</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.6b00060</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.6b00060" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=1%3ACAS%3A528%3ADC%252BC28XktFejsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=520-524&author=S.+C.+Zimmermannauthor=E.+F.+Wolfauthor=A.+Luuauthor=A.+G.+Thomasauthor=M.+Stathisauthor=B.+Pooreauthor=C.+Nguyenauthor=A.+Leauthor=C.+Rojasauthor=B.+S.+Slusherauthor=T.+Tsukamoto&title=Allosteric+glutaminase+inhibitors+based+on+a+1%2C4-di%285-amino-1%2C3%2C4-thiadiazol-2-yl%29butane+scaffold&doi=10.1021%2Facsmedchemlett.6b00060"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit87R"><div class="casContent"><span class="casTitleNuber">87</span><div class="casTitle"><span class="NLM_cas:atitle">Allosteric Glutaminase Inhibitors Based on a 1,4-Di(5-amino-1,3,4-thiadiazol-2-yl)butane Scaffold</span></div><div class="casAuthors">Zimmermann, Sarah C.; Wolf, Emily F.; Luu, Andrew; Thomas, Ajit G.; Stathis, Marigo; Poore, Brad; Nguyen, Christopher; Le, Anne; Rojas, Camilo; Slusher, Barbara S.; Tsukamoto, Takashi</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">520-524</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A series of allosteric kidney-type glutaminase (GLS) inhibitors were designed and synthesized using 1,4-di(5-amino-1,3,4-thiadiazol-2-yl)butane as a core scaffold.  A variety of modified phenylacetyl groups were incorporated into the 5-amino group of the two thiadiazole rings in an attempt to facilitate addnl. binding interactions with the allosteric binding site of GLS.  Among the newly synthesized compds., 4-hydroxy-N-[5-[4-[5-[(2-phenylacetyl)amino]-1,3,4-thiadiazol-2-yl]butyl]-1,3,4-thiadiazol-2-yl]-benzeneacetamide, 2m, potently inhibited GLS with an IC50 value of 70 nM, although it did not exhibit time-dependency as seen with CB-839.  Antiproliferative effects of 2m on human breast cancer lines will be also presented in comparison with those obsd. with CB-839.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpvSab9P2v_OLVg90H21EOLACvtfcHk0ljbpWiMX9yUYA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XktFejsrY%253D&md5=a0e0dc6fcc0f4d343f94f02a50440adf</span></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.6b00060&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.6b00060%26sid%3Dliteratum%253Aachs%26aulast%3DZimmermann%26aufirst%3DS.%2BC.%26aulast%3DWolf%26aufirst%3DE.%2BF.%26aulast%3DLuu%26aufirst%3DA.%26aulast%3DThomas%26aufirst%3DA.%2BG.%26aulast%3DStathis%26aufirst%3DM.%26aulast%3DPoore%26aufirst%3DB.%26aulast%3DNguyen%26aufirst%3DC.%26aulast%3DLe%26aufirst%3DA.%26aulast%3DRojas%26aufirst%3DC.%26aulast%3DSlusher%26aufirst%3DB.%2BS.%26aulast%3DTsukamoto%26aufirst%3DT.%26atitle%3DAllosteric%2520glutaminase%2520inhibitors%2520based%2520on%2520a%25201%252C4-di%25285-amino-1%252C3%252C4-thiadiazol-2-yl%2529butane%2520scaffold%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D7%26spage%3D520%26epage%3D524%26doi%3D10.1021%2Facsmedchemlett.6b00060" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref88"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref88'); return false;" data-citation="" class="refNumLink">88</a></strong><div class="NLM_citation" id="cit88"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lemieux, R. M.</span>; <span class="NLM_string-name">Popovici-Muller, J.</span>; <span class="NLM_string-name">Salituro, F. G.</span>; <span class="NLM_string-name">Saunders, J. O.</span>; <span class="NLM_string-name">Travins, J.</span>; <span class="NLM_string-name">Chen, Y. S.</span></span> <span> </span><span class="NLM_article-title">Compounds and Their Methods of Use</span>. <span class="NLM_patent">US20140142081A1</span>. May 22, <span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=R.+M.+Lemieux&author=J.+Popovici-Muller&author=F.+G.+Salituro&author=J.+O.+Saunders&author=J.+Travins&author=Y.+S.+Chen&title=Compounds+and+Their+Methods+of+Use"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit88&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DLemieux%26aufirst%3DR.%2BM.%26atitle%3DCompounds%2520and%2520Their%2520Methods%2520of%2520Use%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref89"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref89'); return false;" data-citation="" class="refNumLink">89</a></strong><div class="NLM_citation" id="cit89"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bhavar, P. K.</span>; <span class="NLM_string-name">Vakkalanka, S. K. V. S.</span>; <span class="NLM_string-name">Viswanadha, S.</span>; <span class="NLM_string-name">Swaroop, M. G.</span>; <span class="NLM_string-name">Babu, G.</span></span> <span> </span><span class="NLM_article-title">Novel Inhibitors of Glutaminase</span>. <span class="NLM_patent">WO2015101958A2</span>. Jul 09, <span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=P.+K.+Bhavar&author=S.+K.+V.+S.+Vakkalanka&author=S.+Viswanadha&author=M.+G.+Swaroop&author=G.+Babu&title=Novel+Inhibitors+of+Glutaminase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit89&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBhavar%26aufirst%3DP.%2BK.%26atitle%3DNovel%2520Inhibitors%2520of%2520Glutaminase%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref90"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref90'); return false;" data-citation="" class="refNumLink">90</a></strong><div class="NLM_citation" id="cit90"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Finlay, M. R. V.</span>; <span class="NLM_string-name">Ekwuru, C. T.</span>; <span class="NLM_string-name">Charles, M. D.</span>; <span class="NLM_string-name">Raubo, P. A.</span>; <span class="NLM_string-name">Winter, J. J. G.</span>; <span class="NLM_string-name">Nissink, J. W. M.</span></span> <span> </span><span class="NLM_article-title">1,3,4-Thiadiazole Compounds and Their use in Treating Cancer</span>. <span class="NLM_patent">WO2015181539A1</span>. Dec. 03, <span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=M.+R.+V.+Finlay&author=C.+T.+Ekwuru&author=M.+D.+Charles&author=P.+A.+Raubo&author=J.+J.+G.+Winter&author=J.+W.+M.+Nissink&title=1%2C3%2C4-Thiadiazole+Compounds+and+Their+use+in+Treating+Cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit90&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DFinlay%26aufirst%3DM.%2BR.%2BV.%26atitle%3D1%252C3%252C4-Thiadiazole%2520Compounds%2520and%2520Their%2520use%2520in%2520Treating%2520Cancer%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref91"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref91'); return false;" data-citation="" class="refNumLink">91</a></strong><div class="NLM_citation" id="cit91"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mackinnon, A. L.</span>; <span class="NLM_string-name">Rodriguez, M. L.</span></span> <span> </span><span class="NLM_article-title">Treatment of Multiple Myeloma with Heterocyclic Inhibitors of Glutaminase</span>. <span class="NLM_patent">WO2016014890A1</span>. Jan 28, <span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=A.+L.+Mackinnon&author=M.+L.+Rodriguez&title=Treatment+of+Multiple+Myeloma+with+Heterocyclic+Inhibitors+of+Glutaminase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit91&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DMackinnon%26aufirst%3DA.%2BL.%26atitle%3DTreatment%2520of%2520Multiple%2520Myeloma%2520with%2520Heterocyclic%2520Inhibitors%2520of%2520Glutaminase%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref92"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref92'); return false;" data-citation="" class="refNumLink">92</a></strong><div class="NLM_citation" id="cit92"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, Jim.</span>; <span class="NLM_string-name">Chen, L. J.</span>; <span class="NLM_string-name">Goyal, B.</span>; <span class="NLM_string-name">Laidig, G.</span>; <span class="NLM_string-name">Stanton, T. F.</span>; <span class="NLM_string-name">Sjogren, E. B.</span></span> <span> </span><span class="NLM_article-title">Heterocyclic Inhibitors of Glutaminase</span>. <span class="NLM_patent">US8604016B2</span>. Dec 10, <span class="NLM_year">2013</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=Jim.+Li&author=L.+J.+Chen&author=B.+Goyal&author=G.+Laidig&author=T.+F.+Stanton&author=E.+B.+Sjogren&title=Heterocyclic+Inhibitors+of+Glutaminase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit92&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DJim.%26atitle%3DHeterocyclic%2520Inhibitors%2520of%2520Glutaminase%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref93"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref93'); return false;" data-citation="" class="refNumLink">93</a></strong><div class="NLM_citation" id="cit93"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bennett, M. K.</span>; <span class="NLM_string-name">Gross, M.</span>; <span class="NLM_string-name">Bromley, S. D.</span>; <span class="NLM_string-name">Li, J.</span>; <span class="NLM_string-name">Chen, L. J.</span>; <span class="NLM_string-name">Goyal, B.</span>; <span class="NLM_string-name">Laidig, G.</span>; <span class="NLM_string-name">Stanton, T. F.</span>; <span class="NLM_string-name">Sjogren, E. B.</span></span> <span> </span><span class="NLM_article-title">Treatment of Cancer with Heterocyclic Inhibitors of Glutaminase</span>. <span class="NLM_patent">WO2014089048A1</span>. Jun 12, <span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=M.+K.+Bennett&author=M.+Gross&author=S.+D.+Bromley&author=J.+Li&author=L.+J.+Chen&author=B.+Goyal&author=G.+Laidig&author=T.+F.+Stanton&author=E.+B.+Sjogren&title=Treatment+of+Cancer+with+Heterocyclic+Inhibitors+of+Glutaminase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit93&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBennett%26aufirst%3DM.%2BK.%26atitle%3DTreatment%2520of%2520Cancer%2520with%2520Heterocyclic%2520Inhibitors%2520of%2520Glutaminase%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref94"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref94'); return false;" data-citation="" class="refNumLink">94</a></strong><div class="NLM_citation" id="cit94"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Konopleva, M. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flinn, I. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DiNardo, C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bennett, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Molineaux, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maris, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frankfurt, O.</span></span> <span> </span><span class="NLM_article-title">Phase I study: Safety and tolerability of increasing doses of CB-839, an orally administered small molecule inhibitor of glutaminase, in acute leukemia</span>. <i>Haematologica</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>100</i></span>,  <span class="NLM_fpage">378</span>– <span class="NLM_lpage">379</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=100&publication_year=2015&pages=378-379&author=M.+Y.+Konoplevaauthor=I.+W.+Flinnauthor=E.+Wangauthor=C.+D.+DiNardoauthor=M.+Bennettauthor=C.+Molineauxauthor=M.+Leauthor=M.+Marisauthor=O.+Frankfurt&title=Phase+I+study%3A+Safety+and+tolerability+of+increasing+doses+of+CB-839%2C+an+orally+administered+small+molecule+inhibitor+of+glutaminase%2C+in+acute+leukemia"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit94&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKonopleva%26aufirst%3DM.%2BY.%26aulast%3DFlinn%26aufirst%3DI.%2BW.%26aulast%3DWang%26aufirst%3DE.%26aulast%3DDiNardo%26aufirst%3DC.%2BD.%26aulast%3DBennett%26aufirst%3DM.%26aulast%3DMolineaux%26aufirst%3DC.%26aulast%3DLe%26aufirst%3DM.%26aulast%3DMaris%26aufirst%3DM.%26aulast%3DFrankfurt%26aufirst%3DO.%26atitle%3DPhase%2520I%2520study%253A%2520Safety%2520and%2520tolerability%2520of%2520increasing%2520doses%2520of%2520CB-839%252C%2520an%2520orally%2520administered%2520small%2520molecule%2520inhibitor%2520of%2520glutaminase%252C%2520in%2520acute%2520leukemia%26jtitle%3DHaematologica%26date%3D2015%26volume%3D100%26spage%3D378%26epage%3D379" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref95"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref95'); return false;" data-citation="" class="refNumLink">95</a></strong><div class="NLM_citation" id="cit95"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Katt, W. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramachandran, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erickson, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cerione, R. A.</span></span> <span> </span><span class="NLM_article-title">Dibenzophenanthridines as inhibitors of glutaminase C and cancer cell proliferation</span>. <i>Mol. Cancer Ther.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>11</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">1269</span>– <span class="NLM_lpage">1278</span>, <span class="refDoi"> DOI: 10.1158/1535-7163.MCT-11-0942</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=10.1158%2F1535-7163.MCT-11-0942" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=22496480" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=1%3ACAS%3A528%3ADC%252BC38XotlCisLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2012&pages=1269-1278&issue=6&author=W.+P.+Kattauthor=S.+Ramachandranauthor=J.+W.+Ericksonauthor=R.+A.+Cerione&title=Dibenzophenanthridines+as+inhibitors+of+glutaminase+C+and+cancer+cell+proliferation&doi=10.1158%2F1535-7163.MCT-11-0942"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit95R"><div class="casContent"><span class="casTitleNuber">95</span><div class="casTitle"><span class="NLM_cas:atitle">Dibenzophenanthridines as Inhibitors of Glutaminase C and Cancer Cell Proliferation</span></div><div class="casAuthors">Katt, William P.; Ramachandran, Sekar; Erickson, Jon W.; Cerione, Richard A.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1269-1278</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">One hallmark of cancer cells is their adaptation to rely upon an altered metabolic scheme that includes changes in the glycolytic pathway, known as the Warburg effect, and elevated glutamine metab.  Glutaminase, a mitochondrial enzyme, plays a key role in the metab. of glutamine in cancer cells, and its inhibition could significantly impact malignant transformation.  The small mol. 968, a dibenzophenanthridine, was recently shown to inhibit recombinantly expressed glutaminase C, to block the proliferation and anchorage-independent colony formation of human cancer cells in culture, and to inhibit tumor formation in mouse xenograft models.  Here, we examine the structure-activity relationship that leads to 968-based inhibition of glutaminase and cancer cell proliferation, focusing upon a "hot-spot" ring previously identified as crit. to 968 activity.  We find that the hot-spot ring must be substituted with a large, nonplanar functionality (e.g., a t-Bu group) to bestow activity to the series, leading us to a model whereby the mol. binds glutaminase at a previously undescribed allosteric site.  We conduct docking studies to locate potential 968-binding sites and proceed to test a specific set of docking solns. via site-directed mutagenesis.  We verify the results from our initial assay of 968 and its analogs by cellular studies using MDA-MB-231 breast cancer cells.  Mol Cancer Ther; 11(6); 1269-78. ©2012 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr56LeuCKRMMbVg90H21EOLACvtfcHk0ljYfx71Q6LnsQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XotlCisLs%253D&md5=a6e11ed0a50ee567f0013e268e1b36e4</span></div><a href="/servlet/linkout?suffix=cit95&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-11-0942&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-11-0942%26sid%3Dliteratum%253Aachs%26aulast%3DKatt%26aufirst%3DW.%2BP.%26aulast%3DRamachandran%26aufirst%3DS.%26aulast%3DErickson%26aufirst%3DJ.%2BW.%26aulast%3DCerione%26aufirst%3DR.%2BA.%26atitle%3DDibenzophenanthridines%2520as%2520inhibitors%2520of%2520glutaminase%2520C%2520and%2520cancer%2520cell%2520proliferation%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2012%26volume%3D11%26issue%3D6%26spage%3D1269%26epage%3D1278%26doi%3D10.1158%2F1535-7163.MCT-11-0942" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref96"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref96'); return false;" data-citation="" class="refNumLink">96</a></strong><div class="NLM_citation" id="cit96"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stalnecker, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ulrich, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramachandran, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McBrayer, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeBerardinis, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cerione, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erickson, J. W.</span></span> <span> </span><span class="NLM_article-title">Mechanism by which a recently discovered allosteric inhibitor blocks glutamine metabolism in transformed cells</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>112</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">394</span>– <span class="NLM_lpage">399</span>, <span class="refDoi"> DOI: 10.1073/pnas.1414056112</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=10.1073%2Fpnas.1414056112" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=112&publication_year=2015&pages=394-399&issue=2&author=C.+A.+Stalneckerauthor=S.+M.+Ulrichauthor=Y.+Liauthor=S.+Ramachandranauthor=M.+K.+McBrayerauthor=R.+J.+DeBerardinisauthor=R.+A.+Cerioneauthor=J.+W.+Erickson&title=Mechanism+by+which+a+recently+discovered+allosteric+inhibitor+blocks+glutamine+metabolism+in+transformed+cells&doi=10.1073%2Fpnas.1414056112"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit96&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1414056112&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1414056112%26sid%3Dliteratum%253Aachs%26aulast%3DStalnecker%26aufirst%3DC.%2BA.%26aulast%3DUlrich%26aufirst%3DS.%2BM.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DRamachandran%26aufirst%3DS.%26aulast%3DMcBrayer%26aufirst%3DM.%2BK.%26aulast%3DDeBerardinis%26aufirst%3DR.%2BJ.%26aulast%3DCerione%26aufirst%3DR.%2BA.%26aulast%3DErickson%26aufirst%3DJ.%2BW.%26atitle%3DMechanism%2520by%2520which%2520a%2520recently%2520discovered%2520allosteric%2520inhibitor%2520blocks%2520glutamine%2520metabolism%2520in%2520transformed%2520cells%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2015%26volume%3D112%26issue%3D2%26spage%3D394%26epage%3D399%26doi%3D10.1073%2Fpnas.1414056112" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref97"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref97'); return false;" data-citation="" class="refNumLink">97</a></strong><div class="NLM_citation" id="cit97"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gao, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monian, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quadri, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramasamy, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, X. J.</span></span> <span> </span><span class="NLM_article-title">Glutaminolysis and transferrin regulate ferroptosis</span>. <i>Mol. Cell</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>59</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">298</span>– <span class="NLM_lpage">308</span>, <span class="refDoi"> DOI: 10.1016/j.molcel.2015.06.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=10.1016%2Fj.molcel.2015.06.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=26166707" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtFCqtbbK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2015&pages=298-308&issue=2&author=M.+H.+Gaoauthor=P.+Monianauthor=N.+Quadriauthor=R.+Ramasamyauthor=X.+J.+Jiang&title=Glutaminolysis+and+transferrin+regulate+ferroptosis&doi=10.1016%2Fj.molcel.2015.06.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit97R"><div class="casContent"><span class="casTitleNuber">97</span><div class="casTitle"><span class="NLM_cas:atitle">Glutaminolysis and Transferrin Regulate Ferroptosis</span></div><div class="casAuthors">Gao, Minghui; Monian, Prashant; Quadri, Nosirudeen; Ramasamy, Ravichandran; Jiang, Xuejun</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cell</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">298-308</span>CODEN:
                <span class="NLM_cas:coden">MOCEFL</span>;
        ISSN:<span class="NLM_cas:issn">1097-2765</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Ferroptosis has emerged as a new form of regulated necrosis that is implicated in various human diseases.  However, the mechanisms of ferroptosis are not well defined.  This study reports the discovery of multiple mol. components of ferroptosis and its intimate interplay with cellular metab. and redox machinery.  Nutrient starvation often leads to sporadic apoptosis.  Strikingly, we found that upon deprivation of amino acids, a more rapid and potent necrosis process can be induced in a serum-dependent manner, which was subsequently detd. to be ferroptosis.  Two serum factors, the iron-carrier protein transferrin and amino acid glutamine, were identified as the inducers of ferroptosis.  We further found that the cell surface transferrin receptor and the glutamine-fueled intracellular metabolic pathway, glutaminolysis, played crucial roles in the death process.  Inhibition of glutaminolysis, the essential component of ferroptosis, can reduce heart injury triggered by ischemia/reperfusion, suggesting a potential therapeutic approach for treating related diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrJBEfy9dZTELVg90H21EOLACvtfcHk0ljYfx71Q6LnsQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtFCqtbbK&md5=06c80b28b972f851599f995ca3f071e3</span></div><a href="/servlet/linkout?suffix=cit97&amp;dbid=16384&amp;doi=10.1016%2Fj.molcel.2015.06.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molcel.2015.06.011%26sid%3Dliteratum%253Aachs%26aulast%3DGao%26aufirst%3DM.%2BH.%26aulast%3DMonian%26aufirst%3DP.%26aulast%3DQuadri%26aufirst%3DN.%26aulast%3DRamasamy%26aufirst%3DR.%26aulast%3DJiang%26aufirst%3DX.%2BJ.%26atitle%3DGlutaminolysis%2520and%2520transferrin%2520regulate%2520ferroptosis%26jtitle%3DMol.%2520Cell%26date%3D2015%26volume%3D59%26issue%3D2%26spage%3D298%26epage%3D308%26doi%3D10.1016%2Fj.molcel.2015.06.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref98"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref98'); return false;" data-citation="" class="refNumLink">98</a></strong><div class="NLM_citation" id="cit98"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kundu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Viollet, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guan, K. L.</span></span> <span> </span><span class="NLM_article-title">AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1</span>. <i>Nat. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>13</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">132</span>– <span class="NLM_lpage">141</span>, <span class="refDoi"> DOI: 10.1038/ncb2152</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=10.1038%2Fncb2152" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=21258367" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtlamtb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2011&pages=132-141&issue=2&author=J.+Kimauthor=M.+Kunduauthor=B.+Violletauthor=K.+L.+Guan&title=AMPK+and+mTOR+regulate+autophagy+through+direct+phosphorylation+of+Ulk1&doi=10.1038%2Fncb2152"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit98R"><div class="casContent"><span class="casTitleNuber">98</span><div class="casTitle"><span class="NLM_cas:atitle">AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1</span></div><div class="casAuthors">Kim, Joungmok; Kundu, Mondira; Viollet, Benoit; Guan, Kun-Liang</div><div class="citationInfo"><span class="NLM_cas:title">Nature Cell Biology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">132-141</span>CODEN:
                <span class="NLM_cas:coden">NCBIFN</span>;
        ISSN:<span class="NLM_cas:issn">1465-7392</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Autophagy is a process by which components of the cell are degraded to maintain essential activity and viability in response to nutrient limitation.  Extensive genetic studies have shown that the yeast ATG1 kinase has an essential role in autophagy induction.  Furthermore, autophagy is promoted by AMP activated protein kinase (AMPK), which is a key energy sensor and regulates cellular metab. to maintain energy homeostasis.  Conversely, autophagy is inhibited by the mammalian target of rapamycin (mTOR), a central cell-growth regulator that integrates growth factor and nutrient signals.  Here we demonstrate a mol. mechanism for regulation of the mammalian autophagy-initiating kinase Ulk1, a homolog of yeast ATG1.  Under glucose starvation, AMPK promotes autophagy by directly activating Ulk1 through phosphorylation of Ser 317 and Ser 777.  Under nutrient sufficiency, high mTOR activity prevents Ulk1 activation by phosphorylating Ulk1 Ser 757 and disrupting the interaction between Ulk1 and AMPK.  This coordinated phosphorylation is important for Ulk1 in autophagy induction.  This study has revealed a signalling mechanism for Ulk1 regulation and autophagy induction in response to nutrient signalling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpH-jkftukvyrVg90H21EOLACvtfcHk0lg-EBG3zpjocg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtlamtb0%253D&md5=de33381c98f74b2001bea0215b11f594</span></div><a href="/servlet/linkout?suffix=cit98&amp;dbid=16384&amp;doi=10.1038%2Fncb2152&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncb2152%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DJ.%26aulast%3DKundu%26aufirst%3DM.%26aulast%3DViollet%26aufirst%3DB.%26aulast%3DGuan%26aufirst%3DK.%2BL.%26atitle%3DAMPK%2520and%2520mTOR%2520regulate%2520autophagy%2520through%2520direct%2520phosphorylation%2520of%2520Ulk1%26jtitle%3DNat.%2520Cell%2520Biol.%26date%3D2011%26volume%3D13%26issue%3D2%26spage%3D132%26epage%3D141%26doi%3D10.1038%2Fncb2152" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref99"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref99'); return false;" data-citation="" class="refNumLink">99</a></strong><div class="NLM_citation" id="cit99"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Allan, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clarke, P. R.</span></span> <span> </span><span class="NLM_article-title">Apoptosis and autophagy: Regulation of caspase-9 by phosphorylation</span>. <i>FEBS J.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>276</i></span>,  <span class="NLM_fpage">6063</span>– <span class="NLM_lpage">6073</span>, <span class="refDoi"> DOI: 10.1111/j.1742-4658.2009.07330.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=10.1111%2Fj.1742-4658.2009.07330.x" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=276&publication_year=2009&pages=6063-6073&author=L.+A.+Allanauthor=P.+R.+Clarke&title=Apoptosis+and+autophagy%3A+Regulation+of+caspase-9+by+phosphorylation&doi=10.1111%2Fj.1742-4658.2009.07330.x"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit99&amp;dbid=16384&amp;doi=10.1111%2Fj.1742-4658.2009.07330.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1742-4658.2009.07330.x%26sid%3Dliteratum%253Aachs%26aulast%3DAllan%26aufirst%3DL.%2BA.%26aulast%3DClarke%26aufirst%3DP.%2BR.%26atitle%3DApoptosis%2520and%2520autophagy%253A%2520Regulation%2520of%2520caspase-9%2520by%2520phosphorylation%26jtitle%3DFEBS%2520J.%26date%3D2009%26volume%3D276%26spage%3D6063%26epage%3D6073%26doi%3D10.1111%2Fj.1742-4658.2009.07330.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref100"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref100'); return false;" data-citation="" class="refNumLink">100</a></strong><div class="NLM_citation" id="cit100"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kim, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, Y. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, S. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jang, S. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ham, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, B. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeon, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, I. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, K. G.</span></span> <span> </span><span class="NLM_article-title">PPARδ reprograms glutamine metabolism in sorafenib-resistant HCC</span>. <i>Mol. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>15</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">1230</span>– <span class="NLM_lpage">1242</span>, <span class="refDoi"> DOI: 10.1158/1541-7786.MCR-17-0061</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=10.1158%2F1541-7786.MCR-17-0061" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=28584024" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsVCitr3L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2017&pages=1230-1242&issue=9&author=M.+J.+Kimauthor=Y.+K.+Choiauthor=S.+Y.+Parkauthor=S.+Y.+Jangauthor=J.+Y.+Leeauthor=H.+J.+Hamauthor=B.+G.+Kimauthor=H.+J.+Jeonauthor=J.+H.+Kimauthor=J.+G.+Kimauthor=I.+K.+Leeauthor=K.+G.+Park&title=PPAR%CE%B4+reprograms+glutamine+metabolism+in+sorafenib-resistant+HCC&doi=10.1158%2F1541-7786.MCR-17-0061"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit100R"><div class="casContent"><span class="casTitleNuber">100</span><div class="casTitle"><span class="NLM_cas:atitle">PPARδ Reprograms Glutamine Metabolism in Sorafenib-Resistant HCC</span></div><div class="casAuthors">Kim, Mi-Jin; Choi, Yeon-Kyung; Park, Soo Young; Jang, Se Young; Lee, Jung Yi; Ham, Hye Jin; Kim, Byung-Gyu; Jeon, Hui-Jeon; Kim, Ji-Hyun; Kim, Jung-Guk; Lee, In-Kyu; Park, Keun-Gyu</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Research</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1230-1242</span>CODEN:
                <span class="NLM_cas:coden">MCROC5</span>;
        ISSN:<span class="NLM_cas:issn">1541-7786</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">The tyrosine kinase inhibitor sorafenib is the only therapeutic agent approved for the treatment of advanced hepatocellular carcinoma (HCC), but acquired resistance to sorafenib is high.  Here, we report metabolic reprogramming in sorafenib-resistant HCC and identify a regulatory mol., peroxisome proliferator-activated receptor-δ (PPARδ), as a potential therapeutic target.  Sorafenib-resistant HCC cells showed markedly higher glutamine metab. and reductive glutamine carboxylation, which was accompanied by increased glucose-derived pentose phosphate pathway and glutamine-derived lipid biosynthetic pathways and resistance to oxidative stress.  These glutamine-dependent metabolic alterations were attributed to PPARδ, which was upregulated in sorafenib-resistant HCC cells and human HCC tissues.  Furthermore, PPARδ contributed to increased proliferative capacity and redox homeostasis in sorafenib-resistant HCC cells.  Accordingly, inhibiting PPARδ activity reversed compensatory metabolic reprogramming in sorafenib-resistant HCC cells and sensitized them to sorafenib.  Therefore, targeting compensatory metabolic reprogramming of glutamine metab. in sorafenib-resistant HCC by inhibiting PPARδ constitutes a potential therapeutic strategy for overcoming sorafenib-resistance in HCC.  Implications: This study provides novel insight into the mechanism underlying sorafenib resistance and a potential therapeutic strategy targeting PPARδ in advanced hepatocellular carcinoma.  Mol Cancer Res; 15(9); 1230-42. ©2017 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQMERGUuFIyLVg90H21EOLACvtfcHk0lgkaOuUstMVBQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsVCitr3L&md5=cee1545225d001f0e0766f5e84f2afaf</span></div><a href="/servlet/linkout?suffix=cit100&amp;dbid=16384&amp;doi=10.1158%2F1541-7786.MCR-17-0061&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1541-7786.MCR-17-0061%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DM.%2BJ.%26aulast%3DChoi%26aufirst%3DY.%2BK.%26aulast%3DPark%26aufirst%3DS.%2BY.%26aulast%3DJang%26aufirst%3DS.%2BY.%26aulast%3DLee%26aufirst%3DJ.%2BY.%26aulast%3DHam%26aufirst%3DH.%2BJ.%26aulast%3DKim%26aufirst%3DB.%2BG.%26aulast%3DJeon%26aufirst%3DH.%2BJ.%26aulast%3DKim%26aufirst%3DJ.%2BH.%26aulast%3DKim%26aufirst%3DJ.%2BG.%26aulast%3DLee%26aufirst%3DI.%2BK.%26aulast%3DPark%26aufirst%3DK.%2BG.%26atitle%3DPPAR%25CE%25B4%2520reprograms%2520glutamine%2520metabolism%2520in%2520sorafenib-resistant%2520HCC%26jtitle%3DMol.%2520Cancer%2520Res.%26date%3D2017%26volume%3D15%26issue%3D9%26spage%3D1230%26epage%3D1242%26doi%3D10.1158%2F1541-7786.MCR-17-0061" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref101"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref101'); return false;" data-citation="" class="refNumLink">101</a></strong><div class="NLM_citation" id="cit101"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Son, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, S. Y.</span></span> <span> </span><span class="NLM_article-title">Dual targeting of glutaminase 1 and thymidylate synthase elicits death synergistically in NSCLC</span>. <i>Cell Death Dis.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">e2511</span>, <span class="refDoi"> DOI: 10.1038/cddis.2016.404</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=10.1038%2Fcddis.2016.404" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=27929535" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=1%3ACAS%3A528%3ADC%252BC28XitVyrtLfK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=e2511&issue=12&author=J.+S.+Leeauthor=J.+H.+Kangauthor=S.+H.+Leeauthor=D.+Hongauthor=J.+Sonauthor=K.+M.+Hongauthor=J.+Songauthor=S.+Y.+Kim&title=Dual+targeting+of+glutaminase+1+and+thymidylate+synthase+elicits+death+synergistically+in+NSCLC&doi=10.1038%2Fcddis.2016.404"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit101R"><div class="casContent"><span class="casTitleNuber">101</span><div class="casTitle"><span class="NLM_cas:atitle">Dual targeting of glutaminase 1 and thymidylate synthase elicits death synergistically in NSCLC</span></div><div class="casAuthors">Lee, Jae-Seon; Kang, Joon H.; Lee, Seon-Hyeong; Hong, Dongwan; Son, Jaekyoung; Hong, Kyeong M.; Song, Jaewhan; Kim, Soo-Youl</div><div class="citationInfo"><span class="NLM_cas:title">Cell Death & Disease</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">e2511</span>CODEN:
                <span class="NLM_cas:coden">CDDEA4</span>;
        ISSN:<span class="NLM_cas:issn">2041-4889</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Glutaminase 1 (GLS1) expression is increased in non-small cell lung cancer (NSCLC).  GLS1 knockdown using siRNA or inhibition using bis-2-(5-phenylacetamido-1,3,4-thiadiazol-2-yl)ethyl sulfide (BPTES) induced cell cycle arrest with significant redn. of ATP level while levels of reactive oxygen species or glutathione were not affected in NSCLC cell lines.  Recently we found that NSCLC significantly depends on cytosol NADH for ATP prodn.  GLS1 remarkably contributes to ATP prodn. through transferring cytosolic NADH into mitochondria via malate-aspartate shuttle by supply of glutamate in NSCLC.  Regulation of malate-aspartate shuttle by knockdown or inhibition of glutamic-oxaloacetic transaminase 2 or malate dehydrogenase 2 mimicked GLS1 knockdown, which induced cell death with ATP redn. in NSCLC.  Therefore, GLS1 inhibition induced cell cycle arrest with ATP depletion by glutamate redn.  Dual inhibition with BPTES and thymidylate synthase inhibitor, 5-fluorouracil (5-FU), elicits cell death synergistically through cell cycle arrest in NSCLC.  A preclin. xenograft model of NSCLC showed remarkable anti-tumor effect synergistically in the BPTES and 5-FU dual therapy group.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpu_4kCoRTsHbVg90H21EOLACvtfcHk0lgkaOuUstMVBQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XitVyrtLfK&md5=d5db9059ca9a85f81cb209fa60903897</span></div><a href="/servlet/linkout?suffix=cit101&amp;dbid=16384&amp;doi=10.1038%2Fcddis.2016.404&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fcddis.2016.404%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DJ.%2BS.%26aulast%3DKang%26aufirst%3DJ.%2BH.%26aulast%3DLee%26aufirst%3DS.%2BH.%26aulast%3DHong%26aufirst%3DD.%26aulast%3DSon%26aufirst%3DJ.%26aulast%3DHong%26aufirst%3DK.%2BM.%26aulast%3DSong%26aufirst%3DJ.%26aulast%3DKim%26aufirst%3DS.%2BY.%26atitle%3DDual%2520targeting%2520of%2520glutaminase%25201%2520and%2520thymidylate%2520synthase%2520elicits%2520death%2520synergistically%2520in%2520NSCLC%26jtitle%3DCell%2520Death%2520Dis.%26date%3D2016%26volume%3D7%26issue%3D12%26spage%3De2511%26doi%3D10.1038%2Fcddis.2016.404" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref102"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref102'); return false;" data-citation="" class="refNumLink">102</a></strong><div class="NLM_citation" id="cit102"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nagane, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kanai, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shibata, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimizu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshioka, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maruo, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamashita, T.</span></span> <span> </span><span class="NLM_article-title">Sulfasalazine, an inhibitor of the cystine-glutamate antiporter, reduces DNA damage repair and enhances radiosensitivity in murine B16F10 melanoma</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>13</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">e0195151</span>, <span class="refDoi"> DOI: 10.1371/journal.pone.0195151</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=10.1371%2Fjournal.pone.0195151" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=29649284" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhsl2gt73N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2018&pages=e0195151&issue=4&author=M.+Naganeauthor=E.+Kanaiauthor=Y.+Shibataauthor=T.+Shimizuauthor=C.+Yoshiokaauthor=T.+Maruoauthor=T.+Yamashita&title=Sulfasalazine%2C+an+inhibitor+of+the+cystine-glutamate+antiporter%2C+reduces+DNA+damage+repair+and+enhances+radiosensitivity+in+murine+B16F10+melanoma&doi=10.1371%2Fjournal.pone.0195151"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit102R"><div class="casContent"><span class="casTitleNuber">102</span><div class="casTitle"><span class="NLM_cas:atitle">Sulfasalazine, an inhibitor of the cystineglutamate antiporter, reduces DNA damage repair and enhances radiosensitivity in murine B16F10 melanoma</span></div><div class="casAuthors">Nagane, Masaki; Kanai, Eiichi; Shibata, Yuki; Shimizu, Takuto; Yoshioka, Chie; Maruo, Takuya; Yamashita, Tadashi</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">e0195151/1-e0195151/19</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">The sodium-independent cystine-glutamate antiporter plays an important role in extracellular cystine uptake.  It comprises the transmembrane protein, xCT and its chaperone, CD98.  Because glutathione is only weakly cell membrane permeable, cellular uptake of its precursor, cystine, is known to be a key step in glutathione synthesis.  Moreover, it has been reported that xCT expression affects the progression of tumors and their resistance to therapy.  Sulfasalazine is an inhibitor of xCT that is known to increase cellular oxidative stress, giving it anti-tumor potential.  Here, we describe a radio-sensitizing effect of sulfasalazine using a B16F10 melanoma model.  Sulfasalazine decreased glutathione concns. and resistance to H2O2 in B16F10 melanoma cells, but not in mouse embryonic fibroblasts.  It synergistically enhanced the cyto-killing effect of X-irradn. in B16F10 cells.  It inhibited cellular DNA damage repair and prolonged cell cycle arrest after X-irradn.  Furthermore, in an in vivo transplanted melanoma model, sulfasalazine decreased intratumoral glutathione content, leading to enhanced susceptibility to radiation therapy.  These results suggest the possibility of using SAS to augment the treatment of radio-resistant cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrIy6B6Ebt5RrVg90H21EOLACvtfcHk0lgkaOuUstMVBQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhsl2gt73N&md5=417dbfc1124179d9f9f5c7c9cc99d440</span></div><a href="/servlet/linkout?suffix=cit102&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0195151&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0195151%26sid%3Dliteratum%253Aachs%26aulast%3DNagane%26aufirst%3DM.%26aulast%3DKanai%26aufirst%3DE.%26aulast%3DShibata%26aufirst%3DY.%26aulast%3DShimizu%26aufirst%3DT.%26aulast%3DYoshioka%26aufirst%3DC.%26aulast%3DMaruo%26aufirst%3DT.%26aulast%3DYamashita%26aufirst%3DT.%26atitle%3DSulfasalazine%252C%2520an%2520inhibitor%2520of%2520the%2520cystine-glutamate%2520antiporter%252C%2520reduces%2520DNA%2520damage%2520repair%2520and%2520enhances%2520radiosensitivity%2520in%2520murine%2520B16F10%2520melanoma%26jtitle%3DPLoS%2520One%26date%3D2018%26volume%3D13%26issue%3D4%26spage%3De0195151%26doi%3D10.1371%2Fjournal.pone.0195151" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref103"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref103'); return false;" data-citation="" class="refNumLink">103</a></strong><div class="NLM_citation" id="cit103"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schulte, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khodadadi, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cuthbertson, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manning, H. C.</span></span> <span> </span><span class="NLM_article-title">2-Amino-4-bis(aryloxybenzyl)aminobutanoic acids: a novel Scaffold for inhibition of ASCT2-mediated glutamine transport</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">1044</span>– <span class="NLM_lpage">1047</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2015.12.031</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=10.1016%2Fj.bmcl.2015.12.031" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2016&pages=1044-1047&author=M.+L.+Schulteauthor=A.+B.+Khodadadiauthor=M.+L.+Cuthbertsonauthor=J.+A.+Smithauthor=H.+C.+Manning&title=2-Amino-4-bis%28aryloxybenzyl%29aminobutanoic+acids%3A+a+novel+Scaffold+for+inhibition+of+ASCT2-mediated+glutamine+transport&doi=10.1016%2Fj.bmcl.2015.12.031"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit103&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2015.12.031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2015.12.031%26sid%3Dliteratum%253Aachs%26aulast%3DSchulte%26aufirst%3DM.%2BL.%26aulast%3DKhodadadi%26aufirst%3DA.%2BB.%26aulast%3DCuthbertson%26aufirst%3DM.%2BL.%26aulast%3DSmith%26aufirst%3DJ.%2BA.%26aulast%3DManning%26aufirst%3DH.%2BC.%26atitle%3D2-Amino-4-bis%2528aryloxybenzyl%2529aminobutanoic%2520acids%253A%2520a%2520novel%2520Scaffold%2520for%2520inhibition%2520of%2520ASCT2-mediated%2520glutamine%2520transport%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D26%26spage%3D1044%26epage%3D1047%26doi%3D10.1016%2Fj.bmcl.2015.12.031" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref104"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref104'); return false;" data-citation="" class="refNumLink">104</a></strong><div class="NLM_citation" id="cit104"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schulte, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fu, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geng, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, S. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kondo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coffey, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, M. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rathmell, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharick, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skala, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berlin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Washington, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nickels, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manning, H. C.</span></span> <span> </span><span class="NLM_article-title">Pharmacological blockade of ASCT2-dependent glutamine transport leads to antitumor efficacy in preclinical models</span>. <i>Nat. Med.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>24</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">194</span>– <span class="NLM_lpage">202</span>, <span class="refDoi"> DOI: 10.1038/nm.4464</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=10.1038%2Fnm.4464" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=29334372" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=1%3ACAS%3A528%3ADC%252BC1cXovVChsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2018&pages=194-202&issue=2&author=M.+L.+Schulteauthor=A.+Fuauthor=P.+Zhaoauthor=J.+Liauthor=L.+Gengauthor=S.+T.+Smithauthor=J.+Kondoauthor=R.+J.+Coffeyauthor=M.+O.+Johnsonauthor=J.+C.+Rathmellauthor=J.+T.+Sharickauthor=M.+C.+Skalaauthor=J.+A.+Smithauthor=J.+Berlinauthor=M.+K.+Washingtonauthor=M.+L.+Nickelsauthor=H.+C.+Manning&title=Pharmacological+blockade+of+ASCT2-dependent+glutamine+transport+leads+to+antitumor+efficacy+in+preclinical+models&doi=10.1038%2Fnm.4464"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit104R"><div class="casContent"><span class="casTitleNuber">104</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological blockade of ASCT2-dependent glutamine transport leads to antitumor efficacy in preclinical models</span></div><div class="casAuthors">Schulte, Michael L.; Fu, Allie; Zhao, Ping; Li, Jun; Geng, Ling; Smith, Shannon T.; Kondo, Jumpei; Coffey, Robert J.; Johnson, Marc O.; Rathmell, Jeffrey C.; Sharick, Joe T.; Skala, Melissa C.; Smith, Jarrod A.; Berlin, Jordan; Washington, M. Kay; Nickels, Michael L.; Manning, H. Charles</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">194-202</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">The unique metabolic demands of cancer cells underscore potentially fruitful opportunities for drug discovery in the era of precision medicine.  However, therapeutic targeting of cancer metab. has led to surprisingly few new drugs to date.  The neutral amino acid glutamine serves as a key intermediate in numerous metabolic processes leveraged by cancer cells, including biosynthesis, cell signaling, and oxidative protection.  Herein we report the preclin. development of V-9302, a competitive small mol. antagonist of transmembrane glutamine flux that selectively and potently targets the amino acid transporter ASCT2.  Pharmacol. blockade of ASCT2 with V-9302 resulted in attenuated cancer cell growth and proliferation, increased cell death, and increased oxidative stress, which collectively contributed to antitumor responses in vitro and in vivo.  This is the first study, to our knowledge, to demonstrate the utility of a pharmacol. inhibitor of glutamine transport in oncol., representing a new class of targeted therapy and laying a framework for paradigm-shifting therapies targeting cancer cell metab.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGowW77OHf2DsrVg90H21EOLACvtfcHk0ljGlsM5xmTK9Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXovVChsA%253D%253D&md5=e9e185d26bc8dc4938114c3cdd7e2c40</span></div><a href="/servlet/linkout?suffix=cit104&amp;dbid=16384&amp;doi=10.1038%2Fnm.4464&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm.4464%26sid%3Dliteratum%253Aachs%26aulast%3DSchulte%26aufirst%3DM.%2BL.%26aulast%3DFu%26aufirst%3DA.%26aulast%3DZhao%26aufirst%3DP.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DGeng%26aufirst%3DL.%26aulast%3DSmith%26aufirst%3DS.%2BT.%26aulast%3DKondo%26aufirst%3DJ.%26aulast%3DCoffey%26aufirst%3DR.%2BJ.%26aulast%3DJohnson%26aufirst%3DM.%2BO.%26aulast%3DRathmell%26aufirst%3DJ.%2BC.%26aulast%3DSharick%26aufirst%3DJ.%2BT.%26aulast%3DSkala%26aufirst%3DM.%2BC.%26aulast%3DSmith%26aufirst%3DJ.%2BA.%26aulast%3DBerlin%26aufirst%3DJ.%26aulast%3DWashington%26aufirst%3DM.%2BK.%26aulast%3DNickels%26aufirst%3DM.%2BL.%26aulast%3DManning%26aufirst%3DH.%2BC.%26atitle%3DPharmacological%2520blockade%2520of%2520ASCT2-dependent%2520glutamine%2520transport%2520leads%2520to%2520antitumor%2520efficacy%2520in%2520preclinical%2520models%26jtitle%3DNat.%2520Med.%26date%3D2018%26volume%3D24%26issue%3D2%26spage%3D194%26epage%3D202%26doi%3D10.1038%2Fnm.4464" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref105"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref105'); return false;" data-citation="" class="refNumLink">105</a></strong><div class="NLM_citation" id="cit105"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stalnecker, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erickson, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cerione, R. A.</span></span> <span> </span><span class="NLM_article-title">Conformational changes in the activation loop of mitochondrial glutaminase C: A direct fluorescence readout that distinguishes the binding of allosteric inhibitors from activators</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>292</i></span> (<span class="NLM_issue">15</span>),  <span class="NLM_fpage">6095</span>– <span class="NLM_lpage">6107</span>, <span class="refDoi"> DOI: 10.1074/jbc.M116.758219</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=10.1074%2Fjbc.M116.758219" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=292&publication_year=2017&pages=6095-6107&issue=15&author=C.+A.+Stalneckerauthor=J.+W.+Ericksonauthor=R.+A.+Cerione&title=Conformational+changes+in+the+activation+loop+of+mitochondrial+glutaminase+C%3A+A+direct+fluorescence+readout+that+distinguishes+the+binding+of+allosteric+inhibitors+from+activators&doi=10.1074%2Fjbc.M116.758219"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit105&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M116.758219&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M116.758219%26sid%3Dliteratum%253Aachs%26aulast%3DStalnecker%26aufirst%3DC.%2BA.%26aulast%3DErickson%26aufirst%3DJ.%2BW.%26aulast%3DCerione%26aufirst%3DR.%2BA.%26atitle%3DConformational%2520changes%2520in%2520the%2520activation%2520loop%2520of%2520mitochondrial%2520glutaminase%2520C%253A%2520A%2520direct%2520fluorescence%2520readout%2520that%2520distinguishes%2520the%2520binding%2520of%2520allosteric%2520inhibitors%2520from%2520activators%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2017%26volume%3D292%26issue%3D15%26spage%3D6095%26epage%3D6107%26doi%3D10.1074%2Fjbc.M116.758219" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref106"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref106'); return false;" data-citation="" class="refNumLink">106</a></strong><div class="NLM_citation" id="cit106"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Z. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">You, Q. D.</span></span> <span> </span><span class="NLM_article-title">Discovery and development of Kelch-like ECH-Associated Protein 1. Nuclear factor erythroid 2-related factor 2 (KEAP1:NRF2) protein-protein interaction inhibitors: achievements, challenges, and future directions</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span> (<span class="NLM_issue">24</span>),  <span class="NLM_fpage">10837</span>– <span class="NLM_lpage">10858</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00586</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00586" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=1%3ACAS%3A528%3ADC%252BC28Xhs1Smtb%252FO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=10837-10858&issue=24&author=Z.+Y.+Jiangauthor=M.+C.+Luauthor=Q.+D.+You&title=Discovery+and+development+of+Kelch-like+ECH-Associated+Protein+1.+Nuclear+factor+erythroid+2-related+factor+2+%28KEAP1%3ANRF2%29+protein-protein+interaction+inhibitors%3A+achievements%2C+challenges%2C+and+future+directions&doi=10.1021%2Facs.jmedchem.6b00586"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit106R"><div class="casContent"><span class="casTitleNuber">106</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and Development of Kelch-like ECH-Associated Protein 1. Nuclear Factor Erythroid 2-Related Factor 2 (KEAP1:NRF2) Protein-Protein Interaction Inhibitors: Achievements, Challenges, and Future Directions</span></div><div class="casAuthors">Jiang, Zheng-Yu; Lu, Meng-Chen; You, Qi-Dong</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">10837-10858</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The transcription factor Nrf2 is the primary regulator of the cellular defense system, and enhancing Nrf2 activity has potential usages in various diseases, esp. chronic age-related and inflammatory diseases.  Recently, directly targeting Keap1-Nrf2 protein-protein interaction (PPI) has been an emerging strategy to selectively and effectively activate Nrf2.  This Perspective summarizes the progress in the discovery and development of Keap1-Nrf2 PPI inhibitors, including the Keap1-Nrf2 regulatory mechanisms, biochem. techniques for inhibitor identification, and approaches for identifying peptide and small-mol. inhibitors, as well as discusses privileged structures and future directions for further development of Keap1-Nrf2 PPI inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqCuMv4k9xi9LVg90H21EOLACvtfcHk0lhlZdduqHS4BQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xhs1Smtb%252FO&md5=487aa677ae8a86d71e2b15561656b0b7</span></div><a href="/servlet/linkout?suffix=cit106&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00586&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00586%26sid%3Dliteratum%253Aachs%26aulast%3DJiang%26aufirst%3DZ.%2BY.%26aulast%3DLu%26aufirst%3DM.%2BC.%26aulast%3DYou%26aufirst%3DQ.%2BD.%26atitle%3DDiscovery%2520and%2520development%2520of%2520Kelch-like%2520ECH-Associated%2520Protein%25201.%2520Nuclear%2520factor%2520erythroid%25202-related%2520factor%25202%2520%2528KEAP1%253ANRF2%2529%2520protein-protein%2520interaction%2520inhibitors%253A%2520achievements%252C%2520challenges%252C%2520and%2520future%2520directions%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26issue%3D24%26spage%3D10837%26epage%3D10858%26doi%3D10.1021%2Facs.jmedchem.6b00586" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref107"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref107'); return false;" data-citation="" class="refNumLink">107</a></strong><div class="NLM_citation" id="cit107"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fang, J. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruan, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hou, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, W. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruan, B. H.</span></span> <span> </span><span class="NLM_article-title">Biomolecular interaction assays identified dual inhibitors of glutaminase and glutamate dehydrogenase that disrupt mitochondrial function and prevent growth of cancer cells</span>. <i>Anal. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>89</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">1689</span>– <span class="NLM_lpage">1696</span>, <span class="refDoi"> DOI: 10.1021/acs.analchem.6b03849</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.analchem.6b03849" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=89&publication_year=2017&pages=1689-1696&issue=3&author=M.+Zhuauthor=J.+Z.+Fangauthor=J.+J.+Zhangauthor=Z.+Zhangauthor=J.+H.+Xieauthor=Y.+Yuauthor=J.+J.+Ruanauthor=Z.+Chenauthor=W.+Houauthor=G.+S.+Yangauthor=W.+K.+Suauthor=B.+H.+Ruan&title=Biomolecular+interaction+assays+identified+dual+inhibitors+of+glutaminase+and+glutamate+dehydrogenase+that+disrupt+mitochondrial+function+and+prevent+growth+of+cancer+cells&doi=10.1021%2Facs.analchem.6b03849"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit107&amp;dbid=16384&amp;doi=10.1021%2Facs.analchem.6b03849&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.analchem.6b03849%26sid%3Dliteratum%253Aachs%26aulast%3DZhu%26aufirst%3DM.%26aulast%3DFang%26aufirst%3DJ.%2BZ.%26aulast%3DZhang%26aufirst%3DJ.%2BJ.%26aulast%3DZhang%26aufirst%3DZ.%26aulast%3DXie%26aufirst%3DJ.%2BH.%26aulast%3DYu%26aufirst%3DY.%26aulast%3DRuan%26aufirst%3DJ.%2BJ.%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DHou%26aufirst%3DW.%26aulast%3DYang%26aufirst%3DG.%2BS.%26aulast%3DSu%26aufirst%3DW.%2BK.%26aulast%3DRuan%26aufirst%3DB.%2BH.%26atitle%3DBiomolecular%2520interaction%2520assays%2520identified%2520dual%2520inhibitors%2520of%2520glutaminase%2520and%2520glutamate%2520dehydrogenase%2520that%2520disrupt%2520mitochondrial%2520function%2520and%2520prevent%2520growth%2520of%2520cancer%2520cells%26jtitle%3DAnal.%2520Chem.%26date%3D2017%26volume%3D89%26issue%3D3%26spage%3D1689%26epage%3D1696%26doi%3D10.1021%2Facs.analchem.6b03849" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref108"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref108'); return false;" data-citation="" class="refNumLink">108</a></strong><div class="NLM_citation" id="cit108"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Khavrutskii, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yeh, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Timofeeva, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tarasov, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pritt, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stefanisko, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tarasova, N.</span></span> <span> </span><span class="NLM_article-title">Protein purification-free method of binding affinity determination by microscale thermophoresis</span>. <i>J. Visualized Exp.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>, (<span class="NLM_issue">78</span>),  <span class="NLM_fpage">e50541</span>, <span class="refDoi"> DOI: 10.3791/50541</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=10.3791%2F50541" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsFeisLbJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&pages=e50541&issue=78&author=L.+Khavrutskiiauthor=J.+Yehauthor=O.+Timofeevaauthor=S.+G.+Tarasovauthor=S.+Prittauthor=K.+Stefaniskoauthor=N.+Tarasova&title=Protein+purification-free+method+of+binding+affinity+determination+by+microscale+thermophoresis&doi=10.3791%2F50541"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit108R"><div class="casContent"><span class="casTitleNuber">108</span><div class="casTitle"><span class="NLM_cas:atitle">Protein purification-free method of binding affinity determination by microscale thermophoresis</span></div><div class="casAuthors">Khavrutskii, Lyuba; Yeh, Joanna; Timofeeva, Olga; Tarasov, Sergey G.; Pritt, Samuel; Stefanisko, Karen; Tarasova, Nadya</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Visualized Experiments</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume"></span>
        (<span class="NLM_cas:issue">78</span>),
    <span class="NLM_cas:pages">e50541, 6 pp.</span>CODEN:
                <span class="NLM_cas:coden">JVEOA4</span>;
        ISSN:<span class="NLM_cas:issn">1940-087X</span>.
    
            (<span class="NLM_cas:orgname">Journal of Visualized Experiments</span>)
        </div><div class="casAbstract">Quant. characterization of protein interactions is essential in practically any field of life sciences, particularly drug discovery.  Most of currently available methods of KD detn. require access to purified protein of interest, generation of which can be time-consuming and expensive.  We have developed a protocol that allows for detn. of binding affinity by microscale thermophoresis (MST) without purifn. of the target protein from cell lysates.  The method involves overexpression of the GFP-fused protein and cell lysis in non-denaturing conditions.  Application of the method to STAT3-GFP transiently expressed in HEK293 cells allowed to det. for the first time the affinity of the well-studied transcription factor to oligonucleotides with different sequences.  The protocol is straightforward and can have a variety of application for studying interactions of proteins with small mols., peptides, DNA, RNA, and proteins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpH1wuiBSicNbVg90H21EOLACvtfcHk0lhM7IioRLqy9w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsFeisLbJ&md5=3eff1753137b8ae2aaa610dc41e31f66</span></div><a href="/servlet/linkout?suffix=cit108&amp;dbid=16384&amp;doi=10.3791%2F50541&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3791%252F50541%26sid%3Dliteratum%253Aachs%26aulast%3DKhavrutskii%26aufirst%3DL.%26aulast%3DYeh%26aufirst%3DJ.%26aulast%3DTimofeeva%26aufirst%3DO.%26aulast%3DTarasov%26aufirst%3DS.%2BG.%26aulast%3DPritt%26aufirst%3DS.%26aulast%3DStefanisko%26aufirst%3DK.%26aulast%3DTarasova%26aufirst%3DN.%26atitle%3DProtein%2520purification-free%2520method%2520of%2520binding%2520affinity%2520determination%2520by%2520microscale%2520thermophoresis%26jtitle%3DJ.%2520Visualized%2520Exp.%26date%3D2013%26issue%3D78%26spage%3De50541%26doi%3D10.3791%2F50541" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref109"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref109'); return false;" data-citation="" class="refNumLink">109</a></strong><div class="NLM_citation" id="cit109"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Veber, D. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, H.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, B. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ward, K. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kopple, K. D.</span></span> <span> </span><span class="NLM_article-title">Molecular properties that influence the oral bioavailability of drug candidates</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>45</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">2615</span>– <span class="NLM_lpage">2623</span>, <span class="refDoi"> DOI: 10.1021/jm020017n</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm020017n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=1%3ACAS%3A528%3ADC%252BD38XjsFCmt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2002&pages=2615-2623&issue=12&author=D.+F.+Veberauthor=S.+R.+Johnsonauthor=H.-Y.+Chengauthor=B.+R.+Smithauthor=K.+W.+Wardauthor=K.+D.+Kopple&title=Molecular+properties+that+influence+the+oral+bioavailability+of+drug+candidates&doi=10.1021%2Fjm020017n"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit109R"><div class="casContent"><span class="casTitleNuber">109</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular Properties That Influence the Oral Bioavailability of Drug Candidates</span></div><div class="casAuthors">Veber, Daniel F.; Johnson, Stephen R.; Cheng, Hung-Yuan; Smith, Brian R.; Ward, Keith W.; Kopple, Kenneth D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2615-2623</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Oral bioavailability measurements in rats for over 1100 drug candidates studied at Smith-Kline Beecham Pharmaceuticals (now Glaxo Smith-Kline) have allowed us to analyze the relative importance of mol. properties considered to influence that drug property.  Reduced mol. flexibility, as measured by the no. of rotatable bonds, and low polar surface area or total hydrogen bond count (sum of donors and acceptors) are found to be important predictors of good oral bioavailability, independent of mol. wt.  That on av. both the no. of rotatable bonds and polar surface area or hydrogen bond count tend to increase with mol. wt. may in part explain the success of the mol. wt. parameter in predicting oral bioavailability.  The commonly applied mol. wt. cutoff at 500 does not itself significantly sep. compds. with poor oral bioavailability from those with acceptable values in this extensive data set.  Our observations suggest that compds. which meet only the 2 criteria of (1) 10 or fewer rotatable bonds and (2) polar surface area ≤140 Å2 (or 12 or fewer H-bond donors and acceptors) will have a high probability of good oral bioavailability in the rat.  Data sets for the artificial membrane permeation rate and for clearance in the rat were also examd.  Reduced polar surface area correlates better with increased permeation rate than does lipophilicity (C log P), and increased rotatable bond count has a neg. effect on the permeation rate.  A threshold permeation rate is a prerequisite of oral bioavailability.  The rotatable bond count does not correlate with the data examd. here for the in vivo clearance rate in the rat.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3JtJEkO7yVLVg90H21EOLACvtfcHk0lhM7IioRLqy9w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XjsFCmt7g%253D&md5=eaad26ed6a259de82ad65a8834fc397d</span></div><a href="/servlet/linkout?suffix=cit109&amp;dbid=16384&amp;doi=10.1021%2Fjm020017n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm020017n%26sid%3Dliteratum%253Aachs%26aulast%3DVeber%26aufirst%3DD.%2BF.%26aulast%3DJohnson%26aufirst%3DS.%2BR.%26aulast%3DCheng%26aufirst%3DH.-Y.%26aulast%3DSmith%26aufirst%3DB.%2BR.%26aulast%3DWard%26aufirst%3DK.%2BW.%26aulast%3DKopple%26aufirst%3DK.%2BD.%26atitle%3DMolecular%2520properties%2520that%2520influence%2520the%2520oral%2520bioavailability%2520of%2520drug%2520candidates%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2002%26volume%3D45%26issue%3D12%26spage%3D2615%26epage%3D2623%26doi%3D10.1021%2Fjm020017n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref110"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref110'); return false;" data-citation="" class="refNumLink">110</a></strong><div class="NLM_citation" id="cit110"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hopkins, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Groom, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alex, A.</span></span> <span> </span><span class="NLM_article-title">Ligand efficiency: a useful metric for lead selection</span>. <i>Drug Discovery Today</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>9</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">430</span>– <span class="NLM_lpage">431</span>, <span class="refDoi"> DOI: 10.1016/S1359-6446(04)03069-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=10.1016%2FS1359-6446%2804%2903069-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=15109945" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=1%3ACAS%3A280%3ADC%252BD2c3ht1ygtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2004&pages=430-431&issue=10&author=A.+L.+Hopkinsauthor=C.+R.+Groomauthor=A.+Alex&title=Ligand+efficiency%3A+a+useful+metric+for+lead+selection&doi=10.1016%2FS1359-6446%2804%2903069-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit110R"><div class="casContent"><span class="casTitleNuber">110</span><div class="casTitle"><span class="NLM_cas:atitle">Ligand efficiency: a useful metric for lead selection</span></div><div class="casAuthors">Hopkins Andrew L; Groom Colin R; Alex Alexander</div><div class="citationInfo"><span class="NLM_cas:title">Drug discovery today</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">430-1</span>
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSdMyKW_d6RPeIHSmpohpd0fW6udTcc2eaqi-3v0cyza7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2c3ht1ygtw%253D%253D&md5=eb19a1bca53247d0bd9adcb99d5817e6</span></div><a href="/servlet/linkout?suffix=cit110&amp;dbid=16384&amp;doi=10.1016%2FS1359-6446%2804%2903069-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1359-6446%252804%252903069-7%26sid%3Dliteratum%253Aachs%26aulast%3DHopkins%26aufirst%3DA.%2BL.%26aulast%3DGroom%26aufirst%3DC.%2BR.%26aulast%3DAlex%26aufirst%3DA.%26atitle%3DLigand%2520efficiency%253A%2520a%2520useful%2520metric%2520for%2520lead%2520selection%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2004%26volume%3D9%26issue%3D10%26spage%3D430%26epage%3D431%26doi%3D10.1016%2FS1359-6446%2804%2903069-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref111"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref111'); return false;" data-citation="" class="refNumLink">111</a></strong><div class="NLM_citation" id="cit111"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Leeson, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Springthorpe, B.</span></span> <span> </span><span class="NLM_article-title">The influence of drug-like concepts on decision-making in medicinal chemistry</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">881</span>– <span class="NLM_lpage">890</span>, <span class="refDoi"> DOI: 10.1038/nrd2445</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=10.1038%2Fnrd2445" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=17971784" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht1els7rL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2007&pages=881-890&author=P.+D.+Leesonauthor=B.+Springthorpe&title=The+influence+of+drug-like+concepts+on+decision-making+in+medicinal+chemistry&doi=10.1038%2Fnrd2445"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit111R"><div class="casContent"><span class="casTitleNuber">111</span><div class="casTitle"><span class="NLM_cas:atitle">The influence of drug-like concepts on decision-making in medicinal chemistry</span></div><div class="casAuthors">Leeson, Paul D.; Springthorpe, Brian</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">881-890</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Despite the wide acceptance of drug-like principles such as the 'rule of five', this anal. of mols. currently being synthesized in leading pharmaceutical companies reveals that their phys. properties differ significantly from those of recently discovered oral drugs.  The marked increase in lipophilicity in particular could increase the likelihood of attrition in drug development.  The application of guidelines linked to the concept of drug-likeness, such as the 'rule of five', has gained wide acceptance as an approach to reduce attrition in drug discovery and development.  However, despite this acceptance, anal. of recent trends reveals that the phys. properties of mols. that are currently being synthesized in leading drug discovery companies differ significantly from those of recently discovered oral drugs and compds. in clin. development.  The consequences of the marked increase in lipophilicity - the most important drug-like phys. property - include a greater likelihood of lack of selectivity and attrition in drug development.  Tackling the threat of compd.-related toxicol. attrition needs to move to the mainstream of medicinal chem. decision-making.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoTUeonLD6iebVg90H21EOLACvtfcHk0ljbjH0tUQYo_A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht1els7rL&md5=5665a9e2dc266a1ee096e20625757ef7</span></div><a href="/servlet/linkout?suffix=cit111&amp;dbid=16384&amp;doi=10.1038%2Fnrd2445&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd2445%26sid%3Dliteratum%253Aachs%26aulast%3DLeeson%26aufirst%3DP.%2BD.%26aulast%3DSpringthorpe%26aufirst%3DB.%26atitle%3DThe%2520influence%2520of%2520drug-like%2520concepts%2520on%2520decision-making%2520in%2520medicinal%2520chemistry%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2007%26volume%3D6%26spage%3D881%26epage%3D890%26doi%3D10.1038%2Fnrd2445" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref112"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref112'); return false;" data-citation="" class="refNumLink">112</a></strong><div class="NLM_citation" id="cit112"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nicklin, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bergman, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Triantafellow, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nyfeler, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hild, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kung, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Myer, V. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mackeigan, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Porter, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cantley, L. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Finan, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murphy, L. O.</span></span> <span> </span><span class="NLM_article-title">Bidirectional transport of amino acids regulates mTOR and autophagy</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>136</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">521</span>– <span class="NLM_lpage">534</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2008.11.044</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=10.1016%2Fj.cell.2008.11.044" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=19203585" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=1%3ACAS%3A528%3ADC%252BD1MXltFSnsrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=136&publication_year=2009&pages=521-534&issue=3&author=P.+Nicklinauthor=P.+Bergmanauthor=B.+Zhangauthor=E.+Triantafellowauthor=H.+Wangauthor=B.+Nyfelerauthor=H.+Yangauthor=M.+Hildauthor=C.+Kungauthor=C.+Wilsonauthor=V.+E.+Myerauthor=J.+P.+Mackeiganauthor=J.+A.+Porterauthor=Y.+K.+Wangauthor=L.+C.+Cantleyauthor=P.+M.+Finanauthor=L.+O.+Murphy&title=Bidirectional+transport+of+amino+acids+regulates+mTOR+and+autophagy&doi=10.1016%2Fj.cell.2008.11.044"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit112R"><div class="casContent"><span class="casTitleNuber">112</span><div class="casTitle"><span class="NLM_cas:atitle">Bidirectional transport of amino acids regulates mTOR and autophagy</span></div><div class="casAuthors">Nicklin, Paul; Bergman, Philip; Zhang, Bailin; Triantafellow, Ellen; Wang, Henry; Nyfeler, Beat; Yang, Haidi; Hild, Marc; Kung, Charles; Wilson, Christopher; Myer, Vic E.; MacKeigan, Jeffrey P.; Porter, Jeffrey A.; Karen Wang, Y.; Cantley, Lewis C.; Finan, Peter M.; Murphy, Leon O.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">136</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">521-534</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Amino acids are required for activation of the mammalian target of rapamycin (mTOR) kinase which regulates protein translation, cell growth, and autophagy.  Cell surface transporters that allow amino acids to enter the cell and signal to mTOR are unknown.  We show that cellular uptake of L-glutamine and its subsequent rapid efflux in the presence of essential amino acids (EAA) is the rate-limiting step that activates mTOR.  L-Glutamine uptake is regulated by SLC1A5 and loss of SLC1A5 function inhibits cell growth and activates autophagy.  The mol. basis for L-glutamine sensitivity is due to SLC7A5/SLC3A2, a bidirectional transporter that regulates the simultaneous efflux of L-glutamine out of cells and transport of L-leucine/EAA into cells.  Certain tumor cell lines with high basal cellular levels of L-glutamine bypass the need for L-glutamine uptake and are primed for mTOR activation.  Thus, L-glutamine flux regulates mTOR, translation and autophagy to coordinate cell growth and proliferation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGou-WsQFP-BcbVg90H21EOLACvtfcHk0ljbjH0tUQYo_A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXltFSnsrc%253D&md5=bc244efe138359f3090f6fcebe2134cd</span></div><a href="/servlet/linkout?suffix=cit112&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2008.11.044&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2008.11.044%26sid%3Dliteratum%253Aachs%26aulast%3DNicklin%26aufirst%3DP.%26aulast%3DBergman%26aufirst%3DP.%26aulast%3DZhang%26aufirst%3DB.%26aulast%3DTriantafellow%26aufirst%3DE.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DNyfeler%26aufirst%3DB.%26aulast%3DYang%26aufirst%3DH.%26aulast%3DHild%26aufirst%3DM.%26aulast%3DKung%26aufirst%3DC.%26aulast%3DWilson%26aufirst%3DC.%26aulast%3DMyer%26aufirst%3DV.%2BE.%26aulast%3DMackeigan%26aufirst%3DJ.%2BP.%26aulast%3DPorter%26aufirst%3DJ.%2BA.%26aulast%3DWang%26aufirst%3DY.%2BK.%26aulast%3DCantley%26aufirst%3DL.%2BC.%26aulast%3DFinan%26aufirst%3DP.%2BM.%26aulast%3DMurphy%26aufirst%3DL.%2BO.%26atitle%3DBidirectional%2520transport%2520of%2520amino%2520acids%2520regulates%2520mTOR%2520and%2520autophagy%26jtitle%3DCell%26date%3D2009%26volume%3D136%26issue%3D3%26spage%3D521%26epage%3D534%26doi%3D10.1016%2Fj.cell.2008.11.044" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref113"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref113'); return false;" data-citation="" class="refNumLink">113</a></strong><div class="NLM_citation" id="cit113"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wellen, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mancuso, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lemons, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ryczko, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dennis, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rabinowitz, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coller, H. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, C. B.</span></span> <span> </span><span class="NLM_article-title">The hexosamine biosynthetic pathway couples growth factor-induced glutamine uptake to glucose metabolism</span>. <i>Genes Dev.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>24</i></span> (<span class="NLM_issue">24</span>),  <span class="NLM_fpage">2784</span>– <span class="NLM_lpage">2799</span>, <span class="refDoi"> DOI: 10.1101/gad.1985910</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=10.1101%2Fgad.1985910" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2010&pages=2784-2799&issue=24&author=K.+E.+Wellenauthor=C.+Luauthor=A.+Mancusoauthor=J.+M.+Lemonsauthor=M.+Ryczkoauthor=J.+W.+Dennisauthor=J.+D.+Rabinowitzauthor=H.+A.+Collerauthor=C.+B.+Thompson&title=The+hexosamine+biosynthetic+pathway+couples+growth+factor-induced+glutamine+uptake+to+glucose+metabolism&doi=10.1101%2Fgad.1985910"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit113&amp;dbid=16384&amp;doi=10.1101%2Fgad.1985910&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1101%252Fgad.1985910%26sid%3Dliteratum%253Aachs%26aulast%3DWellen%26aufirst%3DK.%2BE.%26aulast%3DLu%26aufirst%3DC.%26aulast%3DMancuso%26aufirst%3DA.%26aulast%3DLemons%26aufirst%3DJ.%2BM.%26aulast%3DRyczko%26aufirst%3DM.%26aulast%3DDennis%26aufirst%3DJ.%2BW.%26aulast%3DRabinowitz%26aufirst%3DJ.%2BD.%26aulast%3DColler%26aufirst%3DH.%2BA.%26aulast%3DThompson%26aufirst%3DC.%2BB.%26atitle%3DThe%2520hexosamine%2520biosynthetic%2520pathway%2520couples%2520growth%2520factor-induced%2520glutamine%2520uptake%2520to%2520glucose%2520metabolism%26jtitle%3DGenes%2520Dev.%26date%3D2010%26volume%3D24%26issue%3D24%26spage%3D2784%26epage%3D2799%26doi%3D10.1101%2Fgad.1985910" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref114"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref114'); return false;" data-citation="" class="refNumLink">114</a></strong><div class="NLM_citation" id="cit114"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lobo, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruiz-Bellido, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aledo, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marquez, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nunez De Castro, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alonso, F. J.</span></span> <span> </span><span class="NLM_article-title">Inhibition of glutaminase expression by antisense mRNA decreases growth and tumourigenicity of tumour cells</span>. <i>Biochem. J.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>348</i></span>,  <span class="NLM_fpage">257</span>– <span class="NLM_lpage">261</span>, <span class="refDoi"> DOI: 10.1042/bj3480257</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=10.1042%2Fbj3480257" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=348&publication_year=2000&pages=257-261&author=C.+Loboauthor=M.+A.+Ruiz-Bellidoauthor=J.+C.+Aledoauthor=J.+Marquezauthor=I.+Nunez+De+Castroauthor=F.+J.+Alonso&title=Inhibition+of+glutaminase+expression+by+antisense+mRNA+decreases+growth+and+tumourigenicity+of+tumour+cells&doi=10.1042%2Fbj3480257"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit114&amp;dbid=16384&amp;doi=10.1042%2Fbj3480257&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252Fbj3480257%26sid%3Dliteratum%253Aachs%26aulast%3DLobo%26aufirst%3DC.%26aulast%3DRuiz-Bellido%26aufirst%3DM.%2BA.%26aulast%3DAledo%26aufirst%3DJ.%2BC.%26aulast%3DMarquez%26aufirst%3DJ.%26aulast%3DNunez%2BDe%2BCastro%26aufirst%3DI.%26aulast%3DAlonso%26aufirst%3DF.%2BJ.%26atitle%3DInhibition%2520of%2520glutaminase%2520expression%2520by%2520antisense%2520mRNA%2520decreases%2520growth%2520and%2520tumourigenicity%2520of%2520tumour%2520cells%26jtitle%3DBiochem.%2520J.%26date%3D2000%26volume%3D348%26spage%3D257%26epage%3D261%26doi%3D10.1042%2Fbj3480257" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref115"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref115'); return false;" data-citation="" class="refNumLink">115</a></strong><div class="NLM_citation" id="cit115"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sudderth, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mullen, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, E. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matés, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeBerardinis, R. J.</span></span> <span> </span><span class="NLM_article-title">Pyruvate carboxylase is required for glutamine-independent growth of tumor cells</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>108</i></span>,  <span class="NLM_fpage">8674</span>– <span class="NLM_lpage">8679</span>, <span class="refDoi"> DOI: 10.1073/pnas.1016627108</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=10.1073%2Fpnas.1016627108" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=21555572" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=1%3ACAS%3A528%3ADC%252BC3MXntVGqur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=108&publication_year=2011&pages=8674-8679&author=T.+Chengauthor=J.+Sudderthauthor=C.+Yangauthor=A.+R.+Mullenauthor=E.+S.+Jinauthor=J.+M.+Mat%C3%A9sauthor=R.+J.+DeBerardinis&title=Pyruvate+carboxylase+is+required+for+glutamine-independent+growth+of+tumor+cells&doi=10.1073%2Fpnas.1016627108"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit115R"><div class="casContent"><span class="casTitleNuber">115</span><div class="casTitle"><span class="NLM_cas:atitle">Pyruvate carboxylase is required for glutamine-independent growth of tumor cells</span></div><div class="casAuthors">Cheng, Tzuling; Sudderth, Jessica; Yang, Chendong; Mullen, Andrew R.; Jin, Eunsook S.; Mates, Jose M.; Deberardinis, Ralph J.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">108</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">8674-8679, S8674/1-S8674/22</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Tumor cells require a const. supply of macromol. precursors, and interrupting this supply was proposed as a therapeutic strategy in cancer.  Precursors for lipids, nucleic acids, and proteins are generated in the tricarboxylic acid (TCA) cycle and removed from the mitochondria to participate in biosynthetic reactions.  Refilling the pool of precursor mols. (anaplerosis) is therefore crucial to maintain cell growth.  Many tumor cells use glutamine to feed anaplerosis.  Here we studied how "glutamine-addicted" cells react to interruptions of glutamine metab.  Silencing of glutaminase (GLS), which catalyzes the first step in glutamine-dependent anaplerosis, suppressed but did not eliminate the growth of glioblastoma cells in culture and in vivo.  Profiling metabolic fluxes in GLS-suppressed cells revealed induction of a compensatory anaplerotic mechanism catalyzed by pyruvate carboxylase (PC), allowing the cells to use glucose-derived pyruvate rather than glutamine for anaplerosis.  Although PC was dispensable when glutamine was available, forcing cells to adapt to low-glutamine conditions rendered them absolutely dependent on PC for growth.  Furthermore, in other cell lines, measuring PC activity in nutrient-replete conditions predicted dependence on specific anaplerotic enzymes.  Cells with high PC activity were resistant to GLS silencing and did not require glutamine for survival or growth, but displayed suppressed growth when PC was silenced.  Thus, PC-mediated, glucose-dependent anaplerosis allows cells to achieve glutamine independence.  Induction of PC during chronic suppression of glutamine metab. may prove to be a mechanism of resistance to therapies targeting glutaminolysis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqsPp-FJtjQSbVg90H21EOLACvtfcHk0lhaw_6xvgvLVA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXntVGqur4%253D&md5=109e2a63458ec384aa873c9a4bb95334</span></div><a href="/servlet/linkout?suffix=cit115&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1016627108&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1016627108%26sid%3Dliteratum%253Aachs%26aulast%3DCheng%26aufirst%3DT.%26aulast%3DSudderth%26aufirst%3DJ.%26aulast%3DYang%26aufirst%3DC.%26aulast%3DMullen%26aufirst%3DA.%2BR.%26aulast%3DJin%26aufirst%3DE.%2BS.%26aulast%3DMat%25C3%25A9s%26aufirst%3DJ.%2BM.%26aulast%3DDeBerardinis%26aufirst%3DR.%2BJ.%26atitle%3DPyruvate%2520carboxylase%2520is%2520required%2520for%2520glutamine-independent%2520growth%2520of%2520tumor%2520cells%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2011%26volume%3D108%26spage%3D8674%26epage%3D8679%26doi%3D10.1073%2Fpnas.1016627108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref116"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref116'); return false;" data-citation="" class="refNumLink">116</a></strong><div class="NLM_citation" id="cit116"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lacey, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilmore, D. W.</span></span> <span> </span><span class="NLM_article-title">Is glutamine a conditionally essential amino acid?</span>. <i>Nutr. Rev.</i> <span class="NLM_year" style="font-weight: bold;">1990</span>,  <span class="NLM_volume"><i>48</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">297</span>– <span class="NLM_lpage">309</span>, <span class="refDoi"> DOI: 10.1111/j.1753-4887.1990.tb02967.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=10.1111%2Fj.1753-4887.1990.tb02967.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=2080048" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=1%3ACAS%3A280%3ADyaK3M7nvFKgtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=1990&pages=297-309&issue=8&author=J.+M.+Laceyauthor=D.+W.+Wilmore&title=Is+glutamine+a+conditionally+essential+amino+acid%3F&doi=10.1111%2Fj.1753-4887.1990.tb02967.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit116R"><div class="casContent"><span class="casTitleNuber">116</span><div class="casTitle"><span class="NLM_cas:atitle">Is glutamine a conditionally essential amino acid?</span></div><div class="casAuthors">Lacey J M; Wilmore D W</div><div class="citationInfo"><span class="NLM_cas:title">Nutrition reviews</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">297-309</span>
        ISSN:<span class="NLM_cas:issn">0029-6643</span>.
    </div><div class="casAbstract">The nonessential amino acid glutamine has recently been the focus of extensive scientific interest because of its importance in cell and tissue cultures and its physiologic role in animals and humans.  Glutamine appears to be a unique amino acid, serving as a preferred respiratory fuel for rapidly proliferating cells, such as enterocytes and lymphocytes; a regulator of acid-base balance through the production of urinary ammonia; a carrier of nitrogen between tissues; and an important precursor of nucleic acids, nucleotides, amino sugars, and proteins.  Abundant evidence suggests that glutamine may become a "conditionally essential" amino acid in the critically ill.  During stress the body's requirements for glutamine appear to exceed the individual's ability to produce sufficient amounts of this amino acid.  Provision of supplemental glutamine in specialized enteral or parenteral feeding may enhance nutritional management and augment recovery of the seriously ill while minimizing hospital stay.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTZrSpilggmhresJRIHUP1ofW6udTcc2ebyyieEnq7zKbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK3M7nvFKgtA%253D%253D&md5=c7303162e9a8cd16cac816282693c1a5</span></div><a href="/servlet/linkout?suffix=cit116&amp;dbid=16384&amp;doi=10.1111%2Fj.1753-4887.1990.tb02967.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1753-4887.1990.tb02967.x%26sid%3Dliteratum%253Aachs%26aulast%3DLacey%26aufirst%3DJ.%2BM.%26aulast%3DWilmore%26aufirst%3DD.%2BW.%26atitle%3DIs%2520glutamine%2520a%2520conditionally%2520essential%2520amino%2520acid%253F%26jtitle%3DNutr.%2520Rev.%26date%3D1990%26volume%3D48%26issue%3D8%26spage%3D297%26epage%3D309%26doi%3D10.1111%2Fj.1753-4887.1990.tb02967.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref117"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref117'); return false;" data-citation="" class="refNumLink">117</a></strong><div class="NLM_citation" id="cit117"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rubin, A. L.</span></span> <span> </span><span class="NLM_article-title">Suppression of transformation by and growth adaptation to low concentrations of glutamine in NIH-3T3 cells</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">1990</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">2832</span>– <span class="NLM_lpage">2839</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=2328506" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=1%3ACAS%3A528%3ADyaK3cXitlChtb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=1990&pages=2832-2839&author=A.+L.+Rubin&title=Suppression+of+transformation+by+and+growth+adaptation+to+low+concentrations+of+glutamine+in+NIH-3T3+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit117R"><div class="casContent"><span class="casTitleNuber">117</span><div class="casTitle"><span class="NLM_cas:atitle">Suppression of transformation by and growth adaptation to low concentrations of glutamine in NIH-3T3 cells</span></div><div class="casAuthors">Rubin, Andrew L.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2832-9</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    </div><div class="casAbstract">NIH-3T3 cells, commonly used as targets for oncogene-mediated neoplastic transformation, undergo high rates of spontaneous transformation.  When the glutamine concn. in the medium was reduced from 5 to ≤1 mM, the transformation rate was reduced.  This effect was not dependent upon a redn. in the growth rate, which remained unaffected by redn. of glutamine even to 0.6 mM.  Upon trypsinization and transfer to 5 mM glutamine-contg. medium, cells exposed to 0.2 mM glutamine for as little as 4 days formed fewer foci than control cells exposed over a similar period to 5 mM glutamine.  Thus, short-term changes in the supply of this polyfunctional metabolite have heritable consequences in later cell generations.  If populations contg. highly transformed cells were passaged weekly for 1-3 wk in 0.2 mM glutamine, resultant populations were better adapted to grow in low-glutamine medium and formed fewer transformed foci upon re-transfer to 5 mM glutamine medium, suggesting that the transformed state is at least partially reversible.  If similar cell populations were exposed to low-glutamine medium but were not passaged, growth adaptation occurred but there was no redn. in focus formation, indicating that maintenance of a moderate rate of cell division may be required in addn. to the lowered glutamine for reversal of transformation.  Transformed and nontransformed cells originating from foci and from nonfocal areas of the same culture dishes multiplied at the same reduced rate in 0.2 mM glutamine.  Apparently, suppression of spontaneous transformation in low-glutamine medium was not the result of selecting pre-existing variants but was itself an adaptive response of the population.  The results obtained with this model system were discussed with respect to the nutritional effects of glutamine on neoplastic transformation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpPSNwdYVjj67Vg90H21EOLACvtfcHk0lhmH-deL6nsLQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3cXitlChtb8%253D&md5=78a1298e03ce1fdc6ccbb884fc48f2d4</span></div><a href="/servlet/linkout?suffix=cit117&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRubin%26aufirst%3DA.%2BL.%26atitle%3DSuppression%2520of%2520transformation%2520by%2520and%2520growth%2520adaptation%2520to%2520low%2520concentrations%2520of%2520glutamine%2520in%2520NIH-3T3%2520cells%26jtitle%3DCancer%2520Res.%26date%3D1990%26volume%3D50%26spage%3D2832%26epage%3D2839" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref118"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref118'); return false;" data-citation="" class="refNumLink">118</a></strong><div class="NLM_citation" id="cit118"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yuneva, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zamboni, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oefner, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sachidanandam, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lazebnik, Y.</span></span> <span> </span><span class="NLM_article-title">Deficiency in glutamine but not glucose induces MYC-dependent apoptosis in human cells</span>. <i>J. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>178</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">93</span>– <span class="NLM_lpage">105</span>, <span class="refDoi"> DOI: 10.1083/jcb.200703099</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=10.1083%2Fjcb.200703099" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=178&publication_year=2007&pages=93-105&issue=1&author=M.+Yunevaauthor=N.+Zamboniauthor=P.+Oefnerauthor=R.+Sachidanandamauthor=Y.+Lazebnik&title=Deficiency+in+glutamine+but+not+glucose+induces+MYC-dependent+apoptosis+in+human+cells&doi=10.1083%2Fjcb.200703099"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit118&amp;dbid=16384&amp;doi=10.1083%2Fjcb.200703099&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1083%252Fjcb.200703099%26sid%3Dliteratum%253Aachs%26aulast%3DYuneva%26aufirst%3DM.%26aulast%3DZamboni%26aufirst%3DN.%26aulast%3DOefner%26aufirst%3DP.%26aulast%3DSachidanandam%26aufirst%3DR.%26aulast%3DLazebnik%26aufirst%3DY.%26atitle%3DDeficiency%2520in%2520glutamine%2520but%2520not%2520glucose%2520induces%2520MYC-dependent%2520apoptosis%2520in%2520human%2520cells%26jtitle%3DJ.%2520Cell%2520Biol.%26date%3D2007%26volume%3D178%26issue%3D1%26spage%3D93%26epage%3D105%26doi%3D10.1083%2Fjcb.200703099" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref119"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref119'); return false;" data-citation="" class="refNumLink">119</a></strong><div class="NLM_citation" id="cit119"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kvamme, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Torgner, I. A.</span></span> <span> </span><span class="NLM_article-title">Regulatory effects of fatty acyl-coenzyme a derivatives on phosphate-activated pig brain and kidney glutaminase in vitro</span>. <i>Biochem. J.</i> <span class="NLM_year" style="font-weight: bold;">1975</span>,  <span class="NLM_volume"><i>149</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">83</span>– <span class="NLM_lpage">91</span>, <span class="refDoi"> DOI: 10.1042/bj1490083</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=10.1042%2Fbj1490083" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=149&publication_year=1975&pages=83-91&issue=1&author=E.+Kvammeauthor=I.+A.+Torgner&title=Regulatory+effects+of+fatty+acyl-coenzyme+a+derivatives+on+phosphate-activated+pig+brain+and+kidney+glutaminase+in+vitro&doi=10.1042%2Fbj1490083"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit119&amp;dbid=16384&amp;doi=10.1042%2Fbj1490083&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252Fbj1490083%26sid%3Dliteratum%253Aachs%26aulast%3DKvamme%26aufirst%3DE.%26aulast%3DTorgner%26aufirst%3DI.%2BA.%26atitle%3DRegulatory%2520effects%2520of%2520fatty%2520acyl-coenzyme%2520a%2520derivatives%2520on%2520phosphate-activated%2520pig%2520brain%2520and%2520kidney%2520glutaminase%2520in%2520vitro%26jtitle%3DBiochem.%2520J.%26date%3D1975%26volume%3D149%26issue%3D1%26spage%3D83%26epage%3D91%26doi%3D10.1042%2Fbj1490083" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59'],'ref60':['cit60'],'ref61':['cit61'],'ref62':['cit62'],'ref63':['cit63'],'ref64':['cit64'],'ref65':['cit65'],'ref66':['cit66'],'ref67':['cit67'],'ref68':['cit68'],'ref69':['cit69'],'ref70':['cit70'],'ref71':['cit71'],'ref72':['cit72'],'ref73':['cit73'],'ref74':['cit74'],'ref75':['cit75'],'ref76':['cit76'],'ref77':['cit77'],'ref78':['cit78'],'ref79':['cit79'],'ref80':['cit80'],'ref81':['cit81'],'ref82':['cit82'],'ref83':['cit83'],'ref84':['cit84'],'ref85':['cit85'],'ref86':['cit86'],'ref87':['cit87'],'ref88':['cit88'],'ref89':['cit89'],'ref90':['cit90'],'ref91':['cit91'],'ref92':['cit92'],'ref93':['cit93'],'ref94':['cit94'],'ref95':['cit95'],'ref96':['cit96'],'ref97':['cit97'],'ref98':['cit98'],'ref99':['cit99'],'ref100':['cit100'],'ref101':['cit101'],'ref102':['cit102'],'ref103':['cit103'],'ref104':['cit104'],'ref105':['cit105'],'ref106':['cit106'],'ref107':['cit107'],'ref108':['cit108'],'ref109':['cit109'],'ref110':['cit110'],'ref111':['cit111'],'ref112':['cit112'],'ref113':['cit113'],'ref114':['cit114'],'ref115':['cit115'],'ref116':['cit116'],'ref117':['cit117'],'ref118':['cit118'],'ref119':['cit119']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 32 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Xi Xu, Jubo Wang, Min Wang, Xinyu Yuan, Lei Li, Chao Zhang, Huidan Huang, Tian Jing, Chenchen Wang, Chao Tong, Liwen Zhou, Ying Meng, Pengfei Xu, Junping Kou, Zhixia Qiu, Zhiyu Li, <span class="NLM_string-name hlFld-ContribAuthor">Jinlei Bian</span>. </span><span class="cited-content_cbyCitation_article-title">Structure-Enabled Discovery of Novel Macrocyclic Inhibitors Targeting Glutaminase 1 Allosteric Binding Site. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (8)
                                     , 4588-4611. <a href="https://doi.org/10.1021/acs.jmedchem.0c02044" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c02044</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c02044&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c02044%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DStructure-Enabled%252BDiscovery%252Bof%252BNovel%252BMacrocyclic%252BInhibitors%252BTargeting%252BGlutaminase%252B1%252BAllosteric%252BBinding%252BSite%26aulast%3DXu%26aufirst%3DXi%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D25112020%26date%3D01042021%26volume%3D64%26issue%3D8%26spage%3D4588%26epage%3D4611" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Michael J. Soth, Kang Le, Maria Emilia Di Francesco, Matthew M. Hamilton, Gang Liu, Jason P. Burke, Chris L. Carroll, Jeffrey J. Kovacs, Jennifer P. Bardenhagen, Christopher A. Bristow, Mario Cardozo, Barbara Czako, Elisa de Stanchina, Ningping Feng, Jill R. Garvey, Jason P. Gay, Mary K. Geck Do, Jennifer Greer, Michelle Han, Angela Harris, Zachary Herrera, Sha Huang, Virginia Giuliani, Yongying Jiang, Sarah B. Johnson, Troy A. Johnson, Zhijun Kang, Paul G. Leonard, Zhen Liu, Timothy McAfoos, Meredith Miller, Pietro Morlacchi, Robert A. Mullinax, Wylie S. Palmer, Jihai Pang, Norma Rogers, Charles M. Rudin, Hannah E. Shepard, Nakia D. Spencer, Jay Theroff, Qi Wu, Alan Xu, Ju Anne Yau, Giulio Draetta, Carlo Toniatti, Timothy P. Heffernan, <span class="NLM_string-name hlFld-ContribAuthor">Philip Jones</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of IPN60090, a Clinical Stage Selective Glutaminase-1 (GLS-1) Inhibitor with Excellent Pharmacokinetic and Physicochemical Properties. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (21)
                                     , 12957-12977. <a href="https://doi.org/10.1021/acs.jmedchem.0c01398" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01398</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01398&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c01398%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BIPN60090%25252C%252Ba%252BClinical%252BStage%252BSelective%252BGlutaminase-1%252B%252528GLS-1%252529%252BInhibitor%252Bwith%252BExcellent%252BPharmacokinetic%252Band%252BPhysicochemical%252BProperties%26aulast%3DSoth%26aufirst%3DMichael%2BJ.%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D09082020%26date%3D29102020%26volume%3D63%26issue%3D21%26spage%3D12957%26epage%3D12977" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Xi Xu, Zijian Kuang, Jie Han, Ying Meng, Lei Li, Hongyu Luan, Pengfei Xu, Jubo Wang, Cheng Luo, Hong Ding, Zhiyu Li, <span class="NLM_string-name hlFld-ContribAuthor">Jinlei Bian</span>. </span><span class="cited-content_cbyCitation_article-title">Development and Characterization of a Fluorescent Probe for GLS1 and the Application for High-Throughput Screening of Allosteric Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (21)
                                     , 9642-9657. <a href="https://doi.org/10.1021/acs.jmedchem.9b01035" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b01035</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b01035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b01035%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDevelopment%252Band%252BCharacterization%252Bof%252Ba%252BFluorescent%252BProbe%252Bfor%252BGLS1%252Band%252Bthe%252BApplication%252Bfor%252BHigh-Throughput%252BScreening%252Bof%252BAllosteric%252BInhibitors%26aulast%3DXu%26aufirst%3DXi%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D03072019%26date%3D24102019%26date%3D11102019%26volume%3D62%26issue%3D21%26spage%3D9642%26epage%3D9657" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Zhao Chen, Di Li, Ning Xu, Jinzhang Fang, Yan Yu, Wei Hou, Haoqiang Ruan, Panpan Zhu, Renchao Ma, Shiying Lu, Danhui Cao, Rui Wu, Mowei Ni, Wei Zhang, Weike Su, <span class="NLM_string-name hlFld-ContribAuthor">Benfang Helen Ruan</span>. </span><span class="cited-content_cbyCitation_article-title">Novel 1,3,4-Selenadiazole-Containing Kidney-Type Glutaminase Inhibitors Showed Improved Cellular Uptake and Antitumor Activity. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (2)
                                     , 589-603. <a href="https://doi.org/10.1021/acs.jmedchem.8b01198" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b01198</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b01198&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b01198%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DNovel%252B1%25252C3%25252C4-Selenadiazole-Containing%252BKidney-Type%252BGlutaminase%252BInhibitors%252BShowed%252BImproved%252BCellular%252BUptake%252Band%252BAntitumor%252BActivity%26aulast%3DChen%26aufirst%3DZhao%26date%3D2019%26date%3D2018%26date%3D2018%26date%3D30072018%26date%3D31122018%26date%3D13122018%26volume%3D62%26issue%3D2%26spage%3D589%26epage%3D603" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Juan  de los Santos-Jiménez</span>, <span class="hlFld-ContribAuthor ">José A.  Campos-Sandoval</span>, <span class="hlFld-ContribAuthor ">Clara  Márquez-Torres</span>, <span class="hlFld-ContribAuthor ">Nieves  Urbano-Polo</span>, <span class="hlFld-ContribAuthor ">David  Brøndegaard</span>, <span class="hlFld-ContribAuthor ">Mercedes  Martín-Rufián</span>, <span class="hlFld-ContribAuthor ">Carolina  Lobo</span>, <span class="hlFld-ContribAuthor ">Ana  Peñalver</span>, <span class="hlFld-ContribAuthor ">María C.  Gómez-García</span>, <span class="hlFld-ContribAuthor ">Janet  Martín-Campos</span>, <span class="hlFld-ContribAuthor ">Carolina  Cardona</span>, <span class="hlFld-ContribAuthor ">Laura  Castilla</span>, <span class="hlFld-ContribAuthor ">Felipe  da Costa Souza</span>, <span class="hlFld-ContribAuthor ">Tzuling  Cheng</span>, <span class="hlFld-ContribAuthor ">Juan A.  Segura</span>, <span class="hlFld-ContribAuthor ">Francisco J.  Alonso</span>, <span class="hlFld-ContribAuthor ">Rui  Curi</span>, <span class="hlFld-ContribAuthor ">Alison  Colquhoun</span>, <span class="hlFld-ContribAuthor ">Ralph J.  DeBerardinis</span>, <span class="hlFld-ContribAuthor ">Javier  Márquez</span>, <span class="hlFld-ContribAuthor ">José M.  Matés</span>. </span><span class="cited-content_cbyCitation_article-title">Glutaminase isoforms expression switches microRNA levels and oxidative status in glioblastoma cells. </span><span class="cited-content_cbyCitation_journal-name">Journal of Biomedical Science</span><span> <strong>2021,</strong> <em>28 </em>
                                    (1)
                                     <a href="https://doi.org/10.1186/s12929-021-00712-y" title="DOI URL">https://doi.org/10.1186/s12929-021-00712-y</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1186/s12929-021-00712-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1186%2Fs12929-021-00712-y%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Biomedical%2520Science%26atitle%3DGlutaminase%252Bisoforms%252Bexpression%252Bswitches%252BmicroRNA%252Blevels%252Band%252Boxidative%252Bstatus%252Bin%252Bglioblastoma%252Bcells%26aulast%3Dde%2Blos%2BSantos-Jim%25C3%25A9nez%26aufirst%3DJuan%26date%3D2021%26date%3D2021%26volume%3D28%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Paulo José  Basso</span>, <span class="hlFld-ContribAuthor ">Vinicius  Andrade-Oliveira</span>, <span class="hlFld-ContribAuthor ">Niels Olsen Saraiva  Câmara</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting immune cell metabolism in kidney diseases. </span><span class="cited-content_cbyCitation_journal-name">Nature Reviews Nephrology</span><span> <strong>2021,</strong> <em>17 </em>
                                    (7)
                                     , 465-480. <a href="https://doi.org/10.1038/s41581-021-00413-7" title="DOI URL">https://doi.org/10.1038/s41581-021-00413-7</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41581-021-00413-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41581-021-00413-7%26sid%3Dliteratum%253Aachs%26jtitle%3DNature%2520Reviews%2520Nephrology%26atitle%3DTargeting%252Bimmune%252Bcell%252Bmetabolism%252Bin%252Bkidney%252Bdiseases%26aulast%3DBasso%26aufirst%3DPaulo%2BJos%25C3%25A9%26date%3D2021%26date%3D2021%26volume%3D17%26issue%3D7%26spage%3D465%26epage%3D480" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Heena  Jariyal</span>, <span class="hlFld-ContribAuthor ">Chanchal  Gupta</span>, <span class="hlFld-ContribAuthor ">Shambhavi  Andhale</span>, <span class="hlFld-ContribAuthor ">Sonali  Gadge</span>, <span class="hlFld-ContribAuthor ">Akshay  Srivastava</span>. </span><span class="cited-content_cbyCitation_article-title">Comparative stemness and differentiation of luminal and basal breast cancer stem cell type under glutamine‐deprivation. </span><span class="cited-content_cbyCitation_journal-name">Journal of Cell Communication and Signaling</span><span> <strong>2021,</strong> <em>15 </em>
                                    (2)
                                     , 207-222. <a href="https://doi.org/10.1007/s12079-020-00603-1" title="DOI URL">https://doi.org/10.1007/s12079-020-00603-1</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s12079-020-00603-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs12079-020-00603-1%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Cell%2520Communication%2520and%2520Signaling%26atitle%3DComparative%252Bstemness%252Band%252Bdifferentiation%252Bof%252Bluminal%252Band%252Bbasal%252Bbreast%252Bcancer%252Bstem%252Bcell%252Btype%252Bunder%252Bglutamine%2525E2%252580%252590deprivation%26aulast%3DJariyal%26aufirst%3DHeena%26date%3D2021%26date%3D2021%26volume%3D15%26issue%3D2%26spage%3D207%26epage%3D222" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shuai  Wu</span>, <span class="hlFld-ContribAuthor ">Takeshi  Fukumoto</span>, <span class="hlFld-ContribAuthor ">Jianhuang  Lin</span>, <span class="hlFld-ContribAuthor ">Timothy  Nacarelli</span>, <span class="hlFld-ContribAuthor ">Yemin  Wang</span>, <span class="hlFld-ContribAuthor ">Dionzie  Ong</span>, <span class="hlFld-ContribAuthor ">Heng  Liu</span>, <span class="hlFld-ContribAuthor ">Nail  Fatkhutdinov</span>, <span class="hlFld-ContribAuthor ">Joseph A.  Zundell</span>, <span class="hlFld-ContribAuthor ">Sergey  Karakashev</span>, <span class="hlFld-ContribAuthor ">Wei  Zhou</span>, <span class="hlFld-ContribAuthor ">Lauren E.  Schwartz</span>, <span class="hlFld-ContribAuthor ">Hsin-Yao  Tang</span>, <span class="hlFld-ContribAuthor ">Ronny  Drapkin</span>, <span class="hlFld-ContribAuthor ">Qin  Liu</span>, <span class="hlFld-ContribAuthor ">David G.  Huntsman</span>, <span class="hlFld-ContribAuthor ">Andrew V.  Kossenkov</span>, <span class="hlFld-ContribAuthor ">David W.  Speicher</span>, <span class="hlFld-ContribAuthor ">Zachary T.  Schug</span>, <span class="hlFld-ContribAuthor ">Chi  Van Dang</span>, <span class="hlFld-ContribAuthor ">Rugang  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting glutamine dependence through GLS1 inhibition suppresses ARID1A-inactivated clear cell ovarian carcinoma. </span><span class="cited-content_cbyCitation_journal-name">Nature Cancer</span><span> <strong>2021,</strong> <em>2 </em>
                                    (2)
                                     , 189-200. <a href="https://doi.org/10.1038/s43018-020-00160-x" title="DOI URL">https://doi.org/10.1038/s43018-020-00160-x</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s43018-020-00160-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs43018-020-00160-x%26sid%3Dliteratum%253Aachs%26jtitle%3DNature%2520Cancer%26atitle%3DTargeting%252Bglutamine%252Bdependence%252Bthrough%252BGLS1%252Binhibition%252Bsuppresses%252BARID1A-inactivated%252Bclear%252Bcell%252Bovarian%252Bcarcinoma%26aulast%3DWu%26aufirst%3DShuai%26date%3D2021%26date%3D2021%26volume%3D2%26issue%3D2%26spage%3D189%26epage%3D200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ji Hye  Kim</span>, <span class="hlFld-ContribAuthor ">Jinyoung  Lee</span>, <span class="hlFld-ContribAuthor ">Young-Ra  Cho</span>, <span class="hlFld-ContribAuthor ">So-Yeon  Lee</span>, <span class="hlFld-ContribAuthor ">Gi-Jun  Sung</span>, <span class="hlFld-ContribAuthor ">Dong-Myung  Shin</span>, <span class="hlFld-ContribAuthor ">Kyung-Chul  Choi</span>, <span class="hlFld-ContribAuthor ">Jaekyoung  Son</span>. </span><span class="cited-content_cbyCitation_article-title">TFEB Supports Pancreatic Cancer Growth through the Transcriptional Regulation of Glutaminase. </span><span class="cited-content_cbyCitation_journal-name">Cancers</span><span> <strong>2021,</strong> <em>13 </em>
                                    (3)
                                     , 483. <a href="https://doi.org/10.3390/cancers13030483" title="DOI URL">https://doi.org/10.3390/cancers13030483</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/cancers13030483&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fcancers13030483%26sid%3Dliteratum%253Aachs%26jtitle%3DCancers%26atitle%3DTFEB%252BSupports%252BPancreatic%252BCancer%252BGrowth%252Bthrough%252Bthe%252BTranscriptional%252BRegulation%252Bof%252BGlutaminase%26aulast%3DKim%26aufirst%3DJi%2BHye%26date%3D2021%26date%3D2021%26volume%3D13%26issue%3D3%26spage%3D483" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Oleg  Shuvalov</span>, <span class="hlFld-ContribAuthor ">Alexandra  Daks</span>, <span class="hlFld-ContribAuthor ">Olga  Fedorova</span>, <span class="hlFld-ContribAuthor ">Alexey  Petukhov</span>, <span class="hlFld-ContribAuthor ">Nickolai  Barlev</span>. </span><span class="cited-content_cbyCitation_article-title">Linking Metabolic Reprogramming, Plasticity and Tumor Progression. </span><span class="cited-content_cbyCitation_journal-name">Cancers</span><span> <strong>2021,</strong> <em>13 </em>
                                    (4)
                                     , 762. <a href="https://doi.org/10.3390/cancers13040762" title="DOI URL">https://doi.org/10.3390/cancers13040762</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/cancers13040762&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fcancers13040762%26sid%3Dliteratum%253Aachs%26jtitle%3DCancers%26atitle%3DLinking%252BMetabolic%252BReprogramming%25252C%252BPlasticity%252Band%252BTumor%252BProgression%26aulast%3DShuvalov%26aufirst%3DOleg%26date%3D2021%26date%3D2021%26volume%3D13%26issue%3D4%26spage%3D762" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Witchuda  Sukjoi</span>, <span class="hlFld-ContribAuthor ">Jarunya  Ngamkham</span>, <span class="hlFld-ContribAuthor ">Paul V.  Attwood</span>, <span class="hlFld-ContribAuthor ">Sarawut  Jitrapakdee</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting Cancer Metabolism and Current Anti-Cancer Drugs. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2021,</strong>,, 15-48. <a href="https://doi.org/10.1007/978-3-030-55035-6_2" title="DOI URL">https://doi.org/10.1007/978-3-030-55035-6_2</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-3-030-55035-6_2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-3-030-55035-6_2%26sid%3Dliteratum%253Aachs%26atitle%3DTargeting%252BCancer%252BMetabolism%252Band%252BCurrent%252BAnti-Cancer%252BDrugs%26aulast%3DSukjoi%26aufirst%3DWitchuda%26date%3D2021%26date%3D2021%26spage%3D15%26epage%3D48%26pub%3DSpringer%2520International%2520Publishing%26atitle%3DReviews%252Bon%252BNew%252BDrug%252BTargets%252Bin%252BAge-Related%252BDisorders%26aulast%3DGuest%26aufirst%3DPaul%2BC.%26date%3D2021%26volume%3D1286" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ting  Li</span>, <span class="hlFld-ContribAuthor ">Christopher  Copeland</span>, <span class="hlFld-ContribAuthor ">Anne  Le</span>. </span><span class="cited-content_cbyCitation_article-title">Glutamine Metabolism in Cancer. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2021,</strong>,, 17-38. <a href="https://doi.org/10.1007/978-3-030-65768-0_2" title="DOI URL">https://doi.org/10.1007/978-3-030-65768-0_2</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-3-030-65768-0_2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-3-030-65768-0_2%26sid%3Dliteratum%253Aachs%26atitle%3DGlutamine%252BMetabolism%252Bin%252BCancer%26aulast%3DLi%26aufirst%3DTing%26date%3D2021%26date%3D2021%26spage%3D17%26epage%3D38%26pub%3DSpringer%2520International%2520Publishing%26atitle%3DThe%252BHeterogeneity%252Bof%252BCancer%252BMetabolism%26aulast%3DLe%26aufirst%3DAnne%26date%3D2021%26volume%3D1311" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Laura J  Pallett</span>, <span class="hlFld-ContribAuthor ">Sarah  Dimeloe</span>, <span class="hlFld-ContribAuthor ">Linda V  Sinclair</span>, <span class="hlFld-ContribAuthor ">Adam J  Byrne</span>, <span class="hlFld-ContribAuthor ">Anna  Schurich</span>. </span><span class="cited-content_cbyCitation_article-title">A glutamine ‘tug-of-war’: targets to manipulate glutamine metabolism for cancer immunotherapy. </span><span class="cited-content_cbyCitation_journal-name">Immunotherapy Advances</span><span> <strong>2021,</strong> <em>1 </em>
                                    (1)
                                     <a href="https://doi.org/10.1093/immadv/ltab010" title="DOI URL">https://doi.org/10.1093/immadv/ltab010</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1093/immadv/ltab010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1093%2Fimmadv%2Fltab010%26sid%3Dliteratum%253Aachs%26jtitle%3DImmunotherapy%2520Advances%26atitle%3DA%252Bglutamine%252B%2525E2%252580%252598tug-of-war%2525E2%252580%252599%25253A%252Btargets%252Bto%252Bmanipulate%252Bglutamine%252Bmetabolism%252Bfor%252Bcancer%252Bimmunotherapy%26aulast%3DPallett%26aufirst%3DLaura%2BJ%26date%3D2021%26date%3D2021%26volume%3D1%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ishwar  Navin</span>, <span class="hlFld-ContribAuthor ">Michael T.  Lam</span>, <span class="hlFld-ContribAuthor ">Robin  Parihar</span>. </span><span class="cited-content_cbyCitation_article-title">Design and Implementation of NK Cell-Based Immunotherapy to Overcome the Solid Tumor Microenvironment. </span><span class="cited-content_cbyCitation_journal-name">Cancers</span><span> <strong>2020,</strong> <em>12 </em>
                                    (12)
                                     , 3871. <a href="https://doi.org/10.3390/cancers12123871" title="DOI URL">https://doi.org/10.3390/cancers12123871</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/cancers12123871&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fcancers12123871%26sid%3Dliteratum%253Aachs%26jtitle%3DCancers%26atitle%3DDesign%252Band%252BImplementation%252Bof%252BNK%252BCell-Based%252BImmunotherapy%252Bto%252BOvercome%252Bthe%252BSolid%252BTumor%252BMicroenvironment%26aulast%3DNavin%26aufirst%3DIshwar%26date%3D2020%26date%3D2020%26volume%3D12%26issue%3D12%26spage%3D3871" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Fabienne  Guillaumond</span>, <span class="hlFld-ContribAuthor ">Sophie  Vasseur</span>. </span><span class="cited-content_cbyCitation_article-title">Nutriments et cancer : alliés ou ennemis ?. </span><span class="cited-content_cbyCitation_journal-name">Cahiers de Nutrition et de Diététique</span><span> <strong>2020,</strong> <em>55 </em>
                                    (6)
                                     , 276-294. <a href="https://doi.org/10.1016/j.cnd.2020.09.003" title="DOI URL">https://doi.org/10.1016/j.cnd.2020.09.003</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.cnd.2020.09.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.cnd.2020.09.003%26sid%3Dliteratum%253Aachs%26jtitle%3DCahiers%2520de%2520Nutrition%2520et%2520de%2520Di%25C3%25A9t%25C3%25A9tique%26atitle%3DNutriments%252Bet%252Bcancer%2525C2%2525A0%25253A%252Balli%2525C3%2525A9s%252Bou%252Bennemis%2525C2%2525A0%25253F%26aulast%3DGuillaumond%26aufirst%3DFabienne%26date%3D2020%26volume%3D55%26issue%3D6%26spage%3D276%26epage%3D294" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yiqing  Zhao</span>, <span class="hlFld-ContribAuthor ">Xiujing  Feng</span>, <span class="hlFld-ContribAuthor ">Yicheng  Chen</span>, <span class="hlFld-ContribAuthor ">J. Eva  Selfridge</span>, <span class="hlFld-ContribAuthor ">Shashank  Gorityala</span>, <span class="hlFld-ContribAuthor ">Zhanwen  Du</span>, <span class="hlFld-ContribAuthor ">Janet M.  Wang</span>, <span class="hlFld-ContribAuthor ">Yujun  Hao</span>, <span class="hlFld-ContribAuthor ">Gino  Cioffi</span>, <span class="hlFld-ContribAuthor ">Ronald A.  Conlon</span>, <span class="hlFld-ContribAuthor ">Jill S.  Barnholtz-Sloan</span>, <span class="hlFld-ContribAuthor ">Joel  Saltzman</span>, <span class="hlFld-ContribAuthor ">Smitha S.  Krishnamurthi</span>, <span class="hlFld-ContribAuthor ">Shaveta  Vinayak</span>, <span class="hlFld-ContribAuthor ">Martina  Veigl</span>, <span class="hlFld-ContribAuthor ">Yan  Xu</span>, <span class="hlFld-ContribAuthor ">David L.  Bajor</span>, <span class="hlFld-ContribAuthor ">Sanford D.  Markowitz</span>, <span class="hlFld-ContribAuthor ">Neal J.  Meropol</span>, <span class="hlFld-ContribAuthor ">Jennifer R.  Eads</span>, <span class="hlFld-ContribAuthor ">Zhenghe  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">5-Fluorouracil Enhances the Antitumor Activity of the Glutaminase Inhibitor CB-839 against
              PIK3CA
              -Mutant Colorectal Cancers. </span><span class="cited-content_cbyCitation_journal-name">Cancer Research</span><span> <strong>2020,</strong> <em>80 </em>
                                    (21)
                                     , 4815-4827. <a href="https://doi.org/10.1158/0008-5472.CAN-20-0600" title="DOI URL">https://doi.org/10.1158/0008-5472.CAN-20-0600</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1158/0008-5472.CAN-20-0600&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1158%2F0008-5472.CAN-20-0600%26sid%3Dliteratum%253Aachs%26jtitle%3DCancer%2520Research%26atitle%3D5-Fluorouracil%252BEnhances%252Bthe%252BAntitumor%252BActivity%252Bof%252Bthe%252BGlutaminase%252BInhibitor%252BCB-839%252Bagainst%252BPIK3CA%252B-Mutant%252BColorectal%252BCancers%26aulast%3DZhao%26aufirst%3DYiqing%26date%3D2020%26date%3D2020%26volume%3D80%26issue%3D21%26spage%3D4815%26epage%3D4827" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yuan-Yuan  Chen</span>, <span class="hlFld-ContribAuthor ">He-He  Hu</span>, <span class="hlFld-ContribAuthor ">Yan-Ni  Wang</span>, <span class="hlFld-ContribAuthor ">Jing-Ru  Liu</span>, <span class="hlFld-ContribAuthor ">Hai-Jing  Liu</span>, <span class="hlFld-ContribAuthor ">Jian-Ling  Liu</span>, <span class="hlFld-ContribAuthor ">Ying-Yong  Zhao</span>. </span><span class="cited-content_cbyCitation_article-title">Metabolomics in renal cell carcinoma: From biomarker identification to pathomechanism insights. </span><span class="cited-content_cbyCitation_journal-name">Archives of Biochemistry and Biophysics</span><span> <strong>2020,</strong> <em>695 </em>, 108623. <a href="https://doi.org/10.1016/j.abb.2020.108623" title="DOI URL">https://doi.org/10.1016/j.abb.2020.108623</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.abb.2020.108623&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.abb.2020.108623%26sid%3Dliteratum%253Aachs%26jtitle%3DArchives%2520of%2520Biochemistry%2520and%2520Biophysics%26atitle%3DMetabolomics%252Bin%252Brenal%252Bcell%252Bcarcinoma%25253A%252BFrom%252Bbiomarker%252Bidentification%252Bto%252Bpathomechanism%252Binsights%26aulast%3DChen%26aufirst%3DYuan-Yuan%26date%3D2020%26volume%3D695%26spage%3D108623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhefang  Wang</span>, <span class="hlFld-ContribAuthor ">Fanyu  Liu</span>, <span class="hlFld-ContribAuthor ">Ningbo  Fan</span>, <span class="hlFld-ContribAuthor ">Chenghui  Zhou</span>, <span class="hlFld-ContribAuthor ">Dai  Li</span>, <span class="hlFld-ContribAuthor ">Thomas  Macvicar</span>, <span class="hlFld-ContribAuthor ">Qiongzhu  Dong</span>, <span class="hlFld-ContribAuthor ">Christiane J.  Bruns</span>, <span class="hlFld-ContribAuthor ">Yue  Zhao</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting Glutaminolysis: New Perspectives to Understand Cancer Development and Novel Strategies for Potential Target Therapies. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Oncology</span><span> <strong>2020,</strong> <em>10 </em><a href="https://doi.org/10.3389/fonc.2020.589508" title="DOI URL">https://doi.org/10.3389/fonc.2020.589508</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fonc.2020.589508&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffonc.2020.589508%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Oncology%26atitle%3DTargeting%252BGlutaminolysis%25253A%252BNew%252BPerspectives%252Bto%252BUnderstand%252BCancer%252BDevelopment%252Band%252BNovel%252BStrategies%252Bfor%252BPotential%252BTarget%252BTherapies%26aulast%3DWang%26aufirst%3DZhefang%26date%3D2020%26date%3D2020%26volume%3D10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bridget  Duvall</span>, <span class="hlFld-ContribAuthor ">Sarah C.  Zimmermann</span>, <span class="hlFld-ContribAuthor ">Run-Duo  Gao</span>, <span class="hlFld-ContribAuthor ">Ajit G.  Thomas</span>, <span class="hlFld-ContribAuthor ">Filip  Kalčic</span>, <span class="hlFld-ContribAuthor ">Vijayabhaskar  Veeravalli</span>, <span class="hlFld-ContribAuthor ">Amira  Elgogary</span>, <span class="hlFld-ContribAuthor ">Rana  Rais</span>, <span class="hlFld-ContribAuthor ">Camilo  Rojas</span>, <span class="hlFld-ContribAuthor ">Anne  Le</span>, <span class="hlFld-ContribAuthor ">Barbara S.  Slusher</span>, <span class="hlFld-ContribAuthor ">Takashi  Tsukamoto</span>. </span><span class="cited-content_cbyCitation_article-title">Allosteric kidney-type glutaminase (GLS) inhibitors with a mercaptoethyl linker. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2020,</strong> <em>28 </em>
                                    (20)
                                     , 115698. <a href="https://doi.org/10.1016/j.bmc.2020.115698" title="DOI URL">https://doi.org/10.1016/j.bmc.2020.115698</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2020.115698&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2020.115698%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DAllosteric%252Bkidney-type%252Bglutaminase%252B%252528GLS%252529%252Binhibitors%252Bwith%252Ba%252Bmercaptoethyl%252Blinker%26aulast%3DDuvall%26aufirst%3DBridget%26date%3D2020%26volume%3D28%26issue%3D20%26spage%3D115698" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rosa Maria  Pascale</span>, <span class="hlFld-ContribAuthor ">Diego Francesco  Calvisi</span>, <span class="hlFld-ContribAuthor ">Maria Maddalena  Simile</span>, <span class="hlFld-ContribAuthor ">Claudio Francesco  Feo</span>, <span class="hlFld-ContribAuthor ">Francesco  Feo</span>. </span><span class="cited-content_cbyCitation_article-title">The Warburg Effect 97 Years after Its Discovery. </span><span class="cited-content_cbyCitation_journal-name">Cancers</span><span> <strong>2020,</strong> <em>12 </em>
                                    (10)
                                     , 2819. <a href="https://doi.org/10.3390/cancers12102819" title="DOI URL">https://doi.org/10.3390/cancers12102819</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/cancers12102819&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fcancers12102819%26sid%3Dliteratum%253Aachs%26jtitle%3DCancers%26atitle%3DThe%252BWarburg%252BEffect%252B97%252BYears%252Bafter%252BIts%252BDiscovery%26aulast%3DPascale%26aufirst%3DRosa%2BMaria%26date%3D2020%26date%3D2020%26volume%3D12%26issue%3D10%26spage%3D2819" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">José M.  Matés</span>, <span class="hlFld-ContribAuthor ">José A.  Campos-Sandoval</span>, <span class="hlFld-ContribAuthor ">Juan  de los Santos-Jiménez</span>, <span class="hlFld-ContribAuthor ">Juan A.  Segura</span>, <span class="hlFld-ContribAuthor ">Francisco J.  Alonso</span>, <span class="hlFld-ContribAuthor ">Javier  Márquez</span>. </span><span class="cited-content_cbyCitation_article-title">Metabolic Reprogramming of Cancer by Chemicals that Target Glutaminase Isoenzymes. </span><span class="cited-content_cbyCitation_journal-name">Current Medicinal Chemistry</span><span> <strong>2020,</strong> <em>27 </em>
                                    (32)
                                     , 5317-5339. <a href="https://doi.org/10.2174/0929867326666190416165004" title="DOI URL">https://doi.org/10.2174/0929867326666190416165004</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/0929867326666190416165004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F0929867326666190416165004%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Medicinal%2520Chemistry%26atitle%3DMetabolic%252BReprogramming%252Bof%252BCancer%252Bby%252BChemicals%252Bthat%252BTarget%252BGlutaminase%252BIsoenzymes%26aulast%3DMat%25C3%25A9s%26aufirst%3DJos%25C3%25A9%2BM.%26date%3D2020%26volume%3D27%26issue%3D32%26spage%3D5317%26epage%3D5339" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">L. A.  Braun</span>, <span class="hlFld-ContribAuthor ">E. E.  Varpetyan</span>, <span class="hlFld-ContribAuthor ">G. A.  Zav’yalov</span>, <span class="hlFld-ContribAuthor ">F. V.  Kulikov</span>, <span class="hlFld-ContribAuthor ">V. E.  Marievskii</span>, <span class="hlFld-ContribAuthor ">D. A.  Tyul’ganova</span>, <span class="hlFld-ContribAuthor ">A. O.  Shishnenko</span>, <span class="hlFld-ContribAuthor ">D. S.  Stepanova</span>, <span class="hlFld-ContribAuthor ">N. L.  Shimanovskii</span>. </span><span class="cited-content_cbyCitation_article-title">Metabolic Enzymes: New Targets for the Design of Antitumor Drugs. </span><span class="cited-content_cbyCitation_journal-name">Pharmaceutical Chemistry Journal</span><span> <strong>2020,</strong> <em>54 </em>
                                    (6)
                                     , 547-554. <a href="https://doi.org/10.1007/s11094-020-02238-3" title="DOI URL">https://doi.org/10.1007/s11094-020-02238-3</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11094-020-02238-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11094-020-02238-3%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmaceutical%2520Chemistry%2520Journal%26atitle%3DMetabolic%252BEnzymes%25253A%252BNew%252BTargets%252Bfor%252Bthe%252BDesign%252Bof%252BAntitumor%252BDrugs%26aulast%3DBraun%26aufirst%3DL.%2BA.%26date%3D2020%26date%3D2020%26volume%3D54%26issue%3D6%26spage%3D547%26epage%3D554" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hitoshi  Endo</span>, <span class="hlFld-ContribAuthor ">Satoshi  Owada</span>, <span class="hlFld-ContribAuthor ">Yutaka  Inagaki</span>, <span class="hlFld-ContribAuthor ">Yukari  Shida</span>, <span class="hlFld-ContribAuthor ">Masayuki  Tatemichi</span>. </span><span class="cited-content_cbyCitation_article-title">Metabolic reprogramming sustains cancer cell survival following extracellular matrix detachment. </span><span class="cited-content_cbyCitation_journal-name">Redox Biology</span><span> <strong>2020,</strong> <em>36 </em>, 101643. <a href="https://doi.org/10.1016/j.redox.2020.101643" title="DOI URL">https://doi.org/10.1016/j.redox.2020.101643</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.redox.2020.101643&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.redox.2020.101643%26sid%3Dliteratum%253Aachs%26jtitle%3DRedox%2520Biology%26atitle%3DMetabolic%252Breprogramming%252Bsustains%252Bcancer%252Bcell%252Bsurvival%252Bfollowing%252Bextracellular%252Bmatrix%252Bdetachment%26aulast%3DEndo%26aufirst%3DHitoshi%26date%3D2020%26volume%3D36%26spage%3D101643" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Luca  Frattaruolo</span>, <span class="hlFld-ContribAuthor ">Matteo  Brindisi</span>, <span class="hlFld-ContribAuthor ">Rosita  Curcio</span>, <span class="hlFld-ContribAuthor ">Federica  Marra</span>, <span class="hlFld-ContribAuthor ">Vincenza  Dolce</span>, <span class="hlFld-ContribAuthor ">Anna Rita  Cappello</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting the Mitochondrial Metabolic Network: A Promising Strategy in Cancer Treatment. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Sciences</span><span> <strong>2020,</strong> <em>21 </em>
                                    (17)
                                     , 6014. <a href="https://doi.org/10.3390/ijms21176014" title="DOI URL">https://doi.org/10.3390/ijms21176014</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ijms21176014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fijms21176014%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Sciences%26atitle%3DTargeting%252Bthe%252BMitochondrial%252BMetabolic%252BNetwork%25253A%252BA%252BPromising%252BStrategy%252Bin%252BCancer%252BTreatment%26aulast%3DFrattaruolo%26aufirst%3DLuca%26date%3D2020%26date%3D2020%26volume%3D21%26issue%3D17%26spage%3D6014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Camila  Benavides-Rivas</span>, <span class="hlFld-ContribAuthor ">Lina Mariana  Tovar</span>, <span class="hlFld-ContribAuthor ">Nicolás  Zúñiga</span>, <span class="hlFld-ContribAuthor ">Ingrid  Pinto-Borguero</span>, <span class="hlFld-ContribAuthor ">Claudio  Retamal</span>, <span class="hlFld-ContribAuthor ">Gonzalo E.  Yévenes</span>, <span class="hlFld-ContribAuthor ">Gustavo  Moraga-Cid</span>, <span class="hlFld-ContribAuthor ">Jorge  Fuentealba</span>, <span class="hlFld-ContribAuthor ">Leonardo  Guzmán</span>, <span class="hlFld-ContribAuthor ">Claudio  Coddou</span>, <span class="hlFld-ContribAuthor ">Luisa  Bascuñán-Godoy</span>, <span class="hlFld-ContribAuthor ">Patricio A.  Castro</span>. </span><span class="cited-content_cbyCitation_article-title">Altered Glutaminase 1 Activity During Neurulation and Its Potential Implications in Neural Tube Defects. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Pharmacology</span><span> <strong>2020,</strong> <em>11 </em><a href="https://doi.org/10.3389/fphar.2020.00900" title="DOI URL">https://doi.org/10.3389/fphar.2020.00900</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fphar.2020.00900&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffphar.2020.00900%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Pharmacology%26atitle%3DAltered%252BGlutaminase%252B1%252BActivity%252BDuring%252BNeurulation%252Band%252BIts%252BPotential%252BImplications%252Bin%252BNeural%252BTube%252BDefects%26aulast%3DBenavides-Rivas%26aufirst%3DCamila%26date%3D2020%26date%3D2020%26volume%3D11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kai-Yin  Yang</span>, <span class="hlFld-ContribAuthor ">Can-Rong  Wu</span>, <span class="hlFld-ContribAuthor ">Meng-Zhu  Zheng</span>, <span class="hlFld-ContribAuthor ">Ruo-Tian  Tang</span>, <span class="hlFld-ContribAuthor ">Xing-Zhou  Li</span>, <span class="hlFld-ContribAuthor ">Li-Xia  Chen</span>, <span class="hlFld-ContribAuthor ">Hua  Li</span>. </span><span class="cited-content_cbyCitation_article-title">Physapubescin I from husk tomato suppresses SW1990 cancer cell growth by targeting kidney-type glutaminase. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2019,</strong> <em>92 </em>, 103186. <a href="https://doi.org/10.1016/j.bioorg.2019.103186" title="DOI URL">https://doi.org/10.1016/j.bioorg.2019.103186</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2019.103186&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2019.103186%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DPhysapubescin%252BI%252Bfrom%252Bhusk%252Btomato%252Bsuppresses%252BSW1990%252Bcancer%252Bcell%252Bgrowth%252Bby%252Btargeting%252Bkidney-type%252Bglutaminase%26aulast%3DYang%26aufirst%3DKai-Yin%26date%3D2019%26volume%3D92%26spage%3D103186" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Evan C.  Lien</span>, <span class="hlFld-ContribAuthor ">Matthew G.  Vander Heiden</span>. </span><span class="cited-content_cbyCitation_article-title">A framework for examining how diet impacts tumour metabolism. </span><span class="cited-content_cbyCitation_journal-name">Nature Reviews Cancer</span><span> <strong>2019,</strong> <em>19 </em>
                                    (11)
                                     , 651-661. <a href="https://doi.org/10.1038/s41568-019-0198-5" title="DOI URL">https://doi.org/10.1038/s41568-019-0198-5</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41568-019-0198-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41568-019-0198-5%26sid%3Dliteratum%253Aachs%26jtitle%3DNature%2520Reviews%2520Cancer%26atitle%3DA%252Bframework%252Bfor%252Bexamining%252Bhow%252Bdiet%252Bimpacts%252Btumour%252Bmetabolism%26aulast%3DLien%26aufirst%3DEvan%2BC.%26date%3D2019%26date%3D2019%26volume%3D19%26issue%3D11%26spage%3D651%26epage%3D661" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sara  Loponte</span>, <span class="hlFld-ContribAuthor ">Sara  Lovisa</span>, <span class="hlFld-ContribAuthor ">Angela K.  Deem</span>, <span class="hlFld-ContribAuthor ">Alessandro  Carugo</span>, <span class="hlFld-ContribAuthor ">Andrea  Viale</span>. </span><span class="cited-content_cbyCitation_article-title">The Many Facets of Tumor Heterogeneity: Is Metabolism Lagging Behind?. </span><span class="cited-content_cbyCitation_journal-name">Cancers</span><span> <strong>2019,</strong> <em>11 </em>
                                    (10)
                                     , 1574. <a href="https://doi.org/10.3390/cancers11101574" title="DOI URL">https://doi.org/10.3390/cancers11101574</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/cancers11101574&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fcancers11101574%26sid%3Dliteratum%253Aachs%26jtitle%3DCancers%26atitle%3DThe%252BMany%252BFacets%252Bof%252BTumor%252BHeterogeneity%25253A%252BIs%252BMetabolism%252BLagging%252BBehind%25253F%26aulast%3DLoponte%26aufirst%3DSara%26date%3D2019%26date%3D2019%26volume%3D11%26issue%3D10%26spage%3D1574" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wei  Hou</span>, <span class="hlFld-ContribAuthor ">Jinzhang  Fang</span>, <span class="hlFld-ContribAuthor ">Lin  Su</span>, <span class="hlFld-ContribAuthor ">Hengyu  Ye</span>, <span class="hlFld-ContribAuthor ">Benfang Helen  Ruan</span>. </span><span class="cited-content_cbyCitation_article-title">Design and synthesis of biotinylated Hexylselen as a probe to identify KGA allosteric inhibitors by a convenient biomolecular interaction assay. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2019,</strong> <em>29 </em>
                                    (17)
                                     , 2498-2502. <a href="https://doi.org/10.1016/j.bmcl.2019.07.014" title="DOI URL">https://doi.org/10.1016/j.bmcl.2019.07.014</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2019.07.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2019.07.014%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDesign%252Band%252Bsynthesis%252Bof%252Bbiotinylated%252BHexylselen%252Bas%252Ba%252Bprobe%252Bto%252Bidentify%252BKGA%252Ballosteric%252Binhibitors%252Bby%252Ba%252Bconvenient%252Bbiomolecular%252Binteraction%252Bassay%26aulast%3DHou%26aufirst%3DWei%26date%3D2019%26volume%3D29%26issue%3D17%26spage%3D2498%26epage%3D2502" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">William P  Katt</span>, <span class="hlFld-ContribAuthor ">Richard A  Cerione</span>. </span><span class="cited-content_cbyCitation_article-title">Inhibition of cancer metabolism: a patent landscape. </span><span class="cited-content_cbyCitation_journal-name">Pharmaceutical Patent Analyst</span><span> <strong>2019,</strong> <em>8 </em>
                                    (4)
                                     , 117-138. <a href="https://doi.org/10.4155/ppa-2019-0012" title="DOI URL">https://doi.org/10.4155/ppa-2019-0012</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4155/ppa-2019-0012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4155%2Fppa-2019-0012%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmaceutical%2520Patent%2520Analyst%26atitle%3DInhibition%252Bof%252Bcancer%252Bmetabolism%25253A%252Ba%252Bpatent%252Blandscape%26aulast%3DKatt%26aufirst%3DWilliam%2BP%26date%3D2019%26volume%3D8%26issue%3D4%26spage%3D117%26epage%3D138" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Monica  Neagu</span>, <span class="hlFld-ContribAuthor ">Carolina  Constantin</span>, <span class="hlFld-ContribAuthor ">Iulia Dana  Popescu</span>, <span class="hlFld-ContribAuthor ">Donato  Zipeto</span>, <span class="hlFld-ContribAuthor ">George  Tzanakakis</span>, <span class="hlFld-ContribAuthor ">Dragana  Nikitovic</span>, <span class="hlFld-ContribAuthor ">Concettina  Fenga</span>, <span class="hlFld-ContribAuthor ">Constantine A.  Stratakis</span>, <span class="hlFld-ContribAuthor ">Demetrios A.  Spandidos</span>, <span class="hlFld-ContribAuthor ">Aristidis M.  Tsatsakis</span>. </span><span class="cited-content_cbyCitation_article-title">Inflammation and Metabolism in Cancer Cell—Mitochondria Key Player. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Oncology</span><span> <strong>2019,</strong> <em>9 </em><a href="https://doi.org/10.3389/fonc.2019.00348" title="DOI URL">https://doi.org/10.3389/fonc.2019.00348</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fonc.2019.00348&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffonc.2019.00348%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Oncology%26atitle%3DInflammation%252Band%252BMetabolism%252Bin%252BCancer%252BCell%2525E2%252580%252594Mitochondria%252BKey%252BPlayer%26aulast%3DNeagu%26aufirst%3DMonica%26date%3D2019%26date%3D2019%26volume%3D9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Germana  Castelli</span>, <span class="hlFld-ContribAuthor ">Elvira  Pelosi</span>, <span class="hlFld-ContribAuthor ">Ugo  Testa</span>. </span><span class="cited-content_cbyCitation_article-title">Emerging Therapies for Acute Myelogenus Leukemia Patients Targeting Apoptosis and Mitochondrial Metabolism. </span><span class="cited-content_cbyCitation_journal-name">Cancers</span><span> <strong>2019,</strong> <em>11 </em>
                                    (2)
                                     , 260. <a href="https://doi.org/10.3390/cancers11020260" title="DOI URL">https://doi.org/10.3390/cancers11020260</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/cancers11020260&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fcancers11020260%26sid%3Dliteratum%253Aachs%26jtitle%3DCancers%26atitle%3DEmerging%252BTherapies%252Bfor%252BAcute%252BMyelogenus%252BLeukemia%252BPatients%252BTargeting%252BApoptosis%252Band%252BMitochondrial%252BMetabolism%26aulast%3DCastelli%26aufirst%3DGermana%26date%3D2019%26date%3D2019%26volume%3D11%26issue%3D2%26spage%3D260" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b00961/20190211/images/medium/jm-2018-009616_0020.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b00961/20190211/images/large/jm-2018-009616_0020.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00961&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b00961/20190211/images/medium/jm-2018-009616_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b00961/20190211/images/large/jm-2018-009616_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. An overview of the glutamine metabolic pathway for therapy in cancer. Glutamine is imported via SLC1A5 (also known as ASCT2).<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> Glutamine can also be exchanged for essential amino acids, such as leucine, through the <span class="smallcaps smallerCapital">l</span>-type amino acid transporter 1 (LAT1).<a onclick="showRef(event, 'ref112'); return false;" href="javascript:void(0);" class="ref ref112">(112)</a> Glutamine can also contribute to nucleotide biosynthesis and uridine diphosphate <i>N</i>-acetylglucosamine (UDP-GlcNAc) synthesis for support of protein folding and trafficking.<a onclick="showRef(event, 'ref113'); return false;" href="javascript:void(0);" class="ref ref113">(113)</a> Glutamine is hydrolyzed to glutamate through glutaminase (GLS1/2). Glutamate can be converted to α-ketoglutarate (α-KG) through glutamate dehydrogenase (GDH) or aminotransferases.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> Through the actions of various aminotransferases, e.g., phosphoserine aminotransferase 1 (PSAT1), glutamic pyruvate transaminase (GPT), and glutamic oxaloacetic transaminase (GOT), glutamate derived from glutamine can supply nitrogen atoms for the biosynthesis of amino acids. In addition, glutamine can also directly provide nitrogen for asparagine by asparagine synthetase (ASNS). α-KG enters the tricarboxylic acid (TCA) cycle and can provide energy and building blocks for the growth and proliferation of cell. Modulators that target various aspects of glutamine metabolism are shown in red.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b00961/20190211/images/large/jm-2018-009616_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00961&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b00961/20190211/images/medium/jm-2018-009616_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b00961/20190211/images/large/jm-2018-009616_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Schematic view and structure of GLS. (A) KGA/GAC domains. (B) Structure and binding sites of GLS1. Allosteric binding pocket is shown in red, and substrate catalytic site is shown in green.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b00961/20190211/images/large/jm-2018-009616_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00961&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b00961/20190211/images/medium/jm-2018-009616_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b00961/20190211/images/large/jm-2018-009616_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Structure and important amino acids of substrate catalytic site and allosteric binding pocket of GLS1. (A) Structure of GLS1 and bound substrate (GLN) is shown as a purple stick. N-Terminal is labeled as N and C-terminal is labeled as C. (B) The key residues of substrate catalytic site and hydrogen bonds with substrate GLN are shown. The hydrogen bonds were shown as dotted lines. (C) The allosteric binding pocket of GLS1. (D) The key residues in the allosteric binding pocket.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b00961/20190211/images/large/jm-2018-009616_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00961&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b00961/20190211/images/medium/jm-2018-009616_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b00961/20190211/images/large/jm-2018-009616_0004.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. (A) The structures of glutamine mimetics. (B) The interactions of <b>DON</b> with the catalytic site of KGA (cKGA, PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4O7D">4O7D</a>). <b>DON</b> is shown as a red stick, and cKGA residues are shown in cyan. (C) Proposed active site inhibition mechanism of KGA.<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b00961/20190211/images/large/jm-2018-009616_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00961&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b00961/20190211/images/medium/jm-2018-009616_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b00961/20190211/images/large/jm-2018-009616_0005.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Chemical structures of glutamine analogues and the strategy of <b>DON</b> prodrugs.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b00961/20190211/images/large/jm-2018-009616_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00961&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b00961/20190211/images/medium/jm-2018-009616_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b00961/20190211/images/large/jm-2018-009616_0006.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. (A) A close-up view of the interactions of <b>BPTES</b> in the GLS allosteric inhibitor binding pocket. (B) The chemical structure of <b>BPTES</b>. (C) Conformational changes on GLS induced by binding of the <b>BPTES</b>. (<b>BPTES</b>-KGA PDB, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3UO9">3UO9</a>; Apo GLS PDB, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3VOY">3VOY</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b00961/20190211/images/large/jm-2018-009616_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00961&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b00961/20190211/images/medium/jm-2018-009616_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b00961/20190211/images/large/jm-2018-009616_0007.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Representative chemical structures of truncated <b>BPTES</b> analogues.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b00961/20190211/images/large/jm-2018-009616_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00961&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b00961/20190211/images/medium/jm-2018-009616_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b00961/20190211/images/large/jm-2018-009616_0008.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Representative structures of compounds (<b>Zimmermann-2h</b>–<b>2q</b>) with 1,4-di(5-amino-1,3,4-thiadiazol-2-yl)-butane scaffold. These compounds focused on exploring the SAR of terminal phenylacetyl groups.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b00961/20190211/images/large/jm-2018-009616_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00961&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig9" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b00961/20190211/images/medium/jm-2018-009616_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b00961/20190211/images/large/jm-2018-009616_0009.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Representative compounds with appropriate size rings replacing flexible connecting linker.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b00961/20190211/images/large/jm-2018-009616_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00961&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig10" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b00961/20190211/images/medium/jm-2018-009616_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b00961/20190211/images/large/jm-2018-009616_0010.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. Overlay of binding modes of <b>BPTES</b> (pink, PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3UO9">3UO9</a>), <b>McDermott-7d</b> (yellow, PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5FI2">5FI2</a>), <b>McDermott-7e</b> (orange, PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5FI6">5FI6</a>), and <b>McDermott-14d</b> (green, PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5I94">5I94</a>) with GAC.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b00961/20190211/images/large/jm-2018-009616_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00961&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig11" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b00961/20190211/images/medium/jm-2018-009616_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b00961/20190211/images/large/jm-2018-009616_0011.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 11. Cocrystal structures of GLS1 in complex with <b>CB-839</b> bound to the allosteric pocket. (A) Detailed binding mode of <b>CB-839</b>-KGA (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5JYO">5JYO</a>). (B) Detailed binding mode of <b>CB-839</b>-GAC (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5HL1">5HL1</a>). Carbon atoms of <b>CB-839</b> are shown in yellow sticks. The residues involved in allosteric site are highlighted in rose red. Hydrogen bonds are represented by black dashed lines, and H···π binding is represented by red dashed lines. (C) The structures of <b>BPTES</b> and <b>CB-839</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b00961/20190211/images/large/jm-2018-009616_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00961&amp;id=fig11"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig12" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 12</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b00961/20190211/images/medium/jm-2018-009616_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b00961/20190211/images/large/jm-2018-009616_0012.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 12. Structures of <b>968</b> and its representative derivatives. (A) SAR of benzophenanthridinone scaffold derivatives. (B) Crystal structure of the GAC tetramer in complex with <b>BPTES</b> (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3UO9">3UO9</a>), with the proposed <b>968</b>-binding site indicated by the arrow pointing toward the C-terminal monomer–monomer interface. <b>BPTES</b> and <b>968</b> were indicated by red and gray sphere, respectively.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b00961/20190211/images/large/jm-2018-009616_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00961&amp;id=fig12"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig13" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 13</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b00961/20190211/images/medium/jm-2018-009616_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b00961/20190211/images/large/jm-2018-009616_0013.jpeg" id="rightTab-gr13" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 13. (A) Representative glutaminase inhibitors of thiazolidine-2,4-dione scaffold. (B) Overview of the proposed association of compound <b>Yeh-5</b> in a GLS1 tetramer.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b00961/20190211/images/large/jm-2018-009616_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00961&amp;id=fig13"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig14" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 14</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b00961/20190211/images/medium/jm-2018-009616_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b00961/20190211/images/large/jm-2018-009616_0014.jpeg" id="rightTab-gr14" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 14. Structures of two KGA inhibitors isolated from natural products.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b00961/20190211/images/large/jm-2018-009616_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00961&amp;id=fig14"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig15" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Figure 15</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b00961/20190211/images/medium/jm-2018-009616_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b00961/20190211/images/large/jm-2018-009616_0015.jpeg" id="rightTab-gr15" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 15. Structure of alkyl benzoquinones and the mechanism that <b>AV-1</b> inhibits glutaminase-2.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b00961/20190211/images/large/jm-2018-009616_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00961&amp;id=fig15"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i47">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_17424" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_17424" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 119 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schulze, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harris, A. L.</span></span> <span> </span><span class="NLM_article-title">How cancer metabolism is tuned for proliferation and vulnerable to disruption</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>491</i></span> (<span class="NLM_issue">7424</span>),  <span class="NLM_fpage">364</span>– <span class="NLM_lpage">373</span>, <span class="refDoi"> DOI: 10.1038/nature11706</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=10.1038%2Fnature11706" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=23151579" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhs1Ogt77F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=491&publication_year=2012&pages=364-373&issue=7424&author=A.+Schulzeauthor=A.+L.+Harris&title=How+cancer+metabolism+is+tuned+for+proliferation+and+vulnerable+to+disruption&doi=10.1038%2Fnature11706"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">How cancer metabolism is tuned for proliferation and vulnerable to disruption</span></div><div class="casAuthors">Schulze, Almut; Harris, Adrian L.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">491</span>
        (<span class="NLM_cas:issue">7424</span>),
    <span class="NLM_cas:pages">364-373</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Cancer metab. has received a substantial amt. of interest over the past decade.  The advances in anal. tools have, along with the rapid progress of cancer genomics, generated an increasingly complex understanding of metabolic reprogramming in cancer.  As numerous connections between oncogenic signalling pathways and metabolic activities emerge, the importance of metabolic reprogramming in cancer is being increasingly recognized.  The identification of metabolic weaknesses of cancer cells has been used to create strategies for treating cancer, but there are still challenges to be faced in bringing the drugs that target cancer metab. to the clinic.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoBw8y9SFJ0lLVg90H21EOLACvtfcHk0lgxCq8G4rxMMA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhs1Ogt77F&md5=73cdad5f0a8652993ff162b9b1ba6fe7</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1038%2Fnature11706&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature11706%26sid%3Dliteratum%253Aachs%26aulast%3DSchulze%26aufirst%3DA.%26aulast%3DHarris%26aufirst%3DA.%2BL.%26atitle%3DHow%2520cancer%2520metabolism%2520is%2520tuned%2520for%2520proliferation%2520and%2520vulnerable%2520to%2520disruption%26jtitle%3DNature%26date%3D2012%26volume%3D491%26issue%3D7424%26spage%3D364%26epage%3D373%26doi%3D10.1038%2Fnature11706" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Warburg, O.</span></span> <span> </span><span class="NLM_article-title">On the origin of cancer cells</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">1956</span>,  <span class="NLM_volume"><i>123</i></span>,  <span class="NLM_fpage">309</span>– <span class="NLM_lpage">314</span>, <span class="refDoi"> DOI: 10.1126/science.123.3191.309</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=10.1126%2Fscience.123.3191.309" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=13298683" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=1%3ACAS%3A280%3ADyaG28%252FltV2ktQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=123&publication_year=1956&pages=309-314&author=O.+Warburg&title=On+the+origin+of+cancer+cells&doi=10.1126%2Fscience.123.3191.309"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">On the origin of cancer cells</span></div><div class="casAuthors">WARBURG O</div><div class="citationInfo"><span class="NLM_cas:title">Science (New York, N.Y.)</span>
        (<span class="NLM_cas:date">1956</span>),
    <span class="NLM_cas:volume">123</span>
        (<span class="NLM_cas:issue">3191</span>),
    <span class="NLM_cas:pages">309-14</span>
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRDsp1coYpQW669lAbTj9rGfW6udTcc2eYjPamd4V4s87ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaG28%252FltV2ktQ%253D%253D&md5=860d5ce9456831968fcc897b37d6d9c2</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1126%2Fscience.123.3191.309&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.123.3191.309%26sid%3Dliteratum%253Aachs%26aulast%3DWarburg%26aufirst%3DO.%26atitle%3DOn%2520the%2520origin%2520of%2520cancer%2520cells%26jtitle%3DScience%26date%3D1956%26volume%3D123%26spage%3D309%26epage%3D314%26doi%3D10.1126%2Fscience.123.3191.309" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hensley, C. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wasti, A. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeBerardinis, R. J.</span></span> <span> </span><span class="NLM_article-title">Glutamine and cancer: cell biology, physiology, and clinical opportunities</span>. <i>J. Clin. Invest.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>123</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">3678</span>– <span class="NLM_lpage">3684</span>, <span class="refDoi"> DOI: 10.1172/JCI69600</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=10.1172%2FJCI69600" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=123&publication_year=2013&pages=3678-3684&issue=9&author=C.+T.+Hensleyauthor=A.+T.+Wastiauthor=R.+J.+DeBerardinis&title=Glutamine+and+cancer%3A+cell+biology%2C+physiology%2C+and+clinical+opportunities&doi=10.1172%2FJCI69600"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1172%2FJCI69600&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1172%252FJCI69600%26sid%3Dliteratum%253Aachs%26aulast%3DHensley%26aufirst%3DC.%2BT.%26aulast%3DWasti%26aufirst%3DA.%2BT.%26aulast%3DDeBerardinis%26aufirst%3DR.%2BJ.%26atitle%3DGlutamine%2520and%2520cancer%253A%2520cell%2520biology%252C%2520physiology%252C%2520and%2520clinical%2520opportunities%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2013%26volume%3D123%26issue%3D9%26spage%3D3678%26epage%3D3684%26doi%3D10.1172%2FJCI69600" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bergström, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fürst, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Norée, L. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vinnars, E.</span></span> <span> </span><span class="NLM_article-title">Intracellular free amino acid concentration in human muscle tissue</span>. <i>J. Appl. Physiol.</i> <span class="NLM_year" style="font-weight: bold;">1974</span>,  <span class="NLM_volume"><i>36</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">693</span>– <span class="NLM_lpage">697</span>, <span class="refDoi"> DOI: 10.1152/jappl.1974.36.6.693</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=10.1152%2Fjappl.1974.36.6.693" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=1974&pages=693-697&issue=6&author=J.+Bergstr%C3%B6mauthor=P.+F%C3%BCrstauthor=L.+O.+Nor%C3%A9eauthor=E.+Vinnars&title=Intracellular+free+amino+acid+concentration+in+human+muscle+tissue&doi=10.1152%2Fjappl.1974.36.6.693"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1152%2Fjappl.1974.36.6.693&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1152%252Fjappl.1974.36.6.693%26sid%3Dliteratum%253Aachs%26aulast%3DBergstr%25C3%25B6m%26aufirst%3DJ.%26aulast%3DF%25C3%25BCrst%26aufirst%3DP.%26aulast%3DNor%25C3%25A9e%26aufirst%3DL.%2BO.%26aulast%3DVinnars%26aufirst%3DE.%26atitle%3DIntracellular%2520free%2520amino%2520acid%2520concentration%2520in%2520human%2520muscle%2520tissue%26jtitle%3DJ.%2520Appl.%2520Physiol.%26date%3D1974%26volume%3D36%26issue%3D6%26spage%3D693%26epage%3D697%26doi%3D10.1152%2Fjappl.1974.36.6.693" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dranoff, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elion, G. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Friedman, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campbell, G. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bigner, D. D.</span></span> <span> </span><span class="NLM_article-title">Influence of glutamine on the growth of human glioma and medulloblastoma in culture</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">1985</span>,  <span class="NLM_volume"><i>45</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">4077</span>– <span class="NLM_lpage">4081</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=1985&pages=4077-4081&issue=9&author=G.+Dranoffauthor=G.+B.+Elionauthor=H.+S.+Friedmanauthor=G.+L.+Campbellauthor=D.+D.+Bigner&title=Influence+of+glutamine+on+the+growth+of+human+glioma+and+medulloblastoma+in+culture"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDranoff%26aufirst%3DG.%26aulast%3DElion%26aufirst%3DG.%2BB.%26aulast%3DFriedman%26aufirst%3DH.%2BS.%26aulast%3DCampbell%26aufirst%3DG.%2BL.%26aulast%3DBigner%26aufirst%3DD.%2BD.%26atitle%3DInfluence%2520of%2520glutamine%2520on%2520the%2520growth%2520of%2520human%2520glioma%2520and%2520medulloblastoma%2520in%2520culture%26jtitle%3DCancer%2520Res.%26date%3D1985%26volume%3D45%26issue%3D9%26spage%3D4077%26epage%3D4081" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fogal, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Babic, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pastorino, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mukthavaram, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cho, Y. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pingle, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crawford, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piccioni, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kesari, S.</span></span> <span> </span><span class="NLM_article-title">Mitochondrial p32 is upregulated in Myc expressing brain cancers and mediates glutamine addiction</span>. <i>Oncotarget</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>6</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">1157</span>– <span class="NLM_lpage">1170</span>, <span class="refDoi"> DOI: 10.18632/oncotarget.2708</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=10.18632%2Foncotarget.2708" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=1157-1170&issue=2&author=V.+Fogalauthor=I.+Babicauthor=Y.+Chaoauthor=S.+Pastorinoauthor=R.+Mukthavaramauthor=P.+Jiangauthor=Y.+J.+Choauthor=S.+C.+Pingleauthor=J.+R.+Crawfordauthor=D.+E.+Piccioniauthor=S.+Kesari&title=Mitochondrial+p32+is+upregulated+in+Myc+expressing+brain+cancers+and+mediates+glutamine+addiction&doi=10.18632%2Foncotarget.2708"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.2708&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.2708%26sid%3Dliteratum%253Aachs%26aulast%3DFogal%26aufirst%3DV.%26aulast%3DBabic%26aufirst%3DI.%26aulast%3DChao%26aufirst%3DY.%26aulast%3DPastorino%26aufirst%3DS.%26aulast%3DMukthavaram%26aufirst%3DR.%26aulast%3DJiang%26aufirst%3DP.%26aulast%3DCho%26aufirst%3DY.%2BJ.%26aulast%3DPingle%26aufirst%3DS.%2BC.%26aulast%3DCrawford%26aufirst%3DJ.%2BR.%26aulast%3DPiccioni%26aufirst%3DD.%2BE.%26aulast%3DKesari%26aufirst%3DS.%26atitle%3DMitochondrial%2520p32%2520is%2520upregulated%2520in%2520Myc%2520expressing%2520brain%2520cancers%2520and%2520mediates%2520glutamine%2520addiction%26jtitle%3DOncotarget%26date%3D2015%26volume%3D6%26issue%3D2%26spage%3D1157%26epage%3D1170%26doi%3D10.18632%2Foncotarget.2708" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ru, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chakravarti, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, D.</span></span> <span> </span><span class="NLM_article-title">Tumor metabolism of malignant gliomas</span>. <i>Cancers</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>5</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">1469</span>– <span class="NLM_lpage">1484</span>, <span class="refDoi"> DOI: 10.3390/cancers5041469</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=10.3390%2Fcancers5041469" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2013&pages=1469-1484&issue=4&author=P.+Ruauthor=T.+M.+Williamsauthor=A.+Chakravartiauthor=D.+Guo&title=Tumor+metabolism+of+malignant+gliomas&doi=10.3390%2Fcancers5041469"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.3390%2Fcancers5041469&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fcancers5041469%26sid%3Dliteratum%253Aachs%26aulast%3DRu%26aufirst%3DP.%26aulast%3DWilliams%26aufirst%3DT.%2BM.%26aulast%3DChakravarti%26aufirst%3DA.%26aulast%3DGuo%26aufirst%3DD.%26atitle%3DTumor%2520metabolism%2520of%2520malignant%2520gliomas%26jtitle%3DCancers%26date%3D2013%26volume%3D5%26issue%3D4%26spage%3D1469%26epage%3D1484%26doi%3D10.3390%2Fcancers5041469" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tanaka, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sasayama, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Irino, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takata, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagashima, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Satoh, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kyotani, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mizowaki, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Imahori, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ejima, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Masui, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gini, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hosoda, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sasaki, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mischel, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kohmura, E.</span></span> <span> </span><span class="NLM_article-title">Compensatory glutamine metabolism promotes glioblastoma resistance to mTOR inhibitor treatment</span>. <i>J. Clin. Invest.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>125</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">1591</span>– <span class="NLM_lpage">1602</span>, <span class="refDoi"> DOI: 10.1172/JCI78239</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=10.1172%2FJCI78239" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=125&publication_year=2015&pages=1591-1602&issue=4&author=K.+Tanakaauthor=T.+Sasayamaauthor=Y.+Irinoauthor=K.+Takataauthor=H.+Nagashimaauthor=N.+Satohauthor=K.+Kyotaniauthor=T.+Mizowakiauthor=T.+Imahoriauthor=Y.+Ejimaauthor=K.+Masuiauthor=B.+Giniauthor=H.+Yangauthor=K.+Hosodaauthor=R.+Sasakiauthor=P.+S.+Mischelauthor=E.+Kohmura&title=Compensatory+glutamine+metabolism+promotes+glioblastoma+resistance+to+mTOR+inhibitor+treatment&doi=10.1172%2FJCI78239"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1172%2FJCI78239&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1172%252FJCI78239%26sid%3Dliteratum%253Aachs%26aulast%3DTanaka%26aufirst%3DK.%26aulast%3DSasayama%26aufirst%3DT.%26aulast%3DIrino%26aufirst%3DY.%26aulast%3DTakata%26aufirst%3DK.%26aulast%3DNagashima%26aufirst%3DH.%26aulast%3DSatoh%26aufirst%3DN.%26aulast%3DKyotani%26aufirst%3DK.%26aulast%3DMizowaki%26aufirst%3DT.%26aulast%3DImahori%26aufirst%3DT.%26aulast%3DEjima%26aufirst%3DY.%26aulast%3DMasui%26aufirst%3DK.%26aulast%3DGini%26aufirst%3DB.%26aulast%3DYang%26aufirst%3DH.%26aulast%3DHosoda%26aufirst%3DK.%26aulast%3DSasaki%26aufirst%3DR.%26aulast%3DMischel%26aufirst%3DP.%2BS.%26aulast%3DKohmura%26aufirst%3DE.%26atitle%3DCompensatory%2520glutamine%2520metabolism%2520promotes%2520glioblastoma%2520resistance%2520to%2520mTOR%2520inhibitor%2520treatment%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2015%26volume%3D125%26issue%3D4%26spage%3D1591%26epage%3D1602%26doi%3D10.1172%2FJCI78239" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wise, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, C. B.</span></span> <span> </span><span class="NLM_article-title">Glutamine addiction: a new therapeutic target in cancer</span>. <i>Trends Biochem. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>35</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">427</span>– <span class="NLM_lpage">433</span>, <span class="refDoi"> DOI: 10.1016/j.tibs.2010.05.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=10.1016%2Fj.tibs.2010.05.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=20570523" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=1%3ACAS%3A528%3ADC%252BC3cXpvFKqs7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2010&pages=427-433&issue=8&author=D.+R.+Wiseauthor=C.+B.+Thompson&title=Glutamine+addiction%3A+a+new+therapeutic+target+in+cancer&doi=10.1016%2Fj.tibs.2010.05.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Glutamine addiction: A new therapeutic target in cancer</span></div><div class="casAuthors">Wise, David R.; Thompson, Craig B.</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Biochemical Sciences</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">427-433</span>CODEN:
                <span class="NLM_cas:coden">TBSCDB</span>;
        ISSN:<span class="NLM_cas:issn">0968-0004</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Most cancers depend on a high rate of aerobic glycolysis for their continued growth and survival.  Paradoxically, some cancer cell lines also display addiction to glutamine despite the fact that glutamine is a nonessential amino acid that can be synthesized from glucose.  The high rate of glutamine uptake exhibited by glutamine-dependent cells does not appear to result solely from its role as a nitrogen donor in nucleotide and amino acid biosynthesis.  Instead, glutamine plays a required role in the uptake of essential amino acids and in maintaining activation of TOR (target of rapamycin) kinase.  Moreover, in many cancer cells, glutamine is the primary mitochondrial substrate and is required for maintenance of mitochondrial membrane potential and integrity and for support of the NADPH prodn. needed for redox control and macromol. synthesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo4Gv_LsNdulLVg90H21EOLACvtfcHk0lj2tqqv_zkITw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXpvFKqs7s%253D&md5=915fa51996bc1c9b3ec3970b2dae7163</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2Fj.tibs.2010.05.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tibs.2010.05.003%26sid%3Dliteratum%253Aachs%26aulast%3DWise%26aufirst%3DD.%2BR.%26aulast%3DThompson%26aufirst%3DC.%2BB.%26atitle%3DGlutamine%2520addiction%253A%2520a%2520new%2520therapeutic%2520target%2520in%2520cancer%26jtitle%3DTrends%2520Biochem.%2520Sci.%26date%3D2010%26volume%3D35%26issue%3D8%26spage%3D427%26epage%3D433%26doi%3D10.1016%2Fj.tibs.2010.05.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stern, H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ge, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Brien, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haydu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Honchell, C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haverty, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peters, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, T. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amler, L. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chant, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stokoe, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lackner, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cavet, G.</span></span> <span> </span><span class="NLM_article-title">Genetic alterations and oncogenic pathways associated with breast cancer subtypes</span>. <i>Mol. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">511</span>– <span class="NLM_lpage">522</span>, <span class="refDoi"> DOI: 10.1158/1541-7786.MCR-08-0107</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=10.1158%2F1541-7786.MCR-08-0107" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=19372580" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=1%3ACAS%3A528%3ADC%252BD1MXks1antb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2009&pages=511-522&author=X.+Huauthor=H.+M.+Sternauthor=L.+Geauthor=C.+O%E2%80%99Brienauthor=L.+Hayduauthor=C.+D.+Honchellauthor=P.+M.+Havertyauthor=B.+A.+Petersauthor=T.+D.+Wuauthor=L.+C.+Amlerauthor=J.+Chantauthor=D.+Stokoeauthor=M.+R.+Lacknerauthor=G.+Cavet&title=Genetic+alterations+and+oncogenic+pathways+associated+with+breast+cancer+subtypes&doi=10.1158%2F1541-7786.MCR-08-0107"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Genetic alterations and oncogenic pathways associated with breast cancer subtypes</span></div><div class="casAuthors">Hu, Xiaolan; Stern, Howard M.; Ge, Lin; O'Brien, Carol; Haydu, Lauren; Honchell, Cynthia D.; Haverty, Peter M.; Peters, Brock A.; Wu, Thomas D.; Amler, Lukas C.; Chant, John; Stokoe, David; Lackner, Mark R.; Cavet, Guy</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Research</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">511-522</span>CODEN:
                <span class="NLM_cas:coden">MCROC5</span>;
        ISSN:<span class="NLM_cas:issn">1541-7786</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Breast cancers can be divided into subtypes with important implications for prognosis and treatment.  We set out to characterize the genetic alterations obsd. in different breast cancer subtypes and to identify specific candidate genes and pathways assocd. with subtype biol. mRNA expression levels of estrogen receptor, progesterone receptor, and HER2 were shown to predict marker status detd. by immunohistochem. and to be effective at assigning samples to subtypes.  HER2+ cancers were shown to have the greatest frequency of high-level amplification (independent of the ERBB2 amplicon itself), but triple-neg. cancers had the highest overall frequencies of copy gain.  Triple-neg. cancers also were shown to have more frequent loss of phosphatase and tensin homolog and mutation of RB1, which may contribute to genomic instability.  We identified and validated seven regions of copy no. alteration assocd. with different subtypes, and used integrative bioinformatics anal. to identify candidate oncogenes and tumor suppressors, including ERBB2, GRB7, MYST2, PPM1D, CCND1, HDAC2, FOXA1, and RASA1.  We tested the candidate oncogene MYST2 and showed that it enhances the anchorage-independent growth of breast cancer cells.  The genome-wide and region-specific differences between subtypes suggest the differential activation of oncogenic pathways.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoJudYxsDHmfrVg90H21EOLACvtfcHk0lgdgZ3m4YCLVQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXks1antb0%253D&md5=018b11118ce93239c92e229f81b286e4</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1158%2F1541-7786.MCR-08-0107&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1541-7786.MCR-08-0107%26sid%3Dliteratum%253Aachs%26aulast%3DHu%26aufirst%3DX.%26aulast%3DStern%26aufirst%3DH.%2BM.%26aulast%3DGe%26aufirst%3DL.%26aulast%3DO%25E2%2580%2599Brien%26aufirst%3DC.%26aulast%3DHaydu%26aufirst%3DL.%26aulast%3DHonchell%26aufirst%3DC.%2BD.%26aulast%3DHaverty%26aufirst%3DP.%2BM.%26aulast%3DPeters%26aufirst%3DB.%2BA.%26aulast%3DWu%26aufirst%3DT.%2BD.%26aulast%3DAmler%26aufirst%3DL.%2BC.%26aulast%3DChant%26aufirst%3DJ.%26aulast%3DStokoe%26aufirst%3DD.%26aulast%3DLackner%26aufirst%3DM.%2BR.%26aulast%3DCavet%26aufirst%3DG.%26atitle%3DGenetic%2520alterations%2520and%2520oncogenic%2520pathways%2520associated%2520with%2520breast%2520cancer%2520subtypes%26jtitle%3DMol.%2520Cancer%2520Res.%26date%3D2009%26volume%3D7%26spage%3D511%26epage%3D522%26doi%3D10.1158%2F1541-7786.MCR-08-0107" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bhutia, Y. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Babu, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramachandran, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ganapathy, V.</span></span> <span> </span><span class="NLM_article-title">Amino acid transporters in cancer and their relevance to “glutamine addiction”: novel targets for the design of a new class of anticancer drugs</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>75</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">1782</span>– <span class="NLM_lpage">1788</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-14-3745</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=10.1158%2F0008-5472.CAN-14-3745" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=75&publication_year=2015&pages=1782-1788&issue=9&author=Y.+D.+Bhutiaauthor=E.+Babuauthor=S.+Ramachandranauthor=V.+Ganapathy&title=Amino+acid+transporters+in+cancer+and+their+relevance+to+%E2%80%9Cglutamine+addiction%E2%80%9D%3A+novel+targets+for+the+design+of+a+new+class+of+anticancer+drugs&doi=10.1158%2F0008-5472.CAN-14-3745"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-14-3745&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-14-3745%26sid%3Dliteratum%253Aachs%26aulast%3DBhutia%26aufirst%3DY.%2BD.%26aulast%3DBabu%26aufirst%3DE.%26aulast%3DRamachandran%26aufirst%3DS.%26aulast%3DGanapathy%26aufirst%3DV.%26atitle%3DAmino%2520acid%2520transporters%2520in%2520cancer%2520and%2520their%2520relevance%2520to%2520%25E2%2580%259Cglutamine%2520addiction%25E2%2580%259D%253A%2520novel%2520targets%2520for%2520the%2520design%2520of%2520a%2520new%2520class%2520of%2520anticancer%2520drugs%26jtitle%3DCancer%2520Res.%26date%3D2015%26volume%3D75%26issue%3D9%26spage%3D1782%26epage%3D1788%26doi%3D10.1158%2F0008-5472.CAN-14-3745" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Krebs, H. A.</span></span> <span> </span><span class="NLM_article-title">Metabolism of amino-acids: The synthesis of glutamine from glutamic acid and ammonia, and the enzymic hydrolysis of glutamine in animal tissues</span>. <i>Biochem. J.</i> <span class="NLM_year" style="font-weight: bold;">1935</span>,  <span class="NLM_volume"><i>29</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">1951</span>– <span class="NLM_lpage">1969</span>, <span class="refDoi"> DOI: 10.1042/bj0291951</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=10.1042%2Fbj0291951" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=1935&pages=1951-1969&issue=8&author=H.+A.+Krebs&title=Metabolism+of+amino-acids%3A+The+synthesis+of+glutamine+from+glutamic+acid+and+ammonia%2C+and+the+enzymic+hydrolysis+of+glutamine+in+animal+tissues&doi=10.1042%2Fbj0291951"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1042%2Fbj0291951&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252Fbj0291951%26sid%3Dliteratum%253Aachs%26aulast%3DKrebs%26aufirst%3DH.%2BA.%26atitle%3DMetabolism%2520of%2520amino-acids%253A%2520The%2520synthesis%2520of%2520glutamine%2520from%2520glutamic%2520acid%2520and%2520ammonia%252C%2520and%2520the%2520enzymic%2520hydrolysis%2520of%2520glutamine%2520in%2520animal%2520tissues%26jtitle%3DBiochem.%2520J.%26date%3D1935%26volume%3D29%26issue%3D8%26spage%3D1951%26epage%3D1969%26doi%3D10.1042%2Fbj0291951" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Curthoys, N. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watford, M.</span></span> <span> </span><span class="NLM_article-title">Regulation of glutaminase activity and glutamine metabolism</span>. <i>Annu. Rev. Nutr.</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">133</span>– <span class="NLM_lpage">159</span>, <span class="refDoi"> DOI: 10.1146/annurev.nu.15.070195.001025</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=10.1146%2Fannurev.nu.15.070195.001025" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=8527215" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=1%3ACAS%3A528%3ADyaK2MXntVCjsro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=1995&pages=133-159&author=N.+P.+Curthoysauthor=M.+Watford&title=Regulation+of+glutaminase+activity+and+glutamine+metabolism&doi=10.1146%2Fannurev.nu.15.070195.001025"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Regulation glutaminase activity and glutamine metabolism</span></div><div class="casAuthors">Curthoys, Norman P.; Watford, Malcolm</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Nutrition</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">133-59</span>CODEN:
                <span class="NLM_cas:coden">ARNTD8</span>;
        ISSN:<span class="NLM_cas:issn">0199-9885</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews</span>)
        </div><div class="casAbstract">A review with 140 refs.  Glutamine is synthesized primarily in skeletal muscle, lungs, and adipose tissue.  Plasma glutamine plays an important role as a carrier of nitrogen, carbon, and energy between organs and is used for hepatic urea synthesis, for renal ammoniagenesis, for gluconeogenesis in both liver and kidney, and as a major respiratory fuel for many cells.  The catabolism of glutamine is initiated by either of two isoforms of the mitochondrial glutaminase.  Liver-type glutaminase is expressed only in periportal hepatocytes of the postnatal liver, where it effectively couples ammonia prodn. with urea synthesis.  Kidney-type glutaminase is abundant in kidney, brain, intestine, fetal liver, lymphocytes, and transformed cells, where the resulting ammonia is released without further metab.  The two isoenzymes have different structural and kinetic properties that contribute to their function and short-term regulation.  Although there is a high degree of identity in amino acid sequences, the two glutaminases are the products of different but related genes.  The two isoenzymes are also subject to long-term regulation.  Hepatic glutaminase is increased during starvation, diabetes, and feeding a high-protein diet, whereas kidney-type glutaminase is increased only in kidney in response to metabolic acidosis.  The adaptations in hepatic glutaminase are mediated by changes in the rate of transcription, whereas kidney-type glutaminase is regulated at a posttranscriptional level.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpuwFIcwEfNprVg90H21EOLACvtfcHk0lgdgZ3m4YCLVQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXntVCjsro%253D&md5=dade1bde55e6f616f609d5072bf591db</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1146%2Fannurev.nu.15.070195.001025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.nu.15.070195.001025%26sid%3Dliteratum%253Aachs%26aulast%3DCurthoys%26aufirst%3DN.%2BP.%26aulast%3DWatford%26aufirst%3DM.%26atitle%3DRegulation%2520of%2520glutaminase%2520activity%2520and%2520glutamine%2520metabolism%26jtitle%3DAnnu.%2520Rev.%2520Nutr.%26date%3D1995%26volume%3D15%26spage%3D133%26epage%3D159%26doi%3D10.1146%2Fannurev.nu.15.070195.001025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Moreadith, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lehninger, A. L.</span></span> <span> </span><span class="NLM_article-title">The pathways of glutamate and glutamine oxidation by tumor cell mitochondria. Role of mitochondrial NAD(P)<sup>+</sup>-dependent malic enzyme</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1984</span>,  <span class="NLM_volume"><i>259</i></span>,  <span class="NLM_fpage">6215</span>– <span class="NLM_lpage">6221</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=259&publication_year=1984&pages=6215-6221&author=R.+W.+Moreadithauthor=A.+L.+Lehninger&title=The+pathways+of+glutamate+and+glutamine+oxidation+by+tumor+cell+mitochondria.+Role+of+mitochondrial+NAD%28P%29%2B-dependent+malic+enzyme"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMoreadith%26aufirst%3DR.%2BW.%26aulast%3DLehninger%26aufirst%3DA.%2BL.%26atitle%3DThe%2520pathways%2520of%2520glutamate%2520and%2520glutamine%2520oxidation%2520by%2520tumor%2520cell%2520mitochondria.%2520Role%2520of%2520mitochondrial%2520NAD%2528P%2529%252B-dependent%2520malic%2520enzyme%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1984%26volume%3D259%26spage%3D6215%26epage%3D6221" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sullivan, L. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gui, D. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hosios, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bush, L. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Freinkman, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vander Heiden, M. G.</span></span> <span> </span><span class="NLM_article-title">Supporting aspartate biosynthesis is an essential function of respiration in proliferating cells</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>162</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">552</span>– <span class="NLM_lpage">563</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2015.07.017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=10.1016%2Fj.cell.2015.07.017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=26232225" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=1%3ACAS%3A528%3ADC%252BC2MXht12jsrrO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=162&publication_year=2015&pages=552-563&issue=3&author=L.+B.+Sullivanauthor=D.+Y.+Guiauthor=A.+M.+Hosiosauthor=L.+N.+Bushauthor=E.+Freinkmanauthor=M.+G.+Vander+Heiden&title=Supporting+aspartate+biosynthesis+is+an+essential+function+of+respiration+in+proliferating+cells&doi=10.1016%2Fj.cell.2015.07.017"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Supporting aspartate biosynthesis is an essential function of respiration in proliferating cells</span></div><div class="casAuthors">Sullivan, Lucas B.; Gui, Dan Y.; Hosios, Aaron M.; Bush, Lauren N.; Freinkman, Elizaveta; Vander Heiden, Matthew G.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">162</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">552-563</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Mitochondrial respiration is important for cell proliferation; however, the specific metabolic requirements fulfilled by respiration to support proliferation have not been defined.  Here, the authors show that a major role of respiration in proliferating cells is to provide electron acceptors for aspartate biosynthesis.  This finding was consistent with the observation that cells lacking a functional respiratory chain are auxotrophic for pyruvate, which serves as an exogenous electron acceptor.  Further, the pyruvate requirement could be fulfilled with an alternative electron acceptor, α-ketobutyrate, which provides cells neither carbon nor ATP.  α-Ketobutyrate restores proliferation when respiration is inhibited, suggesting that an alternative electron acceptor can substitute for respiration to support proliferation.  The authors found that electron acceptors were limiting for producing aspartate, and that supplying aspartate enabled proliferation of respiration-deficient cells in the absence of exogenous electron acceptors.  Together, these data argue a major function of respiration in proliferating cells is to support aspartate biosynthesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGodRkr248gPCLVg90H21EOLACvtfcHk0lg1dwSpK49hHw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXht12jsrrO&md5=73ee8247da401b5dbdac31ca1954383e</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2015.07.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2015.07.017%26sid%3Dliteratum%253Aachs%26aulast%3DSullivan%26aufirst%3DL.%2BB.%26aulast%3DGui%26aufirst%3DD.%2BY.%26aulast%3DHosios%26aufirst%3DA.%2BM.%26aulast%3DBush%26aufirst%3DL.%2BN.%26aulast%3DFreinkman%26aufirst%3DE.%26aulast%3DVander%2BHeiden%26aufirst%3DM.%2BG.%26atitle%3DSupporting%2520aspartate%2520biosynthesis%2520is%2520an%2520essential%2520function%2520of%2520respiration%2520in%2520proliferating%2520cells%26jtitle%3DCell%26date%3D2015%26volume%3D162%26issue%3D3%26spage%3D552%26epage%3D563%26doi%3D10.1016%2Fj.cell.2015.07.017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Birsoy, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, W. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Freinkman, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abu-Remaileh, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sabatini, D. M.</span></span> <span> </span><span class="NLM_article-title">An essential role of the mitochondrial electron transport chain in cell proliferation is to enable aspartate synthesis</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>162</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">540</span>– <span class="NLM_lpage">551</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2015.07.016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=10.1016%2Fj.cell.2015.07.016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=26232224" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=1%3ACAS%3A528%3ADC%252BC2MXht12jsrrL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=162&publication_year=2015&pages=540-551&issue=3&author=K.+Birsoyauthor=T.+Wangauthor=W.+W.+Chenauthor=E.+Freinkmanauthor=M.+Abu-Remailehauthor=D.+M.+Sabatini&title=An+essential+role+of+the+mitochondrial+electron+transport+chain+in+cell+proliferation+is+to+enable+aspartate+synthesis&doi=10.1016%2Fj.cell.2015.07.016"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">An essential role of the mitochondrial electron transport chain in cell proliferation is to enable aspartate synthesis</span></div><div class="casAuthors">Birsoy, Kivanc; Wang, Tim; Chen, Walter W.; Freinkman, Elizaveta; Abu-Remaileh, Monther; Sabatini, David M.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">162</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">540-551</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">The mitochondrial electron transport chain (ETC) enables many metabolic processes, but why its inhibition suppresses cell proliferation is unclear.  It is also not well understood why pyruvate supplementation allows cells lacking ETC function to proliferate.  Here, the authors used a CRISPR-based genetic screen to identify genes whose loss sensitizes human cells to phenformin, a complex I inhibitor.  The screen yielded GOT1, the cytosolic aspartate aminotransferase, loss of which kills cells upon ETC inhibition.  GOT1 normally consumes aspartate to transfer electrons into mitochondria, but, upon ETC inhibition, it reverses to generate aspartate in the cytosol, which partially compensates for the loss of mitochondrial aspartate biosynthesis.  Pyruvate stimulates aspartate biosynthesis in a GOT1-dependent fashion, which is required for pyruvate to rescue proliferation of cells with ETC dysfunction.  Aspartate supplementation or overexpression of an aspartate transporter allows cells without ETC activity to proliferate.  Thus, enabling aspartate biosynthesis is an essential role of the ETC in cell proliferation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrSh9Ap9MlPcbVg90H21EOLACvtfcHk0lg1dwSpK49hHw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXht12jsrrL&md5=d2e142821b9e2e5ff8932c6ba60f0892</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2015.07.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2015.07.016%26sid%3Dliteratum%253Aachs%26aulast%3DBirsoy%26aufirst%3DK.%26aulast%3DWang%26aufirst%3DT.%26aulast%3DChen%26aufirst%3DW.%2BW.%26aulast%3DFreinkman%26aufirst%3DE.%26aulast%3DAbu-Remaileh%26aufirst%3DM.%26aulast%3DSabatini%26aufirst%3DD.%2BM.%26atitle%3DAn%2520essential%2520role%2520of%2520the%2520mitochondrial%2520electron%2520transport%2520chain%2520in%2520cell%2520proliferation%2520is%2520to%2520enable%2520aspartate%2520synthesis%26jtitle%3DCell%26date%3D2015%26volume%3D162%26issue%3D3%26spage%3D540%26epage%3D551%26doi%3D10.1016%2Fj.cell.2015.07.016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Venneti, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cross, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takagi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhinder, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Djaballah, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kanai, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, E. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Judkins, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pawel, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baggs, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cherry, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rabinowitz, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, C. B.</span></span> <span> </span><span class="NLM_article-title">Asparagine plays a critical role in regulating cellular adaptation to glutamine depletion</span>. <i>Mol. Cell</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">205</span>– <span class="NLM_lpage">218</span>, <span class="refDoi"> DOI: 10.1016/j.molcel.2014.08.018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=10.1016%2Fj.molcel.2014.08.018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=25242145" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsFyltbbL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2014&pages=205-218&author=J.+Zhangauthor=J.+Fanauthor=S.+Vennetiauthor=J.+R.+Crossauthor=T.+Takagiauthor=B.+Bhinderauthor=H.+Djaballahauthor=M.+Kanaiauthor=E.+H.+Chengauthor=A.+R.+Judkinsauthor=B.+Pawelauthor=J.+Baggsauthor=S.+Cherryauthor=J.+D.+Rabinowitzauthor=C.+B.+Thompson&title=Asparagine+plays+a+critical+role+in+regulating+cellular+adaptation+to+glutamine+depletion&doi=10.1016%2Fj.molcel.2014.08.018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Asparagine Plays a Critical Role in Regulating Cellular Adaptation to Glutamine Depletion</span></div><div class="casAuthors">Zhang, Ji; Fan, Jing; Venneti, Sriram; Cross, Justin R.; Takagi, Toshimitsu; Bhinder, Bhavneet; Djaballah, Hakim; Kanai, Masayuki; Cheng, Emily H.; Judkins, Alexander R.; Pawel, Bruce; Baggs, Julie; Cherry, Sara; Rabinowitz, Joshua D.; Thompson, Craig B.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cell</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">205-218</span>CODEN:
                <span class="NLM_cas:coden">MOCEFL</span>;
        ISSN:<span class="NLM_cas:issn">1097-2765</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Many cancer cells consume large quantities of glutamine to maintain TCA cycle anaplerosis and support cell survival.  It was therefore surprising when RNAi screening revealed that suppression of citrate synthase (CS), the first TCA cycle enzyme, prevented glutamine-withdrawal-induced apoptosis.  CS suppression reduced TCA cycle activity and diverted oxaloacetate, the substrate of CS, into prodn. of the nonessential amino acids aspartate and asparagine.  We found that asparagine was necessary and sufficient to suppress glutamine-withdrawal-induced apoptosis without restoring the levels of other nonessential amino acids or TCA cycle intermediates.  In complete medium, tumor cells exhibiting high rates of glutamine consumption underwent rapid apoptosis when glutamine-dependent asparagine synthesis was suppressed, and expression of asparagine synthetase was statistically correlated with poor prognosis in human tumors.  Coupled with the success of L-asparaginase as a therapy for childhood leukemia, the data suggest that intracellular asparagine is a crit. suppressor of apoptosis in many human tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoQvODG2u6p1LVg90H21EOLACvtfcHk0lg1dwSpK49hHw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsFyltbbL&md5=b43ac7e343ce59ca1eeee592904f1122</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1016%2Fj.molcel.2014.08.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molcel.2014.08.018%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DFan%26aufirst%3DJ.%26aulast%3DVenneti%26aufirst%3DS.%26aulast%3DCross%26aufirst%3DJ.%2BR.%26aulast%3DTakagi%26aufirst%3DT.%26aulast%3DBhinder%26aufirst%3DB.%26aulast%3DDjaballah%26aufirst%3DH.%26aulast%3DKanai%26aufirst%3DM.%26aulast%3DCheng%26aufirst%3DE.%2BH.%26aulast%3DJudkins%26aufirst%3DA.%2BR.%26aulast%3DPawel%26aufirst%3DB.%26aulast%3DBaggs%26aufirst%3DJ.%26aulast%3DCherry%26aufirst%3DS.%26aulast%3DRabinowitz%26aufirst%3DJ.%2BD.%26aulast%3DThompson%26aufirst%3DC.%2BB.%26atitle%3DAsparagine%2520plays%2520a%2520critical%2520role%2520in%2520regulating%2520cellular%2520adaptation%2520to%2520glutamine%2520depletion%26jtitle%3DMol.%2520Cell%26date%3D2014%26volume%3D56%26spage%3D205%26epage%3D218%26doi%3D10.1016%2Fj.molcel.2014.08.018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Locasale, J. W.</span></span> <span> </span><span class="NLM_article-title">Serine, glycine and one-carbon units: cancer metabolism in full circle</span>. <i>Nat. Rev. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>13</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">572</span>– <span class="NLM_lpage">583</span>, <span class="refDoi"> DOI: 10.1038/nrc3557</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=10.1038%2Fnrc3557" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=23822983" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtVGrsLzE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2013&pages=572-583&issue=8&author=J.+W.+Locasale&title=Serine%2C+glycine+and+one-carbon+units%3A+cancer+metabolism+in+full+circle&doi=10.1038%2Fnrc3557"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Serine, glycine and one-carbon units: cancer metabolism in full circle</span></div><div class="casAuthors">Locasale, Jason W.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">572-583</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  One-carbon metab. involving the folate and methionine cycles integrates nutritional status from amino acids, glucose and vitamins, and generates diverse outputs, such as the biosynthesis of lipids, nucleotides and proteins, the maintenance of redox status and the substrates for methylation reactions.  Long considered a 'housekeeping' process, this pathway has recently been shown to have addnl. complexity.  Genetic and functional evidence suggests that hyperactivation of this pathway is a driver of oncogenesis and establishes a link to cellular epigenetic status.  Given the wealth of clin. available agents that target one-carbon metab., these new findings could present opportunities for translation into precision cancer medicine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGro6rIkiwOb8LVg90H21EOLACvtfcHk0liCdfxpHZVZXw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtVGrsLzE&md5=96e34f61a4dd32c09cc196493804b5fc</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1038%2Fnrc3557&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc3557%26sid%3Dliteratum%253Aachs%26aulast%3DLocasale%26aufirst%3DJ.%2BW.%26atitle%3DSerine%252C%2520glycine%2520and%2520one-carbon%2520units%253A%2520cancer%2520metabolism%2520in%2520full%2520circle%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2013%26volume%3D13%26issue%3D8%26spage%3D572%26epage%3D583%26doi%3D10.1038%2Fnrc3557" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Botman, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tigchelaar, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Noorden, C. J.</span></span> <span> </span><span class="NLM_article-title">Determination of glutamate dehydrogenase activity and its kinetics in mouse tissues using metabolic mapping (quantitative enzyme histochemistry)</span>. <i>J. Histochem. Cytochem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>62</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">802</span>– <span class="NLM_lpage">812</span>, <span class="refDoi"> DOI: 10.1369/0022155414549071</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=10.1369%2F0022155414549071" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=25124006" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvFyhsb3M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2014&pages=802-812&issue=11&author=D.+Botmanauthor=W.+Tigchelaarauthor=C.+J.+Van+Noorden&title=Determination+of+glutamate+dehydrogenase+activity+and+its+kinetics+in+mouse+tissues+using+metabolic+mapping+%28quantitative+enzyme+histochemistry%29&doi=10.1369%2F0022155414549071"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Determination of glutamate dehydrogenase activity and its kinetics in mouse tissues using metabolic mapping (quantitative enzyme histochemistry)</span></div><div class="casAuthors">Botman, Dennis; Tigchelaar, Wikky; Van Noorden, Cornelis J. F.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Histochemistry and Cytochemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">802-812, 11 pp.</span>CODEN:
                <span class="NLM_cas:coden">JHCYAS</span>;
        ISSN:<span class="NLM_cas:issn">0022-1554</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications</span>)
        </div><div class="casAbstract">Glutamate dehydrogenase (GDH) catalyzes the reversible conversion of glutamate into α-ketoglutarate with the concomitant redn. of NAD(P)+ to NAD(P)H or vice versa.  GDH activity is subject to complex allosteric regulation including substrate inhibition.  To det. GDH kinetics in situ, we assessed the effects of various glutamate concns. in combination with either the coenzyme NAD+ or NADP+ on GDH activity in mouse liver cryostat sections using metabolic mapping.  NAD+-dependent GDH Vmax was 2.5-fold higher than NADP+-dependent Vmax, whereas the Km was similar, 1.92 mM vs. 1.66 mM, when NAD+ or NADP+ was used, resp.  With either coenzyme, Vmax was detd. at 10 mM glutamate and substrate inhibition was obsd. at higher glutamate concns. with a Ki of 12.2 and 3.95 for NAD+ and NADP+ used as coenzyme, resp.  NAD+- and NADP+-dependent GDH activities were examd. in various mouse tissues.  GDH activity was highest in liver and much lower in other tissues.  In all tissues, the highest activity was found when NAD+ was used as a coenzyme.  In conclusion, GDH activity in mice is highest in the liver with NAD+ as a coenzyme and highest GDH activity was detd. at a glutamate concn. of 10 mM.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqxxK2vgUMwwrVg90H21EOLACvtfcHk0liCdfxpHZVZXw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvFyhsb3M&md5=f43e572599bc5ab53c6a54b3f4e60824</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1369%2F0022155414549071&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1369%252F0022155414549071%26sid%3Dliteratum%253Aachs%26aulast%3DBotman%26aufirst%3DD.%26aulast%3DTigchelaar%26aufirst%3DW.%26aulast%3DVan%2BNoorden%26aufirst%3DC.%2BJ.%26atitle%3DDetermination%2520of%2520glutamate%2520dehydrogenase%2520activity%2520and%2520its%2520kinetics%2520in%2520mouse%2520tissues%2520using%2520metabolic%2520mapping%2520%2528quantitative%2520enzyme%2520histochemistry%2529%26jtitle%3DJ.%2520Histochem.%2520Cytochem.%26date%3D2014%26volume%3D62%26issue%3D11%26spage%3D802%26epage%3D812%26doi%3D10.1369%2F0022155414549071" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Altman, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stine, Z. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dang, C. V.</span></span> <span> </span><span class="NLM_article-title">From kerbs to clinic: glutamine metabolism to cancer therapy</span>. <i>Nat. Rev. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">619</span>– <span class="NLM_lpage">634</span>, <span class="refDoi"> DOI: 10.1038/nrc.2016.71</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=10.1038%2Fnrc.2016.71" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=27492215" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=1%3ACAS%3A528%3ADC%252BC28Xht12jurbI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2016&pages=619-634&author=B.+J.+Altmanauthor=Z.+E.+Stineauthor=C.+V.+Dang&title=From+kerbs+to+clinic%3A+glutamine+metabolism+to+cancer+therapy&doi=10.1038%2Fnrc.2016.71"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">From Krebs to clinic: glutamine metabolism to cancer therapy</span></div><div class="casAuthors">Altman, Brian J.; Stine, Zachary E.; Dang, Chi V.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">619-634</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The resurgence of research into cancer metab. has recently broadened interests beyond glucose and the Warburg effect to other nutrients, including glutamine.  Because oncogenic alterations of metab. render cancer cells addicted to nutrients, pathways involved in glycolysis or glutaminolysis could be exploited for therapeutic purposes.  In this Review, we provide an updated overview of glutamine metab. and its involvement in tumorigenesis in vitro and in vivo, and explore the recent potential applications of basic science discoveries in the clin. setting.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq2GDHcwHXcnLVg90H21EOLACvtfcHk0liCdfxpHZVZXw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xht12jurbI&md5=00b34261d90a91151a3e833605c4aaec</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1038%2Fnrc.2016.71&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc.2016.71%26sid%3Dliteratum%253Aachs%26aulast%3DAltman%26aufirst%3DB.%2BJ.%26aulast%3DStine%26aufirst%3DZ.%2BE.%26aulast%3DDang%26aufirst%3DC.%2BV.%26atitle%3DFrom%2520kerbs%2520to%2520clinic%253A%2520glutamine%2520metabolism%2520to%2520cancer%2520therapy%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2016%26volume%3D16%26spage%3D619%26epage%3D634%26doi%3D10.1038%2Fnrc.2016.71" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nagase, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishikawa, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suyama, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kikuno, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirosawa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miyajima, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanaka, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kotani, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nomura, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohara, O.</span></span> <span> </span><span class="NLM_article-title">Prediction of the coding sequences of unidentifed human genes. XII. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro</span>. <i>DNA Res.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">355</span>– <span class="NLM_lpage">364</span>, <span class="refDoi"> DOI: 10.1093/dnares/5.6.355</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=10.1093%2Fdnares%2F5.6.355" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=10048485" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=1%3ACAS%3A528%3ADyaK1MXpvVSrtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=1998&pages=355-364&author=T.+Nagaseauthor=K.+Ishikawaauthor=M.+Suyamaauthor=R.+Kikunoauthor=M.+Hirosawaauthor=N.+Miyajimaauthor=A.+Tanakaauthor=H.+Kotaniauthor=N.+Nomuraauthor=O.+Ohara&title=Prediction+of+the+coding+sequences+of+unidentifed+human+genes.+XII.+The+complete+sequences+of+100+new+cDNA+clones+from+brain+which+code+for+large+proteins+in+vitro&doi=10.1093%2Fdnares%2F5.6.355"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Prediction of the coding sequences of unidentified human genes. XII. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro</span></div><div class="casAuthors">Nagase, Takahiro; Ishikawa, Ken-Ichi; Suyama, Mikita; Kikuno, Reiko; Hirosawa, Makoto; Miyajima, Nobuyuki; Tanaka, Ayako; Kotani, Hirokazu; Nomura, Nobuo; Ohara, Osamu</div><div class="citationInfo"><span class="NLM_cas:title">DNA Research</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">355-364</span>CODEN:
                <span class="NLM_cas:coden">DARSE8</span>;
        ISSN:<span class="NLM_cas:issn">1340-2838</span>.
    
            (<span class="NLM_cas:orgname">Universal Academy Press</span>)
        </div><div class="casAbstract">In this paper, we report the sequences of 100 cDNA clones newly detd. from a set of size-fractionated human brain cDNA libraries and predict the coding sequences of the corresponding genes, named KIAA0819 to KIAA0918.  These cDNA clones were selected on the basis of their coding potentials of large proteins (50 kDa and more) by using in vitro transcription/translation assays.  The sequence data showed that the av. sizes of the inserts and corresponding open reading frames are 4.4 kb and 2.5 kb (831 amino acid residues), resp.  Homol. and motif/domain searches against the public databases indicated that the predicted coding sequences of 83 genes were similar to those of known genes, 59% of which (49 genes) were categorized as coding for proteins functionally related to cell signaling/communication, cell structure/motility, and nucleic acid management.  The chromosomal locations and the expression profiles of all the genes were also examd.  For 54 clones including brain-specific ones, the mRNA levels were further examd. among 8 brain regions (amygdala, corpus callosum, cerebellum, caudate nucleus, hippocampus, substantia nigra, subthalamic nucleus, and thalamus), spinal cord, and fetal brain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGosaPvKEMOip7Vg90H21EOLACvtfcHk0liCdfxpHZVZXw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXpvVSrtg%253D%253D&md5=7c1dcc5c233dea0ed711a7aca5e765bc</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1093%2Fdnares%2F5.6.355&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fdnares%252F5.6.355%26sid%3Dliteratum%253Aachs%26aulast%3DNagase%26aufirst%3DT.%26aulast%3DIshikawa%26aufirst%3DK.%26aulast%3DSuyama%26aufirst%3DM.%26aulast%3DKikuno%26aufirst%3DR.%26aulast%3DHirosawa%26aufirst%3DM.%26aulast%3DMiyajima%26aufirst%3DN.%26aulast%3DTanaka%26aufirst%3DA.%26aulast%3DKotani%26aufirst%3DH.%26aulast%3DNomura%26aufirst%3DN.%26aulast%3DOhara%26aufirst%3DO.%26atitle%3DPrediction%2520of%2520the%2520coding%2520sequences%2520of%2520unidentifed%2520human%2520genes.%2520XII.%2520The%2520complete%2520sequences%2520of%2520100%2520new%2520cDNA%2520clones%2520from%2520brain%2520which%2520code%2520for%2520large%2520proteins%2520in%2520vitro%26jtitle%3DDNA%2520Res.%26date%3D1998%26volume%3D5%26spage%3D355%26epage%3D364%26doi%3D10.1093%2Fdnares%2F5.6.355" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Elgadi, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meguid, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qian, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Souba, W. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abcouwer, S. F.</span></span> <span> </span><span class="NLM_article-title">Cloning and analysis of unique human glutaminase isoforms generated by tissue-specifc alternative splicing</span>. <i>Physiol. Genomics</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>1</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">51</span>– <span class="NLM_lpage">62</span>, <span class="refDoi"> DOI: 10.1152/physiolgenomics.1999.1.2.51</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=10.1152%2Fphysiolgenomics.1999.1.2.51" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=11015561" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=1%3ACAS%3A528%3ADC%252BD3cXlt1Orsb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=1999&pages=51-62&issue=2&author=K.+M.+Elgadiauthor=R.+A.+Meguidauthor=M.+Qianauthor=W.+W.+Soubaauthor=S.+F.+Abcouwer&title=Cloning+and+analysis+of+unique+human+glutaminase+isoforms+generated+by+tissue-specifc+alternative+splicing&doi=10.1152%2Fphysiolgenomics.1999.1.2.51"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Cloning and analysis of unique human glutaminase isoforms generated by tissue-specific alternative splicing</span></div><div class="casAuthors">Elgadi, Khaled M.; Meguid, Robert A.; Qian, Ming; Souba, Wiley W.; Abcouwer, Steve F.</div><div class="citationInfo"><span class="NLM_cas:title">Physiological Genomics [online computer file]</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">51-62</span>CODEN:
                <span class="NLM_cas:coden">PHGEFP</span>;
        ISSN:<span class="NLM_cas:issn">1094-8341</span>.
    
            (<span class="NLM_cas:orgname">American Physiological Society</span>)
        </div><div class="casAbstract">Three human glutaminase (hGA) isoforms were identified, two of which represent isoforms previously unidentified in any species.  One isoform contains an open reading frame with high homol. with the rat kidney-type glutaminase, suggesting that this isoform represents the human kidney-type glutaminase, hKGA.  A second isoform, termed hGAC, contains an open reading frame that matches hKGA except for a unique COOH-terminal amino acid sequence.  In addn., a third human glutaminase isoform was identified from a computer search and on further anal. was found to represent an addnl. unique isoform, hGAM.  HKGA is expressed predominantly in brain and kidney but not in liver, hGAC is expressed principally in cardiac muscle and pancreas but not in liver or brain, and hGAM is expressed solely in cardiac and skeletal muscle.  HGAC is the predominant isoform expressed by a human breast cancer cell line that exhibits a high rate of glutamine utilization and glutaminase activity.  Genomic Southern anal. as well as isolation and anal. of five glutaminase genomic clones suggested that all three hGA isoforms originate from the same locus and therefore represent mRNA species that are produced by tissue-specific alternative splicing of a single pre-mRNA.  Furthermore, an RT-PCR assay was developed that can be used to easily differentiate between hKGA and hGAC mRNA species.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqVX2eTYfnRjLVg90H21EOLACvtfcHk0lhZJYnrV9WBWQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXlt1Orsb8%253D&md5=668ada41617e771b951b4b23819372de</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1152%2Fphysiolgenomics.1999.1.2.51&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1152%252Fphysiolgenomics.1999.1.2.51%26sid%3Dliteratum%253Aachs%26aulast%3DElgadi%26aufirst%3DK.%2BM.%26aulast%3DMeguid%26aufirst%3DR.%2BA.%26aulast%3DQian%26aufirst%3DM.%26aulast%3DSouba%26aufirst%3DW.%2BW.%26aulast%3DAbcouwer%26aufirst%3DS.%2BF.%26atitle%3DCloning%2520and%2520analysis%2520of%2520unique%2520human%2520glutaminase%2520isoforms%2520generated%2520by%2520tissue-specifc%2520alternative%2520splicing%26jtitle%3DPhysiol.%2520Genomics%26date%3D1999%26volume%3D1%26issue%3D2%26spage%3D51%26epage%3D62%26doi%3D10.1152%2Fphysiolgenomics.1999.1.2.51" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Katt, W. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lukey, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cerione, R. A.</span></span> <span> </span><span class="NLM_article-title">A tale of two glutaminases: homologous enzymes with distinct roles in tumorigenesis</span>. <i>Future Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>9</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">223</span>– <span class="NLM_lpage">243</span>, <span class="refDoi"> DOI: 10.4155/fmc-2016-0190</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=10.4155%2Ffmc-2016-0190" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=28111979" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhslWnur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2017&pages=223-243&issue=2&author=W.+P.+Kattauthor=M.+J.+Lukeyauthor=R.+A.+Cerione&title=A+tale+of+two+glutaminases%3A+homologous+enzymes+with+distinct+roles+in+tumorigenesis&doi=10.4155%2Ffmc-2016-0190"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">A tale of two glutaminases: homologous enzymes with distinct roles in tumorigenesis</span></div><div class="casAuthors">Katt, William P.; Lukey, Michael J.; Cerione, Richard A.</div><div class="citationInfo"><span class="NLM_cas:title">Future Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">223-243</span>CODEN:
                <span class="NLM_cas:coden">FMCUA7</span>;
        ISSN:<span class="NLM_cas:issn">1756-8919</span>.
    
            (<span class="NLM_cas:orgname">Future Science Ltd.</span>)
        </div><div class="casAbstract">A review.  Many cancer cells exhibit an altered metabolic phenotype, in which glutamine consumption is upregulated relative to healthy cells.  This metabolic reprogramming often depends upon mitochondrial glutaminase activity, which converts glutamine to glutamate, a key precursor for biosynthetic and bioenergetic processes.  Two isoenzymes of glutaminase exist, a kidney-type (GLS) and a liver-type enzyme (GLS2 or LGA).  While a majority of studies have focused on GLS, here we summarize key findings on both glutaminases, describing their structure and function, their roles in cancer and pharmacol. approaches to inhibiting their activities.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoTYjzSACf4q7Vg90H21EOLACvtfcHk0lhZJYnrV9WBWQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhslWnur4%253D&md5=6b4bd6dfe8d18402f41bd420c25974b2</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.4155%2Ffmc-2016-0190&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Ffmc-2016-0190%26sid%3Dliteratum%253Aachs%26aulast%3DKatt%26aufirst%3DW.%2BP.%26aulast%3DLukey%26aufirst%3DM.%2BJ.%26aulast%3DCerione%26aufirst%3DR.%2BA.%26atitle%3DA%2520tale%2520of%2520two%2520glutaminases%253A%2520homologous%2520enzymes%2520with%2520distinct%2520roles%2520in%2520tumorigenesis%26jtitle%3DFuture%2520Med.%2520Chem.%26date%3D2017%26volume%3D9%26issue%3D2%26spage%3D223%26epage%3D243%26doi%3D10.4155%2Ffmc-2016-0190" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Robinson, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McBryant, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsukamoto, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rojas, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferraris, D. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamilton, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hansen, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Curthoys, N. P.</span></span> <span> </span><span class="NLM_article-title">Novel mechanism of inhibition of rat kidney-type glutaminase by bis-2-(5-phenylacetamido-1,2,4-thiadiazol-2-yl)ethyl sulfide (BPTES)</span>. <i>Biochem. J.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>406</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">407</span>– <span class="NLM_lpage">414</span>, <span class="refDoi"> DOI: 10.1042/BJ20070039</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=10.1042%2FBJ20070039" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=406&publication_year=2007&pages=407-414&issue=3&author=M.+M.+Robinsonauthor=S.+J.+McBryantauthor=T.+Tsukamotoauthor=C.+Rojasauthor=D.+V.+Ferrarisauthor=S.+K.+Hamiltonauthor=J.+C.+Hansenauthor=N.+P.+Curthoys&title=Novel+mechanism+of+inhibition+of+rat+kidney-type+glutaminase+by+bis-2-%285-phenylacetamido-1%2C2%2C4-thiadiazol-2-yl%29ethyl+sulfide+%28BPTES%29&doi=10.1042%2FBJ20070039"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1042%2FBJ20070039&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBJ20070039%26sid%3Dliteratum%253Aachs%26aulast%3DRobinson%26aufirst%3DM.%2BM.%26aulast%3DMcBryant%26aufirst%3DS.%2BJ.%26aulast%3DTsukamoto%26aufirst%3DT.%26aulast%3DRojas%26aufirst%3DC.%26aulast%3DFerraris%26aufirst%3DD.%2BV.%26aulast%3DHamilton%26aufirst%3DS.%2BK.%26aulast%3DHansen%26aufirst%3DJ.%2BC.%26aulast%3DCurthoys%26aufirst%3DN.%2BP.%26atitle%3DNovel%2520mechanism%2520of%2520inhibition%2520of%2520rat%2520kidney-type%2520glutaminase%2520by%2520bis-2-%25285-phenylacetamido-1%252C2%252C4-thiadiazol-2-yl%2529ethyl%2520sulfide%2520%2528BPTES%2529%26jtitle%3DBiochem.%2520J.%26date%3D2007%26volume%3D406%26issue%3D3%26spage%3D407%26epage%3D414%26doi%3D10.1042%2FBJ20070039" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gross, M. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Demo, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dennison, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chernov-Rogan, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goyal, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janes, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laidig, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lewis, E. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mackinnon, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parlati, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodriguez, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shwonek, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sjogren, E. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stanton, T. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bennett, M. K.</span></span> <span> </span><span class="NLM_article-title">Antitumor activity of the glutaminase inhibitor CB-839 in triple-negative breast cancer</span>. <i>Mol. Cancer Ther.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>13</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">890</span>– <span class="NLM_lpage">901</span>, <span class="refDoi"> DOI: 10.1158/1535-7163.MCT-13-0870</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=10.1158%2F1535-7163.MCT-13-0870" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=24523301" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=1%3ACAS%3A528%3ADC%252BC2cXls1Gjurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2014&pages=890-901&issue=4&author=M.+I.+Grossauthor=S.+D.+Demoauthor=J.+B.+Dennisonauthor=L.+Chenauthor=T.+Chernov-Roganauthor=B.+Goyalauthor=J.+R.+Janesauthor=G.+J.+Laidigauthor=E.+R.+Lewisauthor=J.+Liauthor=A.+L.+Mackinnonauthor=F.+Parlatiauthor=M.+L.+Rodriguezauthor=P.+J.+Shwonekauthor=E.+B.+Sjogrenauthor=T.+F.+Stantonauthor=T.+Wangauthor=J.+Yangauthor=F.+Zhaoauthor=M.+K.+Bennett&title=Antitumor+activity+of+the+glutaminase+inhibitor+CB-839+in+triple-negative+breast+cancer&doi=10.1158%2F1535-7163.MCT-13-0870"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Antitumor Activity of the Glutaminase Inhibitor CB-839 in Triple-Negative Breast Cancer</span></div><div class="casAuthors">Gross, Matt I.; Demo, Susan D.; Dennison, Jennifer B.; Chen, Lijing; Chernov-Rogan, Tania; Goyal, Bindu; Janes, Julie R.; Laidig, Guy J.; Lewis, Evan R.; Li, Jim; MacKinnon, Andrew L.; Parlati, Francesco; Rodriguez, Mirna L. M.; Shwonek, Peter J.; Sjogren, Eric B.; Stanton, Timothy F.; Wang, Taotao; Yang, Jinfu; Zhao, Frances; Bennett, Mark K.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">890-901</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Glutamine serves as an important source of energy and building blocks for many tumor cells.  The first step in glutamine utilization is its conversion to glutamate by the mitochondrial enzyme glutaminase.  CB-839 is a potent, selective, and orally bioavailable inhibitor of both splice variants of glutaminase (KGA and GAC).  CB-839 had antiproliferative activity in a triple-neg. breast cancer (TNBC) cell line, HCC-1806, that was assocd. with a marked decrease in glutamine consumption, glutamate prodn., oxygen consumption, and the steady-state levels of glutathione and several tricarboxylic acid cycle intermediates.  In contrast, no antiproliferative activity was obsd. in an estrogen receptor-pos. cell line, T47D, and only modest effects on glutamine consumption and downstream metabolites were obsd.  Across a panel of breast cancer cell lines, GAC protein expression and glutaminase activity were elevated in the majority of TNBC cell lines relative to receptor pos. cells.  Furthermore, the TNBC subtype displayed the greatest sensitivity to CB-839 treatment and this sensitivity was correlated with (i) dependence on extracellular glutamine for growth, (ii) intracellular glutamate and glutamine levels, and (iii) GAC (but not KGA) expression, a potential biomarker for sensitivity.  CB-839 displayed significant antitumor activity in two xenograft models: as a single agent in a patient-derived TNBC model and in a basal like HER2+ cell line model, JIMT-1, both as a single agent and in combination with paclitaxel.  Together, these data provide a strong rationale for the clin. investigation of CB-839 as a targeted therapeutic in patients with TNBC and other glutamine-dependent tumors.  Mol Cancer Ther; 13(4); 890-901.2014 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpDfUGWU-VZObVg90H21EOLACvtfcHk0liberbZ4OU7jg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXls1Gjurg%253D&md5=5b9ddb35c56409b58ce2b889bbbbc33f</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-13-0870&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-13-0870%26sid%3Dliteratum%253Aachs%26aulast%3DGross%26aufirst%3DM.%2BI.%26aulast%3DDemo%26aufirst%3DS.%2BD.%26aulast%3DDennison%26aufirst%3DJ.%2BB.%26aulast%3DChen%26aufirst%3DL.%26aulast%3DChernov-Rogan%26aufirst%3DT.%26aulast%3DGoyal%26aufirst%3DB.%26aulast%3DJanes%26aufirst%3DJ.%2BR.%26aulast%3DLaidig%26aufirst%3DG.%2BJ.%26aulast%3DLewis%26aufirst%3DE.%2BR.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DMackinnon%26aufirst%3DA.%2BL.%26aulast%3DParlati%26aufirst%3DF.%26aulast%3DRodriguez%26aufirst%3DM.%2BL.%26aulast%3DShwonek%26aufirst%3DP.%2BJ.%26aulast%3DSjogren%26aufirst%3DE.%2BB.%26aulast%3DStanton%26aufirst%3DT.%2BF.%26aulast%3DWang%26aufirst%3DT.%26aulast%3DYang%26aufirst%3DJ.%26aulast%3DZhao%26aufirst%3DF.%26aulast%3DBennett%26aufirst%3DM.%2BK.%26atitle%3DAntitumor%2520activity%2520of%2520the%2520glutaminase%2520inhibitor%2520CB-839%2520in%2520triple-negative%2520breast%2520cancer%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2014%26volume%3D13%26issue%3D4%26spage%3D890%26epage%3D901%26doi%3D10.1158%2F1535-7163.MCT-13-0870" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yeh, T. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuo, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, Y. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ke, Y. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chu, K. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hsu, H. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, H. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuo, P. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shih, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, C. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsou, L. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S. J.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis, and evaluation of thiazolidine-2–4-dione derivatives as a novel class of glutaminase inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span> (<span class="NLM_issue">13</span>),  <span class="NLM_fpage">5599</span>– <span class="NLM_lpage">5612</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00282</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00282" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=5599-5612&issue=13&author=T.+K.+Yehauthor=C.+C.+Kuoauthor=Y.+Z.+Leeauthor=Y.+Y.+Keauthor=K.+F.+Chuauthor=H.+Y.+Hsuauthor=H.+Y.+Changauthor=Y.+W.+Liuauthor=J.+S.+Songauthor=C.+W.+Yangauthor=L.+M.+Linauthor=M.+Sunauthor=S.+H.+Wuauthor=P.+C.+Kuoauthor=C.+Shihauthor=C.+T.+Chenauthor=L.+K.+Tsouauthor=S.+J.+Lee&title=Design%2C+synthesis%2C+and+evaluation+of+thiazolidine-2%E2%80%934-dione+derivatives+as+a+novel+class+of+glutaminase+inhibitors&doi=10.1021%2Facs.jmedchem.7b00282"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00282&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00282%26sid%3Dliteratum%253Aachs%26aulast%3DYeh%26aufirst%3DT.%2BK.%26aulast%3DKuo%26aufirst%3DC.%2BC.%26aulast%3DLee%26aufirst%3DY.%2BZ.%26aulast%3DKe%26aufirst%3DY.%2BY.%26aulast%3DChu%26aufirst%3DK.%2BF.%26aulast%3DHsu%26aufirst%3DH.%2BY.%26aulast%3DChang%26aufirst%3DH.%2BY.%26aulast%3DLiu%26aufirst%3DY.%2BW.%26aulast%3DSong%26aufirst%3DJ.%2BS.%26aulast%3DYang%26aufirst%3DC.%2BW.%26aulast%3DLin%26aufirst%3DL.%2BM.%26aulast%3DSun%26aufirst%3DM.%26aulast%3DWu%26aufirst%3DS.%2BH.%26aulast%3DKuo%26aufirst%3DP.%2BC.%26aulast%3DShih%26aufirst%3DC.%26aulast%3DChen%26aufirst%3DC.%2BT.%26aulast%3DTsou%26aufirst%3DL.%2BK.%26aulast%3DLee%26aufirst%3DS.%2BJ.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520evaluation%2520of%2520thiazolidine-2%25E2%2580%25934-dione%2520derivatives%2520as%2520a%2520novel%2520class%2520of%2520glutaminase%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26issue%3D13%26spage%3D5599%26epage%3D5612%26doi%3D10.1021%2Facs.jmedchem.7b00282" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Timmerman, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holton, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuneva, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Louie, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Padro, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daemen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ethier, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van’tVeer, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Polyak, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCormick, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gray, J. W.</span></span> <span> </span><span class="NLM_article-title">Glutamine sensitivity analysis identifies the xCT antiporter as a common triple-negative breast tumor therapeutic target</span>. <i>Cancer Cell</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>24</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">450</span>– <span class="NLM_lpage">465</span>, <span class="refDoi"> DOI: 10.1016/j.ccr.2013.08.020</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=10.1016%2Fj.ccr.2013.08.020" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=24094812" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsFOltbvM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2013&pages=450-465&issue=4&author=L.+A.+Timmermanauthor=T.+Holtonauthor=M.+Yunevaauthor=R.+J.+Louieauthor=M.+Padroauthor=A.+Daemenauthor=M.+Huauthor=D.+A.+Chanauthor=S.+P.+Ethierauthor=L.+J.+Van%E2%80%99tVeerauthor=K.+Polyakauthor=F.+McCormickauthor=J.+W.+Gray&title=Glutamine+sensitivity+analysis+identifies+the+xCT+antiporter+as+a+common+triple-negative+breast+tumor+therapeutic+target&doi=10.1016%2Fj.ccr.2013.08.020"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Glutamine Sensitivity Analysis Identifies the xCT Antiporter as a Common Triple-Negative Breast Tumor Therapeutic Target</span></div><div class="casAuthors">Timmerman, Luika A.; Holton, Thomas; Yuneva, Mariia; Louie, Raymond J.; Padro, Merce; Daemen, Anneleen; Hu, Min; Chan, Denise A.; Ethier, Stephen P.; Van't Veer, Laura J.; Polyak, Kornelia; McCormick, Frank; Gray, Joe W.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Cell</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">450-465</span>CODEN:
                <span class="NLM_cas:coden">CCAECI</span>;
        ISSN:<span class="NLM_cas:issn">1535-6108</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">A handful of tumor-derived cell lines form the mainstay of cancer therapeutic development, yielding drugs with an impact typically measured as months to disease progression.  To develop more effective breast cancer therapeutics and more readily understand their clin. impact, we constructed a functional metabolic portrait of 46 independently derived breast cell lines.  Our anal. of glutamine uptake and dependence identified a subset of triple-neg. samples that are glutamine auxotrophs.  Ambient glutamine indirectly supports environmental cystine acquisition via the xCT antiporter, which is expressed on one-third of triple-neg. tumors in vivo. xCT inhibition with the clin. approved anti-inflammatory sulfasalazine decreases tumor growth, revealing a therapeutic target in breast tumors of poorest prognosis and a lead compd. for rapid, effective drug development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGooQUS6ziR5HrVg90H21EOLACvtfcHk0liberbZ4OU7jg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsFOltbvM&md5=f3cd8acfc6915115600fcc8cfc6659dd</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1016%2Fj.ccr.2013.08.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ccr.2013.08.020%26sid%3Dliteratum%253Aachs%26aulast%3DTimmerman%26aufirst%3DL.%2BA.%26aulast%3DHolton%26aufirst%3DT.%26aulast%3DYuneva%26aufirst%3DM.%26aulast%3DLouie%26aufirst%3DR.%2BJ.%26aulast%3DPadro%26aufirst%3DM.%26aulast%3DDaemen%26aufirst%3DA.%26aulast%3DHu%26aufirst%3DM.%26aulast%3DChan%26aufirst%3DD.%2BA.%26aulast%3DEthier%26aufirst%3DS.%2BP.%26aulast%3DVan%25E2%2580%2599tVeer%26aufirst%3DL.%2BJ.%26aulast%3DPolyak%26aufirst%3DK.%26aulast%3DMcCormick%26aufirst%3DF.%26aulast%3DGray%26aufirst%3DJ.%2BW.%26atitle%3DGlutamine%2520sensitivity%2520analysis%2520identifies%2520the%2520xCT%2520antiporter%2520as%2520a%2520common%2520triple-negative%2520breast%2520tumor%2520therapeutic%2520target%26jtitle%3DCancer%2520Cell%26date%3D2013%26volume%3D24%26issue%3D4%26spage%3D450%26epage%3D465%26doi%3D10.1016%2Fj.ccr.2013.08.020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cassago, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferreira, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferreira, I. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fornezari, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gomes, E. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greene, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pereira, H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garratt, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dias, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ambrosio, A. L.</span></span> <span> </span><span class="NLM_article-title">Mitochondrial localization and structure-based phosphate activation mechanism of Glutaminase C with implications for cancer metabolism</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>109</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">1092</span>– <span class="NLM_lpage">1097</span>, <span class="refDoi"> DOI: 10.1073/pnas.1112495109</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=10.1073%2Fpnas.1112495109" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2012&pages=1092-1097&issue=4&author=A.+Cassagoauthor=A.+P.+Ferreiraauthor=I.+M.+Ferreiraauthor=C.+Fornezariauthor=E.+R.+Gomesauthor=K.+S.+Greeneauthor=H.+M.+Pereiraauthor=R.+C.+Garrattauthor=S.+M.+Diasauthor=A.+L.+Ambrosio&title=Mitochondrial+localization+and+structure-based+phosphate+activation+mechanism+of+Glutaminase+C+with+implications+for+cancer+metabolism&doi=10.1073%2Fpnas.1112495109"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1112495109&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1112495109%26sid%3Dliteratum%253Aachs%26aulast%3DCassago%26aufirst%3DA.%26aulast%3DFerreira%26aufirst%3DA.%2BP.%26aulast%3DFerreira%26aufirst%3DI.%2BM.%26aulast%3DFornezari%26aufirst%3DC.%26aulast%3DGomes%26aufirst%3DE.%2BR.%26aulast%3DGreene%26aufirst%3DK.%2BS.%26aulast%3DPereira%26aufirst%3DH.%2BM.%26aulast%3DGarratt%26aufirst%3DR.%2BC.%26aulast%3DDias%26aufirst%3DS.%2BM.%26aulast%3DAmbrosio%26aufirst%3DA.%2BL.%26atitle%3DMitochondrial%2520localization%2520and%2520structure-based%2520phosphate%2520activation%2520mechanism%2520of%2520Glutaminase%2520C%2520with%2520implications%2520for%2520cancer%2520metabolism%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2012%26volume%3D109%26issue%3D4%26spage%3D1092%26epage%3D1097%26doi%3D10.1073%2Fpnas.1112495109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Redis, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vela, L. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferreira de Oliveira, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ivan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodriguez-Aguayo, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adamoski, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pasculli, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taguchi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fernandez, A. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valledor, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Roosbroeck, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shah, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kinnebrew, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Atlasi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheung, L. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, G. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monroig, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramirez, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Catela
Ivkovic, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ling, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gafà, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kapitanovic, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lanza, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bankson, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lai, S. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bast, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenblum, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Radovich, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ivan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bartholomeusz, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fraga, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Widger, W. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanash, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berindan-Neagoe, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lopez-Berestein, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ambrosio, A. L. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gomes
Dias, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calin, G. A.</span></span> <span> </span><span class="NLM_article-title">Allele-specific reprogramming of cancer metabolism by the Long Non-coding RNA CCAT2</span>. <i>Mol. Cell</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">520</span>– <span class="NLM_lpage">534</span>, <span class="refDoi"> DOI: 10.1016/j.molcel.2016.01.015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=10.1016%2Fj.molcel.2016.01.015" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2016&pages=520-534&author=R.+S.+Redisauthor=L.+E.+Velaauthor=W.+Luauthor=J.+Ferreira+de+Oliveiraauthor=C.+Ivanauthor=C.+Rodriguez-Aguayoauthor=D.+Adamoskiauthor=B.+Pasculliauthor=A.+Taguchiauthor=Y.+Chenauthor=A.+F.+Fernandezauthor=L.+Valledorauthor=K.+Van+Roosbroeckauthor=S.+Changauthor=M.+Shahauthor=G.+Kinnebrewauthor=L.+Hanauthor=Y.+Atlasiauthor=L.+H.+Cheungauthor=G.+Y.+Huangauthor=P.+Monroigauthor=M.+S.+Ramirezauthor=T.+Catela%0AIvkovicauthor=L.+Vanauthor=H.+Lingauthor=R.+Gaf%C3%A0author=S.+Kapitanovicauthor=G.+Lanzaauthor=J.+A.+Banksonauthor=P.+Huangauthor=S.+Y.+Laiauthor=R.+C.+Bastauthor=M.+G.+Rosenblumauthor=M.+Radovichauthor=M.+Ivanauthor=G.+Bartholomeuszauthor=H.+Liangauthor=M.+F.+Fragaauthor=W.+R.+Widgerauthor=S.+Hanashauthor=I.+Berindan-Neagoeauthor=G.+Lopez-Beresteinauthor=A.+L.+B.+Ambrosioauthor=S.+M.+Gomes%0ADiasauthor=G.+A.+Calin&title=Allele-specific+reprogramming+of+cancer+metabolism+by+the+Long+Non-coding+RNA+CCAT2&doi=10.1016%2Fj.molcel.2016.01.015"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1016%2Fj.molcel.2016.01.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molcel.2016.01.015%26sid%3Dliteratum%253Aachs%26aulast%3DRedis%26aufirst%3DR.%2BS.%26aulast%3DVela%26aufirst%3DL.%2BE.%26aulast%3DLu%26aufirst%3DW.%26aulast%3DFerreira%2Bde%2BOliveira%26aufirst%3DJ.%26aulast%3DIvan%26aufirst%3DC.%26aulast%3DRodriguez-Aguayo%26aufirst%3DC.%26aulast%3DAdamoski%26aufirst%3DD.%26aulast%3DPasculli%26aufirst%3DB.%26aulast%3DTaguchi%26aufirst%3DA.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DFernandez%26aufirst%3DA.%2BF.%26aulast%3DValledor%26aufirst%3DL.%26aulast%3DVan%2BRoosbroeck%26aufirst%3DK.%26aulast%3DChang%26aufirst%3DS.%26aulast%3DShah%26aufirst%3DM.%26aulast%3DKinnebrew%26aufirst%3DG.%26aulast%3DHan%26aufirst%3DL.%26aulast%3DAtlasi%26aufirst%3DY.%26aulast%3DCheung%26aufirst%3DL.%2BH.%26aulast%3DHuang%26aufirst%3DG.%2BY.%26aulast%3DMonroig%26aufirst%3DP.%26aulast%3DRamirez%26aufirst%3DM.%2BS.%26aulast%3DCatela%2BIvkovic%26aufirst%3DT.%26aulast%3DVan%26aufirst%3DL.%26aulast%3DLing%26aufirst%3DH.%26aulast%3DGaf%25C3%25A0%26aufirst%3DR.%26aulast%3DKapitanovic%26aufirst%3DS.%26aulast%3DLanza%26aufirst%3DG.%26aulast%3DBankson%26aufirst%3DJ.%2BA.%26aulast%3DHuang%26aufirst%3DP.%26aulast%3DLai%26aufirst%3DS.%2BY.%26aulast%3DBast%26aufirst%3DR.%2BC.%26aulast%3DRosenblum%26aufirst%3DM.%2BG.%26aulast%3DRadovich%26aufirst%3DM.%26aulast%3DIvan%26aufirst%3DM.%26aulast%3DBartholomeusz%26aufirst%3DG.%26aulast%3DLiang%26aufirst%3DH.%26aulast%3DFraga%26aufirst%3DM.%2BF.%26aulast%3DWidger%26aufirst%3DW.%2BR.%26aulast%3DHanash%26aufirst%3DS.%26aulast%3DBerindan-Neagoe%26aufirst%3DI.%26aulast%3DLopez-Berestein%26aufirst%3DG.%26aulast%3DAmbrosio%26aufirst%3DA.%2BL.%2BB.%26aulast%3DGomes%2BDias%26aufirst%3DS.%2BM.%26aulast%3DCalin%26aufirst%3DG.%2BA.%26atitle%3DAllele-specific%2520reprogramming%2520of%2520cancer%2520metabolism%2520by%2520the%2520Long%2520Non-coding%2520RNA%2520CCAT2%26jtitle%3DMol.%2520Cell%26date%3D2016%26volume%3D61%26spage%3D520%26epage%3D534%26doi%3D10.1016%2Fj.molcel.2016.01.015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xia, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Donehower, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cooper, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neilson, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wheeler, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wagner, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, W.</span></span> <span> </span><span class="NLM_article-title">Dynamic analyses of alternative polyadenylation from RNA-seq reveal a 3′-UTR landscape across seven tumour types</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">5274</span>, <span class="refDoi"> DOI: 10.1038/ncomms6274</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=10.1038%2Fncomms6274" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=25409906" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=1%3ACAS%3A528%3ADC%252BC2MXksVelt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=5274&author=Z.+Xiaauthor=L.+A.+Donehowerauthor=T.+A.+Cooperauthor=J.+R.+Neilsonauthor=D.+A.+Wheelerauthor=E.+J.+Wagnerauthor=W.+Li&title=Dynamic+analyses+of+alternative+polyadenylation+from+RNA-seq+reveal+a+3%E2%80%B2-UTR+landscape+across+seven+tumour+types&doi=10.1038%2Fncomms6274"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Dynamic analyses of alternative polyadenylation from RNA-seq reveal a 3'-UTR landscape across seven tumour types</span></div><div class="casAuthors">Xia, Zheng; Donehower, Lawrence A.; Cooper, Thomas A.; Neilson, Joel R.; Wheeler, David A.; Wagner, Eric J.; Li, Wei</div><div class="citationInfo"><span class="NLM_cas:title">Nature Communications</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">5274</span>CODEN:
                <span class="NLM_cas:coden">NCAOBW</span>;
        ISSN:<span class="NLM_cas:issn">2041-1723</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Alternative polyadenylation (APA) is a pervasive mechanism in the regulation of most human genes, and its implication in diseases including cancer is only beginning to be appreciated.  Since conventional APA profiling has not been widely adopted, global cancer APA studies are very limited.  Here we develop a novel bioinformatics algorithm (DaPars) for the de novo identification of dynamic APAs from std. RNA-seq.  When applied to 358 TCGA Pan-Cancer tumor/normal pairs across seven tumor types, DaPars reveals 1,346 genes with recurrent and tumor-specific APAs.  Most APA genes (91%) have shorter 3'-untranslated regions (3' UTRs) in tumors that can avoid microRNA-mediated repression, including glutaminase (GLS), a key metabolic enzyme for tumor proliferation.  Interestingly, selected APA events add strong prognostic power beyond common clin. and mol. variables, suggesting their potential as novel prognostic biomarkers.  Finally, our results implicate CstF64, an essential polyadenylation factor, as a master regulator of 3'-UTR shortening across multiple tumor types.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqsJbPJg31kHrVg90H21EOLACvtfcHk0lgTn_mqlk68Tg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXksVelt70%253D&md5=545a074f8a01de0d73f4bad0824e8153</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1038%2Fncomms6274&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms6274%26sid%3Dliteratum%253Aachs%26aulast%3DXia%26aufirst%3DZ.%26aulast%3DDonehower%26aufirst%3DL.%2BA.%26aulast%3DCooper%26aufirst%3DT.%2BA.%26aulast%3DNeilson%26aufirst%3DJ.%2BR.%26aulast%3DWheeler%26aufirst%3DD.%2BA.%26aulast%3DWagner%26aufirst%3DE.%2BJ.%26aulast%3DLi%26aufirst%3DW.%26atitle%3DDynamic%2520analyses%2520of%2520alternative%2520polyadenylation%2520from%2520RNA-seq%2520reveal%2520a%25203%25E2%2580%25B2-UTR%2520landscape%2520across%2520seven%2520tumour%2520types%26jtitle%3DNat.%2520Commun.%26date%3D2014%26volume%3D5%26spage%3D5274%26doi%3D10.1038%2Fncomms6274" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">van
den Heuvel, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jing, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wooster, R. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bachman, K. E.</span></span> <span> </span><span class="NLM_article-title">Analysis of glutamine dependency in non-small cell lung cancer: GLS1 splice variant GAC is essential for cancer cell growth</span>. <i>Cancer Biol. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>13</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">1185</span>– <span class="NLM_lpage">1194</span>, <span class="refDoi"> DOI: 10.4161/cbt.21348</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=10.4161%2Fcbt.21348" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=22892846" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=1%3ACAS%3A528%3ADC%252BC3sXisF2nu78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2012&pages=1185-1194&issue=12&author=A.+P.+van%0Aden+Heuvelauthor=J.+Jingauthor=R.+F.+Woosterauthor=K.+E.+Bachman&title=Analysis+of+glutamine+dependency+in+non-small+cell+lung+cancer%3A+GLS1+splice+variant+GAC+is+essential+for+cancer+cell+growth&doi=10.4161%2Fcbt.21348"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Analysis of glutamine dependency in non-small cell lung cancer: GLS1 splice variant GAC is essential for cancer cell growth</span></div><div class="casAuthors">van den Heuvel, A. Pieter J.; Jing, Junping; Wooster, Richard F.; Bachman, Kurtis E.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Biology & Therapy</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1185-1194</span>CODEN:
                <span class="NLM_cas:coden">CBTAAO</span>;
        ISSN:<span class="NLM_cas:issn">1538-4047</span>.
    
            (<span class="NLM_cas:orgname">Landes Bioscience</span>)
        </div><div class="casAbstract">One of the hallmarks of cancer is metabolic deregulation.  Many tumors display increased glucose uptake and breakdown through the process of aerobic glycolysis, also known as the Warburg effect.  Less studied in cancer development and progression is the importance of the glutamine (Gln) pathway, which provides cells with a variety of essential products to sustain cell proliferation, such as ATP and macromols. for biosynthesis.  To this end Gln dependency was assessed in a panel of non-small cell lung cancer lines (NSCLC).  Gln was found to be essential for the growth of cells with high rates of glutaminolysis, and after exploring multiple genes in the Gln pathway, GLS1 was found to be the key enzyme assocd. with this dependence.  This dependence was confirmed by observing the rescue of decreased growth by exogenous addn. of downstream metabolites of glutaminolysis.  Expression of the GLS1 splice variant KGA was found to be decreased in tumors compared with normal lung tissue.  Transient knock down of GLS1 splice variants indicated that loss of GAC had the most detrimental effect on cancer cell growth.  In conclusion, NSCLC cell lines depend on Gln for glutaminolysis to a varying degree, in which the GLS1 splice variant GAC plays an essential role and is a potential target for cancer metab.-directed therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrnWgR5NZWykLVg90H21EOLACvtfcHk0lgTn_mqlk68Tg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXisF2nu78%253D&md5=521cd23a9f2a3a7f31c7024603b3a0ca</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.4161%2Fcbt.21348&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4161%252Fcbt.21348%26sid%3Dliteratum%253Aachs%26aulast%3Dvan%2Bden%2BHeuvel%26aufirst%3DA.%2BP.%26aulast%3DJing%26aufirst%3DJ.%26aulast%3DWooster%26aufirst%3DR.%2BF.%26aulast%3DBachman%26aufirst%3DK.%2BE.%26atitle%3DAnalysis%2520of%2520glutamine%2520dependency%2520in%2520non-small%2520cell%2520lung%2520cancer%253A%2520GLS1%2520splice%2520variant%2520GAC%2520is%2520essential%2520for%2520cancer%2520cell%2520growth%26jtitle%3DCancer%2520Biol.%2520Ther.%26date%3D2012%26volume%3D13%26issue%3D12%26spage%3D1185%26epage%3D1194%26doi%3D10.4161%2Fcbt.21348" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jacque, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ronchetti, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Larrue, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meunier, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Birsen, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Willems, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saland, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Decroocq, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maciel, T. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lambert, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poulain, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hospital, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sujobert, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joseph, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chapuis, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lacombe, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moura, I. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Demo, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sarry, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Recher, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mayeux, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tamburini, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bouscary, D.</span></span> <span> </span><span class="NLM_article-title">Targeting glutaminolysis has antileukemic activity in acute myeloid leukemia and synergizes with BCL-2 inhibition</span>. <i>Blood</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>126</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">1346</span>– <span class="NLM_lpage">1356</span>, <span class="refDoi"> DOI: 10.1182/blood-2015-01-621870</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=10.1182%2Fblood-2015-01-621870" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=26186940" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=1%3ACAS%3A528%3ADC%252BC28Xht1WisLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=126&publication_year=2015&pages=1346-1356&issue=11&author=N.+Jacqueauthor=A.+M.+Ronchettiauthor=C.+Larrueauthor=G.+Meunierauthor=R.+Birsenauthor=L.+Willemsauthor=E.+Salandauthor=J.+Decroocqauthor=T.+T.+Macielauthor=M.+Lambertauthor=L.+Poulainauthor=M.+A.+Hospitalauthor=P.+Sujobertauthor=L.+Josephauthor=N.+Chapuisauthor=C.+Lacombeauthor=I.+C.+Mouraauthor=S.+Demoauthor=J.+E.+Sarryauthor=C.+Recherauthor=P.+Mayeuxauthor=J.+Tamburiniauthor=D.+Bouscary&title=Targeting+glutaminolysis+has+antileukemic+activity+in+acute+myeloid+leukemia+and+synergizes+with+BCL-2+inhibition&doi=10.1182%2Fblood-2015-01-621870"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting glutaminolysis has antileukemic activity in acute myeloid leukemia and synergizes with BCL-2 inhibition</span></div><div class="casAuthors">Jacque, Nathalie; Ronchetti, Anne Marie; Larrue, Clement; Meunier, Godelieve; Birsen, Rudy; Willems, Lise; Saland, Estelle; Decroocq, Justine; Macie, Thiago Trovati; Lambert, Mireille; Poulain, Laury; Hospital, Marie Anne; Sujobert, Pierre; Joseph, Laure; Chapuis, Nicolas; Lacombe, Catherine; Moura, Ivan Cruz; Demo, Susan; Sarry, Jean Emmanuel; Recher, Christian; Mayeux, Patrick; Tamburini, Jerome; Bouscary, Didier</div><div class="citationInfo"><span class="NLM_cas:title">Blood</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">126</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1346-1356</span>CODEN:
                <span class="NLM_cas:coden">BLOOAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-4971</span>.
    
            (<span class="NLM_cas:orgname">American Society of Hematology</span>)
        </div><div class="casAbstract">Cancer cells require glutamine to adapt to increased biosynthetic activity.  The limiting step in intracellular glutamine catabolism involves its conversion to glutamate by glutaminase (GA).  Different GA isoforms are encoded by the genes GLS1 and GLS2 in humans.  Herein, we show that glutamine levels control mitochondrial oxidative phosphorylation (OXPHOS) in acute myeloid leukemia (AML) cells.  Glutaminase C (GAC) is the GA isoform that is most abundantly expressed in AML.  Both knockdown of GLS1 expression and pharmacol. GLS1 inhibition by the drug CB-839 can reduce OXPHOS, leading to leukemic cell proliferation arrest and apoptosis without causing cytotoxic activity against normal human CD34+ progenitors.  Strikingly, GLS1 knockdown dramatically inhibited AML development in NSG mice.  The antileukemic activity of CB-839 was abrogated by both the expression of a hyperactive GACK320A allele and the addn. of the tricarboxyclic acid cycle product α-ketoglutarate, indicating the crit. function of GLS1 in AML cell survival.  Finally, glutaminolysis inhibition activated mitochondrial apoptosis and synergistically sensitized leukemic cells to priming with the BCL-2 inhibitor ABT-199.  These findings show that targeting glutamine addiction via GLS1 inhibition offers a potential novel therapeutic strategy for AML.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr_p-hOsAD2CbVg90H21EOLACvtfcHk0ljtW5J1qkUPtQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xht1WisLs%253D&md5=b4530d3ae6fd6d6c3e74fdcbf8967f76</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1182%2Fblood-2015-01-621870&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2015-01-621870%26sid%3Dliteratum%253Aachs%26aulast%3DJacque%26aufirst%3DN.%26aulast%3DRonchetti%26aufirst%3DA.%2BM.%26aulast%3DLarrue%26aufirst%3DC.%26aulast%3DMeunier%26aufirst%3DG.%26aulast%3DBirsen%26aufirst%3DR.%26aulast%3DWillems%26aufirst%3DL.%26aulast%3DSaland%26aufirst%3DE.%26aulast%3DDecroocq%26aufirst%3DJ.%26aulast%3DMaciel%26aufirst%3DT.%2BT.%26aulast%3DLambert%26aufirst%3DM.%26aulast%3DPoulain%26aufirst%3DL.%26aulast%3DHospital%26aufirst%3DM.%2BA.%26aulast%3DSujobert%26aufirst%3DP.%26aulast%3DJoseph%26aufirst%3DL.%26aulast%3DChapuis%26aufirst%3DN.%26aulast%3DLacombe%26aufirst%3DC.%26aulast%3DMoura%26aufirst%3DI.%2BC.%26aulast%3DDemo%26aufirst%3DS.%26aulast%3DSarry%26aufirst%3DJ.%2BE.%26aulast%3DRecher%26aufirst%3DC.%26aulast%3DMayeux%26aufirst%3DP.%26aulast%3DTamburini%26aufirst%3DJ.%26aulast%3DBouscary%26aufirst%3DD.%26atitle%3DTargeting%2520glutaminolysis%2520has%2520antileukemic%2520activity%2520in%2520acute%2520myeloid%2520leukemia%2520and%2520synergizes%2520with%2520BCL-2%2520inhibition%26jtitle%3DBlood%26date%3D2015%26volume%3D126%26issue%3D11%26spage%3D1346%26epage%3D1356%26doi%3D10.1182%2Fblood-2015-01-621870" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, Y. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, H. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hsu, H. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, I. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiu, Y. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chao, Y. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S. J.</span></span> <span> </span><span class="NLM_article-title">Discovery of selective inhibitors of Glutaminase-2, which inhibit mTORC1, activate autophagy and inhibit proliferation in cancer cells</span>. <i>Oncotarget</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>5</i></span> (<span class="NLM_issue">15</span>),  <span class="NLM_fpage">6087</span>– <span class="NLM_lpage">6101</span>, <span class="refDoi"> DOI: 10.18632/oncotarget.2173</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=10.18632%2Foncotarget.2173" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=25026281" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=1%3ACAS%3A280%3ADC%252BC2cbitF2htA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=6087-6101&issue=15&author=Y.+Z.+Leeauthor=C.+W.+Yangauthor=H.+Y.+Changauthor=H.+Y.+Hsuauthor=I.+S.+Chenauthor=H.+S.+Changauthor=C.+H.+Leeauthor=J.+C.+Leeauthor=C.+R.+Kumarauthor=Y.+Q.+Qiuauthor=Y.+S.+Chaoauthor=S.+J.+Lee&title=Discovery+of+selective+inhibitors+of+Glutaminase-2%2C+which+inhibit+mTORC1%2C+activate+autophagy+and+inhibit+proliferation+in+cancer+cells&doi=10.18632%2Foncotarget.2173"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of selective inhibitors of Glutaminase-2, which inhibit mTORC1, activate autophagy and inhibit proliferation in cancer cells</span></div><div class="casAuthors">Lee Yue-Zhi; Yang Cheng-Wei; Chang Hsin-Yu; Hsu Hsing-Yu; Chen Ih-Shen; Chang Hsun-Shuo; Lee Chih-Hao; Lee Jinq-chyi; Kumar Chidambaram Ramesh; Chao Yu-Sheng; Lee Shiow-Ju; Qiu Ya-Qi</div><div class="citationInfo"><span class="NLM_cas:title">Oncotarget</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">6087-101</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Glutaminase, which converts glutamine to glutamate, is involved in Warburg effect in cancer cells.  Two human glutaminase genes have been identified, GLS (GLS1) and GLS2.  Two alternative transcripts arise from each glutaminase gene: first, the kidney isoform (KGA) and glutaminase C (GAC) for GLS; and, second, the liver isoform (LGA) and glutaminase B (GAB) for GLS2.  While GLS1 is considered as a cancer therapeutic target, the potential role of GLS2 in cancer remains unclear.  Here, we discovered a series of alkyl benzoquinones that preferentially inhibit glutaminase B isoform (GAB, GLS2) rather than the kidney isoform of glutaminase (KGA, GLS1).  We identified amino acid residues in an allosteric binding pocket responsible for the selectivity.  Treatment with the alkyl benzoquinones decreased intracellular glutaminase activity and glutamate levels.  GLS2 inhibition by either alkyl benzoquinones or GLS2 siRNA reduced carcinoma cell proliferation and anchorage-independent colony formation, and induced autophagy via AMPK mediated mTORC1 inhibition.  Our findings demonstrate amino acid sequences for selective inhibition of glutaminase isozymes and validate GLS2 as a potential anti-cancer target.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS7ipugdsmO_SjiVMCqkKxVfW6udTcc2eYzDFv0I80ajLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2cbitF2htA%253D%253D&md5=0f0e4f0d6a1960aa8a87d645f55b5f68</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.2173&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.2173%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DY.%2BZ.%26aulast%3DYang%26aufirst%3DC.%2BW.%26aulast%3DChang%26aufirst%3DH.%2BY.%26aulast%3DHsu%26aufirst%3DH.%2BY.%26aulast%3DChen%26aufirst%3DI.%2BS.%26aulast%3DChang%26aufirst%3DH.%2BS.%26aulast%3DLee%26aufirst%3DC.%2BH.%26aulast%3DLee%26aufirst%3DJ.%2BC.%26aulast%3DKumar%26aufirst%3DC.%2BR.%26aulast%3DQiu%26aufirst%3DY.%2BQ.%26aulast%3DChao%26aufirst%3DY.%2BS.%26aulast%3DLee%26aufirst%3DS.%2BJ.%26atitle%3DDiscovery%2520of%2520selective%2520inhibitors%2520of%2520Glutaminase-2%252C%2520which%2520inhibit%2520mTORC1%252C%2520activate%2520autophagy%2520and%2520inhibit%2520proliferation%2520in%2520cancer%2520cells%26jtitle%3DOncotarget%26date%3D2014%26volume%3D5%26issue%3D15%26spage%3D6087%26epage%3D6101%26doi%3D10.18632%2Foncotarget.2173" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xiao, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ren, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yue, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiu, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qing, G.</span></span> <span> </span><span class="NLM_article-title">Myc promotes glutaminolysis in human neuroblastoma through direct activation of glutaminase 2</span>. <i>Oncotarget</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">40655</span>– <span class="NLM_lpage">40666</span>, <span class="refDoi"> DOI: 10.18632/oncotarget.5821</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=10.18632%2Foncotarget.5821" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=40655-40666&author=D.+Xiaoauthor=P.+Renauthor=H.+Suauthor=M.+Yueauthor=R.+Xiuauthor=Y.+Huauthor=H.+Liuauthor=G.+Qing&title=Myc+promotes+glutaminolysis+in+human+neuroblastoma+through+direct+activation+of+glutaminase+2&doi=10.18632%2Foncotarget.5821"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.5821&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.5821%26sid%3Dliteratum%253Aachs%26aulast%3DXiao%26aufirst%3DD.%26aulast%3DRen%26aufirst%3DP.%26aulast%3DSu%26aufirst%3DH.%26aulast%3DYue%26aufirst%3DM.%26aulast%3DXiu%26aufirst%3DR.%26aulast%3DHu%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DH.%26aulast%3DQing%26aufirst%3DG.%26atitle%3DMyc%2520promotes%2520glutaminolysis%2520in%2520human%2520neuroblastoma%2520through%2520direct%2520activation%2520of%2520glutaminase%25202%26jtitle%3DOncotarget%26date%3D2015%26volume%3D6%26spage%3D40655%26epage%3D40666%26doi%3D10.18632%2Foncotarget.5821" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erickson, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fuji, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramachandran, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dinavahi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, K. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ambrosio, A. L. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dias, S. M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dang, C. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cerione, R. A.</span></span> <span> </span><span class="NLM_article-title">Targeting mitochondrial glutaminase activity inhibits oncogenic transformation</span>. <i>Cancer Cell</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>18</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">207</span>– <span class="NLM_lpage">219</span>, <span class="refDoi"> DOI: 10.1016/j.ccr.2010.08.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=10.1016%2Fj.ccr.2010.08.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=20832749" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtFGht7bO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2010&pages=207-219&issue=3&author=J.+B.+Wangauthor=J.+W.+Ericksonauthor=R.+Fujiauthor=S.+Ramachandranauthor=P.+Gaoauthor=R.+Dinavahiauthor=K.+F.+Wilsonauthor=A.+L.+B.+Ambrosioauthor=S.+M.+G.+Diasauthor=C.+V.+Dangauthor=R.+A.+Cerione&title=Targeting+mitochondrial+glutaminase+activity+inhibits+oncogenic+transformation&doi=10.1016%2Fj.ccr.2010.08.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting Mitochondrial Glutaminase Activity Inhibits Oncogenic Transformation</span></div><div class="casAuthors">Wang, Jian-Bin; Erickson, Jon W.; Fuji, Reina; Ramachandran, Sekar; Gao, Ping; Dinavahi, Ramani; Wilson, Kristin F.; Ambrosio, Andre L. B.; Dias, Sandra M. G.; Dang, Chi-V.; Cerione, Richard A.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Cell</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">207-219</span>CODEN:
                <span class="NLM_cas:coden">CCAECI</span>;
        ISSN:<span class="NLM_cas:issn">1535-6108</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Rho GTPases impact a no. of activities important for oncogenesis.  We describe a small mol. inhibitor that blocks oncogenic transformation induced by various Rho GTPases in fibroblasts, and the growth of human breast cancer and B lymphoma cells, without affecting normal cells.  We identify the target of this inhibitor to be the metabolic enzyme glutaminase, which catalyzes the hydrolysis of glutamine to glutamate.  We show that transformed fibroblasts and breast cancer cells exhibit elevated glutaminase activity that is dependent on Rho GTPases and NF-κB activity, and is blocked by the small mol. inhibitor.  These findings highlight a previously unappreciated connection between Rho GTPase activation and cellular metab. and demonstrate that targeting glutaminase activity can inhibit oncogenic transformation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpTP6YsyzRd1LVg90H21EOLACvtfcHk0lhbI0P2EXfN2w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtFGht7bO&md5=67b64e99c992bbe6636ecfc04b83aac0</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1016%2Fj.ccr.2010.08.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ccr.2010.08.009%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DJ.%2BB.%26aulast%3DErickson%26aufirst%3DJ.%2BW.%26aulast%3DFuji%26aufirst%3DR.%26aulast%3DRamachandran%26aufirst%3DS.%26aulast%3DGao%26aufirst%3DP.%26aulast%3DDinavahi%26aufirst%3DR.%26aulast%3DWilson%26aufirst%3DK.%2BF.%26aulast%3DAmbrosio%26aufirst%3DA.%2BL.%2BB.%26aulast%3DDias%26aufirst%3DS.%2BM.%2BG.%26aulast%3DDang%26aufirst%3DC.%2BV.%26aulast%3DCerione%26aufirst%3DR.%2BA.%26atitle%3DTargeting%2520mitochondrial%2520glutaminase%2520activity%2520inhibits%2520oncogenic%2520transformation%26jtitle%3DCancer%2520Cell%26date%3D2010%26volume%3D18%26issue%3D3%26spage%3D207%26epage%3D219%26doi%3D10.1016%2Fj.ccr.2010.08.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Seltzer, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bennett, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joshi, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferraris, D. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsukamoto, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rojas, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Slusher, B. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rabinowitz, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dang, C. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riggins, G. J.</span></span> <span> </span><span class="NLM_article-title">Inhibition of glutaminase preferentially slows growth of glioma cells with mutant IDH1</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>70</i></span> (<span class="NLM_issue">22</span>),  <span class="NLM_fpage">8981</span>– <span class="NLM_lpage">8987</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-10-1666</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=10.1158%2F0008-5472.CAN-10-1666" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2010&pages=8981-8987&issue=22&author=M.+J.+Seltzerauthor=B.+D.+Bennettauthor=A.+D.+Joshiauthor=P.+Gaoauthor=A.+G.+Thomasauthor=D.+V.+Ferrarisauthor=T.+Tsukamotoauthor=C.+J.+Rojasauthor=B.+S.+Slusherauthor=J.+D.+Rabinowitzauthor=C.+V.+Dangauthor=G.+J.+Riggins&title=Inhibition+of+glutaminase+preferentially+slows+growth+of+glioma+cells+with+mutant+IDH1&doi=10.1158%2F0008-5472.CAN-10-1666"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-10-1666&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-10-1666%26sid%3Dliteratum%253Aachs%26aulast%3DSeltzer%26aufirst%3DM.%2BJ.%26aulast%3DBennett%26aufirst%3DB.%2BD.%26aulast%3DJoshi%26aufirst%3DA.%2BD.%26aulast%3DGao%26aufirst%3DP.%26aulast%3DThomas%26aufirst%3DA.%2BG.%26aulast%3DFerraris%26aufirst%3DD.%2BV.%26aulast%3DTsukamoto%26aufirst%3DT.%26aulast%3DRojas%26aufirst%3DC.%2BJ.%26aulast%3DSlusher%26aufirst%3DB.%2BS.%26aulast%3DRabinowitz%26aufirst%3DJ.%2BD.%26aulast%3DDang%26aufirst%3DC.%2BV.%26aulast%3DRiggins%26aufirst%3DG.%2BJ.%26atitle%3DInhibition%2520of%2520glutaminase%2520preferentially%2520slows%2520growth%2520of%2520glioma%2520cells%2520with%2520mutant%2520IDH1%26jtitle%3DCancer%2520Res.%26date%3D2010%26volume%3D70%26issue%3D22%26spage%3D8981%26epage%3D8987%26doi%3D10.1158%2F0008-5472.CAN-10-1666" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wise, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deberardinis, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mancuso, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sayed, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pfeiffer, H. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nissim, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daikhin, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yudkoff, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McMahon, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, C. B.</span></span> <span> </span><span class="NLM_article-title">Myc regulates a transcriptional program that stimulates mitochondrial glutaminolysis and leads to glutamine addiction</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>105</i></span> (<span class="NLM_issue">48</span>),  <span class="NLM_fpage">18782</span>– <span class="NLM_lpage">18787</span>, <span class="refDoi"> DOI: 10.1073/pnas.0810199105</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=10.1073%2Fpnas.0810199105" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2008&pages=18782-18787&issue=48&author=D.+R.+Wiseauthor=R.+J.+Deberardinisauthor=A.+Mancusoauthor=N.+Sayedauthor=X.+Y.+Zhangauthor=H.+K.+Pfeifferauthor=I.+Nissimauthor=E.+Daikhinauthor=M.+Yudkoffauthor=S.+B.+McMahonauthor=C.+B.+Thompson&title=Myc+regulates+a+transcriptional+program+that+stimulates+mitochondrial+glutaminolysis+and+leads+to+glutamine+addiction&doi=10.1073%2Fpnas.0810199105"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0810199105&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0810199105%26sid%3Dliteratum%253Aachs%26aulast%3DWise%26aufirst%3DD.%2BR.%26aulast%3DDeberardinis%26aufirst%3DR.%2BJ.%26aulast%3DMancuso%26aufirst%3DA.%26aulast%3DSayed%26aufirst%3DN.%26aulast%3DZhang%26aufirst%3DX.%2BY.%26aulast%3DPfeiffer%26aufirst%3DH.%2BK.%26aulast%3DNissim%26aufirst%3DI.%26aulast%3DDaikhin%26aufirst%3DE.%26aulast%3DYudkoff%26aufirst%3DM.%26aulast%3DMcMahon%26aufirst%3DS.%2BB.%26aulast%3DThompson%26aufirst%3DC.%2BB.%26atitle%3DMyc%2520regulates%2520a%2520transcriptional%2520program%2520that%2520stimulates%2520mitochondrial%2520glutaminolysis%2520and%2520leads%2520to%2520glutamine%2520addiction%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2008%26volume%3D105%26issue%3D48%26spage%3D18782%26epage%3D18787%26doi%3D10.1073%2Fpnas.0810199105" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gao, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tchernyshyov, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, T. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, Y. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kita, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ochi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeller, K. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Marzo, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Eyk, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mendell, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dang, C. V.</span></span> <span> </span><span class="NLM_article-title">c-Myc suppression of miR-23a/b enhances mitochondrial glutaminase expression and glutamine metabolism</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>458</i></span> (<span class="NLM_issue">7239</span>),  <span class="NLM_fpage">762</span>– <span class="NLM_lpage">765</span>, <span class="refDoi"> DOI: 10.1038/nature07823</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=10.1038%2Fnature07823" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=19219026" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhvFKjtrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=458&publication_year=2009&pages=762-765&issue=7239&author=P.+Gaoauthor=I.+Tchernyshyovauthor=T.+C.+Changauthor=Y.+S.+Leeauthor=K.+Kitaauthor=T.+Ochiauthor=K.+I.+Zellerauthor=A.+M.+De+Marzoauthor=J.+E.+Van+Eykauthor=J.+T.+Mendellauthor=C.+V.+Dang&title=c-Myc+suppression+of+miR-23a%2Fb+enhances+mitochondrial+glutaminase+expression+and+glutamine+metabolism&doi=10.1038%2Fnature07823"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">c-Myc suppression of miR-23a/b enhances mitochondrial glutaminase expression and glutamine metabolism</span></div><div class="casAuthors">Gao, Ping; Tchernyshyov, Irina; Chang, Tsung-Cheng; Lee, Yun-Sil; Kita, Kayoko; Ochi, Takafumi; Zeller, Karen I.; De Marzo, Angelo M.; Van Eyk, Jennifer E.; Mendell, Joshua T.; Dang, Chi V.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">458</span>
        (<span class="NLM_cas:issue">7239</span>),
    <span class="NLM_cas:pages">762-765</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Altered glucose metab. in cancer cells is termed the Warburg effect, which describes the propensity of most cancer cells to take up glucose avidly and convert it primarily to lactate, despite available oxygen.  Notwithstanding the renewed interest in the Warburg effect, cancer cells also depend on continued mitochondrial function for metab., specifically glutaminolysis that catabolizes glutamine to generate ATP and lactate.  Glutamine, which is highly transported into proliferating cells, is a major source of energy and nitrogen for biosynthesis, and a carbon substrate for anabolic processes in cancer cells, but the regulation of glutamine metab. is not well understood.  Here the authors report that the c-Myc (hereafter referred to as Myc) oncogenic transcription factor, which is known to regulate microRNAs and stimulate cell proliferation, transcriptionally represses miR-23a and miR-23b, resulting in greater expression of their target protein, mitochondrial glutaminase, in human P-493 B lymphoma cells and PC3 prostate cancer cells.  This leads to upregulation of glutamine catabolism.  Glutaminase converts glutamine to glutamate, which is further catabolized through the tricarboxylic acid cycle for the prodn. of ATP or serves as substrate for glutathione synthesis.  The unique means by which Myc regulates glutaminase uncovers a previously unsuspected link between Myc regulation of miRNAs, glutamine metab., and energy and reactive oxygen species homeostasis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqueU1pXBd0orVg90H21EOLACvtfcHk0lhbI0P2EXfN2w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhvFKjtrY%253D&md5=9da429f047042a95d28f8335391db97d</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1038%2Fnature07823&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature07823%26sid%3Dliteratum%253Aachs%26aulast%3DGao%26aufirst%3DP.%26aulast%3DTchernyshyov%26aufirst%3DI.%26aulast%3DChang%26aufirst%3DT.%2BC.%26aulast%3DLee%26aufirst%3DY.%2BS.%26aulast%3DKita%26aufirst%3DK.%26aulast%3DOchi%26aufirst%3DT.%26aulast%3DZeller%26aufirst%3DK.%2BI.%26aulast%3DDe%2BMarzo%26aufirst%3DA.%2BM.%26aulast%3DVan%2BEyk%26aufirst%3DJ.%2BE.%26aulast%3DMendell%26aufirst%3DJ.%2BT.%26aulast%3DDang%26aufirst%3DC.%2BV.%26atitle%3Dc-Myc%2520suppression%2520of%2520miR-23a%252Fb%2520enhances%2520mitochondrial%2520glutaminase%2520expression%2520and%2520glutamine%2520metabolism%26jtitle%3DNature%26date%3D2009%26volume%3D458%26issue%3D7239%26spage%3D762%26epage%3D765%26doi%3D10.1038%2Fnature07823" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Le, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lane, A. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamaker, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bose, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gouw, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barbi, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsukamoto, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rojas, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Slusher, B. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zimmerman, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liebler, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Slebos, R. J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lorkiewicz, P. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Higashi, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, T. W. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dang, C. V.</span></span> <span> </span><span class="NLM_article-title">Glucose-independent glutamine metabolism via TCA cycling for proliferation and survival in B cells</span>. <i>Cell Metab.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>15</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">110</span>– <span class="NLM_lpage">121</span>, <span class="refDoi"> DOI: 10.1016/j.cmet.2011.12.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=10.1016%2Fj.cmet.2011.12.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=22225880" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=1%3ACAS%3A528%3ADC%252BC38XkvF2nsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2012&pages=110-121&issue=1&author=A.+Leauthor=A.+N.+Laneauthor=M.+Hamakerauthor=S.+Boseauthor=A.+Gouwauthor=J.+Barbiauthor=T.+Tsukamotoauthor=C.+J.+Rojasauthor=B.+S.+Slusherauthor=H.+X.+Zhangauthor=L.+J.+Zimmermanauthor=D.+C.+Lieblerauthor=R.+J.+C.+Slebosauthor=P.+K.+Lorkiewiczauthor=R.+M.+Higashiauthor=T.+W.+M.+Fanauthor=C.+V.+Dang&title=Glucose-independent+glutamine+metabolism+via+TCA+cycling+for+proliferation+and+survival+in+B+cells&doi=10.1016%2Fj.cmet.2011.12.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Glucose-Independent Glutamine Metabolism via TCA Cycling for Proliferation and Survival in B Cells</span></div><div class="casAuthors">Le, Anne; Lane, Andrew N.; Hamaker, Max; Bose, Sminu; Gouw, Arvin; Barbi, Joseph; Tsukamoto, Takashi; Rojas, Camilio J.; Slusher, Barbara S.; Zhang, Haixia; Zimmerman, Lisa J.; Liebler, Daniel C.; Slebos, Robbert J. C.; Lorkiewicz, Pawel K.; Higashi, Richard M.; Fan, Teresa W. M.; Dang, Chi V.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Metabolism</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">110-121</span>CODEN:
                <span class="NLM_cas:coden">CMEEB5</span>;
        ISSN:<span class="NLM_cas:issn">1550-4131</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Because MYC plays a causal role in many human cancers, including those with hypoxic and nutrient-poor tumor microenvironments, we have detd. the metabolic responses of a MYC-inducible human Burkitt lymphoma model P493 cell line to aerobic and hypoxic conditions, and to glucose deprivation, using stable isotope-resolved metabolomics.  Using [U-13C]-glucose as the tracer, both glucose consumption and lactate prodn. were increased by MYC expression and hypoxia.  Using [U-13C,15N]-glutamine as the tracer, glutamine import and metab. through the TCA cycle persisted under hypoxia, and glutamine contributed significantly to citrate Cs.  Under glucose deprivation, glutamine-derived fumarate, malate, and citrate were significantly increased.  Their 13C-labeling patterns demonstrate an alternative energy-generating glutaminolysis pathway involving a glucose-independent TCA cycle.  The essential role of glutamine metab. in cell survival and proliferation under hypoxia and glucose deficiency makes them susceptible to the glutaminase inhibitor BPTES and hence could be targeted for cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpxz5K5YyvT6rVg90H21EOLACvtfcHk0lggaqoNXRBYKg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XkvF2nsg%253D%253D&md5=0e71d2f1fff5795ba1d22afc8a2fefae</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1016%2Fj.cmet.2011.12.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cmet.2011.12.009%26sid%3Dliteratum%253Aachs%26aulast%3DLe%26aufirst%3DA.%26aulast%3DLane%26aufirst%3DA.%2BN.%26aulast%3DHamaker%26aufirst%3DM.%26aulast%3DBose%26aufirst%3DS.%26aulast%3DGouw%26aufirst%3DA.%26aulast%3DBarbi%26aufirst%3DJ.%26aulast%3DTsukamoto%26aufirst%3DT.%26aulast%3DRojas%26aufirst%3DC.%2BJ.%26aulast%3DSlusher%26aufirst%3DB.%2BS.%26aulast%3DZhang%26aufirst%3DH.%2BX.%26aulast%3DZimmerman%26aufirst%3DL.%2BJ.%26aulast%3DLiebler%26aufirst%3DD.%2BC.%26aulast%3DSlebos%26aufirst%3DR.%2BJ.%2BC.%26aulast%3DLorkiewicz%26aufirst%3DP.%2BK.%26aulast%3DHigashi%26aufirst%3DR.%2BM.%26aulast%3DFan%26aufirst%3DT.%2BW.%2BM.%26aulast%3DDang%26aufirst%3DC.%2BV.%26atitle%3DGlucose-independent%2520glutamine%2520metabolism%2520via%2520TCA%2520cycling%2520for%2520proliferation%2520and%2520survival%2520in%2520B%2520cells%26jtitle%3DCell%2520Metab.%26date%3D2012%26volume%3D15%26issue%3D1%26spage%3D110%26epage%3D121%26doi%3D10.1016%2Fj.cmet.2011.12.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Son, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lyssiotis, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ying, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hua, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ligorio, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perera, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferrone, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mullarky, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shyh-Chang, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fleming, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bardeesy, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Asara, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haigis, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DePinho, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cantley, L. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kimmelman, A. C.</span></span> <span> </span><span class="NLM_article-title">Glutamine supports pancreatic cancer growth through a Kras-regulated metabolic pathway</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>496</i></span>,  <span class="NLM_fpage">101</span>– <span class="NLM_lpage">105</span>, <span class="refDoi"> DOI: 10.1038/nature12040</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=10.1038%2Fnature12040" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=23535601" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=1%3ACAS%3A528%3ADC%252BC3sXkvFyjsrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=496&publication_year=2013&pages=101-105&author=J.+Sonauthor=C.+A.+Lyssiotisauthor=H.+Yingauthor=X.+Wangauthor=S.+Huaauthor=M.+Ligorioauthor=R.+M.+Pereraauthor=C.+R.+Ferroneauthor=E.+Mullarkyauthor=N.+Shyh-Changauthor=Y.+Kangauthor=J.+B.+Flemingauthor=N.+Bardeesyauthor=J.+M.+Asaraauthor=M.+C.+Haigisauthor=R.+A.+DePinhoauthor=L.+C.+Cantleyauthor=A.+C.+Kimmelman&title=Glutamine+supports+pancreatic+cancer+growth+through+a+Kras-regulated+metabolic+pathway&doi=10.1038%2Fnature12040"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Glutamine supports pancreatic cancer growth through a KRAS-regulated metabolic pathway</span></div><div class="casAuthors">Son, Jaekyoung; Lyssiotis, Costas A.; Ying, Haoqiang; Wang, Xiaoxu; Hua, Sujun; Ligorio, Matteo; Perera, Rushika M.; Ferrone, Cristina R.; Mullarky, Edouard; Ng, Shyh-Chang; Kang, Ya'an; Fleming, Jason B.; Bardeesy, Nabeel; Asara, John M.; Haigis, Marcia C.; DePinho, Ronald A.; Cantley, Lewis C.; Kimmelman, Alec C.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">496</span>
        (<span class="NLM_cas:issue">7443</span>),
    <span class="NLM_cas:pages">101-105</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Cancer cells have metabolic dependencies that distinguish them from their normal counterparts.  Among these dependencies is an increased use of the amino acid glutamine to fuel anabolic processes.  Indeed, the spectrum of glutamine-dependent tumors and the mechanisms whereby glutamine supports cancer metab. remain areas of active investigation.  Here we report the identification of a non-canonical pathway of glutamine use in human pancreatic ductal adenocarcinoma (PDAC) cells that is required for tumor growth.  Whereas most cells use glutamate dehydrogenase (GLUD1) to convert glutamine-derived glutamate into α-ketoglutarate in the mitochondria to fuel the tricarboxylic acid cycle, PDAC relies on a distinct pathway in which glutamine-derived aspartate is transported into the cytoplasm where it can be converted into oxaloacetate by aspartate transaminase (GOT1).  Subsequently, this oxaloacetate is converted into malate and then pyruvate, ostensibly increasing the NADPH/NADP+ ratio which can potentially maintain the cellular redox state.  Importantly, PDAC cells are strongly dependent on this series of reactions, as glutamine deprivation or genetic inhibition of any enzyme in this pathway leads to an increase in reactive oxygen species and a redn. in reduced glutathione.  Moreover, knockdown of any component enzyme in this series of reactions also results in a pronounced suppression of PDAC growth in vitro and in vivo.  Furthermore, we establish that the reprogramming of glutamine metab. is mediated by oncogenic KRAS, the signature genetic alteration in PDAC, through the transcriptional upregulation and repression of key metabolic enzymes in this pathway.  The essentiality of this pathway in PDAC and the fact that it is dispensable in normal cells may provide novel therapeutic approaches to treat these refractory tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpzWAEWZvCWcbVg90H21EOLACvtfcHk0lggaqoNXRBYKg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXkvFyjsrc%253D&md5=162af18c1102745226aa2096179f1cc6</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1038%2Fnature12040&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature12040%26sid%3Dliteratum%253Aachs%26aulast%3DSon%26aufirst%3DJ.%26aulast%3DLyssiotis%26aufirst%3DC.%2BA.%26aulast%3DYing%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DHua%26aufirst%3DS.%26aulast%3DLigorio%26aufirst%3DM.%26aulast%3DPerera%26aufirst%3DR.%2BM.%26aulast%3DFerrone%26aufirst%3DC.%2BR.%26aulast%3DMullarky%26aufirst%3DE.%26aulast%3DShyh-Chang%26aufirst%3DN.%26aulast%3DKang%26aufirst%3DY.%26aulast%3DFleming%26aufirst%3DJ.%2BB.%26aulast%3DBardeesy%26aufirst%3DN.%26aulast%3DAsara%26aufirst%3DJ.%2BM.%26aulast%3DHaigis%26aufirst%3DM.%2BC.%26aulast%3DDePinho%26aufirst%3DR.%2BA.%26aulast%3DCantley%26aufirst%3DL.%2BC.%26aulast%3DKimmelman%26aufirst%3DA.%2BC.%26atitle%3DGlutamine%2520supports%2520pancreatic%2520cancer%2520growth%2520through%2520a%2520Kras-regulated%2520metabolic%2520pathway%26jtitle%3DNature%26date%3D2013%26volume%3D496%26spage%3D101%26epage%3D105%26doi%3D10.1038%2Fnature12040" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Weinberg, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamanaka, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wheaton, W. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weinberg, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joseph, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lopez, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalyanaraman, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mutlu, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Budinger, G. R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chandel, N. S.</span></span> <span> </span><span class="NLM_article-title">Mitochondrial metabolism and ROS generation are essential for Kras-mediated tumorigenicity</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>107</i></span>,  <span class="NLM_fpage">8788</span>– <span class="NLM_lpage">8793</span>, <span class="refDoi"> DOI: 10.1073/pnas.1003428107</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=10.1073%2Fpnas.1003428107" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=20421486" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=1%3ACAS%3A528%3ADC%252BC3cXmsFWmurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=107&publication_year=2010&pages=8788-8793&author=F.+Weinbergauthor=R.+Hamanakaauthor=W.+W.+Wheatonauthor=S.+Weinbergauthor=J.+Josephauthor=M.+Lopezauthor=B.+Kalyanaramanauthor=G.+M.+Mutluauthor=G.+R.+S.+Budingerauthor=N.+S.+Chandel&title=Mitochondrial+metabolism+and+ROS+generation+are+essential+for+Kras-mediated+tumorigenicity&doi=10.1073%2Fpnas.1003428107"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Mitochondrial metabolism and ROS generation are essential for Kras-mediated tumorigenicity</span></div><div class="casAuthors">Weinberg, Frank; Hamanaka, Robert; Wheaton, William W.; Weinberg, Samuel; Joseph, Joy; Lopez, Marcos; Kalyanaraman, Balaraman; Mutlu, Gokhan M.; Budinger, G. R. Scott; Chandel, Navdeep S.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">107</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">8788-8793, S8788/1-S8788/9</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Otto Warburg's theory on the origins of cancer postulates that tumor cells have defects in mitochondrial oxidative phosphorylation and therefore rely on high levels of aerobic glycolysis as the major source of ATP to fuel cellular proliferation (the Warburg effect).  This is in contrast to normal cells, which primarily utilize oxidative phosphorylation for growth and survival.  Here we report that the major function of glucose metab. for Kras-induced anchorage-independent growth, a hallmark of transformed cells, is to support the pentose phosphate pathway.  The major function of glycolytic ATP is to support growth under hypoxic conditions.  Glutamine conversion into the tricarboxylic acid cycle intermediate alpha-ketoglutarate through glutaminase and alanine aminotransferase is essential for Kras-induced anchorage-independent growth.  Mitochondrial metab. allows for the generation of reactive oxygen species (ROS) which are required for Kras-induced anchorage-independent growth through regulation of the ERK MAPK signaling pathway.  We show that the major source of ROS generation required for anchorage-independent growth is the Q0 site of mitochondrial complex III.  Furthermore, disruption of mitochondrial function by loss of the mitochondrial transcription factor A (TFAM) gene reduced tumorigenesis in an oncogenic Kras-driven mouse model of lung cancer.  These results demonstrate that mitochondrial metab. and mitochondrial ROS generation are essential for Kras-induced cell proliferation and tumorigenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGphMhaUC-tau7Vg90H21EOLACvtfcHk0lggaqoNXRBYKg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXmsFWmurs%253D&md5=cc8197db5581ed62f5ce5f5e78823eb0</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1003428107&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1003428107%26sid%3Dliteratum%253Aachs%26aulast%3DWeinberg%26aufirst%3DF.%26aulast%3DHamanaka%26aufirst%3DR.%26aulast%3DWheaton%26aufirst%3DW.%2BW.%26aulast%3DWeinberg%26aufirst%3DS.%26aulast%3DJoseph%26aufirst%3DJ.%26aulast%3DLopez%26aufirst%3DM.%26aulast%3DKalyanaraman%26aufirst%3DB.%26aulast%3DMutlu%26aufirst%3DG.%2BM.%26aulast%3DBudinger%26aufirst%3DG.%2BR.%2BS.%26aulast%3DChandel%26aufirst%3DN.%2BS.%26atitle%3DMitochondrial%2520metabolism%2520and%2520ROS%2520generation%2520are%2520essential%2520for%2520Kras-mediated%2520tumorigenicity%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2010%26volume%3D107%26spage%3D8788%26epage%3D8793%26doi%3D10.1073%2Fpnas.1003428107" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gaglio, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soldati, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vanoni, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alberghina, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiaradonna, F.</span></span> <span> </span><span class="NLM_article-title">Glutamine deprivation induces abortive s-phase rescued by deoxyribonucleotides in k-ras transformed fibroblasts</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>4</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">e4715</span>, <span class="refDoi"> DOI: 10.1371/journal.pone.0004715</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=10.1371%2Fjournal.pone.0004715" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=19262748" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2009&pages=e4715&issue=3&author=D.+Gaglioauthor=C.+Soldatiauthor=M.+Vanoniauthor=L.+Alberghinaauthor=F.+Chiaradonna&title=Glutamine+deprivation+induces+abortive+s-phase+rescued+by+deoxyribonucleotides+in+k-ras+transformed+fibroblasts&doi=10.1371%2Fjournal.pone.0004715"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0004715&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0004715%26sid%3Dliteratum%253Aachs%26aulast%3DGaglio%26aufirst%3DD.%26aulast%3DSoldati%26aufirst%3DC.%26aulast%3DVanoni%26aufirst%3DM.%26aulast%3DAlberghina%26aufirst%3DL.%26aulast%3DChiaradonna%26aufirst%3DF.%26atitle%3DGlutamine%2520deprivation%2520induces%2520abortive%2520s-phase%2520rescued%2520by%2520deoxyribonucleotides%2520in%2520k-ras%2520transformed%2520fibroblasts%26jtitle%3DPLoS%2520One%26date%3D2009%26volume%3D4%26issue%3D3%26spage%3De4715%26doi%3D10.1371%2Fjournal.pone.0004715" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gaglio, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Metallo, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gameiro, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hiller, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Danna, L. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balestrieri, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alberghina, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stephanopoulos, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiaradonna, F.</span></span> <span> </span><span class="NLM_article-title">Oncogenic K-ras decouples glucose and glutamine metabolism to support cancer cell growth</span>. <i>Mol. Syst. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">523</span>, <span class="refDoi"> DOI: 10.1038/msb.2011.56</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=10.1038%2Fmsb.2011.56" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2011&pages=523&author=D.+Gaglioauthor=C.+M.+Metalloauthor=P.+A.+Gameiroauthor=K.+Hillerauthor=L.+S.+Dannaauthor=C.+Balestrieriauthor=L.+Alberghinaauthor=G.+Stephanopoulosauthor=F.+Chiaradonna&title=Oncogenic+K-ras+decouples+glucose+and+glutamine+metabolism+to+support+cancer+cell+growth&doi=10.1038%2Fmsb.2011.56"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1038%2Fmsb.2011.56&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fmsb.2011.56%26sid%3Dliteratum%253Aachs%26aulast%3DGaglio%26aufirst%3DD.%26aulast%3DMetallo%26aufirst%3DC.%2BM.%26aulast%3DGameiro%26aufirst%3DP.%2BA.%26aulast%3DHiller%26aufirst%3DK.%26aulast%3DDanna%26aufirst%3DL.%2BS.%26aulast%3DBalestrieri%26aufirst%3DC.%26aulast%3DAlberghina%26aufirst%3DL.%26aulast%3DStephanopoulos%26aufirst%3DG.%26aulast%3DChiaradonna%26aufirst%3DF.%26atitle%3DOncogenic%2520K-ras%2520decouples%2520glucose%2520and%2520glutamine%2520metabolism%2520to%2520support%2520cancer%2520cell%2520growth%26jtitle%3DMol.%2520Syst.%2520Biol.%26date%3D2011%26volume%3D7%26spage%3D523%26doi%3D10.1038%2Fmsb.2011.56" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Porter, L. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ibrahim, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Curthoys, N. P.</span></span> <span> </span><span class="NLM_article-title">Complexity and species variation of the kidney-type glutaminase gene</span>. <i>Physiol. Genomics</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>9</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">157</span>– <span class="NLM_lpage">166</span>, <span class="refDoi"> DOI: 10.1152/physiolgenomics.00017.2002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=10.1152%2Fphysiolgenomics.00017.2002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=12045296" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=1%3ACAS%3A528%3ADC%252BD38Xms1eju74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2002&pages=157-166&issue=3&author=L.+D.+Porterauthor=H.+Ibrahimauthor=L.+Taylorauthor=N.+P.+Curthoys&title=Complexity+and+species+variation+of+the+kidney-type+glutaminase+gene&doi=10.1152%2Fphysiolgenomics.00017.2002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Complexity and species variation of the kidney-type glutaminase gene</span></div><div class="casAuthors">Porter, L. David; Ibrahim, Hend; Taylor, Lynn; Curthoys, Norman P.</div><div class="citationInfo"><span class="NLM_cas:title">Physiological Genomics [online computer file]</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">157-166</span>CODEN:
                <span class="NLM_cas:coden">PHGEFP</span>;
        ISSN:<span class="NLM_cas:issn">1094-8341</span>.
    
            (<span class="NLM_cas:orgname">American Physiological Society</span>)
        </div><div class="casAbstract">Increased expression of rat kidney-type glutaminase (KGA) during metabolic acidosis results from selective mRNA stabilization.  This process is mediated by an 8-base Au-sequence that functions as a pH-response element (pHRE).  LLC-PK1-FBPase+ cells, a pH-responsive porcine kidney cell line, express four distinct GA mRNAs.  RNase H mapping indicated that three of the GA mRNAs are generated by use of alternative polyadenylation sites and are homologs of the rat KGA mRNA, while the fourth contains a different COOH-terminal coding and 3'-untranslated sequence.  PCR cloning and sequencing established that the latter GA mRNA is the homolog of the human GAC mRNA.  A rat GAC cDNA was also cloned from a rat kidney library.  The 3'-untranslated regions of the GAC mRNAs, but not the porcine or human KGA mRNAs, contain identifiable pHREs.  The human KGA gene spans 82 kb and is composed of 19 exons.  The unique sequence from the hGAC cDNA is contained in a single exon.  Thus in humans, alternative splicing of the initial transcript could produce two GA mRNAs, only one of which may be increased during acidosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGojn1ujZ95BvbVg90H21EOLACvtfcHk0lgfZv0_vxIOrA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xms1eju74%253D&md5=71665cfd66cf3b0ac097f52fe326402d</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1152%2Fphysiolgenomics.00017.2002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1152%252Fphysiolgenomics.00017.2002%26sid%3Dliteratum%253Aachs%26aulast%3DPorter%26aufirst%3DL.%2BD.%26aulast%3DIbrahim%26aufirst%3DH.%26aulast%3DTaylor%26aufirst%3DL.%26aulast%3DCurthoys%26aufirst%3DN.%2BP.%26atitle%3DComplexity%2520and%2520species%2520variation%2520of%2520the%2520kidney-type%2520glutaminase%2520gene%26jtitle%3DPhysiol.%2520Genomics%26date%3D2002%26volume%3D9%26issue%3D3%26spage%3D157%26epage%3D166%26doi%3D10.1152%2Fphysiolgenomics.00017.2002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erickson, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stalnecker, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katt, W. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cerione, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramachandran, S.</span></span> <span> </span><span class="NLM_article-title">Mechanistic basis of glutaminase activation: a key enzyme that promotes glutamine metabolism in cancer cells</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>291</i></span> (<span class="NLM_issue">40</span>),  <span class="NLM_fpage">20900</span>– <span class="NLM_lpage">20910</span>, <span class="refDoi"> DOI: 10.1074/jbc.M116.720268</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=10.1074%2Fjbc.M116.720268" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=291&publication_year=2016&pages=20900-20910&issue=40&author=Y.+Liauthor=J.+W.+Ericksonauthor=C.+A.+Stalneckerauthor=W.+P.+Kattauthor=Q.+Huangauthor=R.+A.+Cerioneauthor=S.+Ramachandran&title=Mechanistic+basis+of+glutaminase+activation%3A+a+key+enzyme+that+promotes+glutamine+metabolism+in+cancer+cells&doi=10.1074%2Fjbc.M116.720268"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M116.720268&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M116.720268%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DY.%26aulast%3DErickson%26aufirst%3DJ.%2BW.%26aulast%3DStalnecker%26aufirst%3DC.%2BA.%26aulast%3DKatt%26aufirst%3DW.%2BP.%26aulast%3DHuang%26aufirst%3DQ.%26aulast%3DCerione%26aufirst%3DR.%2BA.%26aulast%3DRamachandran%26aufirst%3DS.%26atitle%3DMechanistic%2520basis%2520of%2520glutaminase%2520activation%253A%2520a%2520key%2520enzyme%2520that%2520promotes%2520glutamine%2520metabolism%2520in%2520cancer%2520cells%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2016%26volume%3D291%26issue%3D40%26spage%3D20900%26epage%3D20910%26doi%3D10.1074%2Fjbc.M116.720268" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Thangavelu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pan, C. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karlberg, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balaji, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uttamchandani, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suresh, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schuler, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Low, B. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sivaraman, J.</span></span> <span> </span><span class="NLM_article-title">Structural basis for the allosteric inhibitory mechanism of human kidney type glutaminase (KGA) and its regulation by Raf-Mek-Erk signaling in cancer cell metabolism</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>109</i></span> (<span class="NLM_issue">20</span>),  <span class="NLM_fpage">7705</span>– <span class="NLM_lpage">7710</span>, <span class="refDoi"> DOI: 10.1073/pnas.1116573109</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=10.1073%2Fpnas.1116573109" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2012&pages=7705-7710&issue=20&author=K.+Thangaveluauthor=C.+Q.+Panauthor=T.+Karlbergauthor=G.+Balajiauthor=M.+Uttamchandaniauthor=V.+Sureshauthor=H.+Schulerauthor=B.+C.+Lowauthor=J.+Sivaraman&title=Structural+basis+for+the+allosteric+inhibitory+mechanism+of+human+kidney+type+glutaminase+%28KGA%29+and+its+regulation+by+Raf-Mek-Erk+signaling+in+cancer+cell+metabolism&doi=10.1073%2Fpnas.1116573109"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1116573109&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1116573109%26sid%3Dliteratum%253Aachs%26aulast%3DThangavelu%26aufirst%3DK.%26aulast%3DPan%26aufirst%3DC.%2BQ.%26aulast%3DKarlberg%26aufirst%3DT.%26aulast%3DBalaji%26aufirst%3DG.%26aulast%3DUttamchandani%26aufirst%3DM.%26aulast%3DSuresh%26aufirst%3DV.%26aulast%3DSchuler%26aufirst%3DH.%26aulast%3DLow%26aufirst%3DB.%2BC.%26aulast%3DSivaraman%26aufirst%3DJ.%26atitle%3DStructural%2520basis%2520for%2520the%2520allosteric%2520inhibitory%2520mechanism%2520of%2520human%2520kidney%2520type%2520glutaminase%2520%2528KGA%2529%2520and%2520its%2520regulation%2520by%2520Raf-Mek-Erk%2520signaling%2520in%2520cancer%2520cell%2520metabolism%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2012%26volume%3D109%26issue%3D20%26spage%3D7705%26epage%3D7710%26doi%3D10.1073%2Fpnas.1116573109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">DeLaBarre, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gross, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jha, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, W. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hurov, J. B.</span></span> <span> </span><span class="NLM_article-title">Full-length human glutaminase in complex with an allosteric inhibitor</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">10764</span>– <span class="NLM_lpage">10770</span>, <span class="refDoi"> DOI: 10.1021/bi201613d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi201613d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsVSks73K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2011&pages=10764-10770&author=B.+DeLaBarreauthor=S.+Grossauthor=C.+Fangauthor=Y.+Gaoauthor=A.+Jhaauthor=F.+Jiangauthor=J.+Songauthor=W.+T.+Weiauthor=J.+B.+Hurov&title=Full-length+human+glutaminase+in+complex+with+an+allosteric+inhibitor&doi=10.1021%2Fbi201613d"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Full-Length Human Glutaminase in Complex with an Allosteric Inhibitor</span></div><div class="casAuthors">DeLaBarre, Byron; Gross, Stefan; Fang, Cheng; Gao, Yi; Jha, Abhishek; Jiang, Fan; Song J., Juanhua; Wei, Wentao; Hurov, Jonathan B.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">50</span>),
    <span class="NLM_cas:pages">10764-10770</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Glutaminase (GLS1/2) catalyzes the conversion of L-glutamine to L-glutamate and ammonia.  The level of a splice variant of GLS1 (GAC) is elevated in certain cancers, and GAC is specifically inhibited by bis-2-(5-phenylacetimido-1,2,4,thiadiazol-2-yl)ethyl sulfide (BPTES).  We report here the first full-length crystal structure of GAC in the presence and absence of BPTES mols.  Two BPTES mols. bind at an interface region of the GAC tetramer in a manner that appears to lock the GAC tetramer into a nonproductive conformation.  The importance of these loops with regard to overall enzymic activity of the tetramer was revealed by a series of GAC point mutants designed to create a BPTES resistant GAC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrrj21-Ko0HGLVg90H21EOLACvtfcHk0lhgpdWDggjQig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsVSks73K&md5=bd94996062f54c4f51a138c8e9f5f99a</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1021%2Fbi201613d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi201613d%26sid%3Dliteratum%253Aachs%26aulast%3DDeLaBarre%26aufirst%3DB.%26aulast%3DGross%26aufirst%3DS.%26aulast%3DFang%26aufirst%3DC.%26aulast%3DGao%26aufirst%3DY.%26aulast%3DJha%26aufirst%3DA.%26aulast%3DJiang%26aufirst%3DF.%26aulast%3DSong%26aufirst%3DJ.%26aulast%3DWei%26aufirst%3DW.%2BT.%26aulast%3DHurov%26aufirst%3DJ.%2BB.%26atitle%3DFull-length%2520human%2520glutaminase%2520in%2520complex%2520with%2520an%2520allosteric%2520inhibitor%26jtitle%3DBiochemistry%26date%3D2011%26volume%3D50%26spage%3D10764%26epage%3D10770%26doi%3D10.1021%2Fbi201613d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stalnecker, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McDermott, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iyer, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Neill, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reimer, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cerione, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katt, W. P.</span></span> <span> </span><span class="NLM_article-title">Characterization of the interactions of potent allosteric inhibitors with glutaminase C, a key enzyme in cancer cell glutamine metabolism</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>293</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">3535</span>– <span class="NLM_lpage">3545</span>, <span class="refDoi"> DOI: 10.1074/jbc.M117.810101</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=10.1074%2Fjbc.M117.810101" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=293&publication_year=2018&pages=3535-3545&issue=10&author=Q.+Huangauthor=C.+Stalneckerauthor=C.+Zhangauthor=L.+A.+McDermottauthor=P.+Iyerauthor=J.+O%E2%80%99Neillauthor=S.+Reimerauthor=R.+A.+Cerioneauthor=W.+P.+Katt&title=Characterization+of+the+interactions+of+potent+allosteric+inhibitors+with+glutaminase+C%2C+a+key+enzyme+in+cancer+cell+glutamine+metabolism&doi=10.1074%2Fjbc.M117.810101"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M117.810101&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M117.810101%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DQ.%26aulast%3DStalnecker%26aufirst%3DC.%26aulast%3DZhang%26aufirst%3DC.%26aulast%3DMcDermott%26aufirst%3DL.%2BA.%26aulast%3DIyer%26aufirst%3DP.%26aulast%3DO%25E2%2580%2599Neill%26aufirst%3DJ.%26aulast%3DReimer%26aufirst%3DS.%26aulast%3DCerione%26aufirst%3DR.%2BA.%26aulast%3DKatt%26aufirst%3DW.%2BP.%26atitle%3DCharacterization%2520of%2520the%2520interactions%2520of%2520potent%2520allosteric%2520inhibitors%2520with%2520glutaminase%2520C%252C%2520a%2520key%2520enzyme%2520in%2520cancer%2520cell%2520glutamine%2520metabolism%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2018%26volume%3D293%26issue%3D10%26spage%3D3535%26epage%3D3545%26doi%3D10.1074%2Fjbc.M117.810101" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ramachandran, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pan, C. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zimmermann, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duvall, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsukamoto, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Low, B. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sivaraman, J.</span></span> <span> </span><span class="NLM_article-title">Structural basis for exploring the allosteric inhibition of human kidney type glutaminase</span>. <i>Oncotarget</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">57943</span>– <span class="NLM_lpage">57954</span>, <span class="refDoi"> DOI: 10.18632/oncotarget.10791</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=10.18632%2Foncotarget.10791" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=27462863" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=1%3ACAS%3A280%3ADC%252BC2s3kvVSitw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=57943-57954&author=S.+Ramachandranauthor=C.+Q.+Panauthor=S.+C.+Zimmermannauthor=B.+Duvallauthor=T.+Tsukamotoauthor=B.+C.+Lowauthor=J.+Sivaraman&title=Structural+basis+for+exploring+the+allosteric+inhibition+of+human+kidney+type+glutaminase&doi=10.18632%2Foncotarget.10791"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Structural basis for exploring the allosteric inhibition of human kidney type glutaminase</span></div><div class="casAuthors">Ramachandran Sarath; Low Boon Chuan; Sivaraman J; Pan Catherine Qiurong; Low Boon Chuan; Zimmermann Sarah C; Duvall Bridget; Tsukamoto Takashi</div><div class="citationInfo"><span class="NLM_cas:title">Oncotarget</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">36</span>),
    <span class="NLM_cas:pages">57943-57954</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Cancer cells employ glutaminolysis to provide a source of intermediates for their upregulated biosynthetic needs.  Glutaminase, which catalyzes the conversion of glutamine to glutamate, is gaining increasing attention as a potential drug target.  Small-molecule inhibitors such as BPTES and CB-839, which target the allosteric site of glutaminase with high specificity, demonstrate immense promise as anti-tumor drugs.  Here, we report the study of a new BPTES analog, N,N'-(5,5'-(trans-cyclohexane-1,3-diyl)bis(1,3,4-tiadiazole-5,2-diyl))bis(2-phenylacetamide) (trans-CBTBP), and compared its inhibitory effect against that of CB-839 and BPTES.  We show that CB-839 has a 30- and 50-fold lower IC50 than trans-CBTBP and BPTES, respectively.  To explore the structural basis for the differences in their inhibitory efficacy, we solved the complex structures of cKGA with 1S, 3S-CBTBP and CB-839.  We found that CB-839 produces a greater degree of interaction with cKGA than 1S, 3S-CBTBP or BPTES.  The results of this study will facilitate the rational design of new KGA inhibitors to better treat glutamine-addicted cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTM3CV8sADQTzW1zwg2yUK5fW6udTcc2eag6dAKF5u_Vrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2s3kvVSitw%253D%253D&md5=1d2f516dde7da1a59f53d770a0f7c257</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.10791&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.10791%26sid%3Dliteratum%253Aachs%26aulast%3DRamachandran%26aufirst%3DS.%26aulast%3DPan%26aufirst%3DC.%2BQ.%26aulast%3DZimmermann%26aufirst%3DS.%2BC.%26aulast%3DDuvall%26aufirst%3DB.%26aulast%3DTsukamoto%26aufirst%3DT.%26aulast%3DLow%26aufirst%3DB.%2BC.%26aulast%3DSivaraman%26aufirst%3DJ.%26atitle%3DStructural%2520basis%2520for%2520exploring%2520the%2520allosteric%2520inhibition%2520of%2520human%2520kidney%2520type%2520glutaminase%26jtitle%3DOncotarget%26date%3D2016%26volume%3D7%26spage%3D57943%26epage%3D57954%26doi%3D10.18632%2Foncotarget.10791" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McDermott, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iyer, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vernetti, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rimer, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boby, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, T. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fioravanti, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Neill, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drakes, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katt, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, Q. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cerione, R.</span></span> <span> </span><span class="NLM_article-title">Design and evaluation of novel glutaminase inhibitors</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>24</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">1819</span>– <span class="NLM_lpage">1839</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2016.03.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=10.1016%2Fj.bmc.2016.03.009" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2016&pages=1819-1839&issue=8&author=L.+A.+McDermottauthor=P.+Iyerauthor=L.+Vernettiauthor=S.+Rimerauthor=J.+R.+Sunauthor=M.+Bobyauthor=T.+Y.+Yangauthor=M.+Fioravantiauthor=J.+O%E2%80%99Neillauthor=L.+W.+Wangauthor=D.+Drakesauthor=W.+Kattauthor=Q.+Q.+Huangauthor=R.+Cerione&title=Design+and+evaluation+of+novel+glutaminase+inhibitors&doi=10.1016%2Fj.bmc.2016.03.009"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2016.03.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2016.03.009%26sid%3Dliteratum%253Aachs%26aulast%3DMcDermott%26aufirst%3DL.%2BA.%26aulast%3DIyer%26aufirst%3DP.%26aulast%3DVernetti%26aufirst%3DL.%26aulast%3DRimer%26aufirst%3DS.%26aulast%3DSun%26aufirst%3DJ.%2BR.%26aulast%3DBoby%26aufirst%3DM.%26aulast%3DYang%26aufirst%3DT.%2BY.%26aulast%3DFioravanti%26aufirst%3DM.%26aulast%3DO%25E2%2580%2599Neill%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DL.%2BW.%26aulast%3DDrakes%26aufirst%3DD.%26aulast%3DKatt%26aufirst%3DW.%26aulast%3DHuang%26aufirst%3DQ.%2BQ.%26aulast%3DCerione%26aufirst%3DR.%26atitle%3DDesign%2520and%2520evaluation%2520of%2520novel%2520glutaminase%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2016%26volume%3D24%26issue%3D8%26spage%3D1819%26epage%3D1839%26doi%3D10.1016%2Fj.bmc.2016.03.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Scota
Ferreira, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cassago, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Almeida Goncalves, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meira Dias, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adamoski, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodrigues Ascencao, C. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vargas Honorato, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferreira de Oliveira, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monteze
Ferreira, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fornezari, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bettini, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lopes Oliveira, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paes Leme, A. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Villares Portugal, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berteli Ambrosio, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gomes Dias, S. M.</span></span> <span> </span><span class="NLM_article-title">Active glutaminase C self-assembles into a supra-tetrameric oligomer which can be disrupted by an allosteric inhibitor</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>288</i></span>,  <span class="NLM_fpage">28009</span>– <span class="NLM_lpage">28020</span>, <span class="refDoi"> DOI: 10.1074/jbc.M113.501346</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=10.1074%2Fjbc.M113.501346" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=288&publication_year=2013&pages=28009-28020&author=A.+P.+Scota%0AFerreiraauthor=A.+Cassagoauthor=K.+de+Almeida+Goncalvesauthor=M.+Meira+Diasauthor=D.+Adamoskiauthor=C.+F.+Rodrigues+Ascencaoauthor=R.+Vargas+Honoratoauthor=J.+Ferreira+de+Oliveiraauthor=I.+Monteze%0AFerreiraauthor=C.+Fornezariauthor=J.+Bettiniauthor=P.+S.+Lopes+Oliveiraauthor=A.+F.+Paes+Lemeauthor=R.+Villares+Portugalauthor=A.+L.+Berteli+Ambrosioauthor=S.+M.+Gomes+Dias&title=Active+glutaminase+C+self-assembles+into+a+supra-tetrameric+oligomer+which+can+be+disrupted+by+an+allosteric+inhibitor&doi=10.1074%2Fjbc.M113.501346"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M113.501346&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M113.501346%26sid%3Dliteratum%253Aachs%26aulast%3DScota%2BFerreira%26aufirst%3DA.%2BP.%26aulast%3DCassago%26aufirst%3DA.%26aulast%3Dde%2BAlmeida%2BGoncalves%26aufirst%3DK.%26aulast%3DMeira%2BDias%26aufirst%3DM.%26aulast%3DAdamoski%26aufirst%3DD.%26aulast%3DRodrigues%2BAscencao%26aufirst%3DC.%2BF.%26aulast%3DVargas%2BHonorato%26aufirst%3DR.%26aulast%3DFerreira%2Bde%2BOliveira%26aufirst%3DJ.%26aulast%3DMonteze%2BFerreira%26aufirst%3DI.%26aulast%3DFornezari%26aufirst%3DC.%26aulast%3DBettini%26aufirst%3DJ.%26aulast%3DLopes%2BOliveira%26aufirst%3DP.%2BS.%26aulast%3DPaes%2BLeme%26aufirst%3DA.%2BF.%26aulast%3DVillares%2BPortugal%26aufirst%3DR.%26aulast%3DBerteli%2BAmbrosio%26aufirst%3DA.%2BL.%26aulast%3DGomes%2BDias%26aufirst%3DS.%2BM.%26atitle%3DActive%2520glutaminase%2520C%2520self-assembles%2520into%2520a%2520supra-tetrameric%2520oligomer%2520which%2520can%2520be%2520disrupted%2520by%2520an%2520allosteric%2520inhibitor%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2013%26volume%3D288%26spage%3D28009%26epage%3D28020%26doi%3D10.1074%2Fjbc.M113.501346" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Thangavelu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chong, Q. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Low, B. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sivaraman, J.</span></span> <span> </span><span class="NLM_article-title">Structural basis for the active site inhibition mechanism of human kidney-type glutaminase (KGA)</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">3827</span>, <span class="refDoi"> DOI: 10.1038/srep03827</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=10.1038%2Fsrep03827" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2015&pages=3827&author=K.+Thangaveluauthor=Q.+Y.+Chongauthor=B.+C.+Lowauthor=J.+Sivaraman&title=Structural+basis+for+the+active+site+inhibition+mechanism+of+human+kidney-type+glutaminase+%28KGA%29&doi=10.1038%2Fsrep03827"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1038%2Fsrep03827&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsrep03827%26sid%3Dliteratum%253Aachs%26aulast%3DThangavelu%26aufirst%3DK.%26aulast%3DChong%26aufirst%3DQ.%2BY.%26aulast%3DLow%26aufirst%3DB.%2BC.%26aulast%3DSivaraman%26aufirst%3DJ.%26atitle%3DStructural%2520basis%2520for%2520the%2520active%2520site%2520inhibition%2520mechanism%2520of%2520human%2520kidney-type%2520glutaminase%2520%2528KGA%2529%26jtitle%3DSci.%2520Rep.%26date%3D2015%26volume%3D4%26spage%3D3827%26doi%3D10.1038%2Fsrep03827" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kenny, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamm, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toth, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wagers, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Curthoys, N. P.</span></span> <span> </span><span class="NLM_article-title">Bacterial expression, purification, and characterization of rat kidney-type mitochondrial glutaminase</span>. <i>Protein Expression Purif.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>31</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">140</span>– <span class="NLM_lpage">148</span>, <span class="refDoi"> DOI: 10.1016/S1046-5928(03)00161-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=10.1016%2FS1046-5928%2803%2900161-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=12963351" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=1%3ACAS%3A528%3ADC%252BD3sXntVGkt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2003&pages=140-148&issue=1&author=J.+Kennyauthor=Y.+Baoauthor=B.+Hammauthor=L.+Taylorauthor=A.+Tothauthor=B.+Wagersauthor=N.+P.+Curthoys&title=Bacterial+expression%2C+purification%2C+and+characterization+of+rat+kidney-type+mitochondrial+glutaminase&doi=10.1016%2FS1046-5928%2803%2900161-X"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Bacterial expression, purification, and characterization of rat kidney-type mitochondrial glutaminase</span></div><div class="casAuthors">Kenny, John; Bao, Yuhne; Hamm, Brian; Taylor, Lynn; Toth, Ann; Wagers, Brian; Curthoys, Norman P.</div><div class="citationInfo"><span class="NLM_cas:title">Protein Expression and Purification</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">140-148</span>CODEN:
                <span class="NLM_cas:coden">PEXPEJ</span>;
        ISSN:<span class="NLM_cas:issn">1046-5928</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science</span>)
        </div><div class="casAbstract">The human gene that encodes kidney-type glutaminase (KGA) spans 84-kb, contains 19 exons, and encodes 2 alternatively spliced mRNAs.  Here, various segments of rat KGA cDNA were PCR amplified and cloned into a bacterial expression vector and expressed in Escherichia coli to det. whether the N- and C- terminal ends of the glutaminase protein were essential for activity.  A recombinant glutaminase, lacking the coding sequence contained in exon 1, was found to be fully active.  In contrast, proteins that lacked sequences from exons 1 and 2 and exons 1-3 were inactive.  An addnl. construct that corresponded to the sequence encoded by exons 2-14 also retained full activity.  Both of the fully active, truncated proteins were purified to apparent homogeneity using an incorporated N-terminal His6-tag and Ni2+-affinity chromatog.  The Km values for glutamine of the native and recombinant forms of glutaminase were nearly identical.  However, the 2 truncated forms of glutaminase exhibited the characteristic phosphate activation profile only when dialyzed into a buffer lacking phosphate.  Dialysis vs. 10 mM Tris-phosphate was sufficient to form an active tetramer.  Thus, the deleted N-terminal sequence may contribute to the phosphate-dependent oligomerization and activation of the native glutaminase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoDLrJrBVieI7Vg90H21EOLACvtfcHk0liTgTZMLGgoQQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXntVGkt7s%253D&md5=f7e79be9442292154cbd86c162af53d3</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1016%2FS1046-5928%2803%2900161-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1046-5928%252803%252900161-X%26sid%3Dliteratum%253Aachs%26aulast%3DKenny%26aufirst%3DJ.%26aulast%3DBao%26aufirst%3DY.%26aulast%3DHamm%26aufirst%3DB.%26aulast%3DTaylor%26aufirst%3DL.%26aulast%3DToth%26aufirst%3DA.%26aulast%3DWagers%26aufirst%3DB.%26aulast%3DCurthoys%26aufirst%3DN.%2BP.%26atitle%3DBacterial%2520expression%252C%2520purification%252C%2520and%2520characterization%2520of%2520rat%2520kidney-type%2520mitochondrial%2520glutaminase%26jtitle%3DProtein%2520Expression%2520Purif.%26date%3D2003%26volume%3D31%26issue%3D1%26spage%3D140%26epage%3D148%26doi%3D10.1016%2FS1046-5928%2803%2900161-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shukla, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferraris, D. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stathis, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duvall, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delahanty, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alt, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rais, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rojas, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dang, C. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Slusher, B. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsukamoto, T.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis, and pharmacological evaluation of bis-2-(5-phenylacetamido-1,2,4-thiadiazol-2-yl)ethyl sulfide 3 (BPTES) analogs as glutaminase inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span> (<span class="NLM_issue">23</span>),  <span class="NLM_fpage">10551</span>– <span class="NLM_lpage">10563</span>, <span class="refDoi"> DOI: 10.1021/jm301191p</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm301191p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=10551-10563&issue=23&author=K.+Shuklaauthor=D.+V.+Ferrarisauthor=A.+G.+Thomasauthor=M.+Stathisauthor=B.+Duvallauthor=G.+Delahantyauthor=J.+Altauthor=R.+Raisauthor=C.+Rojasauthor=P.+Gaoauthor=Y.+Xiangauthor=C.+V.+Dangauthor=B.+S.+Slusherauthor=T.+Tsukamoto&title=Design%2C+synthesis%2C+and+pharmacological+evaluation+of+bis-2-%285-phenylacetamido-1%2C2%2C4-thiadiazol-2-yl%29ethyl+sulfide+3+%28BPTES%29+analogs+as+glutaminase+inhibitors&doi=10.1021%2Fjm301191p"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1021%2Fjm301191p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301191p%26sid%3Dliteratum%253Aachs%26aulast%3DShukla%26aufirst%3DK.%26aulast%3DFerraris%26aufirst%3DD.%2BV.%26aulast%3DThomas%26aufirst%3DA.%2BG.%26aulast%3DStathis%26aufirst%3DM.%26aulast%3DDuvall%26aufirst%3DB.%26aulast%3DDelahanty%26aufirst%3DG.%26aulast%3DAlt%26aufirst%3DJ.%26aulast%3DRais%26aufirst%3DR.%26aulast%3DRojas%26aufirst%3DC.%26aulast%3DGao%26aufirst%3DP.%26aulast%3DXiang%26aufirst%3DY.%26aulast%3DDang%26aufirst%3DC.%2BV.%26aulast%3DSlusher%26aufirst%3DB.%2BS.%26aulast%3DTsukamoto%26aufirst%3DT.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520pharmacological%2520evaluation%2520of%2520bis-2-%25285-phenylacetamido-1%252C2%252C4-thiadiazol-2-yl%2529ethyl%2520sulfide%25203%2520%2528BPTES%2529%2520analogs%2520as%2520glutaminase%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26issue%3D23%26spage%3D10551%26epage%3D10563%26doi%3D10.1021%2Fjm301191p" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, P. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meng, D. L.</span></span> <span> </span><span class="NLM_article-title">Brachyantheraoside A<sub>8</sub>, a new natural nor-oleanane triterpenoid as a kidney-type glutaminase inhibitor from Stauntonia brachyanthera</span>. <i>RSC Adv.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">52533</span>– <span class="NLM_lpage">52542</span>, <span class="refDoi"> DOI: 10.1039/C7RA11270J</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=10.1039%2FC7RA11270J" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvVSmsbvJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2017&pages=52533-52542&author=R.+Liauthor=P.+F.+Weiauthor=Y.+Wangauthor=Y.+Liuauthor=X.+L.+Liuauthor=D.+L.+Meng&title=Brachyantheraoside+A8%2C+a+new+natural+nor-oleanane+triterpenoid+as+a+kidney-type+glutaminase+inhibitor+from+Stauntonia+brachyanthera&doi=10.1039%2FC7RA11270J"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Brachyantheraoside A8, a new natural nor-oleanane triterpenoid as a kidney-type glutaminase inhibitor from Stauntonia brachyanthera</span></div><div class="casAuthors">Li, Rong; Wei, Peifeng; Wang, Yue; Liu, Ying; Liu, Xuanli; Meng, Dali</div><div class="citationInfo"><span class="NLM_cas:title">RSC Advances</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">83</span>),
    <span class="NLM_cas:pages">52533-52542</span>CODEN:
                <span class="NLM_cas:coden">RSCACL</span>;
        ISSN:<span class="NLM_cas:issn">2046-2069</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">With the aim of finding a better kidney-type glutaminase (KGA) inhibitor with potential anti-cancer properties, 18 nor-oleanane triterpenoids from Stauntonia brachyanthera, including 2 new ones, were screened against KGA.  The structure-based virtual ligand screening identified 8 compds., which might have more chance to become inhibitors of KGA with low binding energy.  Glutaminase inhibition expts. and a series of cellular level assays, including cytotoxicity, wound healing, transwell invasion, western blot, and cell apoptosis, further confirmed the inhibitory effect of 5 (brachyantheraoside A8).  These provided the possibility for 5 to become an inhibitor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqId9qfcQYP4rVg90H21EOLACvtfcHk0lhBXD0WT6Qr2g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvVSmsbvJ&md5=1f1162977499b403d63947bc97717c44</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1039%2FC7RA11270J&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC7RA11270J%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DR.%26aulast%3DWei%26aufirst%3DP.%2BF.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DX.%2BL.%26aulast%3DMeng%26aufirst%3DD.%2BL.%26atitle%3DBrachyantheraoside%2520A8%252C%2520a%2520new%2520natural%2520nor-oleanane%2520triterpenoid%2520as%2520a%2520kidney-type%2520glutaminase%2520inhibitor%2520from%2520Stauntonia%2520brachyanthera%26jtitle%3DRSC%2520Adv.%26date%3D2017%26volume%3D7%26spage%3D52533%26epage%3D52542%26doi%3D10.1039%2FC7RA11270J" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, L. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, L. X.</span></span> <span> </span><span class="NLM_article-title">Physapubescin, a natural withanolide as a kidney-type glutaminase (KGA) inhibitor</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>27</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">1243</span>– <span class="NLM_lpage">1246</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2017.01.057</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=10.1016%2Fj.bmcl.2017.01.057" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2017&pages=1243-1246&issue=5&author=L.+Chengauthor=C.+R.+Wuauthor=L.+H.+Zhuauthor=H.+Liauthor=L.+X.+Chen&title=Physapubescin%2C+a+natural+withanolide+as+a+kidney-type+glutaminase+%28KGA%29+inhibitor&doi=10.1016%2Fj.bmcl.2017.01.057"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2017.01.057&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2017.01.057%26sid%3Dliteratum%253Aachs%26aulast%3DCheng%26aufirst%3DL.%26aulast%3DWu%26aufirst%3DC.%2BR.%26aulast%3DZhu%26aufirst%3DL.%2BH.%26aulast%3DLi%26aufirst%3DH.%26aulast%3DChen%26aufirst%3DL.%2BX.%26atitle%3DPhysapubescin%252C%2520a%2520natural%2520withanolide%2520as%2520a%2520kidney-type%2520glutaminase%2520%2528KGA%2529%2520inhibitor%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2017%26volume%3D27%26issue%3D5%26spage%3D1243%26epage%3D1246%26doi%3D10.1016%2Fj.bmcl.2017.01.057" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Parlati, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gross, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janes, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lewis, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MacKinnon, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodriguez, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shwonek, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bennett, M.</span></span> <span> </span><span class="NLM_article-title">Glutaminase Inhibitor CB-839 Synergizes with Pomalidomide in Preclinical Multiple Myeloma Models</span>. <i>Blood</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>124</i></span>,  <span class="NLM_fpage">4720</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=124&publication_year=2014&pages=4720&author=F.+Parlatiauthor=M.+Grossauthor=J.+Janesauthor=E.+Lewisauthor=A.+MacKinnonauthor=M.+Rodriguezauthor=P.+Shwonekauthor=M.+Bennett&title=Glutaminase+Inhibitor+CB-839+Synergizes+with+Pomalidomide+in+Preclinical+Multiple+Myeloma+Models"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DParlati%26aufirst%3DF.%26aulast%3DGross%26aufirst%3DM.%26aulast%3DJanes%26aufirst%3DJ.%26aulast%3DLewis%26aufirst%3DE.%26aulast%3DMacKinnon%26aufirst%3DA.%26aulast%3DRodriguez%26aufirst%3DM.%26aulast%3DShwonek%26aufirst%3DP.%26aulast%3DBennett%26aufirst%3DM.%26atitle%3DGlutaminase%2520Inhibitor%2520CB-839%2520Synergizes%2520with%2520Pomalidomide%2520in%2520Preclinical%2520Multiple%2520Myeloma%2520Models%26jtitle%3DBlood%26date%3D2014%26volume%3D124%26spage%3D4720" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Parlati, F.</span></span> <span> </span><span class="NLM_article-title">CB-839, A Selective Glutaminase Inhibitor, Synergizes with Signaling Pathway Inhibitors to Produce an Anti-Tumor Effect in cell Lines and Tumor Xenografts</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>75</i></span>,  <span class="NLM_fpage">4711</span>, <span class="refDoi"> DOI: 10.1158/1538-7445.AM2015-4711</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=10.1158%2F1538-7445.AM2015-4711" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=75&publication_year=2015&pages=4711&author=F.+Parlati&title=CB-839%2C+A+Selective+Glutaminase+Inhibitor%2C+Synergizes+with+Signaling+Pathway+Inhibitors+to+Produce+an+Anti-Tumor+Effect+in+cell+Lines+and+Tumor+Xenografts&doi=10.1158%2F1538-7445.AM2015-4711"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1158%2F1538-7445.AM2015-4711&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1538-7445.AM2015-4711%26sid%3Dliteratum%253Aachs%26aulast%3DParlati%26aufirst%3DF.%26atitle%3DCB-839%252C%2520A%2520Selective%2520Glutaminase%2520Inhibitor%252C%2520Synergizes%2520with%2520Signaling%2520Pathway%2520Inhibitors%2520to%2520Produce%2520an%2520Anti-Tumor%2520Effect%2520in%2520cell%2520Lines%2520and%2520Tumor%2520Xenografts%26jtitle%3DCancer%2520Res.%26date%3D2015%26volume%3D75%26spage%3D4711%26doi%3D10.1158%2F1538-7445.AM2015-4711" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Momcilovic, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bailey, S. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fishbein, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Magyar, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Braas, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graeber, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jackson, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Czernin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Emberley, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gross, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janes, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mackinnon, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodriguez, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Works, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parlati, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Demo, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garon, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krysan, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walser, T. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dubinett, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sadeghi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christofk, H. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shackelford, D. B.</span></span> <span> </span><span class="NLM_article-title">Targeted inhibition of EGFR and glutaminase induces metabolic crisis in EGFR mutant lung cancer</span>. <i>Cell Rep.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>18</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">601</span>– <span class="NLM_lpage">610</span>, <span class="refDoi"> DOI: 10.1016/j.celrep.2016.12.061</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=10.1016%2Fj.celrep.2016.12.061" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=28099841" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=1%3ACAS%3A528%3ADC%252BC2sXht1ChsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2017&pages=601-610&issue=3&author=M.+Momcilovicauthor=S.+T.+Baileyauthor=J.+T.+Leeauthor=M.+C.+Fishbeinauthor=C.+Magyarauthor=D.+Braasauthor=T.+Graeberauthor=N.+J.+Jacksonauthor=J.+Czerninauthor=E.+Emberleyauthor=M.+Grossauthor=J.+Janesauthor=A.+Mackinnonauthor=A.+Panauthor=M.+Rodriguezauthor=M.+Worksauthor=W.+Zhangauthor=F.+Parlatiauthor=S.+Demoauthor=E.+Garonauthor=K.+Krysanauthor=T.+C.+Walserauthor=S.+M.+Dubinettauthor=S.+Sadeghiauthor=H.+R.+Christofkauthor=D.+B.+Shackelford&title=Targeted+inhibition+of+EGFR+and+glutaminase+induces+metabolic+crisis+in+EGFR+mutant+lung+cancer&doi=10.1016%2Fj.celrep.2016.12.061"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">Targeted Inhibition of EGFR and Glutaminase Induces Metabolic Crisis in EGFR Mutant Lung Cancer</span></div><div class="casAuthors">Momcilovic, Milica; Bailey, Sean T.; Lee, Jason T.; Fishbein, Michael C.; Magyar, Clara; Braas, Daniel; Graeber, Thomas; Jackson, Nicholas J.; Czernin, Johannes; Emberley, Ethan; Gross, Matthew; Janes, Julie; MacKinnon, Andy; Pan, Alison; Rodriguez, Mirna; Works, Melissa; Zhang, Winter; Parlati, Francesco; Demo, Susan; Garon, Edward; Krysan, Kostyantyn; Walser, Tonya C.; Dubinett, Steven M.; Sadeghi, Saman; Christofk, Heather R.; Shackelford, David B.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Reports</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">601-610</span>CODEN:
                <span class="NLM_cas:coden">CREED8</span>;
        ISSN:<span class="NLM_cas:issn">2211-1247</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Cancer cells exhibit increased use of nutrients, including glucose and glutamine, to support the bioenergetic and biosynthetic demands of proliferation.  We tested the small-mol. inhibitor of glutaminase CB-839 in combination with erlotinib on epidermal growth factor receptor (EGFR) mutant non-small cell lung cancer (NSCLC) as a therapeutic strategy to simultaneously impair cancer glucose and glutamine utilization and thereby suppress tumor growth.  Here, we show that CB-839 cooperates with erlotinib to drive energetic stress and activate the AMP-activated protein kinase (AMPK) pathway in EGFR (del19) lung tumors.  Tumor cells undergo metabolic crisis and cell death, resulting in rapid tumor regression in vivo in mouse NSCLC xenografts.  Consistently, positron emission tomog. (PET) imaging with 18F-fluoro-2-deoxyglucose (18F-FDG) and 11C-glutamine (11C-Gln) of xenografts indicated reduced glucose and glutamine uptake in tumors following treatment with CB-839 + erlotinib.  Therefore, PET imaging with 18F-FDG and 11C-Gln tracers can be used to non-invasively measure metabolic response to CB-839 and erlotinib combination therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqDi9ghbRHBG7Vg90H21EOLACvtfcHk0lhLGHP8-cShVg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXht1ChsL4%253D&md5=b335b9e4ba83b1d462f8baceae85074f</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1016%2Fj.celrep.2016.12.061&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.celrep.2016.12.061%26sid%3Dliteratum%253Aachs%26aulast%3DMomcilovic%26aufirst%3DM.%26aulast%3DBailey%26aufirst%3DS.%2BT.%26aulast%3DLee%26aufirst%3DJ.%2BT.%26aulast%3DFishbein%26aufirst%3DM.%2BC.%26aulast%3DMagyar%26aufirst%3DC.%26aulast%3DBraas%26aufirst%3DD.%26aulast%3DGraeber%26aufirst%3DT.%26aulast%3DJackson%26aufirst%3DN.%2BJ.%26aulast%3DCzernin%26aufirst%3DJ.%26aulast%3DEmberley%26aufirst%3DE.%26aulast%3DGross%26aufirst%3DM.%26aulast%3DJanes%26aufirst%3DJ.%26aulast%3DMackinnon%26aufirst%3DA.%26aulast%3DPan%26aufirst%3DA.%26aulast%3DRodriguez%26aufirst%3DM.%26aulast%3DWorks%26aufirst%3DM.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DParlati%26aufirst%3DF.%26aulast%3DDemo%26aufirst%3DS.%26aulast%3DGaron%26aufirst%3DE.%26aulast%3DKrysan%26aufirst%3DK.%26aulast%3DWalser%26aufirst%3DT.%2BC.%26aulast%3DDubinett%26aufirst%3DS.%2BM.%26aulast%3DSadeghi%26aufirst%3DS.%26aulast%3DChristofk%26aufirst%3DH.%2BR.%26aulast%3DShackelford%26aufirst%3DD.%2BB.%26atitle%3DTargeted%2520inhibition%2520of%2520EGFR%2520and%2520glutaminase%2520induces%2520metabolic%2520crisis%2520in%2520EGFR%2520mutant%2520lung%2520cancer%26jtitle%3DCell%2520Rep.%26date%3D2017%26volume%3D18%26issue%3D3%26spage%3D601%26epage%3D610%26doi%3D10.1016%2Fj.celrep.2016.12.061" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Emberley, E.</span>; <span class="NLM_string-name">Bennett, M.</span>; <span class="NLM_string-name">Chen, J.</span>; <span class="NLM_string-name">Gross, M.</span>; <span class="NLM_string-name">Huang, T.</span>; <span class="NLM_string-name">Li, W.</span>; <span class="NLM_string-name">MacKinnon, A.</span>; <span class="NLM_string-name">Pan, A.</span>; <span class="NLM_string-name">Rodriguez, M.</span>; <span class="NLM_string-name">Steggerda, S.</span>; <span class="NLM_string-name">Wang, T.</span>; <span class="NLM_string-name">Zhang, W.</span>; <span class="NLM_string-name">Zhang, J.</span>; <span class="NLM_string-name">Parlati, F.</span></span> <span> </span><span class="NLM_article-title">CB-839, a Selective Glutaminase Inhibitor, has Anti-Tumor Activity in Renal Cell Carcinoma and Synergizes with Cabozantinib and Everolimus</span>.  <i>Keystone Symposia, Tumor Metabolism: Mechanisms and Targets, Whistler Canada, March 5–9</i>, <span class="NLM_year">2017</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&author=E.+Emberley&author=M.+Bennett&author=J.+Chen&author=M.+Gross&author=T.+Huang&author=W.+Li&author=A.+MacKinnon&author=A.+Pan&author=M.+Rodriguez&author=S.+Steggerda&author=T.+Wang&author=W.+Zhang&author=J.+Zhang&author=F.+Parlati&title=CB-839%2C+a+Selective+Glutaminase+Inhibitor%2C+has+Anti-Tumor+Activity+in+Renal+Cell+Carcinoma+and+Synergizes+with+Cabozantinib+and+Everolimus"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dconf-proc%26sid%3Dliteratum%253Aachs%26aulast%3DEmberley%26aufirst%3DE.%26atitle%3DCB-839%252C%2520a%2520Selective%2520Glutaminase%2520Inhibitor%252C%2520has%2520Anti-Tumor%2520Activity%2520in%2520Renal%2520Cell%2520Carcinoma%2520and%2520Synergizes%2520with%2520Cabozantinib%2520and%2520Everolimus%26jtitle%3DKeystone%2520Symposia%252C%2520Tumor%2520Metabolism%253A%2520Mechanisms%2520and%2520Targets%252C%2520Whistler%2520Canada%252C%2520March%25205%25E2%2580%25939%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit61"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Emberley, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bennett, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gross, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Makkouk, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marguier, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spurlock, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steggerda, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parlati, F.</span></span> <span> </span><span class="NLM_article-title">The Glutaminase Inhibitor CB-839 Synergizes with CDK4/6 and PARP Inhibitors in Pre-Clinical Tumor Models</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>78</i></span>,  <span class="NLM_fpage">3509</span>, <span class="refDoi"> DOI: 10.1158/1538-7445.AM2018-3509</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=10.1158%2F1538-7445.AM2018-3509" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=78&publication_year=2018&pages=3509&author=E.+Emberleyauthor=M.+Bennettauthor=J.+Chenauthor=M.+Grossauthor=T.+Huangauthor=A.+Makkoukauthor=G.+Marguierauthor=A.+Panauthor=S.+Spurlockauthor=S.+Steggerdaauthor=F.+Parlati&title=The+Glutaminase+Inhibitor+CB-839+Synergizes+with+CDK4%2F6+and+PARP+Inhibitors+in+Pre-Clinical+Tumor+Models&doi=10.1158%2F1538-7445.AM2018-3509"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1158%2F1538-7445.AM2018-3509&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1538-7445.AM2018-3509%26sid%3Dliteratum%253Aachs%26aulast%3DEmberley%26aufirst%3DE.%26aulast%3DBennett%26aufirst%3DM.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DGross%26aufirst%3DM.%26aulast%3DHuang%26aufirst%3DT.%26aulast%3DMakkouk%26aufirst%3DA.%26aulast%3DMarguier%26aufirst%3DG.%26aulast%3DPan%26aufirst%3DA.%26aulast%3DSpurlock%26aufirst%3DS.%26aulast%3DSteggerda%26aufirst%3DS.%26aulast%3DParlati%26aufirst%3DF.%26atitle%3DThe%2520Glutaminase%2520Inhibitor%2520CB-839%2520Synergizes%2520with%2520CDK4%252F6%2520and%2520PARP%2520Inhibitors%2520in%2520Pre-Clinical%2520Tumor%2520Models%26jtitle%3DCancer%2520Res.%26date%3D2018%26volume%3D78%26spage%3D3509%26doi%3D10.1158%2F1538-7445.AM2018-3509" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref62"><div class="reference"><strong class="refLabel"><a href="#ref62" class="rightTabRefNumLink">62</a></strong><div class="NLM_citation" id="rightTab-cit62"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Driscoll, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bressler, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaufmann, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rojas, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Slusher, B. S.</span></span> <span> </span><span class="NLM_article-title">Small molecule glutaminase inhibitors block glutamate release from stimulated microglia</span>. <i>Biochem. Biophys. Res. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>443</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">32</span>– <span class="NLM_lpage">36</span>, <span class="refDoi"> DOI: 10.1016/j.bbrc.2013.11.043</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=10.1016%2Fj.bbrc.2013.11.043" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=443&publication_year=2014&pages=32-36&issue=1&author=A.+G.+Thomasauthor=C.+M.+O%E2%80%99Driscollauthor=J.+Bresslerauthor=W.+Kaufmannauthor=C.+J.+Rojasauthor=B.+S.+Slusher&title=Small+molecule+glutaminase+inhibitors+block+glutamate+release+from+stimulated+microglia&doi=10.1016%2Fj.bbrc.2013.11.043"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1016%2Fj.bbrc.2013.11.043&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbrc.2013.11.043%26sid%3Dliteratum%253Aachs%26aulast%3DThomas%26aufirst%3DA.%2BG.%26aulast%3DO%25E2%2580%2599Driscoll%26aufirst%3DC.%2BM.%26aulast%3DBressler%26aufirst%3DJ.%26aulast%3DKaufmann%26aufirst%3DW.%26aulast%3DRojas%26aufirst%3DC.%2BJ.%26aulast%3DSlusher%26aufirst%3DB.%2BS.%26atitle%3DSmall%2520molecule%2520glutaminase%2520inhibitors%2520block%2520glutamate%2520release%2520from%2520stimulated%2520microglia%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2014%26volume%3D443%26issue%3D1%26spage%3D32%26epage%3D36%26doi%3D10.1016%2Fj.bbrc.2013.11.043" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref63"><div class="reference"><strong class="refLabel"><a href="#ref63" class="rightTabRefNumLink">63</a></strong><div class="NLM_citation" id="rightTab-cit63"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pinkus, L. M.</span></span> <span> </span><span class="NLM_article-title">Glutamine binding sites</span>. <i>Methods Enzymol.</i> <span class="NLM_year" style="font-weight: bold;">1977</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">414</span>– <span class="NLM_lpage">427</span>, <span class="refDoi"> DOI: 10.1016/S0076-6879(77)46049-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=10.1016%2FS0076-6879%2877%2946049-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=909432" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=1%3ACAS%3A528%3ADyaE2sXlvFGqu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=1977&pages=414-427&author=L.+M.+Pinkus&title=Glutamine+binding+sites&doi=10.1016%2FS0076-6879%2877%2946049-X"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">Glutamine binding sites</span></div><div class="casAuthors">Pinkus, Lawrence M.</div><div class="citationInfo"><span class="NLM_cas:title">Methods in Enzymology</span>
        (<span class="NLM_cas:date">1977</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">Affinity Labeling</span>),
    <span class="NLM_cas:pages">414-27</span>CODEN:
                <span class="NLM_cas:coden">MENZAU</span>;
        ISSN:<span class="NLM_cas:issn">0076-6879</span>.
    </div><div class="casAbstract">A review with 78 refs. on the use of glutamine analogs as affinity labels for glutamine binding sites on enzymes of N metab., including amidotransferases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGodgvAxF90vv7Vg90H21EOLACvtfcHk0ljolMfQbvQYKg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE2sXlvFGqu7w%253D&md5=681826f0608c7c9b9f7e4aa51c0c078b</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1016%2FS0076-6879%2877%2946049-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0076-6879%252877%252946049-X%26sid%3Dliteratum%253Aachs%26aulast%3DPinkus%26aufirst%3DL.%2BM.%26atitle%3DGlutamine%2520binding%2520sites%26jtitle%3DMethods%2520Enzymol.%26date%3D1977%26volume%3D46%26spage%3D414%26epage%3D427%26doi%3D10.1016%2FS0076-6879%2877%2946049-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref64"><div class="reference"><strong class="refLabel"><a href="#ref64" class="rightTabRefNumLink">64</a></strong><div class="NLM_citation" id="rightTab-cit64"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ahluwalia, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grem, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hao, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cooney, D. A.</span></span> <span> </span><span class="NLM_article-title">Metabolism and action of amino acid analog anti-cancer agents</span>. <i>Pharmacol. Ther.</i> <span class="NLM_year" style="font-weight: bold;">1990</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">243</span>– <span class="NLM_lpage">271</span>, <span class="refDoi"> DOI: 10.1016/0163-7258(90)90094-I</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=10.1016%2F0163-7258%2890%2990094-I" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=2108451" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=1%3ACAS%3A528%3ADyaK3cXhslWmtbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=1990&pages=243-271&author=G.+S.+Ahluwaliaauthor=J.+L.+Gremauthor=Z.+Haoauthor=D.+A.+Cooney&title=Metabolism+and+action+of+amino+acid+analog+anti-cancer+agents&doi=10.1016%2F0163-7258%2890%2990094-I"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">Metabolism and action of amino acid analog anticancer agents</span></div><div class="casAuthors">Ahluwalia, Gurpreet S.; Grem, Jean L.; Hao, Zhang; Cooney, David A.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">243-71</span>CODEN:
                <span class="NLM_cas:coden">PHTHDT</span>;
        ISSN:<span class="NLM_cas:issn">0163-7258</span>.
    </div><div class="casAbstract">A review with ≈320 refs.  The preclin. pharmacol., antitumor activity, and toxicity of seven of the more important amino acid analogs with antineoplastic activity are discussed.  Three of these compds. are antagonists of L-glutamine: acivicin, 6-diazo-5-oxo-L-nonleucine (DON), and azaserine; and two are analogs of L-aspartic acid: N-(phsophonacetyl)-L-aspartate (PALA) and L-alanosine.  All five of these antimetabolites interrupt cellular nucleotide synthesis and thereby halt the formation of DNA and/or RNA in the tumor cell.  Buthionine sulfoximine and difluoromethylornithine are inhibitors of glutathione and polyamine synthesis, resp., with limited intrinsic antitumor activity, however, because of their powerful biochem. actions and their low systemic toxicities, they are being evaluated as chemotherapeutic adjuncts to or modulators of other more toxic antineoplastic agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGprwFG7JaY_7LVg90H21EOLACvtfcHk0ljolMfQbvQYKg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3cXhslWmtbc%253D&md5=57d816e5e990ce0994e51dbda0137ffb</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1016%2F0163-7258%2890%2990094-I&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0163-7258%252890%252990094-I%26sid%3Dliteratum%253Aachs%26aulast%3DAhluwalia%26aufirst%3DG.%2BS.%26aulast%3DGrem%26aufirst%3DJ.%2BL.%26aulast%3DHao%26aufirst%3DZ.%26aulast%3DCooney%26aufirst%3DD.%2BA.%26atitle%3DMetabolism%2520and%2520action%2520of%2520amino%2520acid%2520analog%2520anti-cancer%2520agents%26jtitle%3DPharmacol.%2520Ther.%26date%3D1990%26volume%3D46%26spage%3D243%26epage%3D271%26doi%3D10.1016%2F0163-7258%2890%2990094-I" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref65"><div class="reference"><strong class="refLabel"><a href="#ref65" class="rightTabRefNumLink">65</a></strong><div class="NLM_citation" id="rightTab-cit65"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cervantes-Madrid, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romero, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duenas-Gonzalez, A.</span></span> <span> </span><span class="NLM_article-title">Reviving lonidamine and 6-diazo-5-oxo-L-norleucine to be used in combination for metabolic cancer therapy</span>. <i>BioMed Res. Int.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>2015</i></span>,  <span class="NLM_fpage">690492</span>, <span class="refDoi"> DOI: 10.1155/2015/690492</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=10.1155%2F2015%2F690492" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=26425550" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=1%3ACAS%3A280%3ADC%252BC283nvFaqsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2015&publication_year=2015&pages=690492&author=D.+Cervantes-Madridauthor=Y.+Romeroauthor=A.+Duenas-Gonzalez&title=Reviving+lonidamine+and+6-diazo-5-oxo-L-norleucine+to+be+used+in+combination+for+metabolic+cancer+therapy&doi=10.1155%2F2015%2F690492"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">Reviving Lonidamine and 6-Diazo-5-oxo-L-norleucine to Be Used in Combination for Metabolic Cancer Therapy</span></div><div class="casAuthors">Cervantes-Madrid Diana; Romero Yair; Duenas-Gonzalez Alfonso</div><div class="citationInfo"><span class="NLM_cas:title">BioMed research international</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">2015</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">690492</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Abnormal metabolism is another cancer hallmark.  The two most characterized altered metabolic pathways are high rates of glycolysis and glutaminolysis, which are natural targets for cancer therapy.  Currently, a number of newer compounds to block glycolysis and glutaminolysis are being developed; nevertheless, lonidamine and 6-diazo-5-oxo-L-norleucine (DON) are two old drugs well characterized as inhibitors of glycolysis and glutaminolysis, respectively, whose clinical development was abandoned years ago when the importance of cancer metabolism was not fully appreciated and clinical trial methodology was less developed.  In this review, a PubMed search using the words lonidamine and 6-diazo-5-oxo-L-norleucine (DON) was undertaken to analyse existing information on the preclinical and clinical studies of these drugs for cancer treatment.  Data show that they exhibit antitumor effects; besides there is also the suggestion that they are synergistic.  We conclude that lonidamine and DON are safe and potentially effective drugs that need to be reevaluated in combination as metabolic therapy of cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQXmwDecegJaPSAs_PE1QvifW6udTcc2eY5XDUFL-ira7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC283nvFaqsw%253D%253D&md5=e193b6d310cd748fb76d3b441df2b4b8</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1155%2F2015%2F690492&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1155%252F2015%252F690492%26sid%3Dliteratum%253Aachs%26aulast%3DCervantes-Madrid%26aufirst%3DD.%26aulast%3DRomero%26aufirst%3DY.%26aulast%3DDuenas-Gonzalez%26aufirst%3DA.%26atitle%3DReviving%2520lonidamine%2520and%25206-diazo-5-oxo-L-norleucine%2520to%2520be%2520used%2520in%2520combination%2520for%2520metabolic%2520cancer%2520therapy%26jtitle%3DBioMed%2520Res.%2520Int.%26date%3D2015%26volume%3D2015%26spage%3D690492%26doi%3D10.1155%2F2015%2F690492" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref66"><div class="reference"><strong class="refLabel"><a href="#ref66" class="rightTabRefNumLink">66</a></strong><div class="NLM_citation" id="rightTab-cit66"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Eagan, R. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frytak, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nichols, W. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Creagan, E. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ingle, J. N.</span></span> <span> </span><span class="NLM_article-title">Phase II study on DON in patients with previously treated advanced lung cancer</span>. <i>Cancer Treat. Rep.</i> <span class="NLM_year" style="font-weight: bold;">1982</span>,  <span class="NLM_volume"><i>66</i></span>,  <span class="NLM_fpage">1665</span>– <span class="NLM_lpage">1666</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=6286122" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=1%3ACAS%3A280%3ADyaL383lvFWguw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=1982&pages=1665-1666&author=R.+T.+Eaganauthor=S.+Frytakauthor=W.+C.+Nicholsauthor=E.+T.+Creaganauthor=J.+N.+Ingle&title=Phase+II+study+on+DON+in+patients+with+previously+treated+advanced+lung+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">Phase II study on DON in patients with previously treated advanced lung cancer</span></div><div class="casAuthors">Eagan R T; Frytak S; Nichols W C; Creagan E T; Ingle J N</div><div class="citationInfo"><span class="NLM_cas:title">Cancer treatment reports</span>
        (<span class="NLM_cas:date">1982</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1665-6</span>
        ISSN:<span class="NLM_cas:issn">0361-5960</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRUEh-c_J6KzT69zv1FsJFMfW6udTcc2ebMc437CmYBUbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaL383lvFWguw%253D%253D&md5=01325c423a6c0fbdae0734130cbeba70</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEagan%26aufirst%3DR.%2BT.%26aulast%3DFrytak%26aufirst%3DS.%26aulast%3DNichols%26aufirst%3DW.%2BC.%26aulast%3DCreagan%26aufirst%3DE.%2BT.%26aulast%3DIngle%26aufirst%3DJ.%2BN.%26atitle%3DPhase%2520II%2520study%2520on%2520DON%2520in%2520patients%2520with%2520previously%2520treated%2520advanced%2520lung%2520cancer%26jtitle%3DCancer%2520Treat.%2520Rep.%26date%3D1982%26volume%3D66%26spage%3D1665%26epage%3D1666" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref67"><div class="reference"><strong class="refLabel"><a href="#ref67" class="rightTabRefNumLink">67</a></strong><div class="NLM_citation" id="rightTab-cit67"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Earhart, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koeller, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, H. L.</span></span> <span> </span><span class="NLM_article-title">Phase I trial of 6-diazo-5-oxo-L-norleucine (DON) administered by 5-day courses</span>. <i>Cancer Treat. Rep.</i> <span class="NLM_year" style="font-weight: bold;">1982</span>,  <span class="NLM_volume"><i>66</i></span>,  <span class="NLM_fpage">1215</span>– <span class="NLM_lpage">1217</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=7083223" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=1%3ACAS%3A280%3ADyaL383gvVenuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=1982&pages=1215-1217&author=R.+H.+Earhartauthor=J.+M.+Koellerauthor=H.+L.+Davis&title=Phase+I+trial+of+6-diazo-5-oxo-L-norleucine+%28DON%29+administered+by+5-day+courses"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">Phase I trial of 6-diazo-5-oxo-L-norleucine (DON) administered by 5-day courses</span></div><div class="casAuthors">Earhart R H; Koeller J M; Davis H L</div><div class="citationInfo"><span class="NLM_cas:title">Cancer treatment reports</span>
        (<span class="NLM_cas:date">1982</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1215-7</span>
        ISSN:<span class="NLM_cas:issn">0361-5960</span>.
    </div><div class="casAbstract">6-Diazo-5-oxo-L-norleucine (DON), an L-glutamine antagonist, was administered to 25 evaluable patients with refractory advanced solid tumors in a phase I trial.  A total of 58 evaluable courses of five daily iv injections every 3-4 weeks were given, at doses ranging from 7.5 to 90 mg/m2/day.  The major dose-limiting toxicity was a syndrome of nausea, vomiting, malaise, and anorexia, which became severe at doses greater than 52.5 mg/m2/day.  Diarrhea and stomatitis were less frequent.  Hematologic toxicity included mild leukopenia with nadir on Day 6-8 and mild thrombocytopenia with nadir on Day 7-12.  Transient decreases in serum calcium to 8.5--8.9 mg/dl were seen in seven of 12 patients receiving greater than or equal to 67.5 mg/m2/day.  Dose reduction was required for all patients who received a course of DON at greater than 67.5 mg/m2/day, and a maximum tolerated total dose of 250 mg/m2 (50 mg/m2/day x 5) is suggested for this schedule.  Mixed responses were seen in one patient with bladder carcinoma and in one with pulmonary adenocarcinoma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT6fL2BdWfWCMNIRw0GKUoEfW6udTcc2ebMc437CmYBUbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaL383gvVenuw%253D%253D&md5=cc563efa251aea27609451075dd5bbf2</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEarhart%26aufirst%3DR.%2BH.%26aulast%3DKoeller%26aufirst%3DJ.%2BM.%26aulast%3DDavis%26aufirst%3DH.%2BL.%26atitle%3DPhase%2520I%2520trial%2520of%25206-diazo-5-oxo-L-norleucine%2520%2528DON%2529%2520administered%2520by%25205-day%2520courses%26jtitle%3DCancer%2520Treat.%2520Rep.%26date%3D1982%26volume%3D66%26spage%3D1215%26epage%3D1217" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref68"><div class="reference"><strong class="refLabel"><a href="#ref68" class="rightTabRefNumLink">68</a></strong><div class="NLM_citation" id="rightTab-cit68"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lynch, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kemeny, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Casper, E.</span></span> <span> </span><span class="NLM_article-title">Phase II evaluation of DON (6-diazo-5-oxo-L-norleucine) in patients with advanced colorectal carcinoma</span>. <i>Am. J. Clin. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">1982</span>,  <span class="NLM_volume"><i>5</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">541</span>– <span class="NLM_lpage">543</span>, <span class="refDoi"> DOI: 10.1097/00000421-198210000-00014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=10.1097%2F00000421-198210000-00014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=7180833" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=1%3ACAS%3A280%3ADyaL3s%252FpslChsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=1982&pages=541-543&issue=5&author=G.+Lynchauthor=N.+Kemenyauthor=E.+Casper&title=Phase+II+evaluation+of+DON+%286-diazo-5-oxo-L-norleucine%29+in+patients+with+advanced+colorectal+carcinoma&doi=10.1097%2F00000421-198210000-00014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">Phase II evaluation of DON (6-diazo-5-oxo-L-norleucine) in patients with advanced colorectal carcinoma</span></div><div class="casAuthors">Lynch G; Kemeny N; Casper E</div><div class="citationInfo"><span class="NLM_cas:title">American journal of clinical oncology</span>
        (<span class="NLM_cas:date">1982</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">541-3</span>
        ISSN:<span class="NLM_cas:issn">0277-3732</span>.
    </div><div class="casAbstract">Twenty-three patients with advanced colorectal carcinoma, previously treated with chemotherapy, were entered in a phase II trial of DON (6-Diazo-5-Oxo-L-Norleucine), an antagonist of L-glutamine.  One of 14 adequately treated patients had a partial response of 6 weeks duration.  The dose-limiting toxicity was nausea and vomiting; 48% of patients originally entered on the study withdrew because of vomiting.  Myelosuppression was minimal, with only mild thrombocytopenia noted.  The dose and schedule used in this study were beyond the maximally tolerated dose for many patients; future phase II studies of DON will be difficult to complete unless schedules and doses are found which result in less nausea and vomiting.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR3qxkSLMwzPcvLc4ARHEmzfW6udTcc2eaeURhgtAZDprntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaL3s%252FpslChsA%253D%253D&md5=c5603efffc9908e628d0d780025d60a3</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1097%2F00000421-198210000-00014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F00000421-198210000-00014%26sid%3Dliteratum%253Aachs%26aulast%3DLynch%26aufirst%3DG.%26aulast%3DKemeny%26aufirst%3DN.%26aulast%3DCasper%26aufirst%3DE.%26atitle%3DPhase%2520II%2520evaluation%2520of%2520DON%2520%25286-diazo-5-oxo-L-norleucine%2529%2520in%2520patients%2520with%2520advanced%2520colorectal%2520carcinoma%26jtitle%3DAm.%2520J.%2520Clin.%2520Oncol.%26date%3D1982%26volume%3D5%26issue%3D5%26spage%3D541%26epage%3D543%26doi%3D10.1097%2F00000421-198210000-00014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref69"><div class="reference"><strong class="refLabel"><a href="#ref69" class="rightTabRefNumLink">69</a></strong><div class="NLM_citation" id="rightTab-cit69"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Magill, G. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Myers, W. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reilly, H. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Putnam, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Magill, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sykes, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Escher, G. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karnofsky, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burchenal, J. H.</span></span> <span> </span><span class="NLM_article-title">Pharmacological and initial therapeutic observations on 6-diazo-5-oxo-1-norleucine (DON) in human neoplastic disease</span>. <i>Cancer</i> <span class="NLM_year" style="font-weight: bold;">1957</span>,  <span class="NLM_volume"><i>10</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">1138</span>– <span class="NLM_lpage">1150</span>, <span class="refDoi"> DOI: 10.1002/1097-0142(195711/12)10:6<1138::AID-CNCR2820100608>3.0.CO;2-K</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=10.1002%2F1097-0142%28195711%2F12%2910%3A6%3C1138%3A%3AAID-CNCR2820100608%3E3.0.CO%3B2-K" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=13489662" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=1%3ACAS%3A528%3ADyaG1cXit1aqsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=1957&pages=1138-1150&issue=6&author=G.+B.+Magillauthor=W.+P.+Myersauthor=H.+C.+Reillyauthor=R.+C.+Putnamauthor=J.+W.+Magillauthor=M.+P.+Sykesauthor=G.+C.+Escherauthor=D.+A.+Karnofskyauthor=J.+H.+Burchenal&title=Pharmacological+and+initial+therapeutic+observations+on+6-diazo-5-oxo-1-norleucine+%28DON%29+in+human+neoplastic+disease&doi=10.1002%2F1097-0142%28195711%2F12%2910%3A6%3C1138%3A%3AAID-CNCR2820100608%3E3.0.CO%3B2-K"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit69R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological and initial therapeutic observations on 6-diazo-5-oxo-L-norleucine (DON) in human neoplastic disease</span></div><div class="casAuthors">Magill, G. B.; Myers, W. P. L.; Reilly, H. C.; Putnam, R. C.; Magill, J. W.; Sykes, M. P.; Escher, G. C.; Karnofsky, D. A.; Burchenal, J. H.</div><div class="citationInfo"><span class="NLM_cas:title"></span>
        (<span class="NLM_cas:date">1957</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1138-50</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Peak serum levels of DON were present 5-15 min. after i.v. administration of 0.2-0.3 mg./kg. of the drug to patients.  After i.m. or oral administration the blood-level peaks were at 0.5-1 h. and 15 min.-2 h., resp.  Less than 1% was recovered in active form in the urine.  Patients could tolerate 0.1-0.3 mg./kg./day of DON for prolonged courses.  The drug caused oral soreness, diarrhea, nausea, and vomiting, and other less well defined events such as leukopenia, gastrointestinal bleeding, and thrombocytopenia.  Adenine and 4-amino-5-imidazolecarboxamide appeared to block the oral toxic effects of DON.  Therapy with DON led to more normal serum alk. phosphatase, lactic acid dehydrogenase, and phosphohexose isomerase levels in one patient in whom these enzymes were detd.  DON appeared to cause temporary regressions or some improvement in approx. 25% of the patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoDjNFkXXSxqrVg90H21EOLACvtfcHk0lhI2PKzypExfQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaG1cXit1aqsQ%253D%253D&md5=9ffada87efe0574489415bf431dce5ae</span></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1002%2F1097-0142%28195711%2F12%2910%3A6%3C1138%3A%3AAID-CNCR2820100608%3E3.0.CO%3B2-K&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F1097-0142%2528195711%252F12%252910%253A6%253C1138%253A%253AAID-CNCR2820100608%253E3.0.CO%253B2-K%26sid%3Dliteratum%253Aachs%26aulast%3DMagill%26aufirst%3DG.%2BB.%26aulast%3DMyers%26aufirst%3DW.%2BP.%26aulast%3DReilly%26aufirst%3DH.%2BC.%26aulast%3DPutnam%26aufirst%3DR.%2BC.%26aulast%3DMagill%26aufirst%3DJ.%2BW.%26aulast%3DSykes%26aufirst%3DM.%2BP.%26aulast%3DEscher%26aufirst%3DG.%2BC.%26aulast%3DKarnofsky%26aufirst%3DD.%2BA.%26aulast%3DBurchenal%26aufirst%3DJ.%2BH.%26atitle%3DPharmacological%2520and%2520initial%2520therapeutic%2520observations%2520on%25206-diazo-5-oxo-1-norleucine%2520%2528DON%2529%2520in%2520human%2520neoplastic%2520disease%26jtitle%3DCancer%26date%3D1957%26volume%3D10%26issue%3D6%26spage%3D1138%26epage%3D1150%26doi%3D10.1002%2F1097-0142%28195711%2F12%2910%3A6%3C1138%3A%3AAID-CNCR2820100608%3E3.0.CO%3B2-K" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref70"><div class="reference"><strong class="refLabel"><a href="#ref70" class="rightTabRefNumLink">70</a></strong><div class="NLM_citation" id="rightTab-cit70"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rahman, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, F. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luc, P. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woolley, P. V.</span></span> <span> </span><span class="NLM_article-title">Phase I study and clinical pharmacology of 6-diazo-5-oxo-L-norleucine (DON)</span>. <i>Invest. New Drugs</i> <span class="NLM_year" style="font-weight: bold;">1985</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">369</span>– <span class="NLM_lpage">374</span>, <span class="refDoi"> DOI: 10.1007/BF00170760</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=10.1007%2FBF00170760" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=1985&pages=369-374&author=A.+Rahmanauthor=F.+P.+Smithauthor=P.+T.+Lucauthor=P.+V.+Woolley&title=Phase+I+study+and+clinical+pharmacology+of+6-diazo-5-oxo-L-norleucine+%28DON%29&doi=10.1007%2FBF00170760"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1007%2FBF00170760&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF00170760%26sid%3Dliteratum%253Aachs%26aulast%3DRahman%26aufirst%3DA.%26aulast%3DSmith%26aufirst%3DF.%2BP.%26aulast%3DLuc%26aufirst%3DP.%2BT.%26aulast%3DWoolley%26aufirst%3DP.%2BV.%26atitle%3DPhase%2520I%2520study%2520and%2520clinical%2520pharmacology%2520of%25206-diazo-5-oxo-L-norleucine%2520%2528DON%2529%26jtitle%3DInvest.%2520New%2520Drugs%26date%3D1985%26volume%3D3%26spage%3D369%26epage%3D374%26doi%3D10.1007%2FBF00170760" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref71"><div class="reference"><strong class="refLabel"><a href="#ref71" class="rightTabRefNumLink">71</a></strong><div class="NLM_citation" id="rightTab-cit71"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sklaroff, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Casper, E. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Magill, G. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Young, C. W.</span></span> <span> </span><span class="NLM_article-title">Phase I study of 6-diazo-5-oxo-L-norleucine (DON)</span>. <i>Cancer Treat. Rep.</i> <span class="NLM_year" style="font-weight: bold;">1980</span>,  <span class="NLM_volume"><i>64</i></span>,  <span class="NLM_fpage">1247</span>– <span class="NLM_lpage">1251</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=7471114" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=1%3ACAS%3A280%3ADyaL3M7jsFKgug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=1980&pages=1247-1251&author=R.+B.+Sklaroffauthor=E.+S.+Casperauthor=G.+B.+Magillauthor=C.+W.+Young&title=Phase+I+study+of+6-diazo-5-oxo-L-norleucine+%28DON%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit71R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">Phase I study of 6-diazo-5-oxo-L-norleucine (DON)</span></div><div class="casAuthors">Sklaroff R B; Casper E S; Magill G B; Young C W</div><div class="citationInfo"><span class="NLM_cas:title">Cancer treatment reports</span>
        (<span class="NLM_cas:date">1980</span>),
    <span class="NLM_cas:volume">64</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1247-51</span>
        ISSN:<span class="NLM_cas:issn">0361-5960</span>.
    </div><div class="casAbstract">We conducted a phase I study of 6-diazo-5-oxo-L-norleucine given iv on a twice weekly schedule.  Twenty-six evaluable patients received 31 courses of the drug.  Doses ranged from 100 to 500 mg/m2.  Nausea with vomiting was the dose-limiting toxic effect, transient thrombocytopenia was seen frequently, and mucositis occurred in 39% of the patients.  No definite therapeutic responses were observed in 18 patients with measurable lesions.  The recommended dose for phase II studies is 200-300 mg/m2 iv twice weekly.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRr5J6AmhNS-Q20zIbnCCI3fW6udTcc2eaCy1fRUM4b_Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaL3M7jsFKgug%253D%253D&md5=1e5d3241b3e4834c46fc432306faae4c</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSklaroff%26aufirst%3DR.%2BB.%26aulast%3DCasper%26aufirst%3DE.%2BS.%26aulast%3DMagill%26aufirst%3DG.%2BB.%26aulast%3DYoung%26aufirst%3DC.%2BW.%26atitle%3DPhase%2520I%2520study%2520of%25206-diazo-5-oxo-L-norleucine%2520%2528DON%2529%26jtitle%3DCancer%2520Treat.%2520Rep.%26date%3D1980%26volume%3D64%26spage%3D1247%26epage%3D1251" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref72"><div class="reference"><strong class="refLabel"><a href="#ref72" class="rightTabRefNumLink">72</a></strong><div class="NLM_citation" id="rightTab-cit72"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sullivan, M.
P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beatty, E. C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hyman, C. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murphy, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pierce, M. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Severo, N. C.</span></span> <span> </span><span class="NLM_article-title">A comparison of the effectiveness of standard dose 6-mercaptopurine, combination 6- mercaptopurine and DON, and high-loading 6-mercaptopurine therapies in treatment of the acute leukemias of childhood: results of a cooperative study</span>. <i>Cancer Chemother. Rep.</i> <span class="NLM_year" style="font-weight: bold;">1962</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">161</span>– <span class="NLM_lpage">164</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=13918322" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=1%3ACAS%3A280%3ADyaF387gvF2gsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=1962&pages=161-164&author=M.%0AP.+Sullivanauthor=E.+C.+J.+Beattyauthor=C.+B.+Hymanauthor=M.+L.+Murphyauthor=M.+I.+Pierceauthor=N.+C.+Severo&title=A+comparison+of+the+effectiveness+of+standard+dose+6-mercaptopurine%2C+combination+6-+mercaptopurine+and+DON%2C+and+high-loading+6-mercaptopurine+therapies+in+treatment+of+the+acute+leukemias+of+childhood%3A+results+of+a+cooperative+study"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit72R"><div class="casContent"><span class="casTitleNuber">72</span><div class="casTitle"><span class="NLM_cas:atitle">A comparison of the effectiveness of standard dose 6-mercaptopurine, combination 6-mercaptopurine and DON, and high-loading 6-mercaptopurine therapies in the treatment of acute leukemia in children: results of cooperative study</span></div><div class="casAuthors">SULLIVAN M P; BEATTY E C Jr; HYMAN C P; MURPHY M L; PHERCE M I; SEVERO N C</div><div class="citationInfo"><span class="NLM_cas:title">Cancer chemotherapy reports</span>
        (<span class="NLM_cas:date">1962</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">161-4</span>
        ISSN:<span class="NLM_cas:issn">0069-0112</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRD9eCdRUxoXOLt9HypzAgQfW6udTcc2eaCy1fRUM4b_Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaF387gvF2gsQ%253D%253D&md5=539c8fa3eb8f2960e1b8b88375c9874b</span></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSullivan%26aufirst%3DM.%2BP.%26aulast%3DBeatty%26aufirst%3DE.%2BC.%2BJ.%26aulast%3DHyman%26aufirst%3DC.%2BB.%26aulast%3DMurphy%26aufirst%3DM.%2BL.%26aulast%3DPierce%26aufirst%3DM.%2BI.%26aulast%3DSevero%26aufirst%3DN.%2BC.%26atitle%3DA%2520comparison%2520of%2520the%2520effectiveness%2520of%2520standard%2520dose%25206-mercaptopurine%252C%2520combination%25206-%2520mercaptopurine%2520and%2520DON%252C%2520and%2520high-loading%25206-mercaptopurine%2520therapies%2520in%2520treatment%2520of%2520the%2520acute%2520leukemias%2520of%2520childhood%253A%2520results%2520of%2520a%2520cooperative%2520study%26jtitle%3DCancer%2520Chemother.%2520Rep.%26date%3D1962%26volume%3D16%26spage%3D161%26epage%3D164" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref73"><div class="reference"><strong class="refLabel"><a href="#ref73" class="rightTabRefNumLink">73</a></strong><div class="NLM_citation" id="rightTab-cit73"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Barclay, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phillipps, M. A.</span></span> <span> </span><span class="NLM_article-title">Effects of 6-diazo-5-oxolnorleucine and other tumor inhibitors on the biosynthesis of nicotinamide adenine dinucleotide in mice</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">1966</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">282</span>– <span class="NLM_lpage">286</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=1966&pages=282-286&author=R.+K.+Barclayauthor=M.+A.+Phillipps&title=Effects+of+6-diazo-5-oxolnorleucine+and+other+tumor+inhibitors+on+the+biosynthesis+of+nicotinamide+adenine+dinucleotide+in+mice"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBarclay%26aufirst%3DR.%2BK.%26aulast%3DPhillipps%26aufirst%3DM.%2BA.%26atitle%3DEffects%2520of%25206-diazo-5-oxolnorleucine%2520and%2520other%2520tumor%2520inhibitors%2520on%2520the%2520biosynthesis%2520of%2520nicotinamide%2520adenine%2520dinucleotide%2520in%2520mice%26jtitle%3DCancer%2520Res.%26date%3D1966%26volume%3D26%26spage%3D282%26epage%3D286" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref74"><div class="reference"><strong class="refLabel"><a href="#ref74" class="rightTabRefNumLink">74</a></strong><div class="NLM_citation" id="rightTab-cit74"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hofer, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steverding, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chabes, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brun, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thelander, L.</span></span> <span> </span><span class="NLM_article-title">Trypanosoma brucei CTP synthetase: a target for the treatment of african sleeping sickness</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>98</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">6412</span>– <span class="NLM_lpage">6416</span>, <span class="refDoi"> DOI: 10.1073/pnas.111139498</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=10.1073%2Fpnas.111139498" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=11353848" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=1%3ACAS%3A528%3ADC%252BD3MXktVWkt74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=98&publication_year=2001&pages=6412-6416&issue=11&author=A.+Hoferauthor=D.+Steverdingauthor=A.+Chabesauthor=R.+Brunauthor=L.+Thelander&title=Trypanosoma+brucei+CTP+synthetase%3A+a+target+for+the+treatment+of+african+sleeping+sickness&doi=10.1073%2Fpnas.111139498"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit74R"><div class="casContent"><span class="casTitleNuber">74</span><div class="casTitle"><span class="NLM_cas:atitle">Trypanosoma brucei CTP synthetase: a target for the treatment of African sleeping sickness</span></div><div class="casAuthors">Hofer, Anders; Steverding, Dietmar; Chabes, Andrei; Brun, Reto; Thelander, Lars</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">98</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">6412-6416</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The drugs in clin. use against African sleeping sickness are toxic, costly, or inefficient.  We show that Trypanosoma brucei, which causes this disease, has very low levels of CTP, which are due to a limited capacity for de novo synthesis and the lack of salvage pathways.  The CTP synthetase inhibitors 6-diazo-5-oxo-L-norleucine (DON) and α-amino-3-chloro-4,5-dihydro-5-isoxazoleacetic acid (acivicin) reduced the parasite CTP levels even further and inhibited trypanosome proliferation in vitro and in T. brucei-infected mice.  In mammalian cells, DON mainly inhibits de novo purine biosynthesis, a pathway lacking in trypanosomes.  We could rescue DON-treated human and mouse fibroblasts by the addn. of the purine base hypoxanthine to the growth medium.  For treatment of sleeping sickness, we propose the use of CTP synthetase inhibitors alone or in combination with appropriate nucleosides or bases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr8inLobtvSV7Vg90H21EOLACvtfcHk0lip9YSNW51YJw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXktVWkt74%253D&md5=66c382dafbe2526962f14f0ac9bbdd96</span></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.1073%2Fpnas.111139498&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.111139498%26sid%3Dliteratum%253Aachs%26aulast%3DHofer%26aufirst%3DA.%26aulast%3DSteverding%26aufirst%3DD.%26aulast%3DChabes%26aufirst%3DA.%26aulast%3DBrun%26aufirst%3DR.%26aulast%3DThelander%26aufirst%3DL.%26atitle%3DTrypanosoma%2520brucei%2520CTP%2520synthetase%253A%2520a%2520target%2520for%2520the%2520treatment%2520of%2520african%2520sleeping%2520sickness%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2001%26volume%3D98%26issue%3D11%26spage%3D6412%26epage%3D6416%26doi%3D10.1073%2Fpnas.111139498" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref75"><div class="reference"><strong class="refLabel"><a href="#ref75" class="rightTabRefNumLink">75</a></strong><div class="NLM_citation" id="rightTab-cit75"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Grayzel, A. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seegmiller, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Love, E.</span></span> <span> </span><span class="NLM_article-title">Suppression of uric acid synthesis in the gouty human by the use of 6-diazo-5-oxo-L-norleucine</span>. <i>J. Clin. Invest.</i> <span class="NLM_year" style="font-weight: bold;">1960</span>,  <span class="NLM_volume"><i>39</i></span>,  <span class="NLM_fpage">447</span>– <span class="NLM_lpage">454</span>, <span class="refDoi"> DOI: 10.1172/JCI104057</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=10.1172%2FJCI104057" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=13829149" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=1%3ACAS%3A528%3ADyaF3cXhtFantLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=1960&pages=447-454&author=A.+I.+Grayzelauthor=J.+E.+Seegmillerauthor=E.+Love&title=Suppression+of+uric+acid+synthesis+in+the+gouty+human+by+the+use+of+6-diazo-5-oxo-L-norleucine&doi=10.1172%2FJCI104057"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit75R"><div class="casContent"><span class="casTitleNuber">75</span><div class="casTitle"><span class="NLM_cas:atitle">Suppression of the uric acid synthesis in the gouty human by the use of 6-diazo-5-oxo-L-norleucine (DON)</span></div><div class="casAuthors">Grayzel, Arthur I.; Seegmiller, J. E.; Love, Ethel</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Investigation</span>
        (<span class="NLM_cas:date">1960</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">447-54</span>CODEN:
                <span class="NLM_cas:coden">JCINAO</span>;
        ISSN:<span class="NLM_cas:issn">0021-9738</span>.
    </div><div class="casAbstract">Studies on 3 patients demonstrated that DON suppressed the incorporation of glycine-1-C14 into urinary uric acid.  Balance studies demonstrated that in 2 patients there was a significant decrease in serum urate levels and 24 h. urinary uric acid excretion following administration of DON.  It is concluded that DON suppresses uric acid biosynthesis but such suppression is not always reflected in a short term balance study, esp. in the presence of an expanded urate pool.  The use of pharmacol. agents to suppress synthesis in subjects who overproduce uric acid represents a new and rational approach to their therapy.  DON produces a high incidence of side effects.  25 refs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrSFsZTw-FQarVg90H21EOLACvtfcHk0lip9YSNW51YJw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaF3cXhtFantLo%253D&md5=e8e89e028a8c02bb27b889bc83d4626e</span></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1172%2FJCI104057&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1172%252FJCI104057%26sid%3Dliteratum%253Aachs%26aulast%3DGrayzel%26aufirst%3DA.%2BI.%26aulast%3DSeegmiller%26aufirst%3DJ.%2BE.%26aulast%3DLove%26aufirst%3DE.%26atitle%3DSuppression%2520of%2520uric%2520acid%2520synthesis%2520in%2520the%2520gouty%2520human%2520by%2520the%2520use%2520of%25206-diazo-5-oxo-L-norleucine%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D1960%26volume%3D39%26spage%3D447%26epage%3D454%26doi%3D10.1172%2FJCI104057" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref76"><div class="reference"><strong class="refLabel"><a href="#ref76" class="rightTabRefNumLink">76</a></strong><div class="NLM_citation" id="rightTab-cit76"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shapiro, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clark, V. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Curthoys, N. P.</span></span> <span> </span><span class="NLM_article-title">Inactivation of rat renal phosphate-dependent glutaminase with 6-diazo-5-oxo-L-norleucine. Evidence for interaction at the glutamine binding site</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1979</span>,  <span class="NLM_volume"><i>254</i></span>,  <span class="NLM_fpage">2835</span>– <span class="NLM_lpage">2838</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=429321" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=1%3ACAS%3A528%3ADyaE1MXktFGrtb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=254&publication_year=1979&pages=2835-2838&author=R.+A.+Shapiroauthor=V.+M.+Clarkauthor=N.+P.+Curthoys&title=Inactivation+of+rat+renal+phosphate-dependent+glutaminase+with+6-diazo-5-oxo-L-norleucine.+Evidence+for+interaction+at+the+glutamine+binding+site"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit76R"><div class="casContent"><span class="casTitleNuber">76</span><div class="casTitle"><span class="NLM_cas:atitle">Inactivation of rat renal phosphate-dependent glutaminase with 6-diazo-5-oxo-L-norleucine.  Evidence for interaction at the glutamine binding site</span></div><div class="casAuthors">Shapiro, Richard A.; Clark, Virginia M.; Curthoys, Norman P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">1979</span>),
    <span class="NLM_cas:volume">254</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2835-8</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    </div><div class="casAbstract">Inactivation of rat renal phosphate-dependent glutaminase (I) by 6-diazo-5-oxo-L-norleucine (II) occurred only under conditions where the enzyme was catalytically active.  The I activity and the rate of inactivation by II exhibited very similar phosphate concn.-dependent activation profiles.  Because of this phosphate dependency, it was not possible to differentiate an apparent protection by glutamine from the strong inhibition of inactivation caused by glutamate.  The ability of glutamate to protect I against inactivation was reversed by increasing concns. of phosphate.  The obsd. characteristics of inactivation by II differed considerably from those reported for the inactivation by L-2-amino-4-oxo-5-chloropentanoic acid (III).  In addn. the presence of O-carbamoyl-L-serine stimulated inactivation by II, but protected I against inactivation by III.  Preinactivation of I by II only slightly reduced the stoichiometry of binding of III.  These observations suggest that II and III interact with different sites on I which are specific for binding glutamine and glutamate, resp.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGomJg8GQCT7nbVg90H21EOLACvtfcHk0lip9YSNW51YJw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE1MXktFGrtb8%253D&md5=f866075ef2fb25bd436c87487fb240c6</span></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DShapiro%26aufirst%3DR.%2BA.%26aulast%3DClark%26aufirst%3DV.%2BM.%26aulast%3DCurthoys%26aufirst%3DN.%2BP.%26atitle%3DInactivation%2520of%2520rat%2520renal%2520phosphate-dependent%2520glutaminase%2520with%25206-diazo-5-oxo-L-norleucine.%2520Evidence%2520for%2520interaction%2520at%2520the%2520glutamine%2520binding%2520site%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1979%26volume%3D254%26spage%3D2835%26epage%3D2838" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref77"><div class="reference"><strong class="refLabel"><a href="#ref77" class="rightTabRefNumLink">77</a></strong><div class="NLM_citation" id="rightTab-cit77"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Catane, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Von Hoff, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glaubiger, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muggia, F. M.</span></span> <span> </span><span class="NLM_article-title">Azaserine, DON, and azotomycin: three diazo analogs of L-glutamine with clinical antitumor activity</span>. <i>Cancer Treat. Rep.</i> <span class="NLM_year" style="font-weight: bold;">1979</span>,  <span class="NLM_volume"><i>63</i></span>,  <span class="NLM_fpage">1033</span>– <span class="NLM_lpage">1038</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=380801" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=1%3ACAS%3A280%3ADyaE1M3jsVGnug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=1979&pages=1033-1038&author=R.+Cataneauthor=D.+D.+Von+Hoffauthor=D.+L.+Glaubigerauthor=F.+M.+Muggia&title=Azaserine%2C+DON%2C+and+azotomycin%3A+three+diazo+analogs+of+L-glutamine+with+clinical+antitumor+activity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit77R"><div class="casContent"><span class="casTitleNuber">77</span><div class="casTitle"><span class="NLM_cas:atitle">Azaserine, DON, and azotomycin: three diazo analogs of L-glutamine with clinical antitumor activity</span></div><div class="casAuthors">Catane R; Von Hoff D D; Glaubiger D L; Muggia F M</div><div class="citationInfo"><span class="NLM_cas:title">Cancer treatment reports</span>
        (<span class="NLM_cas:date">1979</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1033-8</span>
        ISSN:<span class="NLM_cas:issn">0361-5960</span>.
    </div><div class="casAbstract">A review of the clinical data on azaserine, DON, and azotomycin reveals that these agents have limited but definite antitumor activity.  All three drugs are analogs of L-glutamine and contain a diazo group.  They have been studied as single agents in a wide variety of human malignancies and have also been included in trials using combination chemotherapy.  Most of these studies were performed early in the history of clinical trials and, therefore, the method of reporting results and the evaluation criteria were quite different from those in use today.  A renewed interest in these agents has been triggered by the remarkable activity of DON and azotomycin against human tumor lines implanted into nude mice.  On the basis of this activity and the clinical data we have compiled, we feel that new clinical trials with these agents are warranted.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTbiKrl9gpbebHHuJhbyicZfW6udTcc2eZIEEp2eP8DXrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaE1M3jsVGnug%253D%253D&md5=614e83ba5c50755ee3f89c0ac10305f1</span></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCatane%26aufirst%3DR.%26aulast%3DVon%2BHoff%26aufirst%3DD.%2BD.%26aulast%3DGlaubiger%26aufirst%3DD.%2BL.%26aulast%3DMuggia%26aufirst%3DF.%2BM.%26atitle%3DAzaserine%252C%2520DON%252C%2520and%2520azotomycin%253A%2520three%2520diazo%2520analogs%2520of%2520L-glutamine%2520with%2520clinical%2520antitumor%2520activity%26jtitle%3DCancer%2520Treat.%2520Rep.%26date%3D1979%26volume%3D63%26spage%3D1033%26epage%3D1038" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref78"><div class="reference"><strong class="refLabel"><a href="#ref78" class="rightTabRefNumLink">78</a></strong><div class="NLM_citation" id="rightTab-cit78"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rais, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jancarik, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tenora, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nedelcovych, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alt, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Englert, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rojas, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elgogary, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monincova, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pate, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adams, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferraris, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Powell, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Majer, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Slusher, B. S.</span></span> <span> </span><span class="NLM_article-title">Discovery of 6-diazo-5-oxo-L-norleucine (DON) prodrugs with enhanced CSF delivery in monkeys: a potential treatment for glioblastoma</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span> (<span class="NLM_issue">18</span>),  <span class="NLM_fpage">8621</span>– <span class="NLM_lpage">8633</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01069</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01069" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=8621-8633&issue=18&author=R.+Raisauthor=A.+Jancarikauthor=L.+Tenoraauthor=M.+Nedelcovychauthor=J.+Altauthor=J.+Englertauthor=C.+Rojasauthor=A.+Leauthor=A.+Elgogaryauthor=J.+Tanauthor=L.+Monincovaauthor=K.+Pateauthor=R.+Adamsauthor=D.+Ferrarisauthor=J.+Powellauthor=P.+Majerauthor=B.+S.+Slusher&title=Discovery+of+6-diazo-5-oxo-L-norleucine+%28DON%29+prodrugs+with+enhanced+CSF+delivery+in+monkeys%3A+a+potential+treatment+for+glioblastoma&doi=10.1021%2Facs.jmedchem.6b01069"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01069&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01069%26sid%3Dliteratum%253Aachs%26aulast%3DRais%26aufirst%3DR.%26aulast%3DJancarik%26aufirst%3DA.%26aulast%3DTenora%26aufirst%3DL.%26aulast%3DNedelcovych%26aufirst%3DM.%26aulast%3DAlt%26aufirst%3DJ.%26aulast%3DEnglert%26aufirst%3DJ.%26aulast%3DRojas%26aufirst%3DC.%26aulast%3DLe%26aufirst%3DA.%26aulast%3DElgogary%26aufirst%3DA.%26aulast%3DTan%26aufirst%3DJ.%26aulast%3DMonincova%26aufirst%3DL.%26aulast%3DPate%26aufirst%3DK.%26aulast%3DAdams%26aufirst%3DR.%26aulast%3DFerraris%26aufirst%3DD.%26aulast%3DPowell%26aufirst%3DJ.%26aulast%3DMajer%26aufirst%3DP.%26aulast%3DSlusher%26aufirst%3DB.%2BS.%26atitle%3DDiscovery%2520of%25206-diazo-5-oxo-L-norleucine%2520%2528DON%2529%2520prodrugs%2520with%2520enhanced%2520CSF%2520delivery%2520in%2520monkeys%253A%2520a%2520potential%2520treatment%2520for%2520glioblastoma%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26issue%3D18%26spage%3D8621%26epage%3D8633%26doi%3D10.1021%2Facs.jmedchem.6b01069" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref79"><div class="reference"><strong class="refLabel"><a href="#ref79" class="rightTabRefNumLink">79</a></strong><div class="NLM_citation" id="rightTab-cit79"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nedelcovych, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tenora, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, B. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelschenbach, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chao, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hadas, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jancarik, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prchalova, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zimmermann, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dash, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gadiano, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garrett, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Furtmuller, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oh, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brandacher, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alt, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Majer, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Volsky, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rais, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Slusher, B. S.</span></span> <span> </span><span class="NLM_article-title">N-(Pivaloyloxy)alkoxy-carbonyl prodrugs of the glutamine antagonist 6-diazo-5-oxo-L- norleucine (DON) as a potential treatment for HIV associated neurocognitive disorders</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span> (<span class="NLM_issue">16</span>),  <span class="NLM_fpage">7186</span>– <span class="NLM_lpage">7198</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00966</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00966" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=7186-7198&issue=16&author=M.+T.+Nedelcovychauthor=L.+Tenoraauthor=B.+H.+Kimauthor=J.+Kelschenbachauthor=W.+Chaoauthor=E.+Hadasauthor=A.+Jancarikauthor=E.+Prchalovaauthor=S.+C.+Zimmermannauthor=R.+P.+Dashauthor=A.+J.+Gadianoauthor=C.+Garrettauthor=G.+Furtmullerauthor=B.+Ohauthor=G.+Brandacherauthor=J.+Altauthor=P.+Majerauthor=D.+J.+Volskyauthor=R.+Raisauthor=B.+S.+Slusher&title=N-%28Pivaloyloxy%29alkoxy-carbonyl+prodrugs+of+the+glutamine+antagonist+6-diazo-5-oxo-L-+norleucine+%28DON%29+as+a+potential+treatment+for+HIV+associated+neurocognitive+disorders&doi=10.1021%2Facs.jmedchem.7b00966"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00966&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00966%26sid%3Dliteratum%253Aachs%26aulast%3DNedelcovych%26aufirst%3DM.%2BT.%26aulast%3DTenora%26aufirst%3DL.%26aulast%3DKim%26aufirst%3DB.%2BH.%26aulast%3DKelschenbach%26aufirst%3DJ.%26aulast%3DChao%26aufirst%3DW.%26aulast%3DHadas%26aufirst%3DE.%26aulast%3DJancarik%26aufirst%3DA.%26aulast%3DPrchalova%26aufirst%3DE.%26aulast%3DZimmermann%26aufirst%3DS.%2BC.%26aulast%3DDash%26aufirst%3DR.%2BP.%26aulast%3DGadiano%26aufirst%3DA.%2BJ.%26aulast%3DGarrett%26aufirst%3DC.%26aulast%3DFurtmuller%26aufirst%3DG.%26aulast%3DOh%26aufirst%3DB.%26aulast%3DBrandacher%26aufirst%3DG.%26aulast%3DAlt%26aufirst%3DJ.%26aulast%3DMajer%26aufirst%3DP.%26aulast%3DVolsky%26aufirst%3DD.%2BJ.%26aulast%3DRais%26aufirst%3DR.%26aulast%3DSlusher%26aufirst%3DB.%2BS.%26atitle%3DN-%2528Pivaloyloxy%2529alkoxy-carbonyl%2520prodrugs%2520of%2520the%2520glutamine%2520antagonist%25206-diazo-5-oxo-L-%2520norleucine%2520%2528DON%2529%2520as%2520a%2520potential%2520treatment%2520for%2520HIV%2520associated%2520neurocognitive%2520disorders%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26issue%3D16%26spage%3D7186%26epage%3D7198%26doi%3D10.1021%2Facs.jmedchem.7b00966" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref80"><div class="reference"><strong class="refLabel"><a href="#ref80" class="rightTabRefNumLink">80</a></strong><div class="NLM_citation" id="rightTab-cit80"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rasheed, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, C. K. A.</span></span> <span> </span><span class="NLM_article-title">Novel approaches on prodrug based drug design</span>. <i>Pharm. Chem. J.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>42</i></span>,  <span class="NLM_fpage">677</span>– <span class="NLM_lpage">686</span>, <span class="refDoi"> DOI: 10.1007/s11094-009-0213-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=10.1007%2Fs11094-009-0213-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=1%3ACAS%3A528%3ADC%252BD1MXksVyisbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2008&pages=677-686&author=A.+Rasheedauthor=C.+K.+A.+Kumar&title=Novel+approaches+on+prodrug+based+drug+design&doi=10.1007%2Fs11094-009-0213-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit80R"><div class="casContent"><span class="casTitleNuber">80</span><div class="casTitle"><span class="NLM_cas:atitle">Novel approaches on prodrug based drug design</span></div><div class="casAuthors">Rasheed, A.; Kumar, C. K. A.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmaceutical Chemistry Journal</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">677-686</span>CODEN:
                <span class="NLM_cas:coden">PCJOAU</span>;
        ISSN:<span class="NLM_cas:issn">0091-150X</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  Prodrug design is really not different from the general drug discovery process, in which a unique substance is obsd. to have desirable pharmacol. effects, and studies of its properties lead to the design of better drugs.  It is a very fruitful way of research, and its introduction in human therapy has given successful results in improving the clin. and therapeutic effectiveness of drugs suffering from some undesirable properties that otherwise hinder their clin. usefulness.  The present article reviews various prodrugs and their applications and presents the developments in this field during the last few decades.  This review also highlights developing strategies in targeted prodrug design, including antibody-directed enzyme prodrug therapy, gene-directed enzyme prodrug therapy and peptide transporter-assocd. prodrug therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGovQl2xd15Bq7Vg90H21EOLACvtfcHk0ljr0XvhxOgPLw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXksVyisbs%253D&md5=2f276e9dcfbebdd479906e3697663121</span></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=10.1007%2Fs11094-009-0213-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11094-009-0213-3%26sid%3Dliteratum%253Aachs%26aulast%3DRasheed%26aufirst%3DA.%26aulast%3DKumar%26aufirst%3DC.%2BK.%2BA.%26atitle%3DNovel%2520approaches%2520on%2520prodrug%2520based%2520drug%2520design%26jtitle%3DPharm.%2520Chem.%2520J.%26date%3D2008%26volume%3D42%26spage%3D677%26epage%3D686%26doi%3D10.1007%2Fs11094-009-0213-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref81"><div class="reference"><strong class="refLabel"><a href="#ref81" class="rightTabRefNumLink">81</a></strong><div class="NLM_citation" id="rightTab-cit81"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maag, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alfredson, T.</span></span> <span> </span><span class="NLM_article-title">Prodrugs of nucleoside analogues for improved oral absorption and tissue targeting</span>. <i>J. Pharm. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>97</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">1109</span>– <span class="NLM_lpage">1134</span>, <span class="refDoi"> DOI: 10.1002/jps.21047</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=10.1002%2Fjps.21047" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=17696166" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=1%3ACAS%3A280%3ADC%252BD1c%252FovVCgtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=97&publication_year=2008&pages=1109-1134&issue=3&author=F.+Liauthor=H.+Maagauthor=T.+Alfredson&title=Prodrugs+of+nucleoside+analogues+for+improved+oral+absorption+and+tissue+targeting&doi=10.1002%2Fjps.21047"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit81R"><div class="casContent"><span class="casTitleNuber">81</span><div class="casTitle"><span class="NLM_cas:atitle">Prodrugs of nucleoside analogues for improved oral absorption and tissue targeting</span></div><div class="casAuthors">Li Fujun; Maag Hans; Alfredson Tom</div><div class="citationInfo"><span class="NLM_cas:title">Journal of pharmaceutical sciences</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">97</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1109-34</span>
        ISSN:<span class="NLM_cas:issn">0022-3549</span>.
    </div><div class="casAbstract">Nucleoside analogues are widely used for the treatment of antiviral infections and anticancer chemotherapy.  However, many nucleoside analogues suffer from poor oral bioavailability due to their high polarity and low intestinal permeability.  In order to improve oral absorption of these polar drugs, prodrugs have been employed to increase lipophilicity by chemical modification of the parent.  Alternatively, prodrugs targeting transporters present in the intestine have been exploited to facilitate the transport of the nucleoside analogues.  Valacyclovir and valganciclovir are two successful valine ester prodrugs transported by the PepT1 transporter.  Recently, research efforts have focused on design of prodrugs for tissue specific delivery to improve efficacy and safety.  This review presents advances of prodrug approaches for improved oral absorption of nucleoside analogues and recent developments in tissue targeting.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS-KOBK65zide2qxNLjzXe8fW6udTcc2eaBxMsEa3TlQbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1c%252FovVCgtQ%253D%253D&md5=ed6aeaf75134be8bc9ef23a89b673b80</span></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=10.1002%2Fjps.21047&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjps.21047%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DF.%26aulast%3DMaag%26aufirst%3DH.%26aulast%3DAlfredson%26aufirst%3DT.%26atitle%3DProdrugs%2520of%2520nucleoside%2520analogues%2520for%2520improved%2520oral%2520absorption%2520and%2520tissue%2520targeting%26jtitle%3DJ.%2520Pharm.%2520Sci.%26date%3D2008%26volume%3D97%26issue%3D3%26spage%3D1109%26epage%3D1134%26doi%3D10.1002%2Fjps.21047" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref82"><div class="reference"><strong class="refLabel"><a href="#ref82" class="rightTabRefNumLink">82</a></strong><div class="NLM_citation" id="rightTab-cit82"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fattash, B.</span>; <span class="NLM_string-name">Karaman, R.</span></span> <i>Chemical Approaches Used in Prodrugs Design in Prodrugs Design—A New Era</i>. <span class="NLM_publisher-name">Nova Science Publishers, Inc.</span>, <span class="NLM_year">2014</span>; pp  <span class="NLM_fpage">103</span>– <span class="NLM_lpage">137</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&pages=103-137&author=B.+Fattash&author=R.+Karaman&title=Chemical+Approaches+Used+in+Prodrugs+Design+in+Prodrugs+Design%E2%80%94A+New+Era"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DFattash%26aufirst%3DB.%26btitle%3DChemical%2520Approaches%2520Used%2520in%2520Prodrugs%2520Design%2520in%2520Prodrugs%2520Design%25E2%2580%2594A%2520New%2520Era%26pub%3DNova%2520Science%2520Publishers%252C%2520Inc%26date%3D2014%26spage%3D103%26epage%3D137" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref83"><div class="reference"><strong class="refLabel"><a href="#ref83" class="rightTabRefNumLink">83</a></strong><div class="NLM_citation" id="rightTab-cit83"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liederer, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borchardt, R. T.</span></span> <span> </span><span class="NLM_article-title">Enzymes involved in the bioconversion of ester-based prodrugs</span>. <i>J. Pharm. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>95</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">1177</span>– <span class="NLM_lpage">1195</span>, <span class="refDoi"> DOI: 10.1002/jps.20542</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=10.1002%2Fjps.20542" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=16639719" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=1%3ACAS%3A528%3ADC%252BD28XlsFWmu7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=2006&pages=1177-1195&issue=6&author=B.+M.+Liedererauthor=R.+T.+Borchardt&title=Enzymes+involved+in+the+bioconversion+of+ester-based+prodrugs&doi=10.1002%2Fjps.20542"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit83R"><div class="casContent"><span class="casTitleNuber">83</span><div class="casTitle"><span class="NLM_cas:atitle">Enzymes involved in the bioconversion of ester-based prodrugs</span></div><div class="casAuthors">Liederer, Bianca M.; Borchardt, Ronald T.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmaceutical Sciences</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">95</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1177-1195</span>CODEN:
                <span class="NLM_cas:coden">JPMSAE</span>;
        ISSN:<span class="NLM_cas:issn">0022-3549</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">A review.  Enzymes are essential for the activation of many prodrugs.  In this review, the most important enzymes (e.g., paraoxonase, carboxylesterase, acetylcholinesterase, cholinesterase) involved in the bioconversion of ester-based prodrugs will be discussed in terms of their biol. and biochem.  Most of these enzymes fall into the category of hydrolytic enzymes.  However, nonhydrolytic enzymes, including cytochrome P450s, can also catalyze the bioconversion of ester prodrugs and thus will be discussed here.  Other factors influencing the ability of these enzymes to catalyze the bioconversion of ester-based prodrugs, particularly species and interindividual differences and stereochem. and structural features of the prodrugs, will be discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp0llDjMqFZU7Vg90H21EOLACvtfcHk0lg6Ajsh61njCg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XlsFWmu7Y%253D&md5=c4bb34d8918f2b4de099a0502c5bdb00</span></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=10.1002%2Fjps.20542&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjps.20542%26sid%3Dliteratum%253Aachs%26aulast%3DLiederer%26aufirst%3DB.%2BM.%26aulast%3DBorchardt%26aufirst%3DR.%2BT.%26atitle%3DEnzymes%2520involved%2520in%2520the%2520bioconversion%2520of%2520ester-based%2520prodrugs%26jtitle%3DJ.%2520Pharm.%2520Sci.%26date%3D2006%26volume%3D95%26issue%3D6%26spage%3D1177%26epage%3D1195%26doi%3D10.1002%2Fjps.20542" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref84"><div class="reference"><strong class="refLabel"><a href="#ref84" class="rightTabRefNumLink">84</a></strong><div class="NLM_citation" id="rightTab-cit84"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Newcomb, R. W.</span>; <span class="NLM_string-name">Newocmb, M.</span></span> <span> </span><span class="NLM_article-title">Selective Inhibition of Glutaminase by Bis-Thiadiazoles</span>. <span class="NLM_patent">US6451828B1</span>, Sep 17, <span class="NLM_year">2002</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2002&author=R.+W.+Newcomb&author=M.+Newocmb&title=Selective+Inhibition+of+Glutaminase+by+Bis-Thiadiazoles"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DNewcomb%26aufirst%3DR.%2BW.%26atitle%3DSelective%2520Inhibition%2520of%2520Glutaminase%2520by%2520Bis-Thiadiazoles%26date%3D2002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref85"><div class="reference"><strong class="refLabel"><a href="#ref85" class="rightTabRefNumLink">85</a></strong><div class="NLM_citation" id="rightTab-cit85"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shapiro, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clark, V. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Curthoys, N. P.</span></span> <span> </span><span class="NLM_article-title">Covalent interaction of L-2-amino-4-oxo-5- chloropentanoic acid with rat renal phosphate-dependent glutaminase. Evidence for a specific glutamate binding site and of subunit heterogeneity</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1978</span>,  <span class="NLM_volume"><i>253</i></span>,  <span class="NLM_fpage">7086</span>– <span class="NLM_lpage">7090</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=253&publication_year=1978&pages=7086-7090&author=R.+A.+Shapiroauthor=V.+M.+Clarkauthor=N.+P.+Curthoys&title=Covalent+interaction+of+L-2-amino-4-oxo-5-+chloropentanoic+acid+with+rat+renal+phosphate-dependent+glutaminase.+Evidence+for+a+specific+glutamate+binding+site+and+of+subunit+heterogeneity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DShapiro%26aufirst%3DR.%2BA.%26aulast%3DClark%26aufirst%3DV.%2BM.%26aulast%3DCurthoys%26aufirst%3DN.%2BP.%26atitle%3DCovalent%2520interaction%2520of%2520L-2-amino-4-oxo-5-%2520chloropentanoic%2520acid%2520with%2520rat%2520renal%2520phosphate-dependent%2520glutaminase.%2520Evidence%2520for%2520a%2520specific%2520glutamate%2520binding%2520site%2520and%2520of%2520subunit%2520heterogeneity%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1978%26volume%3D253%26spage%3D7086%26epage%3D7090" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref86"><div class="reference"><strong class="refLabel"><a href="#ref86" class="rightTabRefNumLink">86</a></strong><div class="NLM_citation" id="rightTab-cit86"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xiang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stine, Z. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xia, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Connor, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Altman, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hsieh, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gouw, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Slusher, B. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhuo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ooi, L. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, C. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mancuso, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCallion, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Milone, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rayport, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Felsher, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dang, C. V.</span></span> <span> </span><span class="NLM_article-title">Targeted inhibition of tumor-specific glutaminase diminishes cell-autonomous tumorigenesis</span>. <i>J. Clin. Invest.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>125</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">2293</span>– <span class="NLM_lpage">2306</span>, <span class="refDoi"> DOI: 10.1172/JCI75836</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=10.1172%2FJCI75836" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=125&publication_year=2015&pages=2293-2306&issue=6&author=Y.+Xiangauthor=Z.+E.+Stineauthor=J.+Xiaauthor=Y.+Luauthor=R.+S.+O%E2%80%99Connorauthor=B.+J.+Altmanauthor=A.+L.+Hsiehauthor=A.+M.+Gouwauthor=A.+G.+Thomasauthor=P.+Gaoauthor=L.+Sunauthor=L.+Songauthor=B.+Yanauthor=B.+S.+Slusherauthor=J.+Zhuoauthor=L.+L.+Ooiauthor=C.+G.+Leeauthor=A.+Mancusoauthor=A.+S.+McCallionauthor=A.+Leauthor=M.+C.+Miloneauthor=S.+Rayportauthor=D.+W.+Felsherauthor=C.+V.+Dang&title=Targeted+inhibition+of+tumor-specific+glutaminase+diminishes+cell-autonomous+tumorigenesis&doi=10.1172%2FJCI75836"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=10.1172%2FJCI75836&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1172%252FJCI75836%26sid%3Dliteratum%253Aachs%26aulast%3DXiang%26aufirst%3DY.%26aulast%3DStine%26aufirst%3DZ.%2BE.%26aulast%3DXia%26aufirst%3DJ.%26aulast%3DLu%26aufirst%3DY.%26aulast%3DO%25E2%2580%2599Connor%26aufirst%3DR.%2BS.%26aulast%3DAltman%26aufirst%3DB.%2BJ.%26aulast%3DHsieh%26aufirst%3DA.%2BL.%26aulast%3DGouw%26aufirst%3DA.%2BM.%26aulast%3DThomas%26aufirst%3DA.%2BG.%26aulast%3DGao%26aufirst%3DP.%26aulast%3DSun%26aufirst%3DL.%26aulast%3DSong%26aufirst%3DL.%26aulast%3DYan%26aufirst%3DB.%26aulast%3DSlusher%26aufirst%3DB.%2BS.%26aulast%3DZhuo%26aufirst%3DJ.%26aulast%3DOoi%26aufirst%3DL.%2BL.%26aulast%3DLee%26aufirst%3DC.%2BG.%26aulast%3DMancuso%26aufirst%3DA.%26aulast%3DMcCallion%26aufirst%3DA.%2BS.%26aulast%3DLe%26aufirst%3DA.%26aulast%3DMilone%26aufirst%3DM.%2BC.%26aulast%3DRayport%26aufirst%3DS.%26aulast%3DFelsher%26aufirst%3DD.%2BW.%26aulast%3DDang%26aufirst%3DC.%2BV.%26atitle%3DTargeted%2520inhibition%2520of%2520tumor-specific%2520glutaminase%2520diminishes%2520cell-autonomous%2520tumorigenesis%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2015%26volume%3D125%26issue%3D6%26spage%3D2293%26epage%3D2306%26doi%3D10.1172%2FJCI75836" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref87"><div class="reference"><strong class="refLabel"><a href="#ref87" class="rightTabRefNumLink">87</a></strong><div class="NLM_citation" id="rightTab-cit87"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zimmermann, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolf, E. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luu, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stathis, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poore, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rojas, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Slusher, B. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsukamoto, T.</span></span> <span> </span><span class="NLM_article-title">Allosteric glutaminase inhibitors based on a 1,4-di(5-amino-1,3,4-thiadiazol-2-yl)butane scaffold</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">520</span>– <span class="NLM_lpage">524</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.6b00060</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.6b00060" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=1%3ACAS%3A528%3ADC%252BC28XktFejsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=520-524&author=S.+C.+Zimmermannauthor=E.+F.+Wolfauthor=A.+Luuauthor=A.+G.+Thomasauthor=M.+Stathisauthor=B.+Pooreauthor=C.+Nguyenauthor=A.+Leauthor=C.+Rojasauthor=B.+S.+Slusherauthor=T.+Tsukamoto&title=Allosteric+glutaminase+inhibitors+based+on+a+1%2C4-di%285-amino-1%2C3%2C4-thiadiazol-2-yl%29butane+scaffold&doi=10.1021%2Facsmedchemlett.6b00060"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit87R"><div class="casContent"><span class="casTitleNuber">87</span><div class="casTitle"><span class="NLM_cas:atitle">Allosteric Glutaminase Inhibitors Based on a 1,4-Di(5-amino-1,3,4-thiadiazol-2-yl)butane Scaffold</span></div><div class="casAuthors">Zimmermann, Sarah C.; Wolf, Emily F.; Luu, Andrew; Thomas, Ajit G.; Stathis, Marigo; Poore, Brad; Nguyen, Christopher; Le, Anne; Rojas, Camilo; Slusher, Barbara S.; Tsukamoto, Takashi</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">520-524</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A series of allosteric kidney-type glutaminase (GLS) inhibitors were designed and synthesized using 1,4-di(5-amino-1,3,4-thiadiazol-2-yl)butane as a core scaffold.  A variety of modified phenylacetyl groups were incorporated into the 5-amino group of the two thiadiazole rings in an attempt to facilitate addnl. binding interactions with the allosteric binding site of GLS.  Among the newly synthesized compds., 4-hydroxy-N-[5-[4-[5-[(2-phenylacetyl)amino]-1,3,4-thiadiazol-2-yl]butyl]-1,3,4-thiadiazol-2-yl]-benzeneacetamide, 2m, potently inhibited GLS with an IC50 value of 70 nM, although it did not exhibit time-dependency as seen with CB-839.  Antiproliferative effects of 2m on human breast cancer lines will be also presented in comparison with those obsd. with CB-839.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpvSab9P2v_OLVg90H21EOLACvtfcHk0ljxEHPSL5iXfw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XktFejsrY%253D&md5=a0e0dc6fcc0f4d343f94f02a50440adf</span></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.6b00060&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.6b00060%26sid%3Dliteratum%253Aachs%26aulast%3DZimmermann%26aufirst%3DS.%2BC.%26aulast%3DWolf%26aufirst%3DE.%2BF.%26aulast%3DLuu%26aufirst%3DA.%26aulast%3DThomas%26aufirst%3DA.%2BG.%26aulast%3DStathis%26aufirst%3DM.%26aulast%3DPoore%26aufirst%3DB.%26aulast%3DNguyen%26aufirst%3DC.%26aulast%3DLe%26aufirst%3DA.%26aulast%3DRojas%26aufirst%3DC.%26aulast%3DSlusher%26aufirst%3DB.%2BS.%26aulast%3DTsukamoto%26aufirst%3DT.%26atitle%3DAllosteric%2520glutaminase%2520inhibitors%2520based%2520on%2520a%25201%252C4-di%25285-amino-1%252C3%252C4-thiadiazol-2-yl%2529butane%2520scaffold%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D7%26spage%3D520%26epage%3D524%26doi%3D10.1021%2Facsmedchemlett.6b00060" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref88"><div class="reference"><strong class="refLabel"><a href="#ref88" class="rightTabRefNumLink">88</a></strong><div class="NLM_citation" id="rightTab-cit88"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lemieux, R. M.</span>; <span class="NLM_string-name">Popovici-Muller, J.</span>; <span class="NLM_string-name">Salituro, F. G.</span>; <span class="NLM_string-name">Saunders, J. O.</span>; <span class="NLM_string-name">Travins, J.</span>; <span class="NLM_string-name">Chen, Y. S.</span></span> <span> </span><span class="NLM_article-title">Compounds and Their Methods of Use</span>. <span class="NLM_patent">US20140142081A1</span>. May 22, <span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=R.+M.+Lemieux&author=J.+Popovici-Muller&author=F.+G.+Salituro&author=J.+O.+Saunders&author=J.+Travins&author=Y.+S.+Chen&title=Compounds+and+Their+Methods+of+Use"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit88&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DLemieux%26aufirst%3DR.%2BM.%26atitle%3DCompounds%2520and%2520Their%2520Methods%2520of%2520Use%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref89"><div class="reference"><strong class="refLabel"><a href="#ref89" class="rightTabRefNumLink">89</a></strong><div class="NLM_citation" id="rightTab-cit89"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bhavar, P. K.</span>; <span class="NLM_string-name">Vakkalanka, S. K. V. S.</span>; <span class="NLM_string-name">Viswanadha, S.</span>; <span class="NLM_string-name">Swaroop, M. G.</span>; <span class="NLM_string-name">Babu, G.</span></span> <span> </span><span class="NLM_article-title">Novel Inhibitors of Glutaminase</span>. <span class="NLM_patent">WO2015101958A2</span>. Jul 09, <span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=P.+K.+Bhavar&author=S.+K.+V.+S.+Vakkalanka&author=S.+Viswanadha&author=M.+G.+Swaroop&author=G.+Babu&title=Novel+Inhibitors+of+Glutaminase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit89&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBhavar%26aufirst%3DP.%2BK.%26atitle%3DNovel%2520Inhibitors%2520of%2520Glutaminase%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref90"><div class="reference"><strong class="refLabel"><a href="#ref90" class="rightTabRefNumLink">90</a></strong><div class="NLM_citation" id="rightTab-cit90"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Finlay, M. R. V.</span>; <span class="NLM_string-name">Ekwuru, C. T.</span>; <span class="NLM_string-name">Charles, M. D.</span>; <span class="NLM_string-name">Raubo, P. A.</span>; <span class="NLM_string-name">Winter, J. J. G.</span>; <span class="NLM_string-name">Nissink, J. W. M.</span></span> <span> </span><span class="NLM_article-title">1,3,4-Thiadiazole Compounds and Their use in Treating Cancer</span>. <span class="NLM_patent">WO2015181539A1</span>. Dec. 03, <span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=M.+R.+V.+Finlay&author=C.+T.+Ekwuru&author=M.+D.+Charles&author=P.+A.+Raubo&author=J.+J.+G.+Winter&author=J.+W.+M.+Nissink&title=1%2C3%2C4-Thiadiazole+Compounds+and+Their+use+in+Treating+Cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit90&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DFinlay%26aufirst%3DM.%2BR.%2BV.%26atitle%3D1%252C3%252C4-Thiadiazole%2520Compounds%2520and%2520Their%2520use%2520in%2520Treating%2520Cancer%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref91"><div class="reference"><strong class="refLabel"><a href="#ref91" class="rightTabRefNumLink">91</a></strong><div class="NLM_citation" id="rightTab-cit91"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mackinnon, A. L.</span>; <span class="NLM_string-name">Rodriguez, M. L.</span></span> <span> </span><span class="NLM_article-title">Treatment of Multiple Myeloma with Heterocyclic Inhibitors of Glutaminase</span>. <span class="NLM_patent">WO2016014890A1</span>. Jan 28, <span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=A.+L.+Mackinnon&author=M.+L.+Rodriguez&title=Treatment+of+Multiple+Myeloma+with+Heterocyclic+Inhibitors+of+Glutaminase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit91&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DMackinnon%26aufirst%3DA.%2BL.%26atitle%3DTreatment%2520of%2520Multiple%2520Myeloma%2520with%2520Heterocyclic%2520Inhibitors%2520of%2520Glutaminase%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref92"><div class="reference"><strong class="refLabel"><a href="#ref92" class="rightTabRefNumLink">92</a></strong><div class="NLM_citation" id="rightTab-cit92"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, Jim.</span>; <span class="NLM_string-name">Chen, L. J.</span>; <span class="NLM_string-name">Goyal, B.</span>; <span class="NLM_string-name">Laidig, G.</span>; <span class="NLM_string-name">Stanton, T. F.</span>; <span class="NLM_string-name">Sjogren, E. B.</span></span> <span> </span><span class="NLM_article-title">Heterocyclic Inhibitors of Glutaminase</span>. <span class="NLM_patent">US8604016B2</span>. Dec 10, <span class="NLM_year">2013</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=Jim.+Li&author=L.+J.+Chen&author=B.+Goyal&author=G.+Laidig&author=T.+F.+Stanton&author=E.+B.+Sjogren&title=Heterocyclic+Inhibitors+of+Glutaminase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit92&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DJim.%26atitle%3DHeterocyclic%2520Inhibitors%2520of%2520Glutaminase%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref93"><div class="reference"><strong class="refLabel"><a href="#ref93" class="rightTabRefNumLink">93</a></strong><div class="NLM_citation" id="rightTab-cit93"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bennett, M. K.</span>; <span class="NLM_string-name">Gross, M.</span>; <span class="NLM_string-name">Bromley, S. D.</span>; <span class="NLM_string-name">Li, J.</span>; <span class="NLM_string-name">Chen, L. J.</span>; <span class="NLM_string-name">Goyal, B.</span>; <span class="NLM_string-name">Laidig, G.</span>; <span class="NLM_string-name">Stanton, T. F.</span>; <span class="NLM_string-name">Sjogren, E. B.</span></span> <span> </span><span class="NLM_article-title">Treatment of Cancer with Heterocyclic Inhibitors of Glutaminase</span>. <span class="NLM_patent">WO2014089048A1</span>. Jun 12, <span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=M.+K.+Bennett&author=M.+Gross&author=S.+D.+Bromley&author=J.+Li&author=L.+J.+Chen&author=B.+Goyal&author=G.+Laidig&author=T.+F.+Stanton&author=E.+B.+Sjogren&title=Treatment+of+Cancer+with+Heterocyclic+Inhibitors+of+Glutaminase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit93&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBennett%26aufirst%3DM.%2BK.%26atitle%3DTreatment%2520of%2520Cancer%2520with%2520Heterocyclic%2520Inhibitors%2520of%2520Glutaminase%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref94"><div class="reference"><strong class="refLabel"><a href="#ref94" class="rightTabRefNumLink">94</a></strong><div class="NLM_citation" id="rightTab-cit94"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Konopleva, M. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flinn, I. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DiNardo, C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bennett, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Molineaux, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maris, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frankfurt, O.</span></span> <span> </span><span class="NLM_article-title">Phase I study: Safety and tolerability of increasing doses of CB-839, an orally administered small molecule inhibitor of glutaminase, in acute leukemia</span>. <i>Haematologica</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>100</i></span>,  <span class="NLM_fpage">378</span>– <span class="NLM_lpage">379</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=100&publication_year=2015&pages=378-379&author=M.+Y.+Konoplevaauthor=I.+W.+Flinnauthor=E.+Wangauthor=C.+D.+DiNardoauthor=M.+Bennettauthor=C.+Molineauxauthor=M.+Leauthor=M.+Marisauthor=O.+Frankfurt&title=Phase+I+study%3A+Safety+and+tolerability+of+increasing+doses+of+CB-839%2C+an+orally+administered+small+molecule+inhibitor+of+glutaminase%2C+in+acute+leukemia"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit94&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKonopleva%26aufirst%3DM.%2BY.%26aulast%3DFlinn%26aufirst%3DI.%2BW.%26aulast%3DWang%26aufirst%3DE.%26aulast%3DDiNardo%26aufirst%3DC.%2BD.%26aulast%3DBennett%26aufirst%3DM.%26aulast%3DMolineaux%26aufirst%3DC.%26aulast%3DLe%26aufirst%3DM.%26aulast%3DMaris%26aufirst%3DM.%26aulast%3DFrankfurt%26aufirst%3DO.%26atitle%3DPhase%2520I%2520study%253A%2520Safety%2520and%2520tolerability%2520of%2520increasing%2520doses%2520of%2520CB-839%252C%2520an%2520orally%2520administered%2520small%2520molecule%2520inhibitor%2520of%2520glutaminase%252C%2520in%2520acute%2520leukemia%26jtitle%3DHaematologica%26date%3D2015%26volume%3D100%26spage%3D378%26epage%3D379" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref95"><div class="reference"><strong class="refLabel"><a href="#ref95" class="rightTabRefNumLink">95</a></strong><div class="NLM_citation" id="rightTab-cit95"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Katt, W. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramachandran, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erickson, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cerione, R. A.</span></span> <span> </span><span class="NLM_article-title">Dibenzophenanthridines as inhibitors of glutaminase C and cancer cell proliferation</span>. <i>Mol. Cancer Ther.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>11</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">1269</span>– <span class="NLM_lpage">1278</span>, <span class="refDoi"> DOI: 10.1158/1535-7163.MCT-11-0942</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=10.1158%2F1535-7163.MCT-11-0942" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=22496480" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=1%3ACAS%3A528%3ADC%252BC38XotlCisLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2012&pages=1269-1278&issue=6&author=W.+P.+Kattauthor=S.+Ramachandranauthor=J.+W.+Ericksonauthor=R.+A.+Cerione&title=Dibenzophenanthridines+as+inhibitors+of+glutaminase+C+and+cancer+cell+proliferation&doi=10.1158%2F1535-7163.MCT-11-0942"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit95R"><div class="casContent"><span class="casTitleNuber">95</span><div class="casTitle"><span class="NLM_cas:atitle">Dibenzophenanthridines as Inhibitors of Glutaminase C and Cancer Cell Proliferation</span></div><div class="casAuthors">Katt, William P.; Ramachandran, Sekar; Erickson, Jon W.; Cerione, Richard A.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1269-1278</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">One hallmark of cancer cells is their adaptation to rely upon an altered metabolic scheme that includes changes in the glycolytic pathway, known as the Warburg effect, and elevated glutamine metab.  Glutaminase, a mitochondrial enzyme, plays a key role in the metab. of glutamine in cancer cells, and its inhibition could significantly impact malignant transformation.  The small mol. 968, a dibenzophenanthridine, was recently shown to inhibit recombinantly expressed glutaminase C, to block the proliferation and anchorage-independent colony formation of human cancer cells in culture, and to inhibit tumor formation in mouse xenograft models.  Here, we examine the structure-activity relationship that leads to 968-based inhibition of glutaminase and cancer cell proliferation, focusing upon a "hot-spot" ring previously identified as crit. to 968 activity.  We find that the hot-spot ring must be substituted with a large, nonplanar functionality (e.g., a t-Bu group) to bestow activity to the series, leading us to a model whereby the mol. binds glutaminase at a previously undescribed allosteric site.  We conduct docking studies to locate potential 968-binding sites and proceed to test a specific set of docking solns. via site-directed mutagenesis.  We verify the results from our initial assay of 968 and its analogs by cellular studies using MDA-MB-231 breast cancer cells.  Mol Cancer Ther; 11(6); 1269-78. ©2012 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr56LeuCKRMMbVg90H21EOLACvtfcHk0lj1LUtPuvfrQA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XotlCisLs%253D&md5=a6e11ed0a50ee567f0013e268e1b36e4</span></div><a href="/servlet/linkout?suffix=cit95&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-11-0942&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-11-0942%26sid%3Dliteratum%253Aachs%26aulast%3DKatt%26aufirst%3DW.%2BP.%26aulast%3DRamachandran%26aufirst%3DS.%26aulast%3DErickson%26aufirst%3DJ.%2BW.%26aulast%3DCerione%26aufirst%3DR.%2BA.%26atitle%3DDibenzophenanthridines%2520as%2520inhibitors%2520of%2520glutaminase%2520C%2520and%2520cancer%2520cell%2520proliferation%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2012%26volume%3D11%26issue%3D6%26spage%3D1269%26epage%3D1278%26doi%3D10.1158%2F1535-7163.MCT-11-0942" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref96"><div class="reference"><strong class="refLabel"><a href="#ref96" class="rightTabRefNumLink">96</a></strong><div class="NLM_citation" id="rightTab-cit96"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stalnecker, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ulrich, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramachandran, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McBrayer, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeBerardinis, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cerione, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erickson, J. W.</span></span> <span> </span><span class="NLM_article-title">Mechanism by which a recently discovered allosteric inhibitor blocks glutamine metabolism in transformed cells</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>112</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">394</span>– <span class="NLM_lpage">399</span>, <span class="refDoi"> DOI: 10.1073/pnas.1414056112</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=10.1073%2Fpnas.1414056112" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=112&publication_year=2015&pages=394-399&issue=2&author=C.+A.+Stalneckerauthor=S.+M.+Ulrichauthor=Y.+Liauthor=S.+Ramachandranauthor=M.+K.+McBrayerauthor=R.+J.+DeBerardinisauthor=R.+A.+Cerioneauthor=J.+W.+Erickson&title=Mechanism+by+which+a+recently+discovered+allosteric+inhibitor+blocks+glutamine+metabolism+in+transformed+cells&doi=10.1073%2Fpnas.1414056112"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit96&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1414056112&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1414056112%26sid%3Dliteratum%253Aachs%26aulast%3DStalnecker%26aufirst%3DC.%2BA.%26aulast%3DUlrich%26aufirst%3DS.%2BM.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DRamachandran%26aufirst%3DS.%26aulast%3DMcBrayer%26aufirst%3DM.%2BK.%26aulast%3DDeBerardinis%26aufirst%3DR.%2BJ.%26aulast%3DCerione%26aufirst%3DR.%2BA.%26aulast%3DErickson%26aufirst%3DJ.%2BW.%26atitle%3DMechanism%2520by%2520which%2520a%2520recently%2520discovered%2520allosteric%2520inhibitor%2520blocks%2520glutamine%2520metabolism%2520in%2520transformed%2520cells%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2015%26volume%3D112%26issue%3D2%26spage%3D394%26epage%3D399%26doi%3D10.1073%2Fpnas.1414056112" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref97"><div class="reference"><strong class="refLabel"><a href="#ref97" class="rightTabRefNumLink">97</a></strong><div class="NLM_citation" id="rightTab-cit97"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gao, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monian, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quadri, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramasamy, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, X. J.</span></span> <span> </span><span class="NLM_article-title">Glutaminolysis and transferrin regulate ferroptosis</span>. <i>Mol. Cell</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>59</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">298</span>– <span class="NLM_lpage">308</span>, <span class="refDoi"> DOI: 10.1016/j.molcel.2015.06.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=10.1016%2Fj.molcel.2015.06.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=26166707" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtFCqtbbK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2015&pages=298-308&issue=2&author=M.+H.+Gaoauthor=P.+Monianauthor=N.+Quadriauthor=R.+Ramasamyauthor=X.+J.+Jiang&title=Glutaminolysis+and+transferrin+regulate+ferroptosis&doi=10.1016%2Fj.molcel.2015.06.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit97R"><div class="casContent"><span class="casTitleNuber">97</span><div class="casTitle"><span class="NLM_cas:atitle">Glutaminolysis and Transferrin Regulate Ferroptosis</span></div><div class="casAuthors">Gao, Minghui; Monian, Prashant; Quadri, Nosirudeen; Ramasamy, Ravichandran; Jiang, Xuejun</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cell</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">298-308</span>CODEN:
                <span class="NLM_cas:coden">MOCEFL</span>;
        ISSN:<span class="NLM_cas:issn">1097-2765</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Ferroptosis has emerged as a new form of regulated necrosis that is implicated in various human diseases.  However, the mechanisms of ferroptosis are not well defined.  This study reports the discovery of multiple mol. components of ferroptosis and its intimate interplay with cellular metab. and redox machinery.  Nutrient starvation often leads to sporadic apoptosis.  Strikingly, we found that upon deprivation of amino acids, a more rapid and potent necrosis process can be induced in a serum-dependent manner, which was subsequently detd. to be ferroptosis.  Two serum factors, the iron-carrier protein transferrin and amino acid glutamine, were identified as the inducers of ferroptosis.  We further found that the cell surface transferrin receptor and the glutamine-fueled intracellular metabolic pathway, glutaminolysis, played crucial roles in the death process.  Inhibition of glutaminolysis, the essential component of ferroptosis, can reduce heart injury triggered by ischemia/reperfusion, suggesting a potential therapeutic approach for treating related diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrJBEfy9dZTELVg90H21EOLACvtfcHk0lj1LUtPuvfrQA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtFCqtbbK&md5=06c80b28b972f851599f995ca3f071e3</span></div><a href="/servlet/linkout?suffix=cit97&amp;dbid=16384&amp;doi=10.1016%2Fj.molcel.2015.06.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molcel.2015.06.011%26sid%3Dliteratum%253Aachs%26aulast%3DGao%26aufirst%3DM.%2BH.%26aulast%3DMonian%26aufirst%3DP.%26aulast%3DQuadri%26aufirst%3DN.%26aulast%3DRamasamy%26aufirst%3DR.%26aulast%3DJiang%26aufirst%3DX.%2BJ.%26atitle%3DGlutaminolysis%2520and%2520transferrin%2520regulate%2520ferroptosis%26jtitle%3DMol.%2520Cell%26date%3D2015%26volume%3D59%26issue%3D2%26spage%3D298%26epage%3D308%26doi%3D10.1016%2Fj.molcel.2015.06.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref98"><div class="reference"><strong class="refLabel"><a href="#ref98" class="rightTabRefNumLink">98</a></strong><div class="NLM_citation" id="rightTab-cit98"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kundu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Viollet, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guan, K. L.</span></span> <span> </span><span class="NLM_article-title">AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1</span>. <i>Nat. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>13</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">132</span>– <span class="NLM_lpage">141</span>, <span class="refDoi"> DOI: 10.1038/ncb2152</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=10.1038%2Fncb2152" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=21258367" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtlamtb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2011&pages=132-141&issue=2&author=J.+Kimauthor=M.+Kunduauthor=B.+Violletauthor=K.+L.+Guan&title=AMPK+and+mTOR+regulate+autophagy+through+direct+phosphorylation+of+Ulk1&doi=10.1038%2Fncb2152"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit98R"><div class="casContent"><span class="casTitleNuber">98</span><div class="casTitle"><span class="NLM_cas:atitle">AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1</span></div><div class="casAuthors">Kim, Joungmok; Kundu, Mondira; Viollet, Benoit; Guan, Kun-Liang</div><div class="citationInfo"><span class="NLM_cas:title">Nature Cell Biology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">132-141</span>CODEN:
                <span class="NLM_cas:coden">NCBIFN</span>;
        ISSN:<span class="NLM_cas:issn">1465-7392</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Autophagy is a process by which components of the cell are degraded to maintain essential activity and viability in response to nutrient limitation.  Extensive genetic studies have shown that the yeast ATG1 kinase has an essential role in autophagy induction.  Furthermore, autophagy is promoted by AMP activated protein kinase (AMPK), which is a key energy sensor and regulates cellular metab. to maintain energy homeostasis.  Conversely, autophagy is inhibited by the mammalian target of rapamycin (mTOR), a central cell-growth regulator that integrates growth factor and nutrient signals.  Here we demonstrate a mol. mechanism for regulation of the mammalian autophagy-initiating kinase Ulk1, a homolog of yeast ATG1.  Under glucose starvation, AMPK promotes autophagy by directly activating Ulk1 through phosphorylation of Ser 317 and Ser 777.  Under nutrient sufficiency, high mTOR activity prevents Ulk1 activation by phosphorylating Ulk1 Ser 757 and disrupting the interaction between Ulk1 and AMPK.  This coordinated phosphorylation is important for Ulk1 in autophagy induction.  This study has revealed a signalling mechanism for Ulk1 regulation and autophagy induction in response to nutrient signalling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpH-jkftukvyrVg90H21EOLACvtfcHk0lhJZc75Eg5ogg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtlamtb0%253D&md5=de33381c98f74b2001bea0215b11f594</span></div><a href="/servlet/linkout?suffix=cit98&amp;dbid=16384&amp;doi=10.1038%2Fncb2152&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncb2152%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DJ.%26aulast%3DKundu%26aufirst%3DM.%26aulast%3DViollet%26aufirst%3DB.%26aulast%3DGuan%26aufirst%3DK.%2BL.%26atitle%3DAMPK%2520and%2520mTOR%2520regulate%2520autophagy%2520through%2520direct%2520phosphorylation%2520of%2520Ulk1%26jtitle%3DNat.%2520Cell%2520Biol.%26date%3D2011%26volume%3D13%26issue%3D2%26spage%3D132%26epage%3D141%26doi%3D10.1038%2Fncb2152" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref99"><div class="reference"><strong class="refLabel"><a href="#ref99" class="rightTabRefNumLink">99</a></strong><div class="NLM_citation" id="rightTab-cit99"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Allan, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clarke, P. R.</span></span> <span> </span><span class="NLM_article-title">Apoptosis and autophagy: Regulation of caspase-9 by phosphorylation</span>. <i>FEBS J.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>276</i></span>,  <span class="NLM_fpage">6063</span>– <span class="NLM_lpage">6073</span>, <span class="refDoi"> DOI: 10.1111/j.1742-4658.2009.07330.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=10.1111%2Fj.1742-4658.2009.07330.x" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=276&publication_year=2009&pages=6063-6073&author=L.+A.+Allanauthor=P.+R.+Clarke&title=Apoptosis+and+autophagy%3A+Regulation+of+caspase-9+by+phosphorylation&doi=10.1111%2Fj.1742-4658.2009.07330.x"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit99&amp;dbid=16384&amp;doi=10.1111%2Fj.1742-4658.2009.07330.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1742-4658.2009.07330.x%26sid%3Dliteratum%253Aachs%26aulast%3DAllan%26aufirst%3DL.%2BA.%26aulast%3DClarke%26aufirst%3DP.%2BR.%26atitle%3DApoptosis%2520and%2520autophagy%253A%2520Regulation%2520of%2520caspase-9%2520by%2520phosphorylation%26jtitle%3DFEBS%2520J.%26date%3D2009%26volume%3D276%26spage%3D6063%26epage%3D6073%26doi%3D10.1111%2Fj.1742-4658.2009.07330.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref100"><div class="reference"><strong class="refLabel"><a href="#ref100" class="rightTabRefNumLink">100</a></strong><div class="NLM_citation" id="rightTab-cit100"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kim, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, Y. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, S. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jang, S. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ham, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, B. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeon, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, I. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, K. G.</span></span> <span> </span><span class="NLM_article-title">PPARδ reprograms glutamine metabolism in sorafenib-resistant HCC</span>. <i>Mol. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>15</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">1230</span>– <span class="NLM_lpage">1242</span>, <span class="refDoi"> DOI: 10.1158/1541-7786.MCR-17-0061</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=10.1158%2F1541-7786.MCR-17-0061" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=28584024" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsVCitr3L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2017&pages=1230-1242&issue=9&author=M.+J.+Kimauthor=Y.+K.+Choiauthor=S.+Y.+Parkauthor=S.+Y.+Jangauthor=J.+Y.+Leeauthor=H.+J.+Hamauthor=B.+G.+Kimauthor=H.+J.+Jeonauthor=J.+H.+Kimauthor=J.+G.+Kimauthor=I.+K.+Leeauthor=K.+G.+Park&title=PPAR%CE%B4+reprograms+glutamine+metabolism+in+sorafenib-resistant+HCC&doi=10.1158%2F1541-7786.MCR-17-0061"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit100R"><div class="casContent"><span class="casTitleNuber">100</span><div class="casTitle"><span class="NLM_cas:atitle">PPARδ Reprograms Glutamine Metabolism in Sorafenib-Resistant HCC</span></div><div class="casAuthors">Kim, Mi-Jin; Choi, Yeon-Kyung; Park, Soo Young; Jang, Se Young; Lee, Jung Yi; Ham, Hye Jin; Kim, Byung-Gyu; Jeon, Hui-Jeon; Kim, Ji-Hyun; Kim, Jung-Guk; Lee, In-Kyu; Park, Keun-Gyu</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Research</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1230-1242</span>CODEN:
                <span class="NLM_cas:coden">MCROC5</span>;
        ISSN:<span class="NLM_cas:issn">1541-7786</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">The tyrosine kinase inhibitor sorafenib is the only therapeutic agent approved for the treatment of advanced hepatocellular carcinoma (HCC), but acquired resistance to sorafenib is high.  Here, we report metabolic reprogramming in sorafenib-resistant HCC and identify a regulatory mol., peroxisome proliferator-activated receptor-δ (PPARδ), as a potential therapeutic target.  Sorafenib-resistant HCC cells showed markedly higher glutamine metab. and reductive glutamine carboxylation, which was accompanied by increased glucose-derived pentose phosphate pathway and glutamine-derived lipid biosynthetic pathways and resistance to oxidative stress.  These glutamine-dependent metabolic alterations were attributed to PPARδ, which was upregulated in sorafenib-resistant HCC cells and human HCC tissues.  Furthermore, PPARδ contributed to increased proliferative capacity and redox homeostasis in sorafenib-resistant HCC cells.  Accordingly, inhibiting PPARδ activity reversed compensatory metabolic reprogramming in sorafenib-resistant HCC cells and sensitized them to sorafenib.  Therefore, targeting compensatory metabolic reprogramming of glutamine metab. in sorafenib-resistant HCC by inhibiting PPARδ constitutes a potential therapeutic strategy for overcoming sorafenib-resistance in HCC.  Implications: This study provides novel insight into the mechanism underlying sorafenib resistance and a potential therapeutic strategy targeting PPARδ in advanced hepatocellular carcinoma.  Mol Cancer Res; 15(9); 1230-42. ©2017 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQMERGUuFIyLVg90H21EOLACvtfcHk0lhJZc75Eg5ogg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsVCitr3L&md5=cee1545225d001f0e0766f5e84f2afaf</span></div><a href="/servlet/linkout?suffix=cit100&amp;dbid=16384&amp;doi=10.1158%2F1541-7786.MCR-17-0061&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1541-7786.MCR-17-0061%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DM.%2BJ.%26aulast%3DChoi%26aufirst%3DY.%2BK.%26aulast%3DPark%26aufirst%3DS.%2BY.%26aulast%3DJang%26aufirst%3DS.%2BY.%26aulast%3DLee%26aufirst%3DJ.%2BY.%26aulast%3DHam%26aufirst%3DH.%2BJ.%26aulast%3DKim%26aufirst%3DB.%2BG.%26aulast%3DJeon%26aufirst%3DH.%2BJ.%26aulast%3DKim%26aufirst%3DJ.%2BH.%26aulast%3DKim%26aufirst%3DJ.%2BG.%26aulast%3DLee%26aufirst%3DI.%2BK.%26aulast%3DPark%26aufirst%3DK.%2BG.%26atitle%3DPPAR%25CE%25B4%2520reprograms%2520glutamine%2520metabolism%2520in%2520sorafenib-resistant%2520HCC%26jtitle%3DMol.%2520Cancer%2520Res.%26date%3D2017%26volume%3D15%26issue%3D9%26spage%3D1230%26epage%3D1242%26doi%3D10.1158%2F1541-7786.MCR-17-0061" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref101"><div class="reference"><strong class="refLabel"><a href="#ref101" class="rightTabRefNumLink">101</a></strong><div class="NLM_citation" id="rightTab-cit101"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Son, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, S. Y.</span></span> <span> </span><span class="NLM_article-title">Dual targeting of glutaminase 1 and thymidylate synthase elicits death synergistically in NSCLC</span>. <i>Cell Death Dis.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">e2511</span>, <span class="refDoi"> DOI: 10.1038/cddis.2016.404</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=10.1038%2Fcddis.2016.404" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=27929535" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=1%3ACAS%3A528%3ADC%252BC28XitVyrtLfK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=e2511&issue=12&author=J.+S.+Leeauthor=J.+H.+Kangauthor=S.+H.+Leeauthor=D.+Hongauthor=J.+Sonauthor=K.+M.+Hongauthor=J.+Songauthor=S.+Y.+Kim&title=Dual+targeting+of+glutaminase+1+and+thymidylate+synthase+elicits+death+synergistically+in+NSCLC&doi=10.1038%2Fcddis.2016.404"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit101R"><div class="casContent"><span class="casTitleNuber">101</span><div class="casTitle"><span class="NLM_cas:atitle">Dual targeting of glutaminase 1 and thymidylate synthase elicits death synergistically in NSCLC</span></div><div class="casAuthors">Lee, Jae-Seon; Kang, Joon H.; Lee, Seon-Hyeong; Hong, Dongwan; Son, Jaekyoung; Hong, Kyeong M.; Song, Jaewhan; Kim, Soo-Youl</div><div class="citationInfo"><span class="NLM_cas:title">Cell Death & Disease</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">e2511</span>CODEN:
                <span class="NLM_cas:coden">CDDEA4</span>;
        ISSN:<span class="NLM_cas:issn">2041-4889</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Glutaminase 1 (GLS1) expression is increased in non-small cell lung cancer (NSCLC).  GLS1 knockdown using siRNA or inhibition using bis-2-(5-phenylacetamido-1,3,4-thiadiazol-2-yl)ethyl sulfide (BPTES) induced cell cycle arrest with significant redn. of ATP level while levels of reactive oxygen species or glutathione were not affected in NSCLC cell lines.  Recently we found that NSCLC significantly depends on cytosol NADH for ATP prodn.  GLS1 remarkably contributes to ATP prodn. through transferring cytosolic NADH into mitochondria via malate-aspartate shuttle by supply of glutamate in NSCLC.  Regulation of malate-aspartate shuttle by knockdown or inhibition of glutamic-oxaloacetic transaminase 2 or malate dehydrogenase 2 mimicked GLS1 knockdown, which induced cell death with ATP redn. in NSCLC.  Therefore, GLS1 inhibition induced cell cycle arrest with ATP depletion by glutamate redn.  Dual inhibition with BPTES and thymidylate synthase inhibitor, 5-fluorouracil (5-FU), elicits cell death synergistically through cell cycle arrest in NSCLC.  A preclin. xenograft model of NSCLC showed remarkable anti-tumor effect synergistically in the BPTES and 5-FU dual therapy group.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpu_4kCoRTsHbVg90H21EOLACvtfcHk0lhJZc75Eg5ogg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XitVyrtLfK&md5=d5db9059ca9a85f81cb209fa60903897</span></div><a href="/servlet/linkout?suffix=cit101&amp;dbid=16384&amp;doi=10.1038%2Fcddis.2016.404&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fcddis.2016.404%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DJ.%2BS.%26aulast%3DKang%26aufirst%3DJ.%2BH.%26aulast%3DLee%26aufirst%3DS.%2BH.%26aulast%3DHong%26aufirst%3DD.%26aulast%3DSon%26aufirst%3DJ.%26aulast%3DHong%26aufirst%3DK.%2BM.%26aulast%3DSong%26aufirst%3DJ.%26aulast%3DKim%26aufirst%3DS.%2BY.%26atitle%3DDual%2520targeting%2520of%2520glutaminase%25201%2520and%2520thymidylate%2520synthase%2520elicits%2520death%2520synergistically%2520in%2520NSCLC%26jtitle%3DCell%2520Death%2520Dis.%26date%3D2016%26volume%3D7%26issue%3D12%26spage%3De2511%26doi%3D10.1038%2Fcddis.2016.404" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref102"><div class="reference"><strong class="refLabel"><a href="#ref102" class="rightTabRefNumLink">102</a></strong><div class="NLM_citation" id="rightTab-cit102"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nagane, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kanai, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shibata, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimizu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshioka, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maruo, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamashita, T.</span></span> <span> </span><span class="NLM_article-title">Sulfasalazine, an inhibitor of the cystine-glutamate antiporter, reduces DNA damage repair and enhances radiosensitivity in murine B16F10 melanoma</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>13</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">e0195151</span>, <span class="refDoi"> DOI: 10.1371/journal.pone.0195151</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=10.1371%2Fjournal.pone.0195151" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=29649284" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhsl2gt73N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2018&pages=e0195151&issue=4&author=M.+Naganeauthor=E.+Kanaiauthor=Y.+Shibataauthor=T.+Shimizuauthor=C.+Yoshiokaauthor=T.+Maruoauthor=T.+Yamashita&title=Sulfasalazine%2C+an+inhibitor+of+the+cystine-glutamate+antiporter%2C+reduces+DNA+damage+repair+and+enhances+radiosensitivity+in+murine+B16F10+melanoma&doi=10.1371%2Fjournal.pone.0195151"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit102R"><div class="casContent"><span class="casTitleNuber">102</span><div class="casTitle"><span class="NLM_cas:atitle">Sulfasalazine, an inhibitor of the cystineglutamate antiporter, reduces DNA damage repair and enhances radiosensitivity in murine B16F10 melanoma</span></div><div class="casAuthors">Nagane, Masaki; Kanai, Eiichi; Shibata, Yuki; Shimizu, Takuto; Yoshioka, Chie; Maruo, Takuya; Yamashita, Tadashi</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">e0195151/1-e0195151/19</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">The sodium-independent cystine-glutamate antiporter plays an important role in extracellular cystine uptake.  It comprises the transmembrane protein, xCT and its chaperone, CD98.  Because glutathione is only weakly cell membrane permeable, cellular uptake of its precursor, cystine, is known to be a key step in glutathione synthesis.  Moreover, it has been reported that xCT expression affects the progression of tumors and their resistance to therapy.  Sulfasalazine is an inhibitor of xCT that is known to increase cellular oxidative stress, giving it anti-tumor potential.  Here, we describe a radio-sensitizing effect of sulfasalazine using a B16F10 melanoma model.  Sulfasalazine decreased glutathione concns. and resistance to H2O2 in B16F10 melanoma cells, but not in mouse embryonic fibroblasts.  It synergistically enhanced the cyto-killing effect of X-irradn. in B16F10 cells.  It inhibited cellular DNA damage repair and prolonged cell cycle arrest after X-irradn.  Furthermore, in an in vivo transplanted melanoma model, sulfasalazine decreased intratumoral glutathione content, leading to enhanced susceptibility to radiation therapy.  These results suggest the possibility of using SAS to augment the treatment of radio-resistant cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrIy6B6Ebt5RrVg90H21EOLACvtfcHk0lhacB2n_wx_9g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhsl2gt73N&md5=417dbfc1124179d9f9f5c7c9cc99d440</span></div><a href="/servlet/linkout?suffix=cit102&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0195151&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0195151%26sid%3Dliteratum%253Aachs%26aulast%3DNagane%26aufirst%3DM.%26aulast%3DKanai%26aufirst%3DE.%26aulast%3DShibata%26aufirst%3DY.%26aulast%3DShimizu%26aufirst%3DT.%26aulast%3DYoshioka%26aufirst%3DC.%26aulast%3DMaruo%26aufirst%3DT.%26aulast%3DYamashita%26aufirst%3DT.%26atitle%3DSulfasalazine%252C%2520an%2520inhibitor%2520of%2520the%2520cystine-glutamate%2520antiporter%252C%2520reduces%2520DNA%2520damage%2520repair%2520and%2520enhances%2520radiosensitivity%2520in%2520murine%2520B16F10%2520melanoma%26jtitle%3DPLoS%2520One%26date%3D2018%26volume%3D13%26issue%3D4%26spage%3De0195151%26doi%3D10.1371%2Fjournal.pone.0195151" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref103"><div class="reference"><strong class="refLabel"><a href="#ref103" class="rightTabRefNumLink">103</a></strong><div class="NLM_citation" id="rightTab-cit103"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schulte, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khodadadi, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cuthbertson, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manning, H. C.</span></span> <span> </span><span class="NLM_article-title">2-Amino-4-bis(aryloxybenzyl)aminobutanoic acids: a novel Scaffold for inhibition of ASCT2-mediated glutamine transport</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">1044</span>– <span class="NLM_lpage">1047</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2015.12.031</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=10.1016%2Fj.bmcl.2015.12.031" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2016&pages=1044-1047&author=M.+L.+Schulteauthor=A.+B.+Khodadadiauthor=M.+L.+Cuthbertsonauthor=J.+A.+Smithauthor=H.+C.+Manning&title=2-Amino-4-bis%28aryloxybenzyl%29aminobutanoic+acids%3A+a+novel+Scaffold+for+inhibition+of+ASCT2-mediated+glutamine+transport&doi=10.1016%2Fj.bmcl.2015.12.031"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit103&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2015.12.031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2015.12.031%26sid%3Dliteratum%253Aachs%26aulast%3DSchulte%26aufirst%3DM.%2BL.%26aulast%3DKhodadadi%26aufirst%3DA.%2BB.%26aulast%3DCuthbertson%26aufirst%3DM.%2BL.%26aulast%3DSmith%26aufirst%3DJ.%2BA.%26aulast%3DManning%26aufirst%3DH.%2BC.%26atitle%3D2-Amino-4-bis%2528aryloxybenzyl%2529aminobutanoic%2520acids%253A%2520a%2520novel%2520Scaffold%2520for%2520inhibition%2520of%2520ASCT2-mediated%2520glutamine%2520transport%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D26%26spage%3D1044%26epage%3D1047%26doi%3D10.1016%2Fj.bmcl.2015.12.031" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref104"><div class="reference"><strong class="refLabel"><a href="#ref104" class="rightTabRefNumLink">104</a></strong><div class="NLM_citation" id="rightTab-cit104"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schulte, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fu, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geng, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, S. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kondo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coffey, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, M. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rathmell, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharick, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skala, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berlin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Washington, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nickels, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manning, H. C.</span></span> <span> </span><span class="NLM_article-title">Pharmacological blockade of ASCT2-dependent glutamine transport leads to antitumor efficacy in preclinical models</span>. <i>Nat. Med.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>24</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">194</span>– <span class="NLM_lpage">202</span>, <span class="refDoi"> DOI: 10.1038/nm.4464</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=10.1038%2Fnm.4464" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=29334372" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=1%3ACAS%3A528%3ADC%252BC1cXovVChsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2018&pages=194-202&issue=2&author=M.+L.+Schulteauthor=A.+Fuauthor=P.+Zhaoauthor=J.+Liauthor=L.+Gengauthor=S.+T.+Smithauthor=J.+Kondoauthor=R.+J.+Coffeyauthor=M.+O.+Johnsonauthor=J.+C.+Rathmellauthor=J.+T.+Sharickauthor=M.+C.+Skalaauthor=J.+A.+Smithauthor=J.+Berlinauthor=M.+K.+Washingtonauthor=M.+L.+Nickelsauthor=H.+C.+Manning&title=Pharmacological+blockade+of+ASCT2-dependent+glutamine+transport+leads+to+antitumor+efficacy+in+preclinical+models&doi=10.1038%2Fnm.4464"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit104R"><div class="casContent"><span class="casTitleNuber">104</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological blockade of ASCT2-dependent glutamine transport leads to antitumor efficacy in preclinical models</span></div><div class="casAuthors">Schulte, Michael L.; Fu, Allie; Zhao, Ping; Li, Jun; Geng, Ling; Smith, Shannon T.; Kondo, Jumpei; Coffey, Robert J.; Johnson, Marc O.; Rathmell, Jeffrey C.; Sharick, Joe T.; Skala, Melissa C.; Smith, Jarrod A.; Berlin, Jordan; Washington, M. Kay; Nickels, Michael L.; Manning, H. Charles</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">194-202</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">The unique metabolic demands of cancer cells underscore potentially fruitful opportunities for drug discovery in the era of precision medicine.  However, therapeutic targeting of cancer metab. has led to surprisingly few new drugs to date.  The neutral amino acid glutamine serves as a key intermediate in numerous metabolic processes leveraged by cancer cells, including biosynthesis, cell signaling, and oxidative protection.  Herein we report the preclin. development of V-9302, a competitive small mol. antagonist of transmembrane glutamine flux that selectively and potently targets the amino acid transporter ASCT2.  Pharmacol. blockade of ASCT2 with V-9302 resulted in attenuated cancer cell growth and proliferation, increased cell death, and increased oxidative stress, which collectively contributed to antitumor responses in vitro and in vivo.  This is the first study, to our knowledge, to demonstrate the utility of a pharmacol. inhibitor of glutamine transport in oncol., representing a new class of targeted therapy and laying a framework for paradigm-shifting therapies targeting cancer cell metab.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGowW77OHf2DsrVg90H21EOLACvtfcHk0lhacB2n_wx_9g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXovVChsA%253D%253D&md5=e9e185d26bc8dc4938114c3cdd7e2c40</span></div><a href="/servlet/linkout?suffix=cit104&amp;dbid=16384&amp;doi=10.1038%2Fnm.4464&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm.4464%26sid%3Dliteratum%253Aachs%26aulast%3DSchulte%26aufirst%3DM.%2BL.%26aulast%3DFu%26aufirst%3DA.%26aulast%3DZhao%26aufirst%3DP.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DGeng%26aufirst%3DL.%26aulast%3DSmith%26aufirst%3DS.%2BT.%26aulast%3DKondo%26aufirst%3DJ.%26aulast%3DCoffey%26aufirst%3DR.%2BJ.%26aulast%3DJohnson%26aufirst%3DM.%2BO.%26aulast%3DRathmell%26aufirst%3DJ.%2BC.%26aulast%3DSharick%26aufirst%3DJ.%2BT.%26aulast%3DSkala%26aufirst%3DM.%2BC.%26aulast%3DSmith%26aufirst%3DJ.%2BA.%26aulast%3DBerlin%26aufirst%3DJ.%26aulast%3DWashington%26aufirst%3DM.%2BK.%26aulast%3DNickels%26aufirst%3DM.%2BL.%26aulast%3DManning%26aufirst%3DH.%2BC.%26atitle%3DPharmacological%2520blockade%2520of%2520ASCT2-dependent%2520glutamine%2520transport%2520leads%2520to%2520antitumor%2520efficacy%2520in%2520preclinical%2520models%26jtitle%3DNat.%2520Med.%26date%3D2018%26volume%3D24%26issue%3D2%26spage%3D194%26epage%3D202%26doi%3D10.1038%2Fnm.4464" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref105"><div class="reference"><strong class="refLabel"><a href="#ref105" class="rightTabRefNumLink">105</a></strong><div class="NLM_citation" id="rightTab-cit105"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stalnecker, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erickson, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cerione, R. A.</span></span> <span> </span><span class="NLM_article-title">Conformational changes in the activation loop of mitochondrial glutaminase C: A direct fluorescence readout that distinguishes the binding of allosteric inhibitors from activators</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>292</i></span> (<span class="NLM_issue">15</span>),  <span class="NLM_fpage">6095</span>– <span class="NLM_lpage">6107</span>, <span class="refDoi"> DOI: 10.1074/jbc.M116.758219</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=10.1074%2Fjbc.M116.758219" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=292&publication_year=2017&pages=6095-6107&issue=15&author=C.+A.+Stalneckerauthor=J.+W.+Ericksonauthor=R.+A.+Cerione&title=Conformational+changes+in+the+activation+loop+of+mitochondrial+glutaminase+C%3A+A+direct+fluorescence+readout+that+distinguishes+the+binding+of+allosteric+inhibitors+from+activators&doi=10.1074%2Fjbc.M116.758219"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit105&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M116.758219&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M116.758219%26sid%3Dliteratum%253Aachs%26aulast%3DStalnecker%26aufirst%3DC.%2BA.%26aulast%3DErickson%26aufirst%3DJ.%2BW.%26aulast%3DCerione%26aufirst%3DR.%2BA.%26atitle%3DConformational%2520changes%2520in%2520the%2520activation%2520loop%2520of%2520mitochondrial%2520glutaminase%2520C%253A%2520A%2520direct%2520fluorescence%2520readout%2520that%2520distinguishes%2520the%2520binding%2520of%2520allosteric%2520inhibitors%2520from%2520activators%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2017%26volume%3D292%26issue%3D15%26spage%3D6095%26epage%3D6107%26doi%3D10.1074%2Fjbc.M116.758219" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref106"><div class="reference"><strong class="refLabel"><a href="#ref106" class="rightTabRefNumLink">106</a></strong><div class="NLM_citation" id="rightTab-cit106"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Z. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">You, Q. D.</span></span> <span> </span><span class="NLM_article-title">Discovery and development of Kelch-like ECH-Associated Protein 1. Nuclear factor erythroid 2-related factor 2 (KEAP1:NRF2) protein-protein interaction inhibitors: achievements, challenges, and future directions</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span> (<span class="NLM_issue">24</span>),  <span class="NLM_fpage">10837</span>– <span class="NLM_lpage">10858</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00586</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00586" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=1%3ACAS%3A528%3ADC%252BC28Xhs1Smtb%252FO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=10837-10858&issue=24&author=Z.+Y.+Jiangauthor=M.+C.+Luauthor=Q.+D.+You&title=Discovery+and+development+of+Kelch-like+ECH-Associated+Protein+1.+Nuclear+factor+erythroid+2-related+factor+2+%28KEAP1%3ANRF2%29+protein-protein+interaction+inhibitors%3A+achievements%2C+challenges%2C+and+future+directions&doi=10.1021%2Facs.jmedchem.6b00586"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit106R"><div class="casContent"><span class="casTitleNuber">106</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and Development of Kelch-like ECH-Associated Protein 1. Nuclear Factor Erythroid 2-Related Factor 2 (KEAP1:NRF2) Protein-Protein Interaction Inhibitors: Achievements, Challenges, and Future Directions</span></div><div class="casAuthors">Jiang, Zheng-Yu; Lu, Meng-Chen; You, Qi-Dong</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">10837-10858</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The transcription factor Nrf2 is the primary regulator of the cellular defense system, and enhancing Nrf2 activity has potential usages in various diseases, esp. chronic age-related and inflammatory diseases.  Recently, directly targeting Keap1-Nrf2 protein-protein interaction (PPI) has been an emerging strategy to selectively and effectively activate Nrf2.  This Perspective summarizes the progress in the discovery and development of Keap1-Nrf2 PPI inhibitors, including the Keap1-Nrf2 regulatory mechanisms, biochem. techniques for inhibitor identification, and approaches for identifying peptide and small-mol. inhibitors, as well as discusses privileged structures and future directions for further development of Keap1-Nrf2 PPI inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqCuMv4k9xi9LVg90H21EOLACvtfcHk0liEU9FpwF0utQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xhs1Smtb%252FO&md5=487aa677ae8a86d71e2b15561656b0b7</span></div><a href="/servlet/linkout?suffix=cit106&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00586&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00586%26sid%3Dliteratum%253Aachs%26aulast%3DJiang%26aufirst%3DZ.%2BY.%26aulast%3DLu%26aufirst%3DM.%2BC.%26aulast%3DYou%26aufirst%3DQ.%2BD.%26atitle%3DDiscovery%2520and%2520development%2520of%2520Kelch-like%2520ECH-Associated%2520Protein%25201.%2520Nuclear%2520factor%2520erythroid%25202-related%2520factor%25202%2520%2528KEAP1%253ANRF2%2529%2520protein-protein%2520interaction%2520inhibitors%253A%2520achievements%252C%2520challenges%252C%2520and%2520future%2520directions%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26issue%3D24%26spage%3D10837%26epage%3D10858%26doi%3D10.1021%2Facs.jmedchem.6b00586" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref107"><div class="reference"><strong class="refLabel"><a href="#ref107" class="rightTabRefNumLink">107</a></strong><div class="NLM_citation" id="rightTab-cit107"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fang, J. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruan, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hou, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, W. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruan, B. H.</span></span> <span> </span><span class="NLM_article-title">Biomolecular interaction assays identified dual inhibitors of glutaminase and glutamate dehydrogenase that disrupt mitochondrial function and prevent growth of cancer cells</span>. <i>Anal. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>89</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">1689</span>– <span class="NLM_lpage">1696</span>, <span class="refDoi"> DOI: 10.1021/acs.analchem.6b03849</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.analchem.6b03849" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=89&publication_year=2017&pages=1689-1696&issue=3&author=M.+Zhuauthor=J.+Z.+Fangauthor=J.+J.+Zhangauthor=Z.+Zhangauthor=J.+H.+Xieauthor=Y.+Yuauthor=J.+J.+Ruanauthor=Z.+Chenauthor=W.+Houauthor=G.+S.+Yangauthor=W.+K.+Suauthor=B.+H.+Ruan&title=Biomolecular+interaction+assays+identified+dual+inhibitors+of+glutaminase+and+glutamate+dehydrogenase+that+disrupt+mitochondrial+function+and+prevent+growth+of+cancer+cells&doi=10.1021%2Facs.analchem.6b03849"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit107&amp;dbid=16384&amp;doi=10.1021%2Facs.analchem.6b03849&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.analchem.6b03849%26sid%3Dliteratum%253Aachs%26aulast%3DZhu%26aufirst%3DM.%26aulast%3DFang%26aufirst%3DJ.%2BZ.%26aulast%3DZhang%26aufirst%3DJ.%2BJ.%26aulast%3DZhang%26aufirst%3DZ.%26aulast%3DXie%26aufirst%3DJ.%2BH.%26aulast%3DYu%26aufirst%3DY.%26aulast%3DRuan%26aufirst%3DJ.%2BJ.%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DHou%26aufirst%3DW.%26aulast%3DYang%26aufirst%3DG.%2BS.%26aulast%3DSu%26aufirst%3DW.%2BK.%26aulast%3DRuan%26aufirst%3DB.%2BH.%26atitle%3DBiomolecular%2520interaction%2520assays%2520identified%2520dual%2520inhibitors%2520of%2520glutaminase%2520and%2520glutamate%2520dehydrogenase%2520that%2520disrupt%2520mitochondrial%2520function%2520and%2520prevent%2520growth%2520of%2520cancer%2520cells%26jtitle%3DAnal.%2520Chem.%26date%3D2017%26volume%3D89%26issue%3D3%26spage%3D1689%26epage%3D1696%26doi%3D10.1021%2Facs.analchem.6b03849" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref108"><div class="reference"><strong class="refLabel"><a href="#ref108" class="rightTabRefNumLink">108</a></strong><div class="NLM_citation" id="rightTab-cit108"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Khavrutskii, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yeh, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Timofeeva, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tarasov, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pritt, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stefanisko, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tarasova, N.</span></span> <span> </span><span class="NLM_article-title">Protein purification-free method of binding affinity determination by microscale thermophoresis</span>. <i>J. Visualized Exp.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>, (<span class="NLM_issue">78</span>),  <span class="NLM_fpage">e50541</span>, <span class="refDoi"> DOI: 10.3791/50541</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=10.3791%2F50541" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsFeisLbJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&pages=e50541&issue=78&author=L.+Khavrutskiiauthor=J.+Yehauthor=O.+Timofeevaauthor=S.+G.+Tarasovauthor=S.+Prittauthor=K.+Stefaniskoauthor=N.+Tarasova&title=Protein+purification-free+method+of+binding+affinity+determination+by+microscale+thermophoresis&doi=10.3791%2F50541"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit108R"><div class="casContent"><span class="casTitleNuber">108</span><div class="casTitle"><span class="NLM_cas:atitle">Protein purification-free method of binding affinity determination by microscale thermophoresis</span></div><div class="casAuthors">Khavrutskii, Lyuba; Yeh, Joanna; Timofeeva, Olga; Tarasov, Sergey G.; Pritt, Samuel; Stefanisko, Karen; Tarasova, Nadya</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Visualized Experiments</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume"></span>
        (<span class="NLM_cas:issue">78</span>),
    <span class="NLM_cas:pages">e50541, 6 pp.</span>CODEN:
                <span class="NLM_cas:coden">JVEOA4</span>;
        ISSN:<span class="NLM_cas:issn">1940-087X</span>.
    
            (<span class="NLM_cas:orgname">Journal of Visualized Experiments</span>)
        </div><div class="casAbstract">Quant. characterization of protein interactions is essential in practically any field of life sciences, particularly drug discovery.  Most of currently available methods of KD detn. require access to purified protein of interest, generation of which can be time-consuming and expensive.  We have developed a protocol that allows for detn. of binding affinity by microscale thermophoresis (MST) without purifn. of the target protein from cell lysates.  The method involves overexpression of the GFP-fused protein and cell lysis in non-denaturing conditions.  Application of the method to STAT3-GFP transiently expressed in HEK293 cells allowed to det. for the first time the affinity of the well-studied transcription factor to oligonucleotides with different sequences.  The protocol is straightforward and can have a variety of application for studying interactions of proteins with small mols., peptides, DNA, RNA, and proteins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpH1wuiBSicNbVg90H21EOLACvtfcHk0liEU9FpwF0utQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsFeisLbJ&md5=3eff1753137b8ae2aaa610dc41e31f66</span></div><a href="/servlet/linkout?suffix=cit108&amp;dbid=16384&amp;doi=10.3791%2F50541&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3791%252F50541%26sid%3Dliteratum%253Aachs%26aulast%3DKhavrutskii%26aufirst%3DL.%26aulast%3DYeh%26aufirst%3DJ.%26aulast%3DTimofeeva%26aufirst%3DO.%26aulast%3DTarasov%26aufirst%3DS.%2BG.%26aulast%3DPritt%26aufirst%3DS.%26aulast%3DStefanisko%26aufirst%3DK.%26aulast%3DTarasova%26aufirst%3DN.%26atitle%3DProtein%2520purification-free%2520method%2520of%2520binding%2520affinity%2520determination%2520by%2520microscale%2520thermophoresis%26jtitle%3DJ.%2520Visualized%2520Exp.%26date%3D2013%26issue%3D78%26spage%3De50541%26doi%3D10.3791%2F50541" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref109"><div class="reference"><strong class="refLabel"><a href="#ref109" class="rightTabRefNumLink">109</a></strong><div class="NLM_citation" id="rightTab-cit109"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Veber, D. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, H.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, B. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ward, K. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kopple, K. D.</span></span> <span> </span><span class="NLM_article-title">Molecular properties that influence the oral bioavailability of drug candidates</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>45</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">2615</span>– <span class="NLM_lpage">2623</span>, <span class="refDoi"> DOI: 10.1021/jm020017n</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm020017n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=1%3ACAS%3A528%3ADC%252BD38XjsFCmt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2002&pages=2615-2623&issue=12&author=D.+F.+Veberauthor=S.+R.+Johnsonauthor=H.-Y.+Chengauthor=B.+R.+Smithauthor=K.+W.+Wardauthor=K.+D.+Kopple&title=Molecular+properties+that+influence+the+oral+bioavailability+of+drug+candidates&doi=10.1021%2Fjm020017n"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit109R"><div class="casContent"><span class="casTitleNuber">109</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular Properties That Influence the Oral Bioavailability of Drug Candidates</span></div><div class="casAuthors">Veber, Daniel F.; Johnson, Stephen R.; Cheng, Hung-Yuan; Smith, Brian R.; Ward, Keith W.; Kopple, Kenneth D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2615-2623</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Oral bioavailability measurements in rats for over 1100 drug candidates studied at Smith-Kline Beecham Pharmaceuticals (now Glaxo Smith-Kline) have allowed us to analyze the relative importance of mol. properties considered to influence that drug property.  Reduced mol. flexibility, as measured by the no. of rotatable bonds, and low polar surface area or total hydrogen bond count (sum of donors and acceptors) are found to be important predictors of good oral bioavailability, independent of mol. wt.  That on av. both the no. of rotatable bonds and polar surface area or hydrogen bond count tend to increase with mol. wt. may in part explain the success of the mol. wt. parameter in predicting oral bioavailability.  The commonly applied mol. wt. cutoff at 500 does not itself significantly sep. compds. with poor oral bioavailability from those with acceptable values in this extensive data set.  Our observations suggest that compds. which meet only the 2 criteria of (1) 10 or fewer rotatable bonds and (2) polar surface area ≤140 Å2 (or 12 or fewer H-bond donors and acceptors) will have a high probability of good oral bioavailability in the rat.  Data sets for the artificial membrane permeation rate and for clearance in the rat were also examd.  Reduced polar surface area correlates better with increased permeation rate than does lipophilicity (C log P), and increased rotatable bond count has a neg. effect on the permeation rate.  A threshold permeation rate is a prerequisite of oral bioavailability.  The rotatable bond count does not correlate with the data examd. here for the in vivo clearance rate in the rat.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3JtJEkO7yVLVg90H21EOLACvtfcHk0liEU9FpwF0utQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XjsFCmt7g%253D&md5=eaad26ed6a259de82ad65a8834fc397d</span></div><a href="/servlet/linkout?suffix=cit109&amp;dbid=16384&amp;doi=10.1021%2Fjm020017n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm020017n%26sid%3Dliteratum%253Aachs%26aulast%3DVeber%26aufirst%3DD.%2BF.%26aulast%3DJohnson%26aufirst%3DS.%2BR.%26aulast%3DCheng%26aufirst%3DH.-Y.%26aulast%3DSmith%26aufirst%3DB.%2BR.%26aulast%3DWard%26aufirst%3DK.%2BW.%26aulast%3DKopple%26aufirst%3DK.%2BD.%26atitle%3DMolecular%2520properties%2520that%2520influence%2520the%2520oral%2520bioavailability%2520of%2520drug%2520candidates%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2002%26volume%3D45%26issue%3D12%26spage%3D2615%26epage%3D2623%26doi%3D10.1021%2Fjm020017n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref110"><div class="reference"><strong class="refLabel"><a href="#ref110" class="rightTabRefNumLink">110</a></strong><div class="NLM_citation" id="rightTab-cit110"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hopkins, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Groom, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alex, A.</span></span> <span> </span><span class="NLM_article-title">Ligand efficiency: a useful metric for lead selection</span>. <i>Drug Discovery Today</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>9</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">430</span>– <span class="NLM_lpage">431</span>, <span class="refDoi"> DOI: 10.1016/S1359-6446(04)03069-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=10.1016%2FS1359-6446%2804%2903069-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=15109945" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=1%3ACAS%3A280%3ADC%252BD2c3ht1ygtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2004&pages=430-431&issue=10&author=A.+L.+Hopkinsauthor=C.+R.+Groomauthor=A.+Alex&title=Ligand+efficiency%3A+a+useful+metric+for+lead+selection&doi=10.1016%2FS1359-6446%2804%2903069-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit110R"><div class="casContent"><span class="casTitleNuber">110</span><div class="casTitle"><span class="NLM_cas:atitle">Ligand efficiency: a useful metric for lead selection</span></div><div class="casAuthors">Hopkins Andrew L; Groom Colin R; Alex Alexander</div><div class="citationInfo"><span class="NLM_cas:title">Drug discovery today</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">430-1</span>
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSdMyKW_d6RPeIHSmpohpd0fW6udTcc2ea9ewoEnfuom7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2c3ht1ygtw%253D%253D&md5=eb19a1bca53247d0bd9adcb99d5817e6</span></div><a href="/servlet/linkout?suffix=cit110&amp;dbid=16384&amp;doi=10.1016%2FS1359-6446%2804%2903069-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1359-6446%252804%252903069-7%26sid%3Dliteratum%253Aachs%26aulast%3DHopkins%26aufirst%3DA.%2BL.%26aulast%3DGroom%26aufirst%3DC.%2BR.%26aulast%3DAlex%26aufirst%3DA.%26atitle%3DLigand%2520efficiency%253A%2520a%2520useful%2520metric%2520for%2520lead%2520selection%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2004%26volume%3D9%26issue%3D10%26spage%3D430%26epage%3D431%26doi%3D10.1016%2FS1359-6446%2804%2903069-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref111"><div class="reference"><strong class="refLabel"><a href="#ref111" class="rightTabRefNumLink">111</a></strong><div class="NLM_citation" id="rightTab-cit111"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Leeson, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Springthorpe, B.</span></span> <span> </span><span class="NLM_article-title">The influence of drug-like concepts on decision-making in medicinal chemistry</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">881</span>– <span class="NLM_lpage">890</span>, <span class="refDoi"> DOI: 10.1038/nrd2445</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=10.1038%2Fnrd2445" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=17971784" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht1els7rL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2007&pages=881-890&author=P.+D.+Leesonauthor=B.+Springthorpe&title=The+influence+of+drug-like+concepts+on+decision-making+in+medicinal+chemistry&doi=10.1038%2Fnrd2445"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit111R"><div class="casContent"><span class="casTitleNuber">111</span><div class="casTitle"><span class="NLM_cas:atitle">The influence of drug-like concepts on decision-making in medicinal chemistry</span></div><div class="casAuthors">Leeson, Paul D.; Springthorpe, Brian</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">881-890</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Despite the wide acceptance of drug-like principles such as the 'rule of five', this anal. of mols. currently being synthesized in leading pharmaceutical companies reveals that their phys. properties differ significantly from those of recently discovered oral drugs.  The marked increase in lipophilicity in particular could increase the likelihood of attrition in drug development.  The application of guidelines linked to the concept of drug-likeness, such as the 'rule of five', has gained wide acceptance as an approach to reduce attrition in drug discovery and development.  However, despite this acceptance, anal. of recent trends reveals that the phys. properties of mols. that are currently being synthesized in leading drug discovery companies differ significantly from those of recently discovered oral drugs and compds. in clin. development.  The consequences of the marked increase in lipophilicity - the most important drug-like phys. property - include a greater likelihood of lack of selectivity and attrition in drug development.  Tackling the threat of compd.-related toxicol. attrition needs to move to the mainstream of medicinal chem. decision-making.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoTUeonLD6iebVg90H21EOLACvtfcHk0ljB5fOt8dEbFQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht1els7rL&md5=5665a9e2dc266a1ee096e20625757ef7</span></div><a href="/servlet/linkout?suffix=cit111&amp;dbid=16384&amp;doi=10.1038%2Fnrd2445&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd2445%26sid%3Dliteratum%253Aachs%26aulast%3DLeeson%26aufirst%3DP.%2BD.%26aulast%3DSpringthorpe%26aufirst%3DB.%26atitle%3DThe%2520influence%2520of%2520drug-like%2520concepts%2520on%2520decision-making%2520in%2520medicinal%2520chemistry%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2007%26volume%3D6%26spage%3D881%26epage%3D890%26doi%3D10.1038%2Fnrd2445" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref112"><div class="reference"><strong class="refLabel"><a href="#ref112" class="rightTabRefNumLink">112</a></strong><div class="NLM_citation" id="rightTab-cit112"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nicklin, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bergman, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Triantafellow, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nyfeler, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hild, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kung, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Myer, V. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mackeigan, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Porter, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cantley, L. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Finan, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murphy, L. O.</span></span> <span> </span><span class="NLM_article-title">Bidirectional transport of amino acids regulates mTOR and autophagy</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>136</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">521</span>– <span class="NLM_lpage">534</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2008.11.044</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=10.1016%2Fj.cell.2008.11.044" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=19203585" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=1%3ACAS%3A528%3ADC%252BD1MXltFSnsrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=136&publication_year=2009&pages=521-534&issue=3&author=P.+Nicklinauthor=P.+Bergmanauthor=B.+Zhangauthor=E.+Triantafellowauthor=H.+Wangauthor=B.+Nyfelerauthor=H.+Yangauthor=M.+Hildauthor=C.+Kungauthor=C.+Wilsonauthor=V.+E.+Myerauthor=J.+P.+Mackeiganauthor=J.+A.+Porterauthor=Y.+K.+Wangauthor=L.+C.+Cantleyauthor=P.+M.+Finanauthor=L.+O.+Murphy&title=Bidirectional+transport+of+amino+acids+regulates+mTOR+and+autophagy&doi=10.1016%2Fj.cell.2008.11.044"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit112R"><div class="casContent"><span class="casTitleNuber">112</span><div class="casTitle"><span class="NLM_cas:atitle">Bidirectional transport of amino acids regulates mTOR and autophagy</span></div><div class="casAuthors">Nicklin, Paul; Bergman, Philip; Zhang, Bailin; Triantafellow, Ellen; Wang, Henry; Nyfeler, Beat; Yang, Haidi; Hild, Marc; Kung, Charles; Wilson, Christopher; Myer, Vic E.; MacKeigan, Jeffrey P.; Porter, Jeffrey A.; Karen Wang, Y.; Cantley, Lewis C.; Finan, Peter M.; Murphy, Leon O.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">136</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">521-534</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Amino acids are required for activation of the mammalian target of rapamycin (mTOR) kinase which regulates protein translation, cell growth, and autophagy.  Cell surface transporters that allow amino acids to enter the cell and signal to mTOR are unknown.  We show that cellular uptake of L-glutamine and its subsequent rapid efflux in the presence of essential amino acids (EAA) is the rate-limiting step that activates mTOR.  L-Glutamine uptake is regulated by SLC1A5 and loss of SLC1A5 function inhibits cell growth and activates autophagy.  The mol. basis for L-glutamine sensitivity is due to SLC7A5/SLC3A2, a bidirectional transporter that regulates the simultaneous efflux of L-glutamine out of cells and transport of L-leucine/EAA into cells.  Certain tumor cell lines with high basal cellular levels of L-glutamine bypass the need for L-glutamine uptake and are primed for mTOR activation.  Thus, L-glutamine flux regulates mTOR, translation and autophagy to coordinate cell growth and proliferation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGou-WsQFP-BcbVg90H21EOLACvtfcHk0ljB5fOt8dEbFQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXltFSnsrc%253D&md5=bc244efe138359f3090f6fcebe2134cd</span></div><a href="/servlet/linkout?suffix=cit112&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2008.11.044&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2008.11.044%26sid%3Dliteratum%253Aachs%26aulast%3DNicklin%26aufirst%3DP.%26aulast%3DBergman%26aufirst%3DP.%26aulast%3DZhang%26aufirst%3DB.%26aulast%3DTriantafellow%26aufirst%3DE.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DNyfeler%26aufirst%3DB.%26aulast%3DYang%26aufirst%3DH.%26aulast%3DHild%26aufirst%3DM.%26aulast%3DKung%26aufirst%3DC.%26aulast%3DWilson%26aufirst%3DC.%26aulast%3DMyer%26aufirst%3DV.%2BE.%26aulast%3DMackeigan%26aufirst%3DJ.%2BP.%26aulast%3DPorter%26aufirst%3DJ.%2BA.%26aulast%3DWang%26aufirst%3DY.%2BK.%26aulast%3DCantley%26aufirst%3DL.%2BC.%26aulast%3DFinan%26aufirst%3DP.%2BM.%26aulast%3DMurphy%26aufirst%3DL.%2BO.%26atitle%3DBidirectional%2520transport%2520of%2520amino%2520acids%2520regulates%2520mTOR%2520and%2520autophagy%26jtitle%3DCell%26date%3D2009%26volume%3D136%26issue%3D3%26spage%3D521%26epage%3D534%26doi%3D10.1016%2Fj.cell.2008.11.044" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref113"><div class="reference"><strong class="refLabel"><a href="#ref113" class="rightTabRefNumLink">113</a></strong><div class="NLM_citation" id="rightTab-cit113"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wellen, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mancuso, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lemons, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ryczko, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dennis, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rabinowitz, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coller, H. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, C. B.</span></span> <span> </span><span class="NLM_article-title">The hexosamine biosynthetic pathway couples growth factor-induced glutamine uptake to glucose metabolism</span>. <i>Genes Dev.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>24</i></span> (<span class="NLM_issue">24</span>),  <span class="NLM_fpage">2784</span>– <span class="NLM_lpage">2799</span>, <span class="refDoi"> DOI: 10.1101/gad.1985910</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=10.1101%2Fgad.1985910" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2010&pages=2784-2799&issue=24&author=K.+E.+Wellenauthor=C.+Luauthor=A.+Mancusoauthor=J.+M.+Lemonsauthor=M.+Ryczkoauthor=J.+W.+Dennisauthor=J.+D.+Rabinowitzauthor=H.+A.+Collerauthor=C.+B.+Thompson&title=The+hexosamine+biosynthetic+pathway+couples+growth+factor-induced+glutamine+uptake+to+glucose+metabolism&doi=10.1101%2Fgad.1985910"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit113&amp;dbid=16384&amp;doi=10.1101%2Fgad.1985910&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1101%252Fgad.1985910%26sid%3Dliteratum%253Aachs%26aulast%3DWellen%26aufirst%3DK.%2BE.%26aulast%3DLu%26aufirst%3DC.%26aulast%3DMancuso%26aufirst%3DA.%26aulast%3DLemons%26aufirst%3DJ.%2BM.%26aulast%3DRyczko%26aufirst%3DM.%26aulast%3DDennis%26aufirst%3DJ.%2BW.%26aulast%3DRabinowitz%26aufirst%3DJ.%2BD.%26aulast%3DColler%26aufirst%3DH.%2BA.%26aulast%3DThompson%26aufirst%3DC.%2BB.%26atitle%3DThe%2520hexosamine%2520biosynthetic%2520pathway%2520couples%2520growth%2520factor-induced%2520glutamine%2520uptake%2520to%2520glucose%2520metabolism%26jtitle%3DGenes%2520Dev.%26date%3D2010%26volume%3D24%26issue%3D24%26spage%3D2784%26epage%3D2799%26doi%3D10.1101%2Fgad.1985910" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref114"><div class="reference"><strong class="refLabel"><a href="#ref114" class="rightTabRefNumLink">114</a></strong><div class="NLM_citation" id="rightTab-cit114"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lobo, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruiz-Bellido, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aledo, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marquez, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nunez De Castro, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alonso, F. J.</span></span> <span> </span><span class="NLM_article-title">Inhibition of glutaminase expression by antisense mRNA decreases growth and tumourigenicity of tumour cells</span>. <i>Biochem. J.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>348</i></span>,  <span class="NLM_fpage">257</span>– <span class="NLM_lpage">261</span>, <span class="refDoi"> DOI: 10.1042/bj3480257</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=10.1042%2Fbj3480257" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=348&publication_year=2000&pages=257-261&author=C.+Loboauthor=M.+A.+Ruiz-Bellidoauthor=J.+C.+Aledoauthor=J.+Marquezauthor=I.+Nunez+De+Castroauthor=F.+J.+Alonso&title=Inhibition+of+glutaminase+expression+by+antisense+mRNA+decreases+growth+and+tumourigenicity+of+tumour+cells&doi=10.1042%2Fbj3480257"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit114&amp;dbid=16384&amp;doi=10.1042%2Fbj3480257&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252Fbj3480257%26sid%3Dliteratum%253Aachs%26aulast%3DLobo%26aufirst%3DC.%26aulast%3DRuiz-Bellido%26aufirst%3DM.%2BA.%26aulast%3DAledo%26aufirst%3DJ.%2BC.%26aulast%3DMarquez%26aufirst%3DJ.%26aulast%3DNunez%2BDe%2BCastro%26aufirst%3DI.%26aulast%3DAlonso%26aufirst%3DF.%2BJ.%26atitle%3DInhibition%2520of%2520glutaminase%2520expression%2520by%2520antisense%2520mRNA%2520decreases%2520growth%2520and%2520tumourigenicity%2520of%2520tumour%2520cells%26jtitle%3DBiochem.%2520J.%26date%3D2000%26volume%3D348%26spage%3D257%26epage%3D261%26doi%3D10.1042%2Fbj3480257" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref115"><div class="reference"><strong class="refLabel"><a href="#ref115" class="rightTabRefNumLink">115</a></strong><div class="NLM_citation" id="rightTab-cit115"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sudderth, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mullen, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, E. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matés, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeBerardinis, R. J.</span></span> <span> </span><span class="NLM_article-title">Pyruvate carboxylase is required for glutamine-independent growth of tumor cells</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>108</i></span>,  <span class="NLM_fpage">8674</span>– <span class="NLM_lpage">8679</span>, <span class="refDoi"> DOI: 10.1073/pnas.1016627108</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=10.1073%2Fpnas.1016627108" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=21555572" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=1%3ACAS%3A528%3ADC%252BC3MXntVGqur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=108&publication_year=2011&pages=8674-8679&author=T.+Chengauthor=J.+Sudderthauthor=C.+Yangauthor=A.+R.+Mullenauthor=E.+S.+Jinauthor=J.+M.+Mat%C3%A9sauthor=R.+J.+DeBerardinis&title=Pyruvate+carboxylase+is+required+for+glutamine-independent+growth+of+tumor+cells&doi=10.1073%2Fpnas.1016627108"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit115R"><div class="casContent"><span class="casTitleNuber">115</span><div class="casTitle"><span class="NLM_cas:atitle">Pyruvate carboxylase is required for glutamine-independent growth of tumor cells</span></div><div class="casAuthors">Cheng, Tzuling; Sudderth, Jessica; Yang, Chendong; Mullen, Andrew R.; Jin, Eunsook S.; Mates, Jose M.; Deberardinis, Ralph J.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">108</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">8674-8679, S8674/1-S8674/22</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Tumor cells require a const. supply of macromol. precursors, and interrupting this supply was proposed as a therapeutic strategy in cancer.  Precursors for lipids, nucleic acids, and proteins are generated in the tricarboxylic acid (TCA) cycle and removed from the mitochondria to participate in biosynthetic reactions.  Refilling the pool of precursor mols. (anaplerosis) is therefore crucial to maintain cell growth.  Many tumor cells use glutamine to feed anaplerosis.  Here we studied how "glutamine-addicted" cells react to interruptions of glutamine metab.  Silencing of glutaminase (GLS), which catalyzes the first step in glutamine-dependent anaplerosis, suppressed but did not eliminate the growth of glioblastoma cells in culture and in vivo.  Profiling metabolic fluxes in GLS-suppressed cells revealed induction of a compensatory anaplerotic mechanism catalyzed by pyruvate carboxylase (PC), allowing the cells to use glucose-derived pyruvate rather than glutamine for anaplerosis.  Although PC was dispensable when glutamine was available, forcing cells to adapt to low-glutamine conditions rendered them absolutely dependent on PC for growth.  Furthermore, in other cell lines, measuring PC activity in nutrient-replete conditions predicted dependence on specific anaplerotic enzymes.  Cells with high PC activity were resistant to GLS silencing and did not require glutamine for survival or growth, but displayed suppressed growth when PC was silenced.  Thus, PC-mediated, glucose-dependent anaplerosis allows cells to achieve glutamine independence.  Induction of PC during chronic suppression of glutamine metab. may prove to be a mechanism of resistance to therapies targeting glutaminolysis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqsPp-FJtjQSbVg90H21EOLACvtfcHk0ljIF8NQZ0eBJw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXntVGqur4%253D&md5=109e2a63458ec384aa873c9a4bb95334</span></div><a href="/servlet/linkout?suffix=cit115&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1016627108&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1016627108%26sid%3Dliteratum%253Aachs%26aulast%3DCheng%26aufirst%3DT.%26aulast%3DSudderth%26aufirst%3DJ.%26aulast%3DYang%26aufirst%3DC.%26aulast%3DMullen%26aufirst%3DA.%2BR.%26aulast%3DJin%26aufirst%3DE.%2BS.%26aulast%3DMat%25C3%25A9s%26aufirst%3DJ.%2BM.%26aulast%3DDeBerardinis%26aufirst%3DR.%2BJ.%26atitle%3DPyruvate%2520carboxylase%2520is%2520required%2520for%2520glutamine-independent%2520growth%2520of%2520tumor%2520cells%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2011%26volume%3D108%26spage%3D8674%26epage%3D8679%26doi%3D10.1073%2Fpnas.1016627108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref116"><div class="reference"><strong class="refLabel"><a href="#ref116" class="rightTabRefNumLink">116</a></strong><div class="NLM_citation" id="rightTab-cit116"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lacey, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilmore, D. W.</span></span> <span> </span><span class="NLM_article-title">Is glutamine a conditionally essential amino acid?</span>. <i>Nutr. Rev.</i> <span class="NLM_year" style="font-weight: bold;">1990</span>,  <span class="NLM_volume"><i>48</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">297</span>– <span class="NLM_lpage">309</span>, <span class="refDoi"> DOI: 10.1111/j.1753-4887.1990.tb02967.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=10.1111%2Fj.1753-4887.1990.tb02967.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=2080048" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=1%3ACAS%3A280%3ADyaK3M7nvFKgtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=1990&pages=297-309&issue=8&author=J.+M.+Laceyauthor=D.+W.+Wilmore&title=Is+glutamine+a+conditionally+essential+amino+acid%3F&doi=10.1111%2Fj.1753-4887.1990.tb02967.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit116R"><div class="casContent"><span class="casTitleNuber">116</span><div class="casTitle"><span class="NLM_cas:atitle">Is glutamine a conditionally essential amino acid?</span></div><div class="casAuthors">Lacey J M; Wilmore D W</div><div class="citationInfo"><span class="NLM_cas:title">Nutrition reviews</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">297-309</span>
        ISSN:<span class="NLM_cas:issn">0029-6643</span>.
    </div><div class="casAbstract">The nonessential amino acid glutamine has recently been the focus of extensive scientific interest because of its importance in cell and tissue cultures and its physiologic role in animals and humans.  Glutamine appears to be a unique amino acid, serving as a preferred respiratory fuel for rapidly proliferating cells, such as enterocytes and lymphocytes; a regulator of acid-base balance through the production of urinary ammonia; a carrier of nitrogen between tissues; and an important precursor of nucleic acids, nucleotides, amino sugars, and proteins.  Abundant evidence suggests that glutamine may become a "conditionally essential" amino acid in the critically ill.  During stress the body's requirements for glutamine appear to exceed the individual's ability to produce sufficient amounts of this amino acid.  Provision of supplemental glutamine in specialized enteral or parenteral feeding may enhance nutritional management and augment recovery of the seriously ill while minimizing hospital stay.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTZrSpilggmhresJRIHUP1ofW6udTcc2eZuKv8KEebDjLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK3M7nvFKgtA%253D%253D&md5=c7303162e9a8cd16cac816282693c1a5</span></div><a href="/servlet/linkout?suffix=cit116&amp;dbid=16384&amp;doi=10.1111%2Fj.1753-4887.1990.tb02967.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1753-4887.1990.tb02967.x%26sid%3Dliteratum%253Aachs%26aulast%3DLacey%26aufirst%3DJ.%2BM.%26aulast%3DWilmore%26aufirst%3DD.%2BW.%26atitle%3DIs%2520glutamine%2520a%2520conditionally%2520essential%2520amino%2520acid%253F%26jtitle%3DNutr.%2520Rev.%26date%3D1990%26volume%3D48%26issue%3D8%26spage%3D297%26epage%3D309%26doi%3D10.1111%2Fj.1753-4887.1990.tb02967.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref117"><div class="reference"><strong class="refLabel"><a href="#ref117" class="rightTabRefNumLink">117</a></strong><div class="NLM_citation" id="rightTab-cit117"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rubin, A. L.</span></span> <span> </span><span class="NLM_article-title">Suppression of transformation by and growth adaptation to low concentrations of glutamine in NIH-3T3 cells</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">1990</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">2832</span>– <span class="NLM_lpage">2839</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=2328506" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=1%3ACAS%3A528%3ADyaK3cXitlChtb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=1990&pages=2832-2839&author=A.+L.+Rubin&title=Suppression+of+transformation+by+and+growth+adaptation+to+low+concentrations+of+glutamine+in+NIH-3T3+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit117R"><div class="casContent"><span class="casTitleNuber">117</span><div class="casTitle"><span class="NLM_cas:atitle">Suppression of transformation by and growth adaptation to low concentrations of glutamine in NIH-3T3 cells</span></div><div class="casAuthors">Rubin, Andrew L.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2832-9</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    </div><div class="casAbstract">NIH-3T3 cells, commonly used as targets for oncogene-mediated neoplastic transformation, undergo high rates of spontaneous transformation.  When the glutamine concn. in the medium was reduced from 5 to ≤1 mM, the transformation rate was reduced.  This effect was not dependent upon a redn. in the growth rate, which remained unaffected by redn. of glutamine even to 0.6 mM.  Upon trypsinization and transfer to 5 mM glutamine-contg. medium, cells exposed to 0.2 mM glutamine for as little as 4 days formed fewer foci than control cells exposed over a similar period to 5 mM glutamine.  Thus, short-term changes in the supply of this polyfunctional metabolite have heritable consequences in later cell generations.  If populations contg. highly transformed cells were passaged weekly for 1-3 wk in 0.2 mM glutamine, resultant populations were better adapted to grow in low-glutamine medium and formed fewer transformed foci upon re-transfer to 5 mM glutamine medium, suggesting that the transformed state is at least partially reversible.  If similar cell populations were exposed to low-glutamine medium but were not passaged, growth adaptation occurred but there was no redn. in focus formation, indicating that maintenance of a moderate rate of cell division may be required in addn. to the lowered glutamine for reversal of transformation.  Transformed and nontransformed cells originating from foci and from nonfocal areas of the same culture dishes multiplied at the same reduced rate in 0.2 mM glutamine.  Apparently, suppression of spontaneous transformation in low-glutamine medium was not the result of selecting pre-existing variants but was itself an adaptive response of the population.  The results obtained with this model system were discussed with respect to the nutritional effects of glutamine on neoplastic transformation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpPSNwdYVjj67Vg90H21EOLACvtfcHk0ljIF8NQZ0eBJw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3cXitlChtb8%253D&md5=78a1298e03ce1fdc6ccbb884fc48f2d4</span></div><a href="/servlet/linkout?suffix=cit117&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRubin%26aufirst%3DA.%2BL.%26atitle%3DSuppression%2520of%2520transformation%2520by%2520and%2520growth%2520adaptation%2520to%2520low%2520concentrations%2520of%2520glutamine%2520in%2520NIH-3T3%2520cells%26jtitle%3DCancer%2520Res.%26date%3D1990%26volume%3D50%26spage%3D2832%26epage%3D2839" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref118"><div class="reference"><strong class="refLabel"><a href="#ref118" class="rightTabRefNumLink">118</a></strong><div class="NLM_citation" id="rightTab-cit118"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yuneva, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zamboni, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oefner, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sachidanandam, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lazebnik, Y.</span></span> <span> </span><span class="NLM_article-title">Deficiency in glutamine but not glucose induces MYC-dependent apoptosis in human cells</span>. <i>J. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>178</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">93</span>– <span class="NLM_lpage">105</span>, <span class="refDoi"> DOI: 10.1083/jcb.200703099</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=10.1083%2Fjcb.200703099" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=178&publication_year=2007&pages=93-105&issue=1&author=M.+Yunevaauthor=N.+Zamboniauthor=P.+Oefnerauthor=R.+Sachidanandamauthor=Y.+Lazebnik&title=Deficiency+in+glutamine+but+not+glucose+induces+MYC-dependent+apoptosis+in+human+cells&doi=10.1083%2Fjcb.200703099"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit118&amp;dbid=16384&amp;doi=10.1083%2Fjcb.200703099&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1083%252Fjcb.200703099%26sid%3Dliteratum%253Aachs%26aulast%3DYuneva%26aufirst%3DM.%26aulast%3DZamboni%26aufirst%3DN.%26aulast%3DOefner%26aufirst%3DP.%26aulast%3DSachidanandam%26aufirst%3DR.%26aulast%3DLazebnik%26aufirst%3DY.%26atitle%3DDeficiency%2520in%2520glutamine%2520but%2520not%2520glucose%2520induces%2520MYC-dependent%2520apoptosis%2520in%2520human%2520cells%26jtitle%3DJ.%2520Cell%2520Biol.%26date%3D2007%26volume%3D178%26issue%3D1%26spage%3D93%26epage%3D105%26doi%3D10.1083%2Fjcb.200703099" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref119"><div class="reference"><strong class="refLabel"><a href="#ref119" class="rightTabRefNumLink">119</a></strong><div class="NLM_citation" id="rightTab-cit119"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kvamme, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Torgner, I. A.</span></span> <span> </span><span class="NLM_article-title">Regulatory effects of fatty acyl-coenzyme a derivatives on phosphate-activated pig brain and kidney glutaminase in vitro</span>. <i>Biochem. J.</i> <span class="NLM_year" style="font-weight: bold;">1975</span>,  <span class="NLM_volume"><i>149</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">83</span>– <span class="NLM_lpage">91</span>, <span class="refDoi"> DOI: 10.1042/bj1490083</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;key=10.1042%2Fbj1490083" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=149&publication_year=1975&pages=83-91&issue=1&author=E.+Kvammeauthor=I.+A.+Torgner&title=Regulatory+effects+of+fatty+acyl-coenzyme+a+derivatives+on+phosphate-activated+pig+brain+and+kidney+glutaminase+in+vitro&doi=10.1042%2Fbj1490083"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit119&amp;dbid=16384&amp;doi=10.1042%2Fbj1490083&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252Fbj1490083%26sid%3Dliteratum%253Aachs%26aulast%3DKvamme%26aufirst%3DE.%26aulast%3DTorgner%26aufirst%3DI.%2BA.%26atitle%3DRegulatory%2520effects%2520of%2520fatty%2520acyl-coenzyme%2520a%2520derivatives%2520on%2520phosphate-activated%2520pig%2520brain%2520and%2520kidney%2520glutaminase%2520in%2520vitro%26jtitle%3DBiochem.%2520J.%26date%3D1975%26volume%3D149%26issue%3D1%26spage%3D83%26epage%3D91%26doi%3D10.1042%2Fbj1490083" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3UO9" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3UO9','PDB','3UO9'); return false;">PDB: 3UO9</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4O7D" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4O7D','PDB','4O7D'); return false;">PDB: 4O7D</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5JYO" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5JYO','PDB','5JYO'); return false;">PDB: 5JYO</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5D3O" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5D3O','PDB','5D3O'); return false;">PDB: 5D3O</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3VOY" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3VOY','PDB','3VOY'); return false;">PDB: 3VOY</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3SS3" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3SS3','PDB','3SS3'); return false;">PDB: 3SS3</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3VP0" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3VP0','PDB','3VP0'); return false;">PDB: 3VP0</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3SS4" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3SS4','PDB','3SS4'); return false;">PDB: 3SS4</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3SS5" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3SS5','PDB','3SS5'); return false;">PDB: 3SS5</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3UNW" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3UNW','PDB','3UNW'); return false;">PDB: 3UNW</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3CZD" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3CZD','PDB','3CZD'); return false;">PDB: 3CZD</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5WJ6" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5WJ6','PDB','5WJ6'); return false;">PDB: 5WJ6</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5UQE" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5UQE','PDB','5UQE'); return false;">PDB: 5UQE</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5JYP" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5JYP','PDB','5JYP'); return false;">PDB: 5JYP</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5I94" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5I94','PDB','5I94'); return false;">PDB: 5I94</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5HL1" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5HL1','PDB','5HL1'); return false;">PDB: 5HL1</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5FI2" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5FI2','PDB','5FI2'); return false;">PDB: 5FI2</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5FI6" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5FI6','PDB','5FI6'); return false;">PDB: 5FI6</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5FI7" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5FI7','PDB','5FI7'); return false;">PDB: 5FI7</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4JKT" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4JKT','PDB','4JKT'); return false;">PDB: 4JKT</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3VOZ" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3VOZ','PDB','3VOZ'); return false;">PDB: 3VOZ</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3VP1" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3VP1','PDB','3VP1'); return false;">PDB: 3VP1</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3VP2" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3VP2','PDB','3VP2'); return false;">PDB: 3VP2</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3VP3" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3VP3','PDB','3VP3'); return false;">PDB: 3VP3</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3VP4" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3VP4','PDB','3VP4'); return false;">PDB: 3VP4</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-NOTES-d7e3009-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i36"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b00961">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_80401"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.8b00961">10.1021/acs.jmedchem.8b00961</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Summary of chemical structures, IC<sub>50</sub>, and reference of representative GLS1 inhibitors (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b00961/suppl_file/jm8b00961_si_001.docx">DOCX</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b00961/suppl_file/jm8b00961_si_001.docx">jm8b00961_si_001.docx (454.37 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.8b00961&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.8b00961%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2019.62.issue-3%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.8b00961" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                9MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"677aa19fdc503c58","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
